https://demo.pharmafocusasia.com/news/fujifilm-biosciences-and-nextcell-launch-new-commercial-platform 2026-05-07 09:29:49 daily 0.1 https://demo.pharmafocusasia.com/news/artera-receives-us-fda-clearance-for-arteraai-breast 2026-05-07 09:23:29 daily 0.1 https://demo.pharmafocusasia.com/news/roche-enters-into-a-definitive-merger-agreement-to-acquire-pathai 2026-05-07 09:22:18 daily 0.1 https://demo.pharmafocusasia.com/news/merck-completes-acquisition-of-terns-pharmaceuticals 2026-05-06 06:30:35 daily 0.1 https://demo.pharmafocusasia.com/news/cs-analytical-announces-major-laboratory-expansion 2026-05-05 06:30:00 daily 0.1 https://demo.pharmafocusasia.com/news/zeta-surgical-receives-fda-510k-clearance 2026-05-05 06:28:46 daily 0.1 https://demo.pharmafocusasia.com/news/tlx101-px-pixlumi-maa-accepted-in-europe 2026-05-02 06:22:32 daily 0.1 https://demo.pharmafocusasia.com/news/truqap-recommended-by-fda-advisory-panel 2026-05-01 06:55:39 daily 0.1 https://demo.pharmafocusasia.com/news/huahui-health-signs-global-agreement-with-beone 2026-05-01 06:48:28 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-secures-grants-to-advance-tuberculosis-treatment 2026-05-01 06:47:52 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-oncology-announces-fda-acceptance 2026-04-29 05:28:37 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-acquires-arcellx-to-strengthen-cancer 2026-04-29 05:27:23 daily 0.1 https://demo.pharmafocusasia.com/news/remepy-partners-with-merck-to-develop-hybrid 2026-04-29 05:25:55 daily 0.1 https://demo.pharmafocusasia.com/news/terns-pharmaceuticals-receives-breakthrough-therapy 2026-04-28 06:55:13 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-to-acquire-ajax-therapeutics-to-advance 2026-04-28 06:53:05 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-secures-us-fda-approval-for-first-ab-rated 2026-04-24 06:12:09 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-to-invest-14-billion-in-new-manufacturing 2026-04-23 06:24:30 daily 0.1 https://demo.pharmafocusasia.com/news/leinco-technologies-and-cellcarta-partner 2026-04-22 06:36:52 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-inc-to-invest-in-felzartamab-rights-in-greater 2026-04-21 05:28:29 daily 0.1 https://demo.pharmafocusasia.com/news/new-combination-therapy-for-advanced-small-cell-lung 2026-04-21 05:25:51 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-receives-usfda-approval-for-glycerol-phenylbutyrate 2026-04-20 07:06:11 daily 0.1 https://demo.pharmafocusasia.com/news/european-commission-approves-mercks-enflonsia 2026-04-20 07:04:43 daily 0.1 https://demo.pharmafocusasia.com/news/piramal-pharma-solutions-and-ajinomoto-bio-pharma 2026-04-17 05:32:28 daily 0.1 https://demo.pharmafocusasia.com/news/pangea-pharmaceuticals-launches-sdamlo-oral-solution 2026-04-16 05:53:47 daily 0.1 https://demo.pharmafocusasia.com/news/vectorbuilder-introduces-high-stability-mutefree 2026-04-15 10:29:30 daily 0.1 https://demo.pharmafocusasia.com/news/sana-biotechnology-and-mayo-clinic-collaborate 2026-04-14 10:04:27 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-and-openai-collaborate-to-improve 2026-04-14 10:04:06 daily 0.1 https://demo.pharmafocusasia.com/news/china-s-13b-pharma-boom-drives-biopharma-growth-amid-us-and-eu-regulatory-hurdles 2026-04-12 23:30:35 daily 0.1 https://demo.pharmafocusasia.com/news/telix-receives-fda-acceptance-for-tlx101-px 2026-04-10 03:12:41 daily 0.1 https://demo.pharmafocusasia.com/news/c4-therapeutics-enters-into-collaboration-with-roche 2026-04-10 03:11:41 daily 0.1 https://demo.pharmafocusasia.com/news/life-sciences-regulatory-updates-2026-key-changes-across-asias-pharma-landscape 2026-04-09 23:30:30 daily 0.1 https://demo.pharmafocusasia.com/news/nxera-pharma-reaches-second-milestone-in-eli-lilly 2026-04-09 00:17:21 daily 0.1 https://demo.pharmafocusasia.com/news/pharma-bets-big-on-chinese-drugmakers-with-over-50-billion-in-licensing-deals-in-early-2026 2026-04-08 23:30:27 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-to-acquire-tubulis-to-strengthen-oncology 2026-04-08 03:18:32 daily 0.1 https://demo.pharmafocusasia.com/news/alloy-therapeutics-partners-with-biogen 2026-04-08 03:17:22 daily 0.1 https://demo.pharmafocusasia.com/news/ac-immune-enters-into-agreement-with-lilly-to-advance 2026-04-08 03:16:18 daily 0.1 https://demo.pharmafocusasia.com/news/intrinseque-health-establishes-first-of-its-kind-gmp-warehouse-in-melaka-malaysia-to-bolster-asias-pharma-supply-chain 2026-04-07 23:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/akari-therapeutics-partners-with-wuxi-xdc-to-advance 2026-04-07 03:19:27 daily 0.1 https://demo.pharmafocusasia.com/news/china-s-nmpa-releases-revised-medical-device-gmp-effective-november-2026-impacting-asia-life-sciences-manufacturing 2026-04-06 23:30:23 daily 0.1 https://demo.pharmafocusasia.com/news/shimadzu-scientific-instruments-opens-new-laboratory-in-san-francisco-bay-area-to-boost-asia-pacific-life-sciences-innovation 2026-04-02 23:30:25 daily 0.1 https://demo.pharmafocusasia.com/news/fore-biotherapeutics-receives-breakthrough 2026-04-02 00:47:37 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-enters-into-collaboration-with-amgen 2026-04-02 00:46:33 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-frontier-biotechnologies-signs-950m-global-licensing-deal-with-gsk-for-sirna-kidney-disease-drugs 2026-04-01 23:30:25 daily 0.1 https://demo.pharmafocusasia.com/news/abbisko-therapeutics-irpagratinib-receives-ema-orphan 2026-04-01 00:51:09 daily 0.1 https://demo.pharmafocusasia.com/news/infinimmune-enters-into-collaboration-with-merck 2026-04-01 00:50:07 daily 0.1 https://demo.pharmafocusasia.com/news/china-biopharmas-56-7b-deal-boom-signals-pillar-industry-dominance-in-2026 2026-03-31 23:30:27 daily 0.1 https://demo.pharmafocusasia.com/news/immuneoncia-therapeutics-enters-into-collaboration 2026-03-31 00:36:16 daily 0.1 https://demo.pharmafocusasia.com/news/sanofis-rezurock-receives-approval-for-chronic 2026-03-31 00:35:02 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-receives-us-approval 2026-03-27 03:23:39 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-to-acquire-excellergy-to-strengthen 2026-03-27 03:22:04 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-reports-fda-ind-clearance-for-neok-bios 2026-03-27 03:20:15 daily 0.1 https://demo.pharmafocusasia.com/news/merck-acquires-terns-pharmaceuticals-to-advance 2026-03-26 01:13:03 daily 0.1 https://demo.pharmafocusasia.com/news/tempus-partners-with-daiichi-sankyo-to-advance 2026-03-26 01:10:53 daily 0.1 https://demo.pharmafocusasia.com/news/corcept-therapeutics-receives-approval-for-relacorilant 2026-03-26 01:05:05 daily 0.1 https://demo.pharmafocusasia.com/news/asia-drives-pharmaceutical-growth-in-2026-with-china-leading-biopharma-innovation-and-production-surge 2026-03-25 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/sk-pharmteco-and-prozomix-partner-to-strengthen-biocatalysis 2026-03-25 03:28:18 daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-establishes-research-hub-in-cambridge 2026-03-25 03:25:47 daily 0.1 https://demo.pharmafocusasia.com/news/niper-raebareli-partners-with-roche-pharma-to-strengthen-pharmaceutical-education-and-research-in-india 2026-03-24 23:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-enters-into-collaboration-with-moonlight-bio-to-advance 2026-03-24 01:11:46 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-to-acquire-ouro-medicines-to-strengthen 2026-03-24 01:09:58 daily 0.1 https://demo.pharmafocusasia.com/news/asia-drives-pharmaceutical-growth-in-2026-with-china-leading-biopharma-innovation-and-production-surge 2026-03-23 23:30:23 daily 0.1 https://demo.pharmafocusasia.com/news/kali-therapeutics-enters-into-agreement-with-sanofi 2026-03-23 06:47:27 daily 0.1 https://demo.pharmafocusasia.com/news/monash-university-enters-into-partnership-with-clinchoice 2026-03-23 05:35:57 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-enters-into-agreement-with-corxel 2026-03-23 05:33:49 daily 0.1 https://demo.pharmafocusasia.com/news/lgm-pharma-expands-cdmo-manufacturing-capacity 2026-03-20 04:22:08 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-earendil-labs-enter-strategic-collaboration-to-accelerate-development-and-manufacturing-of-bispecific-multispecific-antibodies-and-adcs 2026-03-19 23:30:24 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-earendil-labs-enter-strategic-collaboration-to-accelerate-development-and-manufacturing-of-bispecific-multispecific-antibodies-and-adcs 2026-03-18 23:30:25 daily 0.1 https://demo.pharmafocusasia.com/news/voro-therapeutics-enters-into-partnership 2026-03-18 00:05:18 daily 0.1 https://demo.pharmafocusasia.com/news/oxford-nanopore-and-adam-innovations-partner 2026-03-18 00:04:19 daily 0.1 https://demo.pharmafocusasia.com/news/taiwan-bio-partners-with-terumo-bct-to-advance-automated 2026-03-18 00:13:52 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-announces-global-first-in-class-trispecific-antibody-ak150-enters-clinical-trials-a-triple-target-approach-to-overcome-immunotherapy-resistance 2026-03-17 23:30:24 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-and-epis-nexlab-partner 2026-03-17 03:40:59 daily 0.1 https://demo.pharmafocusasia.com/news/roche-launches-nvidia-powered-ai-factory-to-speed 2026-03-17 03:40:01 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-advances-ilumya-with-fda-review 2026-03-17 03:39:04 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-receives-approval-for-tecnis 2026-03-13 00:27:14 daily 0.1 https://demo.pharmafocusasia.com/news/zuellig-pharma-acquires-cialis-tadalafil-rights-from-lilly-in-three-additional-asian-markets 2026-03-12 23:30:30 daily 0.1 https://demo.pharmafocusasia.com/news/therna-enters-into-collaboration-with-charles-river 2026-03-12 00:19:21 daily 0.1 https://demo.pharmafocusasia.com/news/hemab-therapeutics-receives-breakthrough-therapy-designation 2026-03-12 00:18:18 daily 0.1 https://demo.pharmafocusasia.com/news/gaia-and-daiichi-sankyo-partner-to-commercialise-digital 2026-03-12 00:17:16 daily 0.1 https://demo.pharmafocusasia.com/news/tenaya-therapeutics-enters-into-collaboration-with-alnylam 2026-03-12 00:16:25 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-enters-into-partnership-with-gelmedix-to-develop 2026-03-12 00:08:18 daily 0.1 https://demo.pharmafocusasia.com/news/9th-annual-pharma-regulatory-summit-2026-announces-key-agenda-for-asian-pharma-leaders-in-mumbai 2026-03-11 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-enters-into-collaboration-with-eli-lilly 2026-03-11 01:22:55 daily 0.1 https://demo.pharmafocusasia.com/news/csl-seqirus-enters-into-agreement-with-paho 2026-03-11 01:21:46 daily 0.1 https://demo.pharmafocusasia.com/news/china-implements-new-regulations-to-accelerate-biotech-drug-approvals-and-enhance-market-access 2026-03-10 23:30:28 daily 0.1 https://demo.pharmafocusasia.com/news/royalty-pharma-appoints-kenneth-sun-as-senior-vice-president-and-head-of-asia-to-expand-global-platform 2026-03-08 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/chinese-pharma-outlicensing-hits-record-pace-in-early-2026-amid-asias-biopharma-surge 2026-03-05 23:30:30 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-and-inovio-partner-to-advance-combination 2026-03-05 00:26:54 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-inc-secures-nmpa-approval-for-novel-bispecific-antibody-targeting-alzheimers-disease-in-china 2026-03-04 23:30:32 daily 0.1 https://demo.pharmafocusasia.com/news/sinopia-biosciences-enters-into-collaboration 2026-03-04 01:23:37 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-enters-into-agreement-with-ucb-atg-201 2026-03-04 01:14:07 daily 0.1 https://demo.pharmafocusasia.com/news/sciex-localizes-xr-qtof-and-zenotof-systems-in-china-to-advance-life-science-analytical-capabilities 2026-03-03 23:30:29 daily 0.1 https://demo.pharmafocusasia.com/news/sanofis-rilzabrutinib-receives-orphan-drug-status 2026-03-03 03:30:30 daily 0.1 https://demo.pharmafocusasia.com/news/pharmaessentia-announces-japan-approval-of-high-dose 2026-03-03 03:28:45 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-to-invest-over-us505-million-eur400-million 2026-03-03 03:27:51 daily 0.1 https://demo.pharmafocusasia.com/news/largest-pharma-show-in-asia-cphi-pmec-china-2026-returns-to-shanghai 2026-03-02 23:30:27 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-inc-secures-nmpa-approval-for-novel-bispecific-antibody-targeting-alzheimers-disease-in-china 2026-03-01 23:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/synthekine-enters-into-collaboration-with-merck-to-advance 2026-02-27 00:58:43 daily 0.1 https://demo.pharmafocusasia.com/news/neurogene-secures-fda-breakthrough-therapy-designation 2026-02-27 00:57:43 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-receives-fda-approval 2026-02-27 00:56:38 daily 0.1 https://demo.pharmafocusasia.com/news/targeted-partnering-licensing-summit-asia-global-exposure-local-advantage 2026-02-26 23:30:42 daily 0.1 https://demo.pharmafocusasia.com/news/frontier-biotech-enters-into-agreement-with-gsk-for-sirna-therapies 2026-02-26 03:12:46 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-enters-into-collaboration-with-junshi-biosciences 2026-02-26 03:11:38 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-inc-secures-nmpa-approval-for-novel-bispecific-antibody-targeting-alzheimers-in-china 2026-02-25 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/sciwind-biosciences-partners-with-pfizer-china-to-commercialise 2026-02-25 06:08:56 daily 0.1 https://demo.pharmafocusasia.com/news/siren-biotechnology-receives-fda-fast-track-designation 2026-02-25 06:07:35 daily 0.1 https://demo.pharmafocusasia.com/news/china-launches-dual-track-reimbursement-system-for-innovative-drugs-to-boost-global-pharma-access 2026-02-24 23:30:39 daily 0.1 https://demo.pharmafocusasia.com/news/formosa-pharmaceuticals-signs-licensing-deal-with-arrotex 2026-02-24 06:55:00 daily 0.1 https://demo.pharmafocusasia.com/news/tides-asia-2026-premier-summit-on-oligonucleotide-and-peptide-therapeutics-kicks-off-in-tokyo-today 2026-02-23 23:30:29 daily 0.1 https://demo.pharmafocusasia.com/news/china-launches-dual-track-reimbursement-system-for-innovative-drugs-to-boost-global-pharma-access 2026-02-22 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-calquence-plus-venetoclax-approved 2026-02-21 00:22:26 daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-medincell-receives-fda-acceptance-for-once-monthly 2026-02-21 00:21:21 daily 0.1 https://demo.pharmafocusasia.com/news/vivamed-biopharma-enters-into-partnership-with-syngene 2026-02-20 00:41:41 daily 0.1 https://demo.pharmafocusasia.com/news/merck-enters-into-collaboration-with-mayo-clinic-to-advance 2026-02-18 23:57:31 daily 0.1 https://demo.pharmafocusasia.com/news/unnatural-products-enters-into-collaboration-with-novartis 2026-02-18 23:53:03 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-and-sbiomedics-partner-to-advance 2026-02-18 23:52:07 daily 0.1 https://demo.pharmafocusasia.com/news/bostongene-partners-with-daiichi-sankyo-to-advance 2026-02-18 03:36:19 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibbs-iberdomide-nda-accepted-by-fda 2026-02-18 03:35:24 daily 0.1 https://demo.pharmafocusasia.com/news/jax-nyscf-and-gsk-partner-to-advance-translational-models 2026-02-18 03:34:24 daily 0.1 https://demo.pharmafocusasia.com/news/scribe-therapeutics-enters-into-collaboration-with-lilly 2026-02-18 03:33:24 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-inc-secures-nmpa-approval-for-novel-bispecific-antibody-targeting-alzheimers-in-china 2026-02-17 23:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-inc-gains-nmpa-approval-for-novel-bispecific-antibody-targeting-alzheimers-disease-in-china 2026-02-15 23:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/novocure-receives-approval-for-optune-pax-in-locally 2026-02-12 01:09:19 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-ark-biopharmaceutical-receives-fda-clearance-for-phase-2-trial-of-novel-anti-fibrotic-ak3280-in-ipf 2026-02-11 23:30:27 daily 0.1 https://demo.pharmafocusasia.com/news/geminibio-and-tolemy-bio-partners-to-introduce-ai-driven 2026-02-11 00:23:50 daily 0.1 https://demo.pharmafocusasia.com/news/kincell-bio-enters-into-partnership-with-regcell-to-progress 2026-02-11 00:22:45 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-pharma-selects-asc36-oral-amylin-receptor-peptide-agonist-for-clinical-development-targeting-obesity 2026-02-10 23:30:32 daily 0.1 https://demo.pharmafocusasia.com/news/iambic-enters-into-collaboration-with-takeda-for-ai-based 2026-02-10 03:10:30 daily 0.1 https://demo.pharmafocusasia.com/news/evinova-enters-into-collaboration-with-bristol-myers-squibb 2026-02-10 03:09:26 daily 0.1 https://demo.pharmafocusasia.com/news/krystal-biotechs-kb707-receives-rmat-designation 2026-02-10 03:06:18 daily 0.1 https://demo.pharmafocusasia.com/news/china-introduces-dual-track-reimbursement-system-for-innovative-drugs-to-boost-global-pharma-access 2026-02-08 23:30:35 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-receives-breakthrough-therapy-designation 2026-02-06 00:05:07 daily 0.1 https://demo.pharmafocusasia.com/news/asia-photonics-expo-2026-opens-in-singapore-cementing-its-position-as-asias-leading-photonics-platform-for-pharma-and-life-sciences 2026-02-05 23:30:35 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-inc-receives-nmpa-approval-for-novel-bispecific-antibody-ak-targeting-amyloid-beta-and-bbb-receptor-in-china 2026-02-04 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/relay-therapeutics-zovegalisib-receives-breakthrough 2026-02-04 00:12:18 daily 0.1 https://demo.pharmafocusasia.com/news/zonsen-peplib-biotech-enters-into-collaboration-with-lilly 2026-02-04 00:10:45 daily 0.1 https://demo.pharmafocusasia.com/news/japan-leads-asia-with-24-fda-novel-drug-approvals-from-2015-2023-mckinsey-report 2026-02-03 23:30:38 daily 0.1 https://demo.pharmafocusasia.com/news/japan-leads-asia-with-24-fda-novel-drug-approvals-from-2015-2023-mckinsey-report-highlights-regulatory-edge 2026-02-02 23:30:24 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-signs-18.5-billion-weight-loss-drug-deal-with-chinese-firm-cspc 2026-02-01 23:30:42 daily 0.1 https://demo.pharmafocusasia.com/news/recordati-enters-into-collaboration-with-moderna-to-advance 2026-01-30 00:36:31 daily 0.1 https://demo.pharmafocusasia.com/news/asia-drives-pharmaceutical-growth-in-2026-with-china-leading-biopharma-innovation-and-production-surge 2026-01-29 23:30:36 daily 0.1 https://demo.pharmafocusasia.com/news/immix-biopharma-receives-fda-breakthrough-therapy 2026-01-29 01:11:17 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-enters-into-partnership-with-sinorda 2026-01-29 01:10:20 daily 0.1 https://demo.pharmafocusasia.com/news/japan-approves-330-billion-jpy-support-package-to-boost-drug-discovery-and-biopharma-sector 2026-01-28 23:30:32 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-simcere-partner-to-develop 2026-01-28 00:02:39 daily 0.1 https://demo.pharmafocusasia.com/news/insilico-medicine-enters-into-collaboration-with-qilu 2026-01-28 00:00:19 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-enters-into-partnership-with-hanchorbio 2026-01-27 03:13:14 daily 0.1 https://demo.pharmafocusasia.com/news/nuance-pharma-announces-nmpa-acceptance-of-nda-for-ohtuvayre-ensifentrine-for-copd-maintenance-treatment-in-china 2026-01-26 23:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/china-asean-regional-medical-products-trading-platform-concludes-first-2026-transaction-boosting-pharma-exports 2026-01-25 23:30:39 daily 0.1 https://demo.pharmafocusasia.com/news/janux-therapeutics-enters-into-collaboration-with-bristol-myers-squibb 2026-01-23 01:05:22 daily 0.1 https://demo.pharmafocusasia.com/news/wugen-receives-breakthrough-therapy-designation-for-wu-cart 2026-01-22 00:03:31 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-partners-with-gazi-university-on-gene-therapy-manufacturing 2026-01-22 00:01:55 daily 0.1 https://demo.pharmafocusasia.com/news/opna-bio-granted-orphan-drug-designation-for-opn-2853-in-myelofibrosis 2026-01-22 00:00:41 daily 0.1 https://demo.pharmafocusasia.com/news/neok-bio-receives-approval-for-neok001-bispecific-adc-in-solid-tumours 2026-01-21 23:59:19 daily 0.1 https://demo.pharmafocusasia.com/news/syngene-international-extends-research-partnership 2026-01-20 23:57:18 daily 0.1 https://demo.pharmafocusasia.com/news/insilico-medicine-and-hygtia-therapeutics-partner-to-develop 2026-01-20 23:56:12 daily 0.1 https://demo.pharmafocusasia.com/news/aspect-biosystems-and-novo-nordisk-expand-collaboration 2026-01-20 23:55:22 daily 0.1 https://demo.pharmafocusasia.com/news/alteogen-enters-into-agreement-with-tesaro-for-subcutaneous 2026-01-20 23:54:21 daily 0.1 https://demo.pharmafocusasia.com/news/china-s-pharmaceutical-industry-surges-as-new-economic-growth-engine-with-revenue-projected-to-hit-us2-1-trillion-by-2030 2026-01-20 23:30:35 daily 0.1 https://demo.pharmafocusasia.com/news/iregene-therapeutics-receives-fda-rmat-designation 2026-01-19 23:32:13 daily 0.1 https://demo.pharmafocusasia.com/news/chinese-nmpa-accepts-telix-pharmaceuticals-new-drug-application-for-illuccix-prostate-cancer-imaging-agent 2026-01-19 23:30:36 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-lifesciences-completes-acquisition-of-agenus 2026-01-16 01:02:22 daily 0.1 https://demo.pharmafocusasia.com/news/interax-and-alveus-enter-strategic-research-and-licensing 2026-01-16 01:00:27 daily 0.1 https://demo.pharmafocusasia.com/news/kelun-biotech-showcases-innovative-achievements-and-future-development-strategy-at-the-44th-annual-j-p-morgan-healthcare-conference 2026-01-15 23:30:53 daily 0.1 https://demo.pharmafocusasia.com/news/international-healthcare-week-returns-to-thailand-in-2026-with-expanded-industry-reach 2026-01-14 23:30:33 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-presents-innovative-drug-pipeline-and-u-s-manufacturing-and-r-d-expansion-strategy-at-44th-j-p-morgan-healthcare-conference 2026-01-13 23:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/lynk-pharmaceuticals-reports-positive-phase-iii-topline-data-for-jak1-inhibitor-zemprocitinib-in-rheumatoid-arthritis-advancing-greater-china-immunology-strategy 2026-01-11 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/alessa-therapeutics-receives-fda-fast-track-status 2026-01-09 04:15:11 daily 0.1 https://demo.pharmafocusasia.com/news/china-sxt-pharmaceuticals-launches-ai-insights-initiative-to-modernize-traditional-chinese-medicine-portfolio-and-market-strategy 2026-01-08 23:30:40 daily 0.1 https://demo.pharmafocusasia.com/news/helix-signs-multi-year-strategic-collaboration-with-gsk 2026-01-08 07:20:51 daily 0.1 https://demo.pharmafocusasia.com/news/lonzas-synaffix-and-sidewinder-therapeutics-sign-multi-target 2026-01-08 07:19:35 daily 0.1 https://demo.pharmafocusasia.com/news/beone-medicines-reports-positive-phase-3-herizon-gea-01-results-for-ziihera-plus-tevimbra-in-her2-positive-advanced-gastric-and-gastroesophageal-adenocarcinoma-targeting-asian-regulatory-fili 2026-01-07 18:00:14 daily 0.1 https://demo.pharmafocusasia.com/news/betterlife-pharma-participates-in-yafo-capital-access-asia-partnering-forum-during-jpm-week-to-foster-north-american-asian-collaborations 2026-01-06 23:30:15 daily 0.1 https://demo.pharmafocusasia.com/news/protara-therapeutics-gains-fda-breakthrough-therapy 2026-01-06 03:10:44 daily 0.1 https://demo.pharmafocusasia.com/news/kelun-biotech-secures-breakthrough-therapy-status-in-china 2026-01-06 03:08:52 daily 0.1 https://demo.pharmafocusasia.com/news/kazakhstan-launches-full-cycle-biopharmaceutical-complex-in-alatau-sez-with-203m-investment 2026-01-01 23:30:15 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-announces-expanded-coverage-on-chinas-national-reimbursement-drug-list-and-inclusion-in-first-commercial-insurance-drug-list 2025-12-31 23:30:11 daily 0.1 https://demo.pharmafocusasia.com/news/insilico-medicine-successfully-lists-on-hong-kong-stock-exchange-in-landmark-biotech-ipo 2025-12-30 23:30:14 daily 0.1 https://demo.pharmafocusasia.com/news/south-koreas-pharma-industry-faces-regulatory-showdown-over-sweeping-drug-price-cuts-and-reimbursement-reforms 2025-12-28 23:30:13 daily 0.1 https://demo.pharmafocusasia.com/news/abl-bio-secures-55-million-from-eli-lilly-for-grabody-platform-license-and-equity-investment 2025-12-25 23:30:07 daily 0.1 https://demo.pharmafocusasia.com/news/caliway-biopharmaceuticals-completes-u-s-fda-ind-submission-for-phase-2-study-of-cbl-514-in-weight-management-targeting-combination-with-glp-1ra-therapies 2025-12-24 23:30:22 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-receives-china-approval-for-cobenfy 2025-12-24 03:27:44 daily 0.1 https://demo.pharmafocusasia.com/news/rectify-and-boehringer-ingelheim-partner-to-develop 2025-12-23 00:30:44 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-daiichi-sankyos-enhertu-receives 2025-12-23 00:29:37 daily 0.1 https://demo.pharmafocusasia.com/news/merck-receives-approval-for-pimicotinib-in-rare 2025-12-23 00:28:22 daily 0.1 https://demo.pharmafocusasia.com/news/meiji-seika-pharma-establishes-meiji-pharma-asia-pte-ltd-in-singapore-to-bolster-asean-pharma-presence 2025-12-22 23:30:17 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-receives-approval-for-jascayd 2025-12-22 00:26:21 daily 0.1 https://demo.pharmafocusasia.com/news/galux-signs-research-agreement-with-boehringer 2025-12-19 01:02:40 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-receives-positive-chmp-opinion 2025-12-19 01:00:50 daily 0.1 https://demo.pharmafocusasia.com/news/cryoport-systems-named-finalist-in-four-categories-at-asia-pacific-biopharma-excellence-awards-2026 2025-12-18 23:30:20 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-partner-lib-therapeutics-secures 2025-12-18 00:02:35 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncology-receives-nmpa-cde-acceptance-for-ind-application-of-innovative-pd-l1-vegfr2-bispecific-adc-jskn027-for-advanced-solid-tumors 2025-12-17 23:30:17 daily 0.1 https://demo.pharmafocusasia.com/news/incog-biopharma-announces-us200-million-expansion-at-indiana 2025-12-17 00:05:47 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-receives-approval-for-exdensur-depemokimab 2025-12-17 00:03:51 daily 0.1 https://demo.pharmafocusasia.com/news/roslinct-and-ayrmid-partner-to-manufacture-omisirge 2025-12-17 00:01:28 daily 0.1 https://demo.pharmafocusasia.com/news/sandboxaq-enters-into-collaboration-with-maplight 2025-12-16 23:59:47 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-wins-malaysian-snda-approval-expanding-xpovio-selinexor-indications-to-relapsed-or-refractory-dlbcl 2025-12-16 23:30:21 daily 0.1 https://demo.pharmafocusasia.com/news/dren-bio-enters-into-collaboration-with-sanofi 2025-12-16 00:36:35 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-daiichi-sankyo-receives-approval 2025-12-16 00:35:15 daily 0.1 https://demo.pharmafocusasia.com/news/allink-biotherapeutics-raises-47-million-series-a-extension-to-advance-global-adc-clinical-programs-from-shanghai-base 2025-12-15 23:30:24 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-launches-2030-strategy-to-accelerate-asia-focused-biopharma-growth-and-global-rd-globalization 2025-12-14 23:30:28 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharma-signs-international-licence-agreements-with-pfizer-and-sitala-to-expand-global-biopharma-footprint 2025-12-11 23:30:18 daily 0.1 https://demo.pharmafocusasia.com/news/ajax-therapeutics-receives-orphan-drug-designation-for-myelofibrosis-candidate 2025-12-11 05:12:58 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheims-jascayd-receives-approval-for-progressive-pulmonary 2025-12-11 05:11:44 daily 0.1 https://demo.pharmafocusasia.com/news/beren-therapeutics-receives-breakthrough-therapy-designation-for-investigational 2025-12-11 05:10:27 daily 0.1 https://demo.pharmafocusasia.com/news/telix-and-varian-collaboration-to-combine-theranostics-with-ebrt 2025-12-11 05:09:13 daily 0.1 https://demo.pharmafocusasia.com/news/cloudbreak-pharma-strengthens-asia-focused-ophthalmology-pipeline-and-global-commercialisation-prospects-with-new-patents-and-clinical-milestones 2025-12-10 23:30:19 daily 0.1 https://demo.pharmafocusasia.com/news/xcell-biosciences-and-culture-biosciences-partner 2025-12-09 23:56:09 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-to-build-6-billion-api-manufacturing-facility-in-alabama 2025-12-09 23:54:47 daily 0.1 https://demo.pharmafocusasia.com/news/formycon-and-zydus-agreement-for-fyb206 2025-12-09 23:53:35 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-received-approval-for-epinephrine-injection 2025-12-09 23:51:55 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharmas-yao-pharma-signs-us21-billion-global-licensing-deal-with-pfizer-for-oral-glp-1-obesity-drug-candidate-yp05002 2025-12-09 23:30:11 daily 0.1 https://demo.pharmafocusasia.com/news/3rd-edition-remarkable-women-camaraderie-2026-awards 2025-12-09 04:09:31 daily 0.1 https://demo.pharmafocusasia.com/news/9th-annual-pharma-project-portfolio-management-2026 2025-12-09 04:09:04 daily 0.1 https://demo.pharmafocusasia.com/news/5th-edition-drug-safety-symposium-2026 2025-12-09 04:08:26 daily 0.1 https://demo.pharmafocusasia.com/news/immutep-enters-into-collaboration-with-dr-reddys 2025-12-08 23:50:42 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-reports-updated-phase-iii-harmoni-6-data-for-ivonescimab-at-esmo-asia-highlighting-clinical-and-regulatory-momentum-in-china-and-global-markets 2025-12-08 23:30:14 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-secures-expanded-nrdl-coverage-and-commercial-insurance-listing-to-accelerate-oncology-drug-access-in-china 2025-12-07 23:30:11 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-completes-partnership-with-takeda 2025-12-05 00:44:21 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-receives-approval-for-breyanzi 2025-12-05 00:42:39 daily 0.1 https://demo.pharmafocusasia.com/news/oric-pharmaceuticals-highlights-asia-focused-clinical-data-for-enozertinib-at-esmo-asia-congress-2025 2025-12-04 23:30:10 daily 0.1 https://demo.pharmafocusasia.com/news/benuvia-enters-into-partnership-with-cannovation 2025-12-04 00:10:33 daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-pharmaceuticals-receives-breakthrough 2025-12-03 01:03:25 daily 0.1 https://demo.pharmafocusasia.com/news/iqvia-enters-into-collaboration-with-aws 2025-12-03 01:00:33 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-receives-breakthrough-therapy-designation 2025-12-03 00:59:17 daily 0.1 https://demo.pharmafocusasia.com/news/solid-biosciences-receives-rare-pediatric-disease 2025-12-02 00:33:42 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-tessera-therapeutics-partner-to-develop 2025-12-02 00:33:35 daily 0.1 https://demo.pharmafocusasia.com/news/sound-pharmaceuticals-receives-breakthrough-therapy 2025-12-02 00:33:21 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-receives-breakthrough-therapy-designation 2025-12-02 00:33:18 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-receives-approval-for-voyxact-for-reducing 2025-11-26 23:46:01 daily 0.1 https://demo.pharmafocusasia.com/news/beone-medicines-receives-us-fda-priority-review 2025-11-26 23:42:24 daily 0.1 https://demo.pharmafocusasia.com/news/sandoz-launches-afqlir-aflibercept-in-europe-offering 2025-11-26 03:50:56 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-and-rk-pharma-sign-exclusive-licensing 2025-11-26 03:46:34 daily 0.1 https://demo.pharmafocusasia.com/news/prestige-biopharma-and-biosidus-forge-exclusive-license-agreement-for-tuznue-biosimilar-commercialization-across-latin-america 2025-11-25 23:30:18 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-opens-new-manufacturing-facility-in-yokohama-japan-marking-strategic-expansion-in-asian-radiopharmaceuticals 2025-11-24 23:30:16 daily 0.1 https://demo.pharmafocusasia.com/news/china-finalizes-landmark-dual-track-drug-reimbursement-reform-ushering-new-era-for-innovative-pharma-access 2025-11-23 23:30:17 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-presents-new-data-on-lecanemab-for-alzheimers-disease-at-18th-ctad-conference-expanding-asia-focused-clinical-insights 2025-11-18 23:30:15 daily 0.1 https://demo.pharmafocusasia.com/news/merus-enters-into-agreement-with-halozyme-to-develop 2025-11-18 04:10:56 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-to-transform-cancer-care-with-acquisition 2025-11-18 04:09:40 daily 0.1 https://demo.pharmafocusasia.com/news/tcg-labs-soleil-raises-additional-funding-to-accelerate-biotech-innovation-and-rd-hub-integration-in-asia 2025-11-17 23:30:06 daily 0.1 https://demo.pharmafocusasia.com/news/south-korean-biotech-platforms-drive-surge-in-multibillion-dollar-global-licensing-deals 2025-11-16 23:30:24 daily 0.1 https://demo.pharmafocusasia.com/news/kura-oncology-and-kyowa-kirin-receive-approval-for-komzifti 2025-11-14 00:25:10 daily 0.1 https://demo.pharmafocusasia.com/news/numab-therapeutics-enters-into-agreement-with-kaken 2025-11-14 00:24:04 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-groundbreaking-dual-track-drug-reimbursement-reform-ushers-in-new-era-for-pharma-market-access 2025-11-13 23:30:14 daily 0.1 https://demo.pharmafocusasia.com/news/chiesi-group-enters-into-agreement-with-aliada-therapeutics 2025-11-13 00:37:36 daily 0.1 https://demo.pharmafocusasia.com/news/parabilis-medicines-receives-fda-fast-track-designation 2025-11-13 00:35:22 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-announces-co-formulation-of-asc36-once-monthly-next-generation-amylin-receptor-agonist-and-asc35-once-monthly-next-generation-glp-1rgipr-dual-agonist-for-clinical-development 2025-11-12 23:30:16 daily 0.1 https://demo.pharmafocusasia.com/news/march-biosciences-receives-fda-rmat-designation 2025-11-12 01:11:27 daily 0.1 https://demo.pharmafocusasia.com/news/meiragtx-enters-into-collaboration-with-eli-lilly-to-advance 2025-11-11 00:16:56 daily 0.1 https://demo.pharmafocusasia.com/news/an2-therapeutics-enters-into-collaboration-with-gsk 2025-11-11 00:15:16 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-expands-radioligand-therapy-manufacturing 2025-11-11 00:12:57 daily 0.1 https://demo.pharmafocusasia.com/news/shilpa-pharma-lifesciences-awarded-ecovadis-gold-medal-for-outstanding-sustainability-practices 2025-11-10 23:30:18 daily 0.1 https://demo.pharmafocusasia.com/news/kelun-biotech-showcases-breakthrough-trop2-adc-sacituzumab-tirumotecan-clinical-results-at-2025-cchio-congress-in-kunming 2025-11-09 23:30:26 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnsons-darzalex-faspro-receives 2025-11-07 00:44:30 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-pharmaceuticals-unveils-cs2015-ox40l-tslp-bispecific-antibody-at-acaai-2025-advancing-asias-leadership-in-autoimmune-innovation 2025-11-06 23:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/nona-biosciences-enters-into-collaboration 2025-11-06 00:41:59 daily 0.1 https://demo.pharmafocusasia.com/news/jupiter-neurosciences-receives-fda-clearance 2025-11-06 00:40:49 daily 0.1 https://demo.pharmafocusasia.com/news/clariant-completes-strategic-expansion-of-pharmaceutical-excipients-and-specialty-chemicals-manufacturing-in-china 2025-11-05 23:30:40 daily 0.1 https://demo.pharmafocusasia.com/news/4dmt-and-otsuka-pharmaceutical-forge-421-million-strategic-partnership-to-develop-and-commercialize-gene-therapy-4d-150-for-retinal-diseases-in-asia-pacific 2025-11-05 05:30:48 daily 0.1 https://demo.pharmafocusasia.com/news/sanyou-bio-enters-into-collaboration-with-shanghai-zj 2025-11-04 04:25:46 daily 0.1 https://demo.pharmafocusasia.com/news/sumitomo-pharma-america-to-present-new-investigational-data-at-the-2025-american-society-of-hematology-annual-meeting 2025-11-03 23:31:04 daily 0.1 https://demo.pharmafocusasia.com/news/akesos-ivonescimab-achieves-fourth-breakthrough-therapy-designation-in-china-for-first-line-triple-negative-breast-cancer-marking-major-milestone-in-asian-biopharma-innovation 2025-11-02 23:30:38 daily 0.1 https://demo.pharmafocusasia.com/news/intocell-and-xcellon-biologics-sign-mou-to-broaden 2025-11-01 00:14:35 daily 0.1 https://demo.pharmafocusasia.com/news/boryeong-signs-global-cdmo-deal-with-joulik-pharma-to-supply-original-cytotoxic-anticancer-drug-alimita-to-7-southeast-asian-countries 2025-10-29 23:30:57 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharma-reports-surge-in-innovative-drug-revenue-and-rd-investment-in-2025q3-financial-results 2025-10-28 23:30:51 daily 0.1 https://demo.pharmafocusasia.com/news/microbiotix-receives-ind-approval-for-novel-bacteriophage 2025-10-28 00:26:34 daily 0.1 https://demo.pharmafocusasia.com/news/kazia-therapeutics-to-seek-fda-type-c-meeting 2025-10-28 00:24:50 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncology-receives-approval-to-initiate-phase-iii-clinical-trial-of-jskn003-for-her2-positive-advanced-colorectal-cancer-in-china 2025-10-26 23:30:37 daily 0.1 https://demo.pharmafocusasia.com/news/hanchorbio-presents-phase-1-hcb101-clinical-results-at-faco-2025-demonstrating-safety-and-early-antitumor-activity 2025-10-23 23:30:10 daily 0.1 https://demo.pharmafocusasia.com/news/biokin-secures-record-250-million-milestone-payment-in-partnership-with-bms-marking-a-turning-point-for-chinas-innovative-pharma-sector 2025-10-22 23:30:10 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-innovent-biologics-and-takeda-pharmaceutical-announce-114-billion-oncology-partnership-targeting-global-expansion-of-next-gen-cancer-therapies 2025-10-22 04:40:41 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-and-takeda-forge-114-billion-strategic-oncology-alliance-to-accelerate-global-cancer-drug-development 2025-10-22 04:32:26 daily 0.1 https://demo.pharmafocusasia.com/news/biocon-biologics-and-civica-strengthen-collaboration 2025-10-17 01:56:22 daily 0.1 https://demo.pharmafocusasia.com/news/evoq-therapeutics-enters-into-collaboration-with-sanofi 2025-10-17 01:55:53 daily 0.1 https://demo.pharmafocusasia.com/news/atai-life-sciences-and-beckley-psytech-receive-breakthrough 2025-10-17 01:55:28 daily 0.1 https://demo.pharmafocusasia.com/news/minovia-therapeutics-receives-fda-orphan-drug-designation 2025-10-16 00:40:22 daily 0.1 https://demo.pharmafocusasia.com/news/viatris-completes-acquisition-of-aculys-pharma-for-rights 2025-10-16 00:38:27 daily 0.1 https://demo.pharmafocusasia.com/news/avantor-and-bluewhale-bio-partner-to-advance-car-t 2025-10-16 00:37:00 daily 0.1 https://demo.pharmafocusasia.com/news/insitro-and-bristol-myers-squibb-partner-to-advance-ai-driven 2025-10-15 03:20:09 daily 0.1 https://demo.pharmafocusasia.com/news/mabwells-cdh17-targeting-adc-7mw4911-receives-ind-clearance 2025-10-15 03:18:47 daily 0.1 https://demo.pharmafocusasia.com/news/nabla-bio-enters-into-collaboration-with-takeda-to-advance 2025-10-15 03:16:51 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-secures-nmpa-approval-for-evm14 2025-10-13 23:59:50 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-receives-approval-for-eydenzelt-aflibercept-boav 2025-10-10 00:13:51 daily 0.1 https://demo.pharmafocusasia.com/news/cidara-therapeutics-receives-breakthrough-therapy-designation 2025-10-10 00:12:38 daily 0.1 https://demo.pharmafocusasia.com/news/werewolf-therapeutics-receives-fda-fast-track-designation 2025-10-09 03:43:24 daily 0.1 https://demo.pharmafocusasia.com/news/kazia-therapeutics-secures-collaboration-and-in-licensing 2025-10-09 03:42:43 daily 0.1 https://demo.pharmafocusasia.com/news/jcr-pharmaceuticals-advances-gene-therapy-delivery-to-cns 2025-10-08 06:19:49 daily 0.1 https://demo.pharmafocusasia.com/news/molcure-partners-with-boehringer-ingelheim-to-develop 2025-10-07 00:32:49 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-and-celltrion-expand-collaboration-to-enhance-biosimilar 2025-10-06 07:16:20 daily 0.1 https://demo.pharmafocusasia.com/news/algen-biotechnologies-enters-into-partnership-with-astrazeneca 2025-10-06 07:14:00 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibbs-alzheimers-candidate-bms-986446 2025-10-03 01:35:06 daily 0.1 https://demo.pharmafocusasia.com/news/taysha-gene-therapies-receives-breakthrough-therapy-designation 2025-10-03 01:34:03 daily 0.1 https://demo.pharmafocusasia.com/news/labcorp-partners-with-roche-to-strengthen-digital-pathology-capabilities 2025-10-01 00:55:22 daily 0.1 https://demo.pharmafocusasia.com/news/benchsci-enters-into-partnership-with-thermo-fisher-scientific 2025-10-01 00:52:23 daily 0.1 https://demo.pharmafocusasia.com/news/dyne-therapeutics-receives-orphan-drug-designation-in-japan 2025-09-30 00:41:23 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-begins-construction-of-new-active-pharmaceutical-ingredient 2025-09-30 00:40:10 daily 0.1 https://demo.pharmafocusasia.com/news/biostar-pharma-receives-fda-orphan-drug-designation 2025-09-26 00:22:23 daily 0.1 https://demo.pharmafocusasia.com/news/integrated-dna-technologies-introduces-new-enhancer-protein 2025-09-26 00:21:05 daily 0.1 https://demo.pharmafocusasia.com/news/er-kim-enters-into-agreement-with-sentynl-therapeutics 2025-09-25 00:33:54 daily 0.1 https://demo.pharmafocusasia.com/news/cellectar-and-evestia-clinical-partner-to-advance-trial 2025-09-25 00:31:50 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-siemens-partner-to-drive-ai-and-data-led-drug-development 2025-09-24 00:36:11 daily 0.1 https://demo.pharmafocusasia.com/news/gccl-enters-into-agreement-with-frontage-laboratories 2025-09-24 00:35:00 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-to-build-65-billion-manufacturing-site-for-active 2025-09-24 00:33:51 daily 0.1 https://demo.pharmafocusasia.com/news/starpharma-enters-into-collaboration-and-agreement-with-genentech 2025-09-23 00:09:18 daily 0.1 https://demo.pharmafocusasia.com/news/sanofis-sar446268-gene-therapy-receives-us-fast-track 2025-09-23 00:08:12 daily 0.1 https://demo.pharmafocusasia.com/news/sophia-genetics-expands-collaboration-with-astrazeneca 2025-09-23 00:07:09 daily 0.1 https://demo.pharmafocusasia.com/news/minovia-therapeutics-gains-fda-fast-track-designation-for-mnv-201 2025-09-19 00:29:25 daily 0.1 https://demo.pharmafocusasia.com/news/fujifilm-biotechnologies-expands-partnership-with-argenx 2025-09-19 00:28:20 daily 0.1 https://demo.pharmafocusasia.com/news/deciphera-receives-approval-for-romvimza-vimseltinib 2025-09-18 00:59:16 daily 0.1 https://demo.pharmafocusasia.com/news/wheeler-bio-and-mindimmune-therapeutics-partners-to-advance 2025-09-18 00:58:05 daily 0.1 https://demo.pharmafocusasia.com/news/roche-to-acquire-89bio-for-the-treatment-of-moderate-to-severe-mash 2025-09-18 00:56:55 daily 0.1 https://demo.pharmafocusasia.com/news/varmx-partners-with-csl-to-advance-novel-coagulation-treatment 2025-09-17 00:32:20 daily 0.1 https://demo.pharmafocusasia.com/news/adagene-enters-into-collaboration-with-exelixis-to-develop-third 2025-09-17 00:29:16 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-merck-receives-fda-breakthrough-therapy 2025-09-16 01:15:23 daily 0.1 https://demo.pharmafocusasia.com/news/akesos-ligufalimab-receives-fda-orphan-drug-designation 2025-09-16 01:14:10 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-strengthens-oncology-manufacturing-portfolio 2025-09-12 01:32:07 daily 0.1 https://demo.pharmafocusasia.com/news/sanofis-sar402663-receives-us-fast-track-designation 2025-09-11 00:42:31 daily 0.1 https://demo.pharmafocusasia.com/news/scipher-medicine-enters-into-partnership-with-maxymune-therapeutics 2025-09-11 00:40:06 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-receives-fda-approval-for-inlexzo-in-bladder-cancer 2025-09-10 01:16:58 daily 0.1 https://demo.pharmafocusasia.com/news/tevas-emrusolmin-receives-us-fda-fast-track-designation 2025-09-10 01:15:40 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-to-acquire-tourmaline-bio-for-atherosclerotic-cardiovascular 2025-09-09 01:03:14 daily 0.1 https://demo.pharmafocusasia.com/news/cellworks-presents-breakthrough-in-predicting-chemo-immunotherapy 2025-09-09 00:57:09 daily 0.1 https://demo.pharmafocusasia.com/news/china-national-medical-products-administration-updates-drug-approval-guidelines-to-enhance-efficiency 2025-09-08 11:31:40 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-samsung-biologics-forge-strategic-partnership-in-biopharmaceutical-manufacturing 2025-09-08 11:31:40 daily 0.1 https://demo.pharmafocusasia.com/news/lillys-olomorasib-receives-breakthrough-therapy-designation 2025-09-05 00:10:25 daily 0.1 https://demo.pharmafocusasia.com/news/argo-biopharma-enters-into-agreement-with-novartis 2025-09-05 00:09:07 daily 0.1 https://demo.pharmafocusasia.com/news/illumina-introduces-protein-prep-to-advance-proteomic-insights 2025-09-04 00:18:34 daily 0.1 https://demo.pharmafocusasia.com/news/indias-pharmaceutical-industry-set-to-attract-1-billion-in-foreign-investment 2025-09-03 19:06:12 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-national-medical-products-administration-approves-new-guidelines-for-biologics 2025-09-03 19:06:12 daily 0.1 https://demo.pharmafocusasia.com/news/henlius-and-organon-receive-fda-approval-for-denosumab-biosimilars 2025-09-03 01:55:22 daily 0.1 https://demo.pharmafocusasia.com/news/medipal-holdings-enters-into-agreement-with-jcr-pharmaceuticals 2025-09-03 01:54:14 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-completes-acquisition-of-sanofis-ridgefield 2025-09-03 01:53:11 daily 0.1 https://demo.pharmafocusasia.com/news/omass-therapeutics-enters-into-collaboration-with-genentech 2025-09-03 01:52:07 daily 0.1 https://demo.pharmafocusasia.com/news/new-regulatory-guidelines-boost-investment-in-asian-biotechnology-sector 2025-09-02 19:06:06 daily 0.1 https://demo.pharmafocusasia.com/news/innovative-biopharmaceutical-collaboration-announced-between-leading-asian-firms 2025-09-02 19:06:06 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-receives-approval-for-tivdak-in-hong-kong-for-cervical 2025-09-02 00:17:46 daily 0.1 https://demo.pharmafocusasia.com/news/japanese-pharmaceutical-firm-enters-strategic-partnership-to-develop-biosimilars 2025-09-02 00:30:14 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-national-medical-products-administration-finalizes-new-guidelines-for-clinical-trials 2025-09-02 00:29:38 daily 0.1 https://demo.pharmafocusasia.com/news/new-regulatory-guidelines-for-biosimilars-issued-in-china-to-enhance-market-access 2025-09-02 00:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/biotech-firm-in-singapore-launches-new-genomic-analysis-service 2025-09-02 00:31:38 daily 0.1 https://demo.pharmafocusasia.com/news/india-announces-new-guidelines-for-biosimilars-development-to-accelerate-market-entry 2025-08-30 19:06:07 daily 0.1 https://demo.pharmafocusasia.com/news/china-national-medical-products-administration-approves-new-oncology-drug-focusing-on-targeted-therapy 2025-09-02 00:32:01 daily 0.1 https://demo.pharmafocusasia.com/news/indias-department-of-biotechnology-announces-new-funding-for-biopharmaceutical-research 2025-08-29 23:35:34 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-national-medical-products-administration-approves-innovative-alzheimers-treatment 2025-08-29 23:35:34 daily 0.1 https://demo.pharmafocusasia.com/news/d3-bio-receives-fda-breakthrough-and-orphan-drug-designations 2025-08-29 00:34:11 daily 0.1 https://demo.pharmafocusasia.com/news/iqvia-and-flagship-pioneering-form-collaboration-to-support-growth 2025-08-29 00:32:25 daily 0.1 https://demo.pharmafocusasia.com/news/heidelberg-pharmas-partner-telix-receives-fda-complete-response 2025-08-28 00:33:57 daily 0.1 https://demo.pharmafocusasia.com/news/sandoz-launches-rivaroxaban-in-germany-broadening-affordable 2025-08-28 00:31:47 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontechs-comirnaty-covid-19-vaccine-receives 2025-08-28 00:30:21 daily 0.1 https://demo.pharmafocusasia.com/news/travere-therapeutics-receives-approval-for-updated-rems-labelling 2025-08-28 00:29:14 daily 0.1 https://demo.pharmafocusasia.com/news/genentech-and-roche-begin-construction-of-new-manufacturing 2025-08-26 00:31:38 daily 0.1 https://demo.pharmafocusasia.com/news/mannkind-to-acquire-scpharmaceuticals-to-strengthen-position 2025-08-26 00:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/bioarctic-signs-usd-30-million-collaboration-agreement-with-novartis 2025-08-26 00:29:37 daily 0.1 https://demo.pharmafocusasia.com/news/protagonist-therapeutics-secures-breakthrough-therapy-designation 2025-08-26 00:28:32 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-expands-peptide-manufacturing-capabilities-in-waltham 2025-08-25 03:29:04 daily 0.1 https://demo.pharmafocusasia.com/news/crinetics-receives-fda-orphan-drug-designation-for-atumelnant 2025-08-22 01:01:33 daily 0.1 https://demo.pharmafocusasia.com/news/kite-to-acquire-interius-biotherapeutics-to-advance-in-vivo-platform 2025-08-22 01:00:20 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-pharmaceuticals-receives-approval-for-dawnzera 2025-08-22 00:59:16 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-commits-2-billion-for-manufacturing-expansion 2025-08-22 00:58:08 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-enters-into-agreement-with-saniona-for-san2355 2025-08-21 00:23:50 daily 0.1 https://demo.pharmafocusasia.com/news/keros-receives-us-fda-orphan-drug-designation-for-ker-065 2025-08-21 00:22:42 daily 0.1 https://demo.pharmafocusasia.com/news/vasthera-receives-fda-clearance-on-pulmonary-arterial-hypertension 2025-08-20 00:36:20 daily 0.1 https://demo.pharmafocusasia.com/news/madrigal-secures-eu-approval-for-first-mash-treatment 2025-08-20 00:35:23 daily 0.1 https://demo.pharmafocusasia.com/news/skyhawk-therapeutics-enters-into-collaboration-with-merck-to-develop 2025-08-19 00:45:42 daily 0.1 https://demo.pharmafocusasia.com/news/remegen-and-santen-sign-exclusive-licensing-deal-for-ophthalmic 2025-08-19 00:44:33 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-palatin-technologies-partner-on-retinal 2025-08-19 00:43:13 daily 0.1 https://demo.pharmafocusasia.com/news/superluminal-medicines-partners-with-eli-lilly-to-develop-small-molecule 2025-08-16 00:04:41 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-receives-approval-for-tonmya-to-treat-fibromyalgia 2025-08-16 00:03:27 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisks-wegovy-approved-in-the-us-for-treatment-of-mash 2025-08-16 00:02:19 daily 0.1 https://demo.pharmafocusasia.com/news/precigen-receives-approval-for-papzimeos-first-therapy-for-adults-with-recurrent-respiratory-papillomatosis 2025-08-16 00:01:15 daily 0.1 https://demo.pharmafocusasia.com/news/apertura-gene-therapy-licences-blood-brain-barrier-penetrant-aav 2025-08-14 01:05:56 daily 0.1 https://demo.pharmafocusasia.com/news/biocardia-enters-into-partnership-with-cart-tech-for-heart3d 2025-08-14 01:04:12 daily 0.1 https://demo.pharmafocusasia.com/news/avista-therapeutics-partners-with-forge-biologics-for-aav-development 2025-08-14 01:02:18 daily 0.1 https://demo.pharmafocusasia.com/news/airway-therapeutics-receives-approval-for-zelpultide-alfa-study 2025-08-13 01:01:39 daily 0.1 https://demo.pharmafocusasia.com/news/puretech-launches-celea-therapeutics-to-advance-new-treatments 2025-08-13 01:00:40 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-enters-into-collaboration-with-kumquat-biosciences 2025-08-13 00:59:38 daily 0.1 https://demo.pharmafocusasia.com/news/kexing-biopharm-enters-into-partnership-with-iqvia-to-boost-global 2025-08-12 00:57:05 daily 0.1 https://demo.pharmafocusasia.com/news/viatris-receives-fda-approval-for-first-generic-iron-sucrose 2025-08-12 00:55:52 daily 0.1 https://demo.pharmafocusasia.com/news/ono-enters-into-agreement-with-seikagaku-for-joint-development 2025-08-08 00:24:39 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-receives-approval-for-modeyso 2025-08-07 00:44:58 daily 0.1 https://demo.pharmafocusasia.com/news/astria-therapeutics-enters-into-agreement-with-kaken-pharmaceutical 2025-08-07 00:43:42 daily 0.1 https://demo.pharmafocusasia.com/news/metavia-and-syntekabio-partner-to-explore-new-indications 2025-08-06 00:32:05 daily 0.1 https://demo.pharmafocusasia.com/news/axplora-invests-65-million-to-expand-vizag-site-and-achieves 2025-08-06 00:21:26 daily 0.1 https://demo.pharmafocusasia.com/news/porosome-therapeutics-unveils-breakthrough-discoveries-in-alzheimers 2025-08-06 00:20:04 daily 0.1 https://demo.pharmafocusasia.com/news/serb-pharmaceuticals-to-acquire-y-mabs-therapeutics-in-412-million 2025-08-06 00:18:11 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-xdcs-dp3-facility-at-wuxi-site-gains-gmp-approval 2025-08-05 00:48:21 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-receives-approval-for-ind-application-of-oral-glp-1r 2025-08-05 00:47:14 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibbs-breyanzi-accepted-for-priority-review 2025-08-05 00:46:06 daily 0.1 https://demo.pharmafocusasia.com/news/dyne-therapeutics-receives-breakthrough-therapy 2025-08-04 06:56:39 daily 0.1 https://demo.pharmafocusasia.com/news/repligen-enters-into-partnership-with-novasign-to-strengthen 2025-08-01 00:41:15 daily 0.1 https://demo.pharmafocusasia.com/news/altasciences-and-voxcell-bioinnovation-collaborate 2025-08-01 00:40:08 daily 0.1 https://demo.pharmafocusasia.com/news/madrigal-pharmaceuticals-enters-into-agreement-with-cspc 2025-07-31 01:12:29 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-revna-biosciences-partner-to-strengthen 2025-07-31 00:56:19 daily 0.1 https://demo.pharmafocusasia.com/news/alamar-biosciences-and-dzne-collaborate-on-proteomic-profiling 2025-07-30 00:02:45 daily 0.1 https://demo.pharmafocusasia.com/news/bio-usawa-biotechnology-and-sartorius-partner-to-boost 2025-07-30 00:01:25 daily 0.1 https://demo.pharmafocusasia.com/news/antengenes-xpovio-approved-for-second-line-treatment 2025-07-29 00:23:45 daily 0.1 https://demo.pharmafocusasia.com/news/apellis-receives-approval-for-empaveli-c3-inhibitor 2025-07-29 00:22:08 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-re-vana-therapeutics-partners 2025-07-29 00:20:28 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceutical-receives-approval-for-opdivo 2025-07-28 01:24:19 daily 0.1 https://demo.pharmafocusasia.com/news/hengrui-pharma-enters-into-agreement-with-gsk-to-develop 2025-07-28 01:22:58 daily 0.1 https://demo.pharmafocusasia.com/news/matchpoint-therapeutics-enters-into-agreement-with-novartis 2025-07-25 01:09:27 daily 0.1 https://demo.pharmafocusasia.com/news/kling-bio-and-sanofi-partner-to-accelerate-discovery 2025-07-25 01:08:17 daily 0.1 https://demo.pharmafocusasia.com/news/candel-therapeutics-secures-ema-orphan-designation 2025-07-25 01:07:01 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-enters-into-agreement-with-3sbio-for-innovative-cancer-treatment 2025-07-25 01:05:46 daily 0.1 https://demo.pharmafocusasia.com/news/solid-biosciences-receives-fda-fast-track-designation 2025-07-24 00:21:58 daily 0.1 https://demo.pharmafocusasia.com/news/sutro-biopharma-enters-into-collaboration-with-us-fda 2025-07-23 01:07:25 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-vicebio-to-strengthen-respiratory-vaccines 2025-07-22 01:42:39 daily 0.1 https://demo.pharmafocusasia.com/news/promis-neurosciences-receives-fda-fast-track-designation 2025-07-22 00:37:47 daily 0.1 https://demo.pharmafocusasia.com/news/ausperbio-granted-approval-to-begin-phase-iii-trial 2025-07-22 00:36:21 daily 0.1 https://demo.pharmafocusasia.com/news/rocket-pharmaceuticals-receives-fda-rmat-designation 2025-07-18 00:36:07 daily 0.1 https://demo.pharmafocusasia.com/news/aldeyra-therapeutics-reproxalap-nda-accepted-for-review 2025-07-18 00:34:37 daily 0.1 https://demo.pharmafocusasia.com/news/endeavor-biomedicines-secures-orphan-drug-designation 2025-07-17 00:11:44 daily 0.1 https://demo.pharmafocusasia.com/news/acumen-and-jcr-partner-to-develop-advanced-brain-targeted 2025-07-16 00:49:18 daily 0.1 https://demo.pharmafocusasia.com/news/repare-therapeutics-enters-into-agreement-with-debiopharm 2025-07-16 00:47:29 daily 0.1 https://demo.pharmafocusasia.com/news/kalvista-pharmaceuticals-receives-approval-for-ekterly 2025-07-16 00:45:49 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-receives-us-fda-approval-for-finerenone-in-heart-failure 2025-07-15 00:12:00 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-enters-into-agreement-with-nhs-england 2025-07-15 00:10:40 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-breakthrough-therapy-designation-to-transcend 2025-07-11 03:42:51 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-enters-into-agreement-with-beone-medicines 2025-07-10 00:23:01 daily 0.1 https://demo.pharmafocusasia.com/news/sartorius-stedim-biotech-and-sensible-biotechnologies 2025-07-10 00:21:57 daily 0.1 https://demo.pharmafocusasia.com/news/merck-to-acquire-verona-pharma-in-10-billion-deal-adding-copd 2025-07-10 00:20:55 daily 0.1 https://demo.pharmafocusasia.com/news/adcentrx-therapeutics-receives-fda-orphan-drug-designation 2025-07-09 01:01:22 daily 0.1 https://demo.pharmafocusasia.com/news/neuraxpharm-and-dizlin-partner-on-global-development 2025-07-09 00:59:47 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-and-gero-partner-to-develop-new-therapies 2025-07-08 00:04:48 daily 0.1 https://demo.pharmafocusasia.com/news/mustang-bio-receives-fda-orphan-drug-designation-for-mb-101 2025-07-08 00:03:31 daily 0.1 https://demo.pharmafocusasia.com/news/nextcell-pharma-enters-into-collaboration-with-fujifilm-biosciences 2025-07-04 00:19:41 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-receives-fda-accelerated-approval-for-lynozyfic 2025-07-03 00:19:48 daily 0.1 https://demo.pharmafocusasia.com/news/dizals-zegfrovy-receives-fda-accelerated-approval 2025-07-03 00:17:38 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-receives-approval-for-alyftrek-to-treat-cystic-fibrosis 2025-07-02 00:06:44 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-receives-approval-for-ziihera 2025-07-02 00:05:12 daily 0.1 https://demo.pharmafocusasia.com/news/rocket-pharmaceuticals-receives-fda-clearance-to-begin-human-trials 2025-07-01 01:01:24 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-receives-approval-for-gammagard-liquid-erc-a-low-iga 2025-07-01 01:00:06 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-receives-approval-for-orpathys-and-tagrisso-combination 2025-07-01 00:58:51 daily 0.1 https://demo.pharmafocusasia.com/news/mabwell-and-qilu-pharmaceutical-collaborate-on-novel-injection 2025-06-30 01:06:33 daily 0.1 https://demo.pharmafocusasia.com/news/sobi-receives-approval-for-gamifant-as-treatment-for-macrophage 2025-06-30 01:04:46 daily 0.1 https://demo.pharmafocusasia.com/news/kalvista-partners-with-pendopharm-to-commercialise-sebetralstat 2025-06-27 00:13:49 daily 0.1 https://demo.pharmafocusasia.com/news/profound-therapeutics-and-novartis-partner-to-develop-cardiovascular 2025-06-27 00:12:29 daily 0.1 https://demo.pharmafocusasia.com/news/precision-biosciences-receives-fda-rare-paediatric-disease-designation 2025-06-26 00:13:15 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-kymera-therapeutics-partner-to-develop-novel 2025-06-26 00:12:08 daily 0.1 https://demo.pharmafocusasia.com/news/kymera-therapeutics-and-sanofi-advance-kt-485-into-clinical-development 2025-06-26 00:10:49 daily 0.1 https://demo.pharmafocusasia.com/news/medera-and-novoheart-partner-to-develop-patient-specific-mini-heart-models 2025-06-25 00:59:25 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-partners-with-tsinghua-university-to-boost-pharmaceutical-research 2025-06-25 00:58:11 daily 0.1 https://demo.pharmafocusasia.com/news/xcell-biosciences-enters-into-partnership-with-thermo-fisher-scientific 2025-06-25 00:56:26 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-ozempic-recommended-in-the-eu-for-peripheral-arterial 2025-06-24 00:42:38 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazeneca-receive-approval-for-datroway 2025-06-24 00:41:22 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-enters-into-partnership-with-otsuka-to-advance 2025-06-23 00:33:53 daily 0.1 https://demo.pharmafocusasia.com/news/argenx-gains-european-commission-approval-for-subcutaneous-vyvgart 2025-06-21 00:16:36 daily 0.1 https://demo.pharmafocusasia.com/news/archeus-technologies-secures-fda-clearance-for-art-101-to-treat-prostate 2025-06-21 00:15:09 daily 0.1 https://demo.pharmafocusasia.com/news/rybodyn-chosen-to-join-lilly-gateway-labs-to-drive-next-generation 2025-06-19 23:34:45 daily 0.1 https://demo.pharmafocusasia.com/news/annovis-receives-nyse-approval-for-compliance-plan 2025-06-19 23:33:07 daily 0.1 https://demo.pharmafocusasia.com/news/advarra-launches-ai-council-to-advance-responsible-innovation-in-clinical-trials 2025-06-19 00:36:24 daily 0.1 https://demo.pharmafocusasia.com/news/lisata-therapeutics-and-gatc-health-partners-to-advance-ai-based 2025-06-19 00:34:01 daily 0.1 https://demo.pharmafocusasia.com/news/dyne-therapeutics-secures-fda-breakthrough-therapy-designation 2025-06-18 03:25:48 daily 0.1 https://demo.pharmafocusasia.com/news/bioaegis-therapeutics-secures-fda-fast-track-designation-for-lead-ards 2025-06-18 03:24:30 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-enters-into-agreement-with-sino-universal-pharmaceuticals 2025-06-18 00:29:47 daily 0.1 https://demo.pharmafocusasia.com/news/orion-and-glykos-collaboration-for-development-of-next-generation-adcs 2025-06-17 00:52:00 daily 0.1 https://demo.pharmafocusasia.com/news/nextcure-enters-into-partnership-with-simcere-zaiming-to-advance 2025-06-17 00:50:33 daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-fosun-pharma-partner-to-advance-anti-pd1-il2-therapy 2025-06-17 00:49:24 daily 0.1 https://demo.pharmafocusasia.com/news/arkbios-azstarys-granted-priority-review-for-adhd-treatment 2025-06-16 03:11:27 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-gains-fda-approval-for-new-steqeyma-dose-for-paediatric-patients 2025-06-16 03:10:01 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-to-expand-biologics-manufacturing-with-major-investment-in-the-united-states 2025-06-13 00:13:15 daily 0.1 https://demo.pharmafocusasia.com/news/urogen-pharma-receives-us-fda-approval-for-zusduri-as-first 2025-06-13 00:11:56 daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-and-alkyon-therapeutics-collaborate-to-develop-advanced 2025-06-13 00:10:16 daily 0.1 https://demo.pharmafocusasia.com/news/chiesi-group-enters-into-agreement-with-key2brain-for-rare-disease-therapies 2025-06-12 01:06:36 daily 0.1 https://demo.pharmafocusasia.com/news/nuvation-bio-gains-approval-for-ibtrozi-taletrectinib-to-treat-advanced 2025-06-12 01:05:21 daily 0.1 https://demo.pharmafocusasia.com/news/ixcells-biotechnologies-unveils-ipscore-platform-to-enhance-human 2025-06-12 01:04:08 daily 0.1 https://demo.pharmafocusasia.com/news/enanta-pharmaceuticals-and-abbvie-receive-fda-approval-for-expanded 2025-06-12 01:02:56 daily 0.1 https://demo.pharmafocusasia.com/news/salipro-biotech-and-daewoong-pharmaceutical-partner-to-develop 2025-06-11 01:05:35 daily 0.1 https://demo.pharmafocusasia.com/news/bexorg-enters-into-partnership-with-biohaven-to-advance-cns-drug 2025-06-11 01:04:35 daily 0.1 https://demo.pharmafocusasia.com/news/nuevocor-receives-fda-clearance-for-ind-application-of-nvc-001 2025-06-11 01:03:20 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-begins-construction-of-microbial-manufacturing-site 2025-06-10 00:34:12 daily 0.1 https://demo.pharmafocusasia.com/news/medicovestor-and-sanyou-biopharmaceuticals-form-strategic-alliance 2025-06-10 00:32:52 daily 0.1 https://demo.pharmafocusasia.com/news/merck-secures-us-approval-for-enflonsia-targeting-infant-rsv 2025-06-10 00:31:20 daily 0.1 https://demo.pharmafocusasia.com/news/elpis-biopharmaceuticals-and-singapore-general-hospital-collaborate 2025-06-06 01:57:42 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-and-innovent-announce-nda-acceptance-in-china 2025-06-06 01:55:38 daily 0.1 https://demo.pharmafocusasia.com/news/mission-bio-launches-single-cell-multi-omics-assay-to-support-cancer 2025-06-06 01:51:29 daily 0.1 https://demo.pharmafocusasia.com/news/roches-evrysdi-tablet-gains-european-commission-approval-for-spinal 2025-06-04 00:48:13 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-receives-approval-for-third-indication-of-nubeqa-in-advanced 2025-06-04 00:47:05 daily 0.1 https://demo.pharmafocusasia.com/news/immunitybio-granted-fda-expanded-access-for-anktiva-to-treat 2025-06-03 00:31:34 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-and-bristol-myers-squibb-partner-to-advance-bispecific-antibody 2025-06-03 00:27:37 daily 0.1 https://demo.pharmafocusasia.com/news/nxera-pharma-begins-collaboration-with-lilly-to-develop-treatments 2025-06-02 01:08:14 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-blueprint-medicines-to-strengthen-rare-immunological 2025-06-02 01:07:03 daily 0.1 https://demo.pharmafocusasia.com/news/mabwell-secures-nmpa-approval-for-mailisheng-albipagrastim-alfa 2025-05-31 00:12:03 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-secures-global-rights-to-investigational-cldn182-targeting 2025-05-31 00:10:33 daily 0.1 https://demo.pharmafocusasia.com/news/modernas-mnexspike-covid-19-vaccine-approved-by-us-fda 2025-05-31 00:09:09 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-expands-manufacturing-capacity-to-enhance-global-vaccine-supply 2025-05-29 23:59:40 daily 0.1 https://demo.pharmafocusasia.com/news/beam-therapeutics-granted-fda-orphan-drug-designation-for-beam-302 2025-05-29 23:58:12 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-us-fda-accepts-priority-review-for-sevabertinib-in-her2-mutant-nsclc 2025-05-29 00:28:10 daily 0.1 https://demo.pharmafocusasia.com/news/eton-pharmaceuticals-secures-fda-approval-for-khindivi-oral-solution 2025-05-29 00:27:04 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-gains-approval-to-launch-clinical-trial-of-bcl2-inhibitor-mesutoclax 2025-05-29 00:25:41 daily 0.1 https://demo.pharmafocusasia.com/news/sarah-cannon-research-institute-enters-into-partnership-with-abbvie 2025-05-29 00:24:16 daily 0.1 https://demo.pharmafocusasia.com/news/tevas-anti-il-15-candidate-for-celiac-disease-receives-fda-fast-track 2025-05-28 00:43:11 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-city-therapeutics-partnership-to-develop-new-rnai-therapies 2025-05-28 00:41:46 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-receives-nmpa-approval-for-ongericimabs-supplemental 2025-05-28 00:40:38 daily 0.1 https://demo.pharmafocusasia.com/news/coherus-and-storm-launch-combination-trial-of-stc-15-and-loqtorzi 2025-05-28 00:39:24 daily 0.1 https://demo.pharmafocusasia.com/news/eisais-dayvigo-receives-approval-in-china-for-adult-insomnia 2025-05-27 00:13:52 daily 0.1 https://demo.pharmafocusasia.com/news/otsukas-sibeprenlimab-for-iga-nephropathy-granted-fda-priority-review 2025-05-27 00:12:28 daily 0.1 https://demo.pharmafocusasia.com/news/abbisko-therapeutics-secures-breakthrough-therapy-designation 2025-05-26 07:04:47 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-genentechs-susvimo-for-diabetic-retinopathy 2025-05-22 23:39:12 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-vigil-neuroscience-to-strengthen-alzheimers-drug-pipeline 2025-05-22 00:13:10 daily 0.1 https://demo.pharmafocusasia.com/news/sandoz-launches-pyzchiva-autoinjector-in-europe 2025-05-22 00:12:01 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lillys-kisunla-receives-tga-approval-for-early-alzheimer 2025-05-22 00:10:50 daily 0.1 https://demo.pharmafocusasia.com/news/mirai-bio-enters-into-partnership-with-thermo-fisher 2025-05-21 05:35:01 daily 0.1 https://demo.pharmafocusasia.com/news/vizai-partners-with-sanofi-and-regeneron-to-improve-copd-care-with-ai-technology 2025-05-21 05:33:59 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-imec-partner-to-develop-advanced-microphysiological-systems-platform 2025-05-21 05:33:00 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-receives-us-fda-approval-for-covid-19-vaccine-targeting 2025-05-20 00:35:45 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-and-domino-data-lab-partner-to-modernise-statistical-computing 2025-05-20 00:34:44 daily 0.1 https://demo.pharmafocusasia.com/news/crispr-therapeutics-and-sirius-therapeutics-collaborate-on-new-sirna 2025-05-20 00:33:37 daily 0.1 https://demo.pharmafocusasia.com/news/zai-labs-zl-1310-receives-fda-fast-track-designation-for-small-cell-lung 2025-05-20 00:32:27 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-canbridge-celebrate-approval-of-innovative-therapy 2025-05-16 23:56:55 daily 0.1 https://demo.pharmafocusasia.com/news/iqvia-and-scri-partner-to-streamline-global-cancer-clinical-trials 2025-05-16 23:54:59 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-receives-ec-approval-for-opdivo-based-perioperative 2025-05-16 23:53:34 daily 0.1 https://demo.pharmafocusasia.com/news/brainchild-bio-receives-fda-rmat-designation-for-b7-h3-car-t-cell-therapy 2025-05-16 00:12:55 daily 0.1 https://demo.pharmafocusasia.com/news/travere-therapeutics-filspari-snda-accepted-by-fda-for-fsgs-treatment 2025-05-16 00:11:29 daily 0.1 https://demo.pharmafocusasia.com/news/abbvies-emrelis-receives-fda-accelerated-approval-for-advanced 2025-05-15 00:25:19 daily 0.1 https://demo.pharmafocusasia.com/news/tempus-enters-into-collaboration-with-boehringer-ingelheim-to-advance 2025-05-15 00:24:13 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-receives-approval-for-mesutoclax-in-rr-mantle-cell-lymphoma 2025-05-13 00:16:28 daily 0.1 https://demo.pharmafocusasia.com/news/beam-therapeutics-receives-rmat-designation-from-us-fda 2025-05-13 00:15:21 daily 0.1 https://demo.pharmafocusasia.com/news/abli-therapeutics-launches-with-novel-parkinsons-therapy 2025-05-13 00:13:50 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-and-apiject-expand-bfs-capabilities-to-strengthen-us-sterile 2025-05-09 00:11:44 daily 0.1 https://demo.pharmafocusasia.com/news/biovaxys-and-sona-nanotech-collaboration-on-cancer-therapeutics 2025-05-08 00:57:07 daily 0.1 https://demo.pharmafocusasia.com/news/viverita-therapeutics-enters-into-collaboration-with-boehringer-ingelheim 2025-05-08 00:55:36 daily 0.1 https://demo.pharmafocusasia.com/news/adcentrx-therapeutics-receives-fda-fast-track-designation-for-nectin-4-adc 2025-05-07 00:16:31 daily 0.1 https://demo.pharmafocusasia.com/news/genezen-and-optieum-biotechnologies-partnership-to-advance-car-t-therapy 2025-05-06 00:08:01 daily 0.1 https://demo.pharmafocusasia.com/news/alterity-therapeutics-granted-fda-fast-track-designation-for-ath434 2025-05-05 06:50:37 daily 0.1 https://demo.pharmafocusasia.com/news/illumina-and-ovationio-introduce-novel-clinical-dataset-to-tackle 2025-05-02 00:40:57 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-receives-fda-approval-for-imaavy-to-treat 2025-05-01 01:17:47 daily 0.1 https://demo.pharmafocusasia.com/news/dimerix-enters-into-agreement-with-amicus-therapeutics-for-dmx-200 2025-05-01 01:16:32 daily 0.1 https://demo.pharmafocusasia.com/news/creyon-bio-and-eli-lilly-collaborate-on-rna-targeted-oligo-therapy-development 2025-04-30 00:19:32 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-expands-digital-pcr-tools-for-lentivirus-quality-control 2025-04-30 00:18:27 daily 0.1 https://demo.pharmafocusasia.com/news/addex-enters-into-agreement-with-sinntaxis-to-develop-mglu5-inhibitors 2025-04-30 00:16:51 daily 0.1 https://demo.pharmafocusasia.com/news/csl-vifor-and-travere-therapeutics-receive-eu-approval-for-filspari 2025-04-29 01:50:21 daily 0.1 https://demo.pharmafocusasia.com/news/predxbio-enters-into-partnership-with-hamamatsu-photonics-to-advance 2025-04-29 01:56:32 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-and-ask-pharm-receive-approval-for-limertinib-in-the-treatment 2025-04-28 07:00:37 daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-and-oncodesign-services-collaboration-to-advance 2025-04-25 00:56:18 daily 0.1 https://demo.pharmafocusasia.com/news/pci-pharma-expands-us-presence-with-acquisition-of-sterile-fill-finish 2025-04-25 00:55:04 daily 0.1 https://demo.pharmafocusasia.com/news/verastem-oncology-receives-fda-clearance-for-kras-g12d-inhibitor 2025-04-24 00:19:49 daily 0.1 https://demo.pharmafocusasia.com/news/genscript-biotech-enters-into-partnership-with-nsg-bio-to-boost-biotech 2025-04-24 00:10:48 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-tessellate-bio-partners-to-develop-precision 2025-04-23 23:33:38 daily 0.1 https://demo.pharmafocusasia.com/news/aclaris-therapeutics-receives-fda-approval-to-begin-clinical-trial-of-ati-052 2025-04-23 01:06:47 daily 0.1 https://demo.pharmafocusasia.com/news/gene-solutions-and-element-biosciences-collaboration-to-enhance 2025-04-23 01:05:15 daily 0.1 https://demo.pharmafocusasia.com/news/viatris-submits-applications-in-japan-to-expand-effexor-use-for-anxiety 2025-04-22 00:41:31 daily 0.1 https://demo.pharmafocusasia.com/news/ono-and-jorna-therapeutics-partner-to-develop-innovative-rna-editing 2025-04-21 04:51:46 daily 0.1 https://demo.pharmafocusasia.com/news/csl-launches-andembry-for-hereditary-angioedema-treatment-in-japan 2025-04-18 23:33:16 daily 0.1 https://demo.pharmafocusasia.com/news/m42-and-juvenescence-partner-to-develop-ai-enabled-therapies 2025-04-17 00:46:03 daily 0.1 https://demo.pharmafocusasia.com/news/wayfinder-biosciences-partners-with-daiichi-sankyo-to-develop-therapies 2025-04-16 00:25:59 daily 0.1 https://demo.pharmafocusasia.com/news/cellino-and-karis-bio-partners-to-develop-ipsc-therapy-for-cardiovascular 2025-04-16 00:24:21 daily 0.1 https://demo.pharmafocusasia.com/news/sumitomo-pharma-america-enters-into-agreement-with-nci-to-advance 2025-04-15 00:25:37 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-enters-into-partnership-with-cue-biopharma-to-develop 2025-04-15 00:24:19 daily 0.1 https://demo.pharmafocusasia.com/news/soleno-therapeutics-launches-vykat-xr-for-prader-willi-syndrome 2025-04-14 06:52:30 daily 0.1 https://demo.pharmafocusasia.com/news/argenx-receives-fda-approval-for-self-injection-prefilled-syringe 2025-04-10 23:35:24 daily 0.1 https://demo.pharmafocusasia.com/news/renovaro-completes-merger-with-biosymetrics-to-strengthen-ai-capabilities 2025-04-10 00:50:05 daily 0.1 https://demo.pharmafocusasia.com/news/avidity-biosciences-granted-orphan-drug-designation-in-japan 2025-04-09 00:15:13 daily 0.1 https://demo.pharmafocusasia.com/news/poxel-receives-approval-to-extend-twymeeg-use-for-diabetic-patients 2025-04-09 00:12:45 daily 0.1 https://demo.pharmafocusasia.com/news/engine-biosciences-enters-into-partnership-with-eddc-to-develop-new-precision 2025-04-08 00:18:57 daily 0.1 https://demo.pharmafocusasia.com/news/cas-and-cleveland-clinic-partner-to-advance-research-using-ai-and-quantum 2025-04-08 00:17:32 daily 0.1 https://demo.pharmafocusasia.com/news/abl-bio-enters-into-agreement-with-gsk-to-develop-treatments 2025-04-07 04:51:10 daily 0.1 https://demo.pharmafocusasia.com/news/ethris-and-lonza-partner-to-develop-room-temperature-mrna-vaccines 2025-04-07 04:40:14 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazenecas-enhertu-approved-in-eu 2025-04-05 00:21:10 daily 0.1 https://demo.pharmafocusasia.com/news/sangamo-therapeutics-enters-into-agreement-with-lilly 2025-04-04 00:33:30 daily 0.1 https://demo.pharmafocusasia.com/news/santen-secures-nmpa-approval-for-tapcom-to-treat-open-angle-glaucoma 2025-04-04 00:32:26 daily 0.1 https://demo.pharmafocusasia.com/news/flagship-pioneering-and-pfizer-partner-to-develop 2025-04-03 00:59:52 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-secures-fda-approval-for-vanrafia-to-treat-primary-iga-nephropathy 2025-04-03 00:58:51 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-enters-into-collaboration-with-japanese-foundation-for-cancer-research 2025-04-02 00:05:04 daily 0.1 https://demo.pharmafocusasia.com/news/ono-enters-into-collaboration-with-reborna-biosciences-for-rna-targeting 2025-04-01 00:04:35 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-pharmaceuticals-secures-approval-for-qfitlia 2025-03-28 23:55:25 daily 0.1 https://demo.pharmafocusasia.com/news/zenyaku-kogyo-and-chugais-rituxan-gains-approval-for-treating-relapsing 2025-03-28 00:01:52 daily 0.1 https://demo.pharmafocusasia.com/news/iaso-bio-secures-nda-approval-on-equecabtagene-autoleucel-for-multiple 2025-03-28 00:00:08 daily 0.1 https://demo.pharmafocusasia.com/news/gv20-therapeutics-enters-into-collaboration-with-mitsubishi-tanabe-pharma 2025-03-27 00:36:55 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-secures-fda-approval-for-cabometyx-in-advanced-neuroendocrine 2025-03-27 00:33:42 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-secures-approval-for-toripalimab-loqtorzi 2025-03-27 00:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/porosome-therapeutics-unveils-breakthrough-in-alzheimers-disease-research 2025-03-26 00:01:43 daily 0.1 https://demo.pharmafocusasia.com/news/msd-enters-into-agreement-with-hengrui-pharma-for-hrs-5346 2025-03-25 23:59:34 daily 0.1 https://demo.pharmafocusasia.com/news/kelun-biotechs-radionuclide-drug-conjugate-skb107-receives-approval 2025-03-25 23:57:37 daily 0.1 https://demo.pharmafocusasia.com/news/sineugene-therapeutics-receives-clearance-on-snug01-for-gene-therapy 2025-03-25 00:26:07 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-and-the-united-laboratories-international-holdings-limited 2025-03-24 05:25:02 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-receives-fda-clearance-for-investigational-cancer-vaccine 2025-03-24 01:01:17 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-secures-fda-approval-for-fabhalta-iptacopan-in-c3-glomerulopathy 2025-03-21 00:18:20 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-secures-fda-approval-for-amvuttra-vutrisiran-in-treating 2025-03-21 00:16:00 daily 0.1 https://demo.pharmafocusasia.com/news/henlius-secures-us-fda-orphan-drug-designation-for-hlx22-in-gastric-cancer 2025-03-20 00:05:48 daily 0.1 https://demo.pharmafocusasia.com/news/altesa-biosciences-receives-fda-clearance-for-vapendavir-to-treat-rhinovirus 2025-03-20 00:04:01 daily 0.1 https://demo.pharmafocusasia.com/news/vaxxas-secures-us-patent-for-needle-free-vaccine-manufacturing-technology 2025-03-19 00:39:12 daily 0.1 https://demo.pharmafocusasia.com/news/alvotech-and-dr-reddys-announce-fda-acceptance-of-bla-for-avt03 2025-03-19 00:29:43 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-pharmaceutical-to-acquire-araris-biotech-in-oncology-expansion 2025-03-18 00:11:47 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncologys-anti-her2-biparatopic-adc-jskn003-receives-approval 2025-03-18 00:10:13 daily 0.1 https://demo.pharmafocusasia.com/news/akesos-penpulimab-approved-for-first-line-nasopharyngeal-cancer-treatment 2025-03-17 03:56:30 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-receives-approval-of-sycume-for-thyroid-eye-disease-treatment 2025-03-15 03:59:42 daily 0.1 https://demo.pharmafocusasia.com/news/biocity-and-msd-collaborate-on-clinical-trial-for-bc3195-keytruda 2025-03-14 00:49:10 daily 0.1 https://demo.pharmafocusasia.com/news/zai-labs-biologics-licence-for-tivdak-approved-for-advanced-cervical 2025-03-13 01:42:34 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-launches-steqeyma-for-psoriasis-and-inflammatory-diseases 2025-03-13 00:46:59 daily 0.1 https://demo.pharmafocusasia.com/news/nosis-biosciences-and-daiichi-sankyo-partner-to-advance-rna-based-therapies 2025-03-11 23:47:33 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-announces-acquisition-of-checkpoint-therapeutics 2025-03-11 00:40:37 daily 0.1 https://demo.pharmafocusasia.com/news/syngene-acquires-us-manufacturing-facility-to-expand-global-biologics-capabilities 2025-03-11 00:29:28 daily 0.1 https://demo.pharmafocusasia.com/news/scpharmaceuticals-receives-approval-on-furoscix-for-edema-treatment 2025-03-07 00:34:03 daily 0.1 https://demo.pharmafocusasia.com/news/amaran-biotech-enters-into-agreement-with-nippon-fine-chemical 2025-03-07 00:27:28 daily 0.1 https://demo.pharmafocusasia.com/news/bioheng-therapeutics-gains-approval-for-cd7-ucar-t-cell-therapy 2025-03-05 23:05:31 daily 0.1 https://demo.pharmafocusasia.com/news/iqvia-laboratories-advances-clinical-trials-with-digital-innovation 2025-03-05 01:20:40 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-receives-approval-on-xpovio-for-multiple-myeloma 2025-03-05 01:19:29 daily 0.1 https://demo.pharmafocusasia.com/news/laekna-secures-approval-for-lae120-in-advanced-solid-tumours-treatment 2025-03-04 01:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-receives-approval-for-denosumab-biosimilars-stoboclo-and-osenvelt 2025-03-04 01:16:04 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-launches-effix-platform-to-advance-microbial-biologics-production 2025-03-04 01:15:02 daily 0.1 https://demo.pharmafocusasia.com/news/carsgen-receives-approval-for-satri-cel-in-claudin182-positive-gastric-cancer 2025-03-03 06:55:46 daily 0.1 https://demo.pharmafocusasia.com/news/magnet-biomedicine-and-eli-lilly-collaborate-on-molecular-glue-therapies 2025-02-28 23:46:19 daily 0.1 https://demo.pharmafocusasia.com/news/neopharma-technologies-enters-into-partnership-with-auschain-for-neovault 2025-02-28 00:06:17 daily 0.1 https://demo.pharmafocusasia.com/news/medigene-and-epimab-biotherapeutics-partner-to-develop-tcr-guided-t-cell 2025-02-28 00:04:57 daily 0.1 https://demo.pharmafocusasia.com/news/nxera-pharma-enters-into-agreement-with-holling-bio-pharma-for-daridorexant 2025-02-28 00:03:31 daily 0.1 https://demo.pharmafocusasia.com/news/ardelyx-gains-approval-for-tenapanor-to-treat-hyperphosphatemia 2025-02-27 00:20:40 daily 0.1 https://demo.pharmafocusasia.com/news/renovaro-enters-into-agreement-with-biosymetrics-to-advance-ai-driven 2025-02-27 00:19:13 daily 0.1 https://demo.pharmafocusasia.com/news/porosome-therapeutics-receives-fda-orphan-drug-designation-for-cystic 2025-02-26 00:01:23 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-xdc-and-ligachem-expand-partnership-to-advance-adc-development 2025-02-25 23:59:59 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-enters-into-collaboration-with-summit-therapeutics-and-pfizer 2025-02-25 00:32:36 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibbs-opdivo-and-yervoy-accepted-by-fda-for-colorectal-cancer 2025-02-25 00:16:27 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-receives-approval-ipilimumab-injection-colon-cancer 2025-02-24 01:03:15 daily 0.1 https://demo.pharmafocusasia.com/news/specialised-therapeutics-secures-approval-for-yorvipath-in-chronic 2025-02-21 00:19:06 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-enters-into-collaboration-with-insilico-medicine-for-antibody 2025-02-21 00:17:30 daily 0.1 https://demo.pharmafocusasia.com/news/bonus-biogroup-receives-approval-for-mesencure-in-acute-respiratory-distress 2025-02-21 00:15:48 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-receives-fda-approval-for-zongertinib-in-her2-mutant-advanced 2025-02-20 00:21:14 daily 0.1 https://demo.pharmafocusasia.com/news/askbio-receives-approval-on-regenerative-medicine-for-investigational 2025-02-20 00:19:31 daily 0.1 https://demo.pharmafocusasia.com/news/clarity-receives-approval-for-cu-67-sar-bispsma-in-prostate-cancer 2025-02-19 00:25:02 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-enters-into-collaboration-with-stoke-therapeutics-to-develop 2025-02-19 00:23:43 daily 0.1 https://demo.pharmafocusasia.com/news/innovents-ibi363-gains-fda-fast-track-status-for-squamous-non-small-cell 2025-02-18 00:03:34 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-secures-approval-of-orelabrutinib-for-the-treatment-of-cllsll 2025-02-18 00:01:53 daily 0.1 https://demo.pharmafocusasia.com/news/gsks-penmenvy-vaccine-approved-for-prevention-of-invasive-meningococcal 2025-02-17 01:27:41 daily 0.1 https://demo.pharmafocusasia.com/news/bavarian-nordic-secures-approval-for-vimkunya-chikungunya-vaccine 2025-02-17 01:25:46 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-strengthens-bioinformatics-leadership-with-new-data-centre 2025-02-14 03:16:17 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-secures-approval-for-xpovio-in-multiple-myeloma-treatment 2025-02-14 03:15:11 daily 0.1 https://demo.pharmafocusasia.com/news/selkirk-pharma-unveils-clinfast-to-accelerate-fillfinish-for-clinical-trials 2025-02-13 00:05:17 daily 0.1 https://demo.pharmafocusasia.com/news/maxcyte-and-tg-therapeutics-agreement 2025-02-13 00:04:05 daily 0.1 https://demo.pharmafocusasia.com/news/springworks-therapeutics-receives-approval-for-gomekli-mirdametinib 2025-02-12 00:20:30 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-and-deciphex-expand-collaboration-to-enhance-digital-pathology 2025-02-12 00:18:56 daily 0.1 https://demo.pharmafocusasia.com/news/biodexa-receives-us-fda-fast-track-for-erapa-in-familial-adenomatous 2025-02-11 00:36:48 daily 0.1 https://demo.pharmafocusasia.com/news/bio-thera-solutions-enters-into-agreement-with-intas-pharmaceuticals 2025-02-11 00:35:14 daily 0.1 https://demo.pharmafocusasia.com/news/nuance-pharma-secures-approval-for-ohtuvayre-ensifentrine-for-chronic 2025-02-07 00:16:05 daily 0.1 https://demo.pharmafocusasia.com/news/immuneering-enters-into-agreement-with-regeneron-for-cancer-therapy-trial 2025-02-07 00:14:24 daily 0.1 https://demo.pharmafocusasia.com/news/henlius-biotech-receives-approval-for-serplulimab-in-extensive-stage 2025-02-06 00:32:43 daily 0.1 https://demo.pharmafocusasia.com/news/shionogi-and-jordans-guardian-angels-launch-first-clinical-trial 2025-02-05 00:28:14 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-gains-approval-for-hbm9378skb378-in-chronic-obstructive 2025-02-05 00:25:24 daily 0.1 https://demo.pharmafocusasia.com/news/purple-biotech-enters-into-partnership-with-mount-sinai-for-research 2025-02-04 00:57:25 daily 0.1 https://demo.pharmafocusasia.com/news/reshape-lifesciences-secures-international-patent-for-diabetes 2025-02-04 00:55:42 daily 0.1 https://demo.pharmafocusasia.com/news/orion-and-invenra-partner-to-develop-bispecific-antibody-cancer-therapies 2025-01-31 00:06:19 daily 0.1 https://demo.pharmafocusasia.com/news/kazia-therapeutics-begins-trial-of-paxalisib-and-immunotherapy-advanced 2025-01-31 00:04:52 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-gains-fda-approval-for-journavx-a-non-opioid-pain-treatment 2025-01-31 00:03:11 daily 0.1 https://demo.pharmafocusasia.com/news/immunitybio-and-beigene-collaborate-on-phase-anktiva-trial-for-nsclc-treatment 2025-01-30 00:22:00 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisks-ozempic-approved-to-reduce-kidney-disease 2025-01-29 01:49:43 daily 0.1 https://demo.pharmafocusasia.com/news/neurocrine-biosciences-enters-into-collaboration-with-takeda-for-osavampator 2025-01-28 00:38:00 daily 0.1 https://demo.pharmafocusasia.com/news/apellis-receives-approval-for-syfovre-pegcetacoplan-to-treat-geographic 2025-01-28 00:36:37 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazenecas-enhertu-secures-us-fda-approval 2025-01-28 00:34:56 daily 0.1 https://demo.pharmafocusasia.com/news/ocugen-announces-fda-approval-of-ocu500-inhaled-vaccine-for-covid-19 2025-01-27 07:03:54 daily 0.1 https://demo.pharmafocusasia.com/news/alvotech-and-teva-announce-fda-bla-acceptance-for-avt05-biosimilar 2025-01-27 07:01:09 daily 0.1 https://demo.pharmafocusasia.com/news/milliporesigma-collaborates-with-opentrons-labworks-to-advance-laboratory 2025-01-24 00:50:36 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-collaboration-with-neomorph-to-develop-molecular-glue-degraders 2025-01-24 00:48:41 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-announces-c820-million-investment-for-global-expansion 2025-01-24 00:47:17 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-secures-orphan-drug-designation-from-fda-for-zl-1310 2025-01-23 00:07:23 daily 0.1 https://demo.pharmafocusasia.com/news/ipa-innovates-with-ai-to-develop-next-generation-glp-1-therapies-for-diabetes 2025-01-23 00:05:17 daily 0.1 https://demo.pharmafocusasia.com/news/dyne-therapeutics-secures-fda-fast-track-designation-for-dyne-101 2025-01-22 00:39:19 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnsons-spravato-esketamine-approved-monotherapy 2025-01-22 00:35:24 daily 0.1 https://demo.pharmafocusasia.com/news/yoltech-begins-trial-for-yolt-204-gene-therapy-in-beta-thalassemia 2025-01-20 23:53:56 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-partners-with-leo-pharma-for-toripalimab-distribution 2025-01-20 06:48:48 daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-pharmaceuticals-secures-fda-approval-for-plozasiran 2025-01-18 00:05:44 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-announces-acceptance-of-karxt-nda-for-schizophrenia-treatment 2025-01-18 00:03:54 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-and-ask-pharm-announce-approval-of-limertinib-for-lung-cancer 2025-01-17 00:44:37 daily 0.1 https://demo.pharmafocusasia.com/news/cytiva-and-cellular-origins-advance-cell-gene-therapy-with-robotic 2025-01-17 00:42:39 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-secures-breakthrough-therapy-designation-for-ibi343-in-pancreatic 2025-01-16 01:02:16 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lillys-omvoh-gains-fda-approval-for-crohns-disease-treatment 2025-01-16 01:00:04 daily 0.1 https://demo.pharmafocusasia.com/news/immunoforge-secures-approvals-for-key-clinical-trials-in-dmd-cardiomyopathy 2025-01-15 03:59:08 daily 0.1 https://demo.pharmafocusasia.com/news/regenxbio-and-nippon-shinyaku-partner-to-develop-gene-therapies-for-mps-diseases 2025-01-15 03:58:06 daily 0.1 https://demo.pharmafocusasia.com/news/simcere-zaiming-enters-into-partnership-with-abbvie 2025-01-15 03:57:11 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-announce-fda-acceptance-of-leqembi-application 2025-01-15 03:56:05 daily 0.1 https://demo.pharmafocusasia.com/news/menarini-group-and-insilico-medicine-enter-into-agreement-for-ai-discovered 2025-01-13 01:42:13 daily 0.1 https://demo.pharmafocusasia.com/news/sn-bioscience-secures-fda-clearance-for-snb-101-small-cell-lung-cancer-treatment 2025-01-13 01:41:14 daily 0.1 https://demo.pharmafocusasia.com/news/zuellig-pharma-partners-with-stada-as-exclusive-distributor 2025-01-10 00:20:36 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-enters-into-partnership-with-medilink-therapeutics-for-novel-lrrc15 2025-01-10 00:19:16 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-receives-fda-fast-track-designation-for-alzheimers 2025-01-09 00:26:30 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-expands-collaboration-with-ligachem-biosciences 2025-01-09 00:24:39 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-announces-approval-of-padcevtm-with-keytruda 2025-01-09 00:23:18 daily 0.1 https://demo.pharmafocusasia.com/news/valo-health-and-novo-nordisk-expand-partnership-to-develop-cardiometabolic 2025-01-08 06:19:49 daily 0.1 https://demo.pharmafocusasia.com/news/solid-biosciences-receives-fda-clearance-for-gene-therapy-to-treat-friedreich 2025-01-07 23:59:01 daily 0.1 https://demo.pharmafocusasia.com/news/dizals-sunvozertinib-receives-us-fda-approval-for-non-small-cell-lung-cancer 2025-01-07 23:57:06 daily 0.1 https://demo.pharmafocusasia.com/news/gsks-b7-h3-targeted-adc-receives-fda-breakthrough-therapy 2025-01-07 03:20:11 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-enters-into-agreement-with-candid-therapeutics-for-trispecific 2025-01-07 00:44:39 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-announces-approval-of-vyloytm-for-advanced-gastric-cancer 2025-01-06 01:07:04 daily 0.1 https://demo.pharmafocusasia.com/news/abu-dhabi-stem-cells-centre-develops-clinical-grade-ipscs-with-exclusive 2025-01-04 01:10:28 daily 0.1 https://demo.pharmafocusasia.com/news/gsks-nucala-approved-for-treating-chronic-rhinosinusitis-with-nasal-polyps 2025-01-03 03:06:01 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-approval-of-dovbleron-for-non-small-cell-lung-cancer 2025-01-03 00:17:26 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-submits-new-drug-application-nda-for-orpathys 2025-01-02 00:14:13 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-announces-approval-of-vyvdura-with-enhanze-for-cidp-treatment 2024-12-31 00:03:59 daily 0.1 https://demo.pharmafocusasia.com/news/ideaya-biosciences-licenses-shr-4849-from-hengrui-pharma-for-global-development 2024-12-30 23:12:01 daily 0.1 https://demo.pharmafocusasia.com/news/jadeite-medicines-secures-orphan-drug-designation-for-odevixibat 2024-12-26 00:02:35 daily 0.1 https://demo.pharmafocusasia.com/news/keymed-biosciences-gains-approval-for-stapokibart-to-treat-chronic-rhinosinusitis 2024-12-23 23:58:54 daily 0.1 https://demo.pharmafocusasia.com/news/scg-cell-therapy-and-astar-collaborate-to-advance-rna-therapeutics 2024-12-23 04:22:32 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-enters-into-partnership-with-sanofi-to-develop-pneumococcal 2024-12-23 04:20:50 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-and-companys-zepbound-approved-for-obstructive-sleep-apnoea 2024-12-21 00:35:05 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-hangzhou-dac-enter-into-research-agreement 2024-12-20 00:24:46 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-pharmaceuticals-approved-tryngolza-for-treating-familial 2024-12-20 00:23:11 daily 0.1 https://demo.pharmafocusasia.com/news/bioage-labs-enters-into-collaboration-with-novartis-to-identify-therapeutic 2024-12-19 00:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/sumitomo-chemical-enters-into-joint-venture-with-sumitomo-pharma 2024-12-18 00:59:24 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-and-eva-pharma-secures-regulatory-approval-for-insulin-production 2024-12-18 00:58:27 daily 0.1 https://demo.pharmafocusasia.com/news/sk-biopharmaceuticals-enters-into-collaboration-with-proen-therapeutics 2024-12-17 00:07:08 daily 0.1 https://demo.pharmafocusasia.com/news/mercks-keytruda-approved-in-china-for-earlier-stage-nsclc-treatment 2024-12-17 00:05:37 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-enters-into-collaboration-with-eli-lilly-for-jaypirca 2024-12-16 03:40:29 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-gains-positive-chmp-opinion-for-three-biosimilars 2024-12-16 03:39:06 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-and-cspc-pharmaceutical-enter-into-agreement-for-mat2a-inhibitor 2024-12-13 00:31:33 daily 0.1 https://demo.pharmafocusasia.com/news/curegene-secures-clinical-trial-approval-for-cg-0255-injection 2024-12-13 00:29:42 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-announces-the-first-prescription-of-velsipity-issued 2024-12-12 01:49:43 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-secures-breakthrough-therapy-for-orpathys-and-tagrisso 2024-12-12 01:48:23 daily 0.1 https://demo.pharmafocusasia.com/news/santhera-pharmaceuticals-announces-agamree-approval-for-duchenne 2024-12-11 01:26:11 daily 0.1 https://demo.pharmafocusasia.com/news/pilatus-biosciences-earns-fda-orphan-drug-designation-for-plt012 2024-12-11 01:25:03 daily 0.1 https://demo.pharmafocusasia.com/news/seres-therapeutics-receives-breakthrough-therapy-designation-for-ser-155 2024-12-10 01:03:49 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazeneca-secure-approval-for-datopotamab-deruxtecan 2024-12-10 01:02:13 daily 0.1 https://demo.pharmafocusasia.com/news/nona-biosciences-partners-with-kodiak-sciences-for-next-generation-antibody 2024-12-10 01:01:04 daily 0.1 https://demo.pharmafocusasia.com/news/gsks-granted-blenrep-combination-therapy-for-relapsedrefractory 2024-12-09 06:35:52 daily 0.1 https://demo.pharmafocusasia.com/news/roche-seeks-fda-approval-for-columvi-combo-to-treat-relapsed-diffuse 2024-12-06 00:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-enters-into-partnership-with-lilly-to-biotech-manufacturing-capabilities 2024-12-06 00:28:44 daily 0.1 https://demo.pharmafocusasia.com/news/merus-gains-fda-approval-for-bizengri-zenocutuzumab-zbco 2024-12-05 00:38:36 daily 0.1 https://demo.pharmafocusasia.com/news/mesoblast-secures-fda-rmat-designation-for-congenital-heart-disease 2024-12-05 00:36:38 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-receives-approval-for-20-valent-pneumococcal-conjugate-vaccine 2024-12-04 00:30:36 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-enters-into-license-agreement-with-keros-therapeutics 2024-12-04 00:29:36 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceutical-enters-into-collaboration-with-congruence-therapeutics 2024-12-04 00:28:28 daily 0.1 https://demo.pharmafocusasia.com/news/cytokinetics-announces-fda-acceptance-of-aficamten 2024-12-03 00:28:32 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-seeks-fda-approval-for-tremfya-to-treat-paediatric 2024-12-03 00:27:27 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-new-drug-application-for-velsipity-accepted 2024-12-02 06:10:08 daily 0.1 https://demo.pharmafocusasia.com/news/sparsentan-granted-orphan-drug-designation-for-iga-nephropathy-treatment 2024-12-02 06:08:22 daily 0.1 https://demo.pharmafocusasia.com/news/silo-pharma-enters-into-agreement-with-kymanox-to-develop-sp-26-for-p 2024-11-29 23:47:35 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-announces-approval-of-nefecon-for-iga-nephropathy 2024-11-29 03:07:54 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-launch-leqembi-lecanemab-for-alzheimers-disease 2024-11-28 00:09:44 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-secures-approval-for-tevimbra-in-first-line-treatment-of-advanced 2024-11-28 00:08:02 daily 0.1 https://demo.pharmafocusasia.com/news/roche-to-acquire-poseida-therapeutics-expanding-cell-therapy-capabilities 2024-11-27 01:08:14 daily 0.1 https://demo.pharmafocusasia.com/news/vectorbuilder-and-sartorius-partner-to-advance-biopharmaceutical-innovation 2024-11-27 01:06:29 daily 0.1 https://demo.pharmafocusasia.com/news/hanall-biopharma-daewoong-pharmaceutical-and-nurron-pharmaceuticals 2024-11-26 00:38:43 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-pharmaceuticals-fda-accepts-application-for-vutrisiran 2024-11-26 00:26:03 daily 0.1 https://demo.pharmafocusasia.com/news/hanmi-pharmaceutical-advances-clinical-trials-for-bh3120-a-next-generation 2024-11-25 01:51:04 daily 0.1 https://demo.pharmafocusasia.com/news/inxmeds-ifebemtinib-gains-breakthrough-therapy-status-for-kras-g12c 2024-11-22 00:58:59 daily 0.1 https://demo.pharmafocusasia.com/news/zevra-therapeutics-launches-miplyffa-arimoclomol-in-the-us-f 2024-11-22 00:57:10 daily 0.1 https://demo.pharmafocusasia.com/news/biofidelity-launches-aspyre-clinical-test-for-rapid-lung-cancer-profiling 2024-11-22 00:55:28 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-gains-us-fda-approval-for-ziihera-in-her2-positive 2024-11-21 00:57:03 daily 0.1 https://demo.pharmafocusasia.com/news/pfizers-hympavzi-approved-by-european-commission-for-severe 2024-11-21 00:54:33 daily 0.1 https://demo.pharmafocusasia.com/news/kura-oncology-and-kyowa-kirin-announce-strategic-partnership-for-ziftomenib 2024-11-21 00:52:43 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-to-acquire-iqone-healthcare-switzerland-to-strengthen-european 2024-11-20 01:07:54 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-secures-fda-orphan-drug-designation-for-rag-21-in-als 2024-11-20 01:06:25 daily 0.1 https://demo.pharmafocusasia.com/news/sangamo-therapeutics-gains-fda-approval-for-st-503-ind-in-idiopathic 2024-11-20 01:04:55 daily 0.1 https://demo.pharmafocusasia.com/news/velavigo-and-avenzo-partner-to-advance-nectin4trop2-bispecific 2024-11-19 00:34:06 daily 0.1 https://demo.pharmafocusasia.com/news/sk-biopharmaceuticals-enters-into-agreement-with-kirams 2024-11-19 00:32:36 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-and-biogen-secure-ec-approval-for-opuviz-aflibercept 2024-11-19 00:31:00 daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-tagrisso-recommended-for-eu-approval-in-treating-advanced 2024-11-18 04:35:48 daily 0.1 https://demo.pharmafocusasia.com/news/numab-therapeutics-and-kaken-pharmaceutical-collaborate-on-nd081 2024-11-16 00:31:30 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-receives-chmp-endorsement-for-amivantamab-lazertinib-combination 2024-11-16 00:30:09 daily 0.1 https://demo.pharmafocusasia.com/news/acepodia-secures-fda-approval-for-ace1831-in-igg4-related-disease 2024-11-16 00:28:25 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-announces-acquisition-of-iqone-healthcare 2024-11-15 01:03:26 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-gains-fda-approval-for-gene-therapy-targeting-aadc 2024-11-15 01:01:46 daily 0.1 https://demo.pharmafocusasia.com/news/merck-gains-global-licence-for-lanovas-investigational-antibody-lm-299 2024-11-15 01:00:27 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-acquires-biotheus-to-develop-novel-antibody-therapies 2024-11-14 01:45:45 daily 0.1 https://demo.pharmafocusasia.com/news/nippon-shinyaku-and-atsena-therapeutics-enters-into-collaboration 2024-11-14 01:44:10 daily 0.1 https://demo.pharmafocusasia.com/news/actuate-therapeutics-receives-fda-rare-paediatric-disease-designation 2024-11-13 01:37:32 daily 0.1 https://demo.pharmafocusasia.com/news/insilico-medicine-reports-positive-topline-results-for-ai-developed-ism001-055 2024-11-13 01:35:59 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-enters-into-collaboration-with-mcgill-university-to-advance-microbiome 2024-11-13 01:33:27 daily 0.1 https://demo.pharmafocusasia.com/news/apollo-therapeutics-and-sunshine-lake-pharma-enters-into-exclusive-license 2024-11-13 01:31:50 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazeneca-submits-new-bla-for-accelerated-approval 2024-11-13 01:29:49 daily 0.1 https://demo.pharmafocusasia.com/news/neurizon-receives-positive-ema-opinion-for-nuz-001-orphan-designation 2024-11-12 01:18:38 daily 0.1 https://demo.pharmafocusasia.com/news/brainstorm-enters-into-partnership-with-pluri-on-phase-3b-manufacturing 2024-11-12 01:17:15 daily 0.1 https://demo.pharmafocusasia.com/news/zai-lab-and-argenx-secure-chinese-approval-for-vyvgart-hytrulo 2024-11-12 01:15:46 daily 0.1 https://demo.pharmafocusasia.com/news/alteogen-enters-into-agreement-with-daiichi-sankyo-for-enhertu 2024-11-11 06:25:05 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-seeks-us-and-eu-approval-for-subcutaneous 2024-11-11 06:23:22 daily 0.1 https://demo.pharmafocusasia.com/news/clearside-biomedical-signs-agreement-with-santen-pharmaceutical 2024-11-08 00:39:19 daily 0.1 https://demo.pharmafocusasia.com/news/aditum-bio-and-leads-biolabs-join-forces-to-develop-new-autoimmune 2024-11-08 00:37:33 daily 0.1 https://demo.pharmafocusasia.com/news/leads-biolabs-gains-fda-orphan-drug-status-for-innovative-antibody 2024-11-07 00:49:22 daily 0.1 https://demo.pharmafocusasia.com/news/cumberland-pharmaceuticals-secures-orphan-drug-and-rare-pediatric 2024-11-07 00:47:57 daily 0.1 https://demo.pharmafocusasia.com/news/nj-bio-and-charles-river-forge-strategic-alliance-to-advance-adc 2024-11-06 00:34:40 daily 0.1 https://demo.pharmafocusasia.com/news/inocras-and-summit-pharmaceuticals-partner-to-advance-genomic-medicine 2024-11-06 00:32:57 daily 0.1 https://demo.pharmafocusasia.com/news/nxera-and-antiverse-partner-to-develop-novel-gpcr-antibody-therapies 2024-11-06 00:31:26 daily 0.1 https://demo.pharmafocusasia.com/news/y-mabs-enters-into-agreement-with-nobelpharma-for-exclusive 2024-11-05 01:28:52 daily 0.1 https://demo.pharmafocusasia.com/news/ascendis-pharma-and-novo-nordisk-partner-on-transcon-technology 2024-11-05 01:27:03 daily 0.1 https://demo.pharmafocusasia.com/news/ring-therapeutics-enters-into-partnerships-with-astar-and-seri 2024-11-05 01:25:16 daily 0.1 https://demo.pharmafocusasia.com/news/leica-biosystems-and-cst-partner-for-flexible-high-throughput 2024-11-05 01:38:43 daily 0.1 https://demo.pharmafocusasia.com/news/hansoh-pharma-gains-nmpa-breakthrough-therapy 2024-11-02 03:42:18 daily 0.1 https://demo.pharmafocusasia.com/news/valanx-biotech-and-fina-biosolutions-collaborate 2024-11-02 03:41:15 daily 0.1 https://demo.pharmafocusasia.com/news/tevogen-bio-partners-with-microsoft-to-speed-up-drug-development-using-ai 2024-11-01 01:01:15 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-evolveimmune-partner-to-develop-next-generation-cancer-therapies 2024-11-01 00:59:02 daily 0.1 https://demo.pharmafocusasia.com/news/teijin-and-hilleman-laboratories-partner-to-advance-cell-and-gene-therapy-cdmo 2024-11-01 00:58:02 daily 0.1 https://demo.pharmafocusasia.com/news/cstones-sugemalimab-approved-for-first-line-nsclc-treatment-in-uk 2024-11-01 00:55:31 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-neomorph-partner-on-molecular-glue-degraders-for-alzheimers 2024-10-30 01:02:23 daily 0.1 https://demo.pharmafocusasia.com/news/kiora-pharmaceuticals-gains-approval-to-launch-phase-2-trial-of-kio-301 2024-10-30 01:00:38 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-scemblix-gains-fda-approval-for-newly-diagnosed-chronic-myeloid 2024-10-30 00:58:28 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-unveils-wuxia-ridgs-for-antibiotic-free-cell-development 2024-10-29 01:09:39 daily 0.1 https://demo.pharmafocusasia.com/news/genecentric-therapeutics-unveils-expressct-platform-for-liquid-biopsy 2024-10-29 01:07:35 daily 0.1 https://demo.pharmafocusasia.com/news/tempus-and-jw-pharmaceutical-collaborate-to-advance-early-rd 2024-10-29 01:05:37 daily 0.1 https://demo.pharmafocusasia.com/news/gc-biopharma-enters-into-agreement-with-novelty-nobility 2024-10-28 00:31:44 daily 0.1 https://demo.pharmafocusasia.com/news/introducing-iques-2nd-edition-high-throughput-cytometry-handbook 2024-10-27 23:16:57 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-launches-velsipity-in-greater-bay-area-for-moderate 2024-10-25 00:51:09 daily 0.1 https://demo.pharmafocusasia.com/news/lyell-immunopharma-acquires-immpact-bio-on-advance-next-gen 2024-10-25 00:49:30 daily 0.1 https://demo.pharmafocusasia.com/news/hesperos-and-ucf-develop-ipsc-model-to-advance-treatment 2024-10-25 00:46:12 daily 0.1 https://demo.pharmafocusasia.com/news/telix-announces-new-drug-application-for-tlx101-cdx-pixclara-brain 2024-10-24 01:04:58 daily 0.1 https://demo.pharmafocusasia.com/news/lillys-kisunla-donanemab-approved-in-great-britain-for-mild-cognitive 2024-10-24 01:03:23 daily 0.1 https://demo.pharmafocusasia.com/news/help-therapeutics-gains-fda-approval-for-hicm-188-cell-therapy 2024-10-23 00:51:38 daily 0.1 https://demo.pharmafocusasia.com/news/alvotech-and-teva-secure-fda-approval-for-new-selarsdi-presentation 2024-10-23 00:50:01 daily 0.1 https://demo.pharmafocusasia.com/news/molecular-partners-signs-agreement-with-orano-med-to-co-develop 2024-10-22 00:52:29 daily 0.1 https://demo.pharmafocusasia.com/news/editas-enters-into-collaboration-with-genevant-to-develop-gene-editing-therapies 2024-10-22 00:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/adcentrx-therapeutics-receives-fda-clearance-for-adrx-0405-a-new-adc 2024-10-22 00:49:18 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-enters-into-collaboration-with-cambridge-university-on-kidney 2024-10-22 00:47:41 daily 0.1 https://demo.pharmafocusasia.com/news/aft-secures-late-stage-rd-agreement-for-novel-injectable-treatment 2024-10-21 00:39:31 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-receives-taiwan-tfda-approval-for-nefecon 2024-10-21 00:38:18 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-receives-fda-approval-for-vyloy-in-advanced-gastric-and-gej 2024-10-19 00:24:21 daily 0.1 https://demo.pharmafocusasia.com/news/antengenes-xpovio-gains-third-approval-in-south-korea-for-multiple 2024-10-19 00:22:40 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-orano-partner-to-develop-next-generation-radioligand-therapies 2024-10-18 00:55:26 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-receives-approval-of-vyalev-for-adults-with-advanced-parkinsons 2024-10-18 00:54:13 daily 0.1 https://demo.pharmafocusasia.com/news/firefly-neuroscience-enters-into-collaboration-with-bright-minds-to-analyse 2024-10-17 00:54:03 daily 0.1 https://demo.pharmafocusasia.com/news/viatris-enters-into-agreement-with-lexicon-on-global-rights-to-sotagliflozin 2024-10-17 00:52:04 daily 0.1 https://demo.pharmafocusasia.com/news/novocures-optune-lua-approved-by-fda-for-treating-metastatic-non-small 2024-10-16 00:51:32 daily 0.1 https://demo.pharmafocusasia.com/news/alleo-and-ubiquigent-partner-on-ai-driven-initiative-to-accelerate-dub-targeted 2024-10-16 00:49:57 daily 0.1 https://demo.pharmafocusasia.com/news/sellas-granted-fda-rare-paediatric-disease-designation-for-acute-myeloid 2024-10-16 00:48:32 daily 0.1 https://demo.pharmafocusasia.com/news/medic-life-sciences-enters-into-collaboration-with-hanmi-pharmaceutical 2024-10-15 00:54:19 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-enters-into-collaboration-with-merck-to-evaluate-zanzalintinib 2024-10-15 00:51:06 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-launches-advanced-multimodal-scanning-transmission 2024-10-15 00:48:41 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-daiichi-sankyos-enhertu-approved-in-china 2024-10-14 06:13:51 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-secures-fda-approval-for-320-mg-single-injection-bimzelx-device 2024-10-14 06:10:49 daily 0.1 https://demo.pharmafocusasia.com/news/ono-enters-into-agreements-with-ligachem-for-lcb97-and-novel-adc-development 2024-10-11 00:44:33 daily 0.1 https://demo.pharmafocusasia.com/news/roche-gains-fda-approval-for-itovebi-in-advanced-hr-positive 2024-10-11 00:43:25 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-enters-into-collaboration-with-circle-pharma 2024-10-10 01:40:05 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmas-opdivo-approved-with-cisplatin-and-gemcitabine-for-unresectable 2024-10-10 01:38:21 daily 0.1 https://demo.pharmafocusasia.com/news/arbele-enters-into-collaboration-with-bioai-on-ai-driven-precision-oncology 2024-10-10 01:36:19 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-enters-into-collaboration-with-moma-therapeutics-for-oncology-program 2024-10-09 00:58:41 daily 0.1 https://demo.pharmafocusasia.com/news/healgen-scientific-gains-fda-de-novo-authorisation-for-at-home-covid-19 2024-10-09 00:57:15 daily 0.1 https://demo.pharmafocusasia.com/news/tevas-biosimilar-to-prolia-denosumab-accepted-for-review-by-us-fda 2024-10-09 00:55:18 daily 0.1 https://demo.pharmafocusasia.com/news/indiviors-sublocade-rapid-induction-and-injection-site-updates-granted 2024-10-08 01:45:30 daily 0.1 https://demo.pharmafocusasia.com/news/orchard-therapeutics-enters-into-partnership-with-er-kim-to-expand-libmeldy 2024-10-08 01:43:56 daily 0.1 https://demo.pharmafocusasia.com/news/gbi-biomanufacturing-enters-into-collaboration-with-allterum-for-antibody 2024-10-08 01:42:25 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-enters-into-collaboration-with-ask-pharm-limertinib-and-lung-cancer 2024-10-08 01:40:55 daily 0.1 https://demo.pharmafocusasia.com/news/bpgbio-collaborates-with-university-of-oxford-for-research-in-oncology 2024-10-07 07:14:57 daily 0.1 https://demo.pharmafocusasia.com/news/teva-extend-partnership-with-mabxience-for-new-oncology-biosimilar 2024-10-04 00:45:21 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-receives-fda-approval-for-perioperative-opdivo 2024-10-04 00:44:05 daily 0.1 https://demo.pharmafocusasia.com/news/abl-bio-enters-into-collaboration-with-msd-to-trial-abl103-with-keytruda 2024-10-04 00:42:22 daily 0.1 https://demo.pharmafocusasia.com/news/arcus-biosciences-enters-into-collaborate-with-astrazeneca-to-trial-casdatifan 2024-10-03 01:26:12 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-completed-acquisition-with-idt-biologika 2024-10-03 01:24:36 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-enters-into-partnership-with-lundbeck-for-ai-powered-neurological 2024-10-03 01:17:46 daily 0.1 https://demo.pharmafocusasia.com/news/tessellate-bio-enters-into-collaboration-with-omico-and-cmri-to-advance 2024-10-01 00:45:02 daily 0.1 https://demo.pharmafocusasia.com/news/geneditbio-receives-investment-from-gobi-partners-gba-to-drive-genome 2024-10-01 00:43:27 daily 0.1 https://demo.pharmafocusasia.com/news/modalis-therapeutics-receives-fda-rare-paediatric-disease-designation 2024-09-30 01:50:43 daily 0.1 https://demo.pharmafocusasia.com/news/sk-pharmteco-invests-260-million-to-expand-small-molecule-and-peptide 2024-09-30 01:48:51 daily 0.1 https://demo.pharmafocusasia.com/news/anbogen-enters-into-drug-supply-collaboration-with-beigene-for-colorectal 2024-09-30 01:42:07 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-colab-shanghai-launches-as-part-of-global-life-science-incubator 2024-09-27 01:26:36 daily 0.1 https://demo.pharmafocusasia.com/news/biocity-biopharma-receives-breakthrough-therapy-designation-for-sc0062 2024-09-27 01:24:19 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-accepts-new-drug-application-for-picankibart-injection 2024-09-26 01:30:36 daily 0.1 https://demo.pharmafocusasia.com/news/belief-biomed-collbaorates-asklepios-biopharmaceutical-new-gene-therapies 2024-09-26 01:29:08 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-announces-approval-of-kisunla-in-japan-for-alzheimers-disease 2024-09-25 01:00:10 daily 0.1 https://demo.pharmafocusasia.com/news/csl-vifor-receives-approval-for-veltassa-for-the-treatment-of-hyperkalemia 2024-09-25 00:58:37 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-gains-eu-approval-for-vyloytm-with-chemotherapy-in-advanced 2024-09-24 01:29:35 daily 0.1 https://demo.pharmafocusasia.com/news/roche-introduces-first-test-using-tags-technology-detecting-12-respiratory 2024-09-24 01:27:48 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-gains-approval-for-xpovio-selinexor-commercialisation-in-thailand 2024-09-24 01:25:59 daily 0.1 https://demo.pharmafocusasia.com/news/henlius-and-intas-secure-positive-chmp-opinion-for-hetronifly-as-first-line 2024-09-23 00:33:50 daily 0.1 https://demo.pharmafocusasia.com/news/ipsens-iqirvo-approved-as-first-new-primary-biliary-cholangitis-pbc-treatment 2024-09-21 00:52:59 daily 0.1 https://demo.pharmafocusasia.com/news/firefly-neuroscience-advances-ai-bna-technology-in-drug-development 2024-09-21 00:50:10 daily 0.1 https://demo.pharmafocusasia.com/news/axcelead-enters-into-agreement-with-acadia-pharmaceuticals-for-drug-discovery 2024-09-20 01:05:02 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-unveils-new-liquid-phase-peptide-synthesis-technology 2024-09-20 00:49:26 daily 0.1 https://demo.pharmafocusasia.com/news/accord-biopharma-announces-fda-approval-of-420mg-strength-of-hercessi 2024-09-19 00:52:25 daily 0.1 https://demo.pharmafocusasia.com/news/mercks-keytruda-plus-chemotherapy-approved-by-fda-for-advanced-malignant 2024-09-19 00:50:22 daily 0.1 https://demo.pharmafocusasia.com/news/biomed-x-launches-new-immuno-oncology-research-team-with-ono-pharmaceutical 2024-09-18 01:50:52 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-announces-new-drug-application-for-blenrep-in-combination-with-bortezomib 2024-09-18 01:49:09 daily 0.1 https://demo.pharmafocusasia.com/news/senhwa-biosciences-submits-ind-for-pidnarulex-in-nci-sponsored-advanced 2024-09-18 01:47:16 daily 0.1 https://demo.pharmafocusasia.com/news/korro-bio-enters-into-collaboration-with-novo-nordisk-to-develop-rna-based-therapies 2024-09-17 06:20:25 daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-whitelab-genomics-partner-to-advance-oncology-drug-design 2024-09-17 06:18:19 daily 0.1 https://demo.pharmafocusasia.com/news/mercks-keytruda-plus-trastuzumab-and-chemotherapy-significantly 2024-09-16 03:58:38 daily 0.1 https://demo.pharmafocusasia.com/news/maxcyte-enters-partnership-kamau-therapeutics-advance-gene-therapy 2024-09-16 03:56:13 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-launches-shingles-vaccine-in-malaysia 2024-09-16 03:47:29 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-announces-fda-approval-of-tecentriq-hybreza-with-enhanze-for-various-cancers 2024-09-13 00:46:41 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-enter-into-agreement-with-radiomedix-and-orano-med-for-next-generation 2024-09-13 01:03:36 daily 0.1 https://demo.pharmafocusasia.com/news/vironexis-biotherapeutics-secures-fda-clearance-for-first-aav-delivered-cancer 2024-09-13 00:42:55 daily 0.1 https://demo.pharmafocusasia.com/news/actuate-therapeutics-receives-fda-orphan-drug-designation-for-elraglusib-in-soft-tissue-sarcomas 2024-09-12 01:37:17 daily 0.1 https://demo.pharmafocusasia.com/news/alopexx-collaborates-with-bharat-biotech-to-develop-broad-spectrum-antimicrobial 2024-09-12 01:34:58 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-announces-positive-results-for-rag-17-in-als-sod1-treatment-trial 2024-09-11 00:57:29 daily 0.1 https://demo.pharmafocusasia.com/news/sophia-genetics-enters-into-collaborate-with-astrazeneca-to-expand-global-access-to-liquid-biopsy-testing 2024-09-11 00:55:30 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-genesis-therapeutics-strategic-partnership-develop-therapies 2024-09-11 00:53:20 daily 0.1 https://demo.pharmafocusasia.com/news/mgi-unveils-new-cycloneseq-nanopore-sequencing-products 2024-09-10 01:00:22 daily 0.1 https://demo.pharmafocusasia.com/news/vir-biotechnology-completes-exclusive-license-agreement-with-sanofi-for-t-cell 2024-09-10 00:58:39 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazenecas-new-trop2-biomarker-predicts-datopotamab-deruxtecan 2024-09-09 01:19:56 daily 0.1 https://demo.pharmafocusasia.com/news/exyte-acquires-ttp-group-to-boost-biopharma-and-life-sciences-growth 2024-09-06 01:04:19 daily 0.1 https://demo.pharmafocusasia.com/news/travere-therapeutics-gains-fda-approval-for-filspari 2024-09-06 01:19:59 daily 0.1 https://demo.pharmafocusasia.com/news/ultradx-gains-first-clinical-approval-for-single-molecule-analyzer-in-china 2024-09-06 00:59:32 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-eva-pharma-partner-improve-access-baricitinib-low-and-middle-income 2024-09-05 01:27:36 daily 0.1 https://demo.pharmafocusasia.com/news/carterra-launches-sensitive-platform-ultra-advances-fragment-and-small-molecule-discovery 2024-09-05 01:25:03 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-and-insightec-partner-to-advance-neuroscience-therapies 2024-09-05 01:23:22 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-receives-fast-track-designation-ibi363-melanoma-treatment 2024-09-04 03:14:58 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-status-to-skyline-therapeutics-gene-therapy-retinitis-pigmentosa 2024-09-04 03:11:57 daily 0.1 https://demo.pharmafocusasia.com/news/acepodia-partners-with-pfizer-to-advance-antibody-cell-conjugation-therapies 2024-09-04 03:09:06 daily 0.1 https://demo.pharmafocusasia.com/news/nmpa-approves-ind-application-for-henlius-pembrolizumab-biosimilar 2024-09-06 06:29:28 daily 0.1 https://demo.pharmafocusasia.com/news/simcere-zaiming-enters-into-collaboration-with-targetrx-launching-newest-alk 2024-09-06 06:28:50 daily 0.1 https://demo.pharmafocusasia.com/news/chugais-piasky-receives-european-approval-treatment-paroxysmal-nocturnal-hemoglobinuria 2024-09-02 04:34:44 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-licenses-glecirasib-and-jab-3312-to-allist-for-china-market 2024-08-31 00:46:29 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-announces-expanded-indication-arexvy-lower-respiratory-tract-disease 2024-08-30 01:06:16 daily 0.1 https://demo.pharmafocusasia.com/news/biocon-biologics-gains-approval-to-launch-bmab-1200-in-europe-uk-canada 2024-08-30 01:03:59 daily 0.1 https://demo.pharmafocusasia.com/news/flagship-pioneering-and-quotient-therapeutics-forge-agreement-to-discover-novel-targets 2024-08-29 01:30:40 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-pharmaceutical-announces-approval-of-alecensa-in-japan 2024-08-29 01:29:05 daily 0.1 https://demo.pharmafocusasia.com/news/yoltech-and-salubris-sign-agreement-for-yolt-101-development-and-marketing 2024-08-28 01:23:38 daily 0.1 https://demo.pharmafocusasia.com/news/legend-biotech-secures-approval-for-cilta-cel-in-china 2024-08-28 01:21:06 daily 0.1 https://demo.pharmafocusasia.com/news/zuellig-pharma-announces-agreement-with-regeneron-to-introduce-libtayo 2024-08-28 01:19:00 daily 0.1 https://demo.pharmafocusasia.com/news/genfleet-announces-approval-of-kras-g12c-inhibitor-for-advanced-lung-cancer 2024-08-28 01:17:08 daily 0.1 https://demo.pharmafocusasia.com/news/seegene-unveils-mpox-pcr-tests-after-who-health-emergency 2024-08-27 01:16:31 daily 0.1 https://demo.pharmafocusasia.com/news/eu-approves-roches-piasky-as-first-monthly-subcutaneous-treatment-for-pnh 2024-08-27 01:16:46 daily 0.1 https://demo.pharmafocusasia.com/news/fujitsu-addresses-drug-loss-in-japan-with-new-ecosystem-to-speed-up-clinical 2024-08-26 01:28:01 daily 0.1 https://demo.pharmafocusasia.com/news/ec-approves-celltrions-steqeyma-biosimilar-for-chronic-inflammatory-diseases 2024-08-26 01:25:17 daily 0.1 https://demo.pharmafocusasia.com/news/clarity-receives-fda-fast-track-designation-for-64cu-sar-bispsma 2024-08-23 01:20:25 daily 0.1 https://demo.pharmafocusasia.com/news/bridge-biotherapeutics-and-hitgen-collaborate-on-novel-cancer-therapeutics 2024-08-23 01:17:47 daily 0.1 https://demo.pharmafocusasia.com/news/innovents-dupert-gains-nmpa-approval-as-chinas-first-kras-g12c-inhibitor 2024-08-22 01:22:31 daily 0.1 https://demo.pharmafocusasia.com/news/university-nottingham-partnership-touchlight-accelerate-zika-vaccine-development 2024-08-22 01:20:25 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibbs-bla-accepted-fda-first-line-treatment-advanced-liver-cancer 2024-08-22 01:17:38 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-granted-breakthrough-therapy-designation-by-fda-lung-cancer-treatment 2024-08-21 00:58:08 daily 0.1 https://demo.pharmafocusasia.com/news/kelun-biotechs-trop2-adc-sac-tmt-secures-second-nda-egfr-mutant-nsclc 2024-08-21 00:55:52 daily 0.1 https://demo.pharmafocusasia.com/news/pharmadrugs-sairiyo-approved-for-phase-1-trial-of-reformulated-cepharanthine 2024-08-20 01:37:52 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-nmpa-approved-astellas-pharmas-padcev-for-treating-locally-advanced 2024-08-20 01:34:04 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-has-received-approval-from-chinas-nmpa-for-the-manufacturing 2024-08-19 06:12:45 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-priority-review-deciphera-ono-pharmaceuticals-nda-vimseltinib-tgct 2024-08-16 01:51:41 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-pharmaceutical-submits-elevidys-gene-therapy-for-dmd-in-japan 2024-08-16 01:48:30 daily 0.1 https://demo.pharmafocusasia.com/news/nsg-biolabs-enter-into-collaborates-with-merck-boost-biotech-start-ups-drive-innovation 2024-08-16 01:46:45 daily 0.1 https://demo.pharmafocusasia.com/news/enhertu-by-astrazeneca-and-daiichi-sankyo-approved-in-china-for-advanced-her2-gastric-cancer 2024-08-14 01:21:36 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogens-leqembi-lecanemab-approved-for-alzheimers-treatment 2024-08-14 01:18:44 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-university-collaborates-eli-lilly-advance-technology-development-speed-medicine-delivery-patients 2024-08-13 01:18:28 daily 0.1 https://demo.pharmafocusasia.com/news/mabwells-adc-9mw2821-granted-breakthrough-therapy-from-cde-nmpa 2024-08-13 01:07:03 daily 0.1 https://demo.pharmafocusasia.com/news/sable-therapeutics-enter-into-agreement-columbia-university-develop-novel-polycation 2024-08-12 06:04:07 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-medigene-collaborate-on-tcr-guided-t-cell-engagers 2024-08-09 00:55:53 daily 0.1 https://demo.pharmafocusasia.com/news/t-maximum-pharmaceutical-unveils-car-t-breakthrough-for-solid-tumours 2024-08-09 00:54:36 daily 0.1 https://demo.pharmafocusasia.com/news/nec-bio-enter-collaboration-with-agc-biologics-on-personalized-cancer-vaccines 2024-08-08 00:44:12 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-announces-approval-for-adzynma-as-first-cttp-therapy 2024-08-08 00:43:01 daily 0.1 https://demo.pharmafocusasia.com/news/sangamo-therapeutics-enter-into-agreement-with-genentech 2024-08-07 02:03:07 daily 0.1 https://demo.pharmafocusasia.com/news/gsks-jemperli-plus-chemotherapy-receives-approval 2024-08-07 02:01:44 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-merck-expand-global-agreement-to-include-mk-6070 2024-08-06 07:03:17 daily 0.1 https://demo.pharmafocusasia.com/news/formosa-pharmaceuticals-and-apotex-enter-into-agreement 2024-08-06 03:19:28 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-xpovio-approved-for-use-in-malaysia 2024-08-06 03:18:39 daily 0.1 https://demo.pharmafocusasia.com/news/ping-an-shionogi-submits-new-drug-application-for-cefiderocol-in-china 2024-08-06 03:17:36 daily 0.1 https://demo.pharmafocusasia.com/news/meta-pharmaceuticals-secures-fda-rare-paediatric-disease-designation-for-meta-001-ph 2024-08-06 03:16:19 daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-and-bitbiome-partner-to-create-innovative-enzymes-for-cutting-edge-biocatalysis 2024-08-05 07:02:47 daily 0.1 https://demo.pharmafocusasia.com/news/dksh-and-kyowa-kirin-form-strategic-alliance-for-expansion-in-asia-pacific 2024-08-03 05:29:25 daily 0.1 https://demo.pharmafocusasia.com/news/labcorp-receives-fda-de-novo-approval-for-pgdx-elio-plasma-focus-diagnostic-test 2024-08-03 04:53:22 daily 0.1 https://demo.pharmafocusasia.com/news/biosyngen-collaborates-with-singapores-astar-to-develop-advanced-autoimmune-therapies 2024-08-02 03:14:53 daily 0.1 https://demo.pharmafocusasia.com/news/innovents-new-drug-application-for-mazdutide-in-type-2-diabetes-receives-acceptance-from-chinas-nmpa 2024-08-02 03:09:27 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-four-manufacturing-facilities-and-biosafety-testing-center-receive-re-certification-from-european-medicines-agency-for-ten-biologics 2024-08-02 01:55:52 daily 0.1 https://demo.pharmafocusasia.com/news/ideate-lung02-phase-3-trial-begins-for-ifinatamab-deruxtecan-in-relapsed-small-cell-lung-cancer-patients 2024-08-02 01:29:39 daily 0.1 https://demo.pharmafocusasia.com/news/bukwang-pharmaceuticals-introduces-latuda-for-schizophrenia-and-bipolar-i-disorder-depression-treatment 2024-08-01 01:38:21 daily 0.1 https://demo.pharmafocusasia.com/news/sirnaomics-partners-with-gore-range-capital-to-establish-sagesse-bio-advancing-rnai-therapeutics-in-aesthetic-medicine 2024-08-01 01:24:22 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-pharmaceutical-announces-acquisition-of-jnana-therapeutics 2024-08-01 01:17:01 daily 0.1 https://demo.pharmafocusasia.com/news/nccn-and-medlive-extend-collaboration-to-improve-cancer-treatment-in-china 2024-07-31 01:37:16 daily 0.1 https://demo.pharmafocusasia.com/news/synthetica-pioneering-completes-series-a-funding-round-to-advance-oncolytic-bacterial-treatment-for-solid-tumors 2024-07-31 01:32:32 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-beckman-coulter-and-fujirebio-team-up-to-develop-blood-based-biomarkers-and-tests-for-tau-pathology-in-alzheimers-disease 2024-07-31 01:27:34 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-designation-to-zymedis-zma001-for-pulmonary-arterial-hypertension 2024-07-31 01:23:51 daily 0.1 https://demo.pharmafocusasia.com/news/compugen-secures-fda-approval-for-ind-application-of-com503-in-solid-tumor-treatment 2024-07-30 01:28:12 daily 0.1 https://demo.pharmafocusasia.com/news/akesos-sbla-for-ivonescimab-in-first-line-therapy-for-pd-l1-positive-nsclc-accepted-by-nmpa 2024-07-30 01:23:51 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-receives-positive-chmp-recommendation-for-zolbetuximab-combined-with-chemotherapy-in-treating-advanced-gastric-and-gastroesophageal-junction-cancer 2024-07-29 06:51:06 daily 0.1 https://demo.pharmafocusasia.com/news/sanyou-bio-congratulates-eluminex-biosciences-and-foreseen-biotechnology-on-major-achievements-in-drug-innovation 2024-07-29 06:47:26 daily 0.1 https://demo.pharmafocusasia.com/news/aforall-secures-fda-approval-for-fifth-generic-drug-application-on-first-submission-cycle 2024-07-26 01:45:55 daily 0.1 https://demo.pharmafocusasia.com/news/iaso-bio-secures-nmpa-approval-to-begin-trials-for-iaso-782-in-systemic-lupus-erythematosus-sle 2024-07-26 01:26:44 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-secures-fda-rare-pediatric-disease-designation-for-rag-18-in-duchenne-muscular-dystrophy-treatment 2024-07-26 01:20:57 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-reveals-successful-phase-3-outcomes-for-hemophilia-a-gene-therapy-candidate 2024-07-25 01:26:17 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-econavista-forge-business-partnership-to-develop-a-dementia-care-ecosystem-and-initiate-collaboration 2024-07-25 01:11:09 daily 0.1 https://demo.pharmafocusasia.com/news/flagship-pioneering-introduces-abiologics-revolutionizing-biotherapeutics-with-advanced-capabilities 2024-07-24 01:30:50 daily 0.1 https://demo.pharmafocusasia.com/news/brenig-therapeutics-raises-65-million-in-series-a-funding-to-advance-pre-clinical-pipeline-for-parkinsons-disease 2024-07-24 01:25:50 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-launches-us-biologics-manufacturing-and-rd-facility-advancing-global-expansion-to-serve-more-patients 2024-07-24 01:19:44 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-approval-for-samsung-bioepis-epysqli-as-a-biosimilar-to-soliris 2024-07-23 01:22:14 daily 0.1 https://demo.pharmafocusasia.com/news/mastercontrol-introduces-gxpassist-ai-to-enhance-life-science-processes 2024-07-23 01:15:19 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-successful-phase-3-trial-results-for-mazdutide-in-type-2-diabetes-patients-in-china-and-plans-to-submit-nda-to-nmpa 2024-07-22 06:33:25 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-begins-dosing-in-china-for-global-phase-2b-trial-of-zetomipzomib-for-lupus-nephritis 2024-07-22 06:29:43 daily 0.1 https://demo.pharmafocusasia.com/news/shenzhen-chipscreen-biosciences-co-ltd-receives-nmpa-approval-for-chiglitazar-metformin-combination-therapy-for-type-2-diabetes 2024-07-20 01:59:29 daily 0.1 https://demo.pharmafocusasia.com/news/zuellig-pharma-and-institut-allergosan-establish-10-year-alliance-to-launch-omni-biotic-probiotics-in-key-asian-markets 2024-07-19 03:20:25 daily 0.1 https://demo.pharmafocusasia.com/news/phathom-pharmaceuticals-secures-fda-approval-for-voquezna-vonoprazan-tablets-to-alleviate-heartburn-from-non-erosive-gerd-in-adults 2024-07-19 03:13:54 daily 0.1 https://demo.pharmafocusasia.com/news/pluri-cdmo-selected-to-produce-kadimastems-novel-cell-therapy-products 2024-07-19 01:58:37 daily 0.1 https://demo.pharmafocusasia.com/news/cytomed-therapeutics-acquires-cord-blood-banking-license-and-assets-to-enhance-allogeneic-gd-t-cells-technology-for-solid-and-liquid-cancer-treatments 2024-07-18 03:21:58 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-receives-official-acceptance-for-nefecon-supplementary-application-from-china-national-medical-products-administration 2024-07-18 03:16:02 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-announces-approval-of-snda-for-toripalimab-and-bevacizumab-combination-therapy-for-advanced-hepatocellular-carcinoma 2024-07-18 03:08:00 daily 0.1 https://demo.pharmafocusasia.com/news/sk-biopharmaceuticals-and-full-life-technologies-announce-collaboration-for-new-therapy-targeting-multiple-solid-tumors 2024-07-17 01:36:56 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-status-to-7mw3711 2024-07-17 01:26:53 daily 0.1 https://demo.pharmafocusasia.com/news/novo-holdings-leads-100-million-series-c-investment-in-asceneuron-to-advance-alzheimers-therapy 2024-07-17 01:17:40 daily 0.1 https://demo.pharmafocusasia.com/news/argenx-and-zai-lab-receive-approval-for-efgartigimod-alfa-injection-in-china-for-generalized-myasthenia-gravis 2024-07-16 01:43:48 daily 0.1 https://demo.pharmafocusasia.com/news/sabin-vaccine-institute-initiates-phase-2-clinical-trial-for-sudan-ebolavirus-vaccine 2024-07-16 01:38:33 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-announces-successful-phase-3-trial-results-for-etrasimod-in-treating-moderately-to-severely-active-ulcerative-colitis-in-asia 2024-07-16 01:32:11 daily 0.1 https://demo.pharmafocusasia.com/news/merck-starts-commercial-production-of-first-gmp-compliant-cell-culture-media-manufacturing-line-in-china 2024-07-16 01:26:41 daily 0.1 https://demo.pharmafocusasia.com/news/adm-korea-launches-first-clinical-trial-of-niclosamide-based-anticancer-drug-for-prostate-cancer-patients-resistant-to-hormone-therapy 2024-07-12 01:13:57 daily 0.1 https://demo.pharmafocusasia.com/news/sanyou-bio-and-biogeometry-join-forces-to-develop-ai-powered-antibody-drug-discovery-platform 2024-07-12 01:10:35 daily 0.1 https://demo.pharmafocusasia.com/news/reviva-pharmaceuticals-receives-european-patent-for-brilaroxazine-in-treating-pulmonary-hypertension 2024-07-11 01:35:41 daily 0.1 https://demo.pharmafocusasia.com/news/leqembi-receives-approval-for-treating-alzheimers-disease-in-hong-kong 2024-07-11 01:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/interius-biotherapeutics-secures-hrec-approval-and-tga-clearance-for-phase-1-trial-of-first-of-its-kind-in-vivo-car-therapy-for-b-cell-cancers 2024-07-11 01:23:45 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lillys-acquisition-of-morphic-therapeutic-aims-to-enhance-treatments-for-inflammatory-bowel-disease-ibd 2024-07-09 01:17:58 daily 0.1 https://demo.pharmafocusasia.com/news/amarin-partner-eddingpharm-secures-approval-for-vascepa-icosapent-ethyl-in-mainland-china-to-reduce-cardiovascular-risk 2024-07-09 01:13:18 daily 0.1 https://demo.pharmafocusasia.com/news/pharmabcine-gains-safety-approval-for-first-dose-group-in-phase-1ab-study-of-pmc-309-in-advanced-or-metastatic-solid-tumors 2024-07-09 01:05:32 daily 0.1 https://demo.pharmafocusasia.com/news/hinova-pharmaceuticals-receives-fda-fast-track-designation-for-hp518-to-treat-ar-triple-negative-breast-cancer 2024-07-06 00:41:20 daily 0.1 https://demo.pharmafocusasia.com/news/genexine-and-epd-biotherapeutics-announce-merger-to-enhance-drug-development-pipeline 2024-07-05 05:29:14 daily 0.1 https://demo.pharmafocusasia.com/news/biostar-pharma-secures-fda-approval-for-phase-2-trial-of-utidelone-injection-utd1-in-her2-negative-breast-cancer-brain-metastases 2024-07-05 05:25:21 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-afrigen-biologics-have-entered-into-a-non-binding-memorandum-of-understanding-mou-to-collaborate-on-developing-an-mrna-vaccine-technology-platform 2024-07-04 01:24:28 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-announces-chinas-acceptance-of-priority-review-nda-for-tazemetostat-in-treating-relapsed-or-refractory-follicular-lymphoma 2024-07-04 01:14:13 daily 0.1 https://demo.pharmafocusasia.com/news/annovis-bios-phase-iii-study-shows-buntanetap-improves-unified-parkinsons-disease-rating-scale-mds-updrs-and-cognitive-function 2024-07-03 05:27:31 daily 0.1 https://demo.pharmafocusasia.com/news/valgenesis-announces-strategic-partnership-with-validator-kk-to-expand-in-japan 2024-07-03 05:22:13 daily 0.1 https://demo.pharmafocusasia.com/news/n-power-medicine-and-merck-collaborate-to-expand-oncologist-and-patient-access-to-clinical-trials 2024-07-02 03:42:34 daily 0.1 https://demo.pharmafocusasia.com/news/hiro-acquires-deltamed-solutions-enhances-cross-border-operations-in-the-us 2024-07-02 03:38:38 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-samsung-bioepis-pyzchiva-ustekinumab-ttwe-a-biosimilar-to-stelara 2024-07-01 05:22:43 daily 0.1 https://demo.pharmafocusasia.com/news/23andme-and-nightingale-health-to-collaborate-on-pilot-for-blood-biomarker-panel 2024-06-29 01:06:32 daily 0.1 https://demo.pharmafocusasia.com/news/epcoritamab-tepkinly-gains-positive-chmp-endorsement-for-adult-relapsedrefractory-follicular-lymphoma-treatment 2024-06-29 01:03:09 daily 0.1 https://demo.pharmafocusasia.com/news/meitheal-pharmaceuticals-secures-exclusive-us-licensing-deal-for-humira-biosimilar-yusimry-to-enhance-biologics-portfolio 2024-06-28 05:24:00 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-receive-positive-chmp-recommendation-for-eu-approval-of-omicron-jn1-adapted-covid-19-vaccine 2024-06-28 05:19:39 daily 0.1 https://demo.pharmafocusasia.com/news/epcoritamab-epkinly-fda-approved-for-patients-with-relapsed-or-refractory-follicular-lymphoma-fl 2024-06-27 01:03:05 daily 0.1 https://demo.pharmafocusasia.com/news/simcere-and-zaiming-announce-nmpa-approval-for-cetuximab-beta-in-china 2024-06-27 00:58:42 daily 0.1 https://demo.pharmafocusasia.com/news/agile-therapeutics-inc-and-insud-pharma-sl-sign-definitive-merger-agreement 2024-06-27 00:54:22 daily 0.1 https://demo.pharmafocusasia.com/news/porton-advanced-launches-maxcyte-expert-gtx-flow-electroporation-system-to-enhance-cell-and-gene-therapy-offerings 2024-06-26 03:37:28 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-openai-collaborate-on-developing-new-treatments-for-drug-resistant-bacteria 2024-06-26 03:34:43 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-receives-approval-for-toripalimab-as-a-first-line-therapy-for-advanced-triple-negative-breast-cancer 2024-06-26 03:31:35 daily 0.1 https://demo.pharmafocusasia.com/news/gsks-omjjara-momelotinib-receives-approval-in-japan-for-treating-myelofibrosis 2024-06-25 06:18:30 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-and-sanofi-receive-ind-approval-for-phase-3-global-clinical-trial-of-next-generation-pneumococcal-vaccine 2024-06-25 01:39:39 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-plans-to-expand-its-rare-disease-business-by-acquiring-alimera-sciences 2024-06-25 01:35:56 daily 0.1 https://demo.pharmafocusasia.com/news/iliad-biotechnologies-plans-collaboration-with-emmes-group-a-new-mountain-capital-portfolio-company-for-phase-iii-clinical-trials-of-bpze1-a-next-generation-pertussis-vaccine 2024-06-25 01:27:54 daily 0.1 https://demo.pharmafocusasia.com/news/biond-biologics-begins-phase-1-clinical-trial-administers-first-dose-of-bnd-35 2024-06-25 01:23:31 daily 0.1 https://demo.pharmafocusasia.com/news/roche-introduces-advanced-analytical-units-for-cobas-pro-integrated-solutions-boosting-laboratory-efficiency-and-capacity 2024-06-24 06:08:58 daily 0.1 https://demo.pharmafocusasia.com/news/astrivax-begins-clinical-trials-for-innovative-vaccine-platform-technology 2024-06-24 06:04:52 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-announces-fda-accelerated-approval-of-krazati-adagrasib-combined-with-cetuximab-for-kras-g12c-mutated-colorectal-cancer 2024-06-24 05:10:10 daily 0.1 https://demo.pharmafocusasia.com/news/nephrodi-therapeutics-receives-investment-from-sound-bioventures-to-hasten-development-of-ndi-5001-for-pediatric-orphan-kidney-disease 2024-06-21 01:22:48 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-introduces-south-koreas-inaugural-ai-driven-experiment-design-system 2024-06-21 01:18:07 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-therapeutics-announces-fda-expansion-of-elevidys-for-duchenne-muscular-dystrophy-patients-aged-4-and-up 2024-06-21 01:03:59 daily 0.1 https://demo.pharmafocusasia.com/news/roche-launches-new-test-for-early-detection-of-b-cell-lymphoma 2024-06-20 01:59:58 daily 0.1 https://demo.pharmafocusasia.com/news/golidocitinib-receives-approval-in-china-as-the-first-jak1-selective-inhibitor-for-treating-relapsed-or-refractory-peripheral-t-cell-lymphoma 2024-06-20 01:51:25 daily 0.1 https://demo.pharmafocusasia.com/news/genfleet-receives-ind-approval-from-chinas-nmpa-for-gfh375-an-oral-kras-g12d-onoff-inhibitor-to-initiate-phase-iii-clinical-trials-in-patients-with-advanced-solid-tumors 2024-06-20 01:34:49 daily 0.1 https://demo.pharmafocusasia.com/news/spyre-therapeutics-initiates-phase-1-study-of-spy001-a-novel-antibody-targeting-a4b7-for-inflammatory-bowel-disease-therapy 2024-06-19 01:04:54 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-and-otsuka-expand-licensing-agreement-for-hereditary-angioedema-drug-donidalorsen-in-asia-pacific 2024-06-19 01:02:03 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-gains-approval-for-snda-of-toripalimab-as-first-line-therapy-for-small-cell-lung-cancer 2024-06-19 00:57:15 daily 0.1 https://demo.pharmafocusasia.com/news/northwest-biotherapeutics-acquires-exclusive-rights-to-dendritic-cell-technology-suite 2024-06-18 02:28:10 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-phase-ii-study-of-ruxoprubart-for-anca-associated-vasculitis 2024-06-18 02:23:25 daily 0.1 https://demo.pharmafocusasia.com/news/revir-therapeutics-and-asieris-pharmaceuticals-reach-milestone-in-rna-targeted-cancer-therapy-development 2024-06-18 02:09:24 daily 0.1 https://demo.pharmafocusasia.com/news/mgi-tech-and-seqone-collaborate-to-advance-complete-genomic-analysis 2024-06-17 06:14:11 daily 0.1 https://demo.pharmafocusasia.com/news/imfinzi-in-combination-with-chemotherapy-has-received-approval-in-the-us-for-treating-advanced-or-recurrent-endometrial-cancer-with-mismatch-repair-deficiency 2024-06-17 06:09:21 daily 0.1 https://demo.pharmafocusasia.com/news/new-kite-research-highlights-yescarta-effectiveness-in-earlier-treatment-stages-for-large-b-cell-lymphoma 2024-06-15 02:33:55 daily 0.1 https://demo.pharmafocusasia.com/news/invivyd-announces-vyd222s-effectiveness-against-new-sars-cov-2-kp11-flirt-and-kp3-variants 2024-06-15 02:16:24 daily 0.1 https://demo.pharmafocusasia.com/news/lg-chem-and-aveo-oncology-have-announced-the-commencement-of-phase-1-clinical-trials-for-lg-chems-inaugural-proprietary-anti-cancer-compound-with-dosing-initiated-in-the-united-states 2024-06-14 01:19:35 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-and-newbridge-pharmaceuticals-conclude-partnership-for-brukinsa-zanubrutinib-in-the-mena-region 2024-06-14 01:14:22 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-secures-fast-track-status-from-the-fda-for-ibi343-a-monotherapy-for-advanced-pancreatic-cancer 2024-06-13 03:28:54 daily 0.1 https://demo.pharmafocusasia.com/news/iqvia-introduces-one-home-platform-to-simplify-clinical-trials-and-reduce-site-burden 2024-06-13 03:25:27 daily 0.1 https://demo.pharmafocusasia.com/news/nsg-biolabs-and-eppendorf-group-form-alliance-to-enhance-biotech-support-in-singapore 2024-06-13 03:19:38 daily 0.1 https://demo.pharmafocusasia.com/news/asgard-therapeutics-collaborates-with-exothera-to-advance-at-108-into-clinical-trials 2024-06-12 01:28:23 daily 0.1 https://demo.pharmafocusasia.com/news/doh-and-penn-medicine-to-expand-partnership-in-translational-research-opening-additional-labs-in-abu-dhabi 2024-06-12 01:24:06 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-announces-nmpa-acceptance-of-zanidatamab-biologics-license-application-for-second-line-treatment-of-biliary-tract-cancer-in-china 2024-06-11 03:33:24 daily 0.1 https://demo.pharmafocusasia.com/news/santhera-launches-early-access-program-for-agamree-in-china-through-sperogenix-collaboration 2024-06-10 04:56:11 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-application-for-leqembi-lecanemab-irmb-to-add-iv-maintenance-dosing-for-early-alzheimers-disease-treatment 2024-06-10 04:53:03 daily 0.1 https://demo.pharmafocusasia.com/news/easl-wrap-up-session-unveils-late-breaking-data-on-scg101-innovative-hbv-specific-tcr-t-cell-therapy-boosts-survival-in-hbv-associated-liver-cancer 2024-06-10 04:48:24 daily 0.1 https://demo.pharmafocusasia.com/news/inis-and-alpha-nuclides-establish-strategic-development-and-distribution-agreements-for-china 2024-06-10 04:36:04 daily 0.1 https://demo.pharmafocusasia.com/news/luye-pharma-submits-nda-in-japan-for-twice-weekly-rivastigmine-patch-for-alzheimers-treatment 2024-06-07 03:38:32 daily 0.1 https://demo.pharmafocusasia.com/news/micurx-completes-phase-i-clinical-trial-successfully-for-self-developed-mrx-8-antibacterial-drug-in-china 2024-06-07 03:14:52 daily 0.1 https://demo.pharmafocusasia.com/news/engeneic-and-singapore-institute-of-advanced-medicine-holdings-announce-strategic-alliance-to-transform-cancer-treatment-in-asia 2024-06-07 02:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/vyne-therapeutics-launches-phase-2b-clinical-trial-for-vyn201-a-new-bet-inhibitor-in-vitiligo-research 2024-06-06 01:48:14 daily 0.1 https://demo.pharmafocusasia.com/news/indevr-and-sino-biological-join-forces-to-provide-advanced-multiplexed-analytical-solutions-for-mrna-vaccines-and-cell-gene-therapies 2024-06-06 01:35:03 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-introduces-new-digital-pcr-assay-design-tool-for-qiacuity-enhances-geneglobe-platform-customization 2024-06-06 01:23:17 daily 0.1 https://demo.pharmafocusasia.com/news/spruce-biosciences-and-hmnc-brain-health-team-up-to-develop-innovative-treatment-for-major-depressive-disorder-mdd 2024-06-05 04:22:48 daily 0.1 https://demo.pharmafocusasia.com/news/bioversys-secures-non-dilutive-funding-from-cf-amr-syndicate-collaborative-discovery-programme 2024-06-05 04:15:26 daily 0.1 https://demo.pharmafocusasia.com/news/syngene-introduces-innovative-platform-for-quick-and-enhanced-protein-production 2024-06-05 03:48:52 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-boosts-venture-investment-focus-to-drive-drug-discovery-innovation-and-foster-ecosystem-platform 2024-06-04 01:15:35 daily 0.1 https://demo.pharmafocusasia.com/news/7-hills-pharma-secures-47-million-grant-to-advance-first-of-its-kind-cellgene-therapy-technology-into-clinical-trials 2024-06-04 01:00:31 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-enhances-syndromic-testing-in-malaysia-with-mda-approval-of-advanced-qiastat-dx-respiratory-panel 2024-06-04 00:55:39 daily 0.1 https://demo.pharmafocusasia.com/news/invivyd-and-us-fda-collaborate-on-streamlined-path-for-covid-19-prevention-and-treatment-with-serial-monoclonal-antibodies 2024-06-03 04:23:37 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-modernas-rsv-vaccine-mresviar 2024-06-03 04:19:27 daily 0.1 https://demo.pharmafocusasia.com/news/ema-grants-orphan-drug-status-to-sn-biosciences-nano-anti-cancer-drug-snb-101-for-small-cell-lung-cancer 2024-06-03 04:14:11 daily 0.1 https://demo.pharmafocusasia.com/news/larimar-therapeutics-receives-fda-nod-to-join-start-pilot-program-for-nomlabofusp-in-friedreichs-ataxia 2024-05-31 01:55:09 daily 0.1 https://demo.pharmafocusasia.com/news/dupilumab-dupixent-recommended-for-copd-treatment-approval-by-eu-chmp 2024-05-31 01:36:10 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-and-myriad-genetics-team-up-to-create-global-hrd-test-for-research-and-companion-diagnostics 2024-05-31 01:28:07 daily 0.1 https://demo.pharmafocusasia.com/news/roches-inavolisib-receives-fda-priority-review-for-advanced-hormone-receptor-positive-her2-negative-breast-cancer-with-pik3ca-mutation 2024-05-30 01:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/fusion-pharmaceuticals-acquisition-by-astrazeneca-gets-shareholder-approval 2024-05-30 01:11:21 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-and-cepi-partner-to-enhance-africas-mrna-vaccine-ecosystem 2024-05-30 01:02:10 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-initial-interchangeable-biosimilar-for-two-rare-conditions 2024-05-29 03:35:20 daily 0.1 https://demo.pharmafocusasia.com/news/cytek-biosciences-gains-approval-for-1-laser-and-2-laser-6-color-tbnk-reagents-for-clinical-use-in-china 2024-05-29 03:31:23 daily 0.1 https://demo.pharmafocusasia.com/news/aprea-therapeutics-safety-review-committee-approves-800-mg-dosing-of-atrn-119-in-aboya-119-trial 2024-05-29 03:27:13 daily 0.1 https://demo.pharmafocusasia.com/news/datopotamab-deruxtecan-demonstrates-clinically-significant-increase-in-overall-survival-compared-to-chemotherapy-for-advanced-nonsquamous-non-small-cell-lung-cancer 2024-05-28 01:16:34 daily 0.1 https://demo.pharmafocusasia.com/news/fda-prioritizes-review-of-sarclisa-for-newly-diagnosed-multiple-myeloma-patients-excluded-from-transplant-eligibility 2024-05-28 01:10:23 daily 0.1 https://demo.pharmafocusasia.com/news/roche-and-hitachi-high-tech-extend-their-46-year-collaboration-enabling-further-progress-in-diagnostic-testing 2024-05-28 01:05:25 daily 0.1 https://demo.pharmafocusasia.com/news/dizal-unveils-new-biomarker-analysis-data-showcasing-sunvozertinibs-effectiveness-for-treating-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations 2024-05-28 01:02:40 daily 0.1 https://demo.pharmafocusasia.com/news/providence-collaborates-with-ontario-institute-for-cancer-research-to-explore-mrna-therapeutics 2024-05-24 01:25:34 daily 0.1 https://demo.pharmafocusasia.com/news/laekna-gains-fda-approval-for-phase-iii-trial-of-lae002-afuresertib-and-lae001-in-prostate-cancer-treatment 2024-05-24 01:18:27 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-strengthens-late-stage-pipeline-and-expands-immunology-portfolio-with-acquisition-of-human-immunology-biosciences 2024-05-23 00:43:10 daily 0.1 https://demo.pharmafocusasia.com/news/gccl-enhances-genecell-therapy-clinical-trials-through-ddpcr-technology 2024-05-23 00:35:15 daily 0.1 https://demo.pharmafocusasia.com/news/cartesian-therapeutics-receives-fda-rmat-designation-for-descartes-08-to-treat-myasthenia-gravis 2024-05-23 00:29:51 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-and-bioconnection-join-forces-to-offer-integrated-biopharmaceutical-development-and-manufacturing-solutions 2024-05-23 00:25:51 daily 0.1 https://demo.pharmafocusasia.com/news/mira-pharmaceuticals-and-memorial-sloan-kettering-in-talks-to-partner-on-preclinical-cancer-pain-model-utilizing-new-oral-ketamine-analog 2024-05-22 01:17:54 daily 0.1 https://demo.pharmafocusasia.com/news/new-cas-biofinder-platform-revolutionizes-drug-discovery-with-cutting-edge-insights-innovation-and-efficiency 2024-05-22 01:08:42 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-therapeutics-gains-fda-fast-track-status-for-pioneering-sarna-therapy-rag-01-for-bladder-cancer 2024-05-22 01:04:17 daily 0.1 https://demo.pharmafocusasia.com/news/zymfentra-infliximab-dyyb-demonstrates-enduring-efficacy-and-safety-in-maintenance-treatment-for-adults-with-moderately-to-severely-active-crohns-disease-and-ulcerative-colitis 2024-05-21 01:04:24 daily 0.1 https://demo.pharmafocusasia.com/news/duoning-and-bioelectronica-collaborate-to-launch-advanced-single-cell-sorting-system-for-antibody-discovery 2024-05-21 00:57:02 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-nmpa-acceptance-of-nda-for-ibi311-igf-1r-antibody-to-treat-thyroid-eye-disease-in-china 2024-05-21 00:52:58 daily 0.1 https://demo.pharmafocusasia.com/news/vicore-announces-favorable-outcomes-from-phase-2a-air-trial-showing-buloxibutids-36-week-lung-function-improvement-in-idiopathic-pulmonary-fibrosis-patients 2024-05-20 07:44:28 daily 0.1 https://demo.pharmafocusasia.com/news/parallel-bio-introduces-novel-clinical-trial-methodology-using-organoids-for-accelerated-drug-discovery 2024-05-17 04:18:58 daily 0.1 https://demo.pharmafocusasia.com/news/voyager-therapeutics-doses-first-participants-in-vy-tau01-trial-for-alzheimers-disease 2024-05-17 01:26:38 daily 0.1 https://demo.pharmafocusasia.com/news/arexvy-the-first-rsv-vaccine-for-older-adults-granted-approval-by-hsa 2024-05-16 01:26:16 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-therapeutics-receives-approval-from-chinas-nmpa-to-commence-phase-1-clinical-trials-for-rag-17-in-sod1-als-patients 2024-05-16 01:07:00 daily 0.1 https://demo.pharmafocusasia.com/news/ocugen-completes-dosing-of-stargardt-disease-patients-in-phase-12-gardian-trial-for-ocu410st-gene-therapy 2024-05-16 01:03:19 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-introduces-nefecon-to-mainland-china-with-commercial-launch-and-first-prescription 2024-05-15 01:51:22 daily 0.1 https://demo.pharmafocusasia.com/news/zai-labs-application-for-priority-review-of-efgartigimod-alfa-injection-accepted-for-chronic-inflammatory-demyelinating-polyneuropathy-cidp-in-china 2024-05-15 01:37:19 daily 0.1 https://demo.pharmafocusasia.com/news/launch-of-tiopronin-delayed-release-tablets-with-patient-support-for-cystinuria-treatment-in-the-united-states 2024-05-14 01:18:00 daily 0.1 https://demo.pharmafocusasia.com/news/mabwell-updates-on-clinical-trial-development-of-9mw2821-for-triple-negative-breast-cancer 2024-05-14 01:11:42 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-commences-raphael-registrational-phase-iii-trial-of-hmpl-306-for-chinese-patients-with-idh1-andor-idh2-mutated-relapsedrefractory-acute-myeloid-leukemia 2024-05-14 01:07:58 daily 0.1 https://demo.pharmafocusasia.com/news/qiagens-syndromic-qiastat-dx-test-granted-fda-clearance-for-rapid-and-accurate-respiratory-disease-diagnosis 2024-05-13 07:01:15 daily 0.1 https://demo.pharmafocusasia.com/news/dupixent-dupilumab-under-fda-priority-review-for-adolescent-chronic-rhinosinusitis-with-nasal-polyposis-treatment 2024-05-13 06:56:02 daily 0.1 https://demo.pharmafocusasia.com/news/sn-bioscience-granted-fda-fast-track-status-for-small-cell-lung-cancer-therapy 2024-05-10 01:43:32 daily 0.1 https://demo.pharmafocusasia.com/news/arcellx-and-kite-continue-progress-with-advances-in-anito-cel-multiple-myeloma-program 2024-05-10 01:38:33 daily 0.1 https://demo.pharmafocusasia.com/news/cytomx-therapeutics-shares-positive-phase-1a-dose-escalation-findings-for-monotherapy-cx-904-egfrxcd3-probody-t-cell-engager 2024-05-09 01:49:34 daily 0.1 https://demo.pharmafocusasia.com/news/proqr-unveils-preclinical-proof-of-concept-findings-for-ax-0810-axiomer-rna-editing-initiative-targeting-ntcp-in-combatting-cholestatic-conditions 2024-05-09 01:26:22 daily 0.1 https://demo.pharmafocusasia.com/news/bioversys-expands-collaboration-with-gsk-and-boosts-series-c-funding-by-chf-123-million 2024-05-08 01:17:06 daily 0.1 https://demo.pharmafocusasia.com/news/nsg-biolabs-drives-biotech-innovation-in-singapore-and-southeast-asia-through-enterprisesg-and-merck-collaborations-supported-by-investments-from-celadon-partners-and-clavystbio 2024-05-08 01:07:59 daily 0.1 https://demo.pharmafocusasia.com/news/adcentrx-therapeutics-receives-ind-clearance-from-china-nmpa-for-adrx-0706-a-novel-nectin-4-adc-aimed-at-advanced-solid-tumors 2024-05-07 01:19:06 daily 0.1 https://demo.pharmafocusasia.com/news/bioatla-receives-fda-clearance-for-investigational-new-drug-application-for-ba3361-a-cab-nectin-4-antibody-drug-conjugate-targeting-multiple-tumors 2024-05-07 01:14:56 daily 0.1 https://demo.pharmafocusasia.com/news/vyne-therapeutics-receives-fda-clearance-for-ind-application-of-vyn202-a-unique-bd2-selective-bet-inhibitor 2024-05-07 01:07:07 daily 0.1 https://demo.pharmafocusasia.com/news/discovery-of-a-lesser-known-choline-transporter-in-the-brain-highlights-potential-therapeutic-avenue-for-age-related-cognitive-decline-and-alzheimers-disease 2024-05-06 06:31:09 daily 0.1 https://demo.pharmafocusasia.com/news/calliditas-announces-positive-topline-results-from-phase-2-trial-of-setanaxib-its-lead-nox-inhibitor-candidate-in-head-and-neck-cancer 2024-05-06 06:26:19 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-launches-new-secondary-analysis-solution-tailored-for-oncology-and-inherited-disease-bioinformatics-workflows 2024-05-03 03:29:44 daily 0.1 https://demo.pharmafocusasia.com/news/immunitybio-and-serum-institute-of-india-reach-exclusive-agreement-for-global-bcg-supply-in-treating-all-cancer-types 2024-05-03 01:33:59 daily 0.1 https://demo.pharmafocusasia.com/news/galecto-starts-phase-2-trial-with-first-patient-dosed-in-investigator-initiated-study-combining-gb1211-and-pembrolizumab 2024-05-02 04:32:04 daily 0.1 https://demo.pharmafocusasia.com/news/aileron-therapeutics-announces-positive-results-from-first-cohort-of-phase-1b-clinical-trial-assessing-lti-03-for-idiopathic-pulmonary-fibrosis-ipf 2024-05-02 04:15:34 daily 0.1 https://demo.pharmafocusasia.com/news/ono-announces-agreement-to-acquire-deciphera-pharmaceuticals 2024-05-02 03:59:40 daily 0.1 https://demo.pharmafocusasia.com/news/soleno-therapeutics-secures-fda-breakthrough-therapy-designation-for-dccr-extended-release-tablets-targeting-prader-willi-syndrome-pws 2024-04-30 01:16:48 daily 0.1 https://demo.pharmafocusasia.com/news/aribio-granted-ema-authorization-for-phase-3-clinical-trial-of-ar1001-in-alzheimers-treatment-polaris-ad 2024-04-29 04:44:37 daily 0.1 https://demo.pharmafocusasia.com/news/hyundai-bioscience-reveals-clinical-strategy-for-niclosamide-based-metabolic-anticancer-treatment-aimed-at-p53-mutation-associated-cancer 2024-04-26 01:59:15 daily 0.1 https://demo.pharmafocusasia.com/news/avistone-secures-approval-for-vebreltinib-as-initial-met-tki-therapy-for-rare-brain-glioma-subtype-in-china 2024-04-26 01:52:53 daily 0.1 https://demo.pharmafocusasia.com/news/apollomics-receives-approval-in-china-for-vebreltinib-a-novel-treatment-targeting-gliomas-with-met-fusion-gene 2024-04-26 01:39:40 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-secures-fda-approval-for-otc-naloxone-hydrochloride-nasal-spray-to-treat-opioid-overdose-emergencies 2024-04-25 01:20:11 daily 0.1 https://demo.pharmafocusasia.com/news/nektar-therapeutics-exercises-license-option-with-biolojic-design-for-ai-crafted-agonistic-antibody-aimed-at-tnfr2-to-treat-autoimmune-diseases 2024-04-25 01:08:35 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-gets-nda-approval-for-toripalimab-in-hong-kong 2024-04-25 01:04:29 daily 0.1 https://demo.pharmafocusasia.com/news/beigenes-tislelizumab-granted-european-commission-approval-for-non-small-cell-lung-cancer-treatment 2024-04-24 01:03:59 daily 0.1 https://demo.pharmafocusasia.com/news/genscript-singapore-hosts-open-day-showcasing-cutting-edge-ai-advancements-in-recombinant-protein-production-and-drug-discovery 2024-04-24 00:59:12 daily 0.1 https://demo.pharmafocusasia.com/news/hanmi-enters-clinical-trial-collaboration-and-supply-pact-with-msd-to-assess-bh3120-with-keytruda 2024-04-24 00:50:08 daily 0.1 https://demo.pharmafocusasia.com/news/enlivex-initiates-dosing-of-initial-two-patients-in-phase-iii-trial-to-evaluate-allocetra-for-knee-osteoarthritis 2024-04-23 01:39:50 daily 0.1 https://demo.pharmafocusasia.com/news/osr-holdings-and-sillajen-collaborate-to-develop-new-therapies-and-expand-into-the-us-market 2024-04-23 01:35:23 daily 0.1 https://demo.pharmafocusasia.com/news/bgi-genomics-launches-first-clinical-laboratory-in-uruguay-spearheading-innovation 2024-04-22 06:33:53 daily 0.1 https://demo.pharmafocusasia.com/news/tiziana-life-sciences-reveals-results-of-study-on-intranasal-anti-cd3-foralumab-in-multiple-sclerosis-patients-highlighting-pira-significance-in-neurology-today 2024-04-20 01:57:52 daily 0.1 https://demo.pharmafocusasia.com/news/proqr-successfully-protects-axiomer-ip-portfolio-from-new-challenge 2024-04-20 01:44:51 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-pharmaceuticals-announces-progress-of-suzetrigine-vx-548-in-addressing-acute-and-neuropathic-pain 2024-04-19 03:14:05 daily 0.1 https://demo.pharmafocusasia.com/news/pharmather-provides-update-of-its-priority-original-abbreviated-new-drug-application-for-ketamine 2024-04-19 01:52:54 daily 0.1 https://demo.pharmafocusasia.com/news/taigen-successfully-concludes-phase-iii-study-of-tg-1000 2024-04-18 03:34:55 daily 0.1 https://demo.pharmafocusasia.com/news/evaxions-phase-2-clinical-trial-sees-progress-initial-patient-receives-dosing-with-personalized-cancer-vaccine-evx-01 2024-04-18 03:18:28 daily 0.1 https://demo.pharmafocusasia.com/news/abvc-biopharma-secures-global-licensing-agreement-for-nsclc-treatment-projecting-1375m-in-income-and-up-to-1250m-in-royalties 2024-04-18 02:00:12 daily 0.1 https://demo.pharmafocusasia.com/news/precision-biosciences-concludes-partnership-with-prevail-therapeutics-and-resumes-programs 2024-04-17 01:54:49 daily 0.1 https://demo.pharmafocusasia.com/news/scg-cell-therapy-and-astar-collaborate-on-joint-labs-investing-close-to-s30-million-to-advance-ipsc-technology-for-scalable-gmp-manufacturing-of-cellular-immunotherapies 2024-04-17 01:51:04 daily 0.1 https://demo.pharmafocusasia.com/news/enlivex-receives-approval-from-danish-regulatory-agency-for-phase-iii-trial-investigating-allocetra-in-patients-with-knee-osteoarthritis 2024-04-17 01:50:45 daily 0.1 https://demo.pharmafocusasia.com/news/expansion-study-for-bile-tract-cancer-commences-following-approval-of-imugenes-mast-trial-high-dose-cohort 2024-04-16 04:27:05 daily 0.1 https://demo.pharmafocusasia.com/news/reviva-and-fda-reach-consensus-on-brilaroxazine-clinical-trials-for-schizophrenia-nda 2024-04-16 04:06:48 daily 0.1 https://demo.pharmafocusasia.com/news/bc-platforms-and-ntt-group-announce-inaugural-ceremony-for-exclusive-collaboration-and-debut-of-japanese-precision-medicine-platform 2024-04-15 07:24:13 daily 0.1 https://demo.pharmafocusasia.com/news/teva-confirms-ajovy-fremanezumab-effectiveness-and-safety-in-preventing-migraines-with-phase-3-trial-results-in-china 2024-04-12 01:23:28 daily 0.1 https://demo.pharmafocusasia.com/news/sen-jam-pharma-collaborates-with-specialty-manufacturer-for-innovative-anti-inflammatory-injectable 2024-04-12 01:17:49 daily 0.1 https://demo.pharmafocusasia.com/news/maiweijian-becomes-chinas-initial-approved-biosimilar-for-denosumab-120mg 2024-04-10 04:45:02 daily 0.1 https://demo.pharmafocusasia.com/news/phanes-therapeutics-pt217-receives-fast-track-designation-from-fda 2024-04-10 04:39:31 daily 0.1 https://demo.pharmafocusasia.com/news/mitsubishi-tanabe-pharma-america-granted-orphan-drug-exclusivity-for-radicava-ors-edaravone-by-fda 2024-04-10 04:18:27 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-obtains-approval-for-snda-of-toripalimab-for-first-line-renal-cancer-treatment 2024-04-08 03:46:15 daily 0.1 https://demo.pharmafocusasia.com/news/recent-analyses-from-reduce-it-demonstrate-benefits-of-vascepavazkepa-icosapent-ethyl-in-specific-high-risk-cardiovascular-disease-patient-groups 2024-04-08 03:41:46 daily 0.1 https://demo.pharmafocusasia.com/news/tcbp-announces-preliminary-agreement-for-acquisition-of-nk-platform-technologies 2024-04-05 01:29:36 daily 0.1 https://demo.pharmafocusasia.com/news/sophia-genetics-and-strand-life-sciences-forge-fresh-strategic-alliance 2024-04-05 01:25:56 daily 0.1 https://demo.pharmafocusasia.com/news/gwangju-institute-of-science-and-technology-researchers-unveil-innovative-drug-candidate-for-fatty-liver-disease-treatment 2024-04-05 01:21:10 daily 0.1 https://demo.pharmafocusasia.com/news/partner-therapeutics-leukine-sargramostim-granted-approval-in-japan-for-treating-autoimmune-pulmonary-alveolar-proteinosis-apap 2024-04-04 01:41:19 daily 0.1 https://demo.pharmafocusasia.com/news/prozomix-and-ginkgo-bioworks-partner-on-advancing-sustainable-api-manufacturing-through-next-gen-enzyme-development 2024-04-04 01:36:07 daily 0.1 https://demo.pharmafocusasia.com/news/splisense-granted-fda-clearance-for-investigational-new-drug-application-to-initiate-phase-2-trials-of-spl84-in-cystic-fibrosis-treatment 2024-04-04 01:08:57 daily 0.1 https://demo.pharmafocusasia.com/news/initial-dosing-of-patient-commences-in-clinical-study-investigating-yolt-101-for-fh-therapy 2024-04-03 03:55:03 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-bioworks-strengthens-next-gen-car-designs-through-acquisition-of-modulus-therapeutics-cell-therapy-assets 2024-04-03 03:43:51 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-completes-biologics-license-application-for-zanidatamab-targeting-previously-treated-her2-positive-metastatic-biliary-tract-cancer 2024-04-03 03:27:42 daily 0.1 https://demo.pharmafocusasia.com/news/datopotamab-deruxtecan-biologics-license-application-accepted-for-previously-treated-metastatic-hr-positive-her2-negative-breast-cancer-in-the-us 2024-04-02 04:05:02 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-submits-supplemental-biologics-license-application-to-fda-for-iv-maintenance-dosing-of-leqembi-in-early-alzheimers-treatment 2024-04-01 03:22:11 daily 0.1 https://demo.pharmafocusasia.com/news/alebunds-ap303-granted-fda-orphan-drug-designation-for-autosomal-dominant-polycystic-kidney-disease 2024-03-30 01:37:55 daily 0.1 https://demo.pharmafocusasia.com/news/bridge-biotherapeutics-partners-with-emory-university-school-of-medicine-to-investigate-combination-therapy-of-bbt-877-for-krasp53-mutant-nsclc-patients-resistant-to-anti-pd-1-blockade 2024-03-30 01:34:25 daily 0.1 https://demo.pharmafocusasia.com/news/genfleet-and-beigene-announce-trial-partnership-for-phase-ibii-study-of-gfh009-cdk9-inhibitor-and-brukinsa-zanubrutinib-combination-therapy-for-diffuse-large-b-cell-lymphoma 2024-03-30 01:26:05 daily 0.1 https://demo.pharmafocusasia.com/news/breakthrough-discovery-aims-to-reduce-healthcare-costs-associated-with-wound-healing 2024-03-28 01:20:38 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-announces-acceptance-of-savolitinib-snda-in-china-for-locally-advanced-or-metastatic-met-exon-14-nsclc-both-in-treatment-naive-and-previously-treated-patients 2024-03-28 01:15:57 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-receives-approval-for-adzynma-intravenous-injection-1500-in-japan-to-treat-congenital-thrombotic-thrombocytopenic-purpura-cttp 2024-03-27 01:48:20 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-vyloy-zolbetuximab-receives-regulatory-approval-in-japan-for-gastric-cancer-therapy 2024-03-27 01:40:55 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncology-marks-milestone-as-first-patient-receives-dose-in-australian-clinical-trial-for-subcutaneous-formulation-jskn033 2024-03-26 01:13:50 daily 0.1 https://demo.pharmafocusasia.com/news/digmbio-partnered-with-bioduro-sundia-announces-clearance-of-dm5167-a-selective-parp1-inhibitor-for-ind-by-korea-mfds 2024-03-26 01:10:09 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-and-abl-bio-form-partnership-to-advance-development-of-innovative-bispecific-antibody-drug-conjugates-adcs 2024-03-26 01:05:06 daily 0.1 https://demo.pharmafocusasia.com/news/aribio-secures-exclusive-marketing-rights-for-ar1001-to-address-alzheimers-disease-in-china-through-770-million-agreement 2024-03-25 01:51:27 daily 0.1 https://demo.pharmafocusasia.com/news/nurexone-enters-agreement-for-large-scale-preclinical-testing-of-exopten-advancing-spinal-cord-injury-therapy-toward-human-clinical-trials 2024-03-25 01:44:40 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-expands-into-southern-hemisphere-vaccine-market-with-influenza-vaccine-export-to-thailand 2024-03-22 01:26:07 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-launches-registration-phase-for-sovleplenib-trial-targeting-warm-antibody-autoimmune-hemolytic-anemia-in-china 2024-03-22 01:18:43 daily 0.1 https://demo.pharmafocusasia.com/news/23andme-launches-phase-1-trial-for-23me-01473-antibody-targeting-ulbp6 2024-03-21 03:15:52 daily 0.1 https://demo.pharmafocusasia.com/news/senhwa-biosciences-starts-phase-ii-study-of-silmitasertib-for-community-acquired-pneumonia-with-viral-infection-in-taiwan 2024-03-21 01:40:33 daily 0.1 https://demo.pharmafocusasia.com/news/scilex-holding-company-settles-patent-dispute-with-takeda-pharmaceuticals-over-gloperba-label-expansion 2024-03-21 01:33:13 daily 0.1 https://demo.pharmafocusasia.com/news/bill-melinda-gates-medical-research-institute-launches-phase-3-trial-for-tuberculosis-vaccine-candidate 2024-03-20 01:20:43 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-receives-approval-from-singapore-health-sciences-authority-for-nefegan-in-treating-primary-iga-nephropathy-among-adult-patients 2024-03-20 01:17:14 daily 0.1 https://demo.pharmafocusasia.com/news/south-african-medical-research-council-and-thermo-fisher-scientific-collaborate-to-create-center-of-excellence-in-south-africa 2024-03-19 01:47:11 daily 0.1 https://demo.pharmafocusasia.com/news/sanyou-bio-and-biogeometry-team-up-to-develop-innovative-antibody-drug-discovery-platform-driven-by-aigc 2024-03-19 01:34:50 daily 0.1 https://demo.pharmafocusasia.com/news/arrayjets-arrayplex-platform-has-been-selected-by-immunome-for-its-discovery-of-targeted-cancer-therapies 2024-03-18 07:35:27 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-expands-biopharmaceutical-manufacturing-facility-in-singapore 2024-03-16 01:38:46 daily 0.1 https://demo.pharmafocusasia.com/news/biotheus-and-hansoh-pharma-expand-partnership-for-egfrcmet-bispecific-antibody-drug-conjugate-development 2024-03-16 01:34:11 daily 0.1 https://demo.pharmafocusasia.com/news/beigenes-tevimbra-granted-fda-approval-for-advanced-or-metastatic-esophageal-squamous-cell-carcinoma-following-prior-chemotherapy 2024-03-16 01:31:41 daily 0.1 https://demo.pharmafocusasia.com/news/bio-inx-and-rousselot-forge-partnership-to-improve-3d-bioprinting-materials 2024-03-16 01:26:22 daily 0.1 https://demo.pharmafocusasia.com/news/neurobo-pharmaceuticals-receives-approval-from-safety-review-committee-to-advance-phase-2a-trial-for-mash-treatment-with-da-1241 2024-03-14 01:28:00 daily 0.1 https://demo.pharmafocusasia.com/news/radyus-research-and-southern-research-form-strategic-partnership-to-drive-life-sciences-commercialization 2024-03-14 01:17:45 daily 0.1 https://demo.pharmafocusasia.com/news/metabolon-and-cardiff-universitys-division-of-psychological-medicine-and-clinical-neuroscience-join-forces-for-advancing-multiple-sclerosis-research 2024-03-13 06:46:44 daily 0.1 https://demo.pharmafocusasia.com/news/domain-therapeutics-and-chime-biologics-have-agreed-to-collaborate-on-manufacturing-to-advance-a-new-anti-ccr8-antibody-for-cancer-immunotherapy 2024-03-13 01:31:04 daily 0.1 https://demo.pharmafocusasia.com/news/alcami-and-tanvex-cdmo-collaborate-to-offer-comprehensive-solutions-for-biologics-developers 2024-03-13 01:26:15 daily 0.1 https://demo.pharmafocusasia.com/news/arecor-and-trx-biosciences-establish-partnership-for-advancing-oral-glp-1-therapy-with-improved-bioavailability 2024-03-13 01:22:14 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-and-pediatric-exclusivities-for-cresemba-isavuconazonium-sulfate-in-pediatric-patients-with-invasive-aspergillosis-and-invasive-mucormycosis 2024-03-12 01:18:54 daily 0.1 https://demo.pharmafocusasia.com/news/tiumbio-to-begin-phase-2-study-for-tu2218-in-cancer-therapy 2024-03-12 01:10:37 daily 0.1 https://demo.pharmafocusasia.com/news/ono-and-harvard-university-forge-university-wide-research-alliance-agreement 2024-03-12 01:04:15 daily 0.1 https://demo.pharmafocusasia.com/news/duke-nus-study-unveils-zika-virus-vaccines-potential-as-brain-cancer-treatment 2024-03-11 01:15:48 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-successfully-completes-acquisition-of-ambrx 2024-03-08 01:52:12 daily 0.1 https://demo.pharmafocusasia.com/news/luye-pharma-launches-zepzelca-lurbinectedin-in-hong-kong-and-macao 2024-03-07 01:51:58 daily 0.1 https://demo.pharmafocusasia.com/news/sonata-therapeutics-and-the-champalimaud-foundation-announce-joint-research-effort-for-snt-3012-targeting-pancreatic-and-colorectal-cancers 2024-03-06 01:42:04 daily 0.1 https://demo.pharmafocusasia.com/news/caris-life-sciences-and-the-beat-childhood-cancer-research-consortium-at-penn-state-university-join-forces-to-enhance-outcomes-for-pediatric-patients 2024-03-06 01:35:12 daily 0.1 https://demo.pharmafocusasia.com/news/medigene-expands-patent-portfolio-in-japan-for-im-tcr-technology-enhancing-tcr-t-safety-and-efficacy 2024-03-05 01:26:34 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-clobetasol-propionate-ophthalmic-suspension-for-post-operative-pain-after-ocular-surgery 2024-03-05 01:22:26 daily 0.1 https://demo.pharmafocusasia.com/news/anheart-therapeutics-and-innovent-announce-chinas-nmpa-acceptance-of-second-new-drug-application-for-taletrectinib-in-first-line-treatment-of-ros1-positive-lung-cancer 2024-03-05 01:11:38 daily 0.1 https://demo.pharmafocusasia.com/news/c4-therapeutics-and-merck-kgaa-darmstadt-germany-team-up-in-strategic-discovery-collaboration-against-critical-oncogenic-proteins 2024-03-05 00:50:18 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-pharma-secures-ind-approval-for-p53-y220c-activator-jab-30300-in-the-us 2024-03-02 01:37:26 daily 0.1 https://demo.pharmafocusasia.com/news/recce-pharmaceuticals-and-murdoch-childrens-research-institute-extend-collaborative-partnership 2024-03-01 01:29:11 daily 0.1 https://demo.pharmafocusasia.com/news/cardiff-oncology-initiates-randomized-trial-for-first-line-ras-mutated-metastatic-colorectal-cancer-treatment-crdf-004 2024-03-01 01:22:25 daily 0.1 https://demo.pharmafocusasia.com/news/scisparc-launches-clinical-trial-for-autism-spectrum-disorder-treatment-commencing-dosing-phase 2024-03-01 01:18:15 daily 0.1 https://demo.pharmafocusasia.com/news/arcutis-and-sato-enter-strategic-collaboration-and-licensing-agreement-for-topical-roflumilast-in-japan 2024-02-29 01:25:39 daily 0.1 https://demo.pharmafocusasia.com/news/biolinerx-initiates-first-patient-dosing-in-randomized-phase-2-combination-clinical-trial-for-motixafortide-in-first-line-pancreatic-cancer-pdac 2024-02-29 01:21:51 daily 0.1 https://demo.pharmafocusasia.com/news/myriad-genetics-and-national-cancer-center-hospital-east-in-japan-partner-on-pan-cancer-mrd-monitoring-clinical-trial-scrum-monstar-screen-3 2024-02-28 03:56:39 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-introduces-ai-driven-biomedical-knowledge-base-for-accelerating-data-enabled-drug-discovery 2024-02-28 03:11:29 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-and-kezar-life-sciences-obtain-ind-approval-from-china-nmpa-for-palizade-trial-in-lupus-nephritis 2024-02-27 01:57:49 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-biological-e-limited-collaborate-to-expedite-dengue-vaccine-availability-in-endemic-areas 2024-02-27 01:52:14 daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-jiangsu-nhwa-establish-strategic-collaboration-to-enhance-patient-access-to-austedo-in-china 2024-02-27 01:45:43 daily 0.1 https://demo.pharmafocusasia.com/news/csl-vifor-and-travere-therapeutics-announce-that-sparsentan-has-obtained-a-positive-chmp-opinion-for-the-treatment-of-iga-nephropathy 2024-02-26 04:21:42 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-partner-eisai-receives-approval-in-japan-for-injection-formulation-of-antiepileptic-drug-fycompa 2024-02-23 01:23:14 daily 0.1 https://demo.pharmafocusasia.com/news/rhythm-pharmaceuticals-reveals-clinical-development-strategy-for-setmelanotide-in-addressing-hypothalamic-obesity-in-japan 2024-02-23 01:18:06 daily 0.1 https://demo.pharmafocusasia.com/news/dyadic-strengthens-collaboration-with-israel-institute-for-biological-research-iibr-to-address-bio-threats-and-emerging-disease-solutions 2024-02-22 01:19:33 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-advanced-therapies-receives-fda-approval-for-manufacturing-iovances-amtagvi-lifileucel-for-advanced-melanoma 2024-02-22 01:14:21 daily 0.1 https://demo.pharmafocusasia.com/news/immuneerings-imm-1-104-receives-fda-fast-track-designation-for-pancreatic-cancer 2024-02-21 00:33:46 daily 0.1 https://demo.pharmafocusasia.com/news/mabwells-innovative-b7-h3-adc-7mw3711-receives-fda-ind-approval 2024-02-21 00:28:42 daily 0.1 https://demo.pharmafocusasia.com/news/cellenkos-receives-approval-to-proceed-with-ck0803-neurotrophic-t-regulatory-cell-therapy-for-second-cohort-in-als-trial 2024-02-20 00:57:55 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceuticals-and-inveniai-collaborate-to-discover-new-therapeutic-targets-through-research-agreement 2024-02-19 05:08:55 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-secures-china-cde-clearance-for-phase-iii-clinical-trial-of-shp2-inhibitor-and-kras-g12c-inhibitor-combination 2024-02-19 04:51:45 daily 0.1 https://demo.pharmafocusasia.com/news/metoject-subcutaneous-injection-pen-for-methotrexate-receives-regulatory-approval-as-autoinjector-in-japan 2024-02-17 01:26:59 daily 0.1 https://demo.pharmafocusasia.com/news/pressure-biosciences-completes-move-to-new-manufacturing-facility-uniting-rd-with-expanded-ultrashear-equipment-development-and-contract-manufacturing 2024-02-16 01:14:02 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-collaborates-with-kelonia-therapeutics-to-develop-innovative-immuno-oncology-therapies 2024-02-16 01:10:05 daily 0.1 https://demo.pharmafocusasia.com/news/carrick-therapeutics-initiates-phase-1b2-clinical-trial-treating-advanced-breast-cancer-patients-with-samuraciclib-in-combination-with-vepdegestrant-first-patient-dosed 2024-02-15 03:08:36 daily 0.1 https://demo.pharmafocusasia.com/news/can-3110-granted-fda-fast-track-status-for-treating-recurrent-high-grade-glioma 2024-02-15 01:56:47 daily 0.1 https://demo.pharmafocusasia.com/news/university-forms-research-partnership-in-precision-medicine-with-bruker 2024-02-15 01:53:48 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-expands-liver-portfolio-with-acquisition-of-cymabay-therapeutics 2024-02-13 03:30:44 daily 0.1 https://demo.pharmafocusasia.com/news/nuvig-launches-clinical-development-for-nvg-2089-its-latest-immune-modulator 2024-02-13 03:26:21 daily 0.1 https://demo.pharmafocusasia.com/news/vicore-pharma-and-nippon-shinyaku-forge-exclusive-license-partnership-for-c21-development-and-marketing-in-japan 2024-02-13 03:22:17 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-submits-revised-application-for-ipx203-new-drug-approval 2024-02-13 03:17:17 daily 0.1 https://demo.pharmafocusasia.com/news/pacira-biosciences-secures-agreement-for-brand-pharmaceuticals-with-premier-inc 2024-02-08 01:43:51 daily 0.1 https://demo.pharmafocusasia.com/news/genprex-partners-with-researchers-to-expand-nonclinical-programs-into-new-therapeutic-indications 2024-02-08 01:40:17 daily 0.1 https://demo.pharmafocusasia.com/news/bridgebio-pharma-and-kyowa-kirin-forge-partnership-with-100-million-upfront-payment-for-exclusive-license-of-infigratinib-in-skeletal-dysplasias-in-japan 2024-02-08 01:35:37 daily 0.1 https://demo.pharmafocusasia.com/news/nouvneu001-hits-milestone-with-successful-dosing-of-first-patient-in-iregene-therapeutics-multicenter-clinical-trial-for-novel-parkinsons-disease-therapy 2024-02-06 03:14:59 daily 0.1 https://demo.pharmafocusasia.com/news/fermions-tyk2-jh2-inhibitor-fz007-119-receives-ind-approval-from-chinas-nmpa 2024-02-06 03:08:15 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-has-revealed-that-the-singapore-health-sciences-authority-has-accepted-the-new-drug-application-for-toripalimab 2024-02-03 01:24:48 daily 0.1 https://demo.pharmafocusasia.com/news/clearmind-medicine-secures-exclusive-long-term-licensing-agreement-with-leading-israeli-research-center 2024-02-02 01:38:08 daily 0.1 https://demo.pharmafocusasia.com/news/pixelgen-technologies-secures-distribution-agreement-in-the-japanese-market 2024-02-02 01:38:47 daily 0.1 https://demo.pharmafocusasia.com/news/infinity-bio-introduces-cutting-edge-antibody-profiling-platform-incorporating-mipsa-technology 2024-02-01 01:28:56 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-protagonist-therapeutics-announce-global-license-and-collaboration-agreement-for-rusfertide-an-advanced-rare-hematology-asset 2024-02-01 01:23:34 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-establishes-regeneron-cell-medicines-through-the-acquisition-of-2seventy-bio-platforms-and-clinical-programs 2024-01-31 03:46:47 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibbs-breyanzi-receives-regulatory-approval-in-the-us-and-japan-for-relapsed-or-refractory-follicular-lymphoma-and-relapsed-or-refractory-mantle-cell-lymphoma 2024-01-31 01:59:11 daily 0.1 https://demo.pharmafocusasia.com/news/gracell-biotechnologies-receives-fda-clearance-for-phase-1-clinical-trial-of-fastcar-t-gc012f-as-an-early-line-therapy-for-multiple-myeloma 2024-01-30 01:02:46 daily 0.1 https://demo.pharmafocusasia.com/news/enhertu-receives-priority-review-in-the-us-for-patients-diagnosed-with-metastatic-her2-positive-solid-tumors 2024-01-30 00:58:48 daily 0.1 https://demo.pharmafocusasia.com/news/redhill-announces-new-uspto-patent-grant-for-talicia-for-h-pylori-treatment-through-2042 2024-01-29 04:08:00 daily 0.1 https://demo.pharmafocusasia.com/news/renalys-pharma-is-introduced-to-bring-groundbreaking-medicines-to-patients-in-japan-and-various-asian-countries 2024-01-29 01:59:06 daily 0.1 https://demo.pharmafocusasia.com/news/jiangsu-alphamab-biopharmaceuticals-3d-medicines-beijing-and-glenmark-have-signed-a-license-agreement-for-kn035-envafolimab-to-be-distributed-globally 2024-01-25 04:34:39 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-launches-wuxia-adcc-plus-to-advance-the-development-and-manufacturing-of-afucosylated-antibodies-enhancing-adcc-effect 2024-01-25 01:14:37 daily 0.1 https://demo.pharmafocusasia.com/news/pharmabcine-initiates-phase-1ab-trial-for-pmc-309-with-keytruda-in-advanced-solid-tumors-first-dose-administered-successfully 2024-01-24 00:49:25 daily 0.1 https://demo.pharmafocusasia.com/news/sciwind-biosciences-announces-encouraging-results-from-the-phase-1-clinical-trial-of-xw004-an-oral-formulation-of-the-long-acting-glp-1-analog-ecnoglutide 2024-01-24 00:44:34 daily 0.1 https://demo.pharmafocusasia.com/news/nk-celltech-obtains-fda-clearance-for-nk010-clinical-trial 2024-01-23 01:03:20 daily 0.1 https://demo.pharmafocusasia.com/news/galderma-has-received-regulatory-approval-for-restylane-shaype-a-novel-hyaluronic-acid-injectable-designed-for-enhancing-the-chin-region 2024-01-22 05:41:53 daily 0.1 https://demo.pharmafocusasia.com/news/the-sanyou-super-trillion-peptide-molecule-discovery-platform-was-officially-launched-today 2024-01-20 01:36:13 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-announces-that-argenx-has-obtained-approval-in-japan-for-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-co-formulated-with-enhanze 2024-01-19 03:06:32 daily 0.1 https://demo.pharmafocusasia.com/news/eiger-and-partner-anges-gain-japan-approval-for-zokinvy-in-progeria-syndromes 2024-01-19 01:35:00 daily 0.1 https://demo.pharmafocusasia.com/news/xenetic-biosciences-inc-and-the-university-of-virginia-have-initiated-a-research-agreement-to-advance-their-oncology-platform-based-on-dnase-technology 2024-01-18 01:56:34 daily 0.1 https://demo.pharmafocusasia.com/news/windtree-therapeutics-and-lees-pharmaceuticals-license-istaroxime-dual-serca2a-activators-and-rostafuroxin-for-greater-chinaasia-pacific 2024-01-18 01:48:40 daily 0.1 https://demo.pharmafocusasia.com/news/willow-and-enterin-collaborate-to-develop-sustainable-intermediates-and-active-pharmaceutical-ingredients-apis 2024-01-17 01:21:29 daily 0.1 https://demo.pharmafocusasia.com/news/nurix-therapeutics-granted-fast-track-designation-by-the-us-fda-for-nx-5948-in-the-treatment-of-relapsed-or-refractory-cll-and-sll 2024-01-17 01:05:19 daily 0.1 https://demo.pharmafocusasia.com/news/carsgens-ct011-secures-nmpa-investigational-new-drug-clearance-for-stage-a-hepatocellular-carcinoma-with-high-recurrence-risk-after-surgical-resection-and-gpc3-positivity 2024-01-16 04:38:35 daily 0.1 https://demo.pharmafocusasia.com/news/syntheticgestalt-and-enamine-forge-partnership-to-develop-ai-driven-model-for-streamlining-drug-discovery 2024-01-12 01:44:12 daily 0.1 https://demo.pharmafocusasia.com/news/genfleet-therapeutics-gfh009-granted-fda-fast-track-and-orphan-drug-designations-for-lymphomas-and-leukemia 2024-01-12 01:36:50 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmeds-sovleplenib-receives-nda-approval-in-china-for-primary-immune-thrombocytopenia-treatment-with-priority-review-status 2024-01-12 01:16:56 daily 0.1 https://demo.pharmafocusasia.com/news/leqembi-receives-approval-for-the-treatment-of-alzheimers-disease-in-china 2024-01-10 01:23:01 daily 0.1 https://demo.pharmafocusasia.com/news/abbisko-therapeutics-has-been-granted-orphan-drug-designation-by-the-european-medicines-agency-ema-for-its-csf-1r-inhibitor-pimicotinib-absk021 2024-01-09 00:43:16 daily 0.1 https://demo.pharmafocusasia.com/news/obi-pharmas-partner-biosion-announces-fda-approval-of-ind-application-for-phase-12-trial-of-obi-992-trop2-adc 2024-01-09 00:30:28 daily 0.1 https://demo.pharmafocusasia.com/news/isomorphic-labs-and-novartis-establish-strategic-collaboration-for-multi-target-research 2024-01-08 04:20:54 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-argo-unveils-multiple-rnai-licensing-agreements-and-establishes-strategic-collaborations-with-novartis 2024-01-08 04:04:51 daily 0.1 https://demo.pharmafocusasia.com/news/praxis-precision-medicines-and-tenacia-biotechnology-have-entered-into-a-licensing-and-collaboration-agreement-for-ulixacaltamide-in-the-greater-china-region 2024-01-06 01:15:02 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-announces-the-acquisition-of-sanreno-therapeutics-in-a-significant-transaction-aimed-at-advancing-innovative-treatments-for-kidney-disease 2024-01-06 01:11:11 daily 0.1 https://demo.pharmafocusasia.com/news/jiangsu-vcare-submits-non-disclosure-agreement-nda-for-vicagrel-capsules-to-us-fda 2024-01-05 01:39:16 daily 0.1 https://demo.pharmafocusasia.com/news/avenzo-therapeutics-licenses-arts-021-a-clinical-stage-cdk2-inhibitor-from-allorion 2024-01-05 01:32:22 daily 0.1 https://demo.pharmafocusasia.com/news/obi-992-secures-fda-approval-to-commence-phase-iii-clinical-trials 2024-01-04 01:39:08 daily 0.1 https://demo.pharmafocusasia.com/news/iaso-bio-and-umoja-biopharma-establish-a-novel-partnership-for-advancing-ex-vivo-and-in-vivo-cell-and-gene-therapies 2024-01-04 01:23:06 daily 0.1 https://demo.pharmafocusasia.com/news/cgbios-novosis-putty-attains-fda-breakthrough-device-designation-paving-the-way-for-expedited-entry-into-the-us-market 2024-01-03 01:42:10 daily 0.1 https://demo.pharmafocusasia.com/news/medilink-therapeutics-and-roche-establish-worldwide-partnership-and-license-agreement-for-the-development-of-advanced-oncology-antibody-drug-conjugate 2024-01-03 01:32:20 daily 0.1 https://demo.pharmafocusasia.com/news/beyfortus-granted-approval-in-china-for-preventing-rsv-disease-in-infants 2024-01-02 06:44:17 daily 0.1 https://demo.pharmafocusasia.com/news/positive-outcomes-revealed-in-interim-analysis-of-rec610-recbios-innovative-adjuvanted-recombinant-shingles-vaccine-clinical-trial-in-the-philippines 2023-12-29 00:50:54 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-and-ctm-bio-make-noteworthy-progress-in-collaborative-development-of-tcr-mimic-antibody-based-multi-specific-t-cell-engager-targeting-wt1hla-a02 2023-12-28 01:31:54 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-and-xuanzhu-partner-on-sintilimab-combination-trial-for-advanced-solid-tumors-in-china 2023-12-28 01:08:16 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-has-received-approval-for-the-new-drug-application-nda-for-nefecon-in-taiwan-aimed-at-treating-primary-iga-nephropathy-in-adult-patients 2023-12-27 01:02:29 daily 0.1 https://demo.pharmafocusasia.com/news/lianbio-enters-into-an-agreement-transferring-rights-for-nbtxr3-in-china-and-other-asian-markets 2023-12-26 04:57:25 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-label-revision-for-brukinsa-zanubrutinib-in-chronic-lymphocytic-leukemia-cll 2023-12-26 01:11:11 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-transfers-its-exclusive-rights-for-tibsovo-to-servier-in-greater-china-and-singapore 2023-12-22 00:54:10 daily 0.1 https://demo.pharmafocusasia.com/news/impact-biotech-secures-fda-approval-for-ind-application-of-padeliporfin-vtp-in-pancreatic-cancer 2023-12-21 01:48:48 daily 0.1 https://demo.pharmafocusasia.com/news/nmpa-approves-mabwells-new-drug-application-for-8mw0511-injection 2023-12-20 03:59:45 daily 0.1 https://demo.pharmafocusasia.com/news/ono-and-evqlv-collaborate-to-utilize-ai-powered-antibody-design-for-the-development-of-novel-antibody-drugs-against-multiple-targets 2023-12-20 01:19:25 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-investigational-new-drug-status-for-rsv-mrna-vaccine-developed-by-rnaimmune-in-collaboration-with-innoforce 2023-12-19 00:48:51 daily 0.1 https://demo.pharmafocusasia.com/news/rnaimmune-secures-fda-approval-for-investigational-new-drug-application-of-mrna-based-respiratory-syncytial-virus-vaccine-rv-1770 2023-12-19 00:43:23 daily 0.1 https://demo.pharmafocusasia.com/news/genequantum-and-biomap-form-strategic-collaboration-to-advance-next-generation-adc-therapeutics 2023-12-18 01:53:39 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-alyglo-10-for-adult-primary-immunodeficiency 2023-12-18 01:48:04 daily 0.1 https://demo.pharmafocusasia.com/news/abelzeta-announces-a-modification-to-its-worldwide-collaboration-and-licensing-agreement-with-janssen-now-extending-to-include-china 2023-12-15 00:48:31 daily 0.1 https://demo.pharmafocusasia.com/news/nona-biosciences-and-pfizer-have-entered-into-a-worldwide-license-agreement-for-hbm9033-an-antibody-drug-conjugate-adc-targeting-msln 2023-12-15 00:43:43 daily 0.1 https://demo.pharmafocusasia.com/news/abbisko-therapeutics-announces-that-its-csf-1r-inhibitor-pimicotinib-absk021-has-been-granted-fast-track-designation-by-the-us-fda 2023-12-14 01:16:29 daily 0.1 https://demo.pharmafocusasia.com/news/nmpa-approves-new-drug-application-for-henlius-anti-pd-1-mab-serplulimab-combined-with-chemotherapy-in-first-line-non-squamous-nsclc-treatment 2023-12-13 01:07:55 daily 0.1 https://demo.pharmafocusasia.com/news/leqembi-scheduled-for-launch-in-japan-for-alzheimers-disease-treatment-on-december-20th 2023-12-13 01:00:52 daily 0.1 https://demo.pharmafocusasia.com/news/mabwells-nectin-4-adc-approved-for-phase-iii-trial-by-cde 2023-12-12 01:41:17 daily 0.1 https://demo.pharmafocusasia.com/news/rafarma-pharmaceutical-discloses-recent-partnerships-with-kelun-lifesciences-pvt-ltd-in-sri-lanka-and-el-salvador-university 2023-12-12 01:42:48 daily 0.1 https://demo.pharmafocusasia.com/news/nmpa-grants-approval-for-sugemalimab-as-first-line-treatment-for-esophageal-squamous-cell-carcinoma-as-announced-by-cstone 2023-12-11 04:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/rigel-pharmaceuticals-and-md-anderson-establish-strategic-collaboration-to-progress-rezlidhia-olutasidenib-in-aml-and-other-cancer-forms 2023-12-11 04:42:38 daily 0.1 https://demo.pharmafocusasia.com/news/abelzeta-pharma-and-astrazeneca-announce-collaboration-for-the-joint-development-of-an-original-glypican-3-gpc3-armored-car-t-therapy-in-china 2023-12-08 01:43:53 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-avzivi-bevacizumab-tnjn-a-biosimilar-referencing-avastin-developed-by-bio-thera-solutions 2023-12-08 01:39:23 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-and-synaffix-broaden-adc-collaboration-after-positive-initial-clinical-signals-from-ongoing-phase-1-study 2023-12-08 01:39:32 daily 0.1 https://demo.pharmafocusasia.com/news/synplogen-and-ginkgo-bioworks-announce-collaborative-efforts-to-boost-worldwide-dna-manufacturing-and-gene-therapy-platform-services-in-japan 2023-12-07 01:06:05 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-therapeutics-advances-to-clinical-stage-with-revolutionary-sarna-medication-rag-01 2023-12-07 00:40:06 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-receives-regulatory-approval-in-macau-for-xpovio-in-the-treatment-of-relapsed-andor-refractory-multiple-myeloma 2023-12-07 00:35:25 daily 0.1 https://demo.pharmafocusasia.com/news/merck-introduces-innovative-ai-solution-for-seamless-integration-of-drug-discovery-and-synthesis 2023-12-06 01:34:05 daily 0.1 https://demo.pharmafocusasia.com/news/clarivate-extends-partnership-with-verisim-life-to-accelerate-and-de-risk-research-and-drug-development 2023-12-06 01:25:25 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-ind-for-carsgens-ct071-in-the-treatment-of-relapsedrefractory-multiple-myeloma-and-relapsedrefractory-primary-plasma-cell-leukemia 2023-12-05 01:30:26 daily 0.1 https://demo.pharmafocusasia.com/news/abbisko-therapeutics-and-merck-finalize-licensing-agreement-for-pimicotinib-absk021 2023-12-05 01:18:58 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-receives-approval-for-investigational-new-drug-application-of-zetomipzomib-in-china 2023-12-04 01:45:02 daily 0.1 https://demo.pharmafocusasia.com/news/psychogenics-has-acquired-the-exclusive-global-license-for-an-ind-ready-ent1-inhibitor-designed-for-the-treatment-of-neuropsychiatric-disorders 2023-12-04 01:36:20 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-announces-the-approval-of-new-drug-applications-for-nefecon-in-the-treatment-of-primary-iga-nephropathy-among-adult-patients-in-south-korea 2023-12-04 01:30:27 daily 0.1 https://demo.pharmafocusasia.com/news/ascendis-pharma-and-teijin-limited-establish-strategic-collaboration-in-japan 2023-11-30 04:03:59 daily 0.1 https://demo.pharmafocusasia.com/news/prism-biolab-and-lilly-collaborate-in-drug-discovery-aimed-at-protein-protein-interaction-target 2023-11-29 01:08:42 daily 0.1 https://demo.pharmafocusasia.com/news/gracell-biotechnologies-fastcar-t-gc012f-receives-fda-clearance-for-phase-12-trial-in-refractory-systemic-lupus-erythematosus 2023-11-28 01:01:48 daily 0.1 https://demo.pharmafocusasia.com/news/xtalpi-and-the-university-of-hong-kongs-advanced-biomedical-instrumentation-centre-establish-collaboration-to-accelerate-deep-tech-commercialization 2023-11-28 00:42:13 daily 0.1 https://demo.pharmafocusasia.com/news/ark-biopharmaceuticals-ak0610-receives-ind-approval-for-rsv-antibody 2023-11-24 00:33:06 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-acceptance-and-priority-review-designation-for-ibi351-new-drug-application-by-chinas 2023-11-24 00:38:45 daily 0.1 https://demo.pharmafocusasia.com/news/xtalpi-and-eddc-announce-a-fresh-collaboration-to-fuel-biomedical-advancements-with-the-integration 2023-11-23 01:24:20 daily 0.1 https://demo.pharmafocusasia.com/news/eirgenixs-breast-cancer-biosimilar-secures-marketing-authorization-from-the-european-commission 2023-11-23 01:19:38 daily 0.1 https://demo.pharmafocusasia.com/news/connect-biopharma-and-simcere-forge-exclusive-licensing-and-collaboration-deal-in-greater-china 2023-11-22 01:32:57 daily 0.1 https://demo.pharmafocusasia.com/news/senhwa-biosciences-granted-fda-approval-for-silmitasertib-phase-ii-study-in-viral-cap 2023-11-22 01:25:19 daily 0.1 https://demo.pharmafocusasia.com/news/porton-advanced-and-ascle-therapeutics-have-established-a-strategic-partnership-to-enhance-the-utilization-of-nk-cells-in-cancer-prevention 2023-11-21 00:44:47 daily 0.1 https://demo.pharmafocusasia.com/news/bioforum-enhances-clinical-trial-technology-and-services-with-validify-acquisition 2023-11-21 00:37:40 daily 0.1 https://demo.pharmafocusasia.com/news/chiesi-group-and-haisco-pharmaceutical-collaborate-on-new-bronchiectasis-treatment 2023-11-20 05:25:15 daily 0.1 https://demo.pharmafocusasia.com/news/sanyous-stal-platform-represents-a-groundbreaking-leap-forward-in-the-realm-of-drug-discovery 2023-11-18 00:55:35 daily 0.1 https://demo.pharmafocusasia.com/news/acrobiosystems-unveils-genetically-modified-dll4-protein-to-accelerate-stem-cell-manufacturing 2023-11-17 01:07:30 daily 0.1 https://demo.pharmafocusasia.com/news/polaris-group-submits-bla-for-adi-peg-20-to-us-fda-for-malignant-pleural-mesothelioma 2023-11-17 00:44:41 daily 0.1 https://demo.pharmafocusasia.com/news/arcellx-and-kite-reveal-an-extended-collaboration-within-their-strategic-partnership 2023-11-16 01:19:29 daily 0.1 https://demo.pharmafocusasia.com/news/chemomab-therapeutics-secures-fda-fast-track-designation-for-cm-101-in-the-treatment-of-primary-sclerosing-cholangitis 2023-11-16 01:12:01 daily 0.1 https://demo.pharmafocusasia.com/news/telix-proposes-acquisition-of-qsam-biosciences-and-its-leading-therapeutic-candidate-cyclosam 2023-11-15 01:22:55 daily 0.1 https://demo.pharmafocusasia.com/news/lexogen-launches-luthor-high-definition-single-cell-3-mrna-seq-kit-paving-the-way-for-a-revolution-in-single-cell-rna-sequencing 2023-11-15 01:27:35 daily 0.1 https://demo.pharmafocusasia.com/news/nona-biosciences-and-genequantum-healthcare-forge-strategic-alliance-to-enhance-early-discovery-of-next-generation-bioconjugates 2023-11-14 03:46:38 daily 0.1 https://demo.pharmafocusasia.com/news/aurinia-pharmaceuticals-and-its-collaborative-partner-otsuka-have-jointly-filed-a-new-drug-application-nda-for-lupkynis-voclosporin-in-japan 2023-11-14 03:32:15 daily 0.1 https://demo.pharmafocusasia.com/news/gc-genome-and-mp-group-enter-into-licensing-agreement 2023-11-14 04:34:10 daily 0.1 https://demo.pharmafocusasia.com/news/rznomics-inc-announces-collaboration-for-clinical-trial-and-supply-agreement-to-evaluate-rz-001-in-combination-with-anti-pdl1-in-liver-cancer-patients 2023-11-14 01:43:46 daily 0.1 https://demo.pharmafocusasia.com/news/eccogene-and-astrazeneca-enter-exclusive-agreement-to-develop-small-molecule-glp-1-receptor-agonist-ecc5004-for-cardiometabolic-conditions 2023-11-10 01:35:08 daily 0.1 https://demo.pharmafocusasia.com/news/casi-pharmaceuticals-receives-regulatory-approval-for-cnct19-from-chinas-nmpa 2023-11-09 00:55:41 daily 0.1 https://demo.pharmafocusasia.com/news/porton-advanced-and-biomap-establish-a-strategic-partnership-for-ai-driven-advancements-in-aav-gene-therapy-development 2023-11-09 00:48:41 daily 0.1 https://demo.pharmafocusasia.com/news/bioray-initiates-phase-i-clinical-trial-for-bry812-a-novel-antibody-drug-conjugate-targeting-liv-1 2023-11-08 01:08:55 daily 0.1 https://demo.pharmafocusasia.com/news/menarini-and-sciclone-partner-for-orserdu-in-china-to-address-advanced-breast-cancer 2023-11-08 01:01:12 daily 0.1 https://demo.pharmafocusasia.com/news/senti-bio-and-celest-therapeutics-announce-new-collaboration-for-clinical-development-of-senti-301a-in-china 2023-11-07 00:53:29 daily 0.1 https://demo.pharmafocusasia.com/news/biotheus-and-biontech-partner-for-bispecific-antibody-in-solid-tumor-treatment 2023-11-07 00:46:56 daily 0.1 https://demo.pharmafocusasia.com/news/fronteo-and-axcelead-ddp-forge-essential-ai-enabled-drug-discovery-support-partnership 2023-11-06 01:56:16 daily 0.1 https://demo.pharmafocusasia.com/news/gc-biopharma-requests-mfds-approval-for-pioneering-recombinant-anthrax-vaccine 2023-11-06 01:50:20 daily 0.1 https://demo.pharmafocusasia.com/news/xtalpi-and-ck-life-sciences-enter-into-agreement-to-create-ai-driven-cancer-molecular-diagnostic-models-with-biomarker-data 2023-11-06 01:42:58 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-and-lupin-enter-into-a-licensing-agreement-to-jointly-promote-saroglitazar 2023-11-04 01:32:24 daily 0.1 https://demo.pharmafocusasia.com/news/felzartamab-granted-breakthrough-therapy-designation-for-primary-membranous-nephropathy 2023-11-03 01:13:00 daily 0.1 https://demo.pharmafocusasia.com/news/chipscreens-new-cs32582-capsules-granted-clinical-approval-for-psoriasis-treatment 2023-11-03 01:07:39 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-and-3sbio-establish-exclusive-licensing-agreement-and-strategic-partnership-for-nofazinlimab-anti-pd-1-antibody-in-mainland-china 2023-11-02 00:56:19 daily 0.1 https://demo.pharmafocusasia.com/news/intron-enters-into-an-evaluation-license-and-option-agreement-for-sal200 2023-11-01 01:15:38 daily 0.1 https://demo.pharmafocusasia.com/news/cstones-sugemalimab-granted-nmpa-approval-for-relapsed-or-refractory-extranodal-nkt-cell-lymphoma 2023-11-01 01:03:37 daily 0.1 https://demo.pharmafocusasia.com/news/rational-vaccines-and-shenzhen-mellow-hope-pharm-industrial-co-ltd-establish-collaboration 2023-10-31 00:58:36 daily 0.1 https://demo.pharmafocusasia.com/news/nurexone-biologic-secures-fda-orphan-drug-designation-to-expedite-development-of-exopten-therapy 2023-10-31 00:49:46 daily 0.1 https://demo.pharmafocusasia.com/news/hengrui-pharmaceuticals-and-merck-kgaa-darmstadt-germany-join-forces-to-advance-innovative-cancer-therapies 2023-10-30 06:42:01 daily 0.1 https://demo.pharmafocusasia.com/news/henlius-strengthens-collaboration-with-intas-to-bring-novel-anti-pd-1-mab-serplulimab-to-europe-and-india 2023-10-30 01:45:28 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-receives-approval-from-the-pharmaceutical-administration-bureau-of-macau-for-nefecon-in-the-treatment-of-primary-iga-nephropathy 2023-10-27 01:49:30 daily 0.1 https://demo.pharmafocusasia.com/news/biosyngens-bst02-secures-fda-approval-for-investigational-new-drug-ind-in-liver-cancer-til-therapy-a-historic-milestone 2023-10-27 01:43:41 daily 0.1 https://demo.pharmafocusasia.com/news/medicenna-therapeutics-administers-initial-dose-in-phase-2-monotherapy-dose-expansion-component-of-ability 2023-10-26 01:25:29 daily 0.1 https://demo.pharmafocusasia.com/news/the-phase-3-clinical-trial-for-first-line-ls-sclc-utilizing-henlius-anti-pd-1-mab-serplulimab-begins-patient-dosing-in-europe 2023-10-26 01:17:29 daily 0.1 https://demo.pharmafocusasia.com/news/life-molecular-imaging-and-sinotau-pharmaceutical-group-announce-regulatory-approval-for-amyloid-pet-imaging-radiopharmaceutical-neuraceq-in-china 2023-10-25 00:49:04 daily 0.1 https://demo.pharmafocusasia.com/news/liantuo-biotech-and-bristol-myers-squibb-enter-into-agreement-for-mavacamten-rights-in-china-and-asian-markets 2023-10-25 00:34:44 daily 0.1 https://demo.pharmafocusasia.com/news/bioray-pharmaceuticals-br105-injection-clinical-trial-application-ind-secures-us-fda-approval 2023-10-25 00:27:31 daily 0.1 https://demo.pharmafocusasia.com/news/mindray-expands-its-cardiac-biomarker-portfolio-with-state-of-the-art-hs-ctni-and-nt-probnp-assays 2023-10-24 03:04:38 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-and-kurma-partners-establish-strategic-collaboration-for-biologics-development-and-manufacturing-for-kurmas-portfolio-companies 2023-10-24 02:00:01 daily 0.1 https://demo.pharmafocusasia.com/news/zhimeng-biopharmas-cb03-granted-orphan-drug-status-by-the-us-fda 2023-10-21 00:55:50 daily 0.1 https://demo.pharmafocusasia.com/news/endeavor-biomedicines-acquires-global-rights-to-hmbd-501-a-next-generation-her3-targeted-antibody-drug 2023-10-20 00:37:13 daily 0.1 https://demo.pharmafocusasia.com/news/china-nmpa-approves-skyline-therapeutics-skg0106-for-neovascular-age-related-macular-degeneration-gene-therapy 2023-10-20 00:21:37 daily 0.1 https://demo.pharmafocusasia.com/news/novavaxs-covid-19-vaccine-nuvaxovid-granted-full-approval-in-singapore 2023-10-19 01:52:36 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-approval-to-orasis-pharmaceuticals-for-qlosi-in-the-management-of-presbyopia 2023-10-19 01:46:46 daily 0.1 https://demo.pharmafocusasia.com/news/elevar-therapeutics-and-jiangsu-hengrui-pharma-partner-for-worldwide-licensing-of-camrelizumab-and-rivoceranib-for-unresectable-hepatocellular-carcinoma 2023-10-18 01:55:37 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-xdc-and-hkstp-partner-to-foster-growth-in-hong-kongs-bioconjugate-drug-sector 2023-10-18 01:45:29 daily 0.1 https://demo.pharmafocusasia.com/news/ideaya-biosciences-announces-phase-2-expansion-for-darovasertib-and-crizotinib-combination-in-gnaq11-mutated-metastatic-cutaneous-melanoma 2023-10-17 00:38:02 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-and-astrazeneca-collaborate-on-phase-iii-study-for-first-line-cllsll-treatment-with-bcl-2-inhibitor-lisaftoclax-and-btk-inhibitor-acalabrutinib 2023-10-16 23:18:15 daily 0.1 https://demo.pharmafocusasia.com/news/foresee-pharmaceuticals-advances-phase-3-trial-for-leuprolide-fp-001-in-central-precocious-puberty 2023-10-16 23:13:52 daily 0.1 https://demo.pharmafocusasia.com/news/medilink-therapeutics-announces-global-license-agreement-and-strategic-collaboration-with-biontech-for-advancing-next-generation-anti-cancer-antibody-drug-conjugates 2023-10-16 03:33:52 daily 0.1 https://demo.pharmafocusasia.com/news/immetas-and-gc-biopharma-collaborate-on-mrna-therapeutics-for-autoimmune-diseases 2023-10-12 22:56:15 daily 0.1 https://demo.pharmafocusasia.com/news/fujitsu-and-riken-develop-ai-technology-for-predicting-protein-structural-changes 2023-10-13 00:33:42 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-biolabs-and-mitsui-fudosan-collaborate-to-enhance-life-science-ecosystems-in-japan 2023-10-13 00:32:12 daily 0.1 https://demo.pharmafocusasia.com/news/monash-university-partners-with-orio-therapeutics-to-transform-regenerative-medicine 2023-10-10 06:09:22 daily 0.1 https://demo.pharmafocusasia.com/news/belite-bio-submits-tinlarebant-phase-3-ga-clinical-trial-application-to-swissmedic 2023-10-10 04:12:23 daily 0.1 https://demo.pharmafocusasia.com/news/gc-biopharma-announces-fda-orphan-drug-designation-for-gc1126a 2023-10-06 05:16:04 daily 0.1 https://demo.pharmafocusasia.com/news/kyowa-kirin-announces-acquisition-of-orchard-therapeutics 2023-10-06 05:14:32 daily 0.1 https://demo.pharmafocusasia.com/news/biomx-completes-patient-dosing-in-phase-1b2a-study-for-bx004-in-cystic-fibrosis 2023-10-06 00:25:26 daily 0.1 https://demo.pharmafocusasia.com/news/transcenta-holding-receives-fda-clearance-to-proceed-with-global-phase-iii-trial-of-osemitamab 2023-10-04 03:16:06 daily 0.1 https://demo.pharmafocusasia.com/news/pharmaessentia-enters-into-global-licence-agreement-with-wuxi-biologics 2023-10-04 03:14:21 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-congratulates-amicus-therapeutics-on-fda-approval-for-pompe-disease-treatment 2023-10-03 03:26:49 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-announces-availability-of-rimegepant-in-hong-kong-for-migraine-management 2023-10-03 03:24:09 daily 0.1 https://demo.pharmafocusasia.com/news/structural-genomics-consortium-and-hitgen-announce-research-collaboration 2023-10-03 01:55:42 daily 0.1 https://demo.pharmafocusasia.com/news/biocity-biopharm-and-astrazeneca-enter-into-collaboration-agreement 2023-09-28 02:53:44 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceutical-enters-into-drug-discovery-collaboration-agreement-with-adimab 2023-09-28 02:51:06 daily 0.1 https://demo.pharmafocusasia.com/news/remegen-obtains-positive-phase-iii-results-for-new-drug-telitacicept 2023-09-27 01:52:52 daily 0.1 https://demo.pharmafocusasia.com/news/gracell-biotechnologies-initiates-phase-1b2-trial-for-gc012f-in-relapsedrefractory-multiple-myeloma 2023-09-27 01:49:15 daily 0.1 https://demo.pharmafocusasia.com/news/genmab-announces-approval-of-epkinlytm-to-treat-relapsed-or-refractory-large-b-cell-lymphoma 2023-09-26 05:32:39 daily 0.1 https://demo.pharmafocusasia.com/news/chime-biologics-enters-into-agreement-with-kings-pharm 2023-09-26 05:35:29 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-receives-approval-for-arexvy-as-the-first-rsv-vaccine-for-older-adults 2023-09-26 05:58:29 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-announced-the-approval-of-leqembi-in-japan 2023-09-25 23:31:31 daily 0.1 https://demo.pharmafocusasia.com/news/chime-biologics-enters-into-agreement-with-panolos-bioscience 2023-09-25 23:32:33 daily 0.1 https://demo.pharmafocusasia.com/news/the-university-of-queensland-and-oxford-nanopore-technologies-announce-research-partnership 2023-09-22 01:56:47 daily 0.1 https://demo.pharmafocusasia.com/news/mabwell-announces-fda-fast-track-designation-to-9mw3011 2023-09-22 01:58:28 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-enters-into-licence-agreement-with-kezar-life-sciences 2023-09-21 01:59:48 daily 0.1 https://demo.pharmafocusasia.com/news/inventiva-and-hepalys-pharma-announce-licence-agreement-to-commercialize-lanifibranor 2023-09-21 01:58:36 daily 0.1 https://demo.pharmafocusasia.com/news/hepagene-therapeutics-receives-fda-clearance-for-hpg7233-thr-beta-agonist-ind-application 2023-09-21 01:55:59 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-and-genentech-enter-into-collaboration-and-licence-agreement 2023-09-20 01:38:19 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-enter-into-agreement-with-novartis 2023-09-20 01:32:05 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-technologies-and-national-cancer-centre-singapore-enter-into-research-collaboration-agreement 2023-09-19 01:44:01 daily 0.1 https://demo.pharmafocusasia.com/news/redhill-biopharma-announces-approval-for-talicia 2023-09-19 01:39:02 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-daiichi-sankyo-recommend-for-approval-of-enhertu 2023-09-16 03:48:59 daily 0.1 https://demo.pharmafocusasia.com/news/oscotec-and-adel-receive-fda-clearance-for-adel-y01 2023-09-15 01:45:50 daily 0.1 https://demo.pharmafocusasia.com/news/mgi-tech-partners-with-national-cancer-centre-singapore 2023-09-15 01:44:32 daily 0.1 https://demo.pharmafocusasia.com/news/dizals-golidocitinib-new-drug-application-accepted-in-china 2023-09-15 01:43:06 daily 0.1 https://demo.pharmafocusasia.com/news/pharmazz-and-sun-pharmaceutical-industries-enter-into-agreement 2023-09-14 06:56:35 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceuticals-announces-fda-acceptance-of-biologics-licence-application-for-entyvio 2023-09-14 06:51:44 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-henlius-biotech-expands-collaboration-with-kgbio-genexine-biologics 2023-09-13 01:46:07 daily 0.1 https://demo.pharmafocusasia.com/news/entera-bio-announces-collaboration-with-opko-biologics 2023-09-13 01:44:04 daily 0.1 https://demo.pharmafocusasia.com/news/biolinerx-receives-fda-approval-of-aphexda-in-combination-with-filgrastim 2023-09-11 22:54:54 daily 0.1 https://demo.pharmafocusasia.com/news/biosyngen-announces-fda-approval-of-phase-clinical-trials-for-brl03 2023-09-11 23:09:49 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-pharmaceutical-collaborates-with-shapetx 2023-09-08 07:35:56 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-pharmaceuticals-and-myricx-bio-enter-into-licence-agreement-for-adc-development 2023-09-08 07:34:21 daily 0.1 https://demo.pharmafocusasia.com/news/clearmind-medicine-collaborates-with-johns-hopkins-university-for-clinical-research 2023-09-07 01:03:44 daily 0.1 https://demo.pharmafocusasia.com/news/skan-research-trust-collaborates-with-university-of-cambridge 2023-09-07 01:06:07 daily 0.1 https://demo.pharmafocusasia.com/news/zenas-biopharma-announces-collaboration-agreement-with-bristol-myers-squibb 2023-09-06 01:50:51 daily 0.1 https://demo.pharmafocusasia.com/news/xtalpi-announces-partnership-with-parthenon-therapeutics 2023-09-06 01:52:39 daily 0.1 https://demo.pharmafocusasia.com/news/fivephusion-commences-deflexifol-at-relapse-trial-with-successful-first-patient-treatment 2023-09-05 23:36:00 daily 0.1 https://demo.pharmafocusasia.com/news/acm-biolabs-announced-positive-phase-i-trial-results-for-sars-cov-2-booster-vaccine 2023-09-05 23:37:35 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-announces-approval-of-calquence-in-china 2023-09-04 02:56:18 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceutical-enters-into-drug-discovery-collaboration-agreement-with-twist-bioscience 2023-09-01 23:31:27 daily 0.1 https://demo.pharmafocusasia.com/news/new-york-structural-biology-centre-and-syncell-partner-for-microscopy-guided-proteomics 2023-09-01 23:28:53 daily 0.1 https://demo.pharmafocusasia.com/news/kyowa-kirin-receives-approval-for-orkedia-tablets-in-japan 2023-08-31 05:53:44 daily 0.1 https://demo.pharmafocusasia.com/news/eucure-and-syncromune-enter-into-technology-transfer-agreement 2023-08-31 05:55:10 daily 0.1 https://demo.pharmafocusasia.com/news/bioskryb-genomics-partners-with-research-instruments 2023-08-30 04:28:53 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-pharmaceutical-announces-the-launch-of-fgfr-inhibitor-lytgobi-in-japan 2023-08-30 04:23:27 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-pharmaceutical-and-phost-in-therapeutics-announce-licence-agreement-on-gnt-v-inhibitor-phox430 2023-08-29 04:32:02 daily 0.1 https://demo.pharmafocusasia.com/news/phebra-and-university-of-wollongong-enter-into-collaboration-agreement 2023-08-29 04:34:24 daily 0.1 https://demo.pharmafocusasia.com/news/immunogen-collaborates-with-takeda-pharmaceuticals-to-develop-and-commercialise-elahere-in-japan 2023-08-28 06:11:56 daily 0.1 https://demo.pharmafocusasia.com/news/specialised-therapeutics-acquires-commercialisation-rights-for-new-motor-neuron-disease-therapy 2023-08-28 01:56:24 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-announces-approval-of-lynparza-in-japan 2023-08-25 07:39:55 daily 0.1 https://demo.pharmafocusasia.com/news/radiopharm-theranostics-expands-supply-agreement-with-terthera-for-terbium-161-isotope-use-in-prostate-cancer 2023-08-28 01:00:14 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-and-vaxxas-enter-joint-development-agreement 2023-08-24 03:02:26 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-announces-approval-of-enhertu-in-japan 2023-08-24 03:01:17 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-astellas-pharma-announce-fda-priority-review-for-xtandi 2023-08-24 03:00:09 daily 0.1 https://demo.pharmafocusasia.com/news/mgi-announces-partnership-with-ngenebio 2023-08-23 01:14:57 daily 0.1 https://demo.pharmafocusasia.com/news/sanyou-biopharmaceuticals-and-sinorda-biomedicine-enter-into-agreement 2023-08-23 01:12:41 daily 0.1 https://demo.pharmafocusasia.com/news/carsgen-therapeutics-collaborates-with-moderna 2023-08-22 03:41:58 daily 0.1 https://demo.pharmafocusasia.com/news/canariabio-receives-fda-orphan-drug-designation-for-mab-ar20-in-pancreatic-cancer 2023-08-22 03:40:26 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-partner-calliditas-therapeutics-announces-fda-approval-of-nefecon 2023-08-21 06:44:11 daily 0.1 https://demo.pharmafocusasia.com/news/nagasaki-university-collaborates-with-nec-oncoimmunity 2023-08-21 06:46:57 daily 0.1 https://demo.pharmafocusasia.com/news/illumina-expands-genomics-capabilities-with-the-opening-of-solutions-centre-in-india 2023-08-19 04:31:06 daily 0.1 https://demo.pharmafocusasia.com/news/sk-biopharmaceuticals-enters-mena-through-strategic-partnership-with-hikma 2023-08-19 04:43:40 daily 0.1 https://demo.pharmafocusasia.com/news/akeso-initiates-phase-3-trial-for-ivonescimab-vs-tislelizumab-in-first-line-squamous-nsclc-treatment 2023-08-19 03:09:52 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-receives-nmpa-approval-of-sintbilo-for-hypercholesterolaemia-treatment 2023-08-17 03:14:59 daily 0.1 https://demo.pharmafocusasia.com/news/cytomed-therapeutics-and-hangzhou-cnk-therapeutics-enter-memorandum-of-understanding 2023-08-16 03:23:50 daily 0.1 https://demo.pharmafocusasia.com/news/venatorx-everest-medicines-accept-new-drug-application-for-cefepime-taniborbactam 2023-08-16 03:25:02 daily 0.1 https://demo.pharmafocusasia.com/news/corium-and-lotus-pharmaceutical-form-exclusive-licence-agreement-for-adlarity 2023-08-11 01:57:55 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-pharmaceuticals-rakuten-medical-sign-exclusive-agreement-for-alluminox-cancer-treatment 2023-08-11 03:24:10 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-enters-into-partnership-with-hansoh-pharma 2023-08-11 03:30:37 daily 0.1 https://demo.pharmafocusasia.com/news/genscript-biotech-collaborates-with-t-maximum-biotech 2023-08-10 06:57:31 daily 0.1 https://demo.pharmafocusasia.com/news/marinomed-biotech-forms-long-term-solv4u-partnership-with-shanghais-sph-sinae-pharmaceuticals 2023-08-10 07:00:28 daily 0.1 https://demo.pharmafocusasia.com/news/lemonexs-mrna-degradaball-vaccine-ind-application-approved-for-phase-1-clinical-trial 2023-08-10 07:03:35 daily 0.1 https://demo.pharmafocusasia.com/news/astex-pharmaceuticals-expands-drug-discovery-collaboration-with-merck 2023-08-09 01:56:50 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-bolsters-strategic-partnership-with-novavax-through-equity-investment 2023-08-09 02:00:50 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-pharmas-glecirasib-kras-g12c-inhibitor-receives-china-cdes-breakthrough-therapy-designation 2023-08-08 03:44:57 daily 0.1 https://demo.pharmafocusasia.com/news/biocity-biopharma-cd3-egfr-bispecific-antibody-granted-fda-clearance-for-ind-application 2023-08-08 03:42:00 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-receives-clearance-from-us-fda-to-proceed-with-phase-iii-clinical-trial-for-lisaftoclax 2023-08-07 05:17:19 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-impact-biotechs-phase-1-clinical-programme-for-padeliporfin-vtp-in-lung-cancer 2023-08-06 03:57:50 daily 0.1 https://demo.pharmafocusasia.com/news/iveric-bio-receives-us-fda-approval-for-izervay 2023-08-06 03:59:50 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-pharmaceutical-and-taiho-oncology-receive-approval-for-lonsurf 2023-08-04 01:58:24 daily 0.1 https://demo.pharmafocusasia.com/news/abvc-biopharma-receives-taiwan-science-park-administrations-approval-for-gmp-production-facility-plan 2023-08-04 02:00:07 daily 0.1 https://demo.pharmafocusasia.com/news/phc-corporation-and-cyfuse-enter-into-agreement 2023-08-04 07:09:28 daily 0.1 https://demo.pharmafocusasia.com/news/abm-therapeutics-announces-us-fda-orphan-drug-designation-to-abm-1310 2023-08-03 08:32:13 daily 0.1 https://demo.pharmafocusasia.com/news/redhill-biopharma-announces-approval-for-talicia 2023-08-04 07:10:14 daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-doer-biologics-announces-phase-i-trial-of-dr10624 2023-08-04 07:09:53 daily 0.1 https://demo.pharmafocusasia.com/news/amarin-and-lotus-pharmaceuticals-announce-exclusive-partnership-to-commercialize-vazkepa 2023-08-01 09:15:49 daily 0.1 https://demo.pharmafocusasia.com/news/zuellig-pharma-enters-into-agreement-with-gsk 2023-08-01 09:12:12 daily 0.1 https://demo.pharmafocusasia.com/news/transcenta-holding-announces-approval-to-initiate-phase-ii-clinical-trial-of-tst002 2023-07-31 09:18:23 daily 0.1 https://demo.pharmafocusasia.com/news/leads-biolabs-receives-approval-for-first-in-human-clinical-trials-of-lbl-034-in-relapsed-multiple-myeloma 2023-07-31 09:20:49 daily 0.1 https://demo.pharmafocusasia.com/news/ayala-pharmaceuticals-and-biosight-enter-into-merger-agreement 2023-07-28 05:56:56 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-vaccines-achieves-gmp-release-for-first-drug-substance-facility-in-china 2023-07-28 05:58:24 daily 0.1 https://demo.pharmafocusasia.com/news/lianbio-partner-tarsus-pharmaceuticals-receives-fda-approval-for-xdemvy 2023-07-27 02:34:15 daily 0.1 https://demo.pharmafocusasia.com/news/hummingbird-bioscience-initiates-hmbd-001-phase-ib-trials-in-australia-and-partners-with-omico 2023-07-27 02:14:29 daily 0.1 https://demo.pharmafocusasia.com/news/fapon-launches-chemiluminescence-immunoassay-analyser 2023-07-27 02:04:18 daily 0.1 https://demo.pharmafocusasia.com/news/haemalogix-enters-into-agreement-with-peter-maccallum-cancer-centre 2023-07-26 03:15:51 daily 0.1 https://demo.pharmafocusasia.com/news/overland-adct-biopharma-announces-biologics-license-application-for-zynlonta 2023-07-25 02:54:49 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceuticals-and-alvotech-announce-update-on-strategic-biosimilars-partnership 2023-07-25 02:53:31 daily 0.1 https://demo.pharmafocusasia.com/news/hanchorbio-announces-approval-for-multi-regional-clinical-trial-of-hcb101 2023-07-25 02:51:55 daily 0.1 https://demo.pharmafocusasia.com/news/daewoong-pharmaceuticals-fexuprazan-enters-africa-in-partnership-with-cooper-pharma 2023-07-24 07:34:26 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-heptares-acquires-idorsias-pharmaceuticals-business-in-japan-and-apac 2023-07-21 03:47:34 daily 0.1 https://demo.pharmafocusasia.com/news/renovorx-collaborates-with-imugene 2023-07-21 03:38:21 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-receives-us-fda-approval-for-vanflyta-first-flt3-inhibitor 2023-07-21 03:53:40 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-accepts-supplemental-new-drug-application-for-toripalimab 2023-07-20 04:03:03 daily 0.1 https://demo.pharmafocusasia.com/news/scg-cell-therapy-opens-state-of-the-art-facility-in-singapore 2023-07-20 04:00:14 daily 0.1 https://demo.pharmafocusasia.com/news/mabwell-announces-the-nmpa-approval-of-novel-trop-2-adc 2023-07-20 07:35:03 daily 0.1 https://demo.pharmafocusasia.com/news/lianbio-partner-nanobiotix-enters-into-licence-agreement-with-janssen 2023-07-20 07:27:22 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-launches-new-sglt-2-inhibitor-esgliteo 2023-07-18 22:49:29 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-pharmaceuticals-and-omron-collaborate-to-enhance-automation-in-drug-discovery-research 2023-07-18 22:45:00 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-pharma-collaborates-with-arrivent-biopharma 2023-07-17 03:31:10 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-receives-regulatory-approval-for-xpovio-in-hong-kong 2023-07-17 00:42:03 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-marketing-authorisation-application-for-zolbetuximab-accepted-by-the-european-medicines-agency 2023-07-17 04:36:41 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-pharmaceutical-omron-and-omron-sinic-x-collaborate-on-testing-human-friendly-lab-automation-system 2023-07-17 03:40:32 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-pharma-collaborates-with-arrivent-biopharma 2023-07-14 03:42:46 daily 0.1 https://demo.pharmafocusasia.com/news/lianbio-announces-clinical-supply-agreement-with-astrazeneca-in-china 2023-07-13 01:31:27 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-beigenes-supplemental-new-drug-application-for-brukinsa 2023-07-13 01:26:39 daily 0.1 https://demo.pharmafocusasia.com/news/avantor-expands-singapore-hub 2023-07-17 05:21:13 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-announces-acceptance-of-the-supplemental-new-drug-application-for-toripalimab 2023-07-17 05:17:58 daily 0.1 https://demo.pharmafocusasia.com/news/biosyngen-receives-us-fda-fast-track-designation-for-brg01 2023-07-17 05:13:00 daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-doer-biologics-announces-licence-agreement-with-biontech 2023-07-11 01:11:49 daily 0.1 https://demo.pharmafocusasia.com/news/hutchmed-initiates-phase-i-study-of-novel-shp2-inhibitor-hmpl-415 2023-07-11 01:08:15 daily 0.1 https://demo.pharmafocusasia.com/news/remegen-collaborates-with-innovent-bio 2023-07-10 22:48:16 daily 0.1 https://demo.pharmafocusasia.com/news/inoviq-and-promega-enter-into-global-joint-marketing-agreement 2023-07-07 06:50:56 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-announce-priority-review-of-us-fda-licence-application-for-zolbetuxima 2023-07-07 06:43:15 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-announce-the-traditional-approval-for-leqembi 2023-07-07 06:32:26 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-pharmaceuticals-and-pheon-therapeutics-announced-a-license-agreement 2023-07-06 06:24:00 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-government-pharmaceutical-organisation-signed-a-memorandum-of-understanding 2023-07-06 06:15:26 daily 0.1 https://demo.pharmafocusasia.com/news/tiumbio-and-hansoh-pharma-announce-clinical-trial-approval-of-hs-10518 2023-07-06 06:06:44 daily 0.1 https://demo.pharmafocusasia.com/news/rarestone-group-received-approval-for-pitolisant-by-chinas-nmpa 2023-07-05 01:39:43 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-pharma-announces-first-clinical-trial-of-tyk2-allosteric-inhibitor-icp-488-in-china 2023-07-05 01:29:16 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-pharma-receives-centre-for-drug-evaluation-approval-for-pivotal-study-of-glecirasib-in-pancreatic-cancer 2023-07-05 01:24:16 daily 0.1 https://demo.pharmafocusasia.com/news/skyline-therapeutics-announces-us-fda-clearance-for-phase-i-iia-clinical-trial-of-skg0106 2023-07-04 05:07:06 daily 0.1 https://demo.pharmafocusasia.com/news/maruho-enters-into-licence-agreement-with-alchemedicine 2023-07-04 04:45:55 daily 0.1 https://demo.pharmafocusasia.com/news/canbridge-to-continue-can008-phase-2-trial-in-glioblastoma-multiforme-in-china 2023-07-04 04:43:26 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-bio-and-iaso-biotechnology-announced-national-medical-products-administration-approval-for-fucaso 2023-07-03 01:08:08 daily 0.1 https://demo.pharmafocusasia.com/news/lifera-enters-into-strategic-collaboration-with-centogene 2023-07-03 01:06:42 daily 0.1 https://demo.pharmafocusasia.com/news/chime-biologics-announces-strategic-cooperation-with-leads-biolabs-and-beigene 2023-07-01 05:34:20 daily 0.1 https://demo.pharmafocusasia.com/news/argenx-and-zai-lab-announces-biologics-licence-application-for-vyvgart 2023-07-01 05:30:53 daily 0.1 https://demo.pharmafocusasia.com/news/biosyngen-opens-new-cell-therapy-gmp-facility-in-singapore 2023-06-30 04:40:28 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-accepts-biologics-licence-application-of-batoclimab 2023-06-30 04:33:01 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-sanofi-announce-positive-results-of-21-valent-pneumococcal-conjugate-vaccine-candidate 2023-06-30 04:23:35 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-gates-ventures-hdr-uk-lifearc-and-the-university-of-edinburgh-announce-new-neurii-research-collaboration 2023-06-29 07:00:52 daily 0.1 https://demo.pharmafocusasia.com/news/ausperbio-announces-investigational-new-drug-application-approval-of-ahb-137 2023-06-29 06:52:28 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-to-open-innovation-hub-for-tumour-microenvironment-research 2023-06-29 06:46:30 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-receives-national-medical-products-administration-approval-for-xigduo-xr 2023-06-28 08:27:50 daily 0.1 https://demo.pharmafocusasia.com/news/specialised-therapeutics-announces-approval-of-minjuvi 2023-06-28 08:23:43 daily 0.1 https://demo.pharmafocusasia.com/news/microba-life-sciences-collaborates-with-queensland-university-of-technology 2023-06-28 08:12:21 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-partners-with-pharmadule-morimatsu 2023-06-27 03:31:45 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-pharmaceuticals-receives-national-medical-products-administration-approval-for-gavreto 2023-06-27 03:17:39 daily 0.1 https://demo.pharmafocusasia.com/news/brii-biosciences-and-qpex-biopharma-enter-into-agreement-to-acquire-global-rights-for-brii-693 2023-06-26 04:22:10 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-enters-into-clinical-trial-collaboration-with-remegen 2023-06-26 04:12:42 daily 0.1 https://demo.pharmafocusasia.com/news/aslan-pharmaceuticals-enters-into-licencing-agreement-with-zenyaku-kogyo 2023-06-23 04:01:03 daily 0.1 https://demo.pharmafocusasia.com/news/sk-pharmteco-expands-production-capacity 2023-06-23 03:51:21 daily 0.1 https://demo.pharmafocusasia.com/news/amarin-corporation-receives-saudi-food-and-drug-authority-approval-for-vascepa 2023-06-22 01:26:04 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-receives-emergency-use-listing-for-skycovione 2023-06-22 01:05:08 daily 0.1 https://demo.pharmafocusasia.com/news/tg-immunopharma-receives-fda-approval-to-initiate-clinical-trial-for-tgi-6-bispecific-antibody 2023-06-20 01:48:29 daily 0.1 https://demo.pharmafocusasia.com/news/vaxxas-opens-world-class-manufacturing-facility 2023-06-19 05:32:39 daily 0.1 https://demo.pharmafocusasia.com/news/tg-immunopharma-announces-fda-clearance-for-clinical-trial-of-tgi-6 2023-06-17 05:06:10 daily 0.1 https://demo.pharmafocusasia.com/news/cholesgen-enters-into-drug-discovery-collaboration-and-agreement-with-astrazeneca 2023-06-17 04:21:36 daily 0.1 https://demo.pharmafocusasia.com/news/mabwell-receives-us-fda-approval-of-clinical-trial-application-for-9mw3811 2023-06-16 05:14:54 daily 0.1 https://demo.pharmafocusasia.com/news/biostar-pharma-announces-approval-of-utidelone-injectable-phase-multi-national-clinical-trial 2023-06-16 05:10:41 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-enters-into-collaboration-and-option-agreement-with-cullgen 2023-06-15 05:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/pistoia-alliance-partners-with-matador 2023-06-15 05:47:08 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-pharmaceutical-submits-a-new-drug-application-for-crovalimab-in-japan 2023-06-15 05:43:51 daily 0.1 https://demo.pharmafocusasia.com/news/senju-pharmaceutical-and-novaliq-enter-into-licence-agreement 2023-06-14 05:12:36 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-announces-approval-of-soliris-in-china 2023-06-14 05:07:02 daily 0.1 https://demo.pharmafocusasia.com/news/simcere-pharmaceutical-group-announces-research-agreement-with-mass-general-brigham 2023-06-14 04:40:36 daily 0.1 https://demo.pharmafocusasia.com/news/hanall-biopharma-and-daewoong-pharmaceutical-co-invest-in-vincere-biosciences 2023-06-12 12:26:47 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-japan-and-mitsubishi-tanabe-pharma-corporation-announce-new-launch-of-mounjaro 2023-06-12 12:23:01 daily 0.1 https://demo.pharmafocusasia.com/news/westvac-biopharma-receives-emergency-use-authorisation-for-coviccine-trivalent-xbb 2023-06-09 06:25:42 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-and-kate-therapeutics-enter-into-licence-agreement-for-kt430 2023-06-09 06:19:22 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-collaborates-with-pfizer 2023-06-08 03:10:38 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-fosun-pharmaceutical-group-partners-with-ifc 2023-06-07 03:46:32 daily 0.1 https://demo.pharmafocusasia.com/news/sol-gel-technologies-enters-into-licence-agreement-with-searchlight-pharma 2023-06-08 02:01:23 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-american-regent-announce-approval-of-injectafer-a 2023-06-06 02:00:30 daily 0.1 https://demo.pharmafocusasia.com/news/biondvax-pharmaceuticals-signs-exclusive-licence-agreement-to-develop-and-commercialise-novel-anti-il-17-antibody 2023-06-06 01:50:48 daily 0.1 https://demo.pharmafocusasia.com/news/nrx-pharmaceuticals-lotus-pharmaceuticals-and-alvogen-collaborate-to-develop-and-commercialise-nrx-101 2023-06-06 01:33:02 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-receives-chinas-national-medical-products-administration-approval-for-olverembatinib 2023-06-03 03:16:33 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-announces-exclusive-licence-agreement-with-cedilla-therapeutics 2023-06-02 05:34:39 daily 0.1 https://demo.pharmafocusasia.com/news/lonza-acquires-synaffix 2023-06-02 05:28:49 daily 0.1 https://demo.pharmafocusasia.com/news/astrea-bioseparations-joins-biotage-enabling-groundbreaking-chromatography-solutions 2023-06-02 04:13:19 daily 0.1 https://demo.pharmafocusasia.com/news/vazyme-enters-into-global-strategic-collaboration-agreement-with-azenta 2023-06-01 06:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-announces-approval-of-abrysvo 2023-06-01 06:44:04 daily 0.1 https://demo.pharmafocusasia.com/news/rp-a501-gene-therapy-granted-priority-medicines-designation-by-rocket-pharmaceuticals 2023-06-01 06:34:53 daily 0.1 https://demo.pharmafocusasia.com/news/sgs-receives-who-pqt-approval-for-its-navi-mumbai-laboratory-bolstering-support-to-the-global-pharma-industry 2023-05-31 05:30:53 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-and-philogen-enter-into-an-exclusive-distribution-licence-and-supply-agreement 2023-05-30 01:57:56 daily 0.1 https://demo.pharmafocusasia.com/news/the-university-of-sydney-enters-into-memorandum-of-understanding-with-pharos-therapeutics 2023-05-30 01:56:06 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-announces-fda-approval-of-paxlovid-for-adult-patients 2023-05-26 00:44:12 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-janssen-pharmaceuticals-collaborate-to-receive-fda-fast-track-designation-for-milvexian 2023-05-26 00:42:14 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-hutchmed-announce-fda-new-drug-application-forfruquintinib 2023-05-26 00:39:59 daily 0.1 https://demo.pharmafocusasia.com/news/pyxis-oncology-acquires-apexigen 2023-05-25 01:48:29 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-partners-with-the-governments-of-canada-and-british-columbia 2023-05-25 01:48:14 daily 0.1 https://demo.pharmafocusasia.com/news/clearpoint-neuro-enters-into-licence-agreement-with-ucb 2023-05-25 01:47:56 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-collaborates-with-life-edit-therapeutics 2023-05-25 00:55:57 daily 0.1 https://demo.pharmafocusasia.com/news/pharmabcine-receives-ind-approval-from-the-korean-mfds 2023-05-24 03:27:13 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-collaborates-with-veeva-systems 2023-05-24 03:23:04 daily 0.1 https://demo.pharmafocusasia.com/news/rocket-pharmaceuticals-receives-fda-regenerative-medicine-advanced-therapy 2023-05-24 03:22:41 daily 0.1 https://demo.pharmafocusasia.com/news/cohbar-and-morphogenesis-enter-into-merger-agreement 2023-05-24 01:18:34 daily 0.1 https://demo.pharmafocusasia.com/news/inovio-receives-european-commission-orphan-drug-designation-for-ino-3107 2023-05-24 01:17:03 daily 0.1 https://demo.pharmafocusasia.com/news/blueprint-medicines-announces-us-fda-approval-of-ayvakit 2023-05-23 05:16:19 daily 0.1 https://demo.pharmafocusasia.com/news/sangamo-therapeutics-receives-us-fda-fast-track-designation-for-isaralgagene-civaparvovec 2023-05-23 05:16:29 daily 0.1 https://demo.pharmafocusasia.com/news/castle-biosciences-opens-new-state-of-the-art-laboratory 2023-05-23 03:40:50 daily 0.1 https://demo.pharmafocusasia.com/news/coherus-biosciences-announces-us-launch-of-udenyca-autoinjector 2023-05-23 03:38:11 daily 0.1 https://demo.pharmafocusasia.com/news/ironwood-pharmaceuticals-enters-into-agreement-to-acquire-vectivbio 2023-05-22 07:32:27 daily 0.1 https://demo.pharmafocusasia.com/news/centessa-pharmaceuticals-receives-us-fda-fast-track-designation 2023-05-22 07:13:46 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-announces-us-fda-fast-track-designation-for-asundexian-atrial-fibrillation-programme 2023-05-21 23:53:45 daily 0.1 https://demo.pharmafocusasia.com/news/rznomics-received-fda-approval-to-initiate-clinical-development-of-trans-splicing-ribozyme-based-rna 2023-05-20 01:32:18 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-announces-us-fda-approval-of-epkinly 2023-05-20 01:30:06 daily 0.1 https://demo.pharmafocusasia.com/news/krystal-biotech-receives-fda-approval-for-vyjuvek 2023-05-20 01:27:05 daily 0.1 https://demo.pharmafocusasia.com/news/asieris-pharmaceuticals-announces-strategic-partnership-with-uroviu 2023-05-19 02:53:23 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-announces-us-fda-approval-for-rinvoq 2023-05-20 01:20:10 daily 0.1 https://demo.pharmafocusasia.com/news/revvity-announces-new-licence-agreement-with-astrazeneca 2023-05-19 01:13:54 daily 0.1 https://demo.pharmafocusasia.com/news/galera-therapeutics-announces-fda-orphan-drug-designation-for-rucosopasem 2023-05-19 01:06:26 daily 0.1 https://demo.pharmafocusasia.com/news/ksq-therapeutics-and-takeda-expand-strategic-immuno-oncology-collaboration 2023-05-18 01:03:19 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-clearance-of-us-ind-for-the-phase-i-trial 2023-05-18 00:59:36 daily 0.1 https://demo.pharmafocusasia.com/news/closed-loop-medicine-and-pharmanovia-enter-into-partnership 2023-05-18 00:50:54 daily 0.1 https://demo.pharmafocusasia.com/news/aitia-enters-into-collaboration-with-servier 2023-05-18 00:47:45 daily 0.1 https://demo.pharmafocusasia.com/news/qsam-biosciences-and-rls-announce-clinical-and-commercial-supply-agreement 2023-05-17 05:53:16 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-announces-manufacturing-partnership-with-inflarx 2023-05-17 05:52:57 daily 0.1 https://demo.pharmafocusasia.com/news/cabaletta-bio-receives-fda-clearance-of-ind-application-for-caba-201 2023-05-17 05:53:44 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-announces-us-fda-acceptance-of-biologics-licence-application-for-tak-755 2023-05-17 03:44:00 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-arcus-biosciences-expand-partnership 2023-05-16 05:26:27 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-announces-acceptance-of-new-drug-submission-for-lecanemab 2023-05-16 05:24:53 daily 0.1 https://demo.pharmafocusasia.com/news/sony-and-astellas-pharma-enter-into-collaborative-research-agreement 2023-05-16 05:22:14 daily 0.1 https://demo.pharmafocusasia.com/news/nuvectis-pharma-announces-fda-clearance-of-nxp900-ind 2023-05-16 05:18:42 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-and-ariceum-therapeutics-sign-a-strategic-research-collaboration 2023-05-12 03:42:46 daily 0.1 https://demo.pharmafocusasia.com/news/kinarus-therapeutics-signs-agreement-with-chaodian-investment-management 2023-05-12 03:41:13 daily 0.1 https://demo.pharmafocusasia.com/news/angelini-pharma-collaborates-with-jcr-pharmaceuticals 2023-05-12 03:39:25 daily 0.1 https://demo.pharmafocusasia.com/news/mitsubishi-tanabe-pharma-announces-approval-of-radivava 2023-05-12 03:18:16 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-and-bicycle-therapeutics-enter-into-strategic-collaboration 2023-05-12 03:19:11 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-announces-approval-of-ultomiris-in-the-european-union 2023-05-12 03:18:51 daily 0.1 https://demo.pharmafocusasia.com/news/sobi-acquires-cti-bio-pharma 2023-05-12 03:18:34 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-announces-partnership-with-pfizer 2023-05-10 06:54:37 daily 0.1 https://demo.pharmafocusasia.com/news/rocket-pharmaceuticals-announces-fda-clearance-of-investigational-new-drug 2023-05-10 06:53:18 daily 0.1 https://demo.pharmafocusasia.com/news/roche-announces-us-fda-acceptance-of-supplemental-biologics-licence-application 2023-05-10 06:49:46 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-acquires-xinthera-to-strengthen-early-pipeline-in-oncology 2023-05-10 06:46:47 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-collaborates-with-tscan-therapeutics 2023-05-10 06:41:12 daily 0.1 https://demo.pharmafocusasia.com/news/trevena-announces-approval-of-olinvyk-in-china 2023-05-10 03:15:49 daily 0.1 https://demo.pharmafocusasia.com/news/promis-neurosciences-announces-fda-clearance-of-investigational-new-drug 2023-05-10 03:16:17 daily 0.1 https://demo.pharmafocusasia.com/news/curevac-announces-dosing-of-first-participant 2023-05-09 05:24:27 daily 0.1 https://demo.pharmafocusasia.com/news/eyenovia-announces-fda-approval-of-mydcombi 2023-05-10 03:16:31 daily 0.1 https://demo.pharmafocusasia.com/news/recursion-enters-into-agreements-to-acquire-cyclica-and-valence 2023-05-10 03:16:41 daily 0.1 https://demo.pharmafocusasia.com/news/life-biosciences-and-forge-fiologics-announce-cgmp-manufacturing-partnership 2023-05-09 02:52:56 daily 0.1 https://demo.pharmafocusasia.com/news/acorda-therapeutics-and-chance-pharmaceuticals-announce-agreement 2023-05-09 01:51:55 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-bioworks-partners-with-boehringeringelheim-to-develop-breakthrough-therapies 2023-05-09 00:35:24 daily 0.1 https://demo.pharmafocusasia.com/news/koselugo-approved-in-china-for-paediatric-patients 2023-05-08 23:20:51 daily 0.1 https://demo.pharmafocusasia.com/news/amphista-therapeutics-achieves-first-discovery-milestone-in-collaboration 2023-05-08 23:18:19 daily 0.1 https://demo.pharmafocusasia.com/news/full-life-technologies-announces-land-purchase-in-belgium 2023-05-04 03:38:43 daily 0.1 https://demo.pharmafocusasia.com/news/atea-pharmaceuticals-announces-us-fda-fast-track-designation 2023-04-27 00:22:51 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-announces-us-approval-for-qalsody-for-sod1-als 2023-04-27 00:21:55 daily 0.1 https://demo.pharmafocusasia.com/news/alx-oncology-holdings-announces-clinical-trial-collaboration-with-sanofi 2023-04-26 23:57:21 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-inaugurates-the-new-high-tech-facility 2023-04-25 06:25:31 daily 0.1 https://demo.pharmafocusasia.com/news/lantheus-and-point-biopharma-announce-fast-track-designation-grant 2023-04-25 06:24:46 daily 0.1 https://demo.pharmafocusasia.com/news/cidara-therapeutics-receives-milestone-payment-following-fda-approval-of-rezzayo 2023-04-25 06:23:06 daily 0.1 https://demo.pharmafocusasia.com/news/angle-announces-agreement-with-bioview 2023-04-20 06:08:22 daily 0.1 https://demo.pharmafocusasia.com/news/roche-announces-us-fda-approval-of-polivy-in-combination-with-r-chp 2023-04-20 01:52:19 daily 0.1 https://demo.pharmafocusasia.com/news/oncotelic-therapeutics-announces-partnership-with-vectara 2023-04-20 06:08:31 daily 0.1 https://demo.pharmafocusasia.com/news/meridian-bioscience-announces-fda-clearance-of-innovative-curian-shiga-toxin-assay 2023-04-20 01:47:51 daily 0.1 https://demo.pharmafocusasia.com/news/bio-techne-announces-partnership-with-lunaphore 2023-04-18 01:12:43 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-merck-announces-mrna-4157-in-combination-with-keytruda 2023-04-18 01:11:59 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-announces-european-commission-approval-of-rinvoq 2023-04-18 01:09:22 daily 0.1 https://demo.pharmafocusasia.com/news/merck-strengthens-immunology-pipeline-with-acquisition-of-prometheus-biosciences 2023-04-18 01:08:30 daily 0.1 https://demo.pharmafocusasia.com/news/bracco-imaging-announces-new-agreement-with-sonothera 2023-04-15 04:11:00 daily 0.1 https://demo.pharmafocusasia.com/news/merck-announces-us-fda-acceptance-of-biologics-licence-application-for-keytruda 2023-04-15 04:10:11 daily 0.1 https://demo.pharmafocusasia.com/news/agena-bioscience-enters-into-partnership-with-nrichdx 2023-04-15 04:09:31 daily 0.1 https://demo.pharmafocusasia.com/news/essa-pharma-announces-clinical-trial-support-agreement-with-janssen 2023-04-13 23:10:19 daily 0.1 https://demo.pharmafocusasia.com/news/aspect-biosystems-enter-into-partnership-with-novo-nordisk 2023-04-13 23:09:38 daily 0.1 https://demo.pharmafocusasia.com/news/adaptive-biotechnologies-corporation-announces-translational-collaboration-with-takeda 2023-04-13 23:08:56 daily 0.1 https://demo.pharmafocusasia.com/news/kala-pharmaceuticals-receives-fda-fast-track-designation-for-kpi-012 2023-04-13 23:07:58 daily 0.1 https://demo.pharmafocusasia.com/news/cira-kyoto-university-and-astellas-pharma-enter-into-joint-research-agreement 2023-04-12 02:57:30 daily 0.1 https://demo.pharmafocusasia.com/news/cognisant-collaborates-with-boehringer-ingelheim 2023-04-12 02:56:47 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-announces-acceptance-of-the-supplemental-new-drug 2023-04-12 02:56:05 daily 0.1 https://demo.pharmafocusasia.com/news/panbela-announces-regain-of-worldwide-rights-to-develop-and-commercialise-flynpovitm 2023-04-12 02:54:55 daily 0.1 https://demo.pharmafocusasia.com/news/centogene-extends-strategic-partnership-with-takeda 2023-04-12 02:53:58 daily 0.1 https://demo.pharmafocusasia.com/news/sumitomo-pharma-oncology-receives-orphan-drug-designation-for-tp-1287 2023-04-11 00:49:47 daily 0.1 https://demo.pharmafocusasia.com/news/ultima-genomics-collaborates-with-genome-insight 2023-04-11 00:48:55 daily 0.1 https://demo.pharmafocusasia.com/news/respirerx-pharmaceuticals-announces-collaboration-with-university-college-london-ucl 2023-04-06 01:04:38 daily 0.1 https://demo.pharmafocusasia.com/news/biotheryx-announces-research-collaboration-and-licence-agreement-with-incyte 2023-04-06 01:03:52 daily 0.1 https://demo.pharmafocusasia.com/news/scorpion-therapeutics-announces-collaboration-and-licence-agreement-with-pierre-fabre 2023-04-05 01:39:05 daily 0.1 https://demo.pharmafocusasia.com/news/solvay-collaborates-with-ginkgo-bioworks 2023-04-05 01:38:11 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-announces-fda-acceptance-of-supplemental-new-drug-application 2023-04-05 01:37:25 daily 0.1 https://demo.pharmafocusasia.com/news/inflarx-announces-fda-emergency-use-authorisation-for-gohibic 2023-04-05 01:34:52 daily 0.1 https://demo.pharmafocusasia.com/news/merck-announces-approval-of-keytruda-in-combination-with-padcev 2023-04-04 03:14:34 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-enters-into-agreement-with-national-cancer-centre 2023-04-04 03:12:08 daily 0.1 https://demo.pharmafocusasia.com/news/genenta-science-announces-extension-of-licence-agreement-with-ospedale-san-raffaele 2023-04-04 03:10:39 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-partners-with-duality-biologics 2023-04-04 03:09:45 daily 0.1 https://demo.pharmafocusasia.com/news/sandoz-announces-european-commission-approval-for-hyrimoz-adalimumab 2023-04-04 03:08:44 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-announces-positive-chmp-opinion-for-entresto 2023-04-01 03:09:24 daily 0.1 https://demo.pharmafocusasia.com/news/fennec-pharmaceuticals-receives-positive-opinion-for-pedmarqsi 2023-04-01 03:05:24 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-finalises-agreement-with-the-government-of-the-republic-of-kenya 2023-03-31 03:25:08 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-finalises-agreement-with-the-government-of-the-republic-of-kenya 2023-03-31 03:22:55 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-announces-agreement-with-scynexis-to-commercialise 2023-03-31 03:22:08 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-enters-into-agreement-with-kym-biosciences-for-cmg901 2023-03-31 03:18:43 daily 0.1 https://demo.pharmafocusasia.com/news/galapagos-collaborates-with-novalix 2023-03-31 03:18:00 daily 0.1 https://demo.pharmafocusasia.com/news/aquestive-therapeutics-expands-licence-and-supply-agreement-with-atnahs-pharma 2023-03-30 04:04:36 daily 0.1 https://demo.pharmafocusasia.com/news/avadel-pharmaceuticals-enters-into-royalty-agreement-with-rtw-investments 2023-03-30 04:03:45 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-collaborates-with-arsenal-biosciences 2023-03-30 04:02:43 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-partners-with-bristol-myers 2023-03-29 03:06:52 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-announces-approval-of-sotyktu-deucravacitinib 2023-03-29 03:06:12 daily 0.1 https://demo.pharmafocusasia.com/news/covant-therapeutics-collaborates-with-boehringer-ingelheim 2023-03-29 03:04:22 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-pharmaceuticals-announces-collaboration-with-sonoma-biotherapeutics 2023-03-29 03:03:38 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceuticals-collaborates-with-rimidi 2023-03-28 03:21:27 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-pharmaceuticals-announces-licencing-agreement-with-crispr-therapeutics 2023-03-28 03:13:48 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-opens-cell-therapy-facility 2023-03-28 03:13:00 daily 0.1 https://demo.pharmafocusasia.com/news/radiopharm-theranostics-partners-with-genesiscare 2023-03-28 03:12:14 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-announces-approval-to-manufacture-and-market-entyvio 2023-03-28 03:11:31 daily 0.1 https://demo.pharmafocusasia.com/news/cybeats-announces-trial-evaluation 2023-03-27 06:05:25 daily 0.1 https://demo.pharmafocusasia.com/news/curia-announce-collaboration-with-corning 2023-03-24 05:16:04 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceutical-announces-collaboration-agreement-with-molcure 2023-03-24 05:15:27 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-announces-first-regulatory-approval-for-calquence-in-china 2023-03-24 05:14:30 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-collaborates-with-generation-bio 2023-03-24 05:13:51 daily 0.1 https://demo.pharmafocusasia.com/news/invitae-partners-with-deerfield-management 2023-03-23 05:10:10 daily 0.1 https://demo.pharmafocusasia.com/news/roche-announces-collaboration-with-eli-lilly 2023-03-23 01:12:36 daily 0.1 https://demo.pharmafocusasia.com/news/hovione-announces-agreement-with-laxxon-medical 2023-03-23 01:11:53 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-pharmaceuticals-announces-fda-approval-of-evkeeza 2023-03-23 01:11:08 daily 0.1 https://demo.pharmafocusasia.com/news/marinus-pharmaceuticals-receives-fda-orphan-drug-designation-for-ganaxolone 2023-03-23 01:10:28 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-announces-clinical-collaboration-to-evaluate-cd73 2023-03-23 01:09:36 daily 0.1 https://demo.pharmafocusasia.com/news/hovione-partners-with-ripple-therapeutics-to-expand-epidel-platform 2023-03-21 03:12:02 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-and-oncoc4-announce-strategic-collaboration 2023-03-21 03:11:16 daily 0.1 https://demo.pharmafocusasia.com/news/coya-therapeutics-announces-agreement-with-dr-reddys-laboratories 2023-03-21 03:10:26 daily 0.1 https://demo.pharmafocusasia.com/news/syneos-health-collaborates-with-microsoft 2023-03-21 03:09:44 daily 0.1 https://demo.pharmafocusasia.com/news/processa-pharmaceuticals-announces-first-patient-dosed-in-the-300-mg-dose-group 2023-03-19 22:11:07 daily 0.1 https://demo.pharmafocusasia.com/news/predictive-oncology-partners-with-cancer-research-horizons 2023-03-19 22:10:17 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-announces-us-fda-expanded-indication-for-illuccix 2023-03-17 05:14:58 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-announces-new-fda-pdufa-date-for-investigational-palovarotene 2023-03-17 05:12:11 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-partners-with-bristol-myers-squibb 2023-03-17 05:11:26 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-tafinlar-mekinist-approved-by-fda-for-paediatric-patients 2023-03-17 05:10:23 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncology-announces-the-first-patient-dosed-in-the-phase-trial-of-anti-her2 2023-03-16 03:13:40 daily 0.1 https://demo.pharmafocusasia.com/news/relief-therapeutics-provides-update-from-acer-therapeutics-on-olpruva 2023-03-16 03:02:13 daily 0.1 https://demo.pharmafocusasia.com/news/prelude-therapeutics-announces-clinical-trial-collaboration-with-beigene 2023-03-17 01:50:07 daily 0.1 https://demo.pharmafocusasia.com/news/aitia-and-ucb-announce-strategic-drug-discovery-collaboration 2023-03-16 02:59:58 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-receive-us-emergency-use-authorisation-of-omicron 2023-03-15 01:54:36 daily 0.1 https://demo.pharmafocusasia.com/news/acelrx-pharmaceuticals-announces-divestment-of-dsuvia-to-alora-pharmaceuticals 2023-03-15 01:53:54 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-announces-china-national-medical-products-administration-acceptance-for-nucala 2023-03-15 01:53:06 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-acquires-provention-bio 2023-03-14 05:08:27 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-acquires-seagen-with-an-investment-of-us43-billion 2023-03-14 05:07:41 daily 0.1 https://demo.pharmafocusasia.com/news/cingulate-and-indegene-announce-joint-commercialisation-agreement 2023-03-13 22:11:40 daily 0.1 https://demo.pharmafocusasia.com/news/alx-oncology-and-quantum-leap-healthcare-collaborative-announce-first-patient-dosed 2023-03-13 22:08:13 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-announces-fda-clearance-of-investigational-new-drug-application-for-vx-264 2023-03-10 04:37:56 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-pharmaceuticals-and-medison-pharma-announce-the-expansion-of-collaboration 2023-03-10 04:37:18 daily 0.1 https://demo.pharmafocusasia.com/news/virax-biolabs-introduces-real-time-pcr-test-kit 2023-03-08 00:49:28 daily 0.1 https://demo.pharmafocusasia.com/news/exscientia-announces-collaboration-with-charite 2023-03-08 00:48:39 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-announces-us-fda-acceptance-of-dupixent-application-for-review 2023-03-08 00:47:38 daily 0.1 https://demo.pharmafocusasia.com/news/kiora-pharmaceuticals-receives-investigational-new-drug-approval-for-phase-2 2023-03-08 00:46:12 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-eisai-and-biogen-supplemental-biologics-licence-application 2023-03-07 03:26:04 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-completes-acquisition-of-concert-pharmaceuticals 2023-03-07 02:54:55 daily 0.1 https://demo.pharmafocusasia.com/news/heron-therapeutics-announces-us-commercial-launch-of-aponvie 2023-03-07 02:53:51 daily 0.1 https://demo.pharmafocusasia.com/news/coherus-biosciences-announces-us-fda-approval-of-udenyca-autoinjector 2023-03-07 02:52:06 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-broadens-indication-for-verzenio-abemaciclib 2023-03-05 23:04:26 daily 0.1 https://demo.pharmafocusasia.com/news/ractigen-therapeutics-receives-fda-orphan-drug-designation 2023-03-05 23:03:44 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-and-biofourmis-enter-into-new-partnership 2023-03-03 04:16:39 daily 0.1 https://demo.pharmafocusasia.com/news/intellia-therapeutics-announces-fda-clearance-of-investigational 2023-03-03 04:15:28 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-completes-acquisition-of-albireo 2023-03-03 04:14:32 daily 0.1 https://demo.pharmafocusasia.com/news/the-bristol-myers-squibb-janssen-collaboration-launches-pivotal-phase 2023-03-03 04:12:01 daily 0.1 https://demo.pharmafocusasia.com/news/nubeqa-darolutamide-receives-eu-approval 2023-03-02 01:22:16 daily 0.1 https://demo.pharmafocusasia.com/news/oragenics-enters-into-an-exclusive-global-licence-agreement-with-inspirevax 2023-03-02 01:15:46 daily 0.1 https://demo.pharmafocusasia.com/news/biolife-solutions-launches-ultraguard-phase-change-material-pcm 2023-03-02 01:15:02 daily 0.1 https://demo.pharmafocusasia.com/news/bionxt-signs-agreement-for-study-of-transdermal-rotigotine-patch 2023-03-02 01:14:17 daily 0.1 https://demo.pharmafocusasia.com/news/transcode-therapeutics-announces-orphan-drug-designation-status-for-ttx-mc138 2023-03-01 03:43:03 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-sanofi-announce-us-fda-approval-of-kevzara 2023-03-01 03:42:06 daily 0.1 https://demo.pharmafocusasia.com/news/reata-pharmaceuticals-announces-fda-approval-of-skyclarys 2023-03-01 03:39:31 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-bristol-myers-squibbs-supplemental-biologics-licence-application 2023-03-01 03:38:02 daily 0.1 https://demo.pharmafocusasia.com/news/ocugen-announces-us-fda-submission-of-investigational-new-drug-application 2023-02-28 00:42:47 daily 0.1 https://demo.pharmafocusasia.com/news/rhythm-pharmaceuticals-announces-acquisition-of-xinvento 2023-02-28 00:41:47 daily 0.1 https://demo.pharmafocusasia.com/news/lantern-pharma-and-ttc-oncology-establish-ai-collaboration 2023-02-28 00:40:57 daily 0.1 https://demo.pharmafocusasia.com/news/azenta-launches-cryo-store-pico-a-novel-automated-cryogenic-storage-system 2023-02-28 00:40:16 daily 0.1 https://demo.pharmafocusasia.com/news/singleron-biotechnologies-and-macrogen-europe-announce-a-strategic-alliance 2023-02-27 23:12:16 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-receives-positive-chmp-opinion-for-upadacitinib-rinvoq 2023-02-27 23:11:28 daily 0.1 https://demo.pharmafocusasia.com/news/roche-launches-two-new-antibodies-to-identify-key-clinical-mutations 2023-02-26 22:56:53 daily 0.1 https://demo.pharmafocusasia.com/news/bioatla-announces-fda-clearance-of-investigational-new-drug-application 2023-02-26 22:56:11 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-enters-licence-agreement-with-kym-biosciences 2023-02-26 22:55:02 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-once-weekly-altuviiio-a-new-class-of-factor-viii-therapy 2023-02-26 22:54:07 daily 0.1 https://demo.pharmafocusasia.com/news/eterna-therapeutics-enters-into-licence-agreement-with-lineage-cell-therapeutics 2023-02-23 01:15:21 daily 0.1 https://demo.pharmafocusasia.com/news/pfizers-elranatamab-receives-fda-and-ema-filing-acceptance 2023-02-23 01:14:41 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-life-edit-therapeutics-enter-into-strategic-collaboration 2023-02-23 01:14:02 daily 0.1 https://demo.pharmafocusasia.com/news/calquence-tablet-formulation-receives-approval-in-european-union-eu 2023-02-23 01:13:23 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-priority-review-for-pozelimab-c5-antibody-bla 2023-02-22 03:51:40 daily 0.1 https://demo.pharmafocusasia.com/news/vaxcyte-announces-fda-clearance-of-investigational-new-drug-application-for-vax-24 2023-02-22 03:50:55 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-announces-us-fda-acceptance-of-supplemental-new-drug-application 2023-02-22 03:50:18 daily 0.1 https://demo.pharmafocusasia.com/news/beckley-psytech-receives-fda-investigational-new-drug-ind-approval 2023-02-22 03:49:30 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-gets-us-fda-acceptance-for-biologics-licence-application-for-its-respiratory 2023-02-22 03:48:50 daily 0.1 https://demo.pharmafocusasia.com/news/clover-enters-into-agreement-to-commercialise-quadrivalent 2023-02-21 01:16:03 daily 0.1 https://demo.pharmafocusasia.com/news/european-commission-approved-csls-hemgenix 2023-02-21 01:15:22 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-valnevas-chikungunya-vaccine-licence-application-for-priority-review 2023-02-21 01:14:40 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-for-priority-review-the-supplemental-new-drug-application 2023-02-20 02:47:42 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-fda-approval-of-austedo-xr 2023-02-20 02:46:52 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-and-purespring-therapeutics-announce-gene-therapy-manufacturing-collaboration 2023-02-16 03:30:50 daily 0.1 https://demo.pharmafocusasia.com/news/gritstone-bio-and-the-national-cancer-institute-establish-a-clinical-trial-agreement 2023-02-15 03:06:48 daily 0.1 https://demo.pharmafocusasia.com/news/bio-techne-and-cell-signalling-technology-announce-partnership 2023-02-15 03:05:51 daily 0.1 https://demo.pharmafocusasia.com/news/sentia-medical-sciences-and-neurocrine-biosciences-extend-research-collaboration 2023-02-15 01:55:46 daily 0.1 https://demo.pharmafocusasia.com/news/us-government-and-novavax-extend-partnership 2023-02-14 01:14:41 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-iabl-collaborate-to-ensure-patient-access 2023-02-14 01:13:53 daily 0.1 https://demo.pharmafocusasia.com/news/vir-biotechnology-announces-collaboration-agreement-with-gsk 2023-02-14 01:13:12 daily 0.1 https://demo.pharmafocusasia.com/news/astex-and-cardiff-university-announce-new-drug-discovery-collaboration 2023-02-14 01:11:55 daily 0.1 https://demo.pharmafocusasia.com/news/intelgenx-announces-research-collaboration-with-renowned-neurologist 2023-02-10 01:37:49 daily 0.1 https://demo.pharmafocusasia.com/news/roche-expands-collaboration-with-janssen-to-advance-personalised-healthcare 2023-02-10 01:37:02 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-related-sciences-expand-integrated-drug-discovery-and-development 2023-02-10 01:36:13 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-regenerative-medicine-advanced-therapy 2023-02-09 01:26:52 daily 0.1 https://demo.pharmafocusasia.com/news/west-expands-corning-collaboration-and-launches-first-product 2023-02-09 01:25:56 daily 0.1 https://demo.pharmafocusasia.com/news/creative-medical-technology-holdings-announces-irb-approval-for-fda 2023-02-09 01:25:14 daily 0.1 https://demo.pharmafocusasia.com/news/fintepla-fenfluramine-oral-solution-approved-in-the-eu 2023-02-09 01:24:29 daily 0.1 https://demo.pharmafocusasia.com/news/rocket-pharmaceuticals-receives-fda-regenerative-medicine-advanced-therapy 2023-02-08 00:54:37 daily 0.1 https://demo.pharmafocusasia.com/news/syneos-health-and-haystack-health-partner-to-accelerate-clinical-trials-with-ai 2023-02-08 00:53:51 daily 0.1 https://demo.pharmafocusasia.com/news/kiora-pharmaceuticals-receives-investigational-new-drug-approval-for-kio-101 2023-02-08 00:39:06 daily 0.1 https://demo.pharmafocusasia.com/news/forxiga-approved-in-the-eu-for-the-treatment-of-symptomatic-chronic-heart-failure 2023-02-08 00:38:04 daily 0.1 https://demo.pharmafocusasia.com/news/atreca-and-xencor-to-develop-t-cell-engaging-bispecific-antibody 2023-02-07 03:19:41 daily 0.1 https://demo.pharmafocusasia.com/news/ultima-genomics-announces-collaboration-with-10x-genomics 2023-02-07 03:18:52 daily 0.1 https://demo.pharmafocusasia.com/news/sensei-biotherapeutics-signs-cooperative-research-and-development-agreement 2023-02-07 03:18:09 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-sage-therapeutics-announce-fda-accepts-filing-of-new-drug-application-for-zuranolone 2023-02-07 00:27:55 daily 0.1 https://demo.pharmafocusasia.com/news/sandoz-biologics-licence-application-accepted-by-us-fda-for-biosimilar-denosumab 2023-02-07 00:27:49 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-takedas-takhzyro-to-prevent-hereditary-angioedema 2023-02-04 03:24:40 daily 0.1 https://demo.pharmafocusasia.com/news/revive-therapeutics-enters-into-research-collaboration-agreement-with-pharmather 2023-02-04 03:23:17 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-trodelvy-in-pre-treated-hrher2-metastatic-breast-cancer 2023-02-04 03:22:30 daily 0.1 https://demo.pharmafocusasia.com/news/pliant-therapeutics-announces-fda-clearance-of-investigational-new-drug-application 2023-02-03 01:20:10 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-announces-acquisition-of-preclinical-infectious-disease-portfolio 2023-02-03 01:06:55 daily 0.1 https://demo.pharmafocusasia.com/news/pharmather-holdings-announces-fda-grant-of-orphan-drug-designation-to-ketarx 2023-02-03 01:06:06 daily 0.1 https://demo.pharmafocusasia.com/news/4d-molecular-therapeutics-announces-fda-clearance-of-ind-application 2023-02-03 01:05:18 daily 0.1 https://demo.pharmafocusasia.com/news/jesduvroq-daprodustat-approved-by-us-fda-for-anaemia-of-chronic-kidney-disease 2023-02-02 04:32:19 daily 0.1 https://demo.pharmafocusasia.com/news/cidara-therapeutics-and-wuxi-xdc-expand-collaboration 2023-02-02 04:31:36 daily 0.1 https://demo.pharmafocusasia.com/news/cybin-announces-approval-of-first-in-human-dosing-of-its-proprietary-dmt-molecule-cyb004 2023-02-02 04:30:23 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-granted-orphan-drug-designation-for-benlysta 2023-02-02 04:29:27 daily 0.1 https://demo.pharmafocusasia.com/news/uniqure-and-apic-bio-enter-licencing-agreement-for-apb-102 2023-02-01 01:27:00 daily 0.1 https://demo.pharmafocusasia.com/news/hillstream-biopharma-signs-option-agreement-to-advance-next-generation 2023-02-01 01:25:49 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-announces-us-fda-approval-for-conducting-a-phase-iia-clinical-trial 2023-02-01 01:24:52 daily 0.1 https://demo.pharmafocusasia.com/news/fennec-pharmaceuticals-receives-us-fda-orphan-drug-exclusivity-for-pedmark 2023-02-01 01:23:38 daily 0.1 https://demo.pharmafocusasia.com/news/xeris-biopharma-grants-fda-orphan-drug-exclusivity-for-recorlev 2023-01-31 03:24:58 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-completes-acquisition-of-samdi-tech 2023-01-31 03:24:17 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-acquires-disperzyme-and-phlogam-brands 2023-01-31 01:32:12 daily 0.1 https://demo.pharmafocusasia.com/news/dupixent-approved-as-the-first-and-only-targeted-medicine-for-eosinophilic-oesophagitis 2023-01-31 01:31:19 daily 0.1 https://demo.pharmafocusasia.com/news/roche-launches-covid-19-pcr-test-for-omicron-sub-variant 2023-01-27 00:46:52 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-enters-into-agreement-with-janssen 2023-01-27 00:46:06 daily 0.1 https://demo.pharmafocusasia.com/news/cytomx-therapeutics-announces-probody-t-cell-engaging-bispecific 2023-01-27 00:45:11 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-partners-with-astrazeneca-to-develop-test-for-tagrisso 2023-01-26 22:03:38 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-supplemental-new-drug-application-for-jardiance 2023-01-26 22:02:52 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-digital-health-launches-lyfe-digital-therapeutic-solution 2023-01-26 22:01:59 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-to-acquire-exclusive-worldwide-ex-china-license-of-hutchmed 2023-01-24 06:41:17 daily 0.1 https://demo.pharmafocusasia.com/news/tscan-therapeutics-announces-fda-clearance 2023-01-24 06:40:26 daily 0.1 https://demo.pharmafocusasia.com/news/medicines-announces-fda-acceptance-of-supplemental-new-drug-application 2023-01-24 06:39:18 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-supplemental-new-drug-application-for-jardiance 2023-01-20 23:30:17 daily 0.1 https://demo.pharmafocusasia.com/news/vidprevtyn-beta-covid-19-booster-vaccine 2023-01-20 23:29:42 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-launches-new-collaboration-with-oerth-bio 2023-01-19 23:23:06 daily 0.1 https://demo.pharmafocusasia.com/news/advaxis-and-ayala-pharmaceuticals-complete-merger 2023-01-19 23:22:28 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-nuvaxovid-covid-19-vaccine-approved-in-south-korea-as-an-adult-booster 2023-01-18 22:49:40 daily 0.1 https://demo.pharmafocusasia.com/news/evoq-therapeutics-and-amgen-expanding-collaboration 2023-01-18 22:48:49 daily 0.1 https://demo.pharmafocusasia.com/news/phanes-therapeutics-anti-claudin-182-antibody-patent-granted-in-the-us 2023-01-18 01:06:54 daily 0.1 https://demo.pharmafocusasia.com/news/merck-selects-perceiv-ai-for-inaugural-digital-sciences-studio-cohort 2023-01-18 01:06:30 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-and-ethicann-sign-development-and-license-agreement-for-new-fast-dissolve 2023-01-12 23:27:24 daily 0.1 https://demo.pharmafocusasia.com/news/preveceutical-enters-into-license-option-agreement-with-endosane-pharmaceuticals 2023-01-12 23:26:47 daily 0.1 https://demo.pharmafocusasia.com/news/syneos-health-announces-partnership-with-fosun-pharma-usa-to-launch-serplulimab 2023-01-12 22:20:38 daily 0.1 https://demo.pharmafocusasia.com/news/merck-completes-tender-offer-to-acquire-imago-biosciences 2023-01-12 22:19:39 daily 0.1 https://demo.pharmafocusasia.com/news/alora-pharmaceuticals-celebrates-acquisition-of-monarch-manufacturing-facility 2023-01-10 23:08:59 daily 0.1 https://demo.pharmafocusasia.com/news/janone-inc-completes-acquisition-of-soin-therapeutics 2023-01-10 23:08:18 daily 0.1 https://demo.pharmafocusasia.com/news/selecta-biosciences-and-astellas-announce-exclusive-licensing-and-development-agreement 2023-01-09 23:44:19 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-3t-biosciences-join-forces-to-develop-next-generation-cancer-immunotherapies 2023-01-09 23:43:33 daily 0.1 https://demo.pharmafocusasia.com/news/askbio-announces-strategic-collaboration-with-recode-therapeutics 2023-01-09 23:42:48 daily 0.1 https://demo.pharmafocusasia.com/news/servier-and-aqemia-extend-collaboration-on-undruggable-target-in-immuno-oncology 2023-01-06 23:46:14 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-immunome-announce-strategic-collaboration 2023-01-06 23:44:36 daily 0.1 https://demo.pharmafocusasia.com/news/simnova-and-orna-therapeutics-collaborate-to-advance-ornas-next-generation-circular-rna-technology-in-china 2023-01-05 23:47:58 daily 0.1 https://demo.pharmafocusasia.com/news/orbit-discovery-and-sanegenebio-collaborate-to-identify-targeting-peptides-for-rnai-drugs 2023-01-05 23:47:09 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-to-acquire-oriciro-genomics 2023-01-04 23:14:02 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-gsk-enter-into-license-agreement-on-multiple-novel 2023-01-04 23:13:11 daily 0.1 https://demo.pharmafocusasia.com/news/amerisourcebergen-completes-acquisition-of-pharmalex 2023-01-04 00:59:58 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-evoq-therapeutics-announce-collaboration-to-advance-immunotherapies 2023-01-04 00:59:07 daily 0.1 https://demo.pharmafocusasia.com/news/opus-genetics-announces-acquisition-of-the-rights-to-two-gene-therapy-product 2022-12-28 23:26:06 daily 0.1 https://demo.pharmafocusasia.com/news/mission-bio-and-abiosciences-partner-to-co-develop-bioinformatics 2022-12-28 23:25:30 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-to-acquire-all-remaining-rights-to-potential-first-in-class-immunotherapy 2022-12-28 22:18:27 daily 0.1 https://demo.pharmafocusasia.com/news/kala-pharmaceuticals-announces-fda-acceptance-of-ind-application-for-kpi-012 2022-12-28 22:17:32 daily 0.1 https://demo.pharmafocusasia.com/news/ablaze-pharmaceuticals-and-yonghe-pharma-initiate-services 2022-12-28 22:07:24 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-and-junshi-biosciences-sign-exclusive-licensing-agreement-for-cancer 2022-12-28 22:06:42 daily 0.1 https://demo.pharmafocusasia.com/news/merck-announces-collaboration-with-mersana-therapeutics 2022-12-22 23:12:13 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-proqr-to-expand-rna-editing-collaboration 2022-12-22 23:11:37 daily 0.1 https://demo.pharmafocusasia.com/news/berkeley-lights-to-acquire-isoplexis-creating-a-premier-functional-cell-biology-company 2022-12-22 00:28:41 daily 0.1 https://demo.pharmafocusasia.com/news/ethris-announces-collaboration-with-diosynvax-and-cepi 2022-12-22 00:27:59 daily 0.1 https://demo.pharmafocusasia.com/news/skye-bioscience-receives-fda-authorization-of-investigational-new-drug 2022-12-20 23:09:38 daily 0.1 https://demo.pharmafocusasia.com/news/kite-to-acquire-tmunity-therapeutics-to-pursue-next-generation-car-t-cell 2022-12-20 23:08:10 daily 0.1 https://demo.pharmafocusasia.com/news/enhertu-approved-in-the-eu-for-patients-with-previously-treated 2022-12-20 00:33:32 daily 0.1 https://demo.pharmafocusasia.com/news/bioasis-technologies-inc-agreement-with-midatech-pharma-plc 2022-12-20 00:32:47 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology 2022-12-20 00:31:07 daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-targets-treatment-of-certain-seizures-with-launch-of-generic-lacosamide-injection-usp 2022-12-15 23:51:04 daily 0.1 https://demo.pharmafocusasia.com/news/psyence-and-filament-health-announce-worldwide-licensing-agreement 2022-12-15 23:49:43 daily 0.1 https://demo.pharmafocusasia.com/news/ono-enters-into-a-multi-target-rd-collaboration-agreement-with-precisionlife 2022-12-14 23:29:40 daily 0.1 https://demo.pharmafocusasia.com/news/exicure-inc-announces-termination-of-abbvie-and-ipsen-collaboration-agreements 2022-12-14 23:28:49 daily 0.1 https://demo.pharmafocusasia.com/news/biosion-announces-research-collaboration-with-immunogen 2022-12-13 23:15:04 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-and-praxis-precision-medicines-announce-epilepsy-research-collaboration 2022-12-13 23:14:17 daily 0.1 https://demo.pharmafocusasia.com/news/pasithea-therapeutics-announces-comprehensive-settlement-agreement 2022-12-12 23:01:41 daily 0.1 https://demo.pharmafocusasia.com/news/merck-begins-tender-offer-to-acquire-imago-biosciences 2022-12-12 23:00:47 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-and-towa-launch-edirol-tablet-for-osteoporosis-treatment 2022-12-08 23:39:20 daily 0.1 https://demo.pharmafocusasia.com/news/efruxifermin-granted-fda-breakthrough-therapy-designation-for-nash 2022-12-08 23:38:34 daily 0.1 https://demo.pharmafocusasia.com/news/aarvik-therapeutics-announces-a-global-novel-payload-agreement-with-nj-bio-inc 2022-12-07 23:17:52 daily 0.1 https://demo.pharmafocusasia.com/news/kite-and-daiichi-sankyo-announce-changes-to-yescarta-car-t-cell-therapy 2022-12-07 23:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-clear-creek-bio-to-collaborate-on-research-program-targeting 2022-12-07 00:26:03 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-launches-strategic-collaboration-with-hotspot-therapeutics 2022-12-07 00:25:03 daily 0.1 https://demo.pharmafocusasia.com/news/solid-biosciences-announces-closing-of-acquisition-of-aavantibio-and-concurrent 2022-12-05 23:16:31 daily 0.1 https://demo.pharmafocusasia.com/news/redhills-aemcolo-granted-fda-qidp-5-year-exclusivity-extension 2022-12-05 23:15:53 daily 0.1 https://demo.pharmafocusasia.com/news/immunocore-and-gadeta-announce-agreement-to-develop-first-gamma-delta 2022-12-03 00:35:54 daily 0.1 https://demo.pharmafocusasia.com/news/rocket-pharmaceuticals-completes-acquisition-of-renovacor 2022-12-02 22:56:42 daily 0.1 https://demo.pharmafocusasia.com/news/solid-biosciences-announces-stockholder-approval-of-acquisition-of-aavantibio 2022-12-02 22:55:56 daily 0.1 https://demo.pharmafocusasia.com/news/argenx-enters-into-agreement-to-acquire-priority-review-voucher 2022-12-01 01:50:55 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-and-ryvu-therapeutics-enter-into-global-collaboration 2022-12-01 01:50:02 daily 0.1 https://demo.pharmafocusasia.com/news/ribon-therapeutics-announces-acquisition-of-pre-clinical-cd38-program 2022-11-29 23:54:55 daily 0.1 https://demo.pharmafocusasia.com/news/envisagenics-announces-research-collaboration-with-bristol-myers-squibb 2022-11-29 23:54:06 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-announces-the-fda-approval 2022-11-29 04:03:18 daily 0.1 https://demo.pharmafocusasia.com/news/clinigen-adds-pharmacovigilance-capabilities-with-acquisition-of-drug-safety-navigator 2022-11-29 04:02:04 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-enters-into-antibody-agreement-with-adc-therapeutics 2022-11-27 22:42:21 daily 0.1 https://demo.pharmafocusasia.com/news/sirona-biochem-signs-international-partnership-agreement-with-wanbang-biopharmaceuticals 2022-11-24 01:53:04 daily 0.1 https://demo.pharmafocusasia.com/news/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics 2022-11-24 01:52:00 daily 0.1 https://demo.pharmafocusasia.com/news/fujifilm-invests-188-million-in-new-cell-culture-media-manufacturing-facility 2022-11-22 23:27:50 daily 0.1 https://demo.pharmafocusasia.com/news/obseva-announces-sale-of-ebopiprant-license-agreement-to-xoma-for-up-to-113-million 2022-11-22 23:27:12 daily 0.1 https://demo.pharmafocusasia.com/news/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics 2022-11-22 23:25:56 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-to-acquire-snapdragon-chemistry 2022-11-22 01:07:11 daily 0.1 https://demo.pharmafocusasia.com/news/graybug-and-calcimedica-enter-into-definitive-merger-agreement 2022-11-22 01:06:32 daily 0.1 https://demo.pharmafocusasia.com/news/iveric-bio-announces-fda-has-granted-breakthrough-therapy-designation 2022-11-17 23:52:06 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-cytomx-announce-strategic-research-collaboration 2022-11-17 23:48:31 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-astrazeneca-rare-disease-completes-acquisition-of-logicbio-therapeutics 2022-11-16 23:15:37 daily 0.1 https://demo.pharmafocusasia.com/news/roche-receives-us-fda-emergency-use-authorization-for-its-high-throughput-test 2022-11-16 23:14:35 daily 0.1 https://demo.pharmafocusasia.com/news/simcere-and-idorsia-enter-into-a-licensing-agreement-for-daridorexant-in-china 2022-11-15 23:10:08 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-pharmaceuticals-and-gubra-announce-collaboration-within-inflammatory 2022-11-15 23:08:18 daily 0.1 https://demo.pharmafocusasia.com/news/relief-therapeutics-holding-sa-and-nrx-pharmaceuticals-announce-execution 2022-11-15 00:50:15 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-unique-collaboration-with-rimidi 2022-11-15 00:49:13 daily 0.1 https://demo.pharmafocusasia.com/news/telix-acquires-optimal-tracers 2022-11-13 23:10:20 daily 0.1 https://demo.pharmafocusasia.com/news/nuance-pharma-announces-clearance-of-ind-application-for-respiratory-syncytial-virus 2022-11-13 23:09:34 daily 0.1 https://demo.pharmafocusasia.com/news/nephron-and-sharps-announce-manufacturing-and-research-partnership 2022-11-11 00:24:14 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-acquires-german-biotech-start-up-targenomix 2022-11-11 00:22:56 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-gsks-next-generation-covid-19-booster-vaccine-vidprevtyn-beta-approved 2022-11-11 00:22:26 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-and-sparc-enter-into-a-license-agreement-for-commercialization 2022-11-09 22:35:25 daily 0.1 https://demo.pharmafocusasia.com/news/spero-therapeutics-announces-closing-of-exclusive-license-agreement-with-gsk 2022-11-08 23:38:17 daily 0.1 https://demo.pharmafocusasia.com/news/bruker-announces-acquisition-of-inscopix-for-neuroscience-research 2022-11-08 23:36:33 daily 0.1 https://demo.pharmafocusasia.com/news/olix-pharmaceuticals-announces-positive-preclinical-data-in-nash-non-human-primate-models 2022-11-07 22:35:30 daily 0.1 https://demo.pharmafocusasia.com/news/mauna-kea-technologies-and-tasly-pharmaceutical-announce-the-incorporation 2022-11-07 22:34:46 daily 0.1 https://demo.pharmafocusasia.com/news/hexvix-a-diagnostic-drug-for-bladder-cancer-of-asieris 2022-11-06 23:10:29 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-completes-acquisition-of-central-glass-germany 2022-11-03 23:21:26 daily 0.1 https://demo.pharmafocusasia.com/news/sinovac-varicella-vaccine-prequalified-by-who 2022-11-03 23:19:51 daily 0.1 https://demo.pharmafocusasia.com/news/novo-holdings-acquires-kabafusion 2022-11-02 23:14:01 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-receives-fda-approval-for-leuprolide-acetate-injection 2022-11-02 23:13:22 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-cybrexa-therapeutics-establish-exclusive-collaboration-providing-exelixis 2022-11-02 00:29:59 daily 0.1 https://demo.pharmafocusasia.com/news/csl-enters-licensing-agreement-with-arcturus-therapeutics 2022-11-02 00:28:37 daily 0.1 https://demo.pharmafocusasia.com/news/biofrontera-inc-enters-into-agreements-to-purchase-options-of-biofrontera-ag 2022-10-31 23:16:07 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-to-acquire-the-binding-site-group 2022-10-31 23:15:27 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-announces-first-adolescent-patient-dosed-in-clinical-trial 2022-10-31 03:54:50 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-announces-strategic-financing-collaboration-with-blackstone 2022-10-28 03:47:56 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-to-expand-clinical-research-laboratory-in-kentucky 2022-10-28 03:46:58 daily 0.1 https://demo.pharmafocusasia.com/news/novaccess-global-receives-fda-approval-of-orphan-drug-application-for-tlr-ad1 2022-10-27 22:51:52 daily 0.1 https://demo.pharmafocusasia.com/news/telix-and-uniquest-to-collaborate-on-radiolabelled-immune-targeting-peptide 2022-10-27 22:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/sk-bioscience-and-cepi-sign-agreement-to-develop-mrna-vaccines 2022-10-25 23:47:24 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-announces-gmp-release-of-commercial-drug-substance-manufacturing-facility 2022-10-25 23:33:41 daily 0.1 https://demo.pharmafocusasia.com/news/fujifilm-diosynth-biotechnologies-and-roosterbio-announce-collaboration 2022-10-24 23:34:14 daily 0.1 https://demo.pharmafocusasia.com/news/sumitovant-biopharma-sumitomo-pharma-and-myovant-sciences-enter-into-definitive-agreement 2022-10-24 23:33:18 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-successfully-completes-acquisition-of-chemocentryx 2022-10-20 22:52:59 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-acquires-djs-antibodies 2022-10-20 22:51:58 daily 0.1 https://demo.pharmafocusasia.com/news/telesis-bio-and-cellibre-announce-collaboration-to-optimize-development 2022-10-20 00:34:32 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-bioworks-completes-acquisition-of-zymergen 2022-10-20 00:33:43 daily 0.1 https://demo.pharmafocusasia.com/news/verseon-acquires-edammo 2022-10-18 23:55:31 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-to-acquire-akouos-to-discover-and-develop-treatments-for-hearing-loss 2022-10-18 23:53:55 daily 0.1 https://demo.pharmafocusasia.com/news/immune-onc-therapeutics-initiates-expansion-cohorts-for-io-108 2022-10-17 22:41:05 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-macrogenics-announce-oncology-collaboration 2022-10-17 22:38:25 daily 0.1 https://demo.pharmafocusasia.com/news/imaginab-and-cyclotek-enter-into-manufacturing-and-distribution-agreement 2022-10-17 03:13:38 daily 0.1 https://demo.pharmafocusasia.com/news/pandemic-response-lab-launches-novel-triple-target-monkeypox-tests 2022-10-14 00:29:19 daily 0.1 https://demo.pharmafocusasia.com/news/xcell-biosciences-and-acgt-vector-collaborate-to-accelerate-development 2022-10-14 00:28:27 daily 0.1 https://demo.pharmafocusasia.com/news/pasithea-therapeutics-acquires-allomek-therapeutics 2022-10-13 00:48:49 daily 0.1 https://demo.pharmafocusasia.com/news/tavros-therapeutics-and-vividion-therapeutics-announce-strategic-collaboration 2022-10-13 00:47:58 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-bioworks-announces-collaboration-with-merck 2022-10-11 22:34:08 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-toregem-biopharma-sign-mou-for-development 2022-10-11 22:33:29 daily 0.1 https://demo.pharmafocusasia.com/news/bluestar-genomics-receives-cap-accreditation-for-its-clinical-laboratory 2022-10-10 22:12:04 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-launches-ce-ivd-marked-panel-to-detect 2022-10-10 22:11:20 daily 0.1 https://demo.pharmafocusasia.com/news/tempus-announces-companion-diagnostic-collaboration-with-kartos-therapeutics 2022-10-06 22:19:47 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-ridgeback-biotherapeutics-provide-update-on-new-clinical 2022-10-06 22:18:34 daily 0.1 https://demo.pharmafocusasia.com/news/myonex-completes-acquisition-of-hubertus-clinical-trial-and-packaging-business 2022-10-06 00:46:02 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-acquisition-of-global-blood-therapeutics 2022-10-06 00:45:08 daily 0.1 https://demo.pharmafocusasia.com/news/lineage-establishes-new-rd-facility-in-us 2022-10-03 23:19:15 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-astrazeneca-rare-disease-to-acquire-logicbio-therapeutics 2022-10-03 23:18:24 daily 0.1 https://demo.pharmafocusasia.com/news/amplifybio-acquires-pact-pharma-assets-to-enhance-cell-and-gene-therapy 2022-10-03 23:17:34 daily 0.1 https://demo.pharmafocusasia.com/news/mckesson-corporation-extends-pharmaceutical-distribution-agreement-with-cvs-health 2022-09-29 22:21:09 daily 0.1 https://demo.pharmafocusasia.com/news/almirall-and-simcere-enter-into-a-licensing-agreement-for-il-2-mu-fc 2022-09-29 22:20:11 daily 0.1 https://demo.pharmafocusasia.com/news/visus-therapeutics-expands-ophthalmic-drug-development-portfolio-with-acquisition 2022-09-28 22:48:53 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-launches-more-sustainable-solution 2022-09-28 22:47:59 daily 0.1 https://demo.pharmafocusasia.com/news/koselugo-approved-in-japan-for-paediatric-patients-with-plexiform 2022-09-28 00:28:05 daily 0.1 https://demo.pharmafocusasia.com/news/scribe-therapeutics-announces-research-collaboration-with-sanofi 2022-09-28 00:27:29 daily 0.1 https://demo.pharmafocusasia.com/news/atamyo-therapeutics-announces-first-patient-dosed-with-ata-100-gene-therapy-in-lgmd-r9-clinical-trial 2022-09-26 22:29:22 daily 0.1 https://demo.pharmafocusasia.com/news/pulse-biosciences-announces-fda-510k-clearance-for-the-treatment 2022-09-26 22:28:36 daily 0.1 https://demo.pharmafocusasia.com/news/massive-bio-continues-to-grow-in-europe 2022-09-26 01:53:13 daily 0.1 https://demo.pharmafocusasia.com/news/clearmind-applies-for-patent-to-treat-obesity-and-metabolic-syndrome 2022-09-23 03:01:59 daily 0.1 https://demo.pharmafocusasia.com/news/aptar-pharma-announces-exclusive-collaboration-with-fluidda 2022-09-23 02:56:15 daily 0.1 https://demo.pharmafocusasia.com/news/coeptis-therapeutics-enters-exclusive-license-agreement-with-university 2022-09-21 23:57:03 daily 0.1 https://demo.pharmafocusasia.com/news/sesen-bio-and-carisma-therapeutics-announce-merger-agreement 2022-09-21 23:56:06 daily 0.1 https://demo.pharmafocusasia.com/news/veranex-expands-european-medtech-capabilities-with-acquisition-of-medidee 2022-09-21 02:00:49 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-completes-acquisition-of-mirobio 2022-09-21 01:59:56 daily 0.1 https://demo.pharmafocusasia.com/news/advanced-nanotherapies-sirplux-duo-drug-coated-balloon-receives-fda-breakthrough 2022-09-21 01:35:45 daily 0.1 https://demo.pharmafocusasia.com/news/repligen-expands-process-analytics-portfolio-with-drs-daylight-solutions-agreement 2022-09-21 01:34:29 daily 0.1 https://demo.pharmafocusasia.com/news/avicanna-expands-its-epilepsy-research-program 2022-09-16 01:10:46 daily 0.1 https://demo.pharmafocusasia.com/news/caladrius-biosciences-and-cend-therapeutics-announce-closing-of-merger 2022-09-16 01:05:58 daily 0.1 https://demo.pharmafocusasia.com/news/briacell-partners-with-caris-life-sciences-to-expand-patient 2022-09-15 00:47:01 daily 0.1 https://demo.pharmafocusasia.com/news/oxford-biomedica-solutions-signs-agreement-with-new-partner-for-aav-platform 2022-09-15 00:45:29 daily 0.1 https://demo.pharmafocusasia.com/news/nacuity-pharmaceuticals-and-arctic-therapeutics-enter-licensing-agreement 2022-09-13 22:54:41 daily 0.1 https://demo.pharmafocusasia.com/news/strata-oncology-announces-expansion-of-clinical-collaboration-with-pfizer 2022-09-13 22:53:52 daily 0.1 https://demo.pharmafocusasia.com/news/amerisourcebergen-to-expand-global-biopharma-services-platform 2022-09-12 22:38:08 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-announces-approval-of-clinical-trial-of-bcl2-inhibitor-icp-248-in-china 2022-09-12 22:37:00 daily 0.1 https://demo.pharmafocusasia.com/news/oncodna-presents-the-oncodeep-genomic-kit-for-the-study-of-solid-tumors-at-esmo 2022-09-12 01:11:06 daily 0.1 https://demo.pharmafocusasia.com/news/indonesian-pharmaceutical-bio-farma-ready-to-produce-indovac-covid-19-vaccines 2022-09-12 01:02:16 daily 0.1 https://demo.pharmafocusasia.com/news/citeline-connect-and-proofpilot-announce-strategic-partnership 2022-09-07 22:59:37 daily 0.1 https://demo.pharmafocusasia.com/news/advanco-and-vantage-partner-to-offer-first-interoperable-pharma-traceability-solution 2022-09-07 22:57:00 daily 0.1 https://demo.pharmafocusasia.com/news/ixlayer-partners-with-curavit-to-enable-convenient-patient-medical-testing 2022-09-06 22:34:38 daily 0.1 https://demo.pharmafocusasia.com/news/nanotics-to-collaborate-with-mass-general-cancer-center-mgcc 2022-09-06 22:33:46 daily 0.1 https://demo.pharmafocusasia.com/news/bertis-announces-proteomic-based-research-results 2022-09-05 22:27:07 daily 0.1 https://demo.pharmafocusasia.com/news/carsgen-releases-the-first-clinical-batch-of-car-t-cells 2022-09-05 22:25:53 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-completes-first-phase-capacity-expansion-project-in-high-point 2022-09-01 22:55:07 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-to-acquire-forma-therapeutics-and-expand-presence 2022-09-01 22:54:19 daily 0.1 https://demo.pharmafocusasia.com/news/proofpilot-announces-partnership-with-human-api 2022-08-31 22:46:33 daily 0.1 https://demo.pharmafocusasia.com/news/spatial-biology-cro-flagship-biosciences-acquires-pharma-services-business 2022-08-31 22:36:09 daily 0.1 https://demo.pharmafocusasia.com/news/gicell-announces-research-collaboration-with-hk-innon-for-next-generation 2022-08-29 23:22:20 daily 0.1 https://demo.pharmafocusasia.com/news/sanyou-biopharmaceuticals-and-kangabio-established-strategic-collaboration 2022-08-29 23:19:57 daily 0.1 https://demo.pharmafocusasia.com/news/aclaris-therapeutics-announces-patent-license-agreement-with-lilly-for-alopecia-areata 2022-08-25 23:13:29 daily 0.1 https://demo.pharmafocusasia.com/news/bota-bio-and-medichem-announce-commercial-development-collaboration 2022-08-25 23:12:35 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-expands-viral-vector-manufacturing-capabilities 2022-08-24 23:20:43 daily 0.1 https://demo.pharmafocusasia.com/news/sonde-health-inks-multi-year-partnership-with-koye-pharmaceuticals 2022-08-24 23:19:42 daily 0.1 https://demo.pharmafocusasia.com/news/zerion-pharma-and-hovione-extend-partnership-to-cover-use 2022-08-23 23:32:55 daily 0.1 https://demo.pharmafocusasia.com/news/windtree-therapeutics-announces-kl4-surfactant-and-aerosurf-global-license-agreement 2022-08-23 23:32:13 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientifics-largest-single-use-technology-manufacturing-site-opens 2022-08-22 22:23:39 daily 0.1 https://demo.pharmafocusasia.com/news/alcon-to-acquire-aerie-pharmaceuticals 2022-08-22 22:22:07 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-astellas-new-drug-application-for-fezolinetant 2022-08-19 23:30:43 daily 0.1 https://demo.pharmafocusasia.com/news/nuance-pharma-announces-clearance-of-ind-application 2022-08-19 23:28:41 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-completes-acquisition-of-turning-point-therapeutics 2022-08-17 22:32:10 daily 0.1 https://demo.pharmafocusasia.com/news/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi 2022-08-17 22:46:04 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-orna-therapeutics-collaborate-to-advance-orna 2022-08-16 22:52:42 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-sta-breaks-ground-for-new-pharmaceutical-manufacturing-facility 2022-08-16 22:50:55 daily 0.1 https://demo.pharmafocusasia.com/news/bridge-biotherapeutics-receives-fda-authorization-to-proceed 2022-08-15 23:37:03 daily 0.1 https://demo.pharmafocusasia.com/news/mitsubishi-tanabe-pharma-america-announces-real-world-data-analysis 2022-08-15 23:36:05 daily 0.1 https://demo.pharmafocusasia.com/news/atyr-pharma-receives-fda-fast-track-designation-for-efzofitimod 2022-08-12 06:39:07 daily 0.1 https://demo.pharmafocusasia.com/news/tron-group-and-nanopharmaceutics-announce-definitive-merger-agreement 2022-08-12 06:36:10 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-biologics-and-alpine-immune-sciences-expand-partnership 2022-08-11 06:08:22 daily 0.1 https://demo.pharmafocusasia.com/news/gentibio-announces-collaboration-with-bristol-myers-squibb-to-pioneer-engineered 2022-08-11 06:12:34 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-to-acquire-metrics-contract-services-for-475-million 2022-08-11 06:19:37 daily 0.1 https://demo.pharmafocusasia.com/news/genixus-introduces-propofol-as-the-first-product-to-be-delivered-within-kinetix-ready-to-administer 2022-08-11 06:17:06 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit 2022-08-11 06:21:17 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-acquire-global-blood-therapeutics 2022-08-11 06:27:19 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-to-acquire-mirobio 2022-08-11 06:29:50 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate 2022-08-11 06:34:08 daily 0.1 https://demo.pharmafocusasia.com/news/radiopharm-enters-into-strategic-collaboration-with-lantheus-and-assumes-pd-l1 2022-08-11 06:37:24 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-juvederm-volux-xc-for-improvement-of-jawline-definition 2022-08-11 06:40:02 daily 0.1 https://demo.pharmafocusasia.com/news/synthego-launches-engineered-cell-libraries 2022-08-11 06:43:58 daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-and-biotia-receive-expanded-emergency-use-authorization-to-report 2022-08-11 06:47:28 daily 0.1 https://demo.pharmafocusasia.com/news/xeris-commercialization-partner-for-ogluo-tetris-pharma-ltd 2022-08-12 06:44:58 daily 0.1 https://demo.pharmafocusasia.com/news/krystal-biotech-receives-fda-acceptance-of-kb407-ind-application 2022-08-12 06:49:15 daily 0.1 https://demo.pharmafocusasia.com/news/syneurx-announces-final-results-of-phase-2-clinical-trial-of-covid-19 2022-08-12 06:53:41 daily 0.1 https://demo.pharmafocusasia.com/news/neurosense-therapeutics-and-neuralight-collaborate-to-detect-als-oculometric 2022-07-29 01:20:11 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-acquires-andas-from-oakrum-pharma-llc 2022-07-29 01:19:12 daily 0.1 https://demo.pharmafocusasia.com/news/sutro-biopharma-achieves-first-in-human-milestone-in-cytokine-derivatives-collaboration-with-merck 2022-07-26 23:07:29 daily 0.1 https://demo.pharmafocusasia.com/news/moonlake-immunotherapeutics-signs-development-and-manufacturing-agreement-with-vetter 2022-07-26 23:06:43 daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-expands-ready-to-administer-portfolio-with-glycopyrrolate-injection 2022-07-26 01:07:47 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-to-acquire-zymergen 2022-07-25 06:24:03 daily 0.1 https://demo.pharmafocusasia.com/news/tezspire-recommended-for-approval-in-the-eu-by-chmp-for-the-treatment-of-severe-asthma 2022-07-25 06:13:40 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-announces-clinical-trial-application-for-olverembatinib-hqp1351-approved-in-canada 2022-07-24 22:50:05 daily 0.1 https://demo.pharmafocusasia.com/news/biogenesis-bago-joins-korean-company-fvc-for-the-construction 2022-07-24 22:48:53 daily 0.1 https://demo.pharmafocusasia.com/news/scientific-innovation-and-collaboration-highlighted-at-aids-2022 2022-07-21 22:58:45 daily 0.1 https://demo.pharmafocusasia.com/news/artizan-biosciences-announces-multi-year-research-collaboration 2022-07-21 22:57:55 daily 0.1 https://demo.pharmafocusasia.com/news/biocytogen-and-liberothera-achieve-milestone-progress-in-co-development 2022-07-20 23:20:54 daily 0.1 https://demo.pharmafocusasia.com/news/daewoong-pharmaceutical-gets-first-korean-us-fda-fast-track 2022-07-20 23:19:49 daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-therapeutics-announces-the-fda-ind-clearance-of-sti-1558 2022-07-19 23:25:23 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-signs-new-joint-procurement-agreement-with-the-european-commission 2022-07-19 23:24:41 daily 0.1 https://demo.pharmafocusasia.com/news/azurity-pharmaceuticals-announces-fda-approval-of-zonisade 2022-07-19 03:01:16 daily 0.1 https://demo.pharmafocusasia.com/news/nabriva-therapeutics-expands-xenleta-presence-with-exclusive-agreement 2022-07-19 02:59:58 daily 0.1 https://demo.pharmafocusasia.com/news/china-cde-grants-breakthrough-therapy-designation-btd-to-neurophths-nr082-in-lhon 2022-07-15 23:06:01 daily 0.1 https://demo.pharmafocusasia.com/news/codexis-announces-agreement-with-pfizer-to-supply-enzyme 2022-07-15 01:48:03 daily 0.1 https://demo.pharmafocusasia.com/news/zymergen-expands-agreement-with-octant 2022-07-15 01:47:13 daily 0.1 https://demo.pharmafocusasia.com/news/labcorp-launches-new-test-to-identify-and-confirm-neurodegenerative-disease 2022-07-14 03:59:52 daily 0.1 https://demo.pharmafocusasia.com/news/dnanexus-and-twist-bioscience-collaborate-to-provide-data-analysis-software-for-ngs-workflow 2022-07-14 03:58:50 daily 0.1 https://demo.pharmafocusasia.com/news/solvias-acquires-cergentis-to-bolster-biologics-and-cell-gene-therapy-capabilities 2022-07-13 00:27:04 daily 0.1 https://demo.pharmafocusasia.com/news/discovery-life-sciences-acquires-allcells 2022-07-13 00:27:42 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-launches-ce-ivd-marked-taqpath-respiratory-viral-select-panel 2022-07-11 22:47:27 daily 0.1 https://demo.pharmafocusasia.com/news/innoviva-to-acquire-la-jolla-pharmaceutical-company 2022-07-11 22:46:45 daily 0.1 https://demo.pharmafocusasia.com/news/anthos-therapeutics-announces-that-abelacimab-has-received-fda-fast-track-designation-for-the-treatment 2022-07-11 03:19:07 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-strategic-research-collaboration-with-innorna 2022-07-06 23:25:19 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-japan-and-mitsubishi-tanabe-pharma-corporation-signed-sales-agreement 2022-07-06 23:24:31 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-completes-acquisition-of-rigenerand 2022-07-05 22:53:19 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-to-acquire-teneotwo-and-its-clinical-stage-t-cell-engager 2022-07-05 22:52:28 daily 0.1 https://demo.pharmafocusasia.com/news/lonza-to-establish-large-scale-commercial-drug-product-fill-finish-facility 2022-07-05 03:59:18 daily 0.1 https://demo.pharmafocusasia.com/news/proteonic-announces-licensing-of-its-premium-2g-unic-technology-platform 2022-07-05 03:51:03 daily 0.1 https://demo.pharmafocusasia.com/news/phanes-therapeutics-pt886-granted-orphan-drug-designation 2022-06-30 23:19:37 daily 0.1 https://demo.pharmafocusasia.com/news/vaxart-announces-agreement-with-hvivo 2022-06-30 23:18:50 daily 0.1 https://demo.pharmafocusasia.com/news/generian-and-astellas-enter-into-collaboration-and-exclusive-license-agreement 2022-06-30 00:23:47 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-announce-new-agreement-with-us-government 2022-06-30 00:22:40 daily 0.1 https://demo.pharmafocusasia.com/news/fate-therapeutics-announces-expansion-of-solid-tumor-collaboration 2022-06-29 00:37:43 daily 0.1 https://demo.pharmafocusasia.com/news/akoya-biosciences-to-partner-with-acrivon-therapeutics 2022-06-29 00:36:56 daily 0.1 https://demo.pharmafocusasia.com/news/arzeda-announces-collaboration-with-w-l-gore-associates 2022-06-27 23:30:22 daily 0.1 https://demo.pharmafocusasia.com/news/hillstream-biopharma-announces-collaboration-with-sapien-biosciences 2022-06-27 23:29:36 daily 0.1 https://demo.pharmafocusasia.com/news/radius-health-announces-agreement-to-be-acquired-by-gurnet-point-capital 2022-06-23 23:17:14 daily 0.1 https://demo.pharmafocusasia.com/news/merck-opens-cdmo-facility-to-address-demand-for-critical-cancer-therapies 2022-06-23 23:16:29 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-announces-fda-approval-and-imminent-launch 2022-06-22 23:33:24 daily 0.1 https://demo.pharmafocusasia.com/news/echosens-and-novo-nordisk-announce-partnership-to-increase-awareness 2022-06-22 23:32:43 daily 0.1 https://demo.pharmafocusasia.com/news/canaglu-tablets-100mg-approved-for-the-indication-of-chronic-kidney-disease 2022-06-22 23:11:38 daily 0.1 https://demo.pharmafocusasia.com/news/truveta-announces-strategic-collaboration-with-pfizer-to-accelerate-safety-insights-in-real-time 2022-06-22 23:04:51 daily 0.1 https://demo.pharmafocusasia.com/news/waters-and-bioinfra-establish-the-asean-academy-for-bioanalysis 2022-06-21 05:47:32 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-opens-first-satellite-center-for-global-health-discovery-in-asia-pacific 2022-06-21 04:44:52 daily 0.1 https://demo.pharmafocusasia.com/news/panbela-therapeutics-closes-acquisition-of-cancer-prevention-pharmaceuticals 2022-06-17 01:54:50 daily 0.1 https://demo.pharmafocusasia.com/news/humanigen-enters-into-agreement-with-pci-pharma-services-as-part-of-preparations 2022-06-17 03:05:18 daily 0.1 https://demo.pharmafocusasia.com/news/kintara-therapeutics-granted-fast-track-designation-from-the-fda-for-val-083-for-newly-diagnosed-glioblastoma 2022-06-16 05:12:05 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-bioinvent-establish-exclusive-option-and-license-agreement-to-develop 2022-06-16 05:19:04 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-enters-a-drug-discovery-collaboration-with-janssen 2022-06-14 23:39:31 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-carthronix-announce-partnership-to-pursue-small-molecule 2022-06-14 23:34:51 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-lilly-and-incytes-olumiant 2022-06-14 00:52:55 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-morphosys-and-incyte-enter-into-clinical-trial 2022-06-14 00:46:51 daily 0.1 https://demo.pharmafocusasia.com/news/amylyx-pharmaceuticals-announces-health-canada-approval 2022-06-13 06:40:26 daily 0.1 https://demo.pharmafocusasia.com/news/immunogen-announces-research-collaboration-with-oxford-biotherapeutics 2022-06-13 06:45:30 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-announces-new-collaboration-for-development-of-olamkicept 2022-06-13 01:56:50 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-foundation-medicines-foundationonecdx 2022-06-13 01:55:02 daily 0.1 https://demo.pharmafocusasia.com/news/integral-molecular-and-optimeos-life-sciences-enter-partnership 2022-06-09 03:02:42 daily 0.1 https://demo.pharmafocusasia.com/news/opiant-pharmaceuticals-and-aptar-pharma-expand-long-term-collaboration 2022-06-09 02:55:41 daily 0.1 https://demo.pharmafocusasia.com/news/biocryst-announces-approval-of-orladeyo-berotralstat-by-swissmedic 2022-06-09 03:12:48 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-bioworks-and-novo-nordisk-to-collaborate-on-expression-systems-for-pharmaceutical-products 2022-06-09 03:10:13 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-hrec-approval-in-australia-for-the-phase-i-trial 2022-06-07 01:25:21 daily 0.1 https://demo.pharmafocusasia.com/news/parse-biosciences-announces-partnership-with-molecular-diagnostics-korea 2022-06-07 01:18:19 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-the-european-commission-agree-on-amendment-to-covid-19-vaccine-supply-agreement 2022-06-07 02:55:24 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-samsung-bioepis-byooviz-ranibizumab-nuna-launches-in-the-united-states 2022-06-07 02:50:51 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-acquires-leading-eu-stability-storage-company-q1-scientific 2022-06-02 05:18:22 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-launches-lyvispah-for-spasticity-related-to-multiple-sclerosis 2022-06-02 05:25:16 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-and-go-therapeutics-enter-into-strategic-research-and-license-agreement 2022-06-01 04:22:40 daily 0.1 https://demo.pharmafocusasia.com/news/bone-therapeutics-signs-definitive-subscription-agreement-for-a-maximum 2022-06-01 04:16:00 daily 0.1 https://demo.pharmafocusasia.com/news/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-in-adults 2022-05-31 01:50:21 daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-hollisterstier-llc-enters-into-cooperative-agreement-with-us-government 2022-05-31 01:56:00 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-announces-collaboration-with-apc-on-real-time-process-monitoring 2022-05-30 01:35:24 daily 0.1 https://demo.pharmafocusasia.com/news/verisim-life-and-total-brain-announce-strategic-collaboration-agreement-applying-ai 2022-05-26 23:28:15 daily 0.1 https://demo.pharmafocusasia.com/news/altesa-biosciences-to-initiate-clinical-trials-of-promising-antiviral 2022-05-26 23:31:21 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-plans-to-invest-21-billion-in-new-manufacturing-sites-in-indiana 2022-05-26 00:01:03 daily 0.1 https://demo.pharmafocusasia.com/news/genomic-testing-cooperative-hematology-profile-plus-solid-tumor-profile-plus 2022-05-25 23:58:11 daily 0.1 https://demo.pharmafocusasia.com/news/amphastar-receives-fda-approval-for-regadenoson 2022-05-24 23:27:28 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-completes-antares-pharma-acquisition 2022-05-24 23:31:33 daily 0.1 https://demo.pharmafocusasia.com/news/medison-pharma-announces-extension-of-multi-territorial-agreement-with-immunocore 2022-05-24 00:45:43 daily 0.1 https://demo.pharmafocusasia.com/news/ocugen-announces-fda-removes-clinical-hold-on-phase-23-clinical-trial 2022-05-24 00:48:34 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-receives-positive-chmp-opinion-for-upstaza 2022-05-22 23:46:13 daily 0.1 https://demo.pharmafocusasia.com/news/simcere-pharma-novel-inhibitor-of-covid-19-3clpro-sim0417-received 2022-05-19 23:53:10 daily 0.1 https://demo.pharmafocusasia.com/news/sinclair-pharma-partners-with-vanguard-aesthetics-to-launch-silhouette-soft-in-malaysia 2022-05-19 23:45:35 daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-announces-asset-purchase-agreement-with-mannkind-corporation 2022-05-19 03:39:16 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-extends-research-collaboration-with-the-university-of-alberta 2022-05-19 03:46:06 daily 0.1 https://demo.pharmafocusasia.com/news/proscia-introduces-ai-powered-quality-control 2022-05-18 01:08:01 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-signs-licence-agreement-with-rq-biotechnology-for-monoclonal-antibodies-against-covid-19 2022-05-18 01:12:23 daily 0.1 https://demo.pharmafocusasia.com/news/proteros-expands-oncology-collaboration-and-license-agreement-with-astrazeneca 2022-05-16 23:40:50 daily 0.1 https://demo.pharmafocusasia.com/news/perkinelmer-expands-genomic-testing-services-with-ultrarapid 2022-05-16 23:32:13 daily 0.1 https://demo.pharmafocusasia.com/news/inmagene-receives-fda-ind-clearance-for-a-third-generation-btk 2022-05-16 03:41:09 daily 0.1 https://demo.pharmafocusasia.com/news/mindset-pharma-progresses-plans-for-clinical-trials 2022-05-12 23:12:04 daily 0.1 https://demo.pharmafocusasia.com/news/neurocrine-biosciences-receives-orphan-drug-designation-for-valbenazine 2022-05-12 23:08:49 daily 0.1 https://demo.pharmafocusasia.com/news/neuvivo-begins-manufacturing-of-np001-for-treatment-of-als 2022-05-12 01:23:55 daily 0.1 https://demo.pharmafocusasia.com/news/nuvig-launches-to-develop-novel-immune-therapeutics-for-chronic-inflammatory 2022-05-12 01:21:39 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-introduces-qualtrak-biopharma-qpcr-solutions 2022-05-10 22:50:30 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-acquire-biohaven-pharmaceuticals 2022-05-10 22:55:25 daily 0.1 https://demo.pharmafocusasia.com/news/hitachi-high-tech-and-invivoscribe-partner-to-advance-molecular-diagnostics 2022-05-09 22:34:19 daily 0.1 https://demo.pharmafocusasia.com/news/opko-health-acquires-modex-therapeutics 2022-05-09 22:41:02 daily 0.1 https://demo.pharmafocusasia.com/news/citius-pharmaceuticals-to-accelerate-phase-3-mino-lok-trial-by-expanding-trial-sites-internationally 2022-05-08 23:37:31 daily 0.1 https://demo.pharmafocusasia.com/news/algernon-pharmaceuticals-announces-last-patient-treated-in-phase-2-study-of-ipf-and-chronic-cough 2022-05-05 22:49:00 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-chooses-cerebras-systems-to-accelerate-ai-biopharmaceutical-research 2022-05-05 22:52:36 daily 0.1 https://demo.pharmafocusasia.com/news/stevanato-group-and-owen-mumford-sign-exclusive-collaboration-agreement 2022-05-05 22:26:32 daily 0.1 https://demo.pharmafocusasia.com/news/brickell-biotech-announces-sale-of-sofpironium-bromide-to-botanix-pharmaceuticals 2022-05-05 07:00:14 daily 0.1 https://demo.pharmafocusasia.com/news/agastiya-biotech-receives-fda-orphan-drug-designation-for-ab001-for-pancreatic-cancer 2022-05-03 23:31:04 daily 0.1 https://demo.pharmafocusasia.com/news/cytena-and-excellgene-to-develop-automated-workflows-for-biotherapeutics 2022-05-03 23:38:38 daily 0.1 https://demo.pharmafocusasia.com/news/nicoya-completes-acquisition-of-lsk-technologies 2022-05-02 23:11:30 daily 0.1 https://demo.pharmafocusasia.com/news/endo-acquires-ready-to-use-injectable-product-candidates-from-nevakar 2022-05-02 23:06:31 daily 0.1 https://demo.pharmafocusasia.com/news/inmagene-receives-fdas-ind-clearance-for-ox40-antagonist 2022-05-02 03:50:21 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-plexium-enter-into-multi-target-strategic-collaboration 2022-04-28 23:14:36 daily 0.1 https://demo.pharmafocusasia.com/news/gc-biopharma-concludes-agreement-with-acuitas-therapeutics 2022-04-28 23:17:22 daily 0.1 https://demo.pharmafocusasia.com/news/virpax-successfully-completes-initial-preclinical-studies-for-vrp324 2022-04-28 23:07:10 daily 0.1 https://demo.pharmafocusasia.com/news/serenity-bioworks-acquires-dc-tab-for-lupus-nephritis 2022-04-28 23:09:36 daily 0.1 https://demo.pharmafocusasia.com/news/rvac-medicines-cbc-incubated-mrna-platform-company-raises-to-expand-rd 2022-04-26 22:54:12 daily 0.1 https://demo.pharmafocusasia.com/news/castle-biosciences-completes-acquisition-of-altheadx 2022-04-26 22:58:25 daily 0.1 https://demo.pharmafocusasia.com/news/turnstone-biologics-announces-til-therapy-research-collaboration 2022-04-25 22:49:05 daily 0.1 https://demo.pharmafocusasia.com/news/porton-advanced-and-sinorda-biomedicine-enter-strategic-collaboration 2022-04-25 22:40:57 daily 0.1 https://demo.pharmafocusasia.com/news/breckenridge-signs-new-product-agreement-with-pts-pharma 2022-04-23 00:55:10 daily 0.1 https://demo.pharmafocusasia.com/news/codexis-and-seqwell-announce-strategic-investment-and-partnership-initiation 2022-04-22 03:17:09 daily 0.1 https://demo.pharmafocusasia.com/news/enzyvant-announces-plans-to-expand-regenerative-medicine-manufacturing-capabilities 2022-04-22 03:14:07 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-terminates-collaboration-with-bioarctic-on-alpha-synuclein-portfolio 2022-04-21 22:31:29 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-completes-full-acquisition-of-samsung-bioepis 2022-04-21 23:00:17 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-enhances-clinical-research-solutions-in-collaboration 2022-04-19 22:24:02 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-to-acquire-checkmate-pharmaceuticals 2022-04-19 22:27:17 daily 0.1 https://demo.pharmafocusasia.com/news/ankyra-therapeutics-announces-cooperative-research-and-development-agreement 2022-04-18 23:42:02 daily 0.1 https://demo.pharmafocusasia.com/news/asahi-kasei-medical-to-acquire-bionova-scientific 2022-04-18 23:51:29 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-announces-approval-of-nuvaxovid-covid-19-vaccine 2022-04-18 23:56:18 daily 0.1 https://demo.pharmafocusasia.com/news/atyr-pharma-announces-fda-orphan-drug-designation-for-efzofitimod 2022-04-14 00:44:04 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-to-acquire-antares-pharma 2022-04-14 00:49:13 daily 0.1 https://demo.pharmafocusasia.com/news/achilles-therapeutics-announces-manufacturing-expansion-in-the-uk 2022-04-13 01:36:46 daily 0.1 https://demo.pharmafocusasia.com/news/persephone-biosciences-and-ginkgo-bioworks-announce-collaboration 2022-04-13 01:31:03 daily 0.1 https://demo.pharmafocusasia.com/news/revive-therapeutics-provides-update-on-phase-3-clinical-trial-for-bucillamine-in-covid-19 2022-04-12 02:58:19 daily 0.1 https://demo.pharmafocusasia.com/news/telix-announces-licence-agreement-with-lilly-for-olaratumab 2022-04-12 03:01:41 daily 0.1 https://demo.pharmafocusasia.com/news/bioasis-enters-into-research-collaboration-with-janssen 2022-04-12 03:06:18 daily 0.1 https://demo.pharmafocusasia.com/news/scirhom-starts-cmc-development-of-its-first-drug-candidate-for-clinical-development 2022-04-11 03:56:27 daily 0.1 https://demo.pharmafocusasia.com/news/andera-partners-to-sell-its-life-sciences-portfolio-company-reviral-to-pfizer 2022-04-07 23:16:01 daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-signs-antibody-discovery-collaboration-with-medisix-therapeutics 2022-04-07 23:19:48 daily 0.1 https://demo.pharmafocusasia.com/news/melinta-therapeutics-acquires-us-rights-to-toprol-xl-from-new-american-therapeutics 2022-04-07 06:01:48 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-laboratories-acquires-explora-biolabs 2022-04-07 06:06:39 daily 0.1 https://demo.pharmafocusasia.com/news/sterling-expands-adc-capabilities-and-laboratory-capacity-at-deeside 2022-04-05 23:40:44 daily 0.1 https://demo.pharmafocusasia.com/news/bruker-acquires-optimal-companies-for-pharma-pat-software 2022-04-05 23:45:52 daily 0.1 https://demo.pharmafocusasia.com/news/invitae-introduces-first-comprehensive-genetic 2022-04-05 00:50:00 daily 0.1 https://demo.pharmafocusasia.com/news/vipergen-establishes-dna-encoded-library-del-based-drug-discovery-partnership 2022-04-05 00:43:07 daily 0.1 https://demo.pharmafocusasia.com/news/cansinobios-covid-19-mrna-vaccine-receives-approval-of-clinical-trial-application-in-china 2022-04-05 00:58:41 daily 0.1 https://demo.pharmafocusasia.com/news/sellas-life-sciences-signs-exclusive-license-agreement-with-genfleet-therapeutics 2022-04-05 01:08:11 daily 0.1 https://demo.pharmafocusasia.com/news/ono-enters-into-a-development-and-license-agreement-with-numab 2022-04-05 01:03:09 daily 0.1 https://demo.pharmafocusasia.com/news/receptor-life-sciences-announces-fda-acceptance-of-ind-application 2022-03-30 23:47:07 daily 0.1 https://demo.pharmafocusasia.com/news/iktos-announces-a-collaboration-with-ono-in-artificial-intelligence-for-new-drug-design 2022-03-30 23:51:23 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-launches-ce-ivd-marked-next-generation-sequencing-instrument-for-use-in-clinical-labs 2022-03-30 01:54:27 daily 0.1 https://demo.pharmafocusasia.com/news/rentschler-biopharma-and-vetter-unveil-xpert-alliance 2022-03-30 02:00:09 daily 0.1 https://demo.pharmafocusasia.com/news/telix-granted-fda-orphan-drug-designation-for-bone-marrow-conditioning-treatment 2022-03-29 03:04:37 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-announces-agreement-to-divest-sunosi-to-axsome-therapeutics 2022-03-29 03:01:27 daily 0.1 https://demo.pharmafocusasia.com/news/stalicla-completes-successful-phase-1b-trials-for-the-first-precision-medicine 2022-03-25 06:16:54 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-therapeutics-and-chugai-pharmaceutical-enter-global-collaboration 2022-03-25 06:28:02 daily 0.1 https://demo.pharmafocusasia.com/news/quest-diagnostics-granted-cdc-contract-to-support-covid-19-infection 2022-03-24 01:34:46 daily 0.1 https://demo.pharmafocusasia.com/news/cyclica-and-arctoris-to-expand-partnership-to-advance-drug-discovery-programs-for-alzheimers-disease 2022-03-24 01:39:35 daily 0.1 https://demo.pharmafocusasia.com/news/acasti-pharma-announces-patents-for-gtx-104-in-europe-gtx-102-in-the-us-and-gtx-101-in-japan 2022-03-22 23:38:04 daily 0.1 https://demo.pharmafocusasia.com/news/proscia-and-visiopharm-partner-to-deliver-ai-powered-pathology 2022-03-22 23:44:09 daily 0.1 https://demo.pharmafocusasia.com/news/teva-reaches-agreement-with-rhode-island-to-settle-opioid-related-claims 2022-03-21 23:54:27 daily 0.1 https://demo.pharmafocusasia.com/news/neurosense-therapeutics-receives-fda-clearance-of-ind-for-primec-for-the-treatment-of-als 2022-03-21 23:49:51 daily 0.1 https://demo.pharmafocusasia.com/news/saniona-ion-channel-research-collaboration-with-boehringer-ingelheim 2022-03-21 22:47:51 daily 0.1 https://demo.pharmafocusasia.com/news/wockhardt-and-serum-life-sciences-uk-announce-collaboration-for-manufacturing 2022-03-21 23:04:28 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-announces-research-collaboration-focused 2022-03-18 01:38:47 daily 0.1 https://demo.pharmafocusasia.com/news/centogene-announces-expansion-of-data-access-and-collaboration 2022-03-18 01:43:36 daily 0.1 https://demo.pharmafocusasia.com/news/actg-and-shionogi-announce-progress-on-global-phase-3-trial 2022-03-16 23:02:02 daily 0.1 https://demo.pharmafocusasia.com/news/oppilotech-and-evariste-technologies-announce-partnership-to-develop 2022-03-16 23:09:55 daily 0.1 https://demo.pharmafocusasia.com/news/qualigen-therapeutics-extends-research-agreement-with-university-of-louisville 2022-03-16 00:35:58 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-scripps-research-announce-collaboration 2022-03-16 00:40:11 daily 0.1 https://demo.pharmafocusasia.com/news/element-biosciences-launches-the-to-democratize-access-to-genomics 2022-03-15 04:18:12 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-to-expand-clinical-research-labs-capacity-in-virginia 2022-03-15 04:12:45 daily 0.1 https://demo.pharmafocusasia.com/news/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag 2022-03-15 03:02:44 daily 0.1 https://demo.pharmafocusasia.com/news/oragenics-engages-kbi-biopharma-to-support-development-of-intranasal 2022-03-10 23:52:43 daily 0.1 https://demo.pharmafocusasia.com/news/cerveau-technologies-inc-signs-agreement-with-roche 2022-03-10 23:57:10 daily 0.1 https://demo.pharmafocusasia.com/news/briori-biotech-granted-patent-for-topical-formulation-of-vioxx 2022-03-10 00:01:00 daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-and-kriya-sign-agreement-to-discover-novel-antibodies 2022-03-10 00:03:44 daily 0.1 https://demo.pharmafocusasia.com/news/ekf-life-sciences-and-abec-partner-for-us-biomanufacturing-expansion 2022-03-08 22:47:43 daily 0.1 https://demo.pharmafocusasia.com/news/aldeyra-therapeutics-initiates-phase-clinical-trial 2022-03-08 22:51:44 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-launch-of-a-first-generic-version-of-revlimid-lenalidomide-capsules-in-the-us 2022-03-08 22:33:53 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-completes-acquisition-of-zogenix-inc 2022-03-08 22:38:41 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-health-canada-approval-for-brukinsa 2022-03-04 03:48:05 daily 0.1 https://demo.pharmafocusasia.com/news/inhibrx-receives-fda-orphan-drug-designation-for-inbrx-101 2022-03-04 03:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/gc-labs-and-two-clinical-diagnostic-companies-enter-the-collaboration 2022-03-02 23:00:54 daily 0.1 https://demo.pharmafocusasia.com/news/newomics-and-bruker-announce-collaborations-on-high-throughput-bioanalysis 2022-03-02 23:05:48 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-enters-us-biosimilars-market-with-approval-of-releukotm 2022-03-01 23:31:59 daily 0.1 https://demo.pharmafocusasia.com/news/ray-therapeutics-and-forge-biologics-announce-viral-vector-contract-development 2022-03-01 23:38:23 daily 0.1 https://demo.pharmafocusasia.com/news/taro-completes-acquisition-of-alchemee 2022-03-01 00:53:19 daily 0.1 https://demo.pharmafocusasia.com/news/virios-therapeutics-announces-research-collaboration-exploring-the-potential 2022-02-28 23:42:39 daily 0.1 https://demo.pharmafocusasia.com/news/edenbridge-pharmaceuticals-announces-the-launch-of-dartisla-odt 2022-02-28 23:26:25 daily 0.1 https://demo.pharmafocusasia.com/news/actym-therapeutics-and-wacker-biotech-sign-manufacturing-contract-for-actyms-lead-candidate-for-the-treatment-of-solid-tumors 2022-02-28 23:36:54 daily 0.1 https://demo.pharmafocusasia.com/news/gi-innovation-signs-mou-with-cellkey-for-biomarker-joint-research-to-develop 2022-02-24 23:57:08 daily 0.1 https://demo.pharmafocusasia.com/news/gliapharm-sa-and-the-wyss-center-enter-collaboration-to-develop-new-therapies-for-alzheimers-disease 2022-02-25 00:46:42 daily 0.1 https://demo.pharmafocusasia.com/news/algernon-pharmaceuticals-begins-manufacturing-of-repirinast-and-launches 2022-02-24 00:47:12 daily 0.1 https://demo.pharmafocusasia.com/news/alvotech-and-fuji-pharma-expand-partnership-for-additional-biosimilar-candidate-in-japan 2022-02-24 00:33:08 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-thermo-fisher-scientific-announce-long-term-strategic-collaboration 2022-02-24 00:42:50 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-the-institute-for-genetic-medicine 2022-02-22 23:43:45 daily 0.1 https://demo.pharmafocusasia.com/news/kiniksa-pharmaceuticals-and-huadong-medicine-announce-strategic-collaboration 2022-02-22 23:51:59 daily 0.1 https://demo.pharmafocusasia.com/news/carsgen-therapeutics-opens-new-us-cgmp-facility-for-car-t-production 2022-02-22 06:28:04 daily 0.1 https://demo.pharmafocusasia.com/news/prestige-biopharmas-herceptin-biosimilar-tuznue-receives-eu-gmp-certification 2022-02-22 06:33:06 daily 0.1 https://demo.pharmafocusasia.com/news/cansinobios-convidecia-approved-as-heterologous-booster-in-china 2022-02-20 23:00:57 daily 0.1 https://demo.pharmafocusasia.com/news/paige-and-flagship-biosciences-announce-partnership-to-expand-access-to-immuno-oncology-biomarker-analysis-toolspaige-and-flagship-biosciences-announce-partnership-to-expand 2022-02-17 23:23:37 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-acquires-artificial-intelligence-technology-to-enhance-lab-productivity 2022-02-17 23:37:47 daily 0.1 https://demo.pharmafocusasia.com/news/equillium-acquires-bioniz-therapeutics-significantly-expanding-pipeline 2022-02-17 01:01:30 daily 0.1 https://demo.pharmafocusasia.com/news/kato-wins-fda-approval-for-human-studies-of-drug-for-retinal-disorders 2022-02-17 01:07:26 daily 0.1 https://demo.pharmafocusasia.com/news/ambrx-biopharma-inc-announces-submission-of-ind-application-for-arx305-with-the-us-fda 2022-02-15 23:10:41 daily 0.1 https://demo.pharmafocusasia.com/news/transperfect-life-sciences-and-innovaderm-research-expand-trial-interactive-partnership 2022-02-15 23:22:36 daily 0.1 https://demo.pharmafocusasia.com/news/adcentrx-and-avantgen-enter-a-new-partnership-with-multi-target-collaboration 2022-02-15 02:52:52 daily 0.1 https://demo.pharmafocusasia.com/news/tetra-bio-pharma-enters-into-a-strategic-partnership-with-avicanna 2022-02-15 03:00:38 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-india-limited-extends-access-to-its-medicines-in-india 2022-02-12 04:33:53 daily 0.1 https://demo.pharmafocusasia.com/news/asymchem-acquires-snapdragon-chemistry 2022-02-12 04:32:33 daily 0.1 https://demo.pharmafocusasia.com/news/quoin-pharmaceuticals-signs-exclusive-distribution-agreement-with-er-kim 2022-02-11 04:20:09 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-receives-us-fda-fast-track-designation-for-asundexian-stroke-program 2022-02-11 04:29:57 daily 0.1 https://demo.pharmafocusasia.com/news/verde-bio-holdings-announces-acquisition-in-oil-rich-permian-basin 2022-02-10 01:05:51 daily 0.1 https://demo.pharmafocusasia.com/news/active-biotech-enters-into-global-patent-license-agreement-with-oncode-institute 2022-02-10 01:01:36 daily 0.1 https://demo.pharmafocusasia.com/news/healx-and-ovid-therapeutics-to-enter-strategic-partnership 2022-02-09 05:31:47 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-completes-acquisition-of-amunix 2022-02-09 05:38:56 daily 0.1 https://demo.pharmafocusasia.com/news/azurity-pharmaceuticals-inc-announces-fda-approval-of-fleqsuvy 2022-02-08 02:15:30 daily 0.1 https://demo.pharmafocusasia.com/news/teva-reaches-agreement-with-texas-to-settle-the-states-opioid-related-claims 2022-02-08 02:15:49 daily 0.1 https://demo.pharmafocusasia.com/news/dyve-biosciences-announces-research-and-development-collaboration-with-moffitt-cancer-center 2022-02-04 01:33:50 daily 0.1 https://demo.pharmafocusasia.com/news/mersana-therapeutics-announces-research-collaboration-and-license-agreement-with-janssen 2022-02-04 01:38:44 daily 0.1 https://demo.pharmafocusasia.com/news/vericel-announces-plans-for-a-new-state-of-the-art-cell-therapy-manufacturing-facility 2022-02-03 23:22:32 daily 0.1 https://demo.pharmafocusasia.com/news/syros-receives-fda-orphan-drug-designation-for-tamibarotene-for-the-treatment-of-mds 2022-02-03 23:18:09 daily 0.1 https://demo.pharmafocusasia.com/news/coriolis-pharma-opens-new-atmp-formulation-development-facilities 2022-02-01 23:57:41 daily 0.1 https://demo.pharmafocusasia.com/news/biomed-x-institute-and-merck-kgaa-darmstadt-germany-extend-collaboration-in-oncology 2022-02-02 00:02:23 daily 0.1 https://demo.pharmafocusasia.com/news/oxford-biomedica-announces-that-sio-gene-therapies-intends-to-cease-the-license-agreement 2022-02-01 06:24:08 daily 0.1 https://demo.pharmafocusasia.com/news/leica-biosystems-and-leap-therapeutics-partner-on-companion-diagnostic 2022-02-01 06:28:56 daily 0.1 https://demo.pharmafocusasia.com/news/european-commission-approves-teysuno-in-metastatic-colorectal-cancer 2022-02-01 06:16:13 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-receives-chmp-positive-opinion-for-novel-covid-19-oral-treatment 2022-01-28 01:12:42 daily 0.1 https://demo.pharmafocusasia.com/news/haemalogix-and-lonza-collaborate-to-manufacture-kappamab 2022-01-27 23:29:34 daily 0.1 https://demo.pharmafocusasia.com/news/polydex-pharmaceuticals-announces-collaboration-with-termanox-water 2022-01-27 23:13:23 daily 0.1 https://demo.pharmafocusasia.com/news/atara-biotherapeutics-enters-strategic-manufacturing-partnership-with-fujifilm 2022-01-27 23:22:09 daily 0.1 https://demo.pharmafocusasia.com/news/prospection-and-novotech-partner-to-accelerate-clinical-trials 2022-01-25 02:55:16 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-announces-the-innovative-seahorse-xf-pro-analyzer 2022-01-25 02:57:18 daily 0.1 https://demo.pharmafocusasia.com/news/mustgrow-and-bayer-sign-exclusive-agreement 2022-01-23 23:57:23 daily 0.1 https://demo.pharmafocusasia.com/news/senhwas-silmitasertib-receives-us-fda-orphan-drug-designation-for-the-treatment-of-biliary-tract-cancer 2022-01-21 22:43:10 daily 0.1 https://demo.pharmafocusasia.com/news/syapse-extends-collaboration-with-pfizer-to-continue-to-generate-real-world-evidence-in-breast-cancer 2022-01-21 22:53:54 daily 0.1 https://demo.pharmafocusasia.com/news/seegene-to-launch-new-covid-19-pcr-test-with-a-reduced-turnaround-time-optimized-for-mass-testing 2022-01-20 06:47:20 daily 0.1 https://demo.pharmafocusasia.com/news/kinnate-biopharma-announces-fda-clearance-of-investigational-drug-application-for-kin-3248 2022-01-19 03:28:28 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-announces-collaboration-with-mabgenesis 2022-01-19 03:45:03 daily 0.1 https://demo.pharmafocusasia.com/news/green-valley-obtains-ind-approval-from-us-fda-for-sodium-oligomannate 2022-01-18 01:30:52 daily 0.1 https://demo.pharmafocusasia.com/news/neutron-therapeutics-and-cosylab-announce-strategic-collaboration 2022-01-12 00:40:42 daily 0.1 https://demo.pharmafocusasia.com/news/bighat-biosciences-completes-first-stage-of-research-collaboration-with-amgen 2022-01-12 00:45:52 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-enters-into-agreement-with-acuitas-therapeutics 2022-01-11 00:27:09 daily 0.1 https://demo.pharmafocusasia.com/news/century-therapeutics-and-bristol-myers-squibb-enter-into-strategic-collaboration 2022-01-11 01:06:15 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-and-molecular-partners-report-positive-topline-data 2022-01-10 23:51:19 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-and-mammoth-biosciences-to-collaborate-on-novel-gene-editing-technology 2022-01-10 23:54:15 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-generate-biomedicines-announce-multi-target 2022-01-07 01:12:12 daily 0.1 https://demo.pharmafocusasia.com/news/trexbio-announces-collaboration-with-janssen 2022-01-07 01:16:19 daily 0.1 https://demo.pharmafocusasia.com/news/sri-international-announces-collaboration-agreement-with-janssen 2022-01-06 01:25:27 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-sign-new-global-collaboration-agreement 2022-01-06 01:29:38 daily 0.1 https://demo.pharmafocusasia.com/news/verseau-therapeutics-announces-fda-clearance-of-investigational-new-drug-application 2022-01-04 23:03:39 daily 0.1 https://demo.pharmafocusasia.com/news/genprex-expands-gene-therapy-oncology-pipeline-to-include-small-cell-lung-cancer 2022-01-04 23:19:51 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-expands-ritonavir-oral-tablet-production-and-announces-oral-direct-acting-antiviral-pipeline-against-sars-cov-2-virus 2022-01-04 01:25:19 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-receive-us-fda-emergency-use-authorization-of-covid-19 2022-01-04 01:25:09 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-and-astrazeneca-close-deal-to-develop-and-commercialize-eplontersen 2021-12-30 00:32:55 daily 0.1 https://demo.pharmafocusasia.com/news/amphastar-receives-fda-tentative-approval-for-vasopressin 2021-12-30 00:34:28 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-announces-completion-of-dicerna-pharmaceuticals-acquisition 2021-12-29 01:36:37 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-immuneoncia-sign-mou-for-development 2021-12-29 01:44:31 daily 0.1 https://demo.pharmafocusasia.com/news/amador-bioscience-completed-the-acquisition-of-ann-arbor-pharmacometrics-group-a2pg 2021-12-29 01:47:10 daily 0.1 https://demo.pharmafocusasia.com/news/sedana-medical-receives-ind-approval-for-us-trial 2021-12-29 01:58:28 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-and-sk-bioscience-expand-manufacturing-agreement 2021-12-29 02:52:15 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-receives-us-fda-emergency-use-authorization-for-novel-covid-19-oral-antiviral-treatment 2021-12-22 22:37:07 daily 0.1 https://demo.pharmafocusasia.com/news/karyopharm-and-menarini-group-enter-into-exclusive-license-agreement 2021-12-22 22:29:39 daily 0.1 https://demo.pharmafocusasia.com/news/telix-collaborates-with-olivia-newton-john-cancer-research-institute-on-brain-cancer-imaging-study 2021-12-22 06:39:05 daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-initiates-project-to-build-new-manufacturing-and-lab-facilities 2021-12-20 23:01:23 daily 0.1 https://demo.pharmafocusasia.com/news/emd-serono-expands-neuroinflammatory-pipeline-with-acquisition-of-chord-therapeutics 2021-12-20 23:00:30 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-telixs-prostate-cancer-imaging-product-illuccix 2021-12-20 22:58:56 daily 0.1 https://demo.pharmafocusasia.com/news/navidea-biopharmaceuticals-announces-launch-of-phase-3-clinical-trial-in-rheumatoid-arthritis 2021-12-16 22:58:38 daily 0.1 https://demo.pharmafocusasia.com/news/biomarin-and-skyline-therapeutics-announce-strategic-collaboration 2021-12-16 22:57:53 daily 0.1 https://demo.pharmafocusasia.com/news/bionaut-labs-and-candel-therapeutics-announce-strategic-collaboration 2021-12-15 23:47:13 daily 0.1 https://demo.pharmafocusasia.com/news/agomab-therapeutics-completes-acquisition-of-origo-biopharma 2021-12-15 23:44:15 daily 0.1 https://demo.pharmafocusasia.com/news/merck-collaborates-with-innovative-biotech-to-support-establishment-of-first-vaccine-production-facility-in-nigeria 2021-12-15 01:09:19 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-therapanacea-announce-new-collaboration-with-the-potential 2021-12-15 01:07:24 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-and-astrazeneca-expand-strategic-manufacturing-partnership 2021-12-13 23:40:35 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-acquire-arena-pharmaceuticals 2021-12-13 23:38:57 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-clinical-collaboration-with-bristol-myers-squibb 2021-12-12 23:33:53 daily 0.1 https://demo.pharmafocusasia.com/news/rapid-dose-therapeutics-signs-product-supply-agreement 2021-12-09 23:05:30 daily 0.1 https://demo.pharmafocusasia.com/news/syndax-pharmaceuticals-announces-closing-of-global-collaboration-agreement 2021-12-09 23:04:21 daily 0.1 https://demo.pharmafocusasia.com/news/genscript-probio-opens-chinas-largest-commercial-gmp-plasmid-manufacturing-facility 2021-12-08 23:15:03 daily 0.1 https://demo.pharmafocusasia.com/news/neurop-receives-fda-orphan-drug-designation-for-np10679 2021-12-08 23:13:59 daily 0.1 https://demo.pharmafocusasia.com/news/telix-and-nucliber-sign-distribution-agreement-for-prostate-cancer-imaging-in-spain 2021-12-07 23:54:37 daily 0.1 https://demo.pharmafocusasia.com/news/pacbio-and-ucla-health-announce-research-collaboration 2021-12-07 23:53:08 daily 0.1 https://demo.pharmafocusasia.com/news/gritstone-bio-and-cepi-expand-vaccine-agreement-to-tackle-omicron-variant 2021-12-06 23:35:56 daily 0.1 https://demo.pharmafocusasia.com/news/recursion-and-bayer-expand-fibrosis-collaboration-to-include-inferential-search-capabilities 2021-12-06 23:35:18 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-receives-ind-approval-for-combination-therapy-of-kras-g12c-and-cetuximab-injection-in-china 2021-12-05 22:49:26 daily 0.1 https://demo.pharmafocusasia.com/news/nj-bio-expands-its-state-of-the-art-facility-in-princeton-new-jersey 2021-12-02 23:05:30 daily 0.1 https://demo.pharmafocusasia.com/news/resilience-acquires-swiftscale-biologics 2021-12-02 23:04:19 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-and-dyno-therapeutics-announce-research-collaboration-to-develop 2021-12-01 23:42:09 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-origimm-biotechnology 2021-12-01 23:41:02 daily 0.1 https://demo.pharmafocusasia.com/news/kymera-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-irakimid 2021-12-01 23:33:09 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-and-chiesi-enter-global-license-agreement-for-zampilimab 2021-12-01 23:20:50 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-confirms-detection-of-sars-cov-2 2021-11-29 22:51:27 daily 0.1 https://demo.pharmafocusasia.com/news/blueprint-medicines-to-expand-precision-therapy-leadership-in-lung-cancer 2021-11-29 22:50:15 daily 0.1 https://demo.pharmafocusasia.com/news/greenlight-biosciences-and-samsung-biologics-announce-collaboration-to-build-capacity 2021-11-24 22:42:40 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-bushu-pharma-announce-expanded-supply-chain-partnership 2021-11-24 22:41:21 daily 0.1 https://demo.pharmafocusasia.com/news/donaldson-company-acquires-solaris-biotechnology 2021-11-23 23:47:23 daily 0.1 https://demo.pharmafocusasia.com/news/valneva-signs-purchase-agreement-with-european-commission 2021-11-23 23:46:18 daily 0.1 https://demo.pharmafocusasia.com/news/vifor-pharma-acquisition-of-sanifit-therapeutics-and-inositec-ag 2021-11-22 23:30:30 daily 0.1 https://demo.pharmafocusasia.com/news/obseva-announces-us-fda-acceptance-of-new-drug-application-for-linzagolix 2021-11-22 23:29:33 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-pharmaceuticals-and-jiangsu-hengrui-pharmaceuticals-announce-strategic-partnership-licensing-agreement 2021-11-21 22:57:01 daily 0.1 https://demo.pharmafocusasia.com/news/zenas-biopharma-acquires-exclusive-worldwide-rights-to-obexelimab-from-xencor 2021-11-21 22:54:14 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-to-acquire-dicerna 2021-11-19 00:02:23 daily 0.1 https://demo.pharmafocusasia.com/news/eqrx-and-evotec-announce-integrated-drug-discovery-and-development-partnership 2021-11-19 00:01:14 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-and-vir-biotechnology-announce-united-states-government-agreements 2021-11-18 00:23:36 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-acquisition-of-trillium-therapeutics 2021-11-18 00:22:03 daily 0.1 https://demo.pharmafocusasia.com/news/lonza-to-expand-microbial-development-laboratories 2021-11-16 22:54:40 daily 0.1 https://demo.pharmafocusasia.com/news/sotio-expands-its-antibody-drug-conjugate-pipeline-with-exclusive-collaboration-and-license-agreement 2021-11-16 22:53:21 daily 0.1 https://demo.pharmafocusasia.com/news/mimivax-receives-fda-approval-to-initiate-a-new-phase-2b-clinical-study 2021-11-15 23:19:42 daily 0.1 https://demo.pharmafocusasia.com/news/bayshore-pharmaceuticals-announces-commercial-launch-of-anda-approved-products 2021-11-15 23:16:23 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-announces-the-clearance-of-clinical-trial-of-novel-shp2-allosteric 2021-11-14 23:14:13 daily 0.1 https://demo.pharmafocusasia.com/news/organon-to-acquire-forendo-pharma 2021-11-11 23:39:01 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-supplemental-new-drug-application 2021-11-11 23:30:22 daily 0.1 https://demo.pharmafocusasia.com/news/valneva-announces-european-commission-approval 2021-11-10 23:37:17 daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-enters-collaboration-to-enhance-controlled-substance-management-in-the-us 2021-11-10 23:35:54 daily 0.1 https://demo.pharmafocusasia.com/news/regenxbio-announces-closing-of-eye-care-collaboration-agreement-with-abbvie 2021-11-10 00:03:09 daily 0.1 https://demo.pharmafocusasia.com/news/karuna-therapeutics-and-zai-lab-announce-strategic-collaboration-for-development-manufacturing 2021-11-10 00:01:18 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-profounda-orphan-drug-designation-approval-for-treatment-of-treatment 2021-11-09 23:59:51 daily 0.1 https://demo.pharmafocusasia.com/news/azurity-pharmaceuticals-announces-fda-approval-of-eprontia 2021-11-08 22:43:51 daily 0.1 https://demo.pharmafocusasia.com/news/acticor-biotech-announces-fda-acceptance-of-ind-application-for-glenzocimab 2021-11-04 23:43:06 daily 0.1 https://demo.pharmafocusasia.com/news/green-circle-life-launches-covid-19-vaccination-mandate-compliance-solution 2021-11-04 23:42:20 daily 0.1 https://demo.pharmafocusasia.com/news/yokogawa-acquires-insilico-biotechnology 2021-11-02 23:09:35 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-metagenomi-establish-collaboration-to-develop-next-generation 2021-11-02 23:07:41 daily 0.1 https://demo.pharmafocusasia.com/news/alivamab-discovery-services-expands-discovery-agreement-with-igm-biosciences 2021-11-01 22:18:59 daily 0.1 https://demo.pharmafocusasia.com/news/venatorx-pharmaceuticals-announces-collaboration-with-roche 2021-11-01 22:16:03 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-launches-a-new-gmp-commercial-drug-product-facility 2021-11-01 05:17:27 daily 0.1 https://demo.pharmafocusasia.com/news/agomab-therapeutics-to-acquire-origo-biopharma 2021-10-28 23:29:36 daily 0.1 https://demo.pharmafocusasia.com/news/ubiquigent-extends-and-expands-drug-discovery-collaboration-with-bristol-myers-squibb 2021-10-28 23:12:25 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-completes-gmp-inspection-by-health-canada-for-drug-substance-facility 2021-10-27 23:01:02 daily 0.1 https://demo.pharmafocusasia.com/news/xtalpi-and-signet-expand-ai-drug-discovery-collaboration-to-novel-cancer-target 2021-10-27 22:59:48 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-partners-with-thoeris-to-investigate 2021-10-27 04:07:14 daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-modag-announce-licensing-collaboration 2021-10-27 04:06:23 daily 0.1 https://demo.pharmafocusasia.com/news/tremeau-expands-pipeline-with-novel-non-opioid-compound 2021-10-25 23:02:27 daily 0.1 https://demo.pharmafocusasia.com/news/xeris-pharmaceuticals-enters-collaboration-agreement-with-merck 2021-10-25 23:01:38 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-genentechs-susvimo-a-first-of-its-kind-therapeutic-approach 2021-10-24 22:54:06 daily 0.1 https://demo.pharmafocusasia.com/news/mablink-bioscience-and-emergence-therapeutics-enter-into-a-licensing-agreement-to-develop-antibody-drug-conjugate-as-a-potential-cancer-therapy 2021-10-22 00:40:24 daily 0.1 https://demo.pharmafocusasia.com/news/oncodesign-and-tiumbio-sign-collaboration-agreement-for-rd-of-fibrosis-drug-candidates 2021-10-22 00:31:20 daily 0.1 https://demo.pharmafocusasia.com/news/biotage-acquires-atdbio-and-strengthens-its-position-in-dna 2021-10-22 00:30:26 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-fda-authorization-of-a-booster-dose-of-moderna 2021-10-22 00:29:18 daily 0.1 https://demo.pharmafocusasia.com/news/cdisc-and-openclinica-collaborate-to-drive-academic-clinical-research-forward 2021-10-19 23:25:17 daily 0.1 https://demo.pharmafocusasia.com/news/fsd-pharma-signs-agreement-with-covar-pharmaceuticals 2021-10-19 23:24:30 daily 0.1 https://demo.pharmafocusasia.com/news/perkinelmer-and-honeycomb-biotechnologies-launch-the-hive-scrnaseq-solution 2021-10-18 23:35:40 daily 0.1 https://demo.pharmafocusasia.com/news/sumitomo-dainippon-pharma-and-behavr-announce-landmark-deal 2021-10-18 23:34:06 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-atu-opens-new-manufacturing-facility-to-further-enhance-its-ctdmo 2021-10-17 22:58:14 daily 0.1 https://demo.pharmafocusasia.com/news/intellia-therapeutics-and-sparingvision-announce-strategic-collaboration 2021-10-13 23:37:59 daily 0.1 https://demo.pharmafocusasia.com/news/immusoft-and-takeda-collaborate-to-discover-and-develop 2021-10-13 23:35:28 daily 0.1 https://demo.pharmafocusasia.com/news/genecentric-therapeutics-collaborates-with-labcorp-to-develop-novel-rna-based-oncology-diagnostics 2021-10-12 23:09:54 daily 0.1 https://demo.pharmafocusasia.com/news/sutro-biopharma-and-bionova-pharmaceuticals-enter-into-collaboration 2021-10-12 23:09:08 daily 0.1 https://demo.pharmafocusasia.com/news/tegsedi-receives-innovative-drug-category-pricing-in-brazil 2021-10-11 22:38:47 daily 0.1 https://demo.pharmafocusasia.com/news/sirtex-medical-and-china-grand-pharmaceutical-announce-successful-first-administration-of-sir-spheres 2021-10-11 22:37:44 daily 0.1 https://demo.pharmafocusasia.com/news/supernus-pharmaceuticals-to-acquire-adamas-pharmaceuticals-strengthening 2021-10-11 05:46:09 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-brukinsa-approved-for-treatment 2021-10-10 23:44:02 daily 0.1 https://demo.pharmafocusasia.com/news/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre 2021-10-07 22:35:50 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-neumora-therapeutics-announce-strategic-rd-collaboration 2021-10-07 22:32:35 daily 0.1 https://demo.pharmafocusasia.com/news/amerisourcebergen-supports-global-distribution-of-covid-19-vaccines 2021-10-06 22:56:50 daily 0.1 https://demo.pharmafocusasia.com/news/eqrx-and-absci-announce-partnership-to-discover-and-develop-next-generation-protein-based-drugs 2021-10-06 22:55:25 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-provides-update-on-tak-994-clinical-program 2021-10-05 23:00:56 daily 0.1 https://demo.pharmafocusasia.com/news/xeris-pharmaceuticals-completes-acquisition-of-strongbridge-biopharma 2021-10-05 23:00:12 daily 0.1 https://demo.pharmafocusasia.com/news/stevanato-group-initiates-construction-on-new-us-facility 2021-10-04 23:02:23 daily 0.1 https://demo.pharmafocusasia.com/news/atara-biotherapeutics-and-pierre-fabre-enter-strategic-collaboration-to-commercialize-tabelecleucel 2021-10-04 23:01:17 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-announces-completion-of-acquisition 2021-10-04 06:06:38 daily 0.1 https://demo.pharmafocusasia.com/news/merck-to-acquire-acceleron-pharma 2021-09-30 22:53:10 daily 0.1 https://demo.pharmafocusasia.com/news/sunovion-sumitomo-dainippon-pharma-and-otsuka-enter-worldwide-development 2021-09-30 22:52:04 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-to-fully-acquire-caelum-biosciences 2021-09-29 23:54:34 daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-and-veeva-systems-partner-for-patient-centric-digital-trials 2021-09-29 23:53:59 daily 0.1 https://demo.pharmafocusasia.com/news/care-access-and-eli-lilly-and-company-partner-to-increase-diversity 2021-09-29 00:03:14 daily 0.1 https://demo.pharmafocusasia.com/news/novabay-pharmaceuticals-signs-agreement-to-acquire-dermadoctor 2021-09-29 00:02:11 daily 0.1 https://demo.pharmafocusasia.com/news/bio-thera-solutions-and-intract-pharma-enter-global-collaboration-and-license-agreement-for-soteria 2021-09-27 23:04:36 daily 0.1 https://demo.pharmafocusasia.com/news/regenerx-licensee-acquired-by-korean-biopharmaceutical-group 2021-09-27 23:01:13 daily 0.1 https://demo.pharmafocusasia.com/news/transcenta-received-ind-clearance-from-nmpa-of-its-anti-sclerostin-monoclonal-antibody-tst002 2021-09-26 23:45:57 daily 0.1 https://demo.pharmafocusasia.com/news/phenomenex-announces-the-release-of-new-biozen-sec-size-exclusion-chromatography-columns 2021-09-23 23:36:15 daily 0.1 https://demo.pharmafocusasia.com/news/amnio-technology-awarded-us-patent-for-amniotic-allografts 2021-09-23 23:34:19 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-and-everest-medicines-announce-multi-target-collaboration-to-advance-new-antibody-therapies 2021-09-22 22:43:25 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-receive-first-us-fda-emergency-use-authorization 2021-09-22 22:41:31 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-lexette-r-for-adolescent-plaque-psoriasis 2021-09-21 22:45:06 daily 0.1 https://demo.pharmafocusasia.com/news/persephone-biosciences-inc-announces-collaboration-with-janssen-biotech 2021-09-21 22:40:56 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-and-faes-farma-enter-into-exclusive-licensing-agreement-for-the-commercialisation 2021-09-21 01:58:10 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-oxford-biotherapeutics-partnership-advances-second-oncology 2021-09-21 01:57:18 daily 0.1 https://demo.pharmafocusasia.com/news/perkinelmer-completes-acquisition-of-antibody-and-reagent-leader-biolegend 2021-09-20 01:05:10 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-health-canada-approves-its-covid-19-vaccine 2021-09-16 22:38:37 daily 0.1 https://demo.pharmafocusasia.com/news/resonant-therapeutics-announces-advancement-in-collaboration-with-janssen 2021-09-16 22:37:47 daily 0.1 https://demo.pharmafocusasia.com/news/infinity-biologix-acquires-roylance-pharma 2021-09-15 22:10:25 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-announces-collaboration-with-moderna-to-discover-therapeutic-antibodies-for-mrna-medicines 2021-09-15 22:09:39 daily 0.1 https://demo.pharmafocusasia.com/news/cem-corporation-ambiopharm-form-us-partnership-for-gmp-peptide-production 2021-09-14 22:52:40 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-completes-acquisition-of-translate-bio 2021-09-14 22:51:42 daily 0.1 https://demo.pharmafocusasia.com/news/cycle-pharmaceuticals-launches-cycle-vita 2021-09-13 22:35:08 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-regenxbio-announce-eye-care-collaboration 2021-09-13 22:34:26 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-statement-on-takeda-agreement-to-provide-doses-of-nvx-cov2373 2021-09-12 23:13:31 daily 0.1 https://demo.pharmafocusasia.com/news/poxel-announces-product-launch-in-japan-for-twymeeg 2021-09-12 23:12:38 daily 0.1 https://demo.pharmafocusasia.com/news/virios-therapeutics-granted-new-patent-for-antiviral-inhibitor-combination 2021-09-08 22:44:36 daily 0.1 https://demo.pharmafocusasia.com/news/resilience-to-manufacture-mrna-for-modernas-covid-19-vaccine 2021-09-08 22:43:00 daily 0.1 https://demo.pharmafocusasia.com/news/inanobio-announces-successful-development-of-novel-nanopore-transistor-prototype 2021-09-07 22:50:24 daily 0.1 https://demo.pharmafocusasia.com/news/telix-to-collaborate-with-kettering-health-on-diagnostic 2021-09-07 22:48:53 daily 0.1 https://demo.pharmafocusasia.com/news/jw-therapeutics-announces-nmpa-approval-of-relmacabtagene-autoleucel-injection-in-china 2021-09-06 22:41:32 daily 0.1 https://demo.pharmafocusasia.com/news/csl-behring-underscores-its-commitment-to-respiratory-patients-with-strong-focus-on-research 2021-09-05 22:54:52 daily 0.1 https://demo.pharmafocusasia.com/news/genequantum-and-brighgene-sign-agreement-for-development-of-antibody 2021-09-05 22:54:14 daily 0.1 https://demo.pharmafocusasia.com/news/curia-completes-acquisition-of-lakepharma 2021-09-02 22:46:39 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-and-visiopharm-expand-collaboration-with-worldwide-distribution-agreement 2021-09-02 22:43:00 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-submission-of-initial-data-to-us-fda-for-its-covid-19-vaccine-booster 2021-09-01 23:35:55 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-and-genfleet-announce-exclusive-global-license-agreement-for-gfh925 2021-09-01 23:34:46 daily 0.1 https://demo.pharmafocusasia.com/news/poseida-therapeutics-announces-fda-clearance-of-investigational-new-drug-application 2021-08-31 23:21:50 daily 0.1 https://demo.pharmafocusasia.com/news/data-from-multiple-studies-show-positive-outcomes-with-gala-therapeutics-rheox-system-for-chronic-bronchitis 2021-08-31 23:20:58 daily 0.1 https://demo.pharmafocusasia.com/news/epygenix-therapeutics-announces-fda-acceptance-of-ind-to-initiate-a-clinical-trial 2021-08-29 23:33:41 daily 0.1 https://demo.pharmafocusasia.com/news/ironwood-pharmaceuticals-announces-fda-approval-of-revised-linzess-linaclotide-label 2021-08-26 23:04:53 daily 0.1 https://demo.pharmafocusasia.com/news/fda-clears-thermo-scientific-elia-smdp-s-test-for-use-in-us 2021-08-26 23:03:56 daily 0.1 https://demo.pharmafocusasia.com/news/provectus-algae-expands-into-new-large-scale-microalgae-biomanufacturing-facility 2021-08-25 23:15:06 daily 0.1 https://demo.pharmafocusasia.com/news/fsd-pharma-announces-definitive-agreement-to-acquire-lucid-psycheceuticals 2021-08-25 23:14:14 daily 0.1 https://demo.pharmafocusasia.com/news/flexcon-announces-global-launch-of-new-pharmcal-portfolio-for-pharmaceutical-labeling 2021-08-25 00:28:19 daily 0.1 https://demo.pharmafocusasia.com/news/index-pharmaceuticals-receives-fda-clearance-to-start-the-phase-iii-study 2021-08-25 00:27:24 daily 0.1 https://demo.pharmafocusasia.com/news/bioduro-sundia-acquires-us-based-phase-iiicommercial-drug-product-manufacturing-facility 2021-08-23 22:39:21 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-acquire-trillium-therapeutics 2021-08-23 22:38:13 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-acceptance-of-a-supplemental-biologics-license-application-in-china 2021-08-22 22:41:56 daily 0.1 https://demo.pharmafocusasia.com/news/jw-therapeutics-announces-strategic-partnership-with-meditrust-health 2021-08-22 22:35:06 daily 0.1 https://demo.pharmafocusasia.com/news/curia-to-expand-us-commercial-manufacturing-capability 2021-08-19 22:56:17 daily 0.1 https://demo.pharmafocusasia.com/news/perkinelmer-expands-automated-mycotoxin-detection-kits 2021-08-19 22:55:35 daily 0.1 https://demo.pharmafocusasia.com/news/roche-receives-fda-approval-for-first-companion-diagnostic-to-identify-dmmr-solid-tumour 2021-08-19 00:52:38 daily 0.1 https://demo.pharmafocusasia.com/news/alligator-bioscience-announces-immuno-oncology-research-collaboration 2021-08-19 00:51:55 daily 0.1 https://demo.pharmafocusasia.com/news/virpax-pharmaceuticals-receives-fda-response-and-guidance-on-mms019 2021-08-17 22:48:01 daily 0.1 https://demo.pharmafocusasia.com/news/nexus-pharmaceuticals-receives-patent-for-emerphed 2021-08-17 22:45:55 daily 0.1 https://demo.pharmafocusasia.com/news/marrone-bio-innovations-collaborates-with-terramera 2021-08-17 00:23:56 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-invenra-expand-collaboration-to-discover-and-develop-novel-biologics-in-oncology 2021-08-17 00:23:07 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-announces-first-subject-dosed-in-clinical-trial-of-icp-332 2021-08-15 22:50:33 daily 0.1 https://demo.pharmafocusasia.com/news/nimbus-therapeutics-and-schrodinger-extend-longstanding-collaboration 2021-08-12 23:01:47 daily 0.1 https://demo.pharmafocusasia.com/news/artiva-biotherapeutics-establishes-us-research-and-manufacturing-facility 2021-08-12 22:54:30 daily 0.1 https://demo.pharmafocusasia.com/news/ceapro-inc-expands-collaboration-with-montreal-heart-institute-with-new-clinical-study 2021-08-11 23:42:34 daily 0.1 https://demo.pharmafocusasia.com/news/c4-therapeutics-announces-fda-orphan-drug-designation-for-cft7455 2021-08-11 23:41:33 daily 0.1 https://demo.pharmafocusasia.com/news/vensica-therapeutics-inks-strategic-partnership-with-merz 2021-08-11 03:42:04 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-canada-announce-collaboration-to-bring-mrna-manufacturing-to-canada 2021-08-11 03:39:45 daily 0.1 https://demo.pharmafocusasia.com/news/fulgent-genetics-announces-acquisition-of-csi-laboratories 2021-08-09 23:01:11 daily 0.1 https://demo.pharmafocusasia.com/news/dalrada-health-and-vivera-pharmaceuticals-announce-new-diagnostic-laboratory-joint-venture 2021-08-09 23:00:12 daily 0.1 https://demo.pharmafocusasia.com/news/epizyme-and-hutchmed-announce-strategic-collaboration-to-develop 2021-08-08 22:58:10 daily 0.1 https://demo.pharmafocusasia.com/news/amring-pharmaceuticals-announces-the-approval-and-launch-of-generic-isoproterenol 2021-08-05 22:58:19 daily 0.1 https://demo.pharmafocusasia.com/news/kite-and-appia-bio-announce-collaboration-to-research-and-develop 2021-08-05 22:54:02 daily 0.1 https://demo.pharmafocusasia.com/news/eqrx-and-abcellera-announce-collaboration-to-accelerate-the-advancement 2021-08-05 00:25:33 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-completes-acquisition-of-kites-neoantigen-tcr-cell-therapy 2021-08-05 00:23:10 daily 0.1 https://demo.pharmafocusasia.com/news/burning-rock-and-impact-therapeutics-announce-a-global-strategic-partnership 2021-08-04 00:32:48 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-translate-bio 2021-08-04 00:32:00 daily 0.1 https://demo.pharmafocusasia.com/news/dispersol-and-catalent-collaborate-to-establish-kinetisol-technology 2021-08-02 23:14:23 daily 0.1 https://demo.pharmafocusasia.com/news/alkermes-receives-fda-fast-track-designation-for-nemvaleukin-alfa 2021-08-02 23:13:39 daily 0.1 https://demo.pharmafocusasia.com/news/gc-pharma-and-tottori-university-enter-research-collaboration-and-license-agreement 2021-08-01 22:48:29 daily 0.1 https://demo.pharmafocusasia.com/news/shuttle-pharma-awarded-a-new-patent-for-selective-inhibitors-for-cancer-treatment 2021-07-29 23:05:01 daily 0.1 https://demo.pharmafocusasia.com/news/melior-pharmaceuticals-announces-execution-of-license-agreement 2021-07-29 23:02:27 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-and-vir-biotechnology-announce-joint-procurement-agreement-with-european 2021-07-29 00:47:26 daily 0.1 https://demo.pharmafocusasia.com/news/bluebird-bio-and-resilience-announce-strategic-alliance-to-develop-next-generation-cell-therapies 2021-07-29 00:46:03 daily 0.1 https://demo.pharmafocusasia.com/news/harrow-health-acquires-patented-ophthalmic-surgical-drug-candidate-from-sintetica 2021-07-27 23:30:06 daily 0.1 https://demo.pharmafocusasia.com/news/cyclo-therapeutics-commences-commercial-scale-manufacturing-for-trappsol-cyclo 2021-07-27 23:29:06 daily 0.1 https://demo.pharmafocusasia.com/news/nexus-pharmaceuticals-announces-launch-of-potassium-chloride-in-water-for-injection 2021-07-26 23:09:34 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-ionis-report-positive-topline-clinical-data-on-investigational-alzheimer 2021-07-26 23:08:53 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-and-cassiopea-spa-announce-signing-of-license-and-supply-agreements 2021-07-26 06:06:01 daily 0.1 https://demo.pharmafocusasia.com/news/imaginab-announces-extension-of-long-standing-partnership-with-boehringer-ingelheim 2021-07-26 00:27:55 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-provides-update-on-us-fda-review-of-abrocitinib-and-xeljanz-filings 2021-07-22 22:59:33 daily 0.1 https://demo.pharmafocusasia.com/news/acorda-therapeutics-announces-agreement-to-commercialize-inbrija-in-spain 2021-07-22 22:58:22 daily 0.1 https://demo.pharmafocusasia.com/news/lexeo-therapeutics-expands-with-acquisition-of-stelios-therapeutics 2021-07-21 23:57:30 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-announce-collaboration-with-biovac 2021-07-21 23:54:56 daily 0.1 https://demo.pharmafocusasia.com/news/relmada-therapeutics-announces-the-acquisition-of-development-and-commercial-rights 2021-07-21 01:21:02 daily 0.1 https://demo.pharmafocusasia.com/news/rxcelerate-establishes-venture-capital-division-and-makes-first-investment-in-us-metabolic-disease-company 2021-07-21 01:20:05 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-to-acquire-kites-neoantigen-tcr-cell-therapy-rd-platform 2021-07-20 00:57:40 daily 0.1 https://demo.pharmafocusasia.com/news/bluerock-therapeutics-receives-fda-fast-track-designation-for-da01-in-the-treatment 2021-07-20 00:56:39 daily 0.1 https://demo.pharmafocusasia.com/news/gentibio-and-forge-biologics-announce-viral-vector-contract-development 2021-07-15 22:50:16 daily 0.1 https://demo.pharmafocusasia.com/news/labgenius-announces-research-collaboration-with-ablynx 2021-07-15 22:46:47 daily 0.1 https://demo.pharmafocusasia.com/news/cti-clinical-trial-and-consulting-services-announce-acquisition-of-european-based-dynakin 2021-07-14 22:46:55 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-acquisition-of-protomer-technologies 2021-07-14 22:45:57 daily 0.1 https://demo.pharmafocusasia.com/news/kintor-pharmaceutical-receives-ind-clearance-by-the-us-fda-for-gt20029 2021-07-14 00:25:36 daily 0.1 https://demo.pharmafocusasia.com/news/flowmetric-life-sciences-introduces-the-breakthrough-vaxeffect 2021-07-14 00:24:22 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-innocare-announce-license-and-collaboration-agreement-for-orelabrutinib-an-innovative-cns-penetrant-btk-inhibitor 2021-07-13 00:20:00 daily 0.1 https://demo.pharmafocusasia.com/news/prothena-and-novo-nordisk-announce-acquisition-agreement-for-prothena 2021-07-13 00:17:02 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-announces-strategic-commercial-partnership-with-tencent 2021-07-11 23:23:02 daily 0.1 https://demo.pharmafocusasia.com/news/chugai-and-alebund-enter-into-option-and-license-agreement-for-eos789 2021-07-10 01:13:54 daily 0.1 https://demo.pharmafocusasia.com/news/vor-biopharma-announces-collaboration-with-janssen-to-develop-engineered 2021-07-09 01:30:45 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-inbrain-neuroelectronics-collaborate-to-develop 2021-07-09 01:27:50 daily 0.1 https://demo.pharmafocusasia.com/news/toxicology-ind-preclinical-research-services-by-altogen-labs-cro 2021-07-05 23:25:55 daily 0.1 https://demo.pharmafocusasia.com/news/spero-therapeutics-entered-into-licensing-agreement-with-pfizer-inc 2021-07-05 05:08:25 daily 0.1 https://demo.pharmafocusasia.com/news/standigm-secures-strategic-investment-from-sk-chemicals 2021-07-02 23:57:38 daily 0.1 https://demo.pharmafocusasia.com/news/seres-therapeutics-nestle-health-science-announce-ser-109-co-commercialization-agreement 2021-07-01 23:18:48 daily 0.1 https://demo.pharmafocusasia.com/news/mandos-llc-completes-acquisition-of-adrabetadex-from-mallinckrodt-pharmaceuticals 2021-07-01 23:17:06 daily 0.1 https://demo.pharmafocusasia.com/news/bioasis-technologies-inc-and-oxyrane-uk-ltd-enter-into-research-collaboration 2021-07-01 01:35:27 daily 0.1 https://demo.pharmafocusasia.com/news/apellis-and-beam-therapeutics-enter-exclusive-research-collaboration-to-apply 2021-07-01 01:32:09 daily 0.1 https://demo.pharmafocusasia.com/news/prilenia-receives-positive-ema-opinion-on-orphan-drug-designation-for-pridopidine-in-als 2021-06-29 22:27:10 daily 0.1 https://demo.pharmafocusasia.com/news/oncusp-therapeutics-commences-operations-to-advance-innovative-oncology-therapies 2021-06-29 22:26:27 daily 0.1 https://demo.pharmafocusasia.com/news/lfb-plasma-acquires-immunotek-bio-center-in-greenacres 2021-06-29 01:56:21 daily 0.1 https://demo.pharmafocusasia.com/news/captivate-bio-signs-exclusive-distribution-agreement-with-pl-bioscience 2021-06-29 01:55:33 daily 0.1 https://demo.pharmafocusasia.com/news/nucleai-and-merck-kgaa-darmstadt-germany-launch-translational-medicine-collaboration 2021-06-25 23:41:40 daily 0.1 https://demo.pharmafocusasia.com/news/natera-and-bgi-genomics-announce-commercial-launch-of-the-bginatera 2021-06-25 23:40:58 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-announces-approval-of-aimovig-in-japan-for-the-suppression 2021-06-24 00:22:41 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-inc-announce-us-fda-grants-breakthough-therapy-designation-for-lecanemab 2021-06-24 00:21:33 daily 0.1 https://demo.pharmafocusasia.com/news/grace-science-receives-us-fda-orphan-drug-designation-for-gs-100 2021-06-23 00:34:22 daily 0.1 https://demo.pharmafocusasia.com/news/eurofins-discovery-and-immunoprecise-announce-collaboration 2021-06-23 00:33:12 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-launches-dedicated-crispr-products-for-rapid-and-simplified-analysis 2021-06-21 23:08:57 daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-pharmaceuticals-and-horizon-therapeutics-announce-collaboration 2021-06-21 23:06:13 daily 0.1 https://demo.pharmafocusasia.com/news/biotage-launches-new-automated-platform-for-plasmid-dna-purification 2021-06-21 04:49:20 daily 0.1 https://demo.pharmafocusasia.com/news/bioheng-biotech-received-orphan-drug-designation-from-the-us-fda 2021-06-21 00:38:55 daily 0.1 https://demo.pharmafocusasia.com/news/cytrx-notes-orphazymes-regulatory-update-from-the-fda 2021-06-18 23:23:51 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-bristol-myers-squibb-enter-into-global-strategic-collaboration 2021-06-17 22:49:26 daily 0.1 https://demo.pharmafocusasia.com/news/kite-and-shoreline-biosciences-enter-into-strategic-partnership-to-develop 2021-06-17 22:48:21 daily 0.1 https://demo.pharmafocusasia.com/news/united-therapeutics-announces-fda-acceptance-of-tyvaso-dpi 2021-06-17 00:51:04 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-receives-fda-breakthrough-therapy-designation-for-investigational-177lu-psma-617 2021-06-17 00:48:53 daily 0.1 https://demo.pharmafocusasia.com/news/pulmosim-therapeutics-granted-orphan-drug-designation-for-pt001-by-the-fda 2021-06-16 01:58:42 daily 0.1 https://demo.pharmafocusasia.com/news/dendreon-pharmaceuticals-invests-in-contract-manufacturing-and-patient-services 2021-06-16 01:57:06 daily 0.1 https://demo.pharmafocusasia.com/news/istari-oncology-announces-fda-granted-fast-track-designation-to-pvsripo 2021-06-14 23:19:14 daily 0.1 https://demo.pharmafocusasia.com/news/aucta-pharma-and-oakrum-pharma-announce-launch-of-generic-version-of-jadenu 2021-06-14 23:17:55 daily 0.1 https://demo.pharmafocusasia.com/news/delytact-oncolytic-virus-g47-approved-in-japan-fortreatment-of-patients-with-malignant-glioma 2021-06-14 00:21:13 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-tabuk-pharmaceuticals-partner-to-commercialize-modernas-covid-19 2021-06-12 00:38:02 daily 0.1 https://demo.pharmafocusasia.com/news/avantor-completes-acquisition-of-ritter-gmbh-and-its-affiliates 2021-06-11 03:00:44 daily 0.1 https://demo.pharmafocusasia.com/news/vicore-announces-fda-acceptance-for-pivotal-phase-3-trial-of-c21-in-covid-19 2021-06-11 02:55:09 daily 0.1 https://demo.pharmafocusasia.com/news/know-labs-announces-successful-results-from-pre-clinical-study-validating-bio-rfid 2021-06-09 23:26:54 daily 0.1 https://demo.pharmafocusasia.com/news/arena-pharmaceuticals-announces-orphan-drug-designation-for-etrasimod-for-the-treatment-of-eosinophilic-esophagitis-eoe 2021-06-09 23:25:56 daily 0.1 https://demo.pharmafocusasia.com/news/icosavax-initiates-phase-12-trial-of-covid-19-vlp-vaccine-candidate 2021-06-08 23:21:56 daily 0.1 https://demo.pharmafocusasia.com/news/calidi-biotherapeutics-announces-partnership-with-genscript-probio 2021-06-08 23:20:47 daily 0.1 https://demo.pharmafocusasia.com/news/biocelerate-continues-to-help-improve-nonclinical-study-operations 2021-06-07 23:52:21 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-medison-pharma-partner-to-commercialize-modernas-covid-19-vaccine 2021-06-07 23:51:07 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-received-china-ind-approval-of-its-fxr-agonist-asc42 2021-06-06 22:41:50 daily 0.1 https://demo.pharmafocusasia.com/news/point-biopharma-announces-first-patients-dosed-in-phase-3-study-of-pnt2002-for-mcrpc 2021-06-05 01:40:52 daily 0.1 https://demo.pharmafocusasia.com/news/biocryst-launches-orladeyo-berotralstat-in-germany 2021-06-04 03:09:48 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-acquires-noria-and-psma-therapeutics-to-expand-portfolio-in-prostate-cancer 2021-06-04 03:08:52 daily 0.1 https://demo.pharmafocusasia.com/news/primordial-genetics-grants-arcturus-therapeutics-exclusive-license-of-an-rna-polymerase 2021-06-02 23:15:54 daily 0.1 https://demo.pharmafocusasia.com/news/genscript-biotech-and-ligand-pharmaceuticals-enter-into-global-licensing-agreement 2021-06-02 23:14:51 daily 0.1 https://demo.pharmafocusasia.com/news/point-biopharma-receives-us-nuclear-regulatory-commission-materials 2021-06-01 22:57:36 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-agreement-with-thermo-fisher-scientific-for-fillfinish-manufacturing 2021-06-01 22:56:46 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-to-add-mrna-vaccine-drug-substance-manufacturing-suite 2021-06-01 00:26:20 daily 0.1 https://demo.pharmafocusasia.com/news/nexturn-bio-inc-acquired-a-50-stake-in-rosvivo-therapeutics 2021-06-01 00:06:25 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-first-patient-dosed-in-phase-iii-trial-of-eltanexor 2021-05-28 00:41:32 daily 0.1 https://demo.pharmafocusasia.com/news/seelos-therapeutics-receives-european-orphan-drug-designation-for-sls-005 2021-05-28 00:38:09 daily 0.1 https://demo.pharmafocusasia.com/news/bioinvent-and-transgene-receive-ind-approval-from-the-us-fda-for-bt-001 2021-05-27 01:58:08 daily 0.1 https://demo.pharmafocusasia.com/news/menarini-silicon-biosystems-launches-new-breakthrough-deparray-plus 2021-05-27 01:57:03 daily 0.1 https://demo.pharmafocusasia.com/news/alloy-therapeutics-and-pyxis-oncology-form-kyma-therapeutics-to-develop-novel-immune-modulating 2021-05-26 02:47:48 daily 0.1 https://demo.pharmafocusasia.com/news/ajinomoto-bio-pharma-services-expands-fill-finish-capacity-with-new-multi-purpose-fill-suite 2021-05-26 02:40:35 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheims-investigational-treatment-for-cognitive-impairment 2021-05-25 01:14:40 daily 0.1 https://demo.pharmafocusasia.com/news/dorian-and-hitgen-announce-research-collaboration-focused 2021-05-25 01:13:29 daily 0.1 https://demo.pharmafocusasia.com/news/libtayo-receives-positive-chmp-opinion-for-the-treatment-in-europe 2021-05-24 00:15:43 daily 0.1 https://demo.pharmafocusasia.com/news/liminal-biosciences-announces-closing-of-divestiture-of-plasma-collection-centers 2021-05-21 23:04:08 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-announces-approval-of-modernas-covid-19-vaccine-in-japan 2021-05-21 03:11:56 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-covid-19-vaccine-vaxzevria-authorised-for-emergency-use-in-japan 2021-05-21 03:10:22 daily 0.1 https://demo.pharmafocusasia.com/news/labcorp-to-expand-bioanalytical-services-with-integrated-laboratory-in-singapore 2021-05-19 22:44:15 daily 0.1 https://demo.pharmafocusasia.com/news/mandos-agrees-to-acquire-adrabetadex-from-mallinckrodt-pharmaceuticals 2021-05-19 22:43:09 daily 0.1 https://demo.pharmafocusasia.com/news/prestige-biopharma-enters-mou-with-busan-city-for-establishment 2021-05-18 23:16:58 daily 0.1 https://demo.pharmafocusasia.com/news/agenus-and-bristol-myers-squibb-announce-exclusive-global-license-for-agenus 2021-05-18 23:15:58 daily 0.1 https://demo.pharmafocusasia.com/news/innocare-announces-approval-of-clinical-trial-of-tyk2-inhibitor-icp-332-in-china 2021-05-17 23:11:30 daily 0.1 https://demo.pharmafocusasia.com/news/affyimmune-therapeutics-aic100-granted-fast-track-designation-for-treating-thyroid-cancer 2021-05-17 23:10:48 daily 0.1 https://demo.pharmafocusasia.com/news/biomed-x-institute-and-merck-extend-collaboration-to-continue-novel-research 2021-05-17 06:49:02 daily 0.1 https://demo.pharmafocusasia.com/news/lennham-pharmaceuticals-announces-issuance-of-us-patent-covering-deuterated 2021-05-14 23:45:43 daily 0.1 https://demo.pharmafocusasia.com/news/perkinelmer-expands-cell-biology-leadership-with-agreement 2021-05-12 23:36:53 daily 0.1 https://demo.pharmafocusasia.com/news/inscopix-expands-global-distribution-network-in-eastern-europe 2021-05-12 23:35:35 daily 0.1 https://demo.pharmafocusasia.com/news/x-chem-announces-opendex-dna-encoded-library-screening 2021-05-11 23:11:44 daily 0.1 https://demo.pharmafocusasia.com/news/feinstein-institutes-clinical-research-to-study-experimental-stroke-drug 2021-05-11 23:11:04 daily 0.1 https://demo.pharmafocusasia.com/news/fore-biotherapeutics-opens-us-headquarters-in-philadelphias-biotech-hub 2021-05-10 23:43:39 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-receive-first-us-authorization-for-emergency 2021-05-10 23:42:42 daily 0.1 https://demo.pharmafocusasia.com/news/ontochem-assigns-anixa-covid-19-drug-discovery-project-to-molgenie 2021-05-09 23:13:10 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-completes-three-acquisitions-to-expand-its-global-network 2021-05-08 00:06:34 daily 0.1 https://demo.pharmafocusasia.com/news/genprex-in-licenses-additional-gene-therapy-technologies-for-treatment-of-lung-cancer 2021-05-06 23:50:24 daily 0.1 https://demo.pharmafocusasia.com/news/itm-establishes-subsidiary-in-shanghai-to-accelerate-introduction 2021-05-06 23:49:17 daily 0.1 https://demo.pharmafocusasia.com/news/crownbio-acquires-ocello-bv-to-expand-its-preclinical-in-vitro-drug 2021-05-05 23:40:33 daily 0.1 https://demo.pharmafocusasia.com/news/esker-therapeutics-launches-to-transform-the-treatment-of-autoimmune-diseases 2021-05-05 23:39:21 daily 0.1 https://demo.pharmafocusasia.com/news/alchemab-to-collaborate-with-astrazeneca 2021-05-05 04:23:50 daily 0.1 https://demo.pharmafocusasia.com/news/vivace-therapeutics-announces-dosing-of-first-cohort-of-patients 2021-05-05 04:23:07 daily 0.1 https://demo.pharmafocusasia.com/news/enteris-biopharma-completes-expansion-of-manufacturing-facility 2021-05-03 23:33:36 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-announces-development-of-ht-kit-to-treat-multiple-orphan-diseases 2021-05-03 23:32:35 daily 0.1 https://demo.pharmafocusasia.com/news/jacobio-announces-fda-approves-ind-application-to-develop-kras-g12c-inhibitor 2021-05-02 23:23:08 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-scientific-e-cfeg-enables-accelerated-cryo-em 2021-04-30 23:27:24 daily 0.1 https://demo.pharmafocusasia.com/news/sirnaomics-enters-partnership-with-walvax-biotechnology-to-co-develop-its-antiviral-rnai-therapeutic-product-candidate-stp702 2021-04-29 22:37:36 daily 0.1 https://demo.pharmafocusasia.com/news/brooklyn-immunotherapeutics-acquires-license-for-mrna-technology-platform-to-develop-genetically-edited-cells-to-treat-multiple-cancers-blood-and-other-disorders 2021-04-29 22:36:35 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-acquires-amplyx-pharmaceuticals 2021-04-28 22:52:35 daily 0.1 https://demo.pharmafocusasia.com/news/essa-pharma-announces-clinical-collaboration-agreement-with-bayer-to-evaluate-the-combination-of-epi-7386-and-darolutamide 2021-04-28 22:36:05 daily 0.1 https://demo.pharmafocusasia.com/news/geneseeq-and-astrazeneca-collaborate-to-build-guangzhou-bio-diagnostics-innovation-center 2021-04-27 22:36:57 daily 0.1 https://demo.pharmafocusasia.com/news/logicbio-therapeutics-announces-strategic-collaboration-and-option-agreement-with-canbridge-pharmaceuticals-leveraging-gene-editing-and-gene-delivery-platforms 2021-04-27 22:28:02 daily 0.1 https://demo.pharmafocusasia.com/news/pieris-pharmaceuticals-and-boston-pharmaceuticals-enter-into-an-exclusive-worldwide-product-license-for-prs-342-a-4-1bbgpc3-immuno-oncology-bispecific 2021-04-26 22:55:47 daily 0.1 https://demo.pharmafocusasia.com/news/carisma-therapeutics-establishes-collaboration-with-leading-cell-therapy-expert-to-explore-and-develop-allogeneic-car-macrophages 2021-04-26 22:53:16 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-and-tg-therapeutics-expand-collaboration-for-the-large-scale-manufacture-of-ublituximab 2021-04-25 22:23:04 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-and-obsidian-therapeutics-establish-collaboration-to-discover-novel-therapies-that-regulate-gene-editing 2021-04-22 22:25:01 daily 0.1 https://demo.pharmafocusasia.com/news/zenith-epigenetics-announces-clinical-collaboration-with-astellas 2021-04-22 22:23:20 daily 0.1 https://demo.pharmafocusasia.com/news/nanoform-and-aprecia-collaborate-to-advance-3d-printed-nanomedicines 2021-04-22 01:40:49 daily 0.1 https://demo.pharmafocusasia.com/news/excellthera-and-ossium-health-announce-a-collaboration-to-advance-their-technologies-and-platforms-to-improve-human-health 2021-04-21 22:34:09 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-new-supply-agreement-with-israel-for-2022 2021-04-20 23:50:05 daily 0.1 https://demo.pharmafocusasia.com/news/prestige-biopharmas-new-vaccine-production-centre-for-infectious-diseases-including-covid-19 2021-04-20 23:49:14 daily 0.1 https://demo.pharmafocusasia.com/news/citrine-medicine-and-sinopharm-group-announce-strategic-partnership-to-broaden-and-accelerate-access-to-rare-disease-drugs-in-china 2021-04-19 22:29:49 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-enters-into-exclusive-worldwide-licensing-agreement-with-oyagen 2021-04-19 22:20:55 daily 0.1 https://demo.pharmafocusasia.com/news/seegene-has-developed-the-worlds-first-covid-19-variant-test-to-identify-the-origin-of-virus-variants 2021-04-18 22:15:49 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-first-immunotherapy-for-initial-treatment-of-gastric-cancer 2021-04-16 22:39:57 daily 0.1 https://demo.pharmafocusasia.com/news/rubryc-therapeutics-announces-research-collaboration-and-licensing-option-agreement-with-zai-labs 2021-04-16 22:19:51 daily 0.1 https://demo.pharmafocusasia.com/news/arch-biopartners-enters-into-worldwide-license-agreement-with-telara-pharma 2021-04-15 22:20:10 daily 0.1 https://demo.pharmafocusasia.com/news/alligator-bioscience-and-macrogenics-enter-into-a-research-collaboration-to-develop-a-novel-immunotherapy 2021-04-15 22:12:05 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-and-empirico-announce-strategic-multi-target-antibody-discovery-collaboration 2021-04-14 22:16:50 daily 0.1 https://demo.pharmafocusasia.com/news/pure-biologics-chooses-to-collaborate-with-twist-bioscience-to-increase-its-potential-in-the-field-of-phage-display-technology 2021-04-14 22:14:46 daily 0.1 https://demo.pharmafocusasia.com/news/spark-therapeutics-enters-collaboration-with-senti-bio-to-bolster-industry-leading-gene-therapy-research-platform 2021-04-13 22:19:48 daily 0.1 https://demo.pharmafocusasia.com/news/senti-bio-enters-collaboration-with-spark-therapeutics-to-develop-next-generation-precision-gene-therapies 2021-04-13 22:14:26 daily 0.1 https://demo.pharmafocusasia.com/news/hec-pharm-selects-abec-large-scale-fermenters-to-increase-biopharmaceutical-production-capacity 2021-04-11 22:59:06 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-first-patient-dosed-in-phase-ii-trial-of-atg-008-onatasertib-in-patients-with-advanced-solid-tumors-with-specific-genetic-alterations 2021-04-11 22:28:09 daily 0.1 https://demo.pharmafocusasia.com/news/context-therapeutics-and-integral-molecular-enter-collaboration-and-license-deal-for-novel-claudin-6-antibodies-for-gynecologic-cancer-therapeutic-program 2021-04-08 22:36:43 daily 0.1 https://demo.pharmafocusasia.com/news/celcuity-announces-worldwide-licensing-agreement-with-pfizer-to-develop-and-commercialize-gedatolisib-a-first-in-class-pi3kmtor-inhibitor-for-breast-cancer 2021-04-08 22:13:36 daily 0.1 https://demo.pharmafocusasia.com/news/hadassah-and-mybiotics-to-collaborate-for-the-discovery-of-microbiome-based-therapy-for-improving-cancer-immunotherapy 2021-04-07 22:40:33 daily 0.1 https://demo.pharmafocusasia.com/news/progenity-and-ionis-pharmaceuticals-enter-into-agreement-to-evaluate-progenitys-ingestible-oral-biotherapeutics-technology-for-delivery-of-antisense-therapies 2021-04-07 22:28:28 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-genechem-co-ltd-genechem-announces-global-collaboration-on-bispecific-antibodies 2021-04-07 22:26:23 daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-enters-into-merger-agreement-to-acquire-late-stage-oncology-company-acea-therapeutics 2021-04-05 22:21:46 daily 0.1 https://demo.pharmafocusasia.com/news/cidara-therapeutics-announces-agreement-with-janssen-to-develop-and-commercialize-avcs-for-the-prevention-and-treatment-of-influenza 2021-04-05 22:10:00 daily 0.1 https://demo.pharmafocusasia.com/news/emergent-biosolutions-announces-topline-data-from-niaid-phase-3-itac-trial-insight-013-evaluating-immunoglobulins-as-a-treatment-for-hospitalized-patients-with-covid-19 2021-04-03 00:26:43 daily 0.1 https://demo.pharmafocusasia.com/news/supernus-announces-fda-approval-of-qelbree-spn-812-for-the-treatment-of-adhd 2021-04-03 00:22:32 daily 0.1 https://demo.pharmafocusasia.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology 2021-03-31 22:44:05 daily 0.1 https://demo.pharmafocusasia.com/news/bioasis-technologies-inc-and-aposense-enter-into-a-research-collaboration 2021-03-31 22:29:48 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-llc-announces-collaboration-with-asher-biotherapeutics-for-systems-pharmacology-modeling-in-oncology 2021-03-30 22:26:04 daily 0.1 https://demo.pharmafocusasia.com/news/bridgene-biosciences-announces-research-collaboration-with-takeda-to-discover-small-molecule-drugs-for-undruggable-targets 2021-03-30 22:21:58 daily 0.1 https://demo.pharmafocusasia.com/news/hansa-biopharma-enters-preclinical-research-collaboration-with-argenx 2021-03-29 22:38:21 daily 0.1 https://demo.pharmafocusasia.com/news/tarsus-pharmaceuticals-and-lianbio-announce-strategic-partnership-to-develop-and-commercialize-tp-03-in-greater-china 2021-03-29 22:34:58 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-receives-positive-chmp-opinion-for-xtanditm-enzalutamide-for-patients-with-metastatic-hormone-sensitive-prostate-cancer 2021-03-28 23:29:54 daily 0.1 https://demo.pharmafocusasia.com/news/bright-peak-therapeutics-inc-and-ajinomoto-co-inc-enter-into-a-research-collaboration-and-license-agreement-to-create-novel-immunocytokines 2021-03-25 22:56:13 daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-and-kyowa-kirin-partner-for-gpcr-antibody-discovery 2021-03-25 22:53:37 daily 0.1 https://demo.pharmafocusasia.com/news/exacis-biotherapeutics-develops-mrna-engineered-ipsc-derived-nk-cells-for-difficult-to-treat-tumors 2021-03-24 23:48:21 daily 0.1 https://demo.pharmafocusasia.com/news/biopharmaceutical-and-technology-leaders-form-collaboration-to-promote-standards-and-a-modern-patient-id-for-advanced-therapies 2021-03-24 23:43:04 daily 0.1 https://demo.pharmafocusasia.com/news/dunad-therapeutics-emerges-to-develop-next-generation-small-molecule-therapeutics-based-on-first-tuneable-targeted-protein-degradation-technology 2021-03-23 23:45:12 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-therapeutics-and-siga-technologies-announce-strategic-partnership-to-support-innovation-and-provide-access-to-novel-antibacterial-drugs-against-biothreats 2021-03-23 23:41:34 daily 0.1 https://demo.pharmafocusasia.com/news/relief-and-acer-therapeutics-sign-collaboration-and-license-agreement-for-worldwide-development-and-commercialization-of-acer-001 2021-03-22 23:34:20 daily 0.1 https://demo.pharmafocusasia.com/news/semathera-enters-into-exclusive-research-collaboration-and-licensing-agreement-with-roche 2021-03-22 23:19:55 daily 0.1 https://demo.pharmafocusasia.com/news/everest-medicines-announces-acceptance-of-new-drug-application-by-china-nmpa-for-xerava-for-the-treatment-of-complicated-intra-abdominal-infections 2021-03-21 23:21:10 daily 0.1 https://demo.pharmafocusasia.com/news/indivumed-announces-expansion-into-drug-development-and-reports-the-formation-of-ix-therapeutics 2021-03-19 23:44:48 daily 0.1 https://demo.pharmafocusasia.com/news/boston-pharmaceuticals-enters-into-unique-multi-year-out-license-and-option-agreement-with-gsk-for-the-advancement-of-multiple-pre-phase-2-programs 2021-03-18 23:29:38 daily 0.1 https://demo.pharmafocusasia.com/news/pyxis-oncology-announces-worldwide-licensing-agreement-with-pfizer-to-develop-and-commercialize-multiple-antibody-drug-conjugates 2021-03-18 23:28:06 daily 0.1 https://demo.pharmafocusasia.com/news/valence-discovery-to-support-repare-therapeutics-on-ai-enabled-drug-discovery 2021-03-17 22:50:52 daily 0.1 https://demo.pharmafocusasia.com/news/m2gen-announces-new-collaboration-with-merck-to-advance-cancer-therapies 2021-03-17 22:49:50 daily 0.1 https://demo.pharmafocusasia.com/news/nurix-therapeutics-announces-collaboration-for-the-discovery-of-novel-drugs-to-treat-pediatric-cancers 2021-03-16 23:33:08 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-to-acquire-biologics-ds-and-dp-manufacturing-facilities-from-pfizer-china 2021-03-16 23:21:19 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-merck-announce-agreement-to-jointly-develop-and-commercialize-long-acting-investigational-treatment-combinations 2021-03-15 22:36:03 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-idt-collaborate-on-johnson-johnson-covid-19-vaccine-manufacturing 2021-03-15 22:25:06 daily 0.1 https://demo.pharmafocusasia.com/news/hepatx-namocell-and-takara-bio-usa-complete-second-phase-of-collaboration-on-single-cell-analysis-for-cell-therapy-to-treat-late-stage-liver-diseases 2021-03-14 22:44:19 daily 0.1 https://demo.pharmafocusasia.com/news/orgenesis-enters-second-phase-of-collaboration-with-hospital-infantil-universitario-nino-jesus 2021-03-12 00:01:30 daily 0.1 https://demo.pharmafocusasia.com/news/phasebio-pharmaceuticals-and-biovectra-enter-into-supply-agreement-to-support-development-and-commercialization-of-bentracimab 2021-03-11 23:41:25 daily 0.1 https://demo.pharmafocusasia.com/news/complix-signs-global-drug-discovery-and-development-agreement-with-i-mab 2021-03-10 22:55:35 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-acquires-maverick-therapeutics-to-advance-t-cell-activator-solid-tumor-treatments-and-expand-new-cancer-immunotherapy-portfolio 2021-03-10 22:52:31 daily 0.1 https://demo.pharmafocusasia.com/news/neurorx-and-tff-pharmaceuticals-announce-entering-into-feasibility-collaboration 2021-03-09 23:19:33 daily 0.1 https://demo.pharmafocusasia.com/news/sparta-biopharma-announces-us-commercial-availability-of-bioenthesis 2021-03-09 23:18:57 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-enters-into-exclusive-license-agreement-with-wuxi-biologics-to-support-further-expansion-of-its-growing-oncology-biologics-pipeline 2021-03-08 23:04:54 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-biolojic-design-announce-research-collaboration-to-discover-and-develop-antibody-therapies-for-diabetes 2021-03-08 22:58:59 daily 0.1 https://demo.pharmafocusasia.com/news/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir 2021-03-07 23:06:17 daily 0.1 https://demo.pharmafocusasia.com/news/abclonal-biotechnology-acquires-yurogen-biosystems-to-better-serve-diagnostic-and-pharmaceutical-researchers-worldwide 2021-03-05 23:29:37 daily 0.1 https://demo.pharmafocusasia.com/news/alx-oncology-and-tallac-therapeutics-announce-collaboration-on-novel-class-of-cancer-immunotherapeutics 2021-03-04 23:18:22 daily 0.1 https://demo.pharmafocusasia.com/news/conserv-bioscience-and-etherna-immunotherapies-to-collaborate-on-development-of-mrna-vaccines-for-infectious-diseases 2021-03-04 23:17:00 daily 0.1 https://demo.pharmafocusasia.com/news/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement 2021-03-03 23:26:11 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-to-support-construction-of-screening-framework 2021-03-03 23:17:19 daily 0.1 https://demo.pharmafocusasia.com/news/tempest-therapeutics-announces-clinical-collaboration-with-roche-to-advance-tpst-1120-into-a-randomized-combination-study-in-first-line-hepatocellular-carcinoma 2021-03-03 23:15:46 daily 0.1 https://demo.pharmafocusasia.com/news/oscotec-and-beactica-therapeutics-announce-license-and-collaboration-agreement-to-develop-new-cancer-drug 2021-03-02 23:04:37 daily 0.1 https://demo.pharmafocusasia.com/news/iktos-announces-collaboration-with-pfizer-in-ai-for-drug-design 2021-03-02 23:02:14 daily 0.1 https://demo.pharmafocusasia.com/news/phio-pharmaceuticals-and-agonox-inc-announce-collaboration-on-clinical-development-of-novel-t-cell-based-cancer-immunotherapies 2021-03-01 23:13:15 daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-grants-a-worldwide-exclusive-license-to-merck-kgaa-darmstadt-germany-for-the-development-and-commercialization-of-xevinapant 2021-03-01 23:09:54 daily 0.1 https://demo.pharmafocusasia.com/news/pharmaron-acquires-state-of-the-art-biomanufacturing-site-in-the-united-kingdom-from-abbvie 2021-02-28 23:08:32 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-uppthera-enter-into-drug-discovery-research-collaboration 2021-02-28 23:07:38 daily 0.1 https://demo.pharmafocusasia.com/news/xencor-and-ucla-enter-collaboration-to-discover-and-develop-novel-xmab-therapeutics 2021-02-25 23:02:25 daily 0.1 https://demo.pharmafocusasia.com/news/shepherd-therapeutics-and-mayo-clinic-announce-collaboration-to-advance-research-in-rhabdomyosarcoma-using-shepherds-precision-oncology-platform-delve 2021-02-25 22:56:13 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-lysa-lysarc-calym-enter-research-collaboration-for-valemetostat-in-patients-with-relapsedrefractory-b-cell-lymphoma 2021-02-24 22:50:51 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-and-inovio-expand-collaboration-to-develop-ngs-companion-diagnostics-for-inovios-vgx-3100-for-advanced-cervical-dysplasia 2021-02-24 22:48:23 daily 0.1 https://demo.pharmafocusasia.com/news/adaptive-biotechnologies-expands-collaboration-with-labcorp-to-increase-access-to-growing-research-and-clinical-diagnostic-portfolio 2021-02-23 22:33:42 daily 0.1 https://demo.pharmafocusasia.com/news/sirion-biotech-announces-collaboration-with-sanofi-to-innovate-gene-therapy-treatments-with-improved-adeno-associated-virus-capsids 2021-02-23 22:30:38 daily 0.1 https://demo.pharmafocusasia.com/news/sunrock-biopharma-and-genscript-probio-to-develop-new-monoclonal-antibody-program 2021-02-22 22:29:12 daily 0.1 https://demo.pharmafocusasia.com/news/compugen-expands-clinical-collaboration-agreement-with-bristol-myers-squibb-with-phase-1b-combination-study-of-com701-with-opdivo 2021-02-22 22:21:46 daily 0.1 https://demo.pharmafocusasia.com/news/nmpa-approves-toripalimab-in-patients-with-recurrent-or-metastatic-nasopharyngeal-carcinoma-after-failure-of-at-least-two-lines-of-prior-systemic-therapy 2021-02-21 22:56:15 daily 0.1 https://demo.pharmafocusasia.com/news/fordoz-enters-contract-manufacturing-agreement-for-oncology-liposomal-product-with-lipomedix 2021-02-19 22:49:09 daily 0.1 https://demo.pharmafocusasia.com/news/boston-immune-technologies-and-therapeutics-and-beigene-enter-into-an-exclusive-option-and-license-agreement-to-develop-novel-tnfr2-antagonists 2021-02-18 23:17:38 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-rigel-enter-strategic-collaboration-to-develop-ripk1-inhibitors-for-the-potential-treatment-of-immunological-and-neurodegenerative-diseases 2021-02-18 23:05:23 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-and-vir-biotechnology-expand-coronavirus-collaboration-to-advance-new-therapeutics-for-influenza-and-other-respiratory-viruses 2021-02-17 23:02:46 daily 0.1 https://demo.pharmafocusasia.com/news/provention-bio-and-huadong-announce-strategic-collaboration-to-develop-and-commercialize-prv-3279-in-greater-china 2021-02-17 22:59:02 daily 0.1 https://demo.pharmafocusasia.com/news/iterion-therapeutics-secures-17-million-to-advance-development-of-tegavivint-in-multiple-tumor-settings 2021-02-16 23:08:16 daily 0.1 https://demo.pharmafocusasia.com/news/alivecor-announces-collaboration-with-astrazeneca-to-develop-non-invasive-potassium-monitoring-solutions 2021-02-16 23:02:43 daily 0.1 https://demo.pharmafocusasia.com/news/avexegen-therapeutics-receives-a-294m-nih-grant-to-advance-treatment-for-inflammatory-bowel-disease 2021-02-15 23:59:19 daily 0.1 https://demo.pharmafocusasia.com/news/shepherd-therapeutics-and-oncoheroes-biosciences-to-partner-for-the-discovery-development-and-commercialization-of-oncology-therapeutics-for-rare-cancers 2021-02-15 23:56:35 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-drug-to-reduce-bone-marrow-suppression-caused-by-chemotherapy 2021-02-14 22:31:24 daily 0.1 https://demo.pharmafocusasia.com/news/mindmed-signs-partnership-with-swiss-psychedelic-drug-discovery-startup-mindshift-compounds-ag 2021-02-11 22:32:53 daily 0.1 https://demo.pharmafocusasia.com/news/molecular-templates-establishes-multi-target-collaboration-with-bristol-myers-squibb-for-the-discovery-and-development-of-next-generation-engineered-toxin-bodies 2021-02-11 22:20:52 daily 0.1 https://demo.pharmafocusasia.com/news/apollomics-inc-and-iterion-therapeutics-announce-exclusive-collaboration-and-license-agreement-to-develop-and-commercialize-tegavivint-in-greater-china 2021-02-10 22:28:47 daily 0.1 https://demo.pharmafocusasia.com/news/i2o-therapeutics-announces-research-collaboration-with-sanofi-to-enable-oral-delivery-of-nanobody-based-medicines 2021-02-10 22:22:22 daily 0.1 https://demo.pharmafocusasia.com/news/hangzhou-chance-pharmaceuticals-expands-pipeline-with-in-licensing-of-aer901-from-aerami-therapeutics 2021-02-09 22:23:10 daily 0.1 https://demo.pharmafocusasia.com/news/nuance-pharma-announces-strategic-licensing-deal-with-antibe-therapeutics-in-china 2021-02-09 22:13:44 daily 0.1 https://demo.pharmafocusasia.com/news/yingli-pharma-and-hengrui-medicine-reach-a-strategic-agreement-to-jointly-explore-the-oncology-market-in-china 2021-02-08 23:08:49 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-partners-with-camargo-pharmaceutical-services-for-the-ht-001-ind-a-treatment-for-cancer-patients 2021-02-08 22:37:08 daily 0.1 https://demo.pharmafocusasia.com/news/ac-immune-initiates-clinical-study-of-first-in-class-diagnostic-for-parkinsons-disease 2021-02-08 06:35:42 daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-announces-multiple-clinical-advancements-of-its-differentiated-cd73-antibody-uliledlimab-in-china-and-the-us 2021-02-05 22:15:40 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma 2021-02-05 22:13:04 daily 0.1 https://demo.pharmafocusasia.com/news/swift-biosciences-accelerates-its-global-expansion-in-china-and-asia-pacific 2021-02-04 22:40:14 daily 0.1 https://demo.pharmafocusasia.com/news/tcg-lifesciences-pvt-ltd-expands-its-footprint-to-the-united-states-with-the-establishment-of-its-subsidiary-tcg-greenchem-inc 2021-02-04 22:37:42 daily 0.1 https://demo.pharmafocusasia.com/news/engrail-therapeutics-acquires-neurocycle-therapeutics-to-improve-and-optimize-drugs-to-improve-the-lives-of-patients-with-central-nervous-system-diseases 2021-02-03 22:20:06 daily 0.1 https://demo.pharmafocusasia.com/news/matrix-medical-network-collaborates-with-astrazeneca-on-phase-iii-clinical-trial-for-covid-19-long-acting-antibody-combination 2021-02-03 22:17:48 daily 0.1 https://demo.pharmafocusasia.com/news/ribon-therapeutics-announces-license-agreement-with-ono-pharmaceutical-co-ltd-to-develop-and-commercialize-rbn-2397-in-japan-south-korea-taiwan-and-asean-countries 2021-02-02 22:24:28 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-gritstone-announce-collaboration-utilizing-gritstones-vaccine-platform-technology-for-hiv-cure 2021-02-02 22:19:40 daily 0.1 https://demo.pharmafocusasia.com/news/zebiai-and-tb-alliance-announce-collaboration-to-apply-ml-driven-discovery-platform-to-tuberculosis-targets 2021-02-01 22:24:31 daily 0.1 https://demo.pharmafocusasia.com/news/evozyne-announces-a-strategic-collaboration-for-development-of-novel-biopharmaceutical-therapeutics 2021-02-01 22:20:28 daily 0.1 https://demo.pharmafocusasia.com/news/phase-1-drug-candidate-glr2007-developed-by-gan-lee-received-fast-track-designation-from-the-us-fda 2021-01-31 22:22:25 daily 0.1 https://demo.pharmafocusasia.com/news/rigel-awarded-165-million-from-us-department-of-defense-for-phase-3-clinical-trial-of-fostamatinib-in-covid-19-patients 2021-01-29 22:21:42 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-expands-research-collaboration-agreement 2021-01-28 22:50:11 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-asahi-kasei-pharma-announce-license-agreement 2021-01-28 22:49:29 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-discovered-antibody-bamlanivimab-to-be-developed-with-vir-7831-for-the-treatment-of-covid-19 2021-01-27 22:21:04 daily 0.1 https://demo.pharmafocusasia.com/news/cognate-bioservices-and-nucleus-biologics-announce-partnership-in-cell-and-gene-therapies 2021-01-27 22:19:51 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-and-fosun-pharma-receive-authorization-for-emergency-use 2021-01-27 03:04:37 daily 0.1 https://demo.pharmafocusasia.com/news/agenus-enters-into-clinical-collaboration-with-nelum-for-zalifrelimab-combination 2021-01-26 22:26:37 daily 0.1 https://demo.pharmafocusasia.com/news/care-access-research-collaborates-with-astrazeneca-on-phase-iii-clinical-trial-for-covid-19-long-acting-antibody-combination 2021-01-26 22:23:06 daily 0.1 https://demo.pharmafocusasia.com/news/menarini-obtains-european-commission-approval-for-the-use-of-elzonris-tagraxofusp-in-the-treatment-of-plasmacetoid-blast-dendritic-cell-neoplasm-ncdpb 2021-01-24 22:22:22 daily 0.1 https://demo.pharmafocusasia.com/news/mitsubishi-tanabe-pharma-america-and-aquestive-therapeutics-announce-us-licensing-and-supply-deal-for-riluzole-oral-film-for-als-treatment 2021-01-21 22:36:44 daily 0.1 https://demo.pharmafocusasia.com/news/servier-and-mina-therapeutics-enter-collaboration-in-neurological-diseases 2021-01-21 22:25:58 daily 0.1 https://demo.pharmafocusasia.com/news/t-cure-bioscience-and-immunotech-biopharm-ltd-announce-license-agreement-for-novel-herv-e-t-cell-receptor-therapy 2021-01-20 22:22:40 daily 0.1 https://demo.pharmafocusasia.com/news/nexelis-acquires-the-gsk-vaccines-clinical-bioanalytical-laboratory-located-in-marburg-germany-and-enters-into-a-5-year-strategic-agreement-with-gsk 2021-01-20 22:21:53 daily 0.1 https://demo.pharmafocusasia.com/news/cocrystal-pharma-announces-further-development-of-influenza-ab-antiviral-compounds-by-merck-under-exclusive-worldwide-license-and-collaboration-agreement 2021-01-19 22:30:49 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-merus-nv-announce-collaboration-to-discover-novel-t-cell-re-directing-bispecific-antibodies 2021-01-19 22:28:31 daily 0.1 https://demo.pharmafocusasia.com/news/cure-genetics-collaborates-with-boehringer-ingelheim-to-develop-novel-aav-vectors-enabling-the-next-generation-liver-targeted-gene-therapy 2021-01-18 23:14:27 daily 0.1 https://demo.pharmafocusasia.com/news/tennor-enters-research-collaboration-with-janssen-for-potential-new-treatments-for-nontuberculous-mycobacteria-diseases 2021-01-18 23:13:32 daily 0.1 https://demo.pharmafocusasia.com/news/artms-and-terix-pharmaceuticals-announce-successful-manufacture-of-psma-11-using-cyclotron-68ga-from-solid-target 2021-01-17 22:44:19 daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-therapeutics-announces-research-collaboration-with-the-wistar-institute-to-evaluate-the-activity-of-novel-pad4-inhibitors-to-reduce-clinical-severity-of-covid-19 2021-01-15 23:16:47 daily 0.1 https://demo.pharmafocusasia.com/news/angelini-pharma-acquires-arvelle-therapeutics-to-create-a-leading-european-innovator-in-central-nervous-system-cns-and-mental-health-disorder-treatments 2021-01-14 22:23:07 daily 0.1 https://demo.pharmafocusasia.com/news/nucleai-and-debiopharm-launch-research-collaboration-utilizing-nucleais-ai-powered-biomarker-platform 2021-01-14 22:17:40 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-heptares-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery-against-challenging-gpcr-target 2021-01-12 22:41:46 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-vir-biotechnology-establish-clinical-collaboration-to-explore-combination-strategies-for-functional-cure-for-chronic-hepatitis-b-virus 2021-01-12 22:39:42 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-collaboration-with-novartis-to-develop-and-commercialize-anti-pd-1-antibody-tislelizumab 2021-01-11 22:10:36 daily 0.1 https://demo.pharmafocusasia.com/news/avantgen-announces-licensing-of-its-anti-sars-cov-2-antibodies-to-igm-biosciences-for-covid-19-therapy-development 2021-01-11 22:09:33 daily 0.1 https://demo.pharmafocusasia.com/news/humanigen-and-eversana-announce-partnership-to-support-the-launch-and-commercialization-of-lenzilumab-for-the-treatment-of-covid-19 2021-01-10 22:30:55 daily 0.1 https://demo.pharmafocusasia.com/news/almirall-and-tyris-therapeutics-enter-into-strategic-partnership-to-develop-next-generation-gene-therapies 2021-01-07 22:24:19 daily 0.1 https://demo.pharmafocusasia.com/news/imaginab-announces-license-and-supply-agreement-with-pfizer-for-cd8-immunopet-technology 2021-01-07 22:23:34 daily 0.1 https://demo.pharmafocusasia.com/news/cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms-english 2021-01-06 22:32:42 daily 0.1 https://demo.pharmafocusasia.com/news/dewpoint-announces-collaboration-with-pfizer-to-develop-potential-therapies-for-a-rare-form-of-muscular-dystrophy 2021-01-06 22:30:09 daily 0.1 https://demo.pharmafocusasia.com/news/morphic-expands-research-and-development-collaboration-with-janssen-through-third-integrin-program 2021-01-05 22:04:50 daily 0.1 https://demo.pharmafocusasia.com/news/akston-biosciences-and-lakepharma-announce-strategic-partnership-to-manufacture-second-generation-covid-19-vaccine 2021-01-05 22:01:20 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-confirms-commercial-expertise-in-gene-and-cell-therapy-as-manufacturer-of-libmeldy 2021-01-04 23:01:35 daily 0.1 https://demo.pharmafocusasia.com/news/angelini-pharma-to-acquire-arvelle-therapeutics-creating-a-leading-european-innovator-in-central-nervous-system-and-mental-illness-therapy 2021-01-04 22:30:54 daily 0.1 https://demo.pharmafocusasia.com/news/immunitybio-simulates-sars-cov-2-spike-protein-binding-using-molecular-dynamics 2021-01-04 23:03:05 daily 0.1 https://demo.pharmafocusasia.com/news/wize-pharma-and-cosmos-capital-enter-into-bid-implementation-agreement 2020-12-30 23:14:29 daily 0.1 https://demo.pharmafocusasia.com/news/incyte-and-cellenkos-enter-into-global-development-collaboration-agreement-for-ck0804 2020-12-30 23:13:37 daily 0.1 https://demo.pharmafocusasia.com/news/insilico-enters-into-a-collaboration-with-aprinoia-to-apply-novel-generative-ai-powered-system 2020-12-30 00:09:31 daily 0.1 https://demo.pharmafocusasia.com/news/pluristem-enters-collaboration-with-pharmaceutical-company-innovare-rd-to-expand-pluristems-ards-associated-with-covid-19-program-to-mexico 2020-12-29 23:57:34 daily 0.1 https://demo.pharmafocusasia.com/news/soligenix-announces-15-million-nih-small-business-innovation-research-award-advancing-covid-19-vaccine-development 2020-12-28 23:35:11 daily 0.1 https://demo.pharmafocusasia.com/news/sumitovant-biopharma-announces-myovant-sciences-and-pfizer-enter-collaboration-to-develop-and-commercialize-relugolix-in-oncology-and-womens-health 2020-12-28 23:24:12 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-the-nmpa-granted-new-indication-approval-for-byvasda-bevacizumab-biosimilar 2020-12-27 23:37:07 daily 0.1 https://demo.pharmafocusasia.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases 2020-12-23 23:54:14 daily 0.1 https://demo.pharmafocusasia.com/news/a2-biotherapeutics-enters-into-collaboration-agreement-with-merck-to-develop-allogeneic-cell-therapy-for-solid-tumor-cancers 2020-12-23 23:42:37 daily 0.1 https://demo.pharmafocusasia.com/news/lsbio-acquires-absolute-antibody-ltd 2020-12-22 23:34:52 daily 0.1 https://demo.pharmafocusasia.com/news/skyhawk-and-vertex-establish-a-strategic-collaboration-to-discover-and-develop-novel-small-molecules-that-modulate-rna-splicing-for-serious-diseases 2020-12-22 23:26:39 daily 0.1 https://demo.pharmafocusasia.com/news/pierre-fabre-selects-agc-biologics-as-cdmo-to-manufacture-the-orphan-drug-er-004 2020-12-21 23:46:24 daily 0.1 https://demo.pharmafocusasia.com/news/allecra-therapeutics-and-shanghai-haini-pharmaceutical-announce-exclusive-licensing-agreement-for-cefepimeenmetazobactam-for-greater-china 2020-12-21 23:41:37 daily 0.1 https://demo.pharmafocusasia.com/news/antengene-announces-its-us-partner-karyopharm-therapeutics-inc-has-received-fda-approval-of-xpovio-selinexor 2020-12-21 00:05:18 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-heptares-and-gsk-enter-global-collaboration-and-license-agreement-targeting-immune-disorders-of-the-digestive-system 2020-12-20 23:55:52 daily 0.1 https://demo.pharmafocusasia.com/news/teijin-pharma-and-transthera-biosciences-form-strategic-rd-collaboration 2020-12-19 00:17:28 daily 0.1 https://demo.pharmafocusasia.com/news/ology-bioservices-enters-phase-1-clinical-trial-for-anti-covid-19-monoclonal-antibodies 2020-12-18 23:23:55 daily 0.1 https://demo.pharmafocusasia.com/news/ultragenyx-and-mereo-biopharma-announce-collaboration-and-license-agreement-for-setrusumab-in-osteogenesis-imperfecta 2020-12-17 23:55:44 daily 0.1 https://demo.pharmafocusasia.com/news/suez-unveils-new-sievers-toc-analyzers-for-online-ultrapure 2020-12-18 00:16:37 daily 0.1 https://demo.pharmafocusasia.com/news/adc-therapeutics-and-overland-pharma-form-strategic-joint-venture-to-expand-adc-drug-development 2020-12-16 23:32:10 daily 0.1 https://demo.pharmafocusasia.com/news/genosity-enters-into-an-agreement-with-gemini-therapeutics-to-develop-a-diagnostic-and-implement-testing-to-support-geminis-age-related-macular-degeneration-trial 2020-12-16 23:28:25 daily 0.1 https://demo.pharmafocusasia.com/news/vtv-therapeutics-announces-licensing-agreement-for-novel-nrf2-activator-to-anteris-bio 2020-12-15 23:14:20 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-agreement-to-acquire-prevail-therapeutics 2020-12-15 23:09:25 daily 0.1 https://demo.pharmafocusasia.com/news/teon-therapeutics-announces-approval-for-collaboration-with-cancer-research-uk 2020-12-14 23:24:13 daily 0.1 https://demo.pharmafocusasia.com/news/ashvattha-therapeutics-announces-collaboration-with-stanford-university-for-preclinical-development-of-a-novel-neuroimaging-agent-op-801 2020-12-14 23:22:47 daily 0.1 https://demo.pharmafocusasia.com/news/sonoma-pharmaceuticals-and-crown-laboratories-announce-an-exclusive-partnership-to-launch-microcyn-technology-based-anti-itch-over-the-counter-products 2020-12-13 23:54:10 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-to-acquire-nbe-therapeutics 2020-12-11 00:30:21 daily 0.1 https://demo.pharmafocusasia.com/news/inveniai-and-kyowa-kirin-enter-ai-powered-novel-target-discovery-collaboration 2020-12-09 23:38:26 daily 0.1 https://demo.pharmafocusasia.com/news/arcus-biosciences-expands-strategic-relationship-with-wuxi-biologics-to-develop-a-best-in-class-anti-cd39-antibody-for-the-treatment-of-cancer 2020-12-09 23:23:43 daily 0.1 https://demo.pharmafocusasia.com/news/intec-pharma-announces-cannabinoid-research-collaboration-with-gw-pharma 2020-12-09 07:10:07 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-llc-announces-collaboration-with-antengene-for-systems-pharmacology-modeling-in-oncology 2020-12-08 23:18:32 daily 0.1 https://demo.pharmafocusasia.com/news/postera-enters-into-strategic-alliance-with-pfizer-inc-to-advance-drug-discovery 2020-12-07 23:42:22 daily 0.1 https://demo.pharmafocusasia.com/news/aligos-enters-into-an-exclusive-license-and-research-collaboration-agreement-with-merck-to-discover-and-develop-an-oligonucleotide-therapy-for-nash 2020-12-07 23:41:03 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-and-atara-biotherapeutics-enter-strategic-collaboration-for-mesothelin-targeted-car-t-cell-therapies-for-solid-tumors 2020-12-06 23:15:12 daily 0.1 https://demo.pharmafocusasia.com/news/y-mabs-and-takeda-announce-exclusive-license-and-distribution-agreement-for-danyelza-naxitamab-gqgk-and-omburtamab-in-israel 2020-12-04 23:40:51 daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-darmstadt-germany-and-artios-pharma-announce-a-global-strategic-collaboration-on-novel-dna-damage-response-targets-in-oncology 2020-12-03 23:45:27 daily 0.1 https://demo.pharmafocusasia.com/news/tevard-biosciences-and-zogenix-announce-collaboration-to-advance-novel-gene-therapies 2020-12-03 23:28:16 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-in-licenses-iconic-therapeutics-tissue-factor-targeting-antibody-drug-conjugate-ahead-of-planned-investigational-new-drug-application 2020-12-02 23:52:32 daily 0.1 https://demo.pharmafocusasia.com/news/tubulis-forms-strategic-partnership-with-wuxi-biologics-and-wuxi-sta 2020-12-02 23:49:49 daily 0.1 https://demo.pharmafocusasia.com/news/atbtherapeutics-initiates-agreement-with-ibio-cdmo-to-manufacture-game-changer-atbodies-to-better-treat-cancer 2020-12-02 00:13:08 daily 0.1 https://demo.pharmafocusasia.com/news/cho-plus-announces-research-collaboration-agreement-with-janssen 2020-12-02 00:07:23 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-limited-acquires-therapharm-gmbh-broadening-reach-to-hematologic-cancers-and-transplant-medicine 2020-11-30 23:31:44 daily 0.1 https://demo.pharmafocusasia.com/news/cedilla-and-hitgen-announce-research-collaboration-focused-on-dna-encoded-library-based-drug-discovery 2020-11-30 23:28:21 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-amendment-to-current-supply-agreement-with-united-kingdom-government-for-an-additional-2-million-doses-of-mrna-vaccine-against-covid-19-mrna-1273 2020-11-29 23:35:03 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-sage-therapeutics-announce-global-collaboration-to-develop-and-commercialize-potential-breakthrough-therapies-in-depression-and-movement-disorders 2020-11-27 07:21:01 daily 0.1 https://demo.pharmafocusasia.com/news/egle-therapeutics-identifies-first-novel-regulatory-t-cell-targets-in-research-alliance-with-takeda 2020-11-26 23:33:21 daily 0.1 https://demo.pharmafocusasia.com/news/bioinvent-and-cantargia-sign-manufacturing-agreement-for-monoclonal-antibody-can10 2020-11-26 04:53:22 daily 0.1 https://demo.pharmafocusasia.com/news/redhill-biopharma-expands-us-based-manufacturing-capacity-of-opaganib 2020-11-26 04:52:25 daily 0.1 https://demo.pharmafocusasia.com/news/quadramune-synergizes-with-metformin 2020-11-25 00:22:41 daily 0.1 https://demo.pharmafocusasia.com/news/oncosec-announces-exclusive-license-agreement-for-cliniporator-gene-electrotransfer 2020-11-25 00:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/hifibio-therapeutics-inks-partnership-with-pharmsynthez-and-ibch-for-the-clinical-development-and-commercialization-of-its-sars-cov-2-neutralizing-antibody-in-russia 2020-11-23 23:34:48 daily 0.1 https://demo.pharmafocusasia.com/news/novellus-and-tempus-announce-collaboration-to-accelerate-clinical-trial-patient-enrollment 2020-11-23 23:30:28 daily 0.1 https://demo.pharmafocusasia.com/news/redhill-biopharma-initiates-phase-3-study-of-rhb-204-for-first-line-treatment-of-ntm-disease 2020-11-22 23:38:09 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-precision-biosciences-announce-genome-editing-research-collaboration-and-license-agreement 2020-11-20 23:08:54 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-lianbio-announce-strategic-collaboration-to-expand-development-of-novel-therapeutics-in-greater-china 2020-11-19 23:30:06 daily 0.1 https://demo.pharmafocusasia.com/news/immunomic-therapeutics-and-coimmune-therapeutics-enter-into-partnership-to-manufacture-iti-1020-a-novel-experimental-cell-therapy-for-glioblastoma 2020-11-19 23:15:06 daily 0.1 https://demo.pharmafocusasia.com/news/inmed-pharmaceuticals-and-baymedica-announce-collaboration-for-manufacturing-and-testing-of-novel-cannabinoid-therapeutics 2020-11-18 23:27:26 daily 0.1 https://demo.pharmafocusasia.com/news/revive-therapeutics-announces-research-collaboration-with-pharmather-for-development-of-psilocybin-in-cancer-and-discovery-of-novel-uses-of-psychedelics 2020-11-18 23:23:38 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-announces-strategic-manufacturing-partnership-with-lilly-to-accelerate-delivery-of-covid-19-antibody-treatments 2020-11-17 23:29:11 daily 0.1 https://demo.pharmafocusasia.com/news/lead-pharma-enters-into-a-research-collaboration-and-license-agreement-with-roche-to-develop-oral-small-molecules-for-immune-mediated-diseases 2020-11-17 23:27:31 daily 0.1 https://demo.pharmafocusasia.com/news/aeterna-zentaris-amends-license-agreement-with-novo-nordisk-for-commercialization-and-development-of-macimorelin 2020-11-16 23:30:32 daily 0.1 https://demo.pharmafocusasia.com/news/assembly-biosciences-and-door-pharmaceuticals-sign-collaboration-and-option-agreement-to-develop-a-novel-class-of-hbv-core-protein-modulators 2020-11-16 23:15:44 daily 0.1 https://demo.pharmafocusasia.com/news/olema-oncology-announces-clinical-trial-agreement-to-evaluate-op-1250-in-combination-with-palbociclib-ibrance-in-advanced-metastatic-breast-cancer 2020-11-15 23:08:34 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-and-lung-therapeutics-enter-into-an-exclusive-license-agreement-in-japan-for-lti-01-treatment-for-loculated-pleural-effusions 2020-11-12 23:54:24 daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-therapeutics-and-onethree-biotech-collaborate-to-advance-precision-oncology 2020-11-13 00:07:28 daily 0.1 https://demo.pharmafocusasia.com/news/xencor-morphosys-and-incyte-enter-into-global-development-collaboration-for-tafasitamab-in-combination-with-plamotamab 2020-11-11 23:43:16 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-reach-an-agreement-to-supply-the-eu-with-200-million-doses-of-their-bnt162b2-mrna-based-vaccine-candidate-against-sars-cov-2 2020-11-11 23:42:15 daily 0.1 https://demo.pharmafocusasia.com/news/medigen-and-bluewillow-biologics-partner-to-develop-intranasal-vaccine-for-sars-cov-2 2020-11-10 23:34:39 daily 0.1 https://demo.pharmafocusasia.com/news/prestige-biopharma-and-teva-israel-announce-license-and-supply-agreement-to-commercialize-prestiges-trastuzumab-biosimilar-tuznue-in-israel 2020-11-10 23:30:18 daily 0.1 https://demo.pharmafocusasia.com/news/ultragenyx-announces-plans-to-build-large-scale-gene-therapy-manufacturing-facility-to-support-pipeline-of-therapies-for-rare-diseases 2020-11-09 23:51:55 daily 0.1 https://demo.pharmafocusasia.com/news/insilico-announces-a-multi-target-ai-powered-drug-discovery-collaboration-with-janssen 2020-11-09 23:13:54 daily 0.1 https://demo.pharmafocusasia.com/news/vifor-pharma-and-angion-sign-license-agreement-for-ang-3777-in-nephrology-indications 2020-11-09 05:13:49 daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-pharma-ltd-and-aavis-pharmaceuticals-launch-hydroxychloroquine-sulfate-tablets-in-the-us-market 2020-11-07 00:26:15 daily 0.1 https://demo.pharmafocusasia.com/news/isotopia-molecular-imaging-begins-clinical-supply-collaboration-with-y-mabs-therapeutics-inc 2020-11-05 23:29:28 daily 0.1 https://demo.pharmafocusasia.com/news/taysha-gene-therapies-bolsters-manufacturing-capacity-through-partnership-with-catalent 2020-11-05 23:26:47 daily 0.1 https://demo.pharmafocusasia.com/news/axsome-therapeutics-and-veeva-systems-partner-to-build-axsomes-digital-centric-commercialization-platform 2020-11-05 00:16:22 daily 0.1 https://demo.pharmafocusasia.com/news/tff-pharmaceuticals-inc-and-augmenta-bioworks-inc-enter-into-a-worldwide-joint-development-agreement-for-covid-19-monoclonal-antibody-therapies 2020-11-04 00:28:50 daily 0.1 https://demo.pharmafocusasia.com/news/humanigen-executes-licensing-agreement-for-lenzilumab-in-covid-19-with-kpm-techtelcon-rf-pharmaceutical-for-south-korea-and-the-philippines 2020-11-04 00:21:56 daily 0.1 https://demo.pharmafocusasia.com/news/zucara-therapeutics-expands-zt-01-development-program-to-type-2-diabetes 2020-11-02 23:33:15 daily 0.1 https://demo.pharmafocusasia.com/news/cepi-extends-partnership-with-clover-biopharmaceuticals-to-fund-covid-19-vaccine-candidate-through-global-phase-23-study-to-licensure 2020-11-02 23:31:48 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-and-china-grand-pharma-announce-strategic-licence-and-commercial-partnership-for-greater-china-market 2020-11-01 23:52:18 daily 0.1 https://demo.pharmafocusasia.com/news/ocular-therapeutix-and-affamed-therapeutics-announce-license-agreement-and-collaboration-for-dextenza-and-otx-tic-in-asia 2020-10-30 23:45:59 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-and-kodiak-sciences-enter-second-antibody-discovery-collaboration-for-ophthalmology-targets 2020-10-29 23:49:12 daily 0.1 https://demo.pharmafocusasia.com/news/protagonist-therapeutics-announces-advancement-of-oral-il-23-receptor-antagonists-program-in-collaboration-with-janssen 2020-10-29 23:48:24 daily 0.1 https://demo.pharmafocusasia.com/news/insitro-announces-five-year-discovery-collaboration-with-bristol-myers-squibb-to-discover-and-develop-novel-treatments 2020-10-29 00:05:44 daily 0.1 https://demo.pharmafocusasia.com/news/releviate-therapeutics-inks-exclusive-license-for-human-monoclonal-antibodies-for-chronic-pain-indications 2020-10-28 23:30:03 daily 0.1 https://demo.pharmafocusasia.com/news/sfj-pharmaceuticals-partner-apellis-enters-strategic-collaboration-with-sobi-to-develop-and-commercialize-pegcetacoplan 2020-10-27 23:51:04 daily 0.1 https://demo.pharmafocusasia.com/news/histogen-and-amerimmune-enter-into-a-collaborative-development-and-commercialization-agreement-for-emricasan-in-the-treatment-of-covid-19 2020-10-27 23:28:13 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-and-eqrx-enter-global-strategic-partnership-for-two-immune-checkpoint-inhibitors-sugemalimab-anti-pd-l1-and-cs1003-anti-pd-1 2020-10-26 23:40:05 daily 0.1 https://demo.pharmafocusasia.com/news/knight-signs-new-exclusive-agreement-for-ambisome-with-gilead-in-brazil 2020-10-26 23:30:09 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-acquires-asklepios-biopharmaceutical-to-broaden-innovation-base-in-cell-and-gene-therapy 2020-10-26 03:47:19 daily 0.1 https://demo.pharmafocusasia.com/news/ultragenyx-and-solid-biosciences-announce-strategic-collaboration-to-develop-and-commercialize-new-gene-therapies-for-duchenne-muscular-dystrophy 2020-10-23 23:26:44 daily 0.1 https://demo.pharmafocusasia.com/news/avalon-globocare-and-adial-pharmaceuticals-announce-strategic-collaboration-for-global-distribution-of-covid-19-point-of-care-antibody-rapid-test-devices 2020-10-22 23:27:52 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-and-brainstorm-cell-therapeutics-announce-partnership-for-the-manufacture-of-mesenchymal-stem-cell-platform-therapy-nurown 2020-10-22 23:23:09 daily 0.1 https://demo.pharmafocusasia.com/news/hemoshear-therapeutics-enters-into-rare-liver-disease-research-collaboration-with-takeda 2020-10-21 23:13:31 daily 0.1 https://demo.pharmafocusasia.com/news/teneobio-announces-a-research-collaboration-and-license-agreement-with-arsenalbio 2020-10-21 23:12:34 daily 0.1 https://demo.pharmafocusasia.com/news/immune-therapeutics-inc-announces-signing-of-definitive-merger-agreement-between-cytocom-and-cleveland-biolabs 2020-10-20 23:30:16 daily 0.1 https://demo.pharmafocusasia.com/news/roche-and-prothena-will-advance-prasinezumab-into-late-stage-clinical-development-study-in-parkinsons-disease 2020-10-20 23:29:02 daily 0.1 https://demo.pharmafocusasia.com/news/ngm-expands-oncology-portfolio-with-first-immuno-oncology-development-candidate-ngm707-a-novel-dual-antagonist-antibody-inhibiting-ilt2-and-ilt4 2020-10-19 23:35:54 daily 0.1 https://demo.pharmafocusasia.com/news/genesis-therapeutics-enters-ai-driven-multi-target-drug-discovery-partnership-with-genentech 2020-10-19 23:34:31 daily 0.1 https://demo.pharmafocusasia.com/news/akron-biotech-signs-agreement-with-synairgen-plc-to-supply-interferon-beta-for-covid-19-treatment 2020-10-19 04:47:54 daily 0.1 https://demo.pharmafocusasia.com/news/orchard-therapeutics-receives-positive-chmp-opinion-for-libmeldy-for-the-treatment-of-early-onset-metachromatic-leukodystrophy-mld 2020-10-16 23:33:14 daily 0.1 https://demo.pharmafocusasia.com/news/allogene-therapeutics-and-md-anderson-announce-strategic-collaboration-to-accelerate-advancement-of-allogeneic-car-t-therapy-allocar-t 2020-10-15 23:44:02 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-agreement-to-acquire-disarm-therapeutics 2020-10-15 23:27:29 daily 0.1 https://demo.pharmafocusasia.com/news/dyno-therapeutics-enters-collaboration-and-license-agreement-with-roche 2020-10-14 23:44:50 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-oxford-biotherapeutics-expand-collaboration-to-discover-novel-selective-tumor-targets-as-first-bispecific-antibody-advanced-into-the-clinic 2020-10-14 23:39:14 daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-and-neogene-announce-broad-strategic-partnership-for-next-generation-personalized-t-cell-therapies 2020-10-14 00:10:21 daily 0.1 https://demo.pharmafocusasia.com/news/nestle-completes-acquisition-of-aimmune-therapeutics 2020-10-14 00:09:29 daily 0.1 https://demo.pharmafocusasia.com/news/axis-therapeutics-announces-research-collaboration-with-pharmaessentia-for-development-of-tcr-t-cell-therapy-in-taiwan 2020-10-12 23:29:36 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-arrowhead-collaborate-on-joint-development-and-commercialization-of-aro-aat-a-candidate-for-the-treatment-of-a-1-antitrypsin-related-liver-disease 2020-10-12 23:27:42 daily 0.1 https://demo.pharmafocusasia.com/news/gannex-received-us-ind-approval-for-its-nash-drug-candidate-asc42an-fxr-agonist 2020-10-12 00:51:05 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-arrowhead-cooperate-to-jointly-develop-and-commercialize-aro-aats-for-alpha-1-antitrypsin-associated-liver-disease 2020-10-09 23:40:47 daily 0.1 https://demo.pharmafocusasia.com/news/competitive-eu-grant-supports-collaboration-to-accelerate-development-of-ac-immunes-first-in-class-tdp-43-diagnostic-agent 2020-10-09 23:35:55 daily 0.1 https://demo.pharmafocusasia.com/news/qualigen-therapeutics-enters-into-commercialization-agreement 2020-10-08 23:48:43 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-arrowhead-collaborate-to-co-develop-and-co-commercialize-aro-aat 2020-10-08 23:47:48 daily 0.1 https://demo.pharmafocusasia.com/news/citius-pharmaceuticals-signs-an-exclusive-worldwide-licensing-agreement-with-novellus-therapeutics 2020-10-07 23:29:55 daily 0.1 https://demo.pharmafocusasia.com/news/olix-pharmaceuticals-announces-expansion-of-collaboration-with-laboratoires-thea-to-develop-sirna-therapeutics-for-ophthalmic-diseases 2020-10-07 23:27:46 daily 0.1 https://demo.pharmafocusasia.com/news/aro-collaboration-with-ionis-advances-with-option-exercise 2020-10-06 23:14:10 daily 0.1 https://demo.pharmafocusasia.com/news/scribe-therapeutics-to-collaborate-with-biogen-to-develop-crispr-based-genetic-medicines-for-neurological-diseases-including-amyotrophic-lateral-sclerosis 2020-10-06 23:13:05 daily 0.1 https://demo.pharmafocusasia.com/news/nimble-announces-strategic-research-collaboration-with-incyte-to-discover-novel-peptide-based-therapeutics 2020-10-05 23:22:30 daily 0.1 https://demo.pharmafocusasia.com/news/springworks-therapeutics-announces-clinical-collaboration-with-pfizer-inc-to-evaluate-nirogacestat-in-combination-with-pf06863135 2020-10-05 23:17:45 daily 0.1 https://demo.pharmafocusasia.com/news/bone-therapeutics-link-health-and-pregene-to-develop-and-commercialize-the-allob-allogeneic-bone-cell-therapy-platform-in-china-and-southeast-asia 2020-10-05 00:05:52 daily 0.1 https://demo.pharmafocusasia.com/news/ibio-enters-into-agreement-with-safi-biosolutions-to-develop-growth-factors-and-cytokines-using-the-fastpharming-system 2020-10-02 23:36:33 daily 0.1 https://demo.pharmafocusasia.com/news/sermonix-pharmaceuticals-partners-with-exactis-innovation-for-elaine-1-clinical-trial-sites-in-canada 2020-10-01 01:49:38 daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-therapeutics-and-viralclear-enter-into-agreement-to-explore-combination-antibody-plus-antiviral-therapy-against-covid-19 2020-09-30 23:42:51 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-pfizer-enter-into-strategic-collaboration-to-address-oncological-needs-in-china 2020-09-29 23:44:06 daily 0.1 https://demo.pharmafocusasia.com/news/orgenesis-announces-agreement-to-acquire-koligo-therapeutics-a-leader-in-personalized-cell-therapies 2020-09-29 23:35:49 daily 0.1 https://demo.pharmafocusasia.com/news/vor-biopharma-and-arbor-biotechnologies-to-collaborate 2020-09-29 06:39:20 daily 0.1 https://demo.pharmafocusasia.com/news/fibrogenesis-announces-manufacturing-agreement-with-ibiologics 2020-09-28 23:28:55 daily 0.1 https://demo.pharmafocusasia.com/news/avrobio-receives-orphan-drug-designation-from-the-european-medicines-agency-for-avr-rd-02-an-investigational-gene-therapy-for-gaucher-disease 2020-09-28 05:54:54 daily 0.1 https://demo.pharmafocusasia.com/news/vivet-therapeutics-and-pfizer-inc-sign-agreement-to-manufacture-investigational-gene-therapy-product-developed-by-vivet-for-wilsons-disease 2020-09-25 23:27:42 daily 0.1 https://demo.pharmafocusasia.com/news/lumen-bioscience-awarded-federal-grant-to-rapidly-develop-nanobody-based-covid-19-therapeutic 2020-09-24 23:48:33 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-and-igm-biosciences-announce-multi-year-antibody-discovery-collaboration 2020-09-24 23:30:47 daily 0.1 https://demo.pharmafocusasia.com/news/insysbio-announces-its-collaboration-with-genmab 2020-09-23 23:44:18 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-signs-strategic-partnership-with-kanaph-therapeutics 2020-09-23 23:43:32 daily 0.1 https://demo.pharmafocusasia.com/news/lantern-pharma-announces-collaboration-and-research-agreement-with-fox-chase-cancer-center 2020-09-22 23:22:31 daily 0.1 https://demo.pharmafocusasia.com/news/anokion-announces-expansion-of-exclusive-collaboration-with-bristol-myers-squibb-to-develop-novel-treatments-for-autoimmune-diseases 2020-09-22 23:20:41 daily 0.1 https://demo.pharmafocusasia.com/news/cend-therapeutics-announces-acquisition-of-impilo-therapeutics 2020-09-21 23:28:52 daily 0.1 https://demo.pharmafocusasia.com/news/collplant-and-united-therapeutics-announce-exercise-of-option-that-will-expand-their-collaboration-to-include-3d-bioprinting-of-human-kidneys-for-transplant 2020-09-21 23:27:20 daily 0.1 https://demo.pharmafocusasia.com/news/t-knife-and-catalent-sign-technology-transfer-and-manufacturing-agreement-for-autologous-t-cell-receptor-based-cell-therapy 2020-09-21 04:51:53 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-chiesi-group-sign-agreement-to-develop-treatment-for-pulmonary-arterial-hypertension-pah 2020-09-18 23:47:21 daily 0.1 https://demo.pharmafocusasia.com/news/immunoprecise-announces-new-multi-specific-sars-cov-2-antibody-collaboration-with-zymeworks 2020-09-17 23:50:38 daily 0.1 https://demo.pharmafocusasia.com/news/papyrus-therapeutics-inc-signs-research-collaboration-with-oxford-biomedica 2020-09-17 23:19:01 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-and-wigen-biomedicine-enter-global-development-and-commercialization-collaboration-for-four-small-molecule-cancer-drug-candidates 2020-09-16 23:14:28 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-signs-development-agreement-with-panolos-for-solid-tumor-treatment 2020-09-16 23:13:12 daily 0.1 https://demo.pharmafocusasia.com/news/axovant-and-viralgen-sign-strategic-gene-therapy-development-and-manufacturing-partnership 2020-09-15 23:21:26 daily 0.1 https://demo.pharmafocusasia.com/news/humanigen-and-lonza-announce-collaboration-to-expand-manufacturing-of-humanigens-covid-19-therapeutic-candidate-lenzilumab 2020-09-15 23:09:06 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-and-merck-announce-two-strategic-oncology-collaborations 2020-09-14 23:49:50 daily 0.1 https://demo.pharmafocusasia.com/news/novus-therapeutics-announces-acquisition-of-anelixis-therapeutics 2020-09-14 23:30:49 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-to-acquire-immunomedics 2020-09-13 23:47:25 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-and-hualan-genetic-announced-collaboration-to-develop-multiple-innovative-antibody-programs 2020-09-12 00:05:56 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-click-therapeutics-enter-into-collaboration-to-develop-and-commercialize-ct-155-a-novel-prescription-digital-therapeutic 2020-09-11 23:58:20 daily 0.1 https://demo.pharmafocusasia.com/news/humanized-chicken-antibody-technology-to-drive-next-generation-of-integral-moleculars-mps-antibody-discovery-platform 2020-09-10 23:30:23 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-expands-omniab-antibody-discovery-platform-through-the-acquisitions-of-xcella-biosciences-and-taurus-biosciences 2020-09-10 23:29:18 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-announces-new-research-collaboration-with-redx-pharma-to-discover-and-develop-two-targeted-cancer-therapies 2020-09-09 23:19:00 daily 0.1 https://demo.pharmafocusasia.com/news/agex-therapeutics-and-lineage-cell-therapeutics-announce-expansion-of-agreement-related-to-esi-clinical-grade-pluripotent-stem-cell-lines-for-therapeutic-purposes 2020-09-09 23:14:44 daily 0.1 https://demo.pharmafocusasia.com/news/anges-and-brickell-biotech-announce-a-collaboration-agreement-for-the-development-of-a-novel-dna-vaccine-candidate-for-covid-19-in-the-us 2020-09-08 22:56:12 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-nbe-therapeutics-enter-into-exclusive-collaboration-and-license-option-agreement-to-discover-and-develop-novel-antibody-drug-conjugates-for-the-treatment-of-cancer 2020-09-08 22:55:07 daily 0.1 https://demo.pharmafocusasia.com/news/aridis-announces-agreement-with-the-fda-on-updated-phase-2-clinical-trial-design-for-ar-501 2020-09-08 06:23:24 daily 0.1 https://demo.pharmafocusasia.com/news/anheart-licenses-two-clinical-stage-oncology-candidates-from-daiichi-sankyo 2020-09-07 23:56:29 daily 0.1 https://demo.pharmafocusasia.com/news/grifols-to-acquire-alkahest-to-enhance-discovery-research-and-development-to-identify-innovative-therapies 2020-09-07 03:17:43 daily 0.1 https://demo.pharmafocusasia.com/news/ehave-signs-licensing-agreement-to-enhance-its-telemedicine-platform 2020-09-05 00:02:59 daily 0.1 https://demo.pharmafocusasia.com/news/ppd-and-lupus-therapeutics-collaborate-to-support-lupus-clinical-research 2020-09-04 00:09:24 daily 0.1 https://demo.pharmafocusasia.com/news/kite-and-hifibio-therapeutics-partner-to-discover-novel-targets-and-antibodies-against-acute-myeloid-leukemia 2020-09-03 23:41:36 daily 0.1 https://demo.pharmafocusasia.com/news/biomx-enters-collaboration-with-boehringer-ingelheim-with-the-goal-of-discovering-microbiome-based-biomarkers-for-inflammatory-bowel-disease 2020-09-02 23:21:25 daily 0.1 https://demo.pharmafocusasia.com/news/igyxos-and-selexis-enter-service-agreement-to-advance-igyxos-first-in-class-monoclonal-antibody-for-the-treatment-of-human-infertility 2020-09-02 23:20:30 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-jounce-therapeutics-announce-exclusive-license-agreement-for-novel-immunotherapy-program 2020-09-01 23:27:12 daily 0.1 https://demo.pharmafocusasia.com/news/revision-therapeutics-inc-announces-license-with-cornell-to-develop-treatment-for-stargardt-disease 2020-09-01 23:19:14 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-llc-announces-collaboration-with-flame-biosciences-for-systems-pharmacology-modeling-in-lung-cancer 2020-08-31 23:50:01 daily 0.1 https://demo.pharmafocusasia.com/news/vor-biopharma-and-metagenomi-to-collaborate-on-engineered-hematopoietic-stem-cell-therapies 2020-08-31 23:49:10 daily 0.1 https://demo.pharmafocusasia.com/news/seneca-therapeutics-inc-licenses-tumor-endothelial-marker-8-tem8-to-enable-better-patient-selection-for-svv-001-therapy 2020-08-31 04:45:33 daily 0.1 https://demo.pharmafocusasia.com/news/ibio-and-planet-biotechnology-enter-into-exclusive-worldwide-license-agreement-for-the-development-of-a-covid-19-therapeutic 2020-08-28 23:39:36 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-exclusive-license-agreement-for-neutralizing-covid-19-antibodies-developed-by-singlomics-biopharmaceuticals 2020-08-27 23:48:33 daily 0.1 https://demo.pharmafocusasia.com/news/piramal-pharma-solutions-to-collaborate-with-epirium-bio-on-exclusive-integrated-development-manufacturing-program-for-orphan-drugs 2020-08-27 23:46:01 daily 0.1 https://demo.pharmafocusasia.com/news/medgenome-announces-strategic-collaboration-in-parkinsons-disease-with-denali-therapeutics 2020-08-27 00:13:08 daily 0.1 https://demo.pharmafocusasia.com/news/ivy-brain-tumor-center-and-vivace-therapeutics-collaborate-to-test-targeted-agent-in-glioblastoma-and-meningioma 2020-08-27 00:00:00 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-almirall-announce-achievement-of-milestone-in-their-strategic-collaboration 2020-08-25 23:32:48 daily 0.1 https://demo.pharmafocusasia.com/news/engitix-signs-collaboration-and-licensing-agreement-with-takeda-to-develop-anti-fibrotic-therapies-in-advanced-liver-diseases 2020-08-25 23:20:03 daily 0.1 https://demo.pharmafocusasia.com/news/epivax-announces-licensing-of-a-covid-19-vaccine-candidate-to-epivax-therapeutics 2020-08-25 23:16:41 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-harvard-university-form-research-alliance-to-address-emergent-viral-diseases 2020-08-25 07:35:06 daily 0.1 https://demo.pharmafocusasia.com/news/bio-thera-solutions-and-beigene-announce-license-distribution-and-supply-agreement-for-avastin-bevacizumab-biosimilar-bat1706-in-china 2020-08-24 23:28:25 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-signs-strategic-collaboration-agreement-with-vir-biotechnology-to-develop-novel-therapies-for-immuno-oncology-and-infectious-diseases 2020-08-24 23:17:51 daily 0.1 https://demo.pharmafocusasia.com/news/renalytixai-to-collaborate-with-astrazeneca-to-improve-outcomes-for-patients-with-chronic-disease 2020-08-24 00:30:20 daily 0.1 https://demo.pharmafocusasia.com/news/sab-biotherapeutics-announces-sab-185-to-first-patient-treatment-for-covid-19-in-phase-1b-clinical-trial 2020-08-24 00:02:04 daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-enters-into-merger-agreement-to-acquire-smartpharm-and-develop-pipeline-of-gene-encoded-therapeutic-antibodies-starting-with-neutralizing-antibodies 2020-08-20 23:14:18 daily 0.1 https://demo.pharmafocusasia.com/news/junshi-biosciences-and-impact-therapeutics-establish-joint-venture-to-develop-parp-inhibitor-senaparib-imp4297-in-china 2020-08-20 23:12:59 daily 0.1 https://demo.pharmafocusasia.com/news/biosymetrics-collaborates-with-janssen-and-sema4-to-predict-the-onset-of-covid-19 2020-08-19 23:26:50 daily 0.1 https://demo.pharmafocusasia.com/news/monopar-and-northstar-partner-with-aragen-for-testing-of-novel-potential-therapeutic-for-severe-covid-19 2020-08-19 23:25:48 daily 0.1 https://demo.pharmafocusasia.com/news/genentech-and-regeneron-collaborate-to-significantly-increase-global-supply-of-regn-cov2-investigational-antibody-combination-for-covid-19 2020-08-19 00:01:35 daily 0.1 https://demo.pharmafocusasia.com/news/zosano-pharma-announces-agreement-to-collaborate-with-mitsubishi-tanabe-pharma-corporation 2020-08-18 23:20:38 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-tango-therapeutics-to-expand-strategic-oncology-collaboration 2020-08-17 23:38:20 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-principia-biopharma 2020-08-17 23:36:47 daily 0.1 https://demo.pharmafocusasia.com/news/qbiotics-announces-clinical-collaboration-with-msd-in-targeting-unresectable-melanoma 2020-08-16 22:21:02 daily 0.1 https://demo.pharmafocusasia.com/news/memo-therapeutics-ag-and-northway-biotechpharma-collaborate-on-the-fast-track-manufacturing-of-a-sars-cov-2-neutralizing-antibody-for-the-therapy-of-covid-19 2020-08-16 22:19:49 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-enters-into-a-partnership-as-cdmo-with-ono-pharmaceuticals 2020-08-13 21:16:30 daily 0.1 https://demo.pharmafocusasia.com/news/tff-pharmaceuticals-enters-into-worldwide-licensing-agreement-with-union-therapeutics-for-its-thin-film-freezing-technology-in-combination-with-niclosamide 2020-08-13 21:15:43 daily 0.1 https://demo.pharmafocusasia.com/news/genecentric-therapeutics-enters-into-research-collaboration-with-janssen-on-genomic-drug-response-biomarkers-for-non-muscle-invasive-bladder-cancer 2020-08-12 22:21:17 daily 0.1 https://demo.pharmafocusasia.com/news/qbiotics-announces-clinical-collaboration-with-msd-targeting-unresectable-melanoma 2020-08-12 22:20:03 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-to-acquire-uk-based-biotech-kandy-therapeutics-ltd 2020-08-11 23:00:28 daily 0.1 https://demo.pharmafocusasia.com/news/ana-therapeutics-and-quotient-sciences-announce-partnership-to-manufacture-niclosamide-drug-candidate-as-a-potential-treatment-for-covid-19 2020-08-11 22:59:20 daily 0.1 https://demo.pharmafocusasia.com/news/monopar-and-northstar-partner-with-isotherapeutics-for-the-manufacturing-of-potential-therapeutic-for-severe-covid-19 2020-08-10 22:10:54 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-expands-partnership-with-novavax 2020-08-10 22:09:08 daily 0.1 https://demo.pharmafocusasia.com/news/new-cyrus-biotechnology-antibody-structure-prediction-software-nextgen-outperforms-schrodinger-and-other-software-in-third-party-test 2020-08-10 05:29:36 daily 0.1 https://demo.pharmafocusasia.com/news/viva-biotech-and-langhua-pharmaceutical-reached-the-strategic-acquisition-agreement 2020-08-10 03:37:02 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-announces-agreement-with-gilead-to-manufacture-remdesivir-for-treatment-of-covid-19 2020-08-07 23:03:18 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-and-takeda-announce-collaboration-for-novavaxs-vaccine-candidate-against-covid-19-in-japan 2020-08-07 22:55:10 daily 0.1 https://demo.pharmafocusasia.com/news/caprion-histogenex-and-viroclinics-ddl-announce-strategic-partnership 2020-08-06 22:50:55 daily 0.1 https://demo.pharmafocusasia.com/news/immvira-and-shanghai-pharma-announce-clinical-collaboration-and-license-agreement-for-commercialization-of-novel-intratumoral-oncolytic-virus-immunotherapies 2020-08-06 22:25:34 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-anuncia-contrato-com-o-governo-dos-eua-para-fornecer-100-milhoes-de-doses-da-vacina-investigacional-para-covid-19 2020-08-05 22:44:16 daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-alvotech-announce-strategic-partnership-to-collaborate-in-the-us-biosimilar-market 2020-08-05 22:34:59 daily 0.1 https://demo.pharmafocusasia.com/news/cellix-bio-pharma-completes-the-acquisition-of-avaca-pharma 2020-08-05 01:53:56 daily 0.1 https://demo.pharmafocusasia.com/news/seismic-bio-partners-with-twist-bioscience-for-discovery-and-optimization-of-antibodies 2020-08-05 01:53:15 daily 0.1 https://demo.pharmafocusasia.com/news/g1-therapeutics-and-simcere-announce-exclusive-license-agreement-for-trilaciclib-in-greater-china 2020-08-03 22:24:28 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-llc-announces-collaboration-with-verseau-therapeutics-for-system-pharmacology-modeling-in-oncology 2020-08-03 22:22:08 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-first-patient-dosed-in-the-phase-1-clinical-trial-of-anti-cd47pd-l1-bispecific-antibody-in-china 2020-08-02 22:47:00 daily 0.1 https://demo.pharmafocusasia.com/news/oxford-biomedica-signs-three-year-clinical-supply-agreement-with-axovant-gene-therapies-for-manufacture-and-supply-of-axo-lenti-pd 2020-07-31 23:08:57 daily 0.1 https://demo.pharmafocusasia.com/news/sesen-bio-announces-an-exclusive-license-agreement-with-qilu-pharmaceutical-for-the-development-and-commercialization-of-vicineum-in-greater-china 2020-07-31 22:47:12 daily 0.1 https://demo.pharmafocusasia.com/news/piramal-pharma-solutions-announces-integrated-development-program-with-bolt-biotherapeutics-for-immunostimulating-antibody-conjugates-and-sterile-final-fillings 2020-07-30 22:56:23 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-announces-strategic-partnership-with-viva-biotech-to-collaborate-on-incubating-innovative-biotech-start-ups 2020-07-30 22:20:15 daily 0.1 https://demo.pharmafocusasia.com/news/piramal-pharma-solutions-announces-integrated-development-program-with-bolt-biotherapeutics-for-immune-stimulating-antibody-conjugates-and-sterile-fill-finish 2020-07-29 22:29:10 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-enters-into-collaboration-with-roche-to-develop-antibody-treatment-for-people-living-with-alzheimers-disease 2020-07-29 22:22:25 daily 0.1 https://demo.pharmafocusasia.com/news/karuna-therapeutics-and-psychogenics-announce-drug-discovery-collaboration 2020-07-28 22:31:16 daily 0.1 https://demo.pharmafocusasia.com/news/viva-biotech-and-schrodinger-announce-strategic-collaboration-to-generate-and-interrogate-structures-for-unsolved-targets 2020-07-28 22:26:40 daily 0.1 https://demo.pharmafocusasia.com/news/zentalis-pharmaceuticals-enters-into-clinical-collaboration-with-eli-lilly-and-company-to-evaluate-its-oral-serd-zn-c5 2020-07-27 22:47:06 daily 0.1 https://demo.pharmafocusasia.com/news/cerevel-therapeutics-and-cyclica-announce-research-collaboration-to-use-artificial-intelligence-to-accelerate-discovery-of-novel-medicines-in-neuroscience 2020-07-27 22:44:24 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-astrazeneca-enter-new-global-development-and-commercialization-collaboration-for-daiichi-sankyos-adc-ds-1062 2020-07-27 03:36:30 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-therapeutics-receives-fast-track-designation-for-srp-9001-micro-dystrophin-gene-therapy-for-the-treatment-of-duchenne-muscular-dystrophy 2020-07-24 23:03:35 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-and-fujifilm-diosynth-biotechnologies-initiate-large-scale-manufacturing-of-covid-19-vaccine-candidate 2020-07-24 23:02:04 daily 0.1 https://demo.pharmafocusasia.com/news/cobomarsen-receives-orphan-drug-designation-from-the-us-fda-for-the-treatment-of-t-cell-lymphoma 2020-07-23 22:35:45 daily 0.1 https://demo.pharmafocusasia.com/news/synaffix-announces-expansion-of-collaboration-with-adc-therapeutics 2020-07-23 22:30:17 daily 0.1 https://demo.pharmafocusasia.com/news/altimmune-announces-manufacturing-agreement-with-vigene-biosciences-for-adcovid-its-single-dose-intranasal-vaccine-candidate-for-covid-19 2020-07-22 22:37:58 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-gustave-roussy-enter-innovative-research-collaboration-for-dxd-adcs-ds-1062-and-patritumab-deruxtecan 2020-07-22 22:31:27 daily 0.1 https://demo.pharmafocusasia.com/news/jnana-therapeutics-enters-collaboration-with-roche 2020-07-21 22:31:22 daily 0.1 https://demo.pharmafocusasia.com/news/clarity-pharmaceuticals-and-imaginab-to-collaborate-on-new-cancer-targets 2020-07-21 22:26:40 daily 0.1 https://demo.pharmafocusasia.com/news/mateon-and-asili-research-alliance-enter-into-partnership-for-the-development-of-artemisinin-against-covid-19 2020-07-20 22:48:34 daily 0.1 https://demo.pharmafocusasia.com/news/jw-therapeutics-acquires-syracuse-biopharma-and-license-to-eureka-therapeutics-solid-tumor-technology-in-china 2020-07-20 23:02:14 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-and-curevac-announce-strategic-mrna-technology-collaboration 2020-07-20 06:52:54 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-announce-agreement-with-the-united-kingdom-for-30-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2 2020-07-20 05:36:46 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-launches-human-clinical-trial-of-potential-covid-19-antiviral-antibody-treatment-following-positive-pre-clinical-results 2020-07-17 23:22:10 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-announces-acceptance-of-a-new-drug-application-of-pamiparib-in-ovarian-cancer-in-china 2020-07-17 23:08:01 daily 0.1 https://demo.pharmafocusasia.com/news/oncorus-announces-clinical-trial-collaboration-with-merck-to-evaluate-the-combination-of-oncorus-oncr-177-with-mercks-keytruda 2020-07-16 22:36:45 daily 0.1 https://demo.pharmafocusasia.com/news/humanigen-expands-partnership-with-catalent-biologics-to-manufacture-investigational-covid-19-therapeutic-candidate-lenzilumab 2020-07-16 22:30:31 daily 0.1 https://demo.pharmafocusasia.com/news/orchard-therapeutics-announces-global-license-agreements-for-stable-cell-line-technology-from-gsk 2020-07-15 22:29:44 daily 0.1 https://demo.pharmafocusasia.com/news/novocure-announces-clinical-trial-collaboration-with-msd-to-evaluate-tumor-treating-fields-together-with-keytruda-pembrolizumab-in-non-small-cell-lung-cancer 2020-07-15 22:18:43 daily 0.1 https://demo.pharmafocusasia.com/news/medicago-begins-phase-i-clinical-trials-for-candidate-vaccine-against-covid-19 2020-07-14 23:28:14 daily 0.1 https://demo.pharmafocusasia.com/news/fate-therapeutics-announces-exclusive-license-agreement-with-baylor-college-of-medicine-for-rejection-resistant-ipsc-derived-cellular-therapies 2020-07-14 23:18:57 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-md-anderson-announce-strategic-collaboration-to-accelerate-oncology-research-and-development 2020-07-14 22:49:11 daily 0.1 https://demo.pharmafocusasia.com/news/merus-and-caris-life-sciences-announce-collaboration-to-detect-nrg1-fusions-in-cancer-patients 2020-07-13 23:59:58 daily 0.1 https://demo.pharmafocusasia.com/news/revitope-and-junshi-biosciences-enter-into-research-collaboration-and-license-agreement-to-explore-next-generation-immunotherapies 2020-07-13 23:43:29 daily 0.1 https://demo.pharmafocusasia.com/news/ovid-therapeutics-and-angelini-pharma-enter-into-exclusive-license-agreement-to-develop-manufacture-and-commercialize-ov101 2020-07-13 23:35:25 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-signs-additional-development-and-manufacturing-agreement-with-stcube 2020-07-12 22:48:38 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-collaborates-with-molecular-partners-ag-to-develop-the-darpin-anti-covid-19-program 2020-07-10 23:04:12 daily 0.1 https://demo.pharmafocusasia.com/news/fate-therapeutics-announces-fda-clearance-of-ind-application-for-first-ever-ipsc-derived-car-t-cell-therapy 2020-07-10 23:01:45 daily 0.1 https://demo.pharmafocusasia.com/news/kymera-therapeutics-and-sanofi-enter-into-strategic-partnership-to-advance-novel-protein-degrader-therapies-to-patients 2020-07-09 22:35:05 daily 0.1 https://demo.pharmafocusasia.com/news/proteinqure-collaborates-with-astrazeneca-to-develop-new-therapeutic-peptides 2020-07-09 22:33:00 daily 0.1 https://demo.pharmafocusasia.com/news/xencor-and-atreca-enter-strategic-collaboration-to-discover-develop-and-commercialize-novel-t-cell-engaging-bispecific-antibodies 2020-07-08 22:29:12 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-announces-new-multispecific-antibody-collaboration-with-merck 2020-07-08 22:27:39 daily 0.1 https://demo.pharmafocusasia.com/news/numab-therapeutics-and-boehringer-ingelheim-enter-into-collaboration-to-develop-multi-specific-antibody-therapeutics-for-cancer-and-retinal-diseases 2020-07-07 22:50:12 daily 0.1 https://demo.pharmafocusasia.com/news/turning-point-therapeutics-and-zai-lab-announce-exclusive-license-agreement-for-repotrectinib-in-greater-china 2020-07-07 22:45:51 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-announces-clinical-trial-collaboration-agreement-with-msd-to-evaluate-apg-115 2020-07-06 23:23:30 daily 0.1 https://demo.pharmafocusasia.com/news/unum-therapeutics-inc-announces-acquisition-of-kiq-llc 2020-07-06 22:43:20 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-morphic-extend-drug-discovery-research-collaboration 2020-07-05 23:01:59 daily 0.1 https://demo.pharmafocusasia.com/news/eusa-pharma-announces-fda-approves-phase-3-clinical-trial-of-silvoximab-for-covid-19-related-acute-respiratory-distress-syndrome-patients 2020-07-03 23:01:55 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-therapeutics-signs-agreement-with-hansa-biopharma-for-imlifidase 2020-07-02 22:26:17 daily 0.1 https://demo.pharmafocusasia.com/news/hansa-biopharma-announces-exclusive-agreement-with-sarepta-therapeutics-to-develop-and-promote-imlifidase 2020-07-02 22:11:33 daily 0.1 https://demo.pharmafocusasia.com/news/bioinvent-extends-research-collaboration-and-license-agreement-with-pfizer-inc 2020-07-01 22:19:26 daily 0.1 https://demo.pharmafocusasia.com/news/aligos-therapeutics-and-ku-leuven-announce-collaboration-for-the-development-of-a-therapeutic-candidate-targeting-coronavirus 2020-07-01 22:13:29 daily 0.1 https://demo.pharmafocusasia.com/news/sinclair-research-announces-successful-validation-of-glp-ototoxicity-testing-services 2020-07-01 00:40:29 daily 0.1 https://demo.pharmafocusasia.com/news/carmine-therapeutics-and-takeda-collaborate-to-discover-and-develop-rare-disease-gene-therapies 2020-06-30 22:43:58 daily 0.1 https://demo.pharmafocusasia.com/news/biocare-medical-and-bethyl-laboratories-announce-strategic-partnership-for-antibody-development 2020-06-29 22:53:58 daily 0.1 https://demo.pharmafocusasia.com/news/vitrac-therapeutics-initiated-global-clinical-development-of-vic-1911-licensed-from-taiho-pharmaceutical 2020-06-29 22:51:19 daily 0.1 https://demo.pharmafocusasia.com/news/nordic-nanovectors-betalutin-receives-fast-track-designation-from-us-fda-for-marginal-zone-lymphoma 2020-06-29 05:32:56 daily 0.1 https://demo.pharmafocusasia.com/news/sfa-therapeutics-announces-fda-approval-to-begin-ind-trial 2020-06-29 05:28:39 daily 0.1 https://demo.pharmafocusasia.com/news/axsome-therapeutics-receives-fda-breakthrough-therapy-designation-for-axs-05-for-the-treatment-of-alzheimers-disease-agitation 2020-06-26 22:42:55 daily 0.1 https://demo.pharmafocusasia.com/news/aldevron-announces-agreement-with-ziopharm-oncology-for-neogmp-production-of-sleeping-beauty-plasmid-dna-to-express-tcrs-for-treatment-of-solid-tumors 2020-06-25 22:34:02 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-catalent-announce-collaboration-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine-candidate 2020-06-25 22:28:41 daily 0.1 https://demo.pharmafocusasia.com/news/replicate-bioscience-and-immunomic-therapeutics-form-collaboration-to-combat-infectious-diseases-and-cancers 2020-06-24 22:47:48 daily 0.1 https://demo.pharmafocusasia.com/news/csl-behring-agrees-to-acquire-novel-late-stage-gene-therapy-candidate-for-hemophilia-b-patients-from-uniqure 2020-06-24 22:45:56 daily 0.1 https://demo.pharmafocusasia.com/news/century-therapeutics-announces-acquisition-of-empirica-therapeutics 2020-06-23 22:33:41 daily 0.1 https://demo.pharmafocusasia.com/news/linnaeus-therapeutics-announces-clinical-trial-collaboration-agreement-with-merck-to-evaluate-lns8801 2020-06-23 22:31:11 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-therapeutics-and-codiak-biosciences-collaborate-to-research-and-develop-exosome-based-therapeutics-for-rare-diseases 2020-06-22 22:48:48 daily 0.1 https://demo.pharmafocusasia.com/news/agenus-and-betta-pharmaceuticals-enter-into-a-license-agreement-for-balstilimab-and-zalifrelimab-in-greater-china 2020-06-22 22:39:46 daily 0.1 https://demo.pharmafocusasia.com/news/neurocline-biosciences-and-takeda-announce-collaboration-to-develop-and-commercialize-drug-candidates-for-mental-illness 2020-06-21 22:27:35 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-enters-clinical-collaboration-to-evaluate-the-combination-of-bcl-2-and-btk-inhibitors 2020-06-21 22:25:06 daily 0.1 https://demo.pharmafocusasia.com/news/ovid-therapeutics-receives-fda-rare-pediatric-disease-designation-for-ov101-for-the-treatment-of-angelman-syndrome 2020-06-19 22:46:05 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-therapeutics-and-selecta-biosciences-enter-into-research-license-and-option-agreement-for-selectas-immtor-immune-tolerance-platform-in-neuromuscular-diseases 2020-06-18 22:50:28 daily 0.1 https://demo.pharmafocusasia.com/news/alpine-immune-sciences-and-abbvie-announce-option-and-license-agreement-for-the-development-and-commercialization-of-alpn-101 2020-06-18 22:36:04 daily 0.1 https://demo.pharmafocusasia.com/news/lassen-therapeutics-launches-to-discover-and-develop-novel-antibody-therapeutics-including-lead-program-targeting-il-11-to-treat-fibrosis-and-oncology 2020-06-17 22:45:12 daily 0.1 https://demo.pharmafocusasia.com/news/isa-pharmaceuticals-strengthens-strategic-immuno-oncology-collaboration-with-regeneron 2020-06-17 22:25:56 daily 0.1 https://demo.pharmafocusasia.com/news/monopar-and-northstar-join-forces-to-develop-radio-immuno-therapeutics-rits-targeting-severe-covid-19 2020-06-16 22:58:45 daily 0.1 https://demo.pharmafocusasia.com/news/neurocrine-biosciences-and-takeda-announce-collaboration-to-develop-and-market-potential-therapies-for-psychiatric-disorders 2020-06-16 22:35:51 daily 0.1 https://demo.pharmafocusasia.com/news/atum-and-phylex-biosciences-collaborate-to-accelerate-the-development-of-a-universal-sars-coronavirus-vaccine 2020-06-15 22:52:13 daily 0.1 https://demo.pharmafocusasia.com/news/medrhythms-receives-fda-breakthrough-device-designation-for-chronic-stroke-digital-therapeutic 2020-06-15 22:50:05 daily 0.1 https://demo.pharmafocusasia.com/news/magenta-therapeutics-and-beam-therapeutics-announce-collaboration-to-evaluate-targeted-antibody-drug-conjugate-adc-mgta-117 2020-06-15 06:06:00 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-mercks-gardasil-9-for-the-prevention-of-certain-hpv-related-head-and-neck-cancers 2020-06-12 23:29:07 daily 0.1 https://demo.pharmafocusasia.com/news/city-of-hope-signs-licensing-agreement-with-scopus-biopharma-inc-to-develop-novel-targeted-immuno-oncology-gene-therapy 2020-06-12 22:49:29 daily 0.1 https://demo.pharmafocusasia.com/news/egle-therapeutics-enters-into-a-corporate-strategic-research-alliance-with-takeda 2020-06-11 22:37:06 daily 0.1 https://demo.pharmafocusasia.com/news/sobi-and-selecta-announce-strategic-licensing-agreement-for-sel-212-a-phase-3-ready-novel-treatment-for-chronic-refractory-gout 2020-06-11 22:28:32 daily 0.1 https://demo.pharmafocusasia.com/news/bryologyx-announces-agreements-with-neurotrope-to-acquire-bryostatin-1-immuno-oncology-data-package-supply-synthetic-bryostatin-1 2020-06-10 22:27:06 daily 0.1 https://demo.pharmafocusasia.com/news/delmar-to-acquire-adgero-biopharmaceuticals-expands-late-stage-oncology-pipeline 2020-06-10 22:21:22 daily 0.1 https://demo.pharmafocusasia.com/news/lyvgen-announces-clinical-trial-collaboration-with-msd 2020-06-09 22:44:50 daily 0.1 https://demo.pharmafocusasia.com/news/evox-therapeutics-announces-a-multi-target-rnai-and-antisense-research-collaboration-and-license-agreement-with-lilly 2020-06-09 22:44:03 daily 0.1 https://demo.pharmafocusasia.com/news/a2a-pharmaceuticals-collaborates-with-laxai-life-sciences-to-co-develop-sars-cov-2-main-proteases-inhibitors-for-the-treatment-of-covid-19 2020-06-08 22:36:03 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncology-and-sanofi-enter-collaboration-on-kn026-in-her2-breast-cancer 2020-06-08 22:28:40 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-evotec-se-enter-into-drug-discovery-research-collaboration 2020-06-07 22:26:53 daily 0.1 https://demo.pharmafocusasia.com/news/ryvu-therapeutics-signs-a-grant-agreement-for-the-development-of-targeted-immuno-oncology-therapy 2020-06-05 22:22:47 daily 0.1 https://demo.pharmafocusasia.com/news/accent-therapeutics-and-astrazeneca-to-discover-and-develop-novel-cancer-therapeutics-in-new-collaboration 2020-06-04 22:55:13 daily 0.1 https://demo.pharmafocusasia.com/news/melinta-therapeutics-to-acquire-tetraphase-pharmaceuticals 2020-06-04 22:49:37 daily 0.1 https://demo.pharmafocusasia.com/news/pharmabcine-signs-a-license-agreement-with-wincal-biopharm-to-expand-indications-of-pharmabcines-existing-assets-to-non-oncology-areas 2020-06-03 23:08:40 daily 0.1 https://demo.pharmafocusasia.com/news/cb-therapeutics-achieves-another-breakthrough-with-the-biosynthesis-of-dmt-and-related-tryptamine-based-compounds 2020-06-03 23:05:56 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-selects-agc-biologics-to-manufacture-adjuvant-matrix-m-for-new-covid-19-vaccine 2020-06-03 08:06:22 daily 0.1 https://demo.pharmafocusasia.com/news/predictive-oncology-completes-acquisition-of-soluble-therapeutics-and-biodtech 2020-06-02 23:21:23 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-intellia-therapeutics-expand-collaboration-to-develop-crisprcas9-based-treatments 2020-06-02 00:05:28 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-jacobio-announce-strategic-collaboration-to-advance-shp2-inhibitors 2020-06-01 23:35:23 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-and-lilly-jointly-announced-the-long-term-follow-up-results-of-tyvyt 2020-05-31 23:27:00 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-announces-clinical-research-collaboration-to-evaluate-ds-1062-in-combination-with-keytruda-pembrolizumab-in-metastatic-non-small-cell-lung-cancer 2020-05-29 23:38:07 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-announces-icagens-expansion-of-collaboration-with-roche-to-develop-and-commercialize-therapies-for-neurological-diseases 2020-05-29 23:33:53 daily 0.1 https://demo.pharmafocusasia.com/news/reflexion-announces-clinical-collaboration-to-evaluate-biology-guided-radiotherapy-with-mercks-keytruda-for-certain-late-stage-cancers 2020-05-28 23:09:48 daily 0.1 https://demo.pharmafocusasia.com/news/cordenpharma-and-moderna-collaborate-in-obtaining-the-coronavirus-vaccine 2020-05-28 23:05:44 daily 0.1 https://demo.pharmafocusasia.com/news/edigene-and-immunochina-announce-research-and-development-collaboration-to-develop-allogeneic-car-t-therapy-for-cancer 2020-05-27 23:23:08 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-arcus-biosciences-establish-10-year-partnership-to-co-develop-and-co-commercialize-next-generation-cancer-immunotherapies 2020-05-27 23:20:45 daily 0.1 https://demo.pharmafocusasia.com/news/repare-therapeutics-announces-multi-target-discovery-collaboration-with-bristol-myers-squibb 2020-05-26 23:12:44 daily 0.1 https://demo.pharmafocusasia.com/news/archerdx-announces-strategic-collaboration-with-astrazeneca 2020-05-26 23:11:04 daily 0.1 https://demo.pharmafocusasia.com/news/oncodesign-and-hitgen-announce-a-strategic-partnership-in-integrated-drug-discovery-services-idds 2020-05-25 23:43:56 daily 0.1 https://demo.pharmafocusasia.com/news/tavotek-announces-a-research-agreement-with-genmab-for-the-development-of-bispecific-antibodies 2020-05-25 23:29:53 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-takedas-alunbrig-brigatinib-as-a-first-line-treatment-for-patients-with-rare-and-severe-forms-of-lung-cancer 2020-05-24 23:18:50 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-announces-multi-year-antibody-discovery-collaboration-with-lilly 2020-05-22 23:03:53 daily 0.1 https://demo.pharmafocusasia.com/news/kleo-pharmaceuticals-and-celularity-enter-into-research-collaboration 2020-05-21 23:22:15 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-partners-with-samsung-biologics-to-secure-additional-manufacturing-capacity-for-innovative-biopharmaceutical-portfolio 2020-05-21 23:16:58 daily 0.1 https://demo.pharmafocusasia.com/news/rentschler-biopharma-licenses-horizon-discoverys-chosource-platform-to-complement-cell-line-development-offering-for-difficult-to-express-proteins 2020-05-20 23:33:48 daily 0.1 https://demo.pharmafocusasia.com/news/kindred-biosciences-announces-covid-19-vaccine-manufacturing-agreement-with-vaxart 2020-05-20 23:23:40 daily 0.1 https://demo.pharmafocusasia.com/news/amplyx-pharmaceuticals-advances-development-of-novel-antifungal-fosmanogepix 2020-05-19 23:47:05 daily 0.1 https://demo.pharmafocusasia.com/news/pharmajet-and-abnova-partner-to-develop-and-deliver-covid-19-mrna-vaccine-using-needle-free-injection-technology 2020-05-19 23:38:47 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-and-md-anderson-announce-a-strategic-collaboration-to-develop-anti-pd-1-therapy-tyvyt-sintilimab-injection-in-rare-cancers 2020-05-18 23:26:40 daily 0.1 https://demo.pharmafocusasia.com/news/enhertu-granted-breakthrough-therapy-designation-in-the-us 2020-05-18 00:50:13 daily 0.1 https://demo.pharmafocusasia.com/news/lava-therapeutics-announces-collaboration-with-janssen-to-develop-bi-specific-gamma-delta-t-cell-engager-therapeutics 2020-05-15 23:14:07 daily 0.1 https://demo.pharmafocusasia.com/news/legochem-biosciences-and-iksuda-enter-licensing-agreement-for-antibody-drug-conjugate-program 2020-05-15 23:13:09 daily 0.1 https://demo.pharmafocusasia.com/news/recursion-enters-into-global-licensing-agreement-with-takeda-to-develop-tak-733-in-hereditary-cancer-syndrome 2020-05-14 23:26:28 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-and-archerdx-announce-global-collaboration-to-develop-next-generation-sequencing-ngs-based-companion-diagnostic-cdx-for-vitrakvi-larotrectinib 2020-05-14 23:24:02 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-collaborates-with-cdr-life-to-develop-antibody-fragment-based-therapeutics-for-geographic-atrophy 2020-05-13 23:41:21 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-signs-license-agreement-with-gilead-for-extended-access-to-covid-19-treatment 2020-05-13 23:31:28 daily 0.1 https://demo.pharmafocusasia.com/news/skyhawk-therapeutics-announces-the-expansion-of-its-collaboration-agreement-with-merck 2020-05-12 23:40:56 daily 0.1 https://demo.pharmafocusasia.com/news/legend-biotech-and-noile-immune-biotech-announce-collaborative-research-and-licensing-agreement 2020-05-12 23:16:01 daily 0.1 https://demo.pharmafocusasia.com/news/bellerophon-therapeutics-announces-fda-clears-initiation-of-phase-3-study-for-inopulse-inhaled-nitric-oxide-therapy-to-treat-covid-19 2020-05-11 23:57:19 daily 0.1 https://demo.pharmafocusasia.com/news/themis-collaborates-with-abl-europe-in-france-on-the-production-of-its-sars-cov-2-vaccine-candidate 2020-05-11 23:15:09 daily 0.1 https://demo.pharmafocusasia.com/news/dyno-therapeutics-announces-ocular-collaboration-with-novartis-to-develop-improved-gene-therapies-with-aav-vectors-based-on-ai-technology 2020-05-11 06:44:06 daily 0.1 https://demo.pharmafocusasia.com/news/fda-authorizes-first-antigen-test-to-help-in-the-rapid-detection-of-the-virus-that-causes-covid-19-in-patients 2020-05-10 23:42:08 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-first-therapy-for-patients-with-lung-and-thyroid-cancers-with-a-certain-genetic-mutation-or-fusion 2020-05-08 23:19:19 daily 0.1 https://demo.pharmafocusasia.com/news/ai-vivo-seeks-collaboration-partners-to-progress-top-ranked-covid-19-therapeutic-candidates 2020-05-07 23:36:25 daily 0.1 https://demo.pharmafocusasia.com/news/zyus-collaborates-with-usasks-vido-intervac-to-develop-a-plant-based-vaccine-for-covid-19 2020-05-07 23:29:48 daily 0.1 https://demo.pharmafocusasia.com/news/avrobio-and-magenta-therapeutics-announce-collaboration-to-evaluate-targeted-antibody-drug-conjugate-as-a-potential-conditioning-regimen-for-lentiviral-gene-therapies 2020-05-06 23:48:20 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-to-acquire-censa-pharmaceuticals 2020-05-06 23:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-partners-with-faron-pharmaceuticals-to-manufacture-cancer-treatments 2020-05-06 00:08:51 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-to-acquire-portola 2020-05-06 00:01:57 daily 0.1 https://demo.pharmafocusasia.com/news/arcturus-therapeutics-and-catalent-announce-partnership-to-manufacture-mrna-based-covid-19-vaccine 2020-05-04 23:32:41 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-junshi-biosciences-to-co-develop-antibody-therapies-for-the-prevention-and-treatment-of-covid-19 2020-05-04 23:19:42 daily 0.1 https://demo.pharmafocusasia.com/news/biomarin-extends-gene-therapy-leadership-with-dinaqor-in-a-preclinical-collaboration-and-license-agreement-to-develop-gene-therapies-for-rare-genetic-cardiomyopathies 2020-05-03 23:07:57 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-mrna-1273-against-novel-coronavirus 2020-05-01 23:36:44 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-announces-janssen-receives-fda-approval-of-darzalex-faspro-utilizing-halozymes-enhanze-technology-for-the-treatment-of-patients-with-multiple-myeloma 2020-05-01 23:35:11 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-aravive-form-strategic-collaboration 2020-04-30 23:23:19 daily 0.1 https://demo.pharmafocusasia.com/news/trio-pharmaceuticals-inc-and-ajinomoto-bio-pharma-services-enter-into-a-development-collaboration-for-a-novel-antibody-therapeutic 2020-04-30 23:22:17 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-signs-agreement-with-johnson-johnson-to-be-us-manufacturing-partner-for-lead-covid-19-vaccine-candidate 2020-04-29 23:42:08 daily 0.1 https://demo.pharmafocusasia.com/news/atreca-beigene-and-igm-biosciences-agree-to-collaborate-on-novel-antibody-treatment-for-covid-19 2020-04-29 23:26:49 daily 0.1 https://demo.pharmafocusasia.com/news/bioduro-neox-partner-to-create-next-generation-antibody-discovery-platform 2020-04-28 23:27:40 daily 0.1 https://demo.pharmafocusasia.com/news/q2earths-bioscience-subsidiary-qsam-therapeutics-signs-license-for-promising-drug-to-treat-bone-cancer 2020-04-28 23:18:11 daily 0.1 https://demo.pharmafocusasia.com/news/m8-pharmaceuticals-and-gennisium-pharma-announce-an-exclusive-license-and-distribution-agreement-of-an-orphan-hybrid-drug 2020-04-28 23:13:52 daily 0.1 https://demo.pharmafocusasia.com/news/jcr-pharmaceuticals-announces-completion-of-acquisition-of-armagen-inc 2020-04-27 23:17:36 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-llc-announces-collaboration-with-xilio-therapeutics 2020-04-27 23:16:23 daily 0.1 https://demo.pharmafocusasia.com/news/sutro-biopharma-announces-encouraging-interim-phase-1-clinical-data-for-a-dose-escalation-study-of-stro-002-antibody-drug-conjugate-in-ovarian-cancer 2020-04-26 23:45:17 daily 0.1 https://demo.pharmafocusasia.com/news/tiziana-life-sciences-acquires-a-nanoparticle-based-formulation-technology-for-controlled-delivery-of-actinomycin-d 2020-04-26 23:38:41 daily 0.1 https://demo.pharmafocusasia.com/news/hansoh-pharma-and-nikang-therapeutics-enter-into-a-development-and-commercialization-partnership-for-a-novel-treatment-for-anti-viral-diseases-in-china 2020-04-23 23:40:07 daily 0.1 https://demo.pharmafocusasia.com/news/prothera-biologics-and-takeda-enter-global-licensing-agreement-to-develop-novel-plasma-derived-therapy-based-on-inter-alpha-inhibitor-proteins-iaip 2020-04-23 23:23:25 daily 0.1 https://demo.pharmafocusasia.com/news/cara-care-announces-collaboration-with-consumer-healthcare-business-unit-of-sanofi-germany-for-digestive-health 2020-04-22 23:27:44 daily 0.1 https://demo.pharmafocusasia.com/news/targovax-and-valo-therapeutics-enter-collaboration-to-develop-ras-neoantigen-coating-of-oncos-viruses-using-pepticrad-technology 2020-04-22 23:25:20 daily 0.1 https://demo.pharmafocusasia.com/news/aptar-and-sonmol-partner-to-develop-digital-platform-for-respiratory-related-therapies 2020-04-21 23:48:52 daily 0.1 https://demo.pharmafocusasia.com/news/mogrify-and-sangamo-announce-collaboration-and-exclusive-license-agreement-for-mogrifys-ipsc-and-esc-derived-regulatory-t-cells 2020-04-21 23:48:08 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-kite-and-onko-innate-announce-research-collaboration-to-discover-cancer-immunotherapies-focused-on-natural-killer-nk-cells 2020-04-21 23:39:59 daily 0.1 https://demo.pharmafocusasia.com/news/anixa-biosciences-and-ontochem-announce-collaboration-to-develop-novel-covid-19-therapeutics 2020-04-20 23:57:07 daily 0.1 https://demo.pharmafocusasia.com/news/amblyotech-a-digital-therapeutics-company-announces-it-has-been-acquired-by-novartis 2020-04-20 23:32:16 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharma-receives-fda-emergency-use-authorization-eua-for-its-covid-19-rt-pcr-detection-kit 2020-04-19 23:49:44 daily 0.1 https://demo.pharmafocusasia.com/news/chi-med-announces-surufatinib-granted-us-fda-fast-track-designations-for-the-treatment-of-both-pancreatic-and-non-pancreatic-neuroendocrine-tumors 2020-04-17 23:48:04 daily 0.1 https://demo.pharmafocusasia.com/news/oncolytics-biotech-updates-clinical-development-and-operations-activities-during-the-covid-19-pandemic 2020-04-17 23:36:17 daily 0.1 https://demo.pharmafocusasia.com/news/legochem-biosciences-and-iksuda-enter-into-a-multi-target-research-collaboration-and-license-agreement-for-the-development-of-antibody-drug-conjugates 2020-04-17 00:37:44 daily 0.1 https://demo.pharmafocusasia.com/news/soligenix-announces-exclusive-licensing-agreement-for-novel-vaccine-adjuvant-from-btg-specialty-pharmaceuticals 2020-04-17 00:23:34 daily 0.1 https://demo.pharmafocusasia.com/news/tscan-announces-collaboration-with-novartis-on-the-discovery-and-development-of-novel-t-cell-receptor-therapies-for-the-treatment-of-solid-tumors 2020-04-16 00:51:45 daily 0.1 https://demo.pharmafocusasia.com/news/immunoprecise-announces-agreement-with-janssen 2020-04-16 00:50:59 daily 0.1 https://demo.pharmafocusasia.com/news/intensity-therapeutics-signs-clinical-collaboration-agreement-with-bristol-myers-squibb-for-advanced-solid-tumors 2020-04-14 23:50:02 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-announces-collaboration-with-oncomyx-therapeutics-for-systems-pharmacology-modeling-in-immuno-oncology 2020-04-14 23:43:31 daily 0.1 https://demo.pharmafocusasia.com/news/thermogenesis-announces-its-immunecyte-joint-venture-acquires-key-technologies-to-develop-fully-human-polyclonal-and-monoclonal-antibody-therapeutics-for-covid-19 2020-04-13 23:48:26 daily 0.1 https://demo.pharmafocusasia.com/news/hope-biosciences-receives-second-fda-clearance-for-a-phase-ii-clinical-trial-for-protection-against-covid-19 2020-04-13 23:33:58 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-first-therapy-for-children-with-debilitating-and-disfiguring-rare-disease 2020-04-12 23:32:17 daily 0.1 https://demo.pharmafocusasia.com/news/neoimmunetech-announces-clinical-collaboration-with-bristol-myers-squibb 2020-04-09 21:27:08 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-biontech-announce-further-details-on-collaboration-to-accelerate-global-covid-19-vaccine-development 2020-04-09 21:25:33 daily 0.1 https://demo.pharmafocusasia.com/news/csl-behring-and-sab-biotherapeutics-join-forces-to-deliver-new-potential-covid-19-therapeutic 2020-04-09 00:00:15 daily 0.1 https://demo.pharmafocusasia.com/news/oncoimmune-receives-fda-approval-for-covid-19-clinical-trial 2020-04-08 23:47:23 daily 0.1 https://demo.pharmafocusasia.com/news/cytovia-therapeutics-and-macromoltek-to-develop-dual-acting-natural-killer-immunotherapy-against-sars-cov2-covid-19 2020-04-07 23:59:39 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-mtpc-enter-into-license-agreement 2020-04-07 23:49:49 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-second-genome-announce-strategic-collaboration-in-biomarker-and-inflammatory-bowel-disease-drug-discovery 2020-04-06 23:48:05 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-and-vir-biotechnology-enter-collaboration-to-find-coronavirus-solutions 2020-04-06 23:37:03 daily 0.1 https://demo.pharmafocusasia.com/news/global-plasma-leaders-collaborate-to-accelerate-development-of-potential-covid-19-hyperimmune-therapy 2020-04-06 05:50:19 daily 0.1 https://demo.pharmafocusasia.com/news/chirin-group-in-collaboration-with-covar-pharmaceuticals 2020-04-05 23:56:51 daily 0.1 https://demo.pharmafocusasia.com/news/seneca-biopharma-inc-announces-the-completion-of-stem-cell-manufacturing-facility-in-china 2020-04-04 00:18:09 daily 0.1 https://demo.pharmafocusasia.com/news/icon-signs-new-service-agreement-with-pfizer 2020-04-03 23:39:18 daily 0.1 https://demo.pharmafocusasia.com/news/kite-licenses-antibodies-and-establishes-collaboration-with-teneobio-in-multiple-myeloma 2020-04-02 23:36:46 daily 0.1 https://demo.pharmafocusasia.com/news/fate-therapeutics-announces-worldwide-collaboration-with-janssen-for-novel-ipsc-derived-cell-based-cancer-immunotherapies 2020-04-02 23:35:31 daily 0.1 https://demo.pharmafocusasia.com/news/mindmed-acquires-exclusive-license-to-eight-clinical-trials-of-lsd-partners-with-world-leading-psychedelic-research-laboratory 2020-04-02 00:13:15 daily 0.1 https://demo.pharmafocusasia.com/news/citius-signs-exclusive-option-with-novellus-to-license-novel-stem-cell-therapy-for-acute-respiratory-distress-syndrome-ards-associated-with-covid-19 2020-04-02 00:08:51 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-sitryx-announce-licensing-and-research-collaboration-to-discover-and-develop-new-immunometabolic-medicines 2020-04-01 00:05:58 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-introduces-new-handheld-raw-material-id-system-for-pharmaceutical-manufacturers 2020-03-31 23:45:29 daily 0.1 https://demo.pharmafocusasia.com/news/ostrich-pharma-usa-produces-antibodies-to-block-the-virus-that-causes-covid-19 2020-03-31 23:33:03 daily 0.1 https://demo.pharmafocusasia.com/news/alphamab-oncology-simcere-and-3d-medicines-announce-partnership-to-develop-and-commercialize-subcutaneous-injectable-anti-pd-l1-antibody 2020-03-30 23:32:28 daily 0.1 https://demo.pharmafocusasia.com/news/imaginab-announces-licensing-deal-with-astrazeneca-for-cd8-immunopet-technology 2020-03-30 23:30:06 daily 0.1 https://demo.pharmafocusasia.com/news/ryvu-therapeutics-receives-orphan-drug-designation-from-fda-for-sel120-to-treat-acute-myeloid-leukemia 2020-03-29 23:50:46 daily 0.1 https://demo.pharmafocusasia.com/news/evox-therapeutics-and-takeda-sign-multi-target-rare-disease-collaboration 2020-03-26 23:38:32 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-enters-into-a-collaboration-with-alector-to-develop-and-commercialize-anti-sirp-alpha-antibody-in-china 2020-03-26 23:35:33 daily 0.1 https://demo.pharmafocusasia.com/news/xencor-and-vir-biotechnology-enter-license-agreement-for-use-of-xtend-xmab-antibody-technology-in-investigational-antibodies-to-treat-covid-19 2020-03-25 23:37:38 daily 0.1 https://demo.pharmafocusasia.com/news/forge-enters-into-collaboration-with-roche-to-develop-novel-antibiotic-to-treat-lung-infections 2020-03-25 23:36:02 daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-and-smartpharm-to-collaborate-to-develop-novel-gene-encoded-antibody-vaccine-intended-to-protect-against-covid-19 2020-03-23 23:33:01 daily 0.1 https://demo.pharmafocusasia.com/news/cytomx-therapeutics-and-astellas-announce-strategic-collaboration-to-develop-probody-t-cell-engaging-bispecific-therapies-for-treatment-of-cancer 2020-03-23 23:31:33 daily 0.1 https://demo.pharmafocusasia.com/news/flexipharm-austrading-announces-product-update-on-arsenic-trioxide-phebra 2020-03-23 05:00:42 daily 0.1 https://demo.pharmafocusasia.com/news/fda-provides-update-on-patient-access-to-certain-rems-drugs-during-covid-19-public-health-emergency 2020-03-23 04:52:03 daily 0.1 https://demo.pharmafocusasia.com/news/tarveda-therapeutics-and-sciclone-pharmaceuticals-international-establish-licensing-agreement-for-pen-866-in-greater-china 2020-03-20 23:32:15 daily 0.1 https://demo.pharmafocusasia.com/news/ridgeback-biotherapeutics-and-drug-innovations-ventures-at-emory-partner-to-develop-clinical-stage-coronavirus-treatment 2020-03-20 00:19:01 daily 0.1 https://demo.pharmafocusasia.com/news/dragonfly-therapeutics-announces-multi-target-expansion-of-its-collaboration-with-merck 2020-03-20 00:04:36 daily 0.1 https://demo.pharmafocusasia.com/news/ideaya-and-pfizer-enter-clinical-trial-collaboration-and-supply-agreement-to-evaluate-clinical-combination 2020-03-18 23:58:14 daily 0.1 https://demo.pharmafocusasia.com/news/askbio-enters-research-collaboration-and-licensing-agreement-with-university-of-north-carolina-unc-for-angelman-syndrome 2020-03-18 23:49:32 daily 0.1 https://demo.pharmafocusasia.com/news/signpath-pharma-to-focus-on-coronavirus-disease-covid-19-by-developing-treatment-for-acute-respiratory-distress-syndrome-ards 2020-03-17 23:44:55 daily 0.1 https://demo.pharmafocusasia.com/news/roosterbio-partners-with-senti-biosciences-to-rapidly-translate-gene-circuit-cell-therapy-into-the-clinic 2020-03-17 23:42:53 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-receives-fda-breakthrough-therapy-designation-for-baricitinib-for-the-treatment-of-alopecia-areata 2020-03-17 00:10:46 daily 0.1 https://demo.pharmafocusasia.com/news/beijing-tide-pharmaceutical-and-insilico-medicine-enter-into-a-strategic-partnership-agreement-for-cancer-therapy 2020-03-16 23:40:51 daily 0.1 https://demo.pharmafocusasia.com/news/emd-serono-and-pfizer-provide-update-on-phase-iii-javelin-head-and-neck-100-study 2020-03-15 23:54:49 daily 0.1 https://demo.pharmafocusasia.com/news/tyligand-bioscience-and-context-therapeutics-sign-strategic-development-agreement-for-onapristone-er 2020-03-12 23:34:53 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-and-lilly-to-co-develop-antibody-therapies-for-the-treatment-of-covid-19 2020-03-12 23:25:48 daily 0.1 https://demo.pharmafocusasia.com/news/ideaya-biosciences-and-cancer-research-uk-announce-expanded-research-collaboration-for-parg-a-ddr-based-synthetic-lethality-target-evaluating-dna-replication-vulnerabilities 2020-03-11 23:41:45 daily 0.1 https://demo.pharmafocusasia.com/news/vir-biotechnology-announces-research-collaboration-with-the-national-institutes-of-health-vaccine-research-center-on-antibodies-against-coronaviruses 2020-03-11 23:39:36 daily 0.1 https://demo.pharmafocusasia.com/news/emergent-biosolutions-signs-development-and-manufacturing-agreement-with-novavax-for-experimental-vaccine-candidate-for-coronavirus-disease 2020-03-10 23:42:34 daily 0.1 https://demo.pharmafocusasia.com/news/phio-pharmaceuticals-and-helmholtz-zentrum-munchen-announce-collaboration-and-option-agreement-with-medigene 2020-03-10 23:40:22 daily 0.1 https://demo.pharmafocusasia.com/news/bridge-biotherapeutics-enters-ai-based-research-collaboration-with-atomwise-to-expand-pellino-inhibitor-pipeline 2020-03-09 23:55:40 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-and-xoma-announce-il-2-based-immuno-oncology-therapy-licensing-agreement 2020-03-09 23:45:50 daily 0.1 https://demo.pharmafocusasia.com/news/nanoform-and-orion-collaborate-on-next-generation-drug-development 2020-03-09 03:37:52 daily 0.1 https://demo.pharmafocusasia.com/news/pmi-biopharma-solutions-and-nashville-biosciences-announce-strategic-alliance-to-combine-comprehensive-drug-discovery-support 2020-03-06 23:26:54 daily 0.1 https://demo.pharmafocusasia.com/news/mount-sinai-and-harbour-biomed-collaborate-to-advance-novel-biotherapies-for-the-treatment-of-cancer-and-coronavirus-covid-19 2020-03-06 23:23:47 daily 0.1 https://demo.pharmafocusasia.com/news/acadia-pharmaceuticals-and-neuren-pharmaceuticals-announce-rare-pediatric-disease-designation-for-trofinetide-for-the-treatment-of-rett-syndrome 2020-03-05 23:57:10 daily 0.1 https://demo.pharmafocusasia.com/news/tg-therapeutics-receives-orphan-drug-designation-for-umbralisib-from-the-us-food-and-drug-administration-for-the-treatment-of-follicular-lymphoma 2020-03-05 23:31:02 daily 0.1 https://demo.pharmafocusasia.com/news/alopexx-oncology-announces-licensing-agreement-with-beijing-shenogen-pharma-group-for-development-and-commercialization-of-novel-immunocytokine 2020-03-04 23:56:41 daily 0.1 https://demo.pharmafocusasia.com/news/vir-and-alnylam-expand-collaboration-to-advance-rnai-therapeutics-for-the-treatment-of-coronavirus-infection-including-covid-19 2020-03-04 23:41:03 daily 0.1 https://demo.pharmafocusasia.com/news/iktos-and-sri-international-announce-collaboration-to-combine-artificial-intelligence-and-novel-automated-discovery-platform 2020-03-03 23:32:10 daily 0.1 https://demo.pharmafocusasia.com/news/acadia-pharmaceuticals-and-neuren-pharmaceuticals-announce-rare-pediatric-disease-designation-for-trofinetide-for-the-treatment-of-rett-syndrome 2020-03-03 23:40:48 daily 0.1 https://demo.pharmafocusasia.com/news/singapore-born-digital-therapeutics-company-inks-deal-with-hong-kong-govt-to-fight-covid-19 2020-03-03 23:04:49 daily 0.1 https://demo.pharmafocusasia.com/news/cytoo-and-askbio-enter-research-agreement-to-screen-gene-therapy-candidates-for-rare-muscle-disorder 2020-03-02 23:29:46 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-and-stcube-enter-into-development-and-manufacturing-agreement-for-novel-target-anticancer-drug 2020-03-02 23:26:56 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-agrees-to-divest-select-otc-and-non-core-assets-in-latin-america-to-hypera-pharma 2020-03-02 06:13:27 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-announces-us-fda-approval-of-ind-for-its-next-generation-anti-ctla-4-antibody-hbm4003-to-treat-cancer 2020-02-28 23:32:22 daily 0.1 https://demo.pharmafocusasia.com/news/zpredicta-enters-strategic-collaboration-with-labcorp-to-advance-the-use-of-3d-cell-cultures-in-research-and-drug-development 2020-02-27 23:33:28 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-sangamo-announce-global-collaboration-to-develop-gene-regulation-therapies 2020-02-27 23:31:42 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-announces-research-collaboration-with-southern-research 2020-02-26 23:36:24 daily 0.1 https://demo.pharmafocusasia.com/news/gemini-therapeutics-and-singapore-eye-research-institute-enter-into-research-collaboration-to-explore-new-targets-for-age-related-macular-degeneration 2020-02-26 23:28:26 daily 0.1 https://demo.pharmafocusasia.com/news/twinstrand-biosciences-launches-duplex-sequencing-technology 2020-02-26 00:21:54 daily 0.1 https://demo.pharmafocusasia.com/news/emcyte-announces-fda-510k-clearance-for-its-pureprp-supraphysiologic-concentrating-system 2020-02-26 00:21:15 daily 0.1 https://demo.pharmafocusasia.com/news/clover-and-gsk-announce-research-collaboration-to-evaluate-coronavirus-covid-19-vaccine-candidate-with-pandemic-adjuvant-system 2020-02-24 23:22:03 daily 0.1 https://demo.pharmafocusasia.com/news/aradigm-announces-entering-into-an-asset-purchase-agreement-with-grifols-sa 2020-02-23 23:43:59 daily 0.1 https://demo.pharmafocusasia.com/news/hummingbird-bioscience-announces-agreement-with-mycenax-biotech-for-production-of-anti-vista-antibody-hmbd-002-for-cancer-clinical-trial 2020-02-20 23:31:30 daily 0.1 https://demo.pharmafocusasia.com/news/immatics-and-gsk-partner-to-develop-novel-adoptive-cell-therapies 2020-02-20 23:20:04 daily 0.1 https://demo.pharmafocusasia.com/news/five-prime-therapeutics-licenses-antibodies-to-seattle-genetics-for-use-in-novel-antibody-drug-conjugate-adc-programs 2020-02-19 23:34:03 daily 0.1 https://demo.pharmafocusasia.com/news/nimble-announces-collaboration-with-genentech-to-discover-and-develop-novel-peptide-based-therapeutics 2020-02-19 23:32:48 daily 0.1 https://demo.pharmafocusasia.com/news/m8-pharmaceuticals-and-vectans-pharma-signed-an-exclusive-licensing-agreement-of-loramyc-miconazole-lauriad-for-mexico-and-brazil 2020-02-18 23:50:36 daily 0.1 https://demo.pharmafocusasia.com/news/eastgate-biotech-pakistan-expands-its-collaboration-in-advancing-the-development-of-a-new-vaccine-against-covid-19 2020-02-18 23:23:14 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-receives-ec-approval-for-beovu-a-next-generation-anti-vegf-treatment-for-wet-amd-a-leading-cause-of-blindness-worldwide 2020-02-17 23:34:38 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-and-jazz-pharmaceuticals-announce-fda-acceptance-and-priority-review-of-new-drug-application 2020-02-17 04:33:01 daily 0.1 https://demo.pharmafocusasia.com/news/epizyme-announces-fda-acceptance-of-new-drug-application-for-filing-with-priority-review-for-tazverik-tazemetostat-for-the-treatment-of-follicular-lymphoma 2020-02-15 00:25:03 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-soligenix-fast-track-designation-for-rivax-in-the-prevention-of-ricin-poisoning 2020-02-14 00:08:22 daily 0.1 https://demo.pharmafocusasia.com/news/ose-immunotherapeutics-announces-artificial-intelligence-antibody-drug-development-collaboration-with-mabsilico 2020-02-12 23:25:48 daily 0.1 https://demo.pharmafocusasia.com/news/wpd-pharmaceuticals-to-conduct-clinical-trials-in-pediatric-brain-tumors-through-collaboration-with-cns-pharmaceuticals 2020-02-12 23:20:14 daily 0.1 https://demo.pharmafocusasia.com/news/cannabics-pharmaceuticals-collaborates-with-rckmc-to-develop-cannabis-strains-targeting-gastrointestinal-cancers 2020-02-11 23:27:28 daily 0.1 https://demo.pharmafocusasia.com/news/advaxis-and-personalis-announce-research-agreement-to-deploy-immunoid-next-platform-in-the-adxs-503-clinical-program 2020-02-11 23:22:24 daily 0.1 https://demo.pharmafocusasia.com/news/reform-biologics-and-milliporesigma-announce-a-licensing-agreement-for-excipient-development-and-commercialization 2020-02-10 23:41:44 daily 0.1 https://demo.pharmafocusasia.com/news/realta-life-sciences-announces-fda-orphan-drug-designation-for-pic1-for-the-treatment-of-hypoxic-ischemic-encephalopathy 2020-02-06 23:47:36 daily 0.1 https://demo.pharmafocusasia.com/news/alk-abello-and-x-chem-announce-drug-discovery-collaboration 2020-02-05 23:14:40 daily 0.1 https://demo.pharmafocusasia.com/news/atreca-announces-strategic-research-collaboration-with-merck 2020-02-05 23:10:56 daily 0.1 https://demo.pharmafocusasia.com/news/q-biomed-partner-mannin-research-developing-potential-treatment-for-patients-infected-with-coronavirus-and-other-infectious-diseases 2020-02-04 23:21:32 daily 0.1 https://demo.pharmafocusasia.com/news/navrogen-and-levena-announce-collaboration-to-develop-antibody-drug-conjugates-adcs-to-treat-humoral-immuno-suppressed-cancers 2020-02-04 23:16:29 daily 0.1 https://demo.pharmafocusasia.com/news/betterlife-pharma-acquires-swiss-based-solmic-ag-with-unique-global-patent-for-production-of-new-generation-cbd-based-biopharmaceuticals 2020-02-03 23:46:15 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-llc-announces-collaboration-with-gritstone-oncology-inc 2020-02-03 23:37:53 daily 0.1 https://demo.pharmafocusasia.com/news/avacta-and-daewoong-agree-collaboration-and-license-agreement-with-affyxell-therapeutics 2020-02-03 06:36:42 daily 0.1 https://demo.pharmafocusasia.com/news/geneyork-pharmaceutical-announces-us-launch-of-generic-version-of-deltasonetablets 2020-02-02 23:22:16 daily 0.1 https://demo.pharmafocusasia.com/news/wpd-pharmaceuticals-completed-the-acquisition-of-two-pancreatic-cancer-drug-candidates 2020-01-31 23:21:00 daily 0.1 https://demo.pharmafocusasia.com/news/inovio-collaborating-with-beijing-advaccine-to-advance-ino-4800-vaccine-against-new-coronavirus-in-china 2020-01-30 23:36:35 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-enables-development-of-multiple-neutralizing-antibodies-for-novel-coronavirus 2020-01-29 23:58:30 daily 0.1 https://demo.pharmafocusasia.com/news/agex-therapeutics-enters-research-collaboration-with-japanese-biopharma-company-to-generate-hypoimmunogenic-cells 2020-01-29 23:55:33 daily 0.1 https://demo.pharmafocusasia.com/news/conatus-pharmaceuticals-and-histogen-enter-into-definitive-merger-agreement 2020-01-28 23:46:29 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-completes-acquisition-of-achillion 2020-01-28 23:40:23 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-allergan-announce-agreements-to-divest-brazikumab-and-zenpep 2020-01-27 23:39:47 daily 0.1 https://demo.pharmafocusasia.com/news/tilt-biotherapeutics-signs-a-licensing-deal-with-biotheus-inc-for-cancer-therapy-with-oncolytic-virus-tilt-123 2020-01-27 23:34:16 daily 0.1 https://demo.pharmafocusasia.com/news/atai-life-sciences-announces-joint-venture-with-demerx-to-develop-ibogaine-for-opioid-use-disorder 2020-01-26 23:57:23 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-indivumed-announce-second-joint-drug-discovery-program 2020-01-24 00:16:50 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-completes-acquisition-of-synthorx 2020-01-24 00:15:56 daily 0.1 https://demo.pharmafocusasia.com/news/inhibitor-therapeutics-receives-prostate-cancer-ind-clearance-from-fda 2020-01-23 01:38:58 daily 0.1 https://demo.pharmafocusasia.com/news/genialis-and-oncologie-collaborate-on-precision-medicine-initiative-in-gastric-cancer 2020-01-22 23:26:43 daily 0.1 https://demo.pharmafocusasia.com/news/hitachi-chemical-advanced-therapeutics-solutions-and-ori-biotech-announce-a-joint-development-agreement 2020-01-21 23:27:12 daily 0.1 https://demo.pharmafocusasia.com/news/ncardia-and-bluerock-therapeutics-announce-collaboration-agreement-and-licensing-of-process-development-technologies 2020-01-21 23:27:52 daily 0.1 https://demo.pharmafocusasia.com/news/crescita-signs-exclusive-distribution-agreement-with-fillmed 2020-01-20 23:24:13 daily 0.1 https://demo.pharmafocusasia.com/news/bridge-biotherapeutics-announces-fda-ind-clearance-for-bbt-176-an-egfr-tki-for-nsclc 2020-01-19 23:40:13 daily 0.1 https://demo.pharmafocusasia.com/news/mundipharma-enters-into-partnership-with-samsung-bioepis-to-expand-biosimilars-to-hong-kong-and-taiwan 2020-01-17 23:28:26 daily 0.1 https://demo.pharmafocusasia.com/news/international-research-collaboration-reveals-promising-drug-candidate-for-treatment-of-blood-cancers 2020-01-16 23:44:58 daily 0.1 https://demo.pharmafocusasia.com/news/can-fite-and-univo-pharmaceuticals-collaboration-result-in-discovery-and-applied-patent-for-cannabinoid-formulations-with-broad-therapeutic-effects 2020-01-16 23:21:45 daily 0.1 https://demo.pharmafocusasia.com/news/numedii-inc-announces-pharmaceutical-discovery-collaboration-for-ulcerative-colitis 2020-01-15 23:27:30 daily 0.1 https://demo.pharmafocusasia.com/news/artisan-bio-announces-global-research-and-discovery-collaboration-agreement-with-takeda-to-develop-next-generation-cell-therapy-products 2020-01-15 23:18:03 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-announces-agreement-with-pfizer-and-initiation-of-a-new-phase-2-trial-evaluating-zw25-in-combination-with-ibrance 2020-01-12 23:55:14 daily 0.1 https://demo.pharmafocusasia.com/news/iovance-biotherapeutics-and-cellectis-enter-into-a-research-collaboration-and-exclusive-worldwide-license-agreement 2020-01-12 23:52:31 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-bayer-announce-new-alliance-focusing-on-drug-discovery-for-polycystic-ovary-syndrome-with-novel-targets-from-celmatix 2020-01-09 23:35:18 daily 0.1 https://demo.pharmafocusasia.com/news/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-for-multiple-bispecific-antibodies-targeting-dermatology-diseases 2020-01-09 23:33:11 daily 0.1 https://demo.pharmafocusasia.com/news/targovax-and-iovaxis-therapeutics-enters-option-agreement-for-tg-mutant-ras-vaccine-license-and-clinical-development-in-china 2020-01-08 23:32:11 daily 0.1 https://demo.pharmafocusasia.com/news/schrodinger-and-bayer-collaborate-to-co-develop-de-novo-design-technology-and-accelerate-drug-discovery 2020-01-08 23:30:57 daily 0.1 https://demo.pharmafocusasia.com/news/galecto-and-pharmakea-merge-to-create-strong-clinical-stage-company-developing-first-in-class-therapeutics-in-fibrosis-and-cancer 2020-01-07 23:35:25 daily 0.1 https://demo.pharmafocusasia.com/news/sab-biotherapeutics-announces-research-collaboration-with-csl-behring 2020-01-07 23:25:36 daily 0.1 https://demo.pharmafocusasia.com/news/curis-announces-option-and-license-agreement-with-immunext 2020-01-07 23:24:41 daily 0.1 https://demo.pharmafocusasia.com/news/inxmed-announces-clinical-collaboration-with-msd-to-evaluate-in10018-in-combination-with-pembrolizumab 2020-01-06 23:44:09 daily 0.1 https://demo.pharmafocusasia.com/news/atai-life-sciences-partners-with-neuronasal-inc-to-develop-novel-treatment-for-mild-traumatic-brain-injury 2020-01-06 23:39:47 daily 0.1 https://demo.pharmafocusasia.com/news/pulmatrix-announces-research-collaboration-with-nocion-therapeutics-to-explore-inhaled-drug-delivery-technologies 2020-01-06 23:38:23 daily 0.1 https://demo.pharmafocusasia.com/news/abcam-announces-successful-acquisition-of-expedeons-proteomics-and-immunology-business-enhancing-its-conjugation-capability 2020-01-06 03:42:22 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-laboratories-completes-the-acquisition-of-hemacare-corporation 2020-01-03 23:14:04 daily 0.1 https://demo.pharmafocusasia.com/news/pulmatrix-announces-kinase-inhibitor-licensing-agreement-with-lung-cancer-initiative-at-johnson-johnson 2020-01-02 23:16:45 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-sta-opens-oligonucleotide-large-scale-manufacturing-facility 2020-01-02 23:16:05 daily 0.1 https://demo.pharmafocusasia.com/news/savara-granted-breakthrough-therapy-designation-for-molgradex 2019-12-31 00:16:18 daily 0.1 https://demo.pharmafocusasia.com/news/acceleron-and-fulcrum-therapeutics-announce-collaboration-agreement 2019-12-30 23:19:11 daily 0.1 https://demo.pharmafocusasia.com/news/cyclo-therapeutics-signs-master-services-agreement-with-worldwide-clinical-trials 2019-12-29 23:33:31 daily 0.1 https://demo.pharmafocusasia.com/news/genscript-and-selecxine-enter-into-strategic-cooperation-agreement 2019-12-26 23:57:37 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-strengthens-immuno-oncology-pipeline-with-acquisition-of-xyphos-biosciences-inc 2019-12-26 23:48:47 daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-signs-agreement-to-divest-emollients-and-proctology-portfolio-to-karo-pharma 2019-12-24 05:19:07 daily 0.1 https://demo.pharmafocusasia.com/news/roche-enters-licensing-agreement-with-sarepta-therapeutics-to-improve-the-lives-of-patients-living-with-duchenne-muscular-dystrophy 2019-12-23 23:28:57 daily 0.1 https://demo.pharmafocusasia.com/news/theravance-biopharma-and-pfizer-inc-enter-global-license-agreement-for-skin-targeted-locally-acting-pan-janus-kinase-jak-inhibitor-program 2019-12-23 23:24:20 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-heptares-announces-the-first-phase-i-clinical-start-from-its-multi-target-drug-discovery-collaboration-with-pfizer 2019-12-23 03:30:16 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-acquires-taris-biomedical-with-focus-on-transforming-the-treatment-of-bladder-cancer 2019-12-20 23:42:03 daily 0.1 https://demo.pharmafocusasia.com/news/rheos-medicines-announces-worldwide-collaboration-with-roche-to-discover-and-develop-novel-medicines 2019-12-19 23:37:17 daily 0.1 https://demo.pharmafocusasia.com/news/genmab-and-curevac-enter-strategic-partnership-to-develop-mrna-based-antibody-therapeutics 2019-12-19 23:33:02 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-and-jazz-pharmaceuticals-sign-exclusive-license-agreement 2019-12-19 23:29:46 daily 0.1 https://demo.pharmafocusasia.com/news/sisaf-establishes-strategic-partnership-with-avellino-labs-usa-to-co-develop-non-viral-topical-gene-therapies-for-corneal-dystrophy 2019-12-19 00:01:00 daily 0.1 https://demo.pharmafocusasia.com/news/arcus-biosciences-in-collaboration-with-genentech 2019-12-18 23:51:02 daily 0.1 https://demo.pharmafocusasia.com/news/gbt-and-syros-partner-to-discover-develop-and-commercialize-novel-therapies-for-sickle-cell-disease-and-beta-thalassemia 2019-12-18 23:49:44 daily 0.1 https://demo.pharmafocusasia.com/news/bioarctic-announces-research-collaboration-with-eisai-regarding-ban2401 2019-12-17 23:53:16 daily 0.1 https://demo.pharmafocusasia.com/news/shandong-fontacea-announces-license-agreement-with-janssen 2019-12-17 23:52:28 daily 0.1 https://demo.pharmafocusasia.com/news/prevail-therapeutics-announces-fda-orphan-drug-designation-granted-to-pr006-for-the-treatment-of-patients-with-frontotemporal-dementia-with-a-grn-mutation 2019-12-16 23:57:05 daily 0.1 https://demo.pharmafocusasia.com/news/organovo-and-tarveda-therapeutics-announce-definitive-merger-agreement 2019-12-16 23:47:26 daily 0.1 https://demo.pharmafocusasia.com/news/genetron-health-announces-strategic-collaboration-with-cstone 2019-12-15 23:25:42 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-partners-with-mitest-health-to-launch-innovative-disease-risk-prediction-tool-to-redefine-crohns-disease-management 2019-12-15 23:21:44 daily 0.1 https://demo.pharmafocusasia.com/news/equillium-biocon-expand-exclusive-licensing-agreement-for-itolizumab-to-include-australia-and-new-zealand 2019-12-12 23:42:29 daily 0.1 https://demo.pharmafocusasia.com/news/iktos-and-almirall-announce-research-collaboration-in-artificial-intelligence-for-new-drug-design 2019-12-12 23:31:53 daily 0.1 https://demo.pharmafocusasia.com/news/forendo-pharma-signs-important-license-and-collaboration-deal-with-leading-pharma-company 2019-12-11 23:47:00 daily 0.1 https://demo.pharmafocusasia.com/news/neoimmunetech-announces-clinical-collaboration-to-evaluate-hyleukin-7-nt-i7 2019-12-11 23:30:55 daily 0.1 https://demo.pharmafocusasia.com/news/bloom-science-collaborates-with-cedars-sinai-medical-center-to-expand-microbiome-research-and-discovery-into-brain-cancer 2019-12-10 23:41:10 daily 0.1 https://demo.pharmafocusasia.com/news/engitix-and-morphic-enter-research-collaboration-to-identify-ecm-related-targets 2019-12-10 23:33:27 daily 0.1 https://demo.pharmafocusasia.com/news/samyang-biopharm-usa-and-talix-therapeutics-nv-announce-global-strategic-collaboration 2019-12-09 23:37:27 daily 0.1 https://demo.pharmafocusasia.com/news/gemini-therapeutics-and-avitide-enter-into-exclusive-license-agreement 2019-12-09 23:35:23 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-to-acquire-investigational-bermekimab-from-xbiotech 2019-12-08 23:38:41 daily 0.1 https://demo.pharmafocusasia.com/news/ge-healthcare-life-sciences-pairs-up-with-advanced-solutions-life-sciences-to-create-new-opportunities-for-regenerative-tissue-manufacturing 2019-12-08 23:38:07 daily 0.1 https://demo.pharmafocusasia.com/news/maxcyte-and-ksq-therapeutics-announce-development-and-commercialization-agreement 2019-12-05 23:57:28 daily 0.1 https://demo.pharmafocusasia.com/news/zionexa-has-signed-an-exclusive-agreement-with-petnet-solutions-inc-for-manufacturing-and-distribution 2019-12-05 23:42:35 daily 0.1 https://demo.pharmafocusasia.com/news/gatehouse-bio-collaborates-with-astrazeneca-to-accelerate-new-drug-discovery 2019-12-04 23:32:44 daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-and-portal-instruments-announce-collaboration-to-develop-needle-free-drug-delivery-device 2019-12-04 23:31:43 daily 0.1 https://demo.pharmafocusasia.com/news/rapt-therapeutics-and-hanmi-pharmaceutical-announce-collaboration-to-develop-and-commercialize-flx475-in-asia 2019-12-03 23:18:53 daily 0.1 https://demo.pharmafocusasia.com/news/resonant-therapeutics-announces-collaboration-with-janssen 2019-12-03 23:16:14 daily 0.1 https://demo.pharmafocusasia.com/news/neurocrine-biosciences-and-xenon-pharmaceuticals-announce-agreement-to-develop-first-in-class-treatments-for-epilepsy 2019-12-02 23:30:42 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-enters-into-definitive-agreement-to-acquire-audentes-therapeutics 2019-12-02 23:21:57 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-biologics-announces-fda-acceptance-of-nda-for-pemigatinib-in-patients 2019-12-01 23:47:22 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-atu-and-genemedicine-sign-development-and-manufacturing-agreement-for-oncolytic-virus-products 2019-11-28 23:37:29 daily 0.1 https://demo.pharmafocusasia.com/news/verrica-pharmaceuticals-announces-fda-filing-acceptance-of-new-drug-application-for-vp-102 2019-11-28 04:35:43 daily 0.1 https://demo.pharmafocusasia.com/news/lonza-and-dinaqor-ag-announce-strategic-collaboration-to-advance-gene-therapy-programs-for-patients-with-monogenic-cardiomyopathies 2019-11-26 23:55:50 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-and-north-carolina-state-university-enter-license-agreement-for-gene-therapy 2019-11-26 23:54:52 daily 0.1 https://demo.pharmafocusasia.com/news/ardelyx-and-kyowa-kirin-expand-partnership-with-two-additional-agreements 2019-11-25 23:44:20 daily 0.1 https://demo.pharmafocusasia.com/news/alkermes-completes-acquisition-of-rodin-therapeutics 2019-11-25 23:28:12 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-priority-review-to-genentechs-risdiplam-for-spinal-muscular-atrophy 2019-11-25 03:05:46 daily 0.1 https://demo.pharmafocusasia.com/news/onconova-therapeutics-announces-exclusive-license-agreement 2019-11-21 23:57:27 daily 0.1 https://demo.pharmafocusasia.com/news/phenomics-health-inc-acquires-patented-drug-metabolome-technology 2019-11-21 23:51:49 daily 0.1 https://demo.pharmafocusasia.com/news/dragonfly-therapeutics-announces-collaboration-with-abbvie-for-autoimmune-diseases-and-oncology 2019-11-20 23:58:01 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-and-welldoc-enter-into-strategic-alliance-for-digital-therapeutics 2019-11-20 23:34:07 daily 0.1 https://demo.pharmafocusasia.com/news/personalis-inc-announces-collaboration-with-merck-kgaa-darmstadt-germany-to-identify-and-develop-novel-biomarkers-for-cancer-therapies 2019-11-19 23:48:37 daily 0.1 https://demo.pharmafocusasia.com/news/antares-pharma-enters-into-a-global-development-agreement-with-idorsia-pharmaceuticals-ltd 2019-11-19 23:34:38 daily 0.1 https://demo.pharmafocusasia.com/news/alkermes-to-acquire-rodin-therapeutics 2019-11-18 23:33:58 daily 0.1 https://demo.pharmafocusasia.com/news/dicerna-and-novo-nordisk-enter-agreement-to-discover-and-develop-rnai-therapies-for-liver-related-cardio-metabolic-diseases 2019-11-18 23:28:56 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-apptecs-lab-testing-division-expands-toxicology-facility-in-suzhou 2019-11-17 23:38:47 daily 0.1 https://demo.pharmafocusasia.com/news/biocorp-signs-exclusive-deal-with-vitrobio-pharma-to-produce-the-first-drug-treatment-against-allergy-related-to-pollution 2019-11-15 23:28:47 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-and-stridebio-announce-multi-target-strategic-collaboration-to-advance-novel-gene-therapies 2019-11-14 23:46:50 daily 0.1 https://demo.pharmafocusasia.com/news/exicure-and-allergan-enter-into-collaboration-option-and-license-agreement-to-discover-and-develop-sna-based-treatments-for-hair-loss-disorders 2019-11-14 23:33:38 daily 0.1 https://demo.pharmafocusasia.com/news/autolus-therapeutics-and-noile-immune-announce-licensing-agreement 2019-11-13 23:40:32 daily 0.1 https://demo.pharmafocusasia.com/news/finch-therapeutics-takeda-expand-collaboration-to-develop-microbiome-therapeutics-using-finchs-human-first-discovery-platform 2019-11-13 23:33:25 daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-exercises-option-with-hitgen-to-license-compounds-for-development-of-novel-class-of-drugs-in-dermatology 2019-11-13 00:00:02 daily 0.1 https://demo.pharmafocusasia.com/news/gossamer-bio-announces-clinical-trial-collaboration-agreement-with-merck 2019-11-12 23:45:38 daily 0.1 https://demo.pharmafocusasia.com/news/galectin-therapeutics-reaches-agreement-with-siemens-healthineers-to-collaborate-on-nash-and-liver-fibrosis 2019-11-11 23:30:02 daily 0.1 https://demo.pharmafocusasia.com/news/urogen-pharma-announces-exclusive-license-agreement-with-agenus-inc-to-advance-treatment-of-urinary-tract-cancers 2019-11-11 23:17:01 daily 0.1 https://demo.pharmafocusasia.com/news/f2g-receives-us-fda-breakthrough-therapy-designation-for-olorofim 2019-11-11 03:00:47 daily 0.1 https://demo.pharmafocusasia.com/news/avantgen-enters-a-strategic-collaboration-agreement-to-develop-novel-anti-cancer-therapeutic-with-its-nk-cell-engager-technology 2019-11-07 23:48:50 daily 0.1 https://demo.pharmafocusasia.com/news/sqz-biotech-and-askbio-announce-research-collaboration-to-create-immune-tolerization-products-for-aav-gene-therapies 2019-11-07 23:31:13 daily 0.1 https://demo.pharmafocusasia.com/news/artios-pharma-md-anderson-and-shangpharma-announce-in-licensing-agreement-for-dna-damage-response-inhibitor 2019-11-06 23:42:51 daily 0.1 https://demo.pharmafocusasia.com/news/amneal-enters-into-a-licensing-agreement-with-kashiv-biosciences-llc-to-develop-and-commercialize-k127-for-the-treatment-of-myasthenia-gravis 2019-11-06 23:34:11 daily 0.1 https://demo.pharmafocusasia.com/news/precision-for-medicine-and-akoya-partner-to-develop-advanced-liquid-biopsy-and-tissue-biomarker-tests 2019-11-05 23:33:39 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-and-beigene-announce-global-license-agreement-for-advanced-preclinical-product-candidate 2019-11-05 23:26:26 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-biologics-and-ichnos-sciences-announce-agreement-for-manufacture-of-isb-830 2019-11-04 23:45:04 daily 0.1 https://demo.pharmafocusasia.com/news/aeromics-and-simcere-announce-collaboration-and-license-agreement-for-aer-271-in-greater-china 2019-11-04 23:43:11 daily 0.1 https://demo.pharmafocusasia.com/news/raybow-pharmaceutical-acquires-pharmagra-labs 2019-11-04 05:02:54 daily 0.1 https://demo.pharmafocusasia.com/news/signpath-pharma-inc-announces-an-out-license-agreement-of-its-correqttm-technology-for-mitigation-of-qt-prolongation-with-rain-therapeutics-inc 2019-11-01 23:35:54 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-enters-into-strategic-collaboration-with-beigene 2019-10-31 23:56:59 daily 0.1 https://demo.pharmafocusasia.com/news/nuchem-therapeutics-completed-the-acquisition-of-amplia-pharmatek 2019-10-31 23:55:17 daily 0.1 https://demo.pharmafocusasia.com/news/pandion-and-astellas-announce-collaboration-to-deliver-pancreas-targeted-immunomodulators 2019-10-30 23:26:03 daily 0.1 https://demo.pharmafocusasia.com/news/cyclo-therapeutics-signs-agreement-with-worldwide-clinical-trials 2019-10-30 23:24:59 daily 0.1 https://demo.pharmafocusasia.com/news/gotham-therapeutics-establishes-advanced-oncology-profiling-cascade-with-proqinase-to-progress-its-portfolio-of-epitranscriptomic-drug-candidates 2019-10-29 23:27:58 daily 0.1 https://demo.pharmafocusasia.com/news/pascal-biosciences-and-y-biologics-announce-research-collaboration-for-development-of-a-bispecific-antibody-for-leukemia 2019-10-29 23:23:40 daily 0.1 https://demo.pharmafocusasia.com/news/ziopharm-oncology-and-md-anderson-cancer-center-announce-new-rd-agreement-to-expand-tcr-t-program 2019-10-28 23:51:35 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-glympse-bio-announce-strategic-collaboration-for-use-of-biomarker-technology-in-nash-clinical-development 2019-10-28 23:39:24 daily 0.1 https://demo.pharmafocusasia.com/news/histoindex-announces-global-partnerships-to-expand-ai-based-digital-pathology-platform 2019-10-27 23:34:26 daily 0.1 https://demo.pharmafocusasia.com/news/aztherapies-strengthens-neuroinflammation-targeted-pipeline-through-acquisition-of-smith-therapeutics 2019-10-25 01:35:41 daily 0.1 https://demo.pharmafocusasia.com/news/avrobio-receives-orphan-drug-designation-from-the-us-fda-for-avrrd02-for-the-treatment-of-gaucher-disease 2019-10-25 01:17:51 daily 0.1 https://demo.pharmafocusasia.com/news/pliant-therapeutics-announces-strategic-collaboration-to-develop-novel-therapies-for-nash-and-fibrotic-diseases 2019-10-23 23:28:48 daily 0.1 https://demo.pharmafocusasia.com/news/foamix-enters-into-manufacturing-and-supply-agreement-for-amzeeq-and-fmx103 2019-10-23 23:23:34 daily 0.1 https://demo.pharmafocusasia.com/news/pds-biotechnology-completes-manufacturing-of-clinical-batches-of-pds0101 2019-10-22 23:46:09 daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-expands-its-peptide-platform-with-acquisition-of-encycle-therapeutics 2019-10-22 23:34:57 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-and-dongkoo-sign-agreement-for-mob-015-in-the-republic-of-korea 2019-10-21 23:44:48 daily 0.1 https://demo.pharmafocusasia.com/news/bryn-pharma-partners-with-aptar-pharma-for-nasal-epinephrine-treatment 2019-10-21 23:44:09 daily 0.1 https://demo.pharmafocusasia.com/news/foamix-receives-fda-approval-of-amzeeq-topical-minocycline-treatment-for-millions-of-moderate-to-severe-acne-sufferers 2019-10-20 23:46:54 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-conduct-precautionary-voluntary-recall-of-zantac-otc-in-us-and-canada 2019-10-18 23:24:51 daily 0.1 https://demo.pharmafocusasia.com/news/teijin-and-neurosigma-enter-into-exclusive-license-agreement 2019-10-17 23:35:01 daily 0.1 https://demo.pharmafocusasia.com/news/simulations-plus-partners-with-large-pharmaceutical-company-to-develop-the-virtual-bioequivalence-trial-simulator-module 2019-10-17 23:28:21 daily 0.1 https://demo.pharmafocusasia.com/news/mycovia-pharmaceuticals-announces-partnership-with-gedeon-richter-to-commercialize-and-manufacture-vt-1161-for-recurrent-vulvovaginal-candidiasis 2019-10-16 23:30:04 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-enters-into-dna-encoded-library-based-drug-discovery-research-collaboration-with-galapagos-nv 2019-10-16 23:28:04 daily 0.1 https://demo.pharmafocusasia.com/news/windmil-therapeutics-and-university-of-california-irvine-announce-collaboration-to-collect-bone-marrow-from-patients-with-gliomas 2019-10-15 23:23:17 daily 0.1 https://demo.pharmafocusasia.com/news/crispr-therapeutics-and-ksq-therapeutics-announce-license-agreement-to-advance-companies-respective-cell-therapy-programs-in-oncology 2019-10-15 23:00:16 daily 0.1 https://demo.pharmafocusasia.com/news/novigenix-and-radiomedix-to-develop-neuroendocrine-cancer-precision-diagnostic-test 2019-10-14 23:30:01 daily 0.1 https://demo.pharmafocusasia.com/news/pharmacyte-biotech-successfully-completes-manufacturing-of-clinical-trial-product 2019-10-14 23:25:55 daily 0.1 https://demo.pharmafocusasia.com/news/shionogi-enters-into-a-new-license-agreement-and-research-collaboration-for-the-treatment-of-mycobacterial-diseases-with-hsiri-therapeutics-inc 2019-10-13 23:30:42 daily 0.1 https://demo.pharmafocusasia.com/news/advaxis-and-ucla-enter-collaboration-for-glioblastoma-immunotherapy-discovery-research 2019-10-10 22:51:27 daily 0.1 https://demo.pharmafocusasia.com/news/neumentum-enters-into-global-licensing-agreement-for-a-novel-class-of-investigational-pain-treatments 2019-10-10 22:50:22 daily 0.1 https://demo.pharmafocusasia.com/news/correcting-and-replacing-virtrial-awarded-fda-approved-decentralized-clinical-trial-with-hope-biosciences 2019-10-09 22:42:50 daily 0.1 https://demo.pharmafocusasia.com/news/viela-bio-enters-strategic-collaboration-with-mitsubishi-tanabe-pharma-to-develop-and-commercialize-inebilizumab-for-autoimmune-diseases-in-japan-and-other-asia-regions 2019-10-09 22:08:10 daily 0.1 https://demo.pharmafocusasia.com/news/prevail-therapeutics-and-lonza-establish-strategic-collaboration-to-develop-and-manufacture-prevails-novel-aav9-gene-therapy-programs 2019-10-08 23:44:16 daily 0.1 https://demo.pharmafocusasia.com/news/4d-pharma-collaborates-with-msd-to-develop-live-biotherapeutic-products-for-vaccines 2019-10-08 23:32:34 daily 0.1 https://demo.pharmafocusasia.com/news/prometheus-biosciences-inc-enters-into-multi-target-strategic-collaboration-with-takeda-to-develop-targeted-therapies-for-inflammatory-bowel-disease 2019-10-03 23:34:46 daily 0.1 https://demo.pharmafocusasia.com/news/goldfinch-bio-announces-licensing-agreement-with-takeda-for-cb1-monoclonal-antibody-for-the-treatment-of-rare-and-metabolic-kidney-diseases 2019-10-03 23:23:13 daily 0.1 https://demo.pharmafocusasia.com/news/xylyx-bio-announces-development-of-disease-specific-cell-culture-products-to-accelerate-anti-fibrotic-drug-discovery-and-screening 2019-10-02 23:40:48 daily 0.1 https://demo.pharmafocusasia.com/news/cellular-biomedicine-group-announces-new-facility-to-expand-research-and-development-and-to-support-clinical-development 2019-10-02 23:39:59 daily 0.1 https://demo.pharmafocusasia.com/news/chimerix-announces-exclusive-global-license-agreement-with-symbio-pharmaceuticals-for-brincidofovir 2019-09-30 23:34:12 daily 0.1 https://demo.pharmafocusasia.com/news/ocugen-and-cansinobio-enter-strategic-partnership-for-gene-therapy-co-development-and-manufacturing 2019-09-30 23:32:18 daily 0.1 https://demo.pharmafocusasia.com/news/currax-pharmaceuticals-llc-announces-the-acquisition-of-nalpropion-pharmaceuticals 2019-09-30 00:08:29 daily 0.1 https://demo.pharmafocusasia.com/news/clover-biopharmaceuticals-doses-first-patient-in-phase-study-of-scb 2019-09-30 00:07:39 daily 0.1 https://demo.pharmafocusasia.com/news/catabasis-pharmaceuticals-and-the-jain-foundation-announce-a-preclinical-research-collaboration-to-study-edasalonexent-in-dysferlinopathy 2019-09-27 00:13:10 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-announces-mrna-immunotherapy-research-collaboration-with-harvard-university 2019-09-26 23:50:46 daily 0.1 https://demo.pharmafocusasia.com/news/neucyte-licenses-promising-novel-compound-for-treatment-of-refractory-epilepsy-and-related-neurological-disorders 2019-09-26 01:16:11 daily 0.1 https://demo.pharmafocusasia.com/news/blade-therapeutics-expands-anti-fibrotic-pipeline-with-acquisition-of-atxco-and-its-autotaxin-inhibitor 2019-09-25 23:30:11 daily 0.1 https://demo.pharmafocusasia.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options 2019-09-24 23:31:48 daily 0.1 https://demo.pharmafocusasia.com/news/immunoprecises-talem-therapeutics-enters-into-an-loi-with-agonox-pharma-in-the-advancement-of-novel-immuno-oncology-therapeutics 2019-09-24 23:26:33 daily 0.1 https://demo.pharmafocusasia.com/news/anchiano-therapeutics-enters-into-an-exclusive-option-to-license-agreement-for-novel-pan-ras-inhibitor-and-pde10b-catenin-inhibitor-programs 2019-09-23 23:25:19 daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-biopharma-announces-clinical-collaboration-to-evaluate-tjc4-in-combination-with-keytruda 2019-09-23 23:23:26 daily 0.1 https://demo.pharmafocusasia.com/news/newron-pharmaceuticals-commercialization-partner-meiji-seika-together-with-eisai-announce-the-approval-of-safinamide-for-parkinsons-disease-in-japan 2019-09-22 23:27:46 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-partners-with-inflammasome-therapeutics-to-develop-novel-therapies-for-patients-with-retinal-diseases 2019-09-20 23:15:09 daily 0.1 https://demo.pharmafocusasia.com/news/y-trap-enters-collaboration-with-merck-kgaato-develop-novel-antibody-ligand-traps-for-immuno-oncology 2019-09-19 23:37:00 daily 0.1 https://demo.pharmafocusasia.com/news/allogene-therapeutics-enters-research-collaboration-directed-at-enhancing-future-cancer-immunotherapies 2019-09-19 23:27:14 daily 0.1 https://demo.pharmafocusasia.com/news/bioxcel-therapeutics-announces-bxcl501-program-initiative-for-prevention-and-treatment-of-acute-agitation-using-wearable-digital-devices 2019-09-18 23:34:18 daily 0.1 https://demo.pharmafocusasia.com/news/clene-nanomedicine-inc-announces-selection-of-cnm-au8-for-the-harvard-led-healey-als-platform-trial-a-clinical-trial-for-amyotrophic-lateral-sclerosis 2019-09-18 23:30:43 daily 0.1 https://demo.pharmafocusasia.com/news/ibios-collaboration-with-south-africas-azargen-biotechnologies-advances-to-next-stage 2019-09-17 23:55:53 daily 0.1 https://demo.pharmafocusasia.com/news/bioq-pharma-announces-partnership-with-avanos-medical 2019-09-17 23:44:03 daily 0.1 https://demo.pharmafocusasia.com/news/hansoh-pharma-and-atomwise-start-strategic-collaboration-on-ai-drug-discovery-for-multiple-therapeutic-areas 2019-09-16 23:27:26 daily 0.1 https://demo.pharmafocusasia.com/news/alivamab-discovery-services-announces-multi-target-agreement-with-janssen 2019-09-16 23:26:31 daily 0.1 https://demo.pharmafocusasia.com/news/akari-therapeutics-nomacopan-granted-us-orphan-drug-designation-for-bullous-pemphigoid 2019-09-16 00:16:58 daily 0.1 https://demo.pharmafocusasia.com/news/hansen-pharmaceuticals-and-atomwise-launch-strategic-collaboration-on-artificial-intelligence-drug-discovery-in-multiple-therapeutic-areas 2019-09-12 23:38:33 daily 0.1 https://demo.pharmafocusasia.com/news/castle-creek-pharmaceutical-holdings-announces-agreement-to-acquire-fibrocell 2019-09-12 23:26:01 daily 0.1 https://demo.pharmafocusasia.com/news/dance-biopharm-partners-with-dariohealth-to-expand-access-to-digital-therapeutics-platform-for-patients-with-chronic-diseases 2019-09-11 23:22:12 daily 0.1 https://demo.pharmafocusasia.com/news/hansoh-pharma-and-atomwise-launch-strategic-ai-drug-discovery-collaboration-for-multiple-therapeutic-areas 2019-09-11 23:18:00 daily 0.1 https://demo.pharmafocusasia.com/news/can-fite-enters-into-strategic-agreement-with-univo-pharmaceuticals-to-develop-cannabinoid-based-pharmaceuticals-and-assays 2019-09-10 23:27:09 daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-biopharma-and-junshi-biosciences-announce-collaboration-to-evaluate-tjd5-in-combination-with-toripalimab 2019-09-10 23:16:43 daily 0.1 https://demo.pharmafocusasia.com/news/flexion-therapeutics-and-xenon-pharmaceuticals-announce-flexions-acquisition-of-an-investigational-nav17-inhibitor-for-the-treatment-of-post-operative-pain 2019-09-09 23:39:40 daily 0.1 https://demo.pharmafocusasia.com/news/wize-pharma-enters-exclusive-license-agreement-for-ophthalmic-non-viral-gene-therapy-technology 2019-09-09 23:37:27 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-signs-agreement-with-lilly-oncology 2019-09-09 03:55:54 daily 0.1 https://demo.pharmafocusasia.com/news/ridgeback-biotherapeutics-lp-announces-receipt-of-breakthrough-therapy-designation-from-fda-for-mab114 2019-09-06 23:36:41 daily 0.1 https://demo.pharmafocusasia.com/news/american-brivision-announces-strategic-collaboration-with-biolite-japan 2019-09-06 00:16:49 daily 0.1 https://demo.pharmafocusasia.com/news/schrodinger-announces-expansion-of-multi-target-research-collaboration-with-takeda-and-achievement-of-first-significant-preclinical-milestone-in-lead-program 2019-09-06 00:12:43 daily 0.1 https://demo.pharmafocusasia.com/news/schrodinger-announces-collaboration-with-astrazeneca-to-deploy-advanced-computing-technology-for-drug-discovery 2019-09-04 23:18:21 daily 0.1 https://demo.pharmafocusasia.com/news/biomotiv-and-bristol-myers-squibb-form-strategic-partnership 2019-09-04 23:17:25 daily 0.1 https://demo.pharmafocusasia.com/news/velabs-therapeutics-announces-strategic-partnership-with-alytas-therapeutics-to-develop-a-novel-immune-based-therapy-for-obesity 2019-09-03 23:29:42 daily 0.1 https://demo.pharmafocusasia.com/news/cidara-therapeutics-and-mundipharma-form-strategic-partnership-to-develop-and-commercialize-rezafungin 2019-09-03 23:27:42 daily 0.1 https://demo.pharmafocusasia.com/news/helsinn-signs-exclusive-distribution-and-license-agreements-with-blanver-and-varifarma-for-pracinostat-in-south-america 2019-09-02 23:28:23 daily 0.1 https://demo.pharmafocusasia.com/news/valo-therapeutics-acquires-peptienv-technology-from-the-university-of-helsinki 2019-09-02 23:25:18 daily 0.1 https://demo.pharmafocusasia.com/news/darwinhealth-announces-a-scientific-collaboration-with-celgene-on-a-discovery-platform-in-systems-biology 2019-08-30 23:22:08 daily 0.1 https://demo.pharmafocusasia.com/news/la-jolla-pharmaceutical-company-receives-european-commission-approval-for-giapreza 2019-08-30 00:14:25 daily 0.1 https://demo.pharmafocusasia.com/news/european-commission-approves-roches-tecentriq-in-combination-with-abraxane-for-people-with-pd-l1-positive-metastatic-triple-negative-breast-cancer 2019-08-28 23:34:53 daily 0.1 https://demo.pharmafocusasia.com/news/adaptimmune-and-noile-immune-announce-agreement-to-develop-spear-t-cell-products-expressing-il-7-and-ccl19-as-a-next-generation-treatment 2019-08-28 23:16:35 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-and-ppd-form-strategic-collaboration-to-develop-innovative-therapeutics-for-oncology-and-immunology 2019-08-27 23:18:57 daily 0.1 https://demo.pharmafocusasia.com/news/machavert-pharmaceuticals-signs-exclusive-license-agreement-to-control-ral-gtpase-inhibitors-against-kras-cancers 2019-08-27 23:12:41 daily 0.1 https://demo.pharmafocusasia.com/news/zogenix-announces-acquisition-of-modis-therapeutics-inc 2019-08-26 23:24:23 daily 0.1 https://demo.pharmafocusasia.com/news/adc-therapeutics-and-freenome-enter-biomarker-development-collaboration 2019-08-26 23:17:50 daily 0.1 https://demo.pharmafocusasia.com/news/hotspot-therapeutics-announces-acquisition-of-macroceutics 2019-08-25 23:49:00 daily 0.1 https://demo.pharmafocusasia.com/news/iconic-therapeutics-signs-ophthalmology-option-agreement 2019-08-22 23:19:40 daily 0.1 https://demo.pharmafocusasia.com/news/enable-injections-enters-into-strategic-partnership-with-genentech-a-member-of-the-roche-group 2019-08-22 23:16:16 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-enters-a-licensing-agreement-with-lilly-to-develop-commercialize-a-novel-diabetes-medicine-in-china 2019-08-21 23:14:58 daily 0.1 https://demo.pharmafocusasia.com/news/enteris-biopharma-and-cara-therapeutics-enter-into-licensing-agreement-for-peptelligence-to-advance-development-of-oral-korsuva 2019-08-21 23:12:52 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharmaceuticals-expands-preclinical-pipeline-with-triple-reuptake-inhibitor-tnx-1600-for-the-treatment-of-ptsd 2019-08-20 23:47:14 daily 0.1 https://demo.pharmafocusasia.com/news/emendo-biotherapeutics-achieves-milestone-of-collaboration-with-takeda-for-its-omni-nuclease-program 2019-08-20 23:44:33 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-receives-fda-fast-track-designation-for-zika-vaccine-mrna-1893 2019-08-19 23:52:54 daily 0.1 https://demo.pharmafocusasia.com/news/mateon-enters-into-merger-agreement-with-pointr-data-to-leverage-disruptive-ai-technology-in-its-innovation-driven-quest-for-a-cure-of-cancer 2019-08-19 23:22:47 daily 0.1 https://demo.pharmafocusasia.com/news/xynomic-research-institute-has-successfully-designed-a-series-of-potent-ret-kinase-inhibitors 2019-08-18 23:33:33 daily 0.1 https://demo.pharmafocusasia.com/news/phio-pharmaceuticals-and-helmholtz-zentrum-munchen-to-collaborate-on-novel-targets 2019-08-15 23:27:09 daily 0.1 https://demo.pharmafocusasia.com/news/genecentric-therapeutics-acquires-select-immunogenomics 2019-08-15 23:16:20 daily 0.1 https://demo.pharmafocusasia.com/news/curevac-enters-into-an-exclusive-collaborative-research-agreement-for-discovery-research-in-mrna-based-lung-therapy-candidates 2019-08-13 23:35:42 daily 0.1 https://demo.pharmafocusasia.com/news/askbio-acquires-synpromics-ltd-and-expands-its-gene-therapy-technology-portfolio 2019-08-13 23:29:32 daily 0.1 https://demo.pharmafocusasia.com/news/oncologie-inc-announces-clinical-trial-collaboration-with-merck-to-evaluate-bavituximab-in-combination-with-keytruda 2019-08-12 23:25:41 daily 0.1 https://demo.pharmafocusasia.com/news/onconova-therapeutics-and-mission-bio-partner-to-advance-precision-oncology-clinical-trials-employing-single-cell-genomics 2019-08-12 23:22:02 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-acquires-bluerock-therapeutics-to-build-leading-position-in-cell-therapy 2019-08-09 00:30:38 daily 0.1 https://demo.pharmafocusasia.com/news/caladrius-biosciences-and-cognate-bioservices-establish-manufacturing-agreement-for-phase-3-confirmatory-pivotal-clinical-trial-of-clbs14 2019-08-07 23:24:50 daily 0.1 https://demo.pharmafocusasia.com/news/vesselon-acquires-fda-approved-lipid-microsphere-drug-imagent-for-therapeutic-platform 2019-08-07 23:18:03 daily 0.1 https://demo.pharmafocusasia.com/news/aquinox-pharmaceuticals-and-neoleukin-therapeutics-announce-merger-agreement 2019-08-06 23:43:02 daily 0.1 https://demo.pharmafocusasia.com/news/adc-therapeutics-and-sophia-genetics-partner-for-biomarker-discovery-in-pivotal-phase-ii-clinical-trial 2019-08-06 23:14:01 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-and-shenogen-announce-collaboration-to-evaluate-tyvyt-sintilimab-injection-in-combination-with-sng1005-for-the-treatment-of-patients-with-advanced-cancer 2019-08-05 23:39:05 daily 0.1 https://demo.pharmafocusasia.com/news/neuropore-therapies-and-benevolentai-enter-strategic-collaboration-to-discover-novel-therapeutics-through-the-application-of-artificial-intelligence 2019-08-05 23:10:50 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-and-german-cancer-research-center-enter-into-collaboration-and-option-agreement 2019-08-04 23:10:38 daily 0.1 https://demo.pharmafocusasia.com/news/harrow-health-forms-stowe-pharmaceuticals-subsidiary-to-develop-broad-spectrum-anti-microbial-ophthalmic-and-otic-therapeutics 2019-08-02 23:29:15 daily 0.1 https://demo.pharmafocusasia.com/news/rafael-pharmaceuticals-announces-expansion-into-austria-south-korea-and-spain-of-pivotal-phase-3-trial-of-cpi-613-in-patients 2019-08-01 23:48:15 daily 0.1 https://demo.pharmafocusasia.com/news/can-fite-signs-agreement-with-kyongbo-pharm-for-the-distribution-in-south-korea-of-piclidenoson-in-the-treatment-of-psoriasis 2019-08-01 23:38:10 daily 0.1 https://demo.pharmafocusasia.com/news/niimbl-and-fda-sign-new-agreement-to-support-advanced-innovation-in-biopharmaceutical-manufacturing 2019-07-31 23:57:45 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-aurigene-enter-into-exclusive-collaboration-option-and-license-agreement-to-discover-and-develop-novel-therapies-for-cancer 2019-07-31 23:31:10 daily 0.1 https://demo.pharmafocusasia.com/news/medicinova-announces-mn-001-research-collaboration-with-the-national-cerebral-and-cardiovascular-disease-research-center 2019-07-31 00:07:12 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-acquisition-of-array-biopharma 2019-07-30 23:13:54 daily 0.1 https://demo.pharmafocusasia.com/news/biodesix-and-immodulon-announce-research-collaboration-for-pancreatic-cancer-treatment 2019-07-29 23:51:08 daily 0.1 https://demo.pharmafocusasia.com/news/tyme-technologies-announces-new-collaboration-with-nyu-langone-to-advance-tymes-cancer-metabolism-based-therapy-sm-88 2019-07-29 23:40:21 daily 0.1 https://demo.pharmafocusasia.com/news/alvotech-and-cipla-gulf-enter-into-a-partnership-for-the-commercialization-of-key-biosimilar-in-select-emerging-markets 2019-07-28 23:39:59 daily 0.1 https://demo.pharmafocusasia.com/news/gemphire-therapeutics-and-neurobo-pharmaceuticals-form-merger-agreement-to-establish-integrated-corporation-for-degenerative-disease-treatment 2019-07-28 23:37:08 daily 0.1 https://demo.pharmafocusasia.com/news/zambon-completes-transformational-acquisition-of-breath-therapeutics 2019-07-25 23:59:16 daily 0.1 https://demo.pharmafocusasia.com/news/biocardia-signs-exclusive-development-agreement-with-astrazeneca 2019-07-25 23:41:35 daily 0.1 https://demo.pharmafocusasia.com/news/aucta-pharmaceuticals-announces-licensing-of-vigabatrin-for-oral-solution-in-china 2019-07-24 23:35:49 daily 0.1 https://demo.pharmafocusasia.com/news/regenxbio-expands-pipeline-using-nav-vectors-to-deliver-therapeutic-antibodies-for-the-treatment-of-hereditary-angioedema-and-neurodegenerative-diseases 2019-07-24 23:18:41 daily 0.1 https://demo.pharmafocusasia.com/news/uman-diagnostics-and-bio-techne-announce-license-and-supply-agreement-for-neurofilament-light-assay 2019-07-23 23:42:38 daily 0.1 https://demo.pharmafocusasia.com/news/opiant-pharmaceuticals-expands-partnership-with-sanofi-signs-agreement-for-manufacturing-opnt004-for-treatment-of-acute-cannabinoid-overdose 2019-07-23 23:21:36 daily 0.1 https://demo.pharmafocusasia.com/news/innovation-pharmaceuticals-announces-license-agreement-with-alfasigma-spa-for-the-development-and-commercialization-of-brilacidin 2019-07-22 23:30:04 daily 0.1 https://demo.pharmafocusasia.com/news/avalon-globocare-and-ge-healthcare-announce-strategic-partnership-to-accelerate-standardized-automation-and-bio-production-for-cellular-medicines 2019-07-22 23:27:25 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-to-initiate-phase-ib-study-of-hqp1351-in-tyrosine-kinase-inhibitors-resistant-chronic-myeloid-leukemia-patients-in-the-us 2019-07-21 23:20:37 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-seeks-ema-approval-for-novel-subcutaneous-formulation-of-darzalex-daratumumab 2019-07-20 00:13:46 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-expands-idiopathic-pulmonary-fibrosis-ipf-pipeline-through-collaboration-and-license-agreement-with-bridge-biotherapeutics 2019-07-18 23:27:48 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-and-silence-therapeutics-announce-collaboration-to-develop-and-commercialize-rnai-therapeutics-for-complement-mediated-diseases 2019-07-18 23:19:48 daily 0.1 https://demo.pharmafocusasia.com/news/anixa-biosciences-announces-a-strategic-alliance-and-licensing-agreement-with-cleveland-clinic 2019-07-17 23:18:18 daily 0.1 https://demo.pharmafocusasia.com/news/puretech-acquires-new-clinical-stage-program-lyt-100-to-treat-lymphedema 2019-07-17 23:17:19 daily 0.1 https://demo.pharmafocusasia.com/news/epistem-licence-hubrecht-organoid-technology-to-expand-pre-clinical-toxicology-service-portfolio 2019-07-16 23:33:40 daily 0.1 https://demo.pharmafocusasia.com/news/convelo-therapeutics-enters-into-collaboration-and-option-to-acquire-agreement-with-genentech-to-discover-novel-remyelinating-therapies 2019-07-16 23:22:47 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-inc-expands-working-relationship-with-the-george-washington-university 2019-07-15 23:22:59 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-enhances-early-stage-oncology-pipeline-with-acquisition-of-mavupharma 2019-07-15 23:20:18 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-galapagos-enter-into-transformative-research-and-development-collaboration 2019-07-14 23:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-launches-ezallor-sprinkle-rosuvastatin-in-the-us-for-people-who-have-difficulty-swallowing 2019-07-14 23:17:39 daily 0.1 https://demo.pharmafocusasia.com/news/forty-seven-inc-and-ono-pharmaceutical-co-ltd-sign-regional-license-agreement-to-develop-manufacture-and-commercialize-5f9 2019-07-11 23:23:42 daily 0.1 https://demo.pharmafocusasia.com/news/ivy-brain-tumor-center-and-karyopharm-therapeutics-collaborate-to-develop-tissue-based-clinical-trial-for-brain-cancer 2019-07-11 23:17:49 daily 0.1 https://demo.pharmafocusasia.com/news/altimmune-signs-definitive-agreement-to-acquire-spitfire-pharma-inc-adding-nash-drug-candidate-to-portfolio 2019-07-10 23:30:16 daily 0.1 https://demo.pharmafocusasia.com/news/macrogenics-and-i-mab-announce-exclusive-collaboration-and-license-agreement-to-develop-and-commercialize-enoblituzumab-in-greater-china 2019-07-10 23:17:12 daily 0.1 https://demo.pharmafocusasia.com/news/imaginab-announces-collaboration-on-cd8-imaging-agent-with-roche 2019-07-09 23:18:16 daily 0.1 https://demo.pharmafocusasia.com/news/mirati-announces-clinical-collaboration-to-evaluate-mrtx849-in-combination-with-shp2-inhibitor-tno155 2019-07-09 23:17:02 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-and-sq-innovation-enter-into-exclusive-worldwide-captisol-license-and-supply-agreements-for-high-concentration-furosemide-formulation 2019-07-08 23:42:25 daily 0.1 https://demo.pharmafocusasia.com/news/lyndra-therapeutics-and-gilead-sciences-to-collaborate-on-development-of-ultra-long-acting-hiv-therapeutics 2019-07-08 23:34:19 daily 0.1 https://demo.pharmafocusasia.com/news/priority-review-granted-to-beigenes-supplemental-new-drug-application-in-china-for-tislelizumab-in-urothelial-carcinoma 2019-07-07 23:23:31 daily 0.1 https://demo.pharmafocusasia.com/news/cyxone-submits-first-application-to-start-clinical-phase-iib-trial-with-rabeximod 2019-07-05 23:25:59 daily 0.1 https://demo.pharmafocusasia.com/news/china-sxt-pharmaceuticals-inc-announces-tcm-homologous-supplements-production 2019-07-04 01:18:57 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-and-grupo-rph-sign-latam-manufacturing-and-distribution-agreement 2019-07-02 23:22:25 daily 0.1 https://demo.pharmafocusasia.com/news/asieris-and-photocure-enter-into-a-license-agreement 2019-07-02 23:20:48 daily 0.1 https://demo.pharmafocusasia.com/news/abveris-and-harbour-antibodies-h2l2-bv-announce-technology-co-offering-agreement-for-fully-human-antibody-discovery 2019-07-01 23:23:22 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-announces-strategic-gene-therapy-licensing-agreement-with-odylia-therapeutics 2019-07-01 23:15:56 daily 0.1 https://demo.pharmafocusasia.com/news/just-biotherapeutics-and-teva-enter-an-agreement-for-the-design-and-development-of-a-high-productivity-biomanufacturing-process 2019-06-30 23:27:10 daily 0.1 https://demo.pharmafocusasia.com/news/aucta-pharmaceuticals-announces-licensing-for-lamotrigine-new-drug-application 2019-06-27 23:28:17 daily 0.1 https://demo.pharmafocusasia.com/news/terns-pharmaceuticals-announces-exclusive-licensing-and-collaboration-agreement-with-genfy-for-development-and-commercialization-of-elafibranol 2019-06-27 23:24:55 daily 0.1 https://demo.pharmafocusasia.com/news/rafael-pharmaceuticals-enters-into-out-licensing-agreement-with-ono-pharmaceutical 2019-06-26 23:42:16 daily 0.1 https://demo.pharmafocusasia.com/news/liquidia-and-gsk-restructure-collaboration-agreement 2019-06-26 23:29:34 daily 0.1 https://demo.pharmafocusasia.com/news/tlc-announces-development-and-license-agreement-with-birdie-biopharmaceuticals-for-nanox-immunotherapy-product 2019-06-25 23:31:17 daily 0.1 https://demo.pharmafocusasia.com/news/intensity-therapeutics-announces-clinical-collaboration-with-merck 2019-06-25 23:20:08 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-carna-biosciences-announce-research-and-development-collaboration-to-develop-novel-immuno-oncology-therapies 2019-06-25 01:57:06 daily 0.1 https://demo.pharmafocusasia.com/news/c4x-discovery-and-phoremost-collaboration-to-accelerate-parkinsons-disease-drug-discovery-pipeline 2019-06-25 01:44:36 daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-pharmaceuticals-receives-orphan-drug-designation-for-aro-apoc3 2019-06-24 00:06:28 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-to-expand-integrated-biologics-conjugation-solution-center-to-include-commercial-manufacturing 2019-06-21 00:02:46 daily 0.1 https://demo.pharmafocusasia.com/news/ultragenyx-and-arcturus-therapeutics-expand-existing-research-collaboration-and-license-agreement 2019-06-19 23:22:56 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-nurix-establish-strategic-collaboration-to-develop-novel-therapies-for-cancer-and-other-diseases 2019-06-19 23:20:53 daily 0.1 https://demo.pharmafocusasia.com/news/premier-inc-partners-with-pensiamo-inc-and-upmc-to-launch-ai-powered-pharmaceutical-supply-chain-solution 2019-06-18 23:23:09 daily 0.1 https://demo.pharmafocusasia.com/news/thermogenesis-receives-health-canada-approval-of-its-next-generation-axp-ii-system-for-cord-blood-processing 2019-06-18 23:22:15 daily 0.1 https://demo.pharmafocusasia.com/news/casi-pharmaceuticals-acquires-worldwide-rights-to-commercialize-anti-cd19-t-cell-therapy 2019-06-17 23:22:01 daily 0.1 https://demo.pharmafocusasia.com/news/halo-labs-to-expand-globally-and-acquire-bophelo-bioscience 2019-06-17 23:20:50 daily 0.1 https://demo.pharmafocusasia.com/news/theravance-biopharma-and-mylan-expand-yupelri-revefenacin-development-and-commercialization-agreement-to-include-china-and-adjacent-territories 2019-06-14 23:19:08 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-and-eczacibasi-monrol-sign-manufacturing-and-distribution-agreement 2019-06-13 23:38:38 daily 0.1 https://demo.pharmafocusasia.com/news/eton-pharmaceuticals-announces-licensing-of-lamotrigine-new-drug-application-and-provides-pipeline-update 2019-06-13 23:27:07 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-biomed-and-erasmus-mc-sign-mou-to-advance-next-generation-immuno-oncology-and-immunology-drug-discovery-and-clinical-development 2019-06-12 23:22:14 daily 0.1 https://demo.pharmafocusasia.com/news/x4-pharmaceuticals-and-invitae-announce-partnership-to-provide-no-cost-genetic-testing 2019-06-12 23:20:39 daily 0.1 https://demo.pharmafocusasia.com/news/biomx-licenses-novel-targets-for-liver-disease-phage-therapy-program-from-jsr-corporation-in-japan 2019-06-11 23:27:03 daily 0.1 https://demo.pharmafocusasia.com/news/genmab-signs-agreement-with-janssen-for-next-generation-cd38-antibody-hexabody-cd38 2019-06-11 23:25:10 daily 0.1 https://demo.pharmafocusasia.com/news/aptar-acquires-nanopharm-and-gateway-analytical-broadening-pharma-services-platform-to-accelerate-customer-drug-development 2019-06-11 00:01:40 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-to-begin-production-of-biolexa-therapeutic-for-upcoming-toxicology-and-clinical-trials 2019-06-10 23:57:15 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-and-bayer-announce-global-collaboration-to-evaluate-pd-l1-monoclonal-antibody-cs1001 2019-06-09 23:24:58 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-expands-into-new-disease-areas-and-enhances-gene-editing-capabilities-through-expanded-collaboration 2019-06-06 23:20:30 daily 0.1 https://demo.pharmafocusasia.com/news/innovation-pharmaceuticals-signs-agreement-for-advanced-oral-tablet-technology-in-treating-inflammatory-bowel-disease 2019-06-06 23:17:43 daily 0.1 https://demo.pharmafocusasia.com/news/abveris-and-tetragenetics-announce-antibody-discovery-collaboration 2019-06-05 23:55:50 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-announces-strategic-partnership-with-drug-delivery-expert-pharmain 2019-06-05 23:41:37 daily 0.1 https://demo.pharmafocusasia.com/news/enable-injections-enters-into-strategic-partnership-with-sanofi 2019-06-04 00:34:44 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-announces-collaboration-with-newomics-to-advance-disease-biomarker-validation 2019-06-04 00:34:01 daily 0.1 https://demo.pharmafocusasia.com/news/biocartis-and-kite-sign-agreement-for-development-of-assays-supporting-kites-therapies 2019-06-03 00:07:38 daily 0.1 https://demo.pharmafocusasia.com/news/modulus-discovery-announces-signing-of-research-data-transfer-agreement-with-astellas-pharma-inc 2019-05-30 23:27:53 daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-and-emory-winship-cancer-institute-to-collaborate-on-clinical-trial-using-advanced-imaging 2019-05-30 23:26:17 daily 0.1 https://demo.pharmafocusasia.com/news/unity-biotechnology-inc-and-ucsf-enter-exclusive-license-agreement-on-alpha-klotho-protein 2019-05-29 23:25:45 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-and-foundation-medicine-announce-global-collaboration 2019-05-29 23:19:07 daily 0.1 https://demo.pharmafocusasia.com/news/armas-and-micro-labs-announce-collaboration-to-launch-generic-injectables-to-us-market 2019-05-28 23:06:29 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-licensing-agreement-for-non-opioid-pain-asset-from-centrexion-therapeutics 2019-05-28 23:05:47 daily 0.1 https://demo.pharmafocusasia.com/news/calecimr-forms-a-major-partnership-with-menarini-asia-pacific 2019-05-27 23:42:22 daily 0.1 https://demo.pharmafocusasia.com/news/avexis-receives-fda-approval-for-zolgensma-the-first-and-only-gene-therap 2019-05-26 23:47:19 daily 0.1 https://demo.pharmafocusasia.com/news/aequus-to-supply-kensington-eye-institute-with-zepto-capsulotomy-system 2019-05-23 23:54:46 daily 0.1 https://demo.pharmafocusasia.com/news/trovagene-announces-research-collaboration-with-nektar-therapeutics 2019-05-23 23:42:34 daily 0.1 https://demo.pharmafocusasia.com/news/be-the-match-biotherapies-announces-strategic-collaboration-with-kiadis-pharma 2019-05-22 23:34:40 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-announces-argenx-has-selected-second-target-under-enhanze-technology-collaboration-and-license-agreement 2019-05-22 23:23:47 daily 0.1 https://demo.pharmafocusasia.com/news/gotham-therapeutics-and-zobio-achieve-significant-milestone-in-epitranscriptomic-drug-discovery-collaboration 2019-05-21 23:20:47 daily 0.1 https://demo.pharmafocusasia.com/news/merck-to-acquire-peloton-therapeutics-bolstering-oncology-pipeline 2019-05-21 23:19:36 daily 0.1 https://demo.pharmafocusasia.com/news/kazia-enters-clinical-collaboration-for-metastatic-brain-cancer-with-alliance-for-clinical-trials-in-oncology 2019-05-20 23:16:28 daily 0.1 https://demo.pharmafocusasia.com/news/personalis-enters-into-a-research-agreement-with-flx-bio-to-provide-comprehensive-tumor-immunogenomic-profiling-for-clinical-study 2019-05-20 23:15:04 daily 0.1 https://demo.pharmafocusasia.com/news/regenerx-partner-receives-patent-for-new-ophthalmic-formulation-of-thymosin-beta-4 2019-05-17 00:14:56 daily 0.1 https://demo.pharmafocusasia.com/news/intec-pharma-announces-research-collaboration-agreement-with-merck 2019-05-16 23:09:47 daily 0.1 https://demo.pharmafocusasia.com/news/cumberland-pharmaceuticals-signs-exclusive-licensing-agreement-for-distribution-in-china 2019-05-15 23:15:42 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-and-kymera-therapeutics-establish-strategic-collaboration-to-discover-and-develop-targeted-protein-degradation-medicines 2019-05-15 23:14:09 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-signs-term-sheet-with-zylo-therapeutics 2019-05-14 23:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-enters-its-first-zymelink-antibody-drug-conjugate-platform-licensing-agreement 2019-05-14 23:13:11 daily 0.1 https://demo.pharmafocusasia.com/news/titan-pharmaceuticals-further-expands-patient-access-to-probuphine-via-product-purchase-and-supply-agreement 2019-05-13 23:36:28 daily 0.1 https://demo.pharmafocusasia.com/news/onconova-therapeutics-announces-license-agreement-with-hanx-biopharmaceuticals 2019-05-13 23:14:08 daily 0.1 https://demo.pharmafocusasia.com/news/forty-seven-inc-and-acerta-enter-collaboration-to-evaluate-novel-immuno-oncology-triple-combination 2019-05-12 23:19:46 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-invests-150-million-to-build-new-cell-culture-technology-center-in-berkeley 2019-05-10 00:13:58 daily 0.1 https://demo.pharmafocusasia.com/news/c3j-therapeutics-and-ampliphi-biosciences-announce-successful-completion 2019-05-09 23:52:26 daily 0.1 https://demo.pharmafocusasia.com/news/adimab-expands-research-agreement-with-regeneron 2019-05-09 03:27:13 daily 0.1 https://demo.pharmafocusasia.com/news/adimab-announces-multi-target-expansion-for-the-discovery-of-antibodies-with-another-global-pharma-partner 2019-05-09 01:49:52 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-apptec-acquires-pharmapace-to-enhance-biometrics-services-for-clinical-development 2019-05-05 23:47:20 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-syapse-enter-precision-medicine-collaboration-in-oncology 2019-05-02 23:35:11 daily 0.1 https://demo.pharmafocusasia.com/news/arcus-biosciences-and-strata-oncology-announce-clinical-development-collaboration 2019-05-02 23:34:04 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-and-numab-announce-exclusive-regional-licensing-agreement-for-nd021 2019-05-01 23:26:30 daily 0.1 https://demo.pharmafocusasia.com/news/tmunity-and-uc-san-francisco-announce-exclusive-license-and-research-collaboration 2019-05-01 23:25:35 daily 0.1 https://demo.pharmafocusasia.com/news/vivera-pharmaceuticals-licenses-tabmelt-a-sublingual-pharmaceutical-drug-delivery-system 2019-04-30 23:40:01 daily 0.1 https://demo.pharmafocusasia.com/news/sandoz-enters-agreement-for-proposed-trastuzumab-biosimilar 2019-04-30 23:26:21 daily 0.1 https://demo.pharmafocusasia.com/news/canopy-biosciences-acquires-zellkraftwerk-gmbh 2019-04-29 23:20:56 daily 0.1 https://demo.pharmafocusasia.com/news/eirgenix-inc-enters-into-global-license-agreement-for-the-commercialization-of-its-biosimilar-drug-eg12014 2019-04-29 23:18:37 daily 0.1 https://demo.pharmafocusasia.com/news/cardinal-health-specialty-solutions-strengthens-cell-and-gene-therapy-offering 2019-04-28 23:23:41 daily 0.1 https://demo.pharmafocusasia.com/news/mateon-and-oncotelic-complete-their-merger-and-create-a-new-immuno-oncology-company-with-a-late-stage-clinical-asset-against-cancer-and-a-promising-product-pipeline 2019-04-25 23:45:12 daily 0.1 https://demo.pharmafocusasia.com/news/salix-enters-into-exclusive-license-agreement-with-mitsubishi-tanabe-pharma 2019-04-25 23:32:12 daily 0.1 https://demo.pharmafocusasia.com/news/adc-therapeutics-and-adagene-announce-license-agreement 2019-04-24 23:34:08 daily 0.1 https://demo.pharmafocusasia.com/news/urogen-pharma-announces-early-stage-feasibility-agreement-with-janssen 2019-04-23 23:44:55 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-avidity-biosciences-announce-licensing-and-research-collaboration 2019-04-23 23:29:18 daily 0.1 https://demo.pharmafocusasia.com/news/elpiscience-and-bio-techne-announce-strategic-collaboration 2019-04-22 23:30:36 daily 0.1 https://demo.pharmafocusasia.com/news/oakrum-pharma-and-biophore-announce-product-development-and-commercialization-partnership 2019-04-22 23:29:00 daily 0.1 https://demo.pharmafocusasia.com/news/tb-alliance-and-mylan-announce-global-collaboration 2019-04-20 03:34:00 daily 0.1 https://demo.pharmafocusasia.com/news/puretech-health-announces-collaboration-with-boehringer-ingelheim- daily 0.1 https://demo.pharmafocusasia.com/news/sk-biopharmaceuticals-and-twoxar-sign-collaboration-agreement-to-discover-and-develop-first-in-class-treatments daily 0.1 https://demo.pharmafocusasia.com/news/recro-pharma-announces-six-year-extension-of-license-and-supply-agreement daily 0.1 https://demo.pharmafocusasia.com/news/ms-pharma-announces-acquisition-of-genepharm-english- daily 0.1 https://demo.pharmafocusasia.com/news/allele-biotechnology-and-scm-lifescience-sign-a-joint-research-and-development-agreement- daily 0.1 https://demo.pharmafocusasia.com/news/eagle-pharmaceuticals-inc-expands-licensing-agreement-for-bendeka daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-laboratories-announces-acquisition-of-anda-portfolio daily 0.1 https://demo.pharmafocusasia.com/news/twist-bioscience-announces-antibody-optimization-agreement-with-pandion-therapeutics daily 0.1 https://demo.pharmafocusasia.com/news/moleculin-announces-agreement-with-emory-university-to-conduct-pediatric-brain-tumor-trial daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-biopharma-signs-agreement-for-clinical-research-of-tjd-in-combination-therapy daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-nbe-therapeutics-announce-a-complete-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/vifor-pharma-and-akebia-therapeutics-announce-expansion-of-licence-agreement daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-and-elektrofi-expand-partnership-to-co-develop-new-antibodies-with-the-aim-of-achieving-improvements daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-announces-clinical-collaboration-with-junshi-bioscience daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-nbe-therapeutics-announce-comprehensive-adc-development-and-manufacturing-partnership daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-partners-with-the-canadian-biotech-company-iprogen-biotech-to-develop-a-series-of-novel-adcs daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-biopharma-and-jiangsu-nhwa-pharmaceutical-announce-strategic-collaboration-agreement- daily 0.1 https://demo.pharmafocusasia.com/news/orgenesis-announces-collaboration-with-digilab- daily 0.1 https://demo.pharmafocusasia.com/news/roivant-and-sinovant-launch-cytovant-sciences-in-partnership-with-medigene- daily 0.1 https://demo.pharmafocusasia.com/news/editas-medicine-and-bluerock-therapeutics-enter-strategic-research-collaboration-and-cross-licensing-agreement- daily 0.1 https://demo.pharmafocusasia.com/news/cellgen-diagnostics-and-genomic-testing-cooperative-partner-to-establish-a-new-standard-in-co-development daily 0.1 https://demo.pharmafocusasia.com/news/clinigen-k-k-and-gc-pharma-announce-exclusive-licensing-agreement-in-japan 2019-04-04 00:19:10 daily 0.1 https://demo.pharmafocusasia.com/news/briacell-announces-clinical-trial-collaboration-agreement-with-incyte daily 0.1 https://demo.pharmafocusasia.com/news/xencor-and-astellas-enter-collaboration-for-novel-bispecific-antibody-program daily 0.1 https://demo.pharmafocusasia.com/news/puma-biotechnology-and-pierre-fabre-enter-into-an-exclusive-license-agreement daily 0.1 https://demo.pharmafocusasia.com/news/pulmatrix-enters-into-binding-term-sheet-with-cipla-technologies-llc-for-the-development-and-commercialization daily 0.1 https://demo.pharmafocusasia.com/news/novartis-to-acquire-ifm-tre-to-develop-first-in-class-nlrp-antagonist-portfolio-targeting-innate-immune-system daily 0.1 https://demo.pharmafocusasia.com/news/endonovo-therapeutics-announces-partnership-with-second-hospital daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-enhances-oncology-r-d-with-novel-macrodel-delivery-technology-via-acquisition-of-icd-therapeutics daily 0.1 https://demo.pharmafocusasia.com/news/barc-lab-and-owl-metabolomics-announce-strategic-partnership-on-deploying-metabolomic-technology-in-clinical-trials daily 0.1 https://demo.pharmafocusasia.com/news/phio-and-glycostem-to-collaborate-on-use-of-its-sd-rxrna-platform-and-glycostems-onkord-cell-therapy-products- daily 0.1 https://demo.pharmafocusasia.com/news/stridebio-and-takeda-sign-collaboration-and-license-agreement-to-advance-novel-gene-therapies daily 0.1 https://demo.pharmafocusasia.com/news/owc-pharmaceutical-research-corp-to-collaborate-with-sourasky-medical-center- daily 0.1 https://demo.pharmafocusasia.com/news/ose-immunotherapeutics-announces-new-research-collaboration-with-leon-berard-cancer-center daily 0.1 https://demo.pharmafocusasia.com/news/immuno-oncology-company-elicio-therapeutics-launches-with-novel-vaccine-immunotherapy- daily 0.1 https://demo.pharmafocusasia.com/news/transgene-and-bioinvent-extend-their-collaboration-to-develop-multifunctional-oncolytic-viruses daily 0.1 https://demo.pharmafocusasia.com/news/vect-horus-enters-into-collaboration-and-license-agreement daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-almirall-enter-dna-encoded-library-based-innovative-drug-discovery-research-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/sourcinglink-net-enters-into-an-exclusive-worldwide-licensing-agreement-with-nanosmart-pharmaceuticals- daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-therapeutics-announces-the-merger-of-scilex-and-semnur-to-create-a-global-leader daily 0.1 https://demo.pharmafocusasia.com/news/legochem-biosciences-and-takeda-enter-into-a-multi-target-research-collaboration-and-license-agreement daily 0.1 https://demo.pharmafocusasia.com/news/alexion-and-affibody-announce-partnership-to-co-develop-anti-fcrn-affibody-molecule daily 0.1 https://demo.pharmafocusasia.com/news/biologics-by-mckesson-expands-specialty-pharmacy-capabilities daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-secures-exclusive-option-to-acquire-gene-therapy-company-vivet-therapeutics daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-hemoshear-therapeutics-extend-exclusive-drug-discovery-partnership daily 0.1 https://demo.pharmafocusasia.com/news/petra-pharma-announces-licensing-agreement-with-takeda-pharmaceutical-company daily 0.1 https://demo.pharmafocusasia.com/news/merck-collaborates-with-genscript-to-accelerate-the-industrialization-of-cellular-and-genetic-therapies 2019-04-17 03:18:37 daily 0.1 https://demo.pharmafocusasia.com/news/eastgate-biotech-signs-strategic-alliance-agreement-with-mj-biopharm-for-insulin-api-supply 2019-04-17 03:18:35 daily 0.1 https://demo.pharmafocusasia.com/news/napajen-pharma-and-astellas-pharma-establish-research-collaboration- 2019-04-17 03:18:34 daily 0.1 https://demo.pharmafocusasia.com/news/ono-pharmaceutical-and-twoxar-announce-drug-discovery-research-collaboration 2019-04-17 03:18:31 daily 0.1 https://demo.pharmafocusasia.com/news/thea-and-olix-announce-collaboration-to-develop-rnai-therapies-for-the-treatment-of-amd 2019-04-17 03:18:30 daily 0.1 https://demo.pharmafocusasia.com/news/-blackstone-signs-definitive-agreement-to-acquire-ayumi-pharmaceutical 2019-04-17 03:18:28 daily 0.1 https://demo.pharmafocusasia.com/news/kitov-to-acquire-clinical-stage-candidate-cm-creating-a-transformational-immuno-oncology-company 2019-04-17 03:18:24 daily 0.1 https://demo.pharmafocusasia.com/news/flow-pharma-and-oncoy-community-collaborate-in-development-of-flowvaxtm-personalized-cancer-vaccine 2019-04-17 03:18:22 daily 0.1 https://demo.pharmafocusasia.com/news/hoth-therapeutics-enters-into-commercial-licensing-agreement-with-university-of-maryland 2019-04-17 03:18:20 daily 0.1 https://demo.pharmafocusasia.com/news/x-pharmaceuticals-completes-merger-with-arsanis 2019-04-17 03:18:18 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-sparc-enter-dna-encoded-library-based-innovative-drug-discovery-research-collaboration 2019-04-17 03:18:16 daily 0.1 https://demo.pharmafocusasia.com/news/secura-bio-acquires-global-rights-to-farydak 2019-04-17 03:18:14 daily 0.1 https://demo.pharmafocusasia.com/news/seres-therapeutics-announces-microbiome-immuno-oncology-focused-collaboration-with-astrazeneca 2019-04-17 03:18:12 daily 0.1 https://demo.pharmafocusasia.com/news/tenax-therapeutics-enrolls-first-patient-for-phase-pulmonary-hypertension-clinical-trial 2019-04-17 03:18:10 daily 0.1 https://demo.pharmafocusasia.com/news/xencor-announces-closing-of-research-collaboration-and-license-agreement-with-genentech 2019-04-17 03:18:08 daily 0.1 https://demo.pharmafocusasia.com/news/vitruvias-therapeutics-launches-shanghai-based-sinotherapeuticss-approved-version-of-propafenone 2019-04-17 03:18:06 daily 0.1 https://demo.pharmafocusasia.com/news/gtx-and-oncternal-therapeutics-enter-into-definitive-merger-agreement- daily 0.1 https://demo.pharmafocusasia.com/news/reform-biologics-announces-cooperation-agreement-with-astellas-pharma 2019-04-17 03:18:02 daily 0.1 https://demo.pharmafocusasia.com/news/ambrx-and-beigene-announce-global-research-and-development-collaboration 2019-04-17 03:18:00 daily 0.1 https://demo.pharmafocusasia.com/news/pacira-to-acquire-myoscience-adding-fda-approved-iovera 2019-04-17 03:17:58 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-announces-agreement-to-acquire-nightstar-therapeutics-to-establish-clinical-pipeline- 2019-04-17 03:17:56 daily 0.1 https://demo.pharmafocusasia.com/news/reform-biologics-announces-collaboration-agreement-with-astellas-pharma-inc- 2019-04-17 03:17:54 daily 0.1 https://demo.pharmafocusasia.com/news/medexus-enters-into-expanded-licensing-agreement-for-gliolan-in-canada 2019-04-17 03:17:52 daily 0.1 https://demo.pharmafocusasia.com/news/nantkwest-signs-worldwide-license-agreement-with-promab-biotechnologies- daily 0.1 https://demo.pharmafocusasia.com/news/-sbio-and-tlc-form-exclusive-partnership-to-commercialize-two-nanox 2019-04-17 03:17:48 daily 0.1 https://demo.pharmafocusasia.com/news/adorx-therapeutics-announces-collaboration-with-johnson-johnson-innovation 2019-04-17 03:17:47 daily 0.1 https://demo.pharmafocusasia.com/news/abpro-and-njcttq-enter-into-partnership-for-development- 2019-04-17 03:17:45 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-and-denali-therapeutics-sign-expanded-multi-year-multi-target-deal 2019-04-17 03:17:43 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-exercises-option-to-acquire-myonexus-therapeutics 2019-04-17 03:17:41 daily 0.1 https://demo.pharmafocusasia.com/news/genesis-drug-discovery-development-announces-operating-agreement- 2019-04-17 03:17:38 daily 0.1 https://demo.pharmafocusasia.com/news/selexis-sa-and-turgut-pharmaceuticals-expand-biosimilar-development-relationship-by-signing-two-commercial-license-agreements 2019-04-17 03:17:36 daily 0.1 https://demo.pharmafocusasia.com/news/imbrium-therapeutics-and-tetragenetics-announce-strategic-research-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/titan-pharmaceuticals-partners-with-alliancerx-walgreens-prime-specialty-pharmacy 2019-04-17 03:17:33 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-announces-collaboration-agreement-of-extracorporeal-photoapheresis- 2019-04-17 03:17:31 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-voyager-therapeutics-announce-collaboration-to-develop-vectorized-antibodies 2019-04-17 03:17:29 daily 0.1 https://demo.pharmafocusasia.com/news/morphic-therapeutic-enters-into-integrin-research-and-development-collaboration 2019-04-17 03:17:27 daily 0.1 https://demo.pharmafocusasia.com/news/torque-announces-clinical-trial-collaboration-with-merck 2019-04-17 03:17:25 daily 0.1 https://demo.pharmafocusasia.com/news/adial-pharmaceuticals-announces-partnership-with-catalent-to-package-and-distribute-adials-ad- 2019-04-17 03:17:23 daily 0.1 https://demo.pharmafocusasia.com/news/nanosphere-signs-definitive-licensing-agreement-in-oregon 2019-04-17 03:17:19 daily 0.1 https://demo.pharmafocusasia.com/news/aucta-pharmaceuticals-and-oakrum-pharma-announce-product-development 2019-04-17 03:17:17 daily 0.1 https://demo.pharmafocusasia.com/news/exicure-announces-license-and-development-agreement-with-dermelix-biotherapeutics 2019-04-17 03:17:15 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-partners-with-ares-genetics-to-advance-global-fight-against-antibiotic-resistant-pathogens 2019-04-17 03:17:13 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-sta-and-biolingus-sign-exclusive-technology-and-marketing-collaboration-for-sublingual-delivery 2019-04-17 03:17:11 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-announces-a-collaboration-with-chipscreen-biosciences-to-evaluate-the-combination-therapy 2019-04-17 03:17:09 daily 0.1 https://demo.pharmafocusasia.com/news/decipher-biosciences-announces-research-collaboration-with-dendreon- 2019-04-17 03:17:07 daily 0.1 https://demo.pharmafocusasia.com/news/nemus-bioscience-signs-agreement-with-pharmaceuticals-international-inc-to-develop-dosage-formulation 2019-04-17 03:17:05 daily 0.1 https://demo.pharmafocusasia.com/news/sk-biopharmaceuticals-and-arvelle-therapeutics-announce-agreement 2019-04-17 03:17:04 daily 0.1 https://demo.pharmafocusasia.com/news/abilita-bio-and-amgen-enter-into-a-multi-target-collaboration 2019-04-17 03:17:02 daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-biosys-expands-collaboration-with-sanofi-for-the-cns-treatment-area 2019-04-17 03:17:00 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-and-bayer-sign-exclusive-license-agreement-for-mob-in-europe 2019-04-17 03:16:58 daily 0.1 https://demo.pharmafocusasia.com/news/regenerxs-u-s-joint-venture-initiates-key-phase-dry-eye-clinical-trial-with-rgn- 2019-04-17 03:16:56 daily 0.1 https://demo.pharmafocusasia.com/news/-sbio-and-verseau-establish-global-clinical-development-collaboration 2019-04-17 03:16:54 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-amicus-sign-exclusive-manufacturing-partnership 2019-04-17 03:16:52 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-and-c-bridge-capital-to-develop-and-commercialize-next-generation-biosimilars 2019-04-17 03:16:50 daily 0.1 https://demo.pharmafocusasia.com/news/cstone-and-impact-therapeutics-clinical-collaboration-progresses-to-ind-filing-acceptance 2019-04-17 03:16:48 daily 0.1 https://demo.pharmafocusasia.com/news/cannabics-pharmaceuticals-and-wize-pharma-to-form-joint-venture 2019-04-17 03:16:46 daily 0.1 https://demo.pharmafocusasia.com/news/arrevus-finalizes-acquisition-of-fusidic-acid-from-melinta-therapeutics 2019-04-17 03:16:44 daily 0.1 https://demo.pharmafocusasia.com/news/novelion-therapeutics-subsidiary-enters-into-licensing-agreement 2019-04-17 03:16:42 daily 0.1 https://demo.pharmafocusasia.com/news/cellect-begins-collaboration-with-washington-university-in-preparation-for-first-u-s-clinical-trial-using-cellects-apograft 2019-04-17 03:16:40 daily 0.1 https://demo.pharmafocusasia.com/news/taiho-pharmaceutical-and-cullinan-oncology-establish-collaboration-to-develop-tas- 2019-04-17 03:16:39 daily 0.1 https://demo.pharmafocusasia.com/news/crescita-therapeutics-incll-and-tetra-natural-health-collaborate-to-enhance-transdermal-delivery-of-beta-caryophyllene 2019-04-17 03:16:37 daily 0.1 https://demo.pharmafocusasia.com/news/trevi-therapeutics-announces-license-agreements-for-use-of-nalbuphine-for-the-treatment-of-levodopa-induced-dyskinesia 2019-04-17 03:16:35 daily 0.1 https://demo.pharmafocusasia.com/news/genequantum-healthcare-and-mitro-biotech-enter-into-strategic-cooperation 2019-04-17 03:16:33 daily 0.1 https://demo.pharmafocusasia.com/news/fortress-biotech-announces-cael-strategic-partnership-with-alexion-pharmaceuticals 2019-04-17 03:16:31 daily 0.1 https://demo.pharmafocusasia.com/news/meiragtx-enters-into-strategic-collaboration-with-janssen-to-develop-and-commercialize-gene-therapy-treatments 2019-04-17 03:16:29 daily 0.1 https://demo.pharmafocusasia.com/news/invenra-and-warf-initiate-a-collaboration-to-discover-and-develop-novel-therapeutics 2019-04-17 03:16:27 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-and-caelum-biosciences-announce-collaboration-to-develop-targeted-therapy 2019-04-17 03:16:25 daily 0.1 https://demo.pharmafocusasia.com/news/repare-therapeutics-announces-a-strategic-partnership-agreement-with-ono-pharmaceutical-co-ltd- daily 0.1 https://demo.pharmafocusasia.com/news/cannassure-therapeutics-announces-strategic-partnership-with-cannika-holdings 2019-04-17 03:16:22 daily 0.1 https://demo.pharmafocusasia.com/news/wcg-partners-with-prudentia-group-to-enhance-drug-safety-in-clinical-development 2019-04-17 03:16:20 daily 0.1 https://demo.pharmafocusasia.com/news/facit-and-triphase-accelerator-announce-new-partnership-with-celgene 2019-04-17 03:16:18 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-discovery-and-rutgers-university-form-exclusive-partnership- 2019-04-17 03:16:16 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-pharma-l-p-and-alivio-therapeutics-enter-into-partnership-to-advance-alv- 2019-04-17 03:16:14 daily 0.1 https://demo.pharmafocusasia.com/news/q-biomed-technology-partner-mannin-research-enters-into-collaboration 2019-04-17 03:16:12 daily 0.1 https://demo.pharmafocusasia.com/news/olon-spa-acquires-capua-bioservices-spa 2019-04-17 03:16:10 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-to-acquire-antibody-generation-unit-of-mab-discovery 2019-04-17 03:16:08 daily 0.1 https://demo.pharmafocusasia.com/news/origenis-gmbh-announces-global-license-and-collaboration-agreement-with-expansion-therapeutics 2019-04-17 03:16:06 daily 0.1 https://demo.pharmafocusasia.com/news/b-mogen-biotechnologies-and-cytosen-therapeutics-partner-on-research-collaboration-to-develop-next-generation-natural-killer-cells daily 0.1 https://demo.pharmafocusasia.com/news/philogen-announces-drug-discovery-collaboration-with-johnson-johnson-innovation 2019-04-17 03:16:03 daily 0.1 https://demo.pharmafocusasia.com/news/gamida-cell-and-be-the-match-biotherapies-announce-strategic-collaboration 2019-04-17 03:16:01 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments 2019-04-17 03:15:59 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-pharmaceuticals-and-medison-pharma-partner-to-commercialize-iarn-therapeutics-in-israel 2019-04-17 03:15:56 daily 0.1 https://demo.pharmafocusasia.com/news/thyas-obtains-exclusive-rights-to-manufacture-induced-pluripotent-stem-cells-derived-killer-t-cells 2019-04-17 03:15:55 daily 0.1 https://demo.pharmafocusasia.com/news/obsidian-therapeutics-announces-strategic-collaboration-with-celgene-to-develop-novel-cell-therapies- daily 0.1 https://demo.pharmafocusasia.com/news/kyn-therapeutics-enters-into-global-strategic-collaboration-with-celgene 2019-04-17 03:15:48 daily 0.1 https://demo.pharmafocusasia.com/news/amag-pharmaceuticals-completes-acquisition-of-perosphere-pharmaceuticals 2019-04-17 03:15:46 daily 0.1 https://demo.pharmafocusasia.com/news/ablexis-announces-expansion-of-non-exclusive-perpetual-license-agreement 2019-04-17 03:15:44 daily 0.1 https://demo.pharmafocusasia.com/news/phoenix-molecular-designs-announces-collaboration-to-develop-diagnostic- 2019-04-17 03:15:42 daily 0.1 https://demo.pharmafocusasia.com/news/luye-pharma-reaches-strategic-partnership-with-astrazeneca-strengthens-commitment- 2019-04-17 03:15:40 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-and-alphamab-announce-strategic-collaboration-and-licensing-agreement-for-anti-pd-l- 2019-04-17 03:15:38 daily 0.1 https://demo.pharmafocusasia.com/news/bioharmony-therapeutics-and-boehringer-ingelheim-collaborate-to-advance-bacteriophage-lysin-therapeutics- daily 0.1 https://demo.pharmafocusasia.com/news/amarantus-announces-commercialization-partnership-with-idea-pharma-for-subsidiaries 2019-04-17 03:15:35 daily 0.1 https://demo.pharmafocusasia.com/news/sirion-biotech-and-denali-therapeutics-join-forces-to-develop-gene-therapies 2019-04-17 03:15:33 daily 0.1 https://demo.pharmafocusasia.com/news/absci-establishes-new-collaboration-with-sanofi 2019-04-17 03:15:31 daily 0.1 https://demo.pharmafocusasia.com/news/generex-biotechnology-completes-acquisition-of-olaregen-therapeutix-inc- 2019-04-17 03:15:29 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-announces-new-license-with-unity-biotechnology 2019-04-17 03:15:27 daily 0.1 https://demo.pharmafocusasia.com/news/fedora-pharmaceuticals-and-meiji-seika-pharma-sign-basic-agreement-to-establish-nacugen-therapeutics-inc-a-joint-venture 2019-04-17 03:15:25 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-and-md-anderson-cancer-center-announce-strategic-alliance 2019-04-17 03:15:23 daily 0.1 https://demo.pharmafocusasia.com/news/ampliphi-biosciences-and-c-j-therapeutics-agree-to-merge 2019-04-17 03:15:21 daily 0.1 https://demo.pharmafocusasia.com/news/adaptive-biotechnologies-to-enter-into-worldwide-collaboration-and-license-agreement-with-genentech 2019-04-17 03:15:20 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-and-click-therapeutics-collaborate-to-develop-and-commercialize-digital-therapeutics 2019-04-17 03:15:18 daily 0.1 https://demo.pharmafocusasia.com/news/flex-pharma-and-salarius-pharmaceuticals-announce-merger-agreement- 2019-04-17 03:15:16 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-and-arbor-biotechnologies-establish-collaboration-to-discover-novel-proteins 2019-04-17 03:15:14 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-plc-and-hemoshear-therapeutics-enter-into-exclusive-drug-discovery-collaboration 2019-04-17 03:15:12 daily 0.1 https://demo.pharmafocusasia.com/news/propanc-biopharma-commences-drug-discovery-research-collaboration 2019-01-03 00:24:31 daily 0.1 https://demo.pharmafocusasia.com/news/ironwood-and-allergan-announce-settlement-with-mylan-resolving-linzess 2019-04-17 03:15:09 daily 0.1 https://demo.pharmafocusasia.com/news/hjb-merges-with-mabspace-biosciences-to-form-transcenta-holding 2019-01-01 23:21:52 daily 0.1 https://demo.pharmafocusasia.com/news/adamis-pharmaceuticals-submits-new-drug-application- 2019-04-17 03:15:05 daily 0.1 https://demo.pharmafocusasia.com/news/inventisbio-and-betta-pharma-to-co-develop-novel-drug 2019-04-17 03:15:03 daily 0.1 https://demo.pharmafocusasia.com/news/hebrew-university-to-collaborate-with-kyorin 2019-04-17 03:15:01 daily 0.1 https://demo.pharmafocusasia.com/news/delcath-announces-commercial-licensing-agreement-for-chemosat 2019-04-17 03:14:59 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-and-abbvie-announce-partnership-to-develop-and-commercialize-novel-oncology-drug 2019-04-17 03:14:57 daily 0.1 https://demo.pharmafocusasia.com/news/recro-pharma-amends-iv-meloxicam-license-agreement-with-alkermes 2019-04-17 03:14:56 daily 0.1 https://demo.pharmafocusasia.com/news/windtree-therapeutics-and-cvie-therapeutics-announce-merger-to-create-a-global-acute-care-company 2019-04-17 03:14:54 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-agenus-enter-into-collaboration-to-develop-immuno-oncology-therapies 2019-04-17 03:14:52 daily 0.1 https://demo.pharmafocusasia.com/news/marken-and-trakcel-collaborate-to-serve-cell-and-gene-trials 2019-04-17 03:14:50 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-announces-strategic-collaboration-with-genor-biopharma 2019-04-17 03:14:48 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-aduro-biotech-announce-research-collaboration-and-license-agreement 2019-04-17 03:14:46 daily 0.1 https://demo.pharmafocusasia.com/news/bridge-biotherapeutics-signs-us-m-license-agreement-with-daewoong-pharmaceutical 2019-04-17 03:14:44 daily 0.1 https://demo.pharmafocusasia.com/news/delsitech-and-innovare-sign-licensing-agreement-for-the-development-of-a-long-acting-hiv-therapy 2019-04-17 03:14:42 daily 0.1 https://demo.pharmafocusasia.com/news/proteostasis-therapeutics-announces-global-license-agreement-with-genentech 2019-04-17 03:14:40 daily 0.1 https://demo.pharmafocusasia.com/news/kineta-enters-research-collaboration-and-license-agreement-with-pfizer 2019-04-17 03:14:38 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-and-incyte-announce-strategic-collaboration-and-licensing-agreement 2019-04-17 03:14:36 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-acquires-potenza-therapeutics 2019-04-17 03:14:35 daily 0.1 https://demo.pharmafocusasia.com/news/amag-pharmaceuticals-enters-into-definitive-merger-agreement 2019-04-17 03:14:33 daily 0.1 https://demo.pharmafocusasia.com/news/almirall-and-x-chem-announce-dermatology-focused-drug-discovery-collaboration 2019-04-17 03:14:31 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-ac-immune-announce-license-and-collaboration-agreement 2019-04-17 03:14:29 daily 0.1 https://demo.pharmafocusasia.com/news/oxforb-biotherapeutics-expands-its-strategic-collaboration-with-wuxi-biologics daily 0.1 https://demo.pharmafocusasia.com/news/vect-horus-announces-agreement-with-johnson-johnson-innovation- daily 0.1 https://demo.pharmafocusasia.com/news/genecentric-therapeutics-enters-bladder-cancer-research-collaboration-with-university-of-north-carolina 2019-04-17 03:14:24 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-mitsubishi-tanabe-pharma-enter-dna-encoded-library-based-innovative-drug-discovery-research-collaboration 2019-04-17 03:14:22 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-announced-exclusive-discovery-research-with-brii-biosciences 2019-04-17 03:14:20 daily 0.1 https://demo.pharmafocusasia.com/news/parexel-collaborates-with-eli-lilly-and-company 2019-04-17 03:14:15 daily 0.1 https://demo.pharmafocusasia.com/news/icagen-enters-into-collaboration-to-develop-and-commercialize-therapy 2019-04-17 03:14:13 daily 0.1 https://demo.pharmafocusasia.com/news/revance-announces-china-market-license-agreement-with-fosun-pharma-for-rt- 2019-04-17 03:14:11 daily 0.1 https://demo.pharmafocusasia.com/news/pluristem-therapeutics-enters-into-cell-thawing-device-license-agreement-with-chart-industries-inc- 2019-04-17 03:14:10 daily 0.1 https://demo.pharmafocusasia.com/news/scientist-com-partners-with-allele-biotech 2019-04-17 03:14:08 daily 0.1 https://demo.pharmafocusasia.com/news/sartorius-and-immunochina-partner-to-advance-immunotherapy-development 2019-04-17 03:14:06 daily 0.1 https://demo.pharmafocusasia.com/news/autolus-therapeutics-announces-update-on-its-novel-car-t-cell-program 2019-04-17 03:14:04 daily 0.1 https://demo.pharmafocusasia.com/news/tracon-pharmaceuticals-and-i-mab-biopharma-announce-strategic-partnerships 2019-04-17 03:14:02 daily 0.1 https://demo.pharmafocusasia.com/news/athenex-announces-license-agreement-with-pharmaessentia-for-oradoxel 2019-04-17 03:14:00 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-collaborates-with-autolus-on-antibody-discovery-project 2019-04-17 03:13:58 daily 0.1 https://demo.pharmafocusasia.com/news/coeptis-pharma-enters-into-agreement-to-acquire-elto-pharma 2019-04-17 03:13:56 daily 0.1 https://demo.pharmafocusasia.com/news/telix-and-nihon-medi-physics-to-collaborate-on-actinium-renal-cancer-therapeutics 2019-04-17 03:13:55 daily 0.1 https://demo.pharmafocusasia.com/news/generex-biotechnology-expands-medical-device-portfolio 2019-04-17 03:13:53 daily 0.1 https://demo.pharmafocusasia.com/news/aiping-pharmaceutical-strikes-ibuprofen-deal-with-xinhua-pharmaceutical 2019-04-17 03:13:51 daily 0.1 https://demo.pharmafocusasia.com/news/genentech-acquires-jecure-therapeutics 2019-04-17 03:13:49 daily 0.1 https://demo.pharmafocusasia.com/news/machavert-pharmaceuticals-unveils-new-bioactive-lipid-drug-candidate-for-cancer-treatment 2019-04-17 03:13:47 daily 0.1 https://demo.pharmafocusasia.com/news/vir-biotechnology-and-alnylam-pharmaceuticals-initiate-phase-study 2019-04-17 03:13:45 daily 0.1 https://demo.pharmafocusasia.com/news/fusion-antibodies-and-analytics-engines-to-incorporate-artificial-intelligence 2019-04-17 03:13:43 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-commenced-construction-of-biologics-innovation-center-in-shanghai 2019-04-17 03:13:42 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-biogen-enter-drug-discovery-research-collaboration 2019-04-17 03:13:40 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-announces-omniab-partnership-with-imetabolic-biopharma-corporation 2019-04-17 03:13:38 daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-and-pellepharm-announce-collaboration 2019-04-17 03:13:36 daily 0.1 https://demo.pharmafocusasia.com/news/ascletis-and-roche-enter-exclusive-pegasys-partnership-in-china-for-viral-hepatitis 2019-04-17 03:13:34 daily 0.1 https://demo.pharmafocusasia.com/news/roivant-sciences-and-intron-bio-sign-licensing-deal 2019-04-17 03:13:32 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharmaceuticals-acquires-worldwide-rights-to-four-products-from-boston-topicals 2019-04-17 03:13:30 daily 0.1 https://demo.pharmafocusasia.com/news/direct-biologics-llc-has-acquired-paisley-laboratories-llc 2019-04-17 03:13:29 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-epizyme-announce-worldwide-collaboration-to-develop-novel-epigenetic-oncology-therapies 2019-04-17 03:13:27 daily 0.1 https://demo.pharmafocusasia.com/news/psioxus-therapeutics-to-collaborate-with-the-parker-institute- daily 0.1 https://demo.pharmafocusasia.com/news/mission-therapeutics-and-abbvie-sign-dubs-collaboration- 2018-11-15 23:07:41 daily 0.1 https://demo.pharmafocusasia.com/news/agios-and-cstone-pharmaceuticals-announce-exclusive-collaboration-and-license-agreement 2019-04-17 03:13:22 daily 0.1 https://demo.pharmafocusasia.com/news/dragonfly-therapeutics-announces-the-expansion-of-its-strategic-collaboration-with-celgene- daily 0.1 https://demo.pharmafocusasia.com/news/grunenthal-acquires-averitas-pharma-and-establishes-commercial-footprint-in-the-us 2019-04-17 03:13:18 daily 0.1 https://demo.pharmafocusasia.com/news/enable-injections-enters-into-strategic-partnerships-with-ucb-and-apellis-pharmaceuticals 2019-04-17 03:13:17 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-pharmaceuticals-enters-exclusive-agreement-with-invo-bioscience 2019-04-17 03:13:15 daily 0.1 https://demo.pharmafocusasia.com/news/ziopharm-oncology-announces-immuno-oncology-clinical-supply-agreement-with-regeneron 2019-04-17 03:13:13 daily 0.1 https://demo.pharmafocusasia.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-children 2019-04-17 03:13:11 daily 0.1 https://demo.pharmafocusasia.com/news/strides-enters-into-strategic-partnership-with-suda-pharmaceuticals-for-the-us-market 2019-04-17 03:13:09 daily 0.1 https://demo.pharmafocusasia.com/news/vectura-group-announces-global-agreement-with-hikma daily 0.1 https://demo.pharmafocusasia.com/news/biotime-and-asterias-biotherapeutics-enter-into-definitive-merger-agreement 2019-04-17 03:13:06 daily 0.1 https://demo.pharmafocusasia.com/news/guided-therapeutics-announces-extension-of-distribution-agreement-for-eastern-europe-and-russia 2019-04-17 03:13:04 daily 0.1 https://demo.pharmafocusasia.com/news/brooklyn-immunotherapeutics-acquires-irx-therapeutics 2019-04-17 03:13:02 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-enters-collaboration-to-combine-pioneering-dna-technologies 2019-04-17 03:13:00 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-provention-bio-announce-co-development-collaboration-in-celiac-disease 2019-04-17 03:12:58 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-nextcure-announce-collaboration 2019-04-17 03:12:56 daily 0.1 https://demo.pharmafocusasia.com/news/pharmatech-associates-launches-international-contracting-and-services-company 2019-04-17 03:12:54 daily 0.1 https://demo.pharmafocusasia.com/news/numedii-announces-research-collaboration-with-leading-academic-research-institution- daily 0.1 https://demo.pharmafocusasia.com/news/pantherx-specialty-pharmacy-and-rxcrossroads-by-mckesson-collaborate- 2019-04-17 03:12:51 daily 0.1 https://demo.pharmafocusasia.com/news/strategic-cooperation-between-genequantum-healthcare-and-biocytogen 2019-04-17 03:12:49 daily 0.1 https://demo.pharmafocusasia.com/news/inflection-biosciences-announces-research-collaboration-with-md-anderson 2019-04-17 03:12:44 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-tango-therapeutics-announce-strategic-collaboration 2019-04-17 03:12:42 daily 0.1 https://demo.pharmafocusasia.com/news/puration-inc-confirms-cannabis-pharmaceutical-partnership-developments 2019-04-17 03:12:40 daily 0.1 https://demo.pharmafocusasia.com/news/pascal-biosciences-and-the-university-of-washington-enter-into-exclusive-license-agreement 2019-04-17 03:12:38 daily 0.1 https://demo.pharmafocusasia.com/news/distributed-bio-inc-announces-collaboration-with-h-biomedicine 2019-04-17 03:12:37 daily 0.1 https://demo.pharmafocusasia.com/news/rigel-pharmaceuticals-enters-collaboration-and-license-agreement-with-kissei-pharmaceutical-co-ltd- 2019-04-17 03:12:35 daily 0.1 https://demo.pharmafocusasia.com/news/bioasis-announces-xb-platform-technology-licensing-agreement-with-prothena 2019-04-17 03:12:33 daily 0.1 https://demo.pharmafocusasia.com/news/canntrust-expands-global-reach-and-access-to-asia-pacific-region 2019-04-17 03:12:31 daily 0.1 https://demo.pharmafocusasia.com/news/compact-imaging-collaborates-with-global-pharma-to-accelerate-development-of-home-monitor- 2019-04-17 03:12:29 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-and-distributed-bio-enter-exclusive-partnership 2019-04-17 03:12:27 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-and-leo-pharma-enter-into-bispecific-antibody-licensing-and-research-collaboration 2019-04-17 03:12:25 daily 0.1 https://demo.pharmafocusasia.com/news/mesoblast-expands-partnership-with-jcr-pharmaceuticals 2019-04-17 03:12:23 daily 0.1 https://demo.pharmafocusasia.com/news/canbridge-pharmaceutical-and-wuxi-biologics-enter-into-strategic-partnership 2019-04-17 03:12:22 daily 0.1 https://demo.pharmafocusasia.com/news/two-labs-acquires-pennside-partners-ltd- 2019-04-17 03:12:20 daily 0.1 https://demo.pharmafocusasia.com/news/orgenesis-announces-collaboration-with-hemogenyx 2019-04-17 03:12:18 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-pharma-l-p-enters-into-exclusive-option-agreement-to-acquire-spinethera-inc-and-its-non-opioid-product 2019-04-17 03:12:16 daily 0.1 https://demo.pharmafocusasia.com/news/lsk-biopharma-and-jiangsu-hengrui-medicine-announce-global-clinical-collaboration 2019-04-17 03:12:14 daily 0.1 https://demo.pharmafocusasia.com/news/natera-and-neon-therapeutics-announce-clinical-trial-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/orgenesis-announces-collaboration-with-immugenyx 2019-04-17 03:12:10 daily 0.1 https://demo.pharmafocusasia.com/news/foundation-medicine-announces-strategic-collaboration 2019-04-17 03:12:09 daily 0.1 https://demo.pharmafocusasia.com/news/endocyte-enters-into-agreement-to-be-acquired-by-novartis-ag-for-billion 2019-04-17 03:12:07 daily 0.1 https://demo.pharmafocusasia.com/news/meiragtx-enters-collaboration-with-johnson-johnson-innovation-to-develop-regulatable-gene-therapy-treatment 2019-04-17 03:12:05 daily 0.1 https://demo.pharmafocusasia.com/news/novan-extends-technical-production-capacity-and-reaches-agreement 2019-04-17 03:12:03 daily 0.1 https://demo.pharmafocusasia.com/news/hifibio-therapeutics-acquires-h-immune-therapeutics 2019-04-17 03:12:01 daily 0.1 https://demo.pharmafocusasia.com/news/aclaris-therapeutics-to-acquire-worldwide-rights-to-rhofade-from-allergan 2019-04-17 03:11:59 daily 0.1 https://demo.pharmafocusasia.com/news/the-menarini-group-announces-commercial-agreement 2019-04-17 03:11:57 daily 0.1 https://demo.pharmafocusasia.com/news/telix-and-anmi-expand-psma-imaging-partnership 2019-04-17 03:11:55 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-compugen-announce-clinical-collaboration 2019-04-17 03:11:53 daily 0.1 https://demo.pharmafocusasia.com/news/mundipharma-strengthens-position-as-a-leader-in-biosimilars 2019-04-17 03:11:51 daily 0.1 https://demo.pharmafocusasia.com/news/roslinct-and-reprocell-awarded-million 2019-04-17 03:11:49 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-enters-new-collaboration-with-partner 2019-04-17 03:11:47 daily 0.1 https://demo.pharmafocusasia.com/news/unicar-therapy-and-terumo-bct-collaborate-to-advance-car-t-cell-therapies 2019-04-17 03:11:45 daily 0.1 https://demo.pharmafocusasia.com/news/neurocrine-biosciences-and-jnana-therapeutics-enter-strategic-collaboration 2019-04-17 03:11:44 daily 0.1 https://demo.pharmafocusasia.com/news/novan-expands-nitric-oxide-dermatology-business-partnership 2019-04-17 03:11:42 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-therapeutics-enters-into-long-term-strategic-manufacturing-partnership 2019-04-17 03:11:40 daily 0.1 https://demo.pharmafocusasia.com/news/akcea-and-ionis-announce-approval-of-tegsedi-in-canada 2018-10-08 00:22:13 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-coordination-pharmaceuticals-ind-approval 2019-04-17 03:11:36 daily 0.1 https://demo.pharmafocusasia.com/news/acurx-pharmaceuticals-to-enter-clinical-trials-with-first-in-class-antibiotics 2019-04-17 03:11:34 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-announces-exclusive-worldwide-license-agreement-with-arrowhead-pharmaceuticals-to-develop-and-commercialize-a-new-treatment 2018-10-04 22:54:57 daily 0.1 https://demo.pharmafocusasia.com/news/boston-pharmaceuticals-acquires-three-novel-anti-infective-programs-from-novartis 2019-04-17 03:11:31 daily 0.1 https://demo.pharmafocusasia.com/news/inmed-pharmaceuticals-signs-agreement-with-the-national-research-council-of-canada 2019-04-17 03:11:29 daily 0.1 https://demo.pharmafocusasia.com/news/gb-sciences-drug-development-program-benefits-from-establishment-of-clear-pathway 2019-04-17 03:11:27 daily 0.1 https://demo.pharmafocusasia.com/news/cytosen-therapeutics-and-kbi-biopharma-enter-into-strategic-partnership 2019-04-17 03:11:25 daily 0.1 https://demo.pharmafocusasia.com/news/enesi-pharma-and-public-health-england-enter-r-d-collaboration 2019-04-17 03:11:23 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-genentechs-xolair-prefilled-syringe-formulation 2019-04-17 03:11:21 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-receives-an-approval-from-the-us-fda-to-initiate-clinical-trials 2019-04-17 03:11:19 daily 0.1 https://demo.pharmafocusasia.com/news/cellular-biomedicine-group-enters-into-strategic-licensing daily 0.1 https://demo.pharmafocusasia.com/news/dova-pharmaceuticals-and-salix-enter-into-exclusive-co-promotion-agreement 2019-04-17 03:11:13 daily 0.1 https://demo.pharmafocusasia.com/news/selexis-sa-and-hoba-therapeutics-team-up-to-advance-hobas 2019-04-17 03:11:11 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-to-acquire-syntimmune 2019-04-17 03:11:08 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-announces-drug-discovery- 2019-04-17 03:11:07 daily 0.1 https://demo.pharmafocusasia.com/news/tris-pharma-expands-adhd-portfolio-with-acquisition-of-nextwave-pharmaceuticals 2019-04-17 03:11:05 daily 0.1 https://demo.pharmafocusasia.com/news/cerveau-technologies-inc-signs-research-agreement-with-ionis-pharmaceuticals-inc 2019-04-17 03:11:03 daily 0.1 https://demo.pharmafocusasia.com/news/knight-therapeutics-and-jaguar-health-announce-strategic-partnership 2019-04-17 03:11:01 daily 0.1 https://demo.pharmafocusasia.com/news/mebias-discovery-receives-grant-from-nida 2019-04-17 03:10:59 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-announces-adcetris-approval-in-japan 2019-04-17 03:10:57 daily 0.1 https://demo.pharmafocusasia.com/news/cardurion-pharmaceuticals-announces-initiation-of-phase-study-of-crd- daily 0.1 https://demo.pharmafocusasia.com/news/emergex-enters-into-mou-with-brazil 2019-04-17 03:10:54 daily 0.1 https://demo.pharmafocusasia.com/news/adverum-biotechnologies-receives-fast-track-designation- 2019-04-17 03:10:52 daily 0.1 https://demo.pharmafocusasia.com/news/propanc-biopharma-enters-into-research-collaboration-agreement 2019-04-17 03:10:50 daily 0.1 https://demo.pharmafocusasia.com/news/valeo-pharma-and-besins-healthcare-announce-partnership-for-utrogestan-in-canada 2019-04-17 03:10:48 daily 0.1 https://demo.pharmafocusasia.com/news/leo-pharma-and-morphosys-expand-strategic-alliance 2019-04-17 03:10:46 daily 0.1 https://demo.pharmafocusasia.com/news/crispr-therapeutics-and-viacyte-announce-strategic-collaboration 2019-04-17 03:10:44 daily 0.1 https://demo.pharmafocusasia.com/news/samumed-and-united-therapeutics-announce-north-american-license-agreement 2019-04-17 03:10:42 daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-announces-approval-of-subcutaneous-formulation-of-trastuzumab 2019-04-17 03:10:40 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-to-acquire-bonti-adding-new-neurotoxin-programs-to-medical-aesthetics-pipeline 2019-04-17 03:10:39 daily 0.1 https://demo.pharmafocusasia.com/news/bioarctic-signs-a-research-agreement-with-brain-biomarker-solutions-in-gothenburg-ab 2019-04-17 03:10:37 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-acquires-all-viratherapeutics-shares 2019-04-17 03:10:35 daily 0.1 https://demo.pharmafocusasia.com/news/paragon-bioteck-reformulated-freshkote-prompting-eyevance-acquisition 2019-04-17 03:10:33 daily 0.1 https://demo.pharmafocusasia.com/news/casma-therapeutics-announces-partnership-with-fondazione-telethon-founder-of-the-telethon-institute-of-genetics-and-medicine 2019-04-17 03:10:31 daily 0.1 https://demo.pharmafocusasia.com/news/eyevance-pharmaceuticals-acquires-freshkote-lubricant-eye-drop-family-of-products 2019-04-17 03:10:29 daily 0.1 https://demo.pharmafocusasia.com/news/opiant-pharmaceuticals-inc-and-consort-medical-plc-announce-manufacturing-agreement 2019-04-17 03:10:27 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-inhibrx-enter-an-exclusive-partnership-for-gmp-manufacturing 2019-04-17 03:10:25 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-to-acquire-advanced-bioprocessing-business-from-bd 2019-04-17 03:10:23 daily 0.1 https://demo.pharmafocusasia.com/news/scilex-presents-ztlido-data-on-superior-adhesion-over-lidocaine-patch-formulation 2019-04-17 03:10:22 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-and-springworks-therapeutics-enter-into-global-clinical-collaboration 2019-04-17 03:10:20 daily 0.1 https://demo.pharmafocusasia.com/news/pliant-therapeutics-announces-research-collaboration- 2019-04-17 03:10:18 daily 0.1 https://demo.pharmafocusasia.com/news/acuitybio-and-cook-biotech-announce-agreements 2019-04-17 03:10:16 daily 0.1 https://demo.pharmafocusasia.com/news/amri-and-metrion-biosciences-collaborate-to-offer-ion-channel-drug-discovery-services 2019-04-17 03:10:14 daily 0.1 https://demo.pharmafocusasia.com/news/united-therapeutics-and-mannkind-announce-collaboration-for-pulmonary-hypertension-products 2019-04-17 03:10:12 daily 0.1 https://demo.pharmafocusasia.com/news/turnstone-biologics-and-the-la-jolla-institute-for-allergy-and-immunology-enter-into-strategic-collaboration 2019-04-17 03:10:10 daily 0.1 https://demo.pharmafocusasia.com/news/novellusdx-and-primetech-sign-an-exclusive-dealer-agreement-in-japan 2018-09-03 23:37:18 daily 0.1 https://demo.pharmafocusasia.com/news/olon-acquires-factory-in-india 2019-04-17 03:10:07 daily 0.1 https://demo.pharmafocusasia.com/news/aquestive-therapeutics-announces-tentative-fda-approval-for-sympazan 2019-04-17 03:10:05 daily 0.1 https://demo.pharmafocusasia.com/news/regenxbio-announces-pipeline-expansion 2019-04-17 03:10:03 daily 0.1 https://demo.pharmafocusasia.com/news/poxel-expands-metabolic-pipeline-through-strategic-acquisition-agreement-with-deuterx daily 0.1 https://demo.pharmafocusasia.com/news/patient-driven-gene-therapy-company-reflectionbio-receives-orphan-drug-designation 2019-04-17 03:10:00 daily 0.1 https://demo.pharmafocusasia.com/news/trovagene-announces-european-commission-grants-orphan-drug-designation-to-onvansertib-pcm-for-treatment-of-acute-myeloid-leukemia-in-europe 2019-04-17 03:09:58 daily 0.1 https://demo.pharmafocusasia.com/news/cycle-pharmaceuticals-receives-fda-approval 2019-04-17 03:09:56 daily 0.1 https://demo.pharmafocusasia.com/news/kbi-biopharma-bvba-opens-in-leuven-belgium 2019-04-17 03:09:54 daily 0.1 https://demo.pharmafocusasia.com/news/centogene-and-evotec-sign-global-strategic-partnership 2019-04-17 03:09:52 daily 0.1 https://demo.pharmafocusasia.com/news/strategia-holdings-announces-strategic-partnership-alliance 2019-04-17 03:09:50 daily 0.1 https://demo.pharmafocusasia.com/news/adverum-biotechnologies-receives-orphan-drug-designation 2019-04-17 03:09:49 daily 0.1 https://demo.pharmafocusasia.com/news/jw-pharmaceutical-signs-global-out-licensing-agreement daily 0.1 https://demo.pharmafocusasia.com/news/telix-pharmaceuticals-university-of-melbourne-and-peter-mac- 2019-04-17 03:09:42 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-successfully-completes-acquisition-of-agilis-biotherapeutics 2019-04-17 03:09:40 daily 0.1 https://demo.pharmafocusasia.com/news/revive-therapeutics-applies-to-fda-for-orphan-drug-designation-of-cannabidiol 2019-04-17 03:09:38 daily 0.1 https://demo.pharmafocusasia.com/news/onconova-therapeutics-announces-plan-for-expanding-rigosertib-clinical-trials 2018-08-23 00:16:10 daily 0.1 https://demo.pharmafocusasia.com/news/bertilimumab-granted-orphan-drug-designation 2019-04-17 03:09:34 daily 0.1 https://demo.pharmafocusasia.com/news/enigma-biomedical-group-and-invicro-sign-a-collaboration-agreement 2019-04-17 03:09:32 daily 0.1 https://demo.pharmafocusasia.com/news/and-platinum-pharmaceuticals-and-columbotech-global-strategic-cooperation 2019-04-17 03:09:31 daily 0.1 https://demo.pharmafocusasia.com/news/xeris-pharmaceuticals-and-ohsu-conducting-artificial-pancreas-clinical-trial 2019-04-17 03:09:29 daily 0.1 https://demo.pharmafocusasia.com/news/tolero-pharmaceuticals-announces-clinical-research-collaboration 2019-04-17 03:09:27 daily 0.1 https://demo.pharmafocusasia.com/news/biontech-signs-collaboration-agreement-with-pfizer 2019-04-17 03:09:25 daily 0.1 https://demo.pharmafocusasia.com/news/agex-therapeutics-acquires-technology-to-regulate-immune-tolerance 2019-04-17 03:09:23 daily 0.1 https://demo.pharmafocusasia.com/news/emalex-biosciences-acquires-psyadon-pharmaceuticals-to-develop-novel-treatment 2019-04-17 03:09:21 daily 0.1 https://demo.pharmafocusasia.com/news/stealth-biotherapeutics-expands-pipeline-advances-new-compound 2019-04-17 03:09:19 daily 0.1 https://demo.pharmafocusasia.com/news/medicure-announces-fda-approval 2019-04-17 03:09:17 daily 0.1 https://demo.pharmafocusasia.com/news/cancer-prevention-pharmaceuticals-completes-north-american-licensing-deal 2019-04-17 03:09:16 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-announces-acquisition-of-quethera 2019-04-17 03:09:14 daily 0.1 https://demo.pharmafocusasia.com/news/jhl-biotech-receives-positive-chmp-scientific-advice daily 0.1 https://demo.pharmafocusasia.com/news/ovascience-and-millendo-therapeutics-announce-merger 2019-04-17 03:09:10 daily 0.1 https://demo.pharmafocusasia.com/news/carolina-biooncology-enters-into-an-agreement-with-xcell-biosciences 2019-04-17 03:09:09 daily 0.1 https://demo.pharmafocusasia.com/news/ambys-medicines-and-takeda-announce-partnership-to-pioneer-first-in-class-therapies 2019-04-17 03:09:07 daily 0.1 https://demo.pharmafocusasia.com/news/synergy-pharmaceuticals-announces-license-agreement-with-luoxin-pharmaceutical-group 2019-04-17 03:09:05 daily 0.1 https://demo.pharmafocusasia.com/news/tanner-pharma-group-signs-distribution-agreement-with-nephcentric-llc 2019-04-17 03:09:03 daily 0.1 https://demo.pharmafocusasia.com/news/acadia-pharmaceuticals-and-neuren-pharmaceuticals-announce-exclusive-license-agreement 2019-04-17 03:09:01 daily 0.1 https://demo.pharmafocusasia.com/news/alteogen-gets-fda-approval-for-orphan-drug-designation 2019-04-17 03:08:59 daily 0.1 https://demo.pharmafocusasia.com/news/selumetinib-granted-orphan-designation-in-europe-for-neurofibromatosis-type- 2019-04-17 03:08:57 daily 0.1 https://demo.pharmafocusasia.com/news/salix-expands-microbiome-research-and-discovery-through-strategic-collaboration 2019-04-17 03:08:56 daily 0.1 https://demo.pharmafocusasia.com/news/tanner-pharma-group-signs-distribution-agreement-with-mannkind-corporation 2019-04-17 03:08:54 daily 0.1 https://demo.pharmafocusasia.com/news/akcea-therapeutics-and-ptc-therapeutics-collaborate-to-commercialize-two-rare-disease-drugs 2019-04-17 03:08:52 daily 0.1 https://demo.pharmafocusasia.com/news/qiagen-creates-collaboration-with-japans-largest-clinical-laboratory- 2019-04-17 03:08:50 daily 0.1 https://demo.pharmafocusasia.com/news/nutriband-inc-completes-acquisition-of-p-therapeutics-inc- 2019-04-17 03:08:48 daily 0.1 https://demo.pharmafocusasia.com/news/puma-biotechnology-files-new-drug-submission-for-nerlynx-in-canada 2019-04-17 03:08:46 daily 0.1 https://demo.pharmafocusasia.com/news/nektar-therapeutics-announces-new-drug-application 2019-04-17 03:08:44 daily 0.1 https://demo.pharmafocusasia.com/news/hifibio-therapeutics-signs-multi-target-antibody-discovery-agreement-with-takeda 2019-04-17 03:08:42 daily 0.1 https://demo.pharmafocusasia.com/news/kymab-announces-promising-results-from-initial-clinical-study-of-new-antibody-ky- 2019-04-17 03:08:40 daily 0.1 https://demo.pharmafocusasia.com/news/keytruda-is-the-first-anti-pd-therapy-approved-in-china 2019-04-17 03:08:38 daily 0.1 https://demo.pharmafocusasia.com/news/genprex-enters-agreement-with-the-university-of-texas-md-anderson-cancer-center 2019-04-17 03:08:37 daily 0.1 https://demo.pharmafocusasia.com/news/innovent-receives-ind-approval-to-initiate-clinical-trials-in-china daily 0.1 https://demo.pharmafocusasia.com/news/medisca-announces-exclusive-partnership-with-german-manufacturer-samix 2019-04-17 03:08:33 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-receives-u-s-fda-approval-of-orilissa 2019-04-17 03:08:31 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-tsinghua-university-announce-collaboration 2019-04-17 03:08:29 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-to-acquire-halo-pharma 2019-04-17 03:08:28 daily 0.1 https://demo.pharmafocusasia.com/news/adamis-pharmaceuticals-adds-sublingual-erectile-dysfunction-product-candidate 2019-04-17 03:08:25 daily 0.1 https://demo.pharmafocusasia.com/news/luye-pharma-well-positioned-for-cns-market-with-the-approval-of-a-new-indication 2019-04-17 03:08:24 daily 0.1 https://demo.pharmafocusasia.com/news/koutif-therapeutics-confirms-clinical-candidate-drug 2019-04-17 03:08:22 daily 0.1 https://demo.pharmafocusasia.com/news/enzyvant-announces-collaboration-with-perkinelmer-to-enable-diagnostic-testing-for-farber-disease 2019-04-17 03:08:20 daily 0.1 https://demo.pharmafocusasia.com/news/yisheng-biopharma-announces-opening-of-new-business-divisions 2019-04-17 03:08:18 daily 0.1 https://demo.pharmafocusasia.com/news/an-innovative-drug-for-alzheimers-disease-from-china-at-the-end-of-phase-clinical-trials 2019-04-17 03:08:14 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-revolution-medicines-launch-global-partnership 2019-04-17 03:08:12 daily 0.1 https://demo.pharmafocusasia.com/news/polyu-axis-therapeutics-joint-center-for-immunotherapy-launched-to-develop-innovative-cancer-treatments 2019-04-17 03:08:10 daily 0.1 https://demo.pharmafocusasia.com/news/rdd-pharma-announces-ind-clearance-to-advance-rdd-to-treat-fecal-incontinence-in-patients-with-spinal-cord-injury 2019-04-17 03:08:09 daily 0.1 https://demo.pharmafocusasia.com/news/advanced-proteome-therapeutics-announces-collaboration-with-noria-pharmaceuticals 2019-04-17 03:08:07 daily 0.1 https://demo.pharmafocusasia.com/news/nohla-therapeutics-receives-fda-orphan-drug-designation-for-dilanubicel-for-hematopoietic-stem-cell-transplant-patients 2019-04-17 03:08:04 daily 0.1 https://demo.pharmafocusasia.com/news/edge-pharmacy-services-bringing-new-unit-dose-pharmaceutical-products-to-canada 2019-04-17 03:08:02 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-the-first-drug-with-an-indication-for-treatment-of-smallpox 2019-04-17 03:08:00 daily 0.1 https://demo.pharmafocusasia.com/news/sirona-biochem-announces-cfda-approval-of-sglt-inhibitor-for-phase-i-clinical-trial 2019-04-17 03:07:58 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-pharmaceutical-to-acquire-visterra 2019-04-17 03:07:56 daily 0.1 https://demo.pharmafocusasia.com/news/cure-pharmaceutical-plans-to-acquire-cannabinoid-based-drug-pipeline-from-therapix-biosciences-ltd 2019-04-17 03:07:54 daily 0.1 https://demo.pharmafocusasia.com/news/sri-international-announces-drug-research-collaboration-with-ionis-pharmaceuticals 2019-04-17 03:07:52 daily 0.1 https://demo.pharmafocusasia.com/news/reata-receives-orphan-drug-designation-from-the-european-commission-for-omaveloxolone-for-the-treatment-of-friedreichs-ataxia 2019-04-17 03:07:50 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-adds-to-central-nervous-system-portfolio-with-launch-of-generic-exelon-patch 2019-04-17 03:07:48 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-launch-of-a-generic-version-of-uceris-in-the-united-states 2019-04-17 03:07:46 daily 0.1 https://demo.pharmafocusasia.com/news/obi-pharma-granted-fda-orphan-drug-designation-for-obi- 2019-04-17 03:07:43 daily 0.1 https://demo.pharmafocusasia.com/news/cleara-biotech-announces-three-collaborations-to-develop-new-therapeutics-targeting-senescent-cells-and-cancer 2019-04-17 03:07:41 daily 0.1 https://demo.pharmafocusasia.com/news/neovii-mundipharma-confirm-in-licensing-agreement-for-the-development-and-promotion-of-grafalon-r-in-china-and-japan 2019-04-17 03:07:39 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-biogen-announce-positive-topline-results-of-the-final-analysis-for-ban-at-months 2019-04-17 03:07:37 daily 0.1 https://demo.pharmafocusasia.com/news/theratechnologies-submits-novel-single-vial-formulation-of-egrifta-tesamorelin-for-injection-for-fda-approval 2019-04-17 03:07:35 daily 0.1 https://demo.pharmafocusasia.com/news/forendo-pharma-initiates-phase-i-study-for-potential-new-targeted-treatment-for-endometriosis 2019-04-17 03:07:33 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-xeomin-incobotulinumtoxina-for-adult-patients-with-sialorrhea 2019-04-17 03:07:31 daily 0.1 https://demo.pharmafocusasia.com/news/menarini-and-orion-sign-regional-partnerships-in-asia-pacific 2019-04-17 03:07:29 daily 0.1 https://demo.pharmafocusasia.com/news/ucb-announces-approval-of-neupro-in-china-to-treat-parkinsons-disease 2019-04-17 03:07:27 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-aristada-initio-for-the-initiation-of-aristada-for-schizophrenia 2019-04-17 03:07:25 daily 0.1 https://demo.pharmafocusasia.com/news/-adamis-pharmaceuticals-announces-distribution-and-commercialization-agreement-for-symjepi 2019-04-17 03:07:23 daily 0.1 https://demo.pharmafocusasia.com/news/owc-pharmaceutical-research-corp-completes-first-part-of-cannabis-based-ointment-safety-study 2019-04-17 03:07:21 daily 0.1 https://demo.pharmafocusasia.com/news/vyxeos-receives-positive-chmp-opinion-for-treatment-of-certain-types-of-high-risk-acute-myeloid-leukaemia 2019-04-17 03:07:19 daily 0.1 https://demo.pharmafocusasia.com/news/novaliqs-novatears-treatment-for-evaporative-dry-eye-disease-is-now-available-across-australia-and-new-zealand 2019-04-17 03:07:17 daily 0.1 https://demo.pharmafocusasia.com/news/redhill-announces-u-s-co-promotion-agreement-with-napo-pharmaceuticals-for-hiv-aids-anti-diarrheal-drug-mytesi 2019-04-17 03:07:15 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-pharma-l-p-announces-successful-completion-of-first-in-human-study-for-oncology-therapy-candidate-tinostamustine 2019-04-17 03:07:13 daily 0.1 https://demo.pharmafocusasia.com/news/nucleobio-concludes-preliminary-tests-for-new-drug-to-treat-aggressive-prostate-cancer 2019-04-17 03:07:11 daily 0.1 https://demo.pharmafocusasia.com/news/erimos-pharmaceuticals-announces-phase-i-oral-study-of-terameprocol-em- 2019-04-17 03:07:09 daily 0.1 https://demo.pharmafocusasia.com/news/isoplexis-announces-research-collaboration-with-nektar-therapeutics 2019-04-17 03:07:06 daily 0.1 https://demo.pharmafocusasia.com/news/roche-expands-access-to-the-diabetes-management-solution-mysugr-in-the-us-and-canada- daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-first-drug-comprised-of-an-active-ingredient-derived-from-marijuana-to-treat-rare-severe-forms-of-epilepsy 2019-04-17 03:07:03 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-harbour-biomed-announce-strategic-development-and-manufacturing-partnership 2019-04-17 03:07:01 daily 0.1 https://demo.pharmafocusasia.com/news/maat-pharma-and-lutech-sign-licensing-agreement-on-microbiome-therapy-for-graft-vs-host-disease 2019-04-17 03:06:58 daily 0.1 https://demo.pharmafocusasia.com/news/aquinnah-pharmaceuticals-receives-m-grant-from-ninds-to-advance-new-therapies-for-als 2019-04-17 03:06:56 daily 0.1 https://demo.pharmafocusasia.com/news/novacap-to-expand-its-pharmaceutical-offering-in-the-u-s-with-the-acquisition-of-pci-synthesis 2019-04-17 03:06:54 daily 0.1 https://demo.pharmafocusasia.com/news/neptune-announces-multi-year-agreement-with-canopy-growth-to-provide-extracted-cannabis-products 2019-04-17 03:06:52 daily 0.1 https://demo.pharmafocusasia.com/news/grifols-expands-its-nat-solutions-portfolio-with-new-fda-approvals-for-two-assays 2019-04-17 03:06:50 daily 0.1 https://demo.pharmafocusasia.com/news/anika-therapeutics-announces-top-line-results-from-cingal-clinical-trial-in-knee-osteoarthritis 2019-04-17 03:06:48 daily 0.1 https://demo.pharmafocusasia.com/news/clover-biopharmaceuticals-doses-first-patient-in-australia-in-phase-i-study-of-scb-for-malignant-ascites 2019-04-17 03:06:46 daily 0.1 https://demo.pharmafocusasia.com/news/acurastem-receives-fast-track-sbir-grant-for-the-development-of-a-novel-small-molecule-therapy-to-treat-als 2019-04-17 03:06:40 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-completes-resubmission-to-fda-for-proposed-trastuzumab-biosimilar 2019-04-17 03:06:38 daily 0.1 https://demo.pharmafocusasia.com/news/teva-provides-update-on-clinical-trial-of-fremanezumab-for-use-in-chronic-cluster-headache 2019-04-17 03:06:36 daily 0.1 https://demo.pharmafocusasia.com/news/apexigen-and-yale-cancer-center-announce-clinical-collaboration 2019-04-17 03:06:34 daily 0.1 https://demo.pharmafocusasia.com/news/acerus-announces-approval-of-natesto-in-south-korea 2019-04-17 03:06:32 daily 0.1 https://demo.pharmafocusasia.com/news/sage-therapeutics-and-shionogi-enter-strategic-collaboration 2019-04-17 03:06:30 daily 0.1 https://demo.pharmafocusasia.com/news/pharmacolog-ab-and-heliometrics-partner-to-provide-critcal-drug-diversion-solutions 2019-04-17 03:06:28 daily 0.1 https://demo.pharmafocusasia.com/news/artelo-biosciences-enters-into-global-rd-partnership 2019-04-17 03:06:26 daily 0.1 https://demo.pharmafocusasia.com/news/labcorp-expands-drug-development-solutions-with-acquisition-of-sciformix 2019-04-17 03:06:24 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-and-complement-pharma-announce-partnership 2019-04-17 03:06:22 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-to-invest-to-establish-biologics-production-facility 2019-04-17 03:06:19 daily 0.1 https://demo.pharmafocusasia.com/news/ironwood-pharmaceuticals-announces-fda-orphan-drug-designation 2019-04-17 03:06:17 daily 0.1 https://demo.pharmafocusasia.com/news/partner-therapeutics-announces-us-fda-approval-of-leukine 2019-04-17 03:06:15 daily 0.1 https://demo.pharmafocusasia.com/news/lakepharma-and-harbour-antibodies-announce-partnership 2019-04-17 03:06:13 daily 0.1 https://demo.pharmafocusasia.com/news/sensei-biotherapeutics-reports-new-data-from-phase-clinical-trial 2019-04-17 03:06:11 daily 0.1 https://demo.pharmafocusasia.com/news/blueprint-medicines-and-cstone-pharmaceuticals-announce-exclusiveagreement 2019-04-17 03:06:09 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-launches-bio-cdmo-business-for-the-development-of-new-drugs 2019-04-17 03:06:07 daily 0.1 https://demo.pharmafocusasia.com/news/viscus-biologics-introduces-new-solubilized-collagen-bioink 2019-04-17 03:06:05 daily 0.1 https://demo.pharmafocusasia.com/news/syndax-and-nektar-therapeutics-announce-immuno-oncology-clinical-trial-collaboration 2019-04-17 03:06:03 daily 0.1 https://demo.pharmafocusasia.com/news/forma-therapeutics-and-hitgen-initiate-multiyear-research-collaboration 2019-04-17 03:06:01 daily 0.1 https://demo.pharmafocusasia.com/news/cloud-pharmaceuticals-forms-drug-design-collaboration-with-gsk 2019-04-17 03:05:59 daily 0.1 https://demo.pharmafocusasia.com/news/five-prime-therapeutics-announces-collaboration-with-roche 2019-04-17 03:05:57 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership 2019-04-17 03:05:55 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-celgene-expand-ipsc-collaboration 2019-04-17 03:05:53 daily 0.1 https://demo.pharmafocusasia.com/news/braeburn-resubmits-new-drug-application 2019-04-17 03:05:50 daily 0.1 https://demo.pharmafocusasia.com/news/luye-pharma-acquires-astrazenecas-signature-products 2019-04-17 03:05:48 daily 0.1 https://demo.pharmafocusasia.com/news/beactica-signs-three-year-extension-agreement-with-sanofi 2019-04-17 03:05:46 daily 0.1 https://demo.pharmafocusasia.com/news/clinigen-signs-agreement-with-nordic-pharma-for-aprotinin 2019-04-17 03:05:44 daily 0.1 https://demo.pharmafocusasia.com/news/avara-pharmaceutical-services-acquires-major-sterile-manufacturing-facility 2019-04-17 03:05:42 daily 0.1 https://demo.pharmafocusasia.com/news/mabxience-and-amneal-enter-into-an-agreement-for-bevacizumab-biosimilar 2019-04-17 03:05:39 daily 0.1 https://demo.pharmafocusasia.com/news/centogene-announces-drug-development-collaboration-with-orphazyme 2019-04-17 03:05:37 daily 0.1 https://demo.pharmafocusasia.com/news/eurofins-expands-its-biopharmaceutical-agreement-with-astellas-in-japan 2019-04-17 03:05:35 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-celgene-enter-into-strategic-oncology-partnership 2019-04-17 03:05:33 daily 0.1 https://demo.pharmafocusasia.com/news/bioasis-and-wuxi-biologics-announce-initial-strategic-collaboration 2019-04-17 03:05:31 daily 0.1 https://demo.pharmafocusasia.com/news/shenzhen-salubris-pharmaceuticals-announces-agreement-with-medalliance 2019-04-17 03:05:29 daily 0.1 https://demo.pharmafocusasia.com/news/mundipharma-and-endoceutics-to-exclusively-license-intrarosa 2019-04-17 03:05:27 daily 0.1 https://demo.pharmafocusasia.com/news/pivot-signs-manufacturing-and-supply-agreement-with-stoney-llc 2019-04-17 03:05:25 daily 0.1 https://demo.pharmafocusasia.com/news/dipharma-francis-completes-acquisition-of-kalexsyn 2019-04-17 03:05:23 daily 0.1 https://demo.pharmafocusasia.com/news/emulate-and-astrazeneca-form-strategic-agreement 2019-04-17 03:05:22 daily 0.1 https://demo.pharmafocusasia.com/news/turnstone-biologics-announces-us-fda-acceptance 2019-04-17 03:05:20 daily 0.1 https://demo.pharmafocusasia.com/news/biolamina-and-novo-nordisk-partner 2019-04-17 03:05:18 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-to-acquire-aurka-pharma 2019-04-17 03:05:16 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-and-daiichi-sankyo-expand-immuno-oncology-collaboration 2019-04-17 03:05:14 daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-drug-fasenra-flops-in-copd-trial 2019-04-17 03:05:09 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-agreement-to-acquire-armo-biosciences 2019-04-17 03:05:07 daily 0.1 https://demo.pharmafocusasia.com/news/aquinox-and-astellas-announce-exclusive-licensing-agreement 2019-04-17 03:05:05 daily 0.1 https://demo.pharmafocusasia.com/news/lodo-therapeutics-collaboration-with-genentech 2019-04-17 03:05:03 daily 0.1 https://demo.pharmafocusasia.com/news/ascendia-pharmaceuticals-announces-product-development-collaboration 2019-04-17 03:05:02 daily 0.1 https://demo.pharmafocusasia.com/news/proposed-acquisition-of-shire-plc-by-takeda 2019-04-17 03:05:00 daily 0.1 https://demo.pharmafocusasia.com/news/lannett-acquires-portfolio-of-generic-products-from-endo-international 2019-04-17 03:04:58 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-and-invitae-expand-partnership-to-advance-clinical-research 2019-04-17 03:04:56 daily 0.1 https://demo.pharmafocusasia.com/news/lonza-to-invest-in-portsmouth-including-mid-scale-biologics 2019-04-17 03:04:54 daily 0.1 https://demo.pharmafocusasia.com/news/moderna-and-merck-expand-mrna-cancer-vaccines-collaboration 2019-04-17 03:04:52 daily 0.1 https://demo.pharmafocusasia.com/news/agc-biologics-enters-into-commercial-manufacturing-agreement-with-horizon-pharma 2019-04-17 03:04:50 daily 0.1 https://demo.pharmafocusasia.com/news/innomar-strategies-enhances-commercialization-expertise 2019-04-17 03:04:48 daily 0.1 https://demo.pharmafocusasia.com/news/bactevo-enters-drug-discovery-agreement-with-boehringer-ingelheim 2019-04-17 03:04:47 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-invenra-enter-into-collaboration-to-discover-and-develop-novel-biologics 2019-04-17 03:04:45 daily 0.1 https://demo.pharmafocusasia.com/news/spectrum-pharmaceuticals-enters-into-partnership-with-thermo-fisher-scientific 2019-04-17 03:04:43 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-laboratories-expands-services-for-early-discovery-screening 2019-04-17 03:04:41 daily 0.1 https://demo.pharmafocusasia.com/news/united-therapeutics-to-acquire-steadymed-ltd 2019-04-17 03:04:39 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-and-verily-announce-scientific-collaboration-to-identify-and-understand-immunological 2019-04-17 03:04:37 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-signs-definitive-agreements-to-acquire-generic-products-and-assets 2019-04-17 03:04:35 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharma-announces-the-launch-of-its-hemorrhoid-drug-xyralid-in-canada 2019-04-17 03:04:33 daily 0.1 https://demo.pharmafocusasia.com/news/juniper-pharmaceuticals-licenses-intravaginal-ring-platform-to-dare-bioscience 2019-04-17 03:04:31 daily 0.1 https://demo.pharmafocusasia.com/news/entasis-therapeutics-and-zai-lab-announce-exclusive-license-agreement-in-asia-pacific 2019-04-17 03:04:30 daily 0.1 https://demo.pharmafocusasia.com/news/freenome-and-biognosys-announce-collaboration-to-improve-early-cancer-detection-and-treatment 2019-04-17 03:04:28 daily 0.1 https://demo.pharmafocusasia.com/news/bioiberica-approves-its-combined-drug-for-osteoarthritis-in-five-more-european-countries 2019-04-17 03:04:26 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-announces-research-collaboration-and-license-agreement-with-simcere 2019-04-17 03:04:24 daily 0.1 https://demo.pharmafocusasia.com/news/dipharma-francis-enters-into-agreement-to-acquire-kalexsyn 2019-04-17 03:04:22 daily 0.1 https://demo.pharmafocusasia.com/news/sterling-pharma-solutions-invests-in-pilot-plant-facility 2019-04-17 03:04:20 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-ionis-expand-strategic-collaboration-to-develop-drug-candidates 2019-04-17 03:04:18 daily 0.1 https://demo.pharmafocusasia.com/news/tocagen-and-apollobio-enter-license-agreement 2019-04-17 03:04:16 daily 0.1 https://demo.pharmafocusasia.com/news/biogo-introduces-bioproduction-agility-to-accelerate-biotech-innovation 2019-04-17 03:04:14 daily 0.1 https://demo.pharmafocusasia.com/news/pfenex-and-nt-pharma-enter-into-a-development-and-license-agreement 2019-04-17 03:04:13 daily 0.1 https://demo.pharmafocusasia.com/news/fusion-pharmaceuticals-licenses-isogenicas-cis-display-technology 2019-04-17 03:04:11 daily 0.1 https://demo.pharmafocusasia.com/news/kinderpharm-llc-and-worldwide-clinical-trials-form-strategic-alliance 2019-04-17 03:04:09 daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight 2019-04-17 03:04:07 daily 0.1 https://demo.pharmafocusasia.com/news/cardurion-pharmaceuticals-licenses-clinical-stage-heart-failure-candidate-from-astellas 2019-04-17 03:04:05 daily 0.1 https://demo.pharmafocusasia.com/news/phoremost-and-plexxikon-collaborate-to-identify-novel-drug-targets 2019-04-17 03:04:03 daily 0.1 https://demo.pharmafocusasia.com/news/shire-announces-sale-of-oncology-business-to-servier 2019-04-17 03:04:01 daily 0.1 https://demo.pharmafocusasia.com/news/frances-sanofi-sells-brands-to-charterhouses-cooper-vemedia 2019-04-17 03:03:59 daily 0.1 https://demo.pharmafocusasia.com/news/halo-pharma-simplifies-topical-drug-product-development-and-manufacturing 2019-04-17 03:03:57 daily 0.1 https://demo.pharmafocusasia.com/news/milliporesigma-helps-accelerate-global-access-to-affordable-vaccines 2019-04-17 03:03:55 daily 0.1 https://demo.pharmafocusasia.com/news/veracyte-announces-precision-medicine-collaboration-with-loxo-oncology 2019-04-17 03:03:54 daily 0.1 https://demo.pharmafocusasia.com/news/fujifilm-kyowa-kirin-biologics-partners-with-mylan 2019-04-17 03:03:52 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-forms-collaboration-with-petra-pharma-on-indigo-platform 2019-04-17 03:03:50 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-to-acquire-wilson-therapeutics 2019-04-17 03:03:48 daily 0.1 https://demo.pharmafocusasia.com/news/promethera-biosciences-acquires-baliopharm-ag 2019-04-17 03:03:43 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-laboratories-and-pathoquest-expand-strategic-biologics-partnership 2019-04-17 03:03:41 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-shells-out-to-buy-avexis 2019-04-17 03:03:39 daily 0.1 https://demo.pharmafocusasia.com/news/pacira-announces-fda-approval-of-supplemental-new-drug-application-for-exparel 2019-04-17 03:03:37 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-acquires-microbiome-pioneer-rebiotix 2019-04-17 03:03:35 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-obtains-exclusive-worldwide-licence-to-epidestinys-sickle-cell-disease-programme 2019-04-17 03:03:33 daily 0.1 https://demo.pharmafocusasia.com/news/qstate-biosciences-and-vertex-pharmaceuticals-enter-into-discovery-collaboration 2019-04-17 03:03:31 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-sigilon-therapeutics-announce-strategic-collaboration 2019-04-17 03:03:28 daily 0.1 https://demo.pharmafocusasia.com/news/cellectis-and-allogene-therapeutics-intend-to-continue-collaboration 2019-04-17 03:03:25 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-technologies-signs-agreement-to-acquire-lasergen 2019-04-17 03:03:23 daily 0.1 https://demo.pharmafocusasia.com/news/compugen-announces-exclusive-license-agreement-with-medimmune 2019-04-17 03:03:21 daily 0.1 https://demo.pharmafocusasia.com/news/duchesnay-usa-announces-launch-of-bonjesta 2019-04-17 03:03:19 daily 0.1 https://demo.pharmafocusasia.com/news/pharmabcine-announces-fda-orphan-drug-designation-granted-to-ttac 2019-04-17 03:03:17 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-enters-into-agreement-with-venbio 2019-04-17 03:03:16 daily 0.1 https://demo.pharmafocusasia.com/news/martin-pharmaceuticals-receives-fda-orphan-drug-designation-for-livantra 2019-04-17 03:03:14 daily 0.1 https://demo.pharmafocusasia.com/news/abide-and-celgene-enter-worldwide-license-agreement 2019-04-17 03:03:12 daily 0.1 https://demo.pharmafocusasia.com/news/actinium-pharmaceuticals-announces-collaborative-research-partnership-with-astellas 2019-04-17 03:03:10 daily 0.1 https://demo.pharmafocusasia.com/news/eagle-pharmaceuticals-announces-new-patent-for-eagle-biologics 2019-04-17 03:03:08 daily 0.1 https://demo.pharmafocusasia.com/news/oncodesign-concludes-long-term-service-based-partnership-with-erytech 2019-04-17 03:03:06 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-and-astellas-receive-fda-breakthrough-therapy 2019-04-17 03:03:04 daily 0.1 https://demo.pharmafocusasia.com/news/syngene-international-signs-rd-agreement-with-gsk 2019-04-17 03:03:02 daily 0.1 https://demo.pharmafocusasia.com/news/therapure-biopharma-launches-biologics-division-as-evolve-biologics 2019-04-17 03:03:00 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-the-launch-of-generic-version-of-aloxi-in-the-united-states 2019-04-17 03:02:58 daily 0.1 https://demo.pharmafocusasia.com/news/curevac-receives-us-patent-covering-entire-process 2019-04-17 03:02:56 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-alnylam-pharmaceuticals-announce-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/innate-biologics-enters-into-collaboration-agreement-with-the-wistar-institute 2019-04-17 03:02:53 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-adds-to-growing-oncology-portfolio-with-launch-of-generic-mutamycin-injection 2019-04-17 03:02:51 daily 0.1 https://demo.pharmafocusasia.com/news/nexcelom-bioscience-announces-strategic-growth-investment-from-ampersand-capital-partners 2019-04-17 03:02:49 daily 0.1 https://demo.pharmafocusasia.com/news/ardelyx-and-knight-collaborate-to-bring-tenapanor-to-patients-in-canada 2019-04-17 03:02:47 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-completes-sale-of-recothrom-and-preveleak-to-baxter 2019-04-17 03:02:45 daily 0.1 https://demo.pharmafocusasia.com/news/intezyne-partners-with-exosome-diagnostics-on-companion-diagnostic 2019-04-17 03:02:40 daily 0.1 https://demo.pharmafocusasia.com/news/revolutionary-dowdupont-technology-available-for-the-first-time-worldwide 2019-04-17 03:02:34 daily 0.1 https://demo.pharmafocusasia.com/news/lundbeck-to-acquire-prexton-therapeutics 2019-04-17 03:02:28 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-and-akcea-partner-to-commercialize-inotersen-for-hattr 2019-04-17 03:02:25 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-announces-us-fda-breakthrough-therapy-designation-for-erdafitinib 2019-04-17 03:02:23 daily 0.1 https://demo.pharmafocusasia.com/news/propanc-biopharma-completes-successful-reproduction-run-for-prp 2019-04-17 03:02:21 daily 0.1 https://demo.pharmafocusasia.com/news/oxthera-announces-the-randomization-of-the-first-patient 2019-04-17 03:02:19 daily 0.1 https://demo.pharmafocusasia.com/news/parexel-and-cha-medical-group-partner 2019-04-17 03:02:17 daily 0.1 https://demo.pharmafocusasia.com/news/tumorgenesis-announces-license-agreement-with-syntarray 2019-04-17 03:02:15 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-to-buy-pfizers-neurology-drug 2019-04-17 03:02:13 daily 0.1 https://demo.pharmafocusasia.com/news/myr-pharma-completes-clinical-trial-of-myrcludex-b-in-chronic-hepatitis-delta 2019-04-17 03:02:11 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-completes-acquisition-of-cascadian-therapeutics 2019-04-17 03:02:09 daily 0.1 https://demo.pharmafocusasia.com/news/covance-forms-immunology-immunotoxicology-unit-focused 2019-04-17 03:02:08 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-completes-acquisition-of-bioverativ 2019-04-17 03:02:06 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-co-ltd-and-merck-enter-global-strategic-oncology-collaboration 2019-04-17 03:02:04 daily 0.1 https://demo.pharmafocusasia.com/news/biotime-announces-dsmb-approval-to-proceed-to-cohort-of-the-opregen-clinical-trial 2019-04-17 03:02:02 daily 0.1 https://demo.pharmafocusasia.com/news/science-and-novartis-sign-strategic-alliance-to-advance-decentralized-clinical-trials 2019-04-17 03:01:58 daily 0.1 https://demo.pharmafocusasia.com/news/constant-pharmaceuticals-announces-japanese-patent-issuance 2019-04-17 03:01:56 daily 0.1 https://demo.pharmafocusasia.com/news/parkinsons-institute-and-clinical-center-collaborates-with-denali-therapeutics 2019-04-17 03:01:54 daily 0.1 https://demo.pharmafocusasia.com/news/glycomimetics-announces-design-of-phase-clinical-trial 2019-04-17 03:01:52 daily 0.1 https://demo.pharmafocusasia.com/news/tabuk-pharmaceuticals-signs-commercial-agreement-with-renapharma-ab 2019-04-17 03:01:50 daily 0.1 https://demo.pharmafocusasia.com/news/roche-achieves-two-major-milestones-in-the-evolution 2019-04-17 03:01:48 daily 0.1 https://demo.pharmafocusasia.com/news/aratana-therapeutics-expands-therapeutic-candidate-pipeline 2019-04-17 03:01:46 daily 0.1 https://demo.pharmafocusasia.com/news/endo-obtains-preliminary-injunction-against-quva-pharma 2019-04-17 03:01:44 daily 0.1 https://demo.pharmafocusasia.com/news/covance-enters-into-strategic-technology-agreement-with-gsk 2019-04-17 03:01:42 daily 0.1 https://demo.pharmafocusasia.com/news/concert-pharmaceuticals-announces-advancement-of-novel-drug-candidate 2019-04-17 03:01:40 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-announces-licensing-agreement-with-kaken-pharmaceutical 2019-04-17 03:01:39 daily 0.1 https://demo.pharmafocusasia.com/news/chugais-hemlibra-approved-by-european-commission 2019-04-17 03:01:36 daily 0.1 https://demo.pharmafocusasia.com/news/xencor-signs-four-commercial-license-agreements-with-selexis-sa 2019-04-17 03:01:35 daily 0.1 https://demo.pharmafocusasia.com/news/lantern-pharma-joins-genomics-england-to-advance-their-precision-oncology-platform 2019-04-17 03:01:33 daily 0.1 https://demo.pharmafocusasia.com/news/kazia-receives-fda-orphan-designation-for-gdc 2019-04-17 03:01:31 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-receives-fda-acceptance-of-stannsoporfin-new-drug-application-filing 2019-04-17 03:01:29 daily 0.1 https://demo.pharmafocusasia.com/news/kite-gilead-company-and-sangamo-therapeutics-announce-collaboration 2019-04-17 03:01:27 daily 0.1 https://demo.pharmafocusasia.com/news/myr-pharma-announces-completion-of-active-treatment-phase 2019-04-17 03:01:25 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-viralytics-announce-acquisition-agreement 2019-04-17 03:01:23 daily 0.1 https://demo.pharmafocusasia.com/news/atum-and-just-biotherapeutics-team-up-to-accelerate-drug-discovery 2019-04-17 03:01:21 daily 0.1 https://demo.pharmafocusasia.com/news/arix-bioscience-and-ipsen-sign-strategic-agreement 2019-04-17 03:01:19 daily 0.1 https://demo.pharmafocusasia.com/news/dandrit-biotech-announces-completion-of-the-acquisition-of-enochian 2019-04-17 03:01:17 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-readies-to-auction-us-generic-pills-business 2019-04-17 03:01:15 daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-immunotherapy-drug-wins-key-lung-cancer-approval 2019-04-17 03:01:14 daily 0.1 https://demo.pharmafocusasia.com/news/roche-to-acquire-flatiron-health 2019-04-17 03:01:12 daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-pharmaceuticals-receives-orphan-drug-designation-for-aro-aat 2019-04-17 03:01:10 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-nektar-therapeutics-announce-collaboration 2019-04-17 03:01:08 daily 0.1 https://demo.pharmafocusasia.com/news/aurinia-pharmaceuticals-launches-new-lupus-nephritis-disease-awareness-program 2019-04-17 03:01:06 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-completes-acquisition-of-sucampo-pharmaceuticals 2019-04-17 03:01:04 daily 0.1 https://demo.pharmafocusasia.com/news/vaxart-closes-merger-with-aviragen-therapeutics 2019-04-17 03:01:02 daily 0.1 https://demo.pharmafocusasia.com/news/lakepharma-announces-expansion-and-new-microbiomanufacturing-center 2019-04-17 03:01:00 daily 0.1 https://demo.pharmafocusasia.com/news/kadmon-announces-positive-topline-results 2019-04-17 03:00:58 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-and-pieris-pharmaceuticals-announce-collaboration 2019-04-17 03:00:57 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-launch-of-generic-version-of-syprine-in-the-united-states 2019-04-17 03:00:55 daily 0.1 https://demo.pharmafocusasia.com/news/certara-acquires-basecase 2019-04-17 03:00:53 daily 0.1 https://demo.pharmafocusasia.com/news/acesion-pharma-receives-approval-for-phase-study-in-atrial-fibrillation 2019-04-17 03:00:51 daily 0.1 https://demo.pharmafocusasia.com/news/theravance-biopharma-enters-global-collaboration-with-janssen 2019-04-17 03:00:49 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-provides-an-update-on-its-immuno-oncology-clinical-program-with-astrazeneca 2019-04-17 03:00:47 daily 0.1 https://demo.pharmafocusasia.com/news/netvation-dl-medicine-announces-research-collaboration-with-pfizer 2019-04-17 03:00:45 daily 0.1 https://demo.pharmafocusasia.com/news/audentes-therapeutics-announces-selection-of-optimized-clinical-development 2019-04-17 03:00:44 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-and-mbc-biolabs-team-up-to-support-life-science-startups-in-the-san-francisco 2019-04-17 03:00:42 daily 0.1 https://demo.pharmafocusasia.com/news/valerion-to-present-initial-clinical-data-with-val-in-pompe-disease 2019-04-17 03:00:40 daily 0.1 https://demo.pharmafocusasia.com/news/portages-ppl-forms-joint-venture-with-university-of-glasgow 2019-04-17 03:00:38 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-flags-return-to-drug-sales-growth 2019-04-17 03:00:33 daily 0.1 https://demo.pharmafocusasia.com/news/avicanna-inc-announces-its-subsidiary-has-obtained-medical-cannabis-licenses-in-colombia 2019-04-17 03:00:31 daily 0.1 https://demo.pharmafocusasia.com/news/syndax-announces-immuno-oncology-clinical-trial-collaboration-with-astrazeneca 2019-04-17 03:00:29 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-expands-access-to-hiv-aids-medicines-with-launch-of-first-generic-sustiva-tablets 2019-04-17 03:00:27 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-s-zomacton-somatropin-for-injection-receives-fda-approval-to-treat-growth-hormone-deficiency 2019-04-17 03:00:25 daily 0.1 https://demo.pharmafocusasia.com/news/aquestive-therapeutics-receives-u-s-fda-orphan-drug-designation-for-riluzole-oral-soluble-film 2019-04-17 03:00:23 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-designation-to-dauntless-pharmaceuticals-dp- 2019-04-17 03:00:21 daily 0.1 https://demo.pharmafocusasia.com/news/upsher-smith-receives-fda-approval-for-bumetanide-tablets-usp 2019-04-17 03:00:19 daily 0.1 https://demo.pharmafocusasia.com/news/cutispharma-announces-fda-approval-of-firvanq-for-treatment-of-cdad-and-staphylococcus-aureus-colitis 2019-04-17 03:00:17 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-s-zika-virus-vaccine-receives-fda-fast-track-designation 2019-04-17 03:00:15 daily 0.1 https://demo.pharmafocusasia.com/news/casi-pharmaceuticals-acquires-anda-portfolio-from-sandoz 2019-04-17 03:00:13 daily 0.1 https://demo.pharmafocusasia.com/news/chugais-hemlibra-gains-positive-chmp-opinion-in-hemophilia-a-with-inhibitors 2019-04-17 03:00:11 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-exclusively-licenses-first-ophthalmology-gene-therapy 2019-04-17 03:00:09 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-completes-acquisition-of-mitobridge 2019-04-17 03:00:07 daily 0.1 https://demo.pharmafocusasia.com/news/cardiome-announces-expanded-label-for-aggrastat-in-china-including-new-stemi-indication daily 0.1 https://demo.pharmafocusasia.com/news/chemdiv-announces-expansion-of-multi-year-hit-identification-collaboration-with-janssen 2019-04-17 03:00:04 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-agreement-with-ferring-pharmaceuticals 2019-04-17 03:00:01 daily 0.1 https://demo.pharmafocusasia.com/news/sillajen-and-abl-europe-expand-strategic-manufacturing-collaboration 2019-04-17 03:00:00 daily 0.1 https://demo.pharmafocusasia.com/news/healthcare-group-sanofi-agrees-to-buy-us-peer-bioverativ 2019-04-17 02:59:58 daily 0.1 https://demo.pharmafocusasia.com/news/enzychem-lifesciences-announces-the-fda-orphan-drug-designation 2019-04-17 02:59:56 daily 0.1 https://demo.pharmafocusasia.com/news/tabuk-pharmaceuticals-signs-agreement-with-red-otc-development-gmbh 2019-04-17 02:59:54 daily 0.1 https://demo.pharmafocusasia.com/news/biohaven-announces-initiation-of-clinical-development-for-bhv 2019-04-17 02:59:52 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-establishes-program-to-develop-captisol-enabled 2019-04-17 02:59:50 daily 0.1 https://demo.pharmafocusasia.com/news/x-chem-enters-collaboration-with-astrazeneca 2019-04-17 02:59:48 daily 0.1 https://demo.pharmafocusasia.com/news/relmada-therapeutics-acquires-global-rights-to-develop-and-market-dextromethadone 2019-04-17 02:59:46 daily 0.1 https://demo.pharmafocusasia.com/news/avantgen-and-tanabe-research-laboratories-expand-collaboration 2019-04-17 02:59:45 daily 0.1 https://demo.pharmafocusasia.com/news/ppd-and-quotient-sciences-form-innovative-partnership 2019-04-17 02:59:43 daily 0.1 https://demo.pharmafocusasia.com/news/grunenthal-and-mundipharma-enter-commercial-partnership-in-china 2019-04-17 02:59:41 daily 0.1 https://demo.pharmafocusasia.com/news/nuvo-pharmaceuticals-acquires-us-product-rights-to-resultz-from-piedmont-pharmaceuticals 2019-04-17 02:59:39 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-agreement-with-glenmark-pharmaceuticals 2019-04-17 02:59:37 daily 0.1 https://demo.pharmafocusasia.com/news/resverlogix-receives-fda-protocol-acceptance-for-the-ongoing-phase-betonmace-trial 2019-04-17 02:59:36 daily 0.1 https://demo.pharmafocusasia.com/news/adimab-announces-antibody-discovery-collaboration-with-boehringer-ingelheim 2019-04-17 02:59:34 daily 0.1 https://demo.pharmafocusasia.com/news/target-pharmasolutions-to-advance-nash-research-through-new-collaboration 2019-04-17 02:59:32 daily 0.1 https://demo.pharmafocusasia.com/news/syapse-enters-strategic-collaboration-with-roche 2019-04-17 02:59:30 daily 0.1 https://demo.pharmafocusasia.com/news/gt-biopharma-announces-completion-of-dosing-in-phase-clinical-trial-of-gtp-for-myasthenia-gravis 2019-04-17 02:59:28 daily 0.1 https://demo.pharmafocusasia.com/news/intec-pharma-announces-development-collaboration-with-global-pharmaceutical-company 2019-04-17 02:59:26 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-will-sell-recothrom-and-preveleak-to-baxter 2019-04-17 02:59:24 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-and-sanofi-enter-into-strategic-restructuring 2019-04-17 02:59:22 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-to-acquire-impact-biomedicines 2019-04-17 02:59:20 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-denali-therapeutics-collaborate-to-develop-and-commercialize-therapies-for-neurodegenerative-diseases 2019-04-17 02:59:18 daily 0.1 https://demo.pharmafocusasia.com/news/avantgen-and-tanabe-research-laboratories-expand-collaboration 2019-04-17 02:59:16 daily 0.1 https://demo.pharmafocusasia.com/news/servier-and-treventis-begin-strategic-research-partnership-in-neurodegenerative-diseases 2019-04-17 02:59:14 daily 0.1 https://demo.pharmafocusasia.com/news/foresee-pharmaceuticals-and-megapharm-announce-license-and-distribution-agreement 2019-04-17 02:59:12 daily 0.1 https://demo.pharmafocusasia.com/news/indivior-and-addex-enter-strategic-collaboration 2019-04-17 02:59:11 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-signs-distribution-license-agreement-for-aplidin 2019-04-17 02:59:05 daily 0.1 https://demo.pharmafocusasia.com/news/soligenix-announces-us-patent-issuance-for-use-of-dusquetide 2019-04-17 02:59:04 daily 0.1 https://demo.pharmafocusasia.com/news/veritas-pharma-subsidiary-receives-health-canada-dealer-licence 2019-04-17 02:59:02 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-fosun-pharmaceutical-group-unit-receives-gmp-certificate 2019-04-17 02:58:59 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-acquires-four-ndas-from-astrazeneca 2019-04-17 02:58:57 daily 0.1 https://demo.pharmafocusasia.com/news/biocon-and-mylans-biosimilar-trastuzumab-receives-approval 2019-04-17 02:58:56 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-exclusive-launch-of-generic-version-of-reyataz 2019-04-17 02:58:54 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-to-acquire-sucampo-pharmaceuticals 2019-04-17 02:58:52 daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-biopharma-signs-licensing-agreement-for-hyleukin 2019-04-17 02:58:50 daily 0.1 https://demo.pharmafocusasia.com/news/nanobiotixs-first-immuno-oncology-trial-approved-by-us-fda 2019-04-17 02:58:48 daily 0.1 https://demo.pharmafocusasia.com/news/roche-and-ignyta-reach-definitive-merger-agreement 2019-04-17 02:58:46 daily 0.1 https://demo.pharmafocusasia.com/news/mra-applauds-fda-approval-of-nivolumab-to-reduce-the-risk-of-melanoma-returning-after-surgery 2019-04-17 02:58:44 daily 0.1 https://demo.pharmafocusasia.com/news/millendo-therapeutics-acquisition-of-alize-pharma 2019-04-17 02:58:42 daily 0.1 https://demo.pharmafocusasia.com/news/confo-therapeutics-enters-into-drug-discovery-collaboration-with-roche 2019-04-17 02:58:41 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-pharmaceutical-and-x-chem-enter-into-drug-discovery-collaboration 2019-04-17 02:58:39 daily 0.1 https://demo.pharmafocusasia.com/news/precision-medicine-group-lands-major-new-investment 2019-04-17 02:58:37 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-isa-pharmaceuticals-announce-collaboration 2019-04-17 02:58:35 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy 2019-04-17 02:58:33 daily 0.1 https://demo.pharmafocusasia.com/news/pixarbio-corporation-announces-signed-agreement-with-lubrizols-division 2019-04-17 02:58:31 daily 0.1 https://demo.pharmafocusasia.com/news/celltrion-receives-positive-chmp-opinion-for-herzuma-for-trastuzumab-biosimilar 2019-04-17 02:58:29 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-exclusive-launch-of-generic-viread-in-the-united-states 2019-04-17 02:58:27 daily 0.1 https://demo.pharmafocusasia.com/news/aratana-therapeutics-announces-study-results-for-at 2019-04-17 02:58:25 daily 0.1 https://demo.pharmafocusasia.com/news/biovectra-and-keryx-biopharmaceuticals-enter-agreement 2019-04-17 02:58:23 daily 0.1 https://demo.pharmafocusasia.com/news/medicure-acquires-exclusive-license-to-sell-and-market-branded-cardiovascular-drug 2019-04-17 02:58:22 daily 0.1 https://demo.pharmafocusasia.com/news/kangen-pharmaceuticals-announces-acquisition-of-kc-specialty-therapeutics 2019-04-17 02:58:20 daily 0.1 https://demo.pharmafocusasia.com/news/aprecia-pharmaceuticals-and-cycle-pharmaceuticals-partner 2019-04-17 02:58:17 daily 0.1 https://demo.pharmafocusasia.com/news/cyclenium-pharma-collaboration-agreement-with-ono-pharmaceutical 2019-04-17 02:58:16 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-and-puma-biotechnology-announce-research-collaboration 2019-04-17 02:58:14 daily 0.1 https://demo.pharmafocusasia.com/news/medigene-collaborates-with-rxi-pharmaceuticals 2019-04-17 02:58:12 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-completes-acquisition-of-ocera-therapeutics 2019-04-17 02:58:10 daily 0.1 https://demo.pharmafocusasia.com/news/prime-therapeutics-signs-contract-with-novo-nordisk 2019-04-17 02:58:08 daily 0.1 https://demo.pharmafocusasia.com/news/roche-lymphoma-drug-drives-high-remission-rate-longer-survival 2019-04-17 02:58:06 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-kite-to-acquire-cell-design-labs 2019-04-17 02:58:04 daily 0.1 https://demo.pharmafocusasia.com/news/aerogen-pharma-and-lyomark-pharma-partner-to-develop-inhaled-surfactant-begin-a-phase-clinical-trial 2017-12-08 02:26:21 daily 0.1 https://demo.pharmafocusasia.com/news/carmot-enters-a-multi-year-drug-discovery-collaboration-with-amgen 2019-04-17 02:58:01 daily 0.1 https://demo.pharmafocusasia.com/news/genomic-health-announces-research-collaboration-with-janssen-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/ampel-biosolutions-horizon-pharma-and-lupus-research-alliance-partner 2019-04-17 02:57:57 daily 0.1 https://demo.pharmafocusasia.com/news/sunovion-receives-fda-approval-for-lonhala-magnair-inhalation-solution 2019-04-17 02:57:55 daily 0.1 https://demo.pharmafocusasia.com/news/dance-biopharm-and-phillips-medisize-enter-into-development-agreement 2019-04-17 02:57:53 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-and-aspen-announce-launch-of-generic-busulfex-injection 2019-04-17 02:57:51 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharma-expands-agreement-in-peru-with-pharma-solutions 2019-04-17 02:57:50 daily 0.1 https://demo.pharmafocusasia.com/news/first-patient-enrolled-in-phase-trial-for-atir-in-adult-patients 2019-04-17 02:57:48 daily 0.1 https://demo.pharmafocusasia.com/news/prime-therapeutics-signs-carecentered-contract 2019-04-17 02:57:46 daily 0.1 https://demo.pharmafocusasia.com/news/rxi-pharmaceuticals-and-the-center-for-cancer-immune-therapy-research-collaboration 2019-04-17 02:57:44 daily 0.1 https://demo.pharmafocusasia.com/news/i-mab-biopharma-partners-with-morphosys-on-cancer-investigational-medicine 2019-04-17 02:57:42 daily 0.1 https://demo.pharmafocusasia.com/news/acea-biosciences-and-ncardia-announce-global-partnership 2019-04-17 02:57:37 daily 0.1 https://demo.pharmafocusasia.com/news/new-ferring-and-ache-laboratorios-farmaceuticos-facility-opens 2019-04-17 02:57:35 daily 0.1 https://demo.pharmafocusasia.com/news/biocad-launches-the-new-manufacturing-site-in-north-africa 2019-04-17 02:57:32 daily 0.1 https://demo.pharmafocusasia.com/news/titan-pharmaceuticals-partners-with-molteni-to-market-probuphine-in-europe 2019-04-17 02:57:29 daily 0.1 https://demo.pharmafocusasia.com/news/cannabics-pharmaceuticals-received-a-new-research-license-for-of-anti-tumor-activity 2019-04-17 02:57:25 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-and-alkermes-announce-license-and-collaboration-agreement 2019-04-17 02:57:23 daily 0.1 https://demo.pharmafocusasia.com/news/sobi-receives-approval-from-health-canada-for-orfadin 2019-04-17 02:57:20 daily 0.1 https://demo.pharmafocusasia.com/news/fda-renews-and-expands-its-portfolio-of-simcyp-simulator-licenses 2019-04-17 02:57:19 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-provides-update-on-eylea-injection 2019-04-17 02:57:17 daily 0.1 https://demo.pharmafocusasia.com/news/kmt-hepatech-announces-strategic-investment-from-phoenixbio 2019-04-17 02:57:15 daily 0.1 https://demo.pharmafocusasia.com/news/puma-biotechnology-and-specialised-therapeutics-asia-enter-into-exclusive-licensing-agreement 2019-04-17 02:57:13 daily 0.1 https://demo.pharmafocusasia.com/news/orig-n-acquires-interleukin-genetics 2019-04-17 02:57:11 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-company-completes-divestiture-of-api-business 2019-04-17 02:57:09 daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-to-expand-pharmaceutical-manufacturing-in-north-carolina 2019-04-17 02:57:07 daily 0.1 https://demo.pharmafocusasia.com/news/biondvax-and-nih-sign-clinical-trial-agreement-for-phase-trial-in-the-us 2019-04-17 02:57:05 daily 0.1 https://demo.pharmafocusasia.com/news/zubsolv-receives-authorization-for-treatment-of-opioid-dependence-in-europe 2019-04-17 02:57:03 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-announces-discovery-collaboration-agreement-with-bayer 2019-04-17 02:57:01 daily 0.1 https://demo.pharmafocusasia.com/news/chugais-bispecific-antibody-emicizumab-meets-primary-endpoint 2019-04-17 02:56:59 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-apptec-selected-by-iqvia-stem-cell-center 2019-04-17 02:56:57 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharmaceuticals-strengthens-its-intellectual-property-portfolio 2019-04-17 02:56:55 daily 0.1 https://demo.pharmafocusasia.com/news/nephron-pharmaceuticals-continues-efforts-to-solve-drug-shortage-crisis 2019-04-17 02:56:54 daily 0.1 https://demo.pharmafocusasia.com/news/arvinas-expands-strategic-license-agreement-with-genentech 2019-04-17 02:56:52 daily 0.1 https://demo.pharmafocusasia.com/news/ascentage-pharma-announces-us-fda-acceptance-of-ind-application 2019-04-17 02:56:50 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-syngene-international-expand-ongoing-research-collaboration 2019-04-17 02:56:48 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-pharma-announces-strategic-investment-in-oncology 2019-04-17 02:56:46 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-announces-license-agreement-with-johnson-innovation 2019-04-17 02:56:44 daily 0.1 https://demo.pharmafocusasia.com/news/avista-pharma-solutions-doubles-api-manufacturing-capacity 2019-04-17 02:56:42 daily 0.1 https://demo.pharmafocusasia.com/news/sunovion-announces-fda-acceptance-for-review-of-new-drug-application 2019-04-17 02:56:40 daily 0.1 https://demo.pharmafocusasia.com/news/gbt-acquires-laboratorio-dosa 2019-04-17 02:56:38 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharma-announces-agreement-with-acon-laboratories 2019-04-17 02:56:36 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-licenses-novel-antisense-drug-for-the-treatment-of-centronuclear-myopathy 2019-04-17 02:56:34 daily 0.1 https://demo.pharmafocusasia.com/news/neurimmune-announces-collaboration-with-ono-pharmaceutical 2019-04-17 02:56:33 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-mina-therapeutics-to-develop-novel-treatment 2019-04-17 02:56:31 daily 0.1 https://demo.pharmafocusasia.com/news/kaken-pharmaceutical-and-tai-tien-pharmaceuticals-distribution-agreement 2019-04-17 02:56:29 daily 0.1 https://demo.pharmafocusasia.com/news/orphazyme-receives-orphan-drug-designation-to-arimoclomol 2019-04-17 02:56:27 daily 0.1 https://demo.pharmafocusasia.com/news/fujifilm-expands-biopharmaceutical-contract-development-and-manufacturing-business 2019-04-17 02:56:25 daily 0.1 https://demo.pharmafocusasia.com/news/therapeuticsmd-announces-plan-to-resubmit-the-new-drug-application 2019-04-17 02:56:23 daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-presents-late-breaking-clinical-data 2019-04-17 02:56:21 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-announces-phase-results-for-tolvaptan 2019-04-17 02:56:19 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-cdrd-announce-joint-investment 2019-04-17 02:56:17 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-and-dicerna-announce-collaboration 2019-04-17 02:56:15 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-pall-corporation-establish-bioprocess-laboratory 2019-04-17 02:56:13 daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-samsung-biologics-expand-strategic-alliance 2019-04-17 02:56:12 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-completion-of-paragard-divestiture-to-coopersurgical 2019-04-17 02:56:07 daily 0.1 https://demo.pharmafocusasia.com/news/impel-neuropharma-announces-first-patient-dosed-clinical-trial-of-inp daily 0.1 https://demo.pharmafocusasia.com/news/arcturus-therapeutics-and-synthetic-genomics-announce-strategic-alliance 2019-04-17 02:56:03 daily 0.1 https://demo.pharmafocusasia.com/news/xynomic-pharma-acquires-global-rights-of-boehringer-ingelheims-bi 2019-04-17 02:56:01 daily 0.1 https://demo.pharmafocusasia.com/news/lannett-and-celgene-enter-into-settlement-and-license-agreement 2019-04-17 02:55:59 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharma-to-buy-frances-tridem 2019-04-17 02:55:58 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-receives-final-approval-from-the-usfda-for-tamoxifen-citrate-tablets 2019-04-17 02:55:56 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-announces-expansion-of-in-vitro-oncology-services 2019-04-17 02:55:54 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-tesaro-enter-strategic-partnership 2019-04-17 02:55:52 daily 0.1 https://demo.pharmafocusasia.com/news/endo-completes-divestiture-of-grupo-farmaceutico-somar 2019-04-17 02:55:50 daily 0.1 https://demo.pharmafocusasia.com/news/incyte-and-macrogenics-announce-global-collaboration 2019-04-17 02:55:48 daily 0.1 https://demo.pharmafocusasia.com/news/amerigen-and-biophore-collaborate-on-penicillamine-generics 2019-04-17 02:55:46 daily 0.1 https://demo.pharmafocusasia.com/news/ortek-therapeutics-announces-fda-clearance 2019-04-17 02:55:44 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-completes-acquisition-of-cook-pharmica 2019-04-17 02:55:42 daily 0.1 https://demo.pharmafocusasia.com/news/qpharma-introduces-crm-system-for-life-sciences 2019-04-17 02:55:41 daily 0.1 https://demo.pharmafocusasia.com/news/tigenix-granted-orphan-drug-designation-from-the-us-fda 2019-04-17 02:55:39 daily 0.1 https://demo.pharmafocusasia.com/news/titan-pharmaceuticals-presents-non-clinical-data 2019-04-17 02:55:37 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-and-universal-cells-announce-collaboration 2019-04-17 02:55:35 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-gsks-shingles-vaccine-with-agenus-qs-stimulon-adjuvant 2019-04-17 02:55:33 daily 0.1 https://demo.pharmafocusasia.com/news/abzena-and-uga-biopharma-partner-to-develop-cell-line 2019-04-17 02:55:31 daily 0.1 https://demo.pharmafocusasia.com/news/quotient-clinical-signs-agreement-with-nuformix 2019-04-17 02:55:29 daily 0.1 https://demo.pharmafocusasia.com/news/askbio-and-columbus-venture-partners-launch-gene-therapy-company 2019-04-17 02:55:27 daily 0.1 https://demo.pharmafocusasia.com/news/eagle-pharmaceuticals-announces-new-patent-for-ryanodex 2019-04-17 02:55:25 daily 0.1 https://demo.pharmafocusasia.com/news/aimmune-therapeutics-announces-clinical-collaboration 2019-04-17 02:55:24 daily 0.1 https://demo.pharmafocusasia.com/news/flex-pharma-initiates-cmt-phase-trial-with-flx-in-us 2019-04-17 02:55:22 daily 0.1 https://demo.pharmafocusasia.com/news/intercept-extends-strategic-partnership-with-target-pharmasolutions 2019-04-17 02:55:20 daily 0.1 https://demo.pharmafocusasia.com/news/renflexis-is-latest-addition-to-therapeutic-drug-monitoring 2019-04-17 02:55:18 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-pharmaceuticals-initiates-clinical-study-of-ionis-mapt-rx 2019-04-17 02:55:16 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-extends-strategic-partnership 2019-04-17 02:55:14 daily 0.1 https://demo.pharmafocusasia.com/news/cordenpharma-acquires-pfizer-api-manufacturing-facility 2019-04-17 02:55:12 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-invests-in-new-vaccine-production-facility-in-france 2019-04-17 02:55:10 daily 0.1 https://demo.pharmafocusasia.com/news/index-pharmaceuticals-gets-new-patent-in-the-us 2019-04-17 02:55:09 daily 0.1 https://demo.pharmafocusasia.com/news/kaleido-biosciences-and-corebiome-partner 2019-04-17 02:55:07 daily 0.1 https://demo.pharmafocusasia.com/news/h-biomedicine-granted-orphan-drug-designation 2019-04-17 02:55:05 daily 0.1 https://demo.pharmafocusasia.com/news/piramal-pharma-solutions-expansion-of-api-manufacturing 2019-04-17 02:55:03 daily 0.1 https://demo.pharmafocusasia.com/news/parata-systems-enters-agreement-with-aap daily 0.1 https://demo.pharmafocusasia.com/news/medibio-enters-into-an-agreement-with-otsuka-pharmaceutical 2019-04-17 02:54:59 daily 0.1 https://demo.pharmafocusasia.com/news/china-to-speed-up-drug-approvals 2019-04-17 02:54:57 daily 0.1 https://demo.pharmafocusasia.com/news/therapix-signs-agreement-with-catalent 2019-04-17 02:54:55 daily 0.1 https://demo.pharmafocusasia.com/news/avara-pharmaceutical-services-acquires-manufacturing-facility-from-astrazeneca 2019-04-17 02:54:53 daily 0.1 https://demo.pharmafocusasia.com/news/promethera-biosciences-and-shibuya-announce-strategic-collaboration 2019-04-17 02:54:51 daily 0.1 https://demo.pharmafocusasia.com/news/enhanced-healthcare-partners-announces-investment-in-sca-pharmaceuticals 2019-04-17 02:54:50 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-announces-new-license-agreement 2019-04-17 02:54:48 daily 0.1 https://demo.pharmafocusasia.com/news/aytu-bioscience-announces-international-distribution-agreement-for-fiera 2019-04-17 02:54:46 daily 0.1 https://demo.pharmafocusasia.com/news/ultragenyx-to-acquire-dimension-therapeutics 2019-04-17 02:54:44 daily 0.1 https://demo.pharmafocusasia.com/news/lonza-to-acquire-us-clinical-manufacturing-site-from-shire 2019-04-17 02:54:39 daily 0.1 https://demo.pharmafocusasia.com/news/titan-pharmaceuticals-and-opiant-pharmaceuticals-collaborate 2019-04-17 02:54:37 daily 0.1 https://demo.pharmafocusasia.com/news/mimedx-completes-divestiture-of-its-stability-biologics-subsidiary 2019-04-17 02:54:35 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-sgc-announce-collaboration-agreement 2019-04-17 02:54:34 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-abbvie-agree-to-settlement 2019-04-17 02:54:32 daily 0.1 https://demo.pharmafocusasia.com/news/foresee-pharmaceuticals-and-trpharm-announce-agreement 2019-04-17 02:54:30 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-invests-in-exscientia-to-advance-ai-driven-drug-discovery 2019-04-17 02:54:28 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-simcere-announce-strategic-collaboration 2019-04-17 02:54:26 daily 0.1 https://demo.pharmafocusasia.com/news/medherant-signs-agreement-transdermal-patch-company 2019-04-17 02:54:24 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-completes-acquisition-of-infacare-pharmaceutical 2019-04-17 02:54:22 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-reintroduction-of-generic-depo-provera 2019-04-17 02:54:20 daily 0.1 https://demo.pharmafocusasia.com/news/konica-minolta-accelerates-expansion-of-precision-medicine-business 2019-04-17 02:54:18 daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-breaks-ground-on-expansion-of-pharmaceutical-manufacturing-site 2019-04-17 02:54:16 daily 0.1 https://demo.pharmafocusasia.com/news/provention-bio-announces-licensing-agreements-with-janssen 2019-04-17 02:54:14 daily 0.1 https://demo.pharmafocusasia.com/news/milliporesigma-opens-chinas-first-bioreliance-biodevelopment-center 2019-04-17 02:54:13 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-astrazeneca-and-labcyte-form-alliance 2019-04-17 02:54:11 daily 0.1 https://demo.pharmafocusasia.com/news/aveo-oncology-and-eusa-pharma-announce-tinivo-combination-study 2019-04-17 02:54:09 daily 0.1 https://demo.pharmafocusasia.com/news/arcus-biosciences-agreement-with-taiho-pharmaceutical 2019-04-17 02:54:07 daily 0.1 https://demo.pharmafocusasia.com/news/absorption-systems-embarks-on-research-collaboration 2019-04-17 02:54:05 daily 0.1 https://demo.pharmafocusasia.com/news/eurofins-to-expand-its-presence-in-north-america 2019-04-17 02:54:03 daily 0.1 https://demo.pharmafocusasia.com/news/tsi-completes-phase-clinical-trial-of-novel-clot-dissolving-therapy 2019-04-17 02:54:01 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-fosun-pharma-to-buy-smaller-stake-in-indian-pharma-firm 2019-04-17 02:54:00 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-sanofi-announce-positive-study-results-for-dupixent 2019-04-17 02:53:58 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-receives-positive-chmp-opinion 2019-04-17 02:53:56 daily 0.1 https://demo.pharmafocusasia.com/news/csl-behring-announces-fda-approval-of-privigen daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-halozyme-enter-agreement daily 0.1 https://demo.pharmafocusasia.com/news/ambry-genetics-announces-integration-with-fdna 2019-04-17 02:53:50 daily 0.1 https://demo.pharmafocusasia.com/news/agilent-obtains-us-fda-approval-for-genetisure-dx-postnatal-assay 2019-04-17 02:53:49 daily 0.1 https://demo.pharmafocusasia.com/news/milliporesigma-expands-celonics-upstream-capabilities 2019-04-17 02:53:47 daily 0.1 https://demo.pharmafocusasia.com/news/abcellera-launches-antibody-discovery-collaboration-with-gsk 2019-04-17 02:53:45 daily 0.1 https://demo.pharmafocusasia.com/news/basilea-announces-distribution-agreement-with-cardiome 2019-04-17 02:53:43 daily 0.1 https://demo.pharmafocusasia.com/news/hanall-biopharma-and-harbour-biomed-sign-collaboration 2019-04-17 02:53:41 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-sale-of-paragard-to-coopersurgical daily 0.1 https://demo.pharmafocusasia.com/news/phosplatin-therapeutics-announces-collaboration-with-pfizer-and-merck daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-takeda-enter-drug-discovery-research-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-completes-acquisition-of-ifm-therapeutics 2019-04-17 02:53:34 daily 0.1 https://demo.pharmafocusasia.com/news/project-als-and-amylyx-enter-collaboration 2019-04-17 02:53:32 daily 0.1 https://demo.pharmafocusasia.com/news/immune-therapeutics-agreement-for-sale-of-lodonal-in-kenya 2019-04-17 02:53:30 daily 0.1 https://demo.pharmafocusasia.com/news/alcami-to-establish-active-pharmaceutical-ingredient-center 2019-04-17 02:53:29 daily 0.1 https://demo.pharmafocusasia.com/news/mei-pharma-agreement-with-presage-biosciences 2019-04-17 02:53:27 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-announces-top-line-results-from-phase-study 2019-04-17 02:53:25 daily 0.1 https://demo.pharmafocusasia.com/news/sbio-accelerates-expansion-of-its-global-biologics-platform-by-acquiring 2019-04-17 02:53:23 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-receives-tentative-fda-approval-of-admelog 2019-04-17 02:53:21 daily 0.1 https://demo.pharmafocusasia.com/news/regenerx-completes-license-expansion 2019-04-17 02:53:19 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-terminates-agreement-with-charleston-laboratories 2019-04-17 02:53:17 daily 0.1 https://demo.pharmafocusasia.com/news/labcyte-and-sengine-precision-medicine-collaborate 2019-04-17 02:53:15 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approval-brings-first-gene-therapy-to-the-united-states 2019-04-17 02:53:14 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-and-immunogen-inc-collaborate-for-antibody-drug daily 0.1 https://demo.pharmafocusasia.com/news/alimera-sciences-signs-agreement-for-iluvien-in-france 2019-04-17 02:53:10 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-enters-worldwide-licensing-agreement 2019-04-17 02:53:05 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-to-acquire-kite-pharma 2019-04-17 02:53:03 daily 0.1 https://demo.pharmafocusasia.com/news/kedrion-biopharma-and-kamada-receive-fda-approval-of-kedrab daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-priority-review-for-genentechs-gazyva 2019-04-17 02:53:00 daily 0.1 https://demo.pharmafocusasia.com/news/chugais-emicizumab-receives-priority-review-designation-by-fda 2019-04-17 02:52:58 daily 0.1 https://demo.pharmafocusasia.com/news/theragnostics-announces-partnership-with-rotop-and-establishes-us-headquarters 2019-04-17 02:52:56 daily 0.1 https://demo.pharmafocusasia.com/news/pharmakea-announces-successful-completion-of-phase-trial 2019-04-17 02:52:54 daily 0.1 https://demo.pharmafocusasia.com/news/argentum-pharmaceuticals-and-eli-lilly-settle-patent-dispute 2019-04-17 02:52:52 daily 0.1 https://demo.pharmafocusasia.com/news/parexel-and-osaka-international-cancer-institute-form-alliance 2019-04-17 02:52:50 daily 0.1 https://demo.pharmafocusasia.com/news/syros-receives-fda-orphan-drug-designation 2019-04-17 02:52:48 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-and-takeda-sign-strategic-collaboration-agreement daily 0.1 https://demo.pharmafocusasia.com/news/mimedx-signs-definitive-agreement-to-divest-stability-biologics-subsidiary 2019-04-17 02:52:45 daily 0.1 https://demo.pharmafocusasia.com/news/medivir-licenses-exclusive-rights-to-miv-for-greater-china-to-ascletis 2019-04-17 02:52:43 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-exclusive-launch-of-generic-axiron-in-the-united-states 2019-04-17 02:52:41 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-announces-new-licensing-agreement-with-takeda 2019-04-17 02:52:39 daily 0.1 https://demo.pharmafocusasia.com/news/bluerock-therapeutics-expands-toronto-presence 2019-04-17 02:52:37 daily 0.1 https://demo.pharmafocusasia.com/news/sillajen-announces-collaboration 2019-04-17 02:52:36 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharma-selects-medidatas-unified-platform-for-clinical-development 2019-04-17 02:52:34 daily 0.1 https://demo.pharmafocusasia.com/news/leidos-and-biosortia-pharmaceuticals-execute-memorandum-of-understanding 2019-04-17 02:52:32 daily 0.1 https://demo.pharmafocusasia.com/news/shuttle-pharmaceuticals-and-pola-pharma-agree-to-license 2019-04-17 02:52:30 daily 0.1 https://demo.pharmafocusasia.com/news/huaren-pharmaceutical-to-set-up-medical-technology-jv-in-jinan 2019-04-17 02:52:28 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-shanghai-pharma-say-bid-for-stake 2019-04-17 02:52:26 daily 0.1 https://demo.pharmafocusasia.com/news/sk-capital-announces-agreement-to-acquire-perrigo-company 2019-04-17 02:52:25 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-and-sema-partner-in-rare-disease-diagnostics-and-systems-biology 2019-04-17 02:52:23 daily 0.1 https://demo.pharmafocusasia.com/news/soin-neuroscience-signs-drug-development-deal-for-non-addicting-pain-killer 2019-04-17 02:52:21 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-starts-quadruple-combination-study 2019-04-17 02:52:19 daily 0.1 https://demo.pharmafocusasia.com/news/la-jolla-pharmaceutical-company-announces-launch-for-ljpc daily 0.1 https://demo.pharmafocusasia.com/news/cingulate-therapeutics-partners-with-camargo-pharmaceutical 2019-04-17 02:52:15 daily 0.1 https://demo.pharmafocusasia.com/news/hitgen-and-leo-pharma-enter-research-collaboration 2019-04-17 02:52:13 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-laboratories-acquires-brains-on-line 2019-04-17 02:52:11 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-designation 2019-04-17 02:52:09 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-to-set-up-osaka-based-special-peptide-drugs-jv 2019-04-17 02:52:08 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-to-acquire-infacare-pharmaceutical-corporation 2019-04-17 02:52:06 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-molecular-templates-announce-collaboration 2019-04-17 02:52:04 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-to-acquire-ifm-therapeutics 2019-04-17 02:52:02 daily 0.1 https://demo.pharmafocusasia.com/news/nexus-pharmaceuticals-receives-fda-approval 2019-04-17 02:52:00 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-cardurion-pharmaceuticals-partnership 2019-04-17 02:51:58 daily 0.1 https://demo.pharmafocusasia.com/news/collidion-acquires-stake-in-plex-pharmaceuticals 2019-04-17 02:51:56 daily 0.1 https://demo.pharmafocusasia.com/news/achieve-life-sciences-announces-closing-of-merger 2019-04-17 02:51:54 daily 0.1 https://demo.pharmafocusasia.com/news/sio-medical-products-and-sanaria-sign-agreement daily 0.1 https://demo.pharmafocusasia.com/news/generex-announces-collaboration-with-merck 2019-04-17 02:51:51 daily 0.1 https://demo.pharmafocusasia.com/news/zoetis-completes-acquisition-of-nexvet-biopharma 2019-04-17 02:51:49 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-to-acquire-aptuit 2019-04-17 02:51:47 daily 0.1 https://demo.pharmafocusasia.com/news/abbvies-drug-for-all-types-of-hepatitis-c-wins-eu-approval 2019-04-17 02:51:45 daily 0.1 https://demo.pharmafocusasia.com/news/cytrx-corporation-announces-global-strategic-license-with-nantcell 2019-04-17 02:51:43 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-pharmaceutical-announces-the-acquisition 2019-04-17 02:51:41 daily 0.1 https://demo.pharmafocusasia.com/news/proteros-enters-into-new-research-collaboration 2019-04-17 02:51:39 daily 0.1 https://demo.pharmafocusasia.com/news/baxter-international-completes-acquisition-of-claris-injectables 2019-04-17 02:51:34 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-merck-establish-strategic-oncology-collaboration 2019-04-17 02:51:32 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-and-xl-protein-gmbh-enter-into-license-agreement 2019-04-17 02:51:30 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-and-biosurfaces-announce-joint-research-program 2019-04-17 02:51:28 daily 0.1 https://demo.pharmafocusasia.com/news/mitsubishi-tanabe-pharma-to-acquire-neuroderm 2019-04-17 02:51:26 daily 0.1 https://demo.pharmafocusasia.com/news/samumed-receives-orphan-drug-designation-from-fda 2019-04-17 02:51:24 daily 0.1 https://demo.pharmafocusasia.com/news/seattle-genetics-announces-clinical-collaboration-with-genentech 2019-04-17 02:51:22 daily 0.1 https://demo.pharmafocusasia.com/news/sta-signs-supply-agreement-with-tesaro 2019-04-17 02:51:21 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-breaks-ground-california-manufacturing-facility 2019-04-17 02:51:19 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-schrodinger-announce-research-collaboration 2019-04-17 02:51:17 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-license-agreement 2019-04-17 02:51:15 daily 0.1 https://demo.pharmafocusasia.com/news/modgene-pharma-announces-issuance-of-us-patent 2019-04-17 02:51:13 daily 0.1 https://demo.pharmafocusasia.com/news/oncology-venture-and-novartis-pharma-enter-into-agreement 2019-04-17 02:51:11 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharmaceuticals-enters-exclusive-agreement-with-cyndea-pharma 2019-04-17 02:51:09 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-and-daiichi-sankyo-announce-successful-achievement 2019-04-17 02:51:07 daily 0.1 https://demo.pharmafocusasia.com/news/norgine-bv-completes-acquisition-of-merus-labs-international 2019-04-17 02:51:05 daily 0.1 https://demo.pharmafocusasia.com/news/luye-life-sciences-expands-global-reach-as-new-boston-rd-center 2019-04-17 02:51:03 daily 0.1 https://demo.pharmafocusasia.com/news/emergent-biosolutions-to-acquire-business-from-sanofi 2019-04-17 02:51:01 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-ucb-provide-update-on-regulatory-status 2019-04-17 02:50:59 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-designation-to-allena-pharmaceuticals-investigational-therapy 2019-04-17 02:50:57 daily 0.1 https://demo.pharmafocusasia.com/news/shangpharma-innovation-and-the-university-of-california-san-francisco-collaboration 2019-04-17 02:50:56 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-fast-track-designation 2019-04-17 02:50:52 daily 0.1 https://demo.pharmafocusasia.com/news/biodelivery-sciences-signs-exclusive-agreement-with-purdue-pharma 2019-04-17 02:50:48 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-acquire-protein-sciences 2019-04-17 02:50:46 daily 0.1 https://demo.pharmafocusasia.com/news/cure-pharmaceutical-therapix-biosciences-signs-mou 2019-04-17 02:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/abzena-and-obi-pharma-sign-thiobridge-licence-agreement 2019-04-17 02:50:42 daily 0.1 https://demo.pharmafocusasia.com/news/inmed-pharmaceuticals-signs-rd-agreement-with-atera 2019-04-17 02:50:40 daily 0.1 https://demo.pharmafocusasia.com/news/race-oncology-limited-joint-venture-with-targimmune 2019-04-17 02:50:38 daily 0.1 https://demo.pharmafocusasia.com/news/eurofins-has-signed-an-exclusive-agreement-to-acquire-amatsigroup daily 0.1 https://demo.pharmafocusasia.com/news/capricor-therapeutics-retains-full-rights 2019-04-17 02:50:35 daily 0.1 https://demo.pharmafocusasia.com/news/oxford-biomedica-announces-major-supply-agreement 2019-04-17 02:50:33 daily 0.1 https://demo.pharmafocusasia.com/news/index-pharmaceuticals-gets-new-patent-granted-in-europe 2019-04-17 02:50:31 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-corporation-enters-into-collaboration-with-beigene 2019-04-17 02:50:29 daily 0.1 https://demo.pharmafocusasia.com/news/rdd-pharma-receives-orphan-designation 2019-04-17 02:50:27 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-starts-phase-trial-of-zyan-for-treating-anemia 2019-04-17 02:50:26 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-samsung-biologics-announce-strategic-manufacturing-tieup 2019-04-17 02:50:24 daily 0.1 https://demo.pharmafocusasia.com/news/endo-completes-divestiture-of-litha-healthcare-group 2019-04-17 02:50:22 daily 0.1 https://demo.pharmafocusasia.com/news/exscientia-enters-strategic-drug-discovery-collaboration-with-gsk 2019-04-17 02:50:20 daily 0.1 https://demo.pharmafocusasia.com/news/arbor-pharmaceuticals-and-debiopharm-international-sa-announce-us-fda-approval 2019-04-17 02:50:18 daily 0.1 https://demo.pharmafocusasia.com/news/breckenridge-pharmaceutical-agreement-with-sam-chun-dang-pharm 2019-04-17 02:50:16 daily 0.1 https://demo.pharmafocusasia.com/news/trovagene-announces-manufacturing-agreement-with-nerpharma 2019-04-17 02:50:14 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-completes-sale-of-dendreon-to-sanpower-group 2019-04-17 02:50:13 daily 0.1 https://demo.pharmafocusasia.com/news/cordenpharma-ge-healthcare-offer-oligonucleotide-drug-development daily 0.1 https://demo.pharmafocusasia.com/news/bioverativ-completes-acquisition-of-true-north-therapeutics 2019-04-17 02:50:09 daily 0.1 https://demo.pharmafocusasia.com/news/neurovive-and-yungjin-pharm-start-clinical-development 2019-04-17 02:50:07 daily 0.1 https://demo.pharmafocusasia.com/news/oramed-granted-japanese-patent 2019-04-17 02:50:02 daily 0.1 https://demo.pharmafocusasia.com/news/breckenridge-pharmaceutical-announces-final-anda-approval 2019-04-17 02:50:00 daily 0.1 https://demo.pharmafocusasia.com/news/semnur-pharmaceuticals-announces-successful-phase-trial 2019-04-17 02:49:59 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-says-obesity-drug-helps-up-to-weight-loss-in-phase-trial 2019-04-17 02:49:57 daily 0.1 https://demo.pharmafocusasia.com/news/enanta-announces-that-abbvie-receives-chmp-positive-opinion 2019-04-17 02:49:55 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-ewopharma-announce-commercial-partnership 2019-04-17 02:49:53 daily 0.1 https://demo.pharmafocusasia.com/news/durect-completes-enrollment-in-persist 2019-04-17 02:49:51 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-wins-from-teva-in-coreg-patent-trial 2019-04-17 02:49:49 daily 0.1 https://demo.pharmafocusasia.com/news/seqirus-announces-next-major-advancement 2019-04-17 02:49:47 daily 0.1 https://demo.pharmafocusasia.com/news/almac-discovery-and-debiopharm-international-announce-licensing-agreement 2019-04-17 02:49:45 daily 0.1 https://demo.pharmafocusasia.com/news/icagen-and-omdana-therapeutics-announce-collaboration 2019-04-17 02:49:43 daily 0.1 https://demo.pharmafocusasia.com/news/shangpharma-announces-second-milestone 2019-04-17 02:49:41 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-rigels-new-drug-application 2019-04-17 02:49:39 daily 0.1 https://demo.pharmafocusasia.com/news/lannett-announces-approval-for-amantadine-hydrochloride-capsules 2019-04-17 02:49:37 daily 0.1 https://demo.pharmafocusasia.com/news/intrexon-integrates-leading-adenoviral-gene-delivery-technology 2019-04-17 02:49:36 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-announces-completion-of-acquisition-of-actelion 2019-04-17 02:49:34 daily 0.1 https://demo.pharmafocusasia.com/news/parexel-collaborates-with-sanofi 2019-04-17 02:49:30 daily 0.1 https://demo.pharmafocusasia.com/news/caretta-therapeutics-signs-second-venodol-api-production-agreement 2019-04-17 02:49:27 daily 0.1 https://demo.pharmafocusasia.com/news/covance-opens-laboratory-for-companion-diagnostics 2019-04-17 02:49:25 daily 0.1 https://demo.pharmafocusasia.com/news/numab-and-kaken-pharmaceutical-enter-into-collaboration 2019-04-17 02:49:23 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-lilly-receive-fda-fast-track-designation-for-tanezumab 2019-04-17 02:49:21 daily 0.1 https://demo.pharmafocusasia.com/news/numerate-and-takeda-enter-agreement-to-generate-novel-clinical-candidates 2019-04-17 02:49:19 daily 0.1 https://demo.pharmafocusasia.com/news/eurofins-expands-its-leadership-in-biopharmaceutical-services 2019-04-17 02:49:17 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-regeneron-announce-positive-results 2019-04-17 02:49:13 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-and-pfizer-announce-amendment-to-clinical-research-protocol 2019-04-17 02:49:11 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-strategic-collaboration-with-keybioscience-ag 2019-04-17 02:49:09 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-announces-sale-of-inova-pharmaceuticals 2019-04-17 02:49:07 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-enters-agreement-with-grunenthal 2019-04-17 02:49:06 daily 0.1 https://demo.pharmafocusasia.com/news/abbvies-rheumatoid-arthritis-drug-succeeds-in-trial 2019-04-17 02:49:04 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-to-acquire-keller-medical daily 0.1 https://demo.pharmafocusasia.com/news/veloxis-pharmaceuticals-announces-agreement-with-chiesi-farmaceutici 2019-04-17 02:48:58 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-receives-fda-fast-track-designation-for-tafamidis 2019-04-17 02:48:56 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-announces-new-collaboration 2019-04-17 02:48:54 daily 0.1 https://demo.pharmafocusasia.com/news/saintyco-introduces-portable-mini-fluid-bed-granulator 2019-04-17 02:48:52 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-regeneron-present-positive-study-results 2019-04-17 02:48:51 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-qiagen-sign-agreement 2019-04-17 02:48:49 daily 0.1 https://demo.pharmafocusasia.com/news/obi-pharma-announces-acquisition-from-threshold-pharmaceuticals 2019-04-17 02:48:47 daily 0.1 https://demo.pharmafocusasia.com/news/kd-pharma-group-invests-in-nutriceutical-holdings 2019-04-17 02:48:45 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-and-johns-hopkins-extend-drug-discovery-collaboration 2019-04-17 02:48:43 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-announces-aziyo-biologics-acquires-commercial-products 2019-04-17 02:48:41 daily 0.1 https://demo.pharmafocusasia.com/news/array-biopharma-and-bristol-myers-squibb-announce-strategic-collaboration 2019-04-17 02:48:39 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-enters-agreement-with-xcella-biosciences 2019-04-17 02:48:37 daily 0.1 https://demo.pharmafocusasia.com/news/lysogene-completes-enrollment-in-first-international-pivotal-observational-study 2019-04-17 02:48:35 daily 0.1 https://demo.pharmafocusasia.com/news/celyad-obtains-additional-us-patent-for-cancer-treatment 2019-04-17 02:48:33 daily 0.1 https://demo.pharmafocusasia.com/news/biopharma-services-successfully-completes-fda-inspections 2019-04-17 02:48:32 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharma-gets-anda-approval-for-nebivolol-tablets 2019-04-17 02:48:27 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-receives-fda-approval-for-expanded-use-of-zykadia 2019-04-17 02:48:25 daily 0.1 https://demo.pharmafocusasia.com/news/kite-receives-us-food-and-drug-administration-priority-review 2019-04-17 02:48:23 daily 0.1 https://demo.pharmafocusasia.com/news/optum-and-merck-collaborate 2019-04-17 02:48:21 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-and-eczacibasi-sign-licensing-agreement 2017-05-25 23:48:07 daily 0.1 https://demo.pharmafocusasia.com/news/lsne-contract-manufacturing-agreement-with-selecta-biosciences 2019-04-17 02:48:18 daily 0.1 https://demo.pharmafocusasia.com/news/jsr-life-sciences-expands-production-capacity-at-kbi-biopharma 2019-04-17 02:48:16 daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-international-sa-enters-the-field-of-antibody-drug-conjugates 2019-04-17 02:48:14 daily 0.1 https://demo.pharmafocusasia.com/news/palladio-biosciences-formed-to-develop-transformative-medicines 2019-04-17 02:48:12 daily 0.1 https://demo.pharmafocusasia.com/news/pci-biotech-and-rxi-pharmaceuticals-extend-research-collaboration 2019-04-17 02:48:10 daily 0.1 https://demo.pharmafocusasia.com/news/miraca-life-sciences-again-expands-therapeutic-drug-monitoring 2019-04-17 02:48:08 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-ucb-announce-top-line-phase-data 2019-04-17 02:48:06 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-receives-chmp-recommendation 2019-04-17 02:48:04 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-acquires-remedy-pharmaceuticals-late-stage-drug-cirara 2019-04-17 02:48:02 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-submits-biologics-license-application 2019-04-17 02:48:00 daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-receives-anda-approval-for-amlodipine-tablets 2019-04-17 02:47:59 daily 0.1 https://demo.pharmafocusasia.com/news/generational-equity-announces-sale-of-sl-pharma-labs 2019-04-17 02:47:57 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-completes-acquisition-of-ogeda-sa 2019-04-17 02:47:55 daily 0.1 https://demo.pharmafocusasia.com/news/pharmadax-receives-fda-approval 2019-04-17 02:47:53 daily 0.1 https://demo.pharmafocusasia.com/news/akebia-and-vifor-pharma-announce-exclusive-license-agreement 2019-04-17 02:47:51 daily 0.1 https://demo.pharmafocusasia.com/news/noxxon-pharma-announces-collaboration-with-national-center 2019-04-17 02:47:49 daily 0.1 https://demo.pharmafocusasia.com/news/alembic-pharmaceuticals-receives-usfda-approval 2019-04-17 02:47:47 daily 0.1 https://demo.pharmafocusasia.com/news/thermo-fisher-scientific-said-in-talks-to-acquire-patheon 2019-04-17 02:47:45 daily 0.1 https://demo.pharmafocusasia.com/news/milliporesigma-and-stelis-biopharma-open-first-joint-bioprocess-scale-up-lab 2019-04-17 02:47:43 daily 0.1 https://demo.pharmafocusasia.com/news/capricor-therapeutics-provides-update-on-allstar-trial 2019-04-17 02:47:41 daily 0.1 https://demo.pharmafocusasia.com/news/hitech-pharmaceuticals-forms-joint-venture-with-chinese-conglomerate 2019-04-17 02:47:39 daily 0.1 https://demo.pharmafocusasia.com/news/ribaxamase-receives-breakthrough-therapy-designation 2019-04-17 02:47:37 daily 0.1 https://demo.pharmafocusasia.com/news/otic-pharma-completes-merger-with-tokai-pharmaceuticals 2019-04-17 02:47:36 daily 0.1 https://demo.pharmafocusasia.com/news/sangamo-therapeutics-and-pfizer-announce-collaboration 2019-04-17 02:47:34 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-gammadelta-therapeutics-announce-collaboration 2017-05-10 02:24:00 daily 0.1 https://demo.pharmafocusasia.com/news/pharnext-partnership-with-tasly-pharmaceutical 2019-04-17 02:47:30 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-inovio-enter-clinical-study-agreement 2019-04-17 02:47:28 daily 0.1 https://demo.pharmafocusasia.com/news/patheon-completes-sterile-expansion-project 2019-04-17 02:47:26 daily 0.1 https://demo.pharmafocusasia.com/news/mt-pharma-america-announces-fda-approval-of-radicava 2019-04-17 02:47:24 daily 0.1 https://demo.pharmafocusasia.com/news/cosmo-pharmaceuticals-announces-success-in-clinical-trial-of-eleview 2019-04-17 02:47:22 daily 0.1 https://demo.pharmafocusasia.com/news/quivive-pharma-partners-with-camargo-pharmaceutical 2019-04-17 02:47:21 daily 0.1 https://demo.pharmafocusasia.com/news/protea-and-proteos-announce-co-marketing-agreement 2019-04-17 02:47:19 daily 0.1 https://demo.pharmafocusasia.com/news/carsgen-therapeutics-opens-car-t-cell-manufacturing-facility 2019-04-17 02:47:17 daily 0.1 https://demo.pharmafocusasia.com/news/cannabics-pharmaceuticals-collaboration-with-ctc-european-lab 2019-04-17 02:47:15 daily 0.1 https://demo.pharmafocusasia.com/news/aries-pharmaceuticals-launches-eleview 2019-04-17 02:47:13 daily 0.1 https://demo.pharmafocusasia.com/news/imprimis-pharmaceuticals-and-sightlife-surgical-sign-agreement 2019-04-17 02:47:11 daily 0.1 https://demo.pharmafocusasia.com/news/shire-and-parion-sciences-enter-into-license-agreement 2019-04-17 02:47:09 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-invests-to-expand-production-capacity-for-benlysta 2019-04-17 02:47:07 daily 0.1 https://demo.pharmafocusasia.com/news/neurotrope-announces-positive-top-line-results-from-phase-study-of-bryostatin daily 0.1 https://demo.pharmafocusasia.com/news/allergan-successfully-completes-zeltiq-aesthetics-acquisition 2019-04-17 02:47:04 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-announces-fda-accelerated-approval 2019-04-17 02:47:02 daily 0.1 https://demo.pharmafocusasia.com/news/bridgebio-pharma-launches-eidos-therapeutics 2019-04-17 02:46:57 daily 0.1 https://demo.pharmafocusasia.com/news/savara-announces-closing-of-merger-with-mast-therapeutics 2019-04-17 02:46:54 daily 0.1 https://demo.pharmafocusasia.com/news/heptares-collaboration-with-astrazeneca-yields-new-insights-to-advance-drug-discovery 2019-04-17 02:46:52 daily 0.1 https://demo.pharmafocusasia.com/news/the-medicines-company-and-alnylam-pharmaceuticals-announce-agreement 2019-04-17 02:46:50 daily 0.1 https://demo.pharmafocusasia.com/news/akebia-therapeutics-and-otsuka-pharmaceutical-collaboration 2019-04-17 02:46:48 daily 0.1 https://demo.pharmafocusasia.com/news/tagrisso-receives-full-approval-in-the-eu 2019-04-17 02:46:47 daily 0.1 https://demo.pharmafocusasia.com/news/delmar-pharmaceuticals-collaborates-with-duke-university daily 0.1 https://demo.pharmafocusasia.com/news/novartis-collaboration-with-amgen 2019-04-17 02:46:43 daily 0.1 https://demo.pharmafocusasia.com/news/orexigen-therapeutics-announces-new-drug-submission 2019-04-17 02:46:41 daily 0.1 https://demo.pharmafocusasia.com/news/servier-and-cti-biopharma-expand-license-and-collaboration-agreement 2019-04-17 02:46:39 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-sanofi-receive-positive-chmp-opinion 2019-04-17 02:46:38 daily 0.1 https://demo.pharmafocusasia.com/news/tiziana-life-sciences-approval-of-phase-clinical-trial 2019-04-17 02:46:36 daily 0.1 https://demo.pharmafocusasia.com/news/sawai-pharmaceutical-to-acquire-the-generics-business 2019-04-17 02:46:34 daily 0.1 https://demo.pharmafocusasia.com/news/biomedicine-extends-collaboration 2019-04-17 02:46:32 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-phase-study 2019-04-17 02:46:30 daily 0.1 https://demo.pharmafocusasia.com/news/medis-group-acquisition-of-winthrop-pharma-senegal 2019-04-17 02:46:28 daily 0.1 https://demo.pharmafocusasia.com/news/cytrx-announces-fda-agreement 2019-04-17 02:46:26 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-enters-into-collaboration-with-ribo 2019-04-17 02:46:24 daily 0.1 https://demo.pharmafocusasia.com/news/nivalis-therapeutics-and-alpine-immune-sciences-agree-to-combine 2019-04-17 02:46:22 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-expands-leading-research-development-nash-program 2019-04-17 02:46:20 daily 0.1 https://demo.pharmafocusasia.com/news/rigel-submits-new-drug-application-to-fda 2019-04-17 02:46:18 daily 0.1 https://demo.pharmafocusasia.com/news/genentech-announces-positive-interim-results 2019-04-17 02:46:16 daily 0.1 https://demo.pharmafocusasia.com/news/legochem-biosciences-receives-us-patent 2019-04-17 02:46:14 daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-collaboration-with-northern-biologics 2019-04-17 02:46:12 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-agreements-biogen-and-roche 2019-04-17 02:46:11 daily 0.1 https://demo.pharmafocusasia.com/news/respira-therapeutics-announces-collaboration 2019-04-17 02:46:09 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharmaceuticals-receives-patent 2019-04-17 02:46:07 daily 0.1 https://demo.pharmafocusasia.com/news/kyorin-acquired-licenses-from-merck 2019-04-17 02:46:05 daily 0.1 https://demo.pharmafocusasia.com/news/cellbio-announces-collaboration-agreement-with-ucb 2019-04-17 02:46:03 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-enters-into-strategic-collaboration-with-nubiyota 2019-04-17 02:46:01 daily 0.1 https://demo.pharmafocusasia.com/news/accenture-and-biocelerate-collaborate 2019-04-17 02:45:59 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-announces-discovery-collaboration 2019-04-17 02:45:57 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-two-hepatitis-c-drugs 2019-04-17 02:45:55 daily 0.1 https://demo.pharmafocusasia.com/news/aurinia-development-plans-for-voclosporin 2019-04-17 02:45:53 daily 0.1 https://demo.pharmafocusasia.com/news/imprimis-pharmaceuticals-acquires-exclusive-license 2019-04-17 02:45:51 daily 0.1 https://demo.pharmafocusasia.com/news/therapix-signs-agreement-with-yissum 2019-04-17 02:45:50 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-reaches-settlement-with-hikma-pharmaceuticals 2019-04-17 02:45:48 daily 0.1 https://demo.pharmafocusasia.com/news/meiji-seika-and-eisai-enter-into-collaboration 2019-04-17 02:45:46 daily 0.1 https://demo.pharmafocusasia.com/news/karyopharm-and-medidata-expand-clinical-trial-partnership 2019-04-17 02:45:44 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-completes-acquisition-of-onivyde 2019-04-17 02:45:42 daily 0.1 https://demo.pharmafocusasia.com/news/mundipharma-receives-approval-for-mundesine 2019-04-17 02:45:40 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-to-acquire-ogeda 2019-04-17 02:45:38 daily 0.1 https://demo.pharmafocusasia.com/news/puma-biotechnology-launches-expanded-access-program 2019-04-17 02:45:36 daily 0.1 https://demo.pharmafocusasia.com/news/miragen-therapeutics-receives-orphan-drug-designation 2019-04-17 02:45:35 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-wins-tecfidera-us-patent-dispute 2019-04-17 02:45:30 daily 0.1 https://demo.pharmafocusasia.com/news/espero-pharmaceuticals-and-armetheon-to-merge 2019-04-17 02:45:28 daily 0.1 https://demo.pharmafocusasia.com/news/hilleman-laboratories-signs-mou-with-niced 2019-04-17 02:45:26 daily 0.1 https://demo.pharmafocusasia.com/news/avillion-signs-agreement-with-merck 2019-04-17 02:45:24 daily 0.1 https://demo.pharmafocusasia.com/news/vanda-and-ucsf-announce-license-agreement 2019-04-17 02:45:22 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-completes-acquisition-of-cold-eeze-brand 2017-03-29 23:30:09 daily 0.1 https://demo.pharmafocusasia.com/news/sonoma-pharmaceuticals-receives-us-fda-clearance 2019-04-17 02:45:19 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-and-paratek-announce-positive-results 2019-04-17 02:45:17 daily 0.1 https://demo.pharmafocusasia.com/news/orexigen-therapeutics-agreement-with-bruno-farmaceutici 2019-04-17 02:45:15 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-completes-divestiture-of-tysabri 2019-04-17 02:45:13 daily 0.1 https://demo.pharmafocusasia.com/news/newron-presents-results-of-its-phase-study 2019-04-17 02:45:11 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-investment-in-us 2019-04-17 02:45:10 daily 0.1 https://demo.pharmafocusasia.com/news/chmp-provides-positive-opinion 2019-04-17 02:45:08 daily 0.1 https://demo.pharmafocusasia.com/news/shangpharma-announces-strategic-corporate-restructuring 2019-04-17 02:45:06 daily 0.1 https://demo.pharmafocusasia.com/news/biolinerx-announces-acquisition-of-agalimmune 2019-04-17 02:45:04 daily 0.1 https://demo.pharmafocusasia.com/news/calico-strategic-partnership 2019-04-17 02:45:02 daily 0.1 https://demo.pharmafocusasia.com/news/elbit-imaging-announces-ema-orphan-drug-designation 2019-04-17 02:45:00 daily 0.1 https://demo.pharmafocusasia.com/news/aprea-therapeutics-research-collaboration 2019-04-17 02:44:58 daily 0.1 https://demo.pharmafocusasia.com/news/moleculin-receives-orphan-drug-designation 2019-04-17 02:44:57 daily 0.1 https://demo.pharmafocusasia.com/news/intec-pharma-initiates-phase-trial 2019-04-17 02:44:55 daily 0.1 https://demo.pharmafocusasia.com/news/pierre-fabre-and-h-immune-partnership daily 0.1 https://demo.pharmafocusasia.com/news/pulmatrix-receives-european-patent 2019-04-17 02:44:51 daily 0.1 https://demo.pharmafocusasia.com/news/argenx-collaboration-broteio-pharma 2019-04-17 02:44:49 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-cytomx-therapeutics-collaboration 2019-04-17 02:44:47 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-completes-sale 2019-04-17 02:44:46 daily 0.1 https://demo.pharmafocusasia.com/news/novaliq-gmbh-agreement-aft-pharmaceuticals 2019-04-17 02:44:44 daily 0.1 https://demo.pharmafocusasia.com/news/jj-and-bayers-xarel-to-cuts-recurrence 2019-04-17 02:44:42 daily 0.1 https://demo.pharmafocusasia.com/news/array-biopharma-provides-nemo-update 2019-04-17 02:44:40 daily 0.1 https://demo.pharmafocusasia.com/news/acura-pharmaceuticals-and-mainpointe-pharmaceuticals-deal 2019-04-17 02:44:38 daily 0.1 https://demo.pharmafocusasia.com/news/threshold-pharmaceuticals-and-molecular-templates-agree-to-combine 2019-04-17 02:44:36 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-agreement-marathon 2019-04-17 02:44:34 daily 0.1 https://demo.pharmafocusasia.com/news/kadimastem-granted-patent-in-the-us 2019-04-17 02:44:32 daily 0.1 https://demo.pharmafocusasia.com/news/alkermes-initiates-phase-study 2019-04-17 02:44:30 daily 0.1 https://demo.pharmafocusasia.com/news/trovagene-and-nerviano-agreement 2019-04-17 02:44:28 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-collaborates-with-icf 2019-04-17 02:44:26 daily 0.1 https://demo.pharmafocusasia.com/news/glycyx-pharmaventures-and-valeant-pharmaceuticals-agree 2019-04-17 02:44:24 daily 0.1 https://demo.pharmafocusasia.com/news/biocept-and-catalyst-pharmaceuticals-collaborate 2019-04-17 02:44:22 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-launches-zavicefta 2019-04-17 02:44:20 daily 0.1 https://demo.pharmafocusasia.com/news/amo-pharma-collaboration-agreement 2019-04-17 02:44:19 daily 0.1 https://demo.pharmafocusasia.com/news/neogenomics-and-definiens-enter-into-agreement 2019-04-17 02:44:17 daily 0.1 https://demo.pharmafocusasia.com/news/charles-river-laboratories-and-chiesi-farmaceutici-spa 2019-04-17 02:44:15 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-announces-global-settlement 2019-04-17 02:44:13 daily 0.1 https://demo.pharmafocusasia.com/news/midatech-announces-successful-initial-scale-up 2019-04-17 02:44:11 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-launches-generic-pristiq-tablets 2019-04-17 02:44:09 daily 0.1 https://demo.pharmafocusasia.com/news/amring-pharmaceuticals-acquired-six-andas 2019-04-17 02:44:07 daily 0.1 https://demo.pharmafocusasia.com/news/pharnext-agreement-galapagos 2019-04-17 02:44:03 daily 0.1 https://demo.pharmafocusasia.com/news/bioreclamationivt-acquires-transcell-science 2019-04-17 02:44:01 daily 0.1 https://demo.pharmafocusasia.com/news/kitov-announces-license-agreement 2019-04-17 02:43:59 daily 0.1 https://demo.pharmafocusasia.com/news/abeona-therapeutics-receives-orphan-drug-designation 2019-04-17 02:43:57 daily 0.1 https://demo.pharmafocusasia.com/news/apricus-biosciences-sale-to-ferring-pharmaceuticals 2019-04-17 02:43:55 daily 0.1 https://demo.pharmafocusasia.com/news/beigene-and-guangzhou-development-district-establish-joint-venture 2019-04-17 02:43:53 daily 0.1 https://demo.pharmafocusasia.com/news/kasten-completes-merger-with-dakota-life-sciences 2019-04-17 02:43:51 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharmaceuticals-receives-fda-clearance 2019-04-17 02:43:49 daily 0.1 https://demo.pharmafocusasia.com/news/vernalis-plc-and-servier-collaboration 2019-04-17 02:43:47 daily 0.1 https://demo.pharmafocusasia.com/news/nuvox-pharma-and-the-university-of-arkansas-initiate-clinical-trial 2019-04-17 02:43:45 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-cabozantinib-granted-orphan-drug-designation 2019-04-17 02:43:43 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-regeneron-say-latest-drug-tests-positive 2019-04-17 02:43:41 daily 0.1 https://demo.pharmafocusasia.com/news/concert-pharmaceuticals-ctp-phase-results 2019-04-17 02:43:39 daily 0.1 https://demo.pharmafocusasia.com/news/sartorius-to-acquire-us-based-essen-bioscience 2019-04-17 02:43:37 daily 0.1 https://demo.pharmafocusasia.com/news/cardiome-announces-commercial-launch-of-xydalba 2019-04-17 02:43:35 daily 0.1 https://demo.pharmafocusasia.com/news/integral-molecular-and-integrated-biotherapeutics-collaboration 2019-04-17 02:43:33 daily 0.1 https://demo.pharmafocusasia.com/news/otsuka-pharmaceutical-to-acquire-neurovance 2019-04-17 02:43:31 daily 0.1 https://demo.pharmafocusasia.com/news/synthon-biopharmaceuticals-enters-collaboration 2019-04-17 02:43:30 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-completes-acquisition-of-colucid-pharmaceuticals 2019-04-17 02:43:28 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-launch-of-generic-pristiq 2019-04-17 02:43:26 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharmaceuticals-and-evestra-announce-partnership 2019-04-17 02:43:24 daily 0.1 https://demo.pharmafocusasia.com/news/baxter-and-scinopharm-announce-partnership 2019-04-17 02:43:22 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-lexicon-pharmas-drug 2019-04-17 02:43:20 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-pharmaceuticals-expands-license-with-sermonix 2019-04-17 02:43:18 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-signs-agreement-to-divest-tysabri 2017-02-27 23:49:15 daily 0.1 https://demo.pharmafocusasia.com/news/arsanis-and-adimab-enter-into-license-agreement 2019-04-17 02:43:14 daily 0.1 https://demo.pharmafocusasia.com/news/regenerx-licensee-receives-fda-permission 2019-04-17 02:43:13 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-lonza-enter-into-strategic-partnership 2019-04-17 02:43:11 daily 0.1 https://demo.pharmafocusasia.com/news/xynomic-pharma-has-acquired-worldwide-rights 2019-04-17 02:43:09 daily 0.1 https://demo.pharmafocusasia.com/news/intellipharmaceutics-announces-fda-approval 2019-04-17 02:43:07 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-acquires-inderal-xl-and-innopran-xl 2019-04-17 02:43:05 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-wins-chmp-nod-for-drug-combo 2019-04-17 02:43:03 daily 0.1 https://demo.pharmafocusasia.com/news/santen-and-twoxar-announce-strategic-collaboration 2019-04-17 02:43:01 daily 0.1 https://demo.pharmafocusasia.com/news/finch-therapeutics-collaboration-with-openbiome 2019-04-17 02:42:59 daily 0.1 https://demo.pharmafocusasia.com/news/cyclacels-leukemia-drug-for-elderly-patients-fails-in-key-study 2019-04-17 02:42:58 daily 0.1 https://demo.pharmafocusasia.com/news/soligenix-receives-european-patent 2019-04-17 02:42:56 daily 0.1 https://demo.pharmafocusasia.com/news/ppd-expands-nephrology-capabilities 2019-04-17 02:42:54 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-and-eyegate-enter-agreement 2019-04-17 02:42:52 daily 0.1 https://demo.pharmafocusasia.com/news/amri-entered-into-agreement 2019-04-17 02:42:50 daily 0.1 https://demo.pharmafocusasia.com/news/fda-rejects-amphastars-nasal-opioid-overdose-treatment 2019-04-17 02:42:48 daily 0.1 https://demo.pharmafocusasia.com/news/icon-selected-by-the-fda-to-validate 2019-04-17 02:42:46 daily 0.1 https://demo.pharmafocusasia.com/news/xbrane-biopharma-obtains-gmp-certification 2019-04-17 02:42:44 daily 0.1 https://demo.pharmafocusasia.com/news/immune-pharmaceuticals-announces-the-launch-of-remain 2017-02-21 00:03:06 daily 0.1 https://demo.pharmafocusasia.com/news/ctt-pharmaceutical-holdings-and-cannimed-therapeutics-licensing-agreement 2019-04-17 02:42:41 daily 0.1 https://demo.pharmafocusasia.com/news/health-canada-approves-otsuka-and-lundbecks-rexulti 2019-04-17 02:42:39 daily 0.1 https://demo.pharmafocusasia.com/news/imprimis-pharmaceuticals-begins-dispensing daily 0.1 https://demo.pharmafocusasia.com/news/dauntless-pharmaceuticals-announces-of-phase-trial daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-receives-second-orphan-drug daily 0.1 https://demo.pharmafocusasia.com/news/xchem-expands-collaboration-with-janssen 2019-04-17 02:42:29 daily 0.1 https://demo.pharmafocusasia.com/news/mayne-pharma-launches-butalbital-acetaminophen-tablets 2019-04-17 02:42:27 daily 0.1 https://demo.pharmafocusasia.com/news/solasia-and-lees-pharma-announce-agreement 2019-04-17 02:42:25 daily 0.1 https://demo.pharmafocusasia.com/news/pra-health-sciences-and-takeda-partnership-expands-to-japan 2019-04-17 02:42:23 daily 0.1 https://demo.pharmafocusasia.com/news/tilray-announces-medical-cannabis-export-to-new-zealand- daily 0.1 https://demo.pharmafocusasia.com/news/novimmune-and-legochem-biosciences-enter-collaboration 2019-04-17 02:42:20 daily 0.1 https://demo.pharmafocusasia.com/news/rprd-diagnostics-announces-strategic-collaboration 2019-04-17 02:42:18 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-to-buy-zeltiq-aesthetics 2019-04-17 02:42:16 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-and-foresee-pharmaceuticals-enter-into-agreement 2019-04-17 02:42:14 daily 0.1 https://demo.pharmafocusasia.com/news/acacia-pharma-announces-positive-results 2019-04-17 02:42:12 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-marathon-pharmaceuticals-drug 2019-04-17 02:42:10 daily 0.1 https://demo.pharmafocusasia.com/news/ovid-therapeutics-and-neuropointdx-announce-collaboration 2019-04-17 02:42:08 daily 0.1 https://demo.pharmafocusasia.com/news/tracon-pharmaceuticals-announces-top-line-results 2019-04-17 02:42:06 daily 0.1 https://demo.pharmafocusasia.com/news/restylane-refyne-and-defyne-dermal-fillers daily 0.1 https://demo.pharmafocusasia.com/news/acceliant-awarded-who-drug-medical-coding-certification 2019-04-17 02:42:03 daily 0.1 https://demo.pharmafocusasia.com/news/epinomics-to-collaborate-with-the-parker daily 0.1 https://demo.pharmafocusasia.com/news/amri-announces-strategic-alliance 2019-04-17 02:42:00 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-amgens-parsabiv 2019-04-17 02:41:58 daily 0.1 https://demo.pharmafocusasia.com/news/vyome-biosciences-announces-results 2019-04-17 02:41:56 daily 0.1 https://demo.pharmafocusasia.com/news/strata-oncology-announces-collaboration-with-epizyme 2017-02-07 22:44:51 daily 0.1 https://demo.pharmafocusasia.com/news/aura-biosciences-receives-fda-clearance daily 0.1 https://demo.pharmafocusasia.com/news/quotient-clinical-expands daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-two-sblas-for-mercks-keytruda 2017-02-06 00:28:05 daily 0.1 https://demo.pharmafocusasia.com/news/portola-pharmaceuticals-signs-million-royalty-agreement 2019-04-17 02:41:47 daily 0.1 https://demo.pharmafocusasia.com/news/cocoon-biotech-announces-partnership 2019-04-17 02:41:46 daily 0.1 https://demo.pharmafocusasia.com/news/lysogene-receives-orphan-drug-designation daily 0.1 https://demo.pharmafocusasia.com/news/teva-confirms-generic-victoza-patent-challenge 2019-04-17 02:41:42 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-completes-lifecell-acquisition 2019-04-17 02:41:40 daily 0.1 https://demo.pharmafocusasia.com/news/meridian-lab-and-apobiologix-enter-into-agreement 2019-04-17 02:41:38 daily 0.1 https://demo.pharmafocusasia.com/news/hope-biosciences-acquires-worldwide-rights-from-neopharm 2019-04-17 02:41:36 daily 0.1 https://demo.pharmafocusasia.com/news/noxopharm-entered-into-research-agreement 2019-04-17 02:41:34 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-to-acquire-primary-care-platform 2019-04-17 02:41:33 daily 0.1 https://demo.pharmafocusasia.com/news/gensight-biologics-receives-fda-orphan-drug-designation 2019-04-17 02:41:31 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-to-sell-intrathecal-therapy-business 2019-04-17 02:41:29 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-pharmaceuticals-enter-license-agreement 2019-04-17 02:41:27 daily 0.1 https://demo.pharmafocusasia.com/news/endo-announces-us-fda-approval 2019-04-17 02:41:25 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-and-ironwood-positive-top-line-results 2019-04-17 02:41:23 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-completes-sale-of-its-nuclear-imaging-business 2019-04-17 02:41:21 daily 0.1 https://demo.pharmafocusasia.com/news/vicore-pharma-is-granted-orphan-drug-designation 2019-04-17 02:41:20 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-to-acquire-delinia 2019-04-17 02:41:18 daily 0.1 https://demo.pharmafocusasia.com/news/medtronic-receives-ide-approval-to-initiate-study 2019-04-17 02:41:16 daily 0.1 https://demo.pharmafocusasia.com/news/crownbio-announces-expansion-of-life-science-division 2019-04-17 02:41:14 daily 0.1 https://demo.pharmafocusasia.com/news/european-commission-grants-orphan-drug-designation 2019-04-17 02:41:12 daily 0.1 https://demo.pharmafocusasia.com/news/biocon-wins-contract-from-moh 2019-04-17 02:41:10 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-enters-drug-discovery-collaboration 2019-04-17 02:41:09 daily 0.1 https://demo.pharmafocusasia.com/news/ethypharm-acquires-martindale-pharma 2019-04-17 02:41:07 daily 0.1 https://demo.pharmafocusasia.com/news/symbiomix-therapeutics 2019-04-17 02:41:05 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-and-colucid-pharmaceuticals-announce-agreement 2019-04-17 02:41:03 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-and-ovid-therapeutics-announce-collaboration 2019-04-17 02:41:01 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-mars-innovation-establish-strategic-partnership 2019-04-17 02:41:00 daily 0.1 https://demo.pharmafocusasia.com/news/progenra-discovers-novel-immune-oncology-drug 2019-04-17 02:40:58 daily 0.1 https://demo.pharmafocusasia.com/news/milliporesigma-opens-production-facility-in-spain 2019-04-17 02:40:53 daily 0.1 https://demo.pharmafocusasia.com/news/benitec-biopharma-receives-orphan-drug-designation-in-the-european-union 2019-04-17 02:40:51 daily 0.1 https://demo.pharmafocusasia.com/news/brazil-issues-first-license-for-sale-of-cannabis-based-drug 2019-04-17 02:40:49 daily 0.1 https://demo.pharmafocusasia.com/news/sunovion-announces-pivotal-study-results-for-novel-drug-candidate-dasotraline 2019-04-17 02:40:47 daily 0.1 https://demo.pharmafocusasia.com/news/us-supreme-court-agrees-to-hear-dispute-over-biologic-drug-sales 2019-04-17 02:40:45 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-launches-generic-morphine-sulfate-tablets-in-us 2019-04-17 02:40:44 daily 0.1 https://demo.pharmafocusasia.com/news/kitov-pharmaceuticals-enters-immuno-oncology-field-through-acquisition-of-tyrnovo 2019-04-17 02:40:42 daily 0.1 https://demo.pharmafocusasia.com/news/harrington-discovery-institute-and-alzheimers-drug-discovery-foundation-expand-collaboration 2019-04-17 02:40:40 daily 0.1 https://demo.pharmafocusasia.com/news/shionogi-announces-positive-top-line-results-for-cefiderocol-pivotal-cuti-clinical-trial 2019-04-17 02:40:38 daily 0.1 https://demo.pharmafocusasia.com/news/maverick-therapeutics-and-takeda-announce-collaboration 2019-04-17 02:40:36 daily 0.1 https://demo.pharmafocusasia.com/news/aralez-pharmaceuticals-announces-issuance-of-additional-us-patent-for-yosprala 2019-04-17 02:40:34 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-accepts-biologics-license-application-for-mylan 2019-04-17 02:40:33 daily 0.1 https://demo.pharmafocusasia.com/news/viracyte-granted-us-fda-fast-track-designation-for-viralym-c 2019-04-17 02:40:31 daily 0.1 https://demo.pharmafocusasia.com/news/chi-med-initiates-hmpl-clinical-trials-in-hematological-cancer 2019-04-17 02:40:29 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-to-sell-dendreon-to-sanpower-group 2019-04-17 02:40:27 daily 0.1 https://demo.pharmafocusasia.com/news/zebra-biologics-to-collaborate-with-abbvie 2019-04-17 02:40:25 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-to-acquire-ariad-pharmaceuticals 2019-04-17 02:40:23 daily 0.1 https://demo.pharmafocusasia.com/news/pure-mhc-to-partner-with-abbvie-on-oncology-research 2019-04-17 02:40:21 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-to-acquire-oncology-assets-from-merrimack-pharmaceuticals 2019-04-17 02:40:19 daily 0.1 https://demo.pharmafocusasia.com/news/enzyvant-to-develop-novel-biologic-therapy 2019-04-17 02:40:18 daily 0.1 https://demo.pharmafocusasia.com/news/mast-therapeutics-and-savara-sign-merger-agreement 2019-04-17 02:40:16 daily 0.1 https://demo.pharmafocusasia.com/news/ambrx-and-mabspace-biosciences-to-collaborate 2019-04-17 02:40:14 daily 0.1 https://demo.pharmafocusasia.com/news/ptc-therapeutics-announces-initiation-of-firefish-study 2019-04-17 02:40:12 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-and-pvp-biologics-announce-development-agreement 2019-04-17 02:40:10 daily 0.1 https://demo.pharmafocusasia.com/news/custopharm-acquires-two-anda-pharmaceutical-products-from-perrigo 2019-04-17 02:40:08 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-grants-orphan-drug-designation-to-yisheng-biopharmas-pika-rabies-vaccine 2019-04-17 02:40:06 daily 0.1 https://demo.pharmafocusasia.com/news/senhwa-biosciences-cx-granted-orphan-drug-designation-by-the-us-fda 2019-04-17 02:40:04 daily 0.1 https://demo.pharmafocusasia.com/news/sharp-edge-labs-enters-into-collaboration-with-sumitomo-dainippon-pharma 2019-04-17 02:40:03 daily 0.1 https://demo.pharmafocusasia.com/news/marinus-pharmaceuticals-receives-fda-orphan-drug-designation-for-ganaxolone 2019-04-17 02:40:01 daily 0.1 https://demo.pharmafocusasia.com/news/dermira-initiates-phase-clinical-program-in-acne 2019-04-17 02:39:59 daily 0.1 https://demo.pharmafocusasia.com/news/suven-life-sciences-secures-two-product-patents-in-eurasia-and-norway 2019-04-17 02:39:57 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-gets-usfda-nod-for-cevimeline-hydrochloride-capsules 2019-04-17 02:39:55 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-pasteur-and-msd-end-joint-vaccines-business-in-europe 2019-04-17 02:39:53 daily 0.1 https://demo.pharmafocusasia.com/news/new-drug-approvals-fall-to-six-year-low 2019-04-17 02:39:51 daily 0.1 https://demo.pharmafocusasia.com/news/eurofins-scientific-to-acquire-villapharma-in-spain 2019-04-17 02:39:49 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-rejects-cempras-antibiotic-for-pneumonia 2019-04-17 02:39:47 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-launches-generic-zovia-tablets 2019-04-17 02:39:46 daily 0.1 https://demo.pharmafocusasia.com/news/versartis-enters-commercial-supply-agreement 2019-04-17 02:39:44 daily 0.1 https://demo.pharmafocusasia.com/news/shire-announces-fda-approval-of-adynovate 2019-04-17 02:39:42 daily 0.1 https://demo.pharmafocusasia.com/news/apricus-biosciences-announces-the-launch-of-vitaros 2019-04-17 02:39:40 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-gets-usfda-nod-for-hypertension-treatment-drug-in-us 2019-04-17 02:39:38 daily 0.1 https://demo.pharmafocusasia.com/news/kubota-pharmaceutical-holdings-signs-letter-of-intent 2019-04-17 02:39:36 daily 0.1 https://demo.pharmafocusasia.com/news/kyorin-holdings-to-transfer-unit-to-taisho-pharmaceutical 2019-04-17 02:39:34 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-acquisition-of-small-molecule-anti-infective-business-from-astrazeneca 2019-04-17 02:39:32 daily 0.1 https://demo.pharmafocusasia.com/news/taro-announces-sale-of-us-rights-to-keveyis daily 0.1 https://demo.pharmafocusasia.com/news/dipexium-pharmaceuticals-and-plx-pharma-announce-merger-agreement 2019-04-17 02:39:26 daily 0.1 https://demo.pharmafocusasia.com/news/roches-emicizumab-for-haemophilia-a-meets-primary-endpoint-in-phase-study 2019-04-17 02:39:24 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-and-chugai-pharmaceutical-enter-into-license-agreement 2019-04-17 02:39:22 daily 0.1 https://demo.pharmafocusasia.com/news/incyte-and-merus-entered-into-research-collaboration 2019-04-17 02:39:21 daily 0.1 https://demo.pharmafocusasia.com/news/concert-pharmaceuticals-initiates-phase-clinical-trial 2019-04-17 02:39:19 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-out-licenses-three-copd-products-in-the-us 2019-04-17 02:39:17 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-to-acquire-acelity-lp-incs-lifecell-corporation 2019-04-17 02:39:15 daily 0.1 https://demo.pharmafocusasia.com/news/soligenix-advances-collaboration-with-idt-biologika 2019-04-17 02:39:13 daily 0.1 https://demo.pharmafocusasia.com/news/x-chem-entered-into-multi-target-drug-discovery-collaboration-with-taiho-pharmaceutical 2019-04-17 02:39:11 daily 0.1 https://demo.pharmafocusasia.com/news/aurinia-pharmaceuticals-entered-agreement-with-lonza 2019-04-17 02:39:09 daily 0.1 https://demo.pharmafocusasia.com/news/cureduchenne-ventures-invests-in-trinds-to-provide-clinical-trial-solutions 2019-04-17 02:39:07 daily 0.1 https://demo.pharmafocusasia.com/news/fda-orphan-drug-designation-granted-to-profounda 2019-04-17 02:39:05 daily 0.1 https://demo.pharmafocusasia.com/news/ionis-pharmaceuticals-earns-from-astrazeneca-for-new-drug 2019-04-17 02:39:04 daily 0.1 https://demo.pharmafocusasia.com/news/regenerx-receives-notice-of-intent-to-grant-patent-in-eu 2019-04-17 02:39:02 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-celgene-enter-into-drug-discovery-collaboration 2019-04-17 02:39:00 daily 0.1 https://demo.pharmafocusasia.com/news/baxter-international-to-acquire-claris-injectables-limited 2019-04-17 02:38:58 daily 0.1 https://demo.pharmafocusasia.com/news/bluebird-bio-and-apceth-biopharma-establish-manufacturing-agreement 2019-04-17 02:38:56 daily 0.1 https://demo.pharmafocusasia.com/news/cfda-granted-approval-for-clinical-trials-of-fadanafil-drug 2019-04-17 02:38:54 daily 0.1 https://demo.pharmafocusasia.com/news/intelgenx-and-redhill-biopharma-signed-license-agreement-with-pharmatronic 2019-04-17 02:38:52 daily 0.1 https://demo.pharmafocusasia.com/news/sage-therapeutics-announces-initiation-of-phase-clinical-development 2019-04-17 02:38:50 daily 0.1 https://demo.pharmafocusasia.com/news/medicure-announces-filing-of-anda-in-collaboration-with-apicore 2019-04-17 02:38:49 daily 0.1 https://demo.pharmafocusasia.com/news/ab-initio-announces-collaboration-agreement-with-pfizer 2019-04-17 02:38:47 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-pharma-to-transfer-the-exclusive-rights-for-qutenza-to-grunenthal 2019-04-17 02:38:45 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-moebius-medical-sign-exclusive-global-licensing-deal 2019-04-17 02:38:43 daily 0.1 https://demo.pharmafocusasia.com/news/bioinvent-international-terminates-current-phase-study 2019-04-17 02:38:41 daily 0.1 https://demo.pharmafocusasia.com/news/sunshine-biopharma-signs-strategic-alliance-agreement-with-atlas-pharma 2019-04-17 02:38:39 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-lilly-enter-into-agreement 2019-04-17 02:38:37 daily 0.1 https://demo.pharmafocusasia.com/news/fda-has-granted-orphan-drug-designation-request-for-biohaven-pharmaceuticals 2019-04-17 02:38:36 daily 0.1 https://demo.pharmafocusasia.com/news/advanced-accelerator-applications-announces-cms-pass-through-reimbursement-code-for-its-first-fda-approved-drug-netspot-r 2019-04-17 02:38:34 daily 0.1 https://demo.pharmafocusasia.com/news/cardiome-announces-commercial-launch-of-xydalba-tm-dalbavancin-in-the-uk 2019-04-17 02:38:32 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-announces-detailed-results-of-solanezumab-phase-expedition-study-at-the-clinical-trials-on-alzheimers-disease-ctad-meeting 2019-04-17 02:38:30 daily 0.1 https://demo.pharmafocusasia.com/news/biohaven-announces-orphan-drug-designation-request-granted-for-bhv-in-the-treatment-of-amyotrophic-lateral-sclerosis-als daily 0.1 https://demo.pharmafocusasia.com/news/novartis-lucentis-received-eu-approval-in-new-indication-lucentis-the-only-treatment-available-for-a-wide-range-of-cnv-conditions daily 0.1 https://demo.pharmafocusasia.com/news/enyo-pharma-receives-a-million-grant-from-eu-under-the-horizon-sme-instrument-phase-programme-for-its-project-mimesis 2019-04-17 02:38:25 daily 0.1 https://demo.pharmafocusasia.com/news/hpharma-aquires-rights-to-mayne-pharma-products 2019-04-17 02:38:23 daily 0.1 https://demo.pharmafocusasia.com/news/saneca-to-drive-rd-initiative-following-million-funding 2019-04-17 02:38:21 daily 0.1 https://demo.pharmafocusasia.com/news/aduro-biotech-announces-anti-cd-agonist-an-investigational-anti-cancer-immunotherapy-advancing-in-collaboration-with-msd- daily 0.1 https://demo.pharmafocusasia.com/news/purdue-pharma-and-anabios-collaborate-to-advance-research-for-non-opioid-non-nsaid-treatments-for-chronic-pain 2019-04-17 02:38:17 daily 0.1 https://demo.pharmafocusasia.com/news/global-pharmaceutical-company-to-invest-m-in-dublin-site 2019-04-17 02:38:15 daily 0.1 https://demo.pharmafocusasia.com/news/-solasia-pharma-and-meiji-seika-pharma-announce-license-and-distribution-agreement-for-episil-oral-liquid 2016-12-05 22:53:53 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-initiates-rolling-submission-of-us-biologics-license-application-bla-for-kte-cd-its-investigational-anti-cd-car-t-therapy-for-the-treatment-of-patients-with-relapsed-refractory-ag 2016-12-05 22:50:54 daily 0.1 https://demo.pharmafocusasia.com/news/ppi-to-manufacture-msd-medicines-approved-by-sfda 2019-04-17 02:38:10 daily 0.1 https://demo.pharmafocusasia.com/news/cancer-drugs-included-in-new-pharmac-deal- daily 0.1 https://demo.pharmafocusasia.com/news/acetylon-pharmaceuticals-entered-into-an-agreement-to-be-acquired-by-celgene-corporation 2019-04-17 02:38:07 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-allergan-apply-for-european-nod-for-avastin-biosimilar 2019-04-17 02:38:05 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-in-broad-drug-deal-with-bicycle-therapeutics 2019-04-17 02:38:03 daily 0.1 https://demo.pharmafocusasia.com/news/diplomat-to-dispense-multiple-myeloma-combination-drug-darzalex 2019-04-17 02:38:01 daily 0.1 https://demo.pharmafocusasia.com/news/merck-wins-uk-okay-for-keytruda-in-lung-cancer-after-price-cut 2019-04-17 02:37:59 daily 0.1 https://demo.pharmafocusasia.com/news/celldex-therapeutics-completes-acquisition-of-kolltan-pharmaceuticals 2019-04-17 02:37:57 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-biotech-asthma-drug-wins-uk-approval-after-extra-price-cut 2019-04-17 02:37:53 daily 0.1 https://demo.pharmafocusasia.com/news/industry-warns-of-brexit-uncertainty-for-thousands-of-medicines 2019-04-17 02:37:51 daily 0.1 https://demo.pharmafocusasia.com/news/west-pharmaceutical-announces-expanded-contract-manufacturing-capabilities-in-ireland 2019-04-17 02:37:49 daily 0.1 https://demo.pharmafocusasia.com/news/german-merck-pfizer-get-fda-priority-review-for-cancer-drug 2019-04-17 02:37:47 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-reports-tresiba-insulin-achieves-target-in-study 2019-04-17 02:37:45 daily 0.1 https://demo.pharmafocusasia.com/news/idera-pharmaceuticals-and-vivelix-pharmaceuticals-enter-into-exclusive-license-agreement 2019-04-17 02:37:43 daily 0.1 https://demo.pharmafocusasia.com/news/patheon-to-acquire-active-pharmaceutical-ingredients-manufacturing-facility 2019-04-17 02:37:41 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-launches-first-branded-drug-bromsite-in-us 2019-04-17 02:37:39 daily 0.1 https://demo.pharmafocusasia.com/news/monosol-rx-filed-new-drug-application-with-us-fda 2019-04-17 02:37:37 daily 0.1 https://demo.pharmafocusasia.com/news/galapagos-nv-reports-initiation-of-a-phase-study-with-glpg 2019-04-17 02:37:35 daily 0.1 https://demo.pharmafocusasia.com/news/fps-still-looks-ahead 2019-04-17 02:37:34 daily 0.1 https://demo.pharmafocusasia.com/news/pharmamar-begins-phase-study 2019-04-17 02:37:32 daily 0.1 https://demo.pharmafocusasia.com/news/galenica-says-fda-approves-supplemental-new-drug-application-for-veltassa 2019-04-17 02:37:30 daily 0.1 https://demo.pharmafocusasia.com/news/jj-makes-takeover-approach-for-swiss-drugmaker-actelion 2019-04-17 02:37:28 daily 0.1 https://demo.pharmafocusasia.com/news/intellipharmaceutics-submits-new-drug-application-for-rexista 2019-04-17 02:37:26 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-divests-pediacare 2019-04-17 02:37:24 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-chases-astra-with-start-of-big-anemia-drug-trials 2019-04-17 02:37:22 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-fosun-pharmaceutical-group-unit-gets-gmp-certificate 2019-04-17 02:37:20 daily 0.1 https://demo.pharmafocusasia.com/news/neovacs-signs-production-partnership 2019-04-17 02:37:18 daily 0.1 https://demo.pharmafocusasia.com/news/lillys-drug-for-alzheimers-fails-big-trial-shares-drop 2019-04-17 02:37:16 daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-biologics-and-prima-signs-mou-and-announces-strategic-development 2019-04-17 02:37:14 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-acquires-chase-pharmaceuticals 2019-04-17 02:37:12 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-cleared-to-resume-enrolment-in-cancer-drug-trials 2019-04-17 02:37:11 daily 0.1 https://demo.pharmafocusasia.com/news/novo-sanofi-go-head-to-head-as-fda-clears-new-diabetes-drugs 2019-04-17 02:37:09 daily 0.1 https://demo.pharmafocusasia.com/news/primex-pharmaceuticals-acquired-italian-leader-ogna 2019-04-17 02:37:07 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-novo-nordisks-diabetes-drug 2019-04-17 02:37:05 daily 0.1 https://demo.pharmafocusasia.com/news/arog-pharmaceuticals-receives-orphan-drug-designation 2019-04-17 02:37:03 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-declines-senate-committee-request-to-testify-about-epipen 2019-04-17 02:37:01 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-buys-us-blood-disease-drugmaker 2019-04-17 02:36:59 daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-seeks-us-approval-for-triple-lung-drug 2019-04-17 02:36:57 daily 0.1 https://demo.pharmafocusasia.com/news/pharmakea-extends-collaboration-with-celgene-corporation 2019-04-17 02:36:55 daily 0.1 https://demo.pharmafocusasia.com/news/spectrum-pharma-says-fda-rejects-its-bladder-cancer-drug 2019-04-17 02:36:53 daily 0.1 https://demo.pharmafocusasia.com/news/reviva-pharmaceuticals-receives-fda-orphan-designation 2019-04-17 02:36:52 daily 0.1 https://demo.pharmafocusasia.com/news/who-says-funds-secured-for-africa-pilots-of-worlds-first-malaria-vaccine 2019-04-17 02:36:50 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-novartis-aim-for-big-crowded-migraine-market-after-new-drug-data 2019-04-17 02:36:48 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-and-enterome-announce-immuno-oncology-collaboration 2019-04-17 02:36:46 daily 0.1 https://demo.pharmafocusasia.com/news/amgens-migraine-drug-succeeds-in-late-stage-trial 2019-04-17 02:36:44 daily 0.1 https://demo.pharmafocusasia.com/news/japan-sets-price-cut-for-bristol-myers-opdivo-cancer-drug 2019-04-17 02:36:42 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-cholesterol-drug-reduces-artery-clogging-plaque-in-study 2019-04-17 02:36:40 daily 0.1 https://demo.pharmafocusasia.com/news/dynavax-says-us-fda-rejects-its-hepatitis-b-vaccine 2019-04-17 02:36:39 daily 0.1 https://demo.pharmafocusasia.com/news/richters-generic-osteoporosis-drug-gets-eu-recommendation 2019-04-17 02:36:37 daily 0.1 https://demo.pharmafocusasia.com/news/corbus-drug-succeeds-in-mid-stage-scleroderma-study 2019-04-17 02:36:35 daily 0.1 https://demo.pharmafocusasia.com/news/roche-announces-positive-results-for-actemra-in-phase-study 2019-04-17 02:36:33 daily 0.1 https://demo.pharmafocusasia.com/news/jj-arthritis-drug-goes-up-against-humira-with-mixed-results 2019-04-17 02:36:28 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-receives-positive-opinion-for-fiasp-drug-in-eu 2019-04-17 02:36:27 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-offers-cut-price-pneumonia-shot-for-humanitarian-crises 2019-04-17 02:36:25 daily 0.1 https://demo.pharmafocusasia.com/news/almac-group-announce-global-expansion 2019-04-17 02:36:23 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-to-review-options-for-multiple-sclerosis-drug-tysabri 2019-04-17 02:36:21 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-deepens-focus-on-fibrosis-with-nitto-deal 2019-04-17 02:36:19 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-wins-eus-approval-for-ibrance-as-novartis-readies-rival-drug 2019-04-17 02:36:17 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-infinity-pharma-to-evaluate-opdivo 2019-04-17 02:36:16 daily 0.1 https://demo.pharmafocusasia.com/news/mabion-signs-agreement-for-rights-to-sell-mabion-cd-drug-in-eu-and-balkans 2019-04-17 02:36:14 daily 0.1 https://demo.pharmafocusasia.com/news/sorrento-therapeutics-closes-acquisition-of-scilex 2019-04-17 02:36:12 daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharma-signs-exclusive-license-and-distribution-agreement-with-elis-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/british-artificial-intelligence-firm-announces-license-agreement-with-janssen 2019-04-17 02:36:09 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-approval-of-generic-tribenzor-in-the-united-states 2019-04-17 02:36:07 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-applies-for-regorafenib-authorization-to-treat-liver-cancer 2019-04-17 02:36:05 daily 0.1 https://demo.pharmafocusasia.com/news/roche-advances-skin-cancer-trials-as-part-of-combination-therapy-strategy 2019-04-17 02:36:03 daily 0.1 https://demo.pharmafocusasia.com/news/intec-pharma-makes-amendment-to-advanced-parkinsons-patients-study 2019-04-17 02:36:01 daily 0.1 https://demo.pharmafocusasia.com/news/mitsubishi-tanabe-pharma-to-set-up-vaccine-jv-in-kagawa 2019-04-17 02:35:59 daily 0.1 https://demo.pharmafocusasia.com/news/guizhou-yibai-pharmaceutical-unit-to-raise-stake-in-tumor-medical-tech-firm 2019-04-17 02:35:57 daily 0.1 https://demo.pharmafocusasia.com/news/hainan-shuangcheng-pharmaceuticals-receives-gmp-certificate 2019-04-17 02:35:55 daily 0.1 https://demo.pharmafocusasia.com/news/endo-considers-sale-of-paladin-labs-to-knight-therapeutics 2019-04-17 02:35:53 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-defends-us-diabetes-drug-pricing 2019-04-17 02:35:51 daily 0.1 https://demo.pharmafocusasia.com/news/vwr-acquires-reliable-biopharmaceutical-and-bioarra 2019-04-17 02:35:50 daily 0.1 https://demo.pharmafocusasia.com/news/study-finds-gene-markers-for-drug-resistant-malaria-in-cambodia 2019-04-17 02:35:48 daily 0.1 https://demo.pharmafocusasia.com/news/pmprb-reaches-agreement-with-baxalta-canada-on-reporting-requirements-for-leukemia-drug 2019-04-17 02:35:46 daily 0.1 https://demo.pharmafocusasia.com/news/china-approves-pfizer-vaccine-prevenar 2019-04-17 02:35:44 daily 0.1 https://demo.pharmafocusasia.com/news/aceto-to-acquire-generic-products-and-related-assets 2019-04-17 02:35:42 daily 0.1 https://demo.pharmafocusasia.com/news/fda-highlights-liver-safety-issues-in-cempra-drug-review 2019-04-17 02:35:40 daily 0.1 https://demo.pharmafocusasia.com/news/medivir-divests-pharmaceutical-company-biophausia-to-karo-pharma 2019-04-17 02:35:39 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-cuts-outlook-ends-development-of-cholesterol-drug 2019-04-17 02:35:37 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-breast-cancer-drug-gets-fda-fast-track-takes-on-pfizer 2019-04-17 02:35:35 daily 0.1 https://demo.pharmafocusasia.com/news/miragen-therapeutics-and-signal-genetics-sign-merger-agreement 2019-04-17 02:35:33 daily 0.1 https://demo.pharmafocusasia.com/news/aralez-completes-acquisition-of-toprol-xl 2019-04-17 02:35:31 daily 0.1 https://demo.pharmafocusasia.com/news/strides-shasun-gets-fda-nod-for-drug-to-treat-hiv 2019-04-17 02:35:29 daily 0.1 https://demo.pharmafocusasia.com/news/novogen-acquires-privately-held-neuro-oncology-company 2019-04-17 02:35:27 daily 0.1 https://demo.pharmafocusasia.com/news/after-india-european-union-to-probe-wanbury-pharma-for-illegal-export 2019-04-17 02:35:25 daily 0.1 https://demo.pharmafocusasia.com/news/taigen-biotechnology-to-establish-new-company-with-hec-pharmaceutical-in-china 2019-04-17 02:35:23 daily 0.1 https://demo.pharmafocusasia.com/news/fda-spurns-sanofi-regeneron-arthritis-drug-due-to-manufacturing-lapses 2019-04-17 02:35:22 daily 0.1 https://demo.pharmafocusasia.com/news/amyris-enters-collaboration-with-top-pharmaceutical-company 2019-04-17 02:35:20 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-to-acquire-ganymed-pharmaceuticals 2019-04-17 02:35:18 daily 0.1 https://demo.pharmafocusasia.com/news/china-resources-pharma-falls-in-hong-kong 2019-04-17 02:35:16 daily 0.1 https://demo.pharmafocusasia.com/news/aerie-pharma-reports-positive-topline-results 2019-04-17 02:35:14 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-pauses-two-cancer-drug-trials-enrolment-due-to-bleeding 2019-04-17 02:35:12 daily 0.1 https://demo.pharmafocusasia.com/news/auven-therapeutics-announces-sale-of-ocular-technologies-to-sun-pharma 2019-04-17 02:35:11 daily 0.1 https://demo.pharmafocusasia.com/news/epipen-rival-plans-return-to-us-market 2019-04-17 02:35:09 daily 0.1 https://demo.pharmafocusasia.com/news/minerva-neurosciences-posts-positive-data-on-schizophrenia-drug 2019-04-17 02:35:07 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-plc-completes-acquisition-of-raptor-pharmaceutical 2019-04-17 02:35:03 daily 0.1 https://demo.pharmafocusasia.com/news/nordic-nanovector-and-heidelberg-pharma-enter-collaboration 2019-04-17 02:35:01 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-ceo-sees-tougher-us-drug-pricing-over-next-three-five-years 2019-04-17 02:34:59 daily 0.1 https://demo.pharmafocusasia.com/news/serodus-orphan-drug-designation-for-ser-in-pah 2019-04-17 02:34:57 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-files-potential-shingles-vaccine-for-us-approval 2019-04-17 02:34:55 daily 0.1 https://demo.pharmafocusasia.com/news/herantis-pharma-and-renishaw-sign-collaboration-agreement 2019-04-17 02:34:53 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-mercks-lung-cancer-drug-as-first-line-treatment 2019-04-17 02:34:51 daily 0.1 https://demo.pharmafocusasia.com/news/oasmia-pharmaceutical-buys-cancer-project-from-karo-pharma 2019-04-17 02:34:50 daily 0.1 https://demo.pharmafocusasia.com/news/sunovion-pharmaceuticals-completes-acquisition-of-cynapsus-therapeutics 2019-04-17 02:34:47 daily 0.1 https://demo.pharmafocusasia.com/news/foreign-investment-review-board-approves-chinese-takeover-of-vitaco 2019-04-17 02:34:46 daily 0.1 https://demo.pharmafocusasia.com/news/cigna-ends-preauthorization-requirement-to-treat-opioid-addiction 2019-04-17 02:34:44 daily 0.1 https://demo.pharmafocusasia.com/news/china-resources-pharmaceutical-raises-hong-kong-ipo 2019-04-17 02:34:42 daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-fda-acceptance-of-resubmitted-new-drug-application 2019-04-17 02:34:40 daily 0.1 https://demo.pharmafocusasia.com/news/alkermes-depression-drug-succeeds-in-key-trial-shares-surge 2019-04-17 02:34:38 daily 0.1 https://demo.pharmafocusasia.com/news/roche-bets-on-new-cancer-drugs-to-offset-patent-expiries 2019-04-17 02:34:36 daily 0.1 https://demo.pharmafocusasia.com/news/cerulean-announces-technology-platform-collaboration-with-novartis 2019-04-17 02:34:35 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-accelerated-approval-to-lillys-soft-tissue-sarcoma-drug 2019-04-17 02:34:33 daily 0.1 https://demo.pharmafocusasia.com/news/mercks-antiviral-drug-meets-main-goal-in-late-stage-trial 2019-04-17 02:34:31 daily 0.1 https://demo.pharmafocusasia.com/news/roche-third-quarter-sales-rise-percent-confirms-outlook 2019-04-17 02:34:29 daily 0.1 https://demo.pharmafocusasia.com/news/roches-lung-cancer-drug-wins-us-approval 2019-04-17 02:34:27 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-icgeb-tie-up-to-develop-dengue-vaccine 2019-04-17 02:34:25 daily 0.1 https://demo.pharmafocusasia.com/news/fda-places-regeneron-and-tevas-pain-drug-study-on-hold 2019-04-17 02:34:24 daily 0.1 https://demo.pharmafocusasia.com/news/indalo-therapeutics-formed-by-merger-of-antegrin-and-cascadia 2019-04-17 02:34:21 daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-astrazenecas-new-hyperkalaemia-drug-application-for-review 2019-04-17 02:34:20 daily 0.1 https://demo.pharmafocusasia.com/news/tigenix-announces-orphan-drug-designation 2019-04-17 02:34:18 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-signs-deal-to-set-up-first-biosimilars-unit-in-south-africa 2019-04-17 02:34:16 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-crohns-drug-benefit-supported-by-image-data-in-trial 2019-04-17 02:34:14 daily 0.1 https://demo.pharmafocusasia.com/news/ema-committee-conditionally-approves-abbvie-leukemia-drug 2019-04-17 02:34:12 daily 0.1 https://demo.pharmafocusasia.com/news/osiris-therapeutics-says-commenced-steps-clinical-trial 2019-04-17 02:34:10 daily 0.1 https://demo.pharmafocusasia.com/news/denmarks-genmab-looks-to-immunotherapy-for-cancer-drug-encore 2019-04-17 02:34:09 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-loses-appeal-in-uk-patent-case-over-use-of-lyrica-drug-for-pain 2019-04-17 02:34:07 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-boehringer-ingelheim-india-to-co-market-diabetes-drug-empagliflozin 2019-04-17 02:34:05 daily 0.1 https://demo.pharmafocusasia.com/news/rxi-pharmaceuticals-enters-into-exclusive-option-agreement-to-acquire-mirimmune 2019-04-17 02:34:03 daily 0.1 https://demo.pharmafocusasia.com/news/synairgen-slumps-by-third-as-astrazeneca-ditches-asthma-drug-study 2019-04-17 02:34:01 daily 0.1 https://demo.pharmafocusasia.com/news/human-stem-cells-institute-to-develop-ischemia-drug-in-us-and-canada 2019-04-17 02:33:59 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-recalls-bottles-of-antidepressant-drug-in-us 2019-04-17 02:33:58 daily 0.1 https://demo.pharmafocusasia.com/news/france-opens-its-first-supervised-injection-center-for-drug-users 2019-04-17 02:33:56 daily 0.1 https://demo.pharmafocusasia.com/news/ablynx-extends-ion-channel-research-collaboration-with-merck 2019-04-17 02:33:54 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-says-fda-accepts-supplemental-new-drug-application-for-avycaz 2019-04-17 02:33:52 daily 0.1 https://demo.pharmafocusasia.com/news/addex-therapeutics-initiates-new-study-with-us-national-institute-of-drug-abuse 2019-04-17 02:33:50 daily 0.1 https://demo.pharmafocusasia.com/news/exelixis-and-pfizer-drugs-face-off-in-kidney-cancer 2019-04-17 02:33:48 daily 0.1 https://demo.pharmafocusasia.com/news/innate-pharma-announced-data-for-two-phase-studies-for-lirilumab-and-nivolumab 2019-04-17 02:33:47 daily 0.1 https://demo.pharmafocusasia.com/news/moleculin-biotech-announces-plan-for-clinical-trial-drug-production 2019-04-17 02:33:45 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-to-pay-over-epipen-medicaid-rebate-dispute 2019-04-17 02:33:40 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-and-monosol-rx-announce-licensing-agreement 2019-04-17 02:33:38 daily 0.1 https://demo.pharmafocusasia.com/news/thousands-of-european-melanoma-patients-lack-access-to-new-drugs 2019-04-17 02:33:36 daily 0.1 https://demo.pharmafocusasia.com/news/raqualia-pharma-gets-substance-patent-for-ghrelin-receptor-agonist-in-japan 2019-04-17 02:33:34 daily 0.1 https://demo.pharmafocusasia.com/news/astellas-filed-lawsuit-against-patent-infringement-of-myrbetriq-in-the-united-states 2019-04-17 02:33:32 daily 0.1 https://demo.pharmafocusasia.com/news/intas-pharmaceuticals-acquires-the-generics-business-of-actavis daily 0.1 https://demo.pharmafocusasia.com/news/us-government-health-plans-spent-on-epipens-over-five-years 2019-04-17 02:33:29 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-reshapes-research-closes-some-swiss-chinese-units 2019-04-17 02:33:27 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-licenses-respiratory-drug-to-insmed 2019-04-17 02:33:25 daily 0.1 https://demo.pharmafocusasia.com/news/aralez-to-acquire-us-rights-from-astrazeneca 2019-04-17 02:33:23 daily 0.1 https://demo.pharmafocusasia.com/news/roche-gets-boost-from-fda-in-bid-to-expand-uses-for-actemra 2019-04-17 02:33:22 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-partners-with-uks-summit-on-duchenne-drugs 2019-04-17 02:33:20 daily 0.1 https://demo.pharmafocusasia.com/news/sanofis-dengue-vaccine-approved-in-countries 2019-04-17 02:33:18 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-seeks-europe-approval-for-copy-of-herceptin-breast-cancer-drug 2019-04-17 02:33:16 daily 0.1 https://demo.pharmafocusasia.com/news/house-committee-taps-mylan-for-more-information-on-epipen-price-figures 2019-04-17 02:33:14 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-licenses-inflammatory-disease-candidate-to-allergan 2019-04-17 02:33:13 daily 0.1 https://demo.pharmafocusasia.com/news/vivus-and-metuchen-pharmaceuticals-announce-license-agreement 2019-04-17 02:33:11 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-bets-on-riskier-insulin-research 2019-04-17 02:33:09 daily 0.1 https://demo.pharmafocusasia.com/news/morphosys-moves-closer-to-getting-first-antibody-drug-on-market 2019-04-17 02:33:07 daily 0.1 https://demo.pharmafocusasia.com/news/jj-psoriasis-drug-tops-placebo-humira-in-late-stage-study 2019-04-17 02:33:05 daily 0.1 https://demo.pharmafocusasia.com/news/regenerons-eylea-combination-therapy-fails-mid-stage-study 2019-04-17 02:33:04 daily 0.1 https://demo.pharmafocusasia.com/news/endo-pharmaceuticals-presents-new-mid-stage-data-evaluating-safety 2019-04-17 02:33:02 daily 0.1 https://demo.pharmafocusasia.com/news/hanmi-pharmaceutical-enters-into-an-exclusive-license-agreement 2019-04-17 02:33:00 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-and-medicines-for-malaria-venture-sign-agreement 2019-04-17 02:32:58 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-and-delsitech-partner-to-develop-innovative-drug-delivery-technology 2019-04-17 02:32:56 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-arrowhead-team-up-on-gene-therapies-for-heart-disease 2019-04-17 02:32:54 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-enters-into-strategic-multi-target-alliance-with-cx-discovery 2019-04-17 02:32:53 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-expanded-use-of-vertex-pharmas-cystic-fibrosis-drug 2019-04-17 02:32:51 daily 0.1 https://demo.pharmafocusasia.com/news/zymeworks-and-daiichi-sankyo-announce-immuno-oncology-cross-licensing-agreement 2019-04-17 02:32:49 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-acquisition-of-medivation 2019-04-17 02:32:47 daily 0.1 https://demo.pharmafocusasia.com/news/amgens-multiple-myeloma-drug-falls-short-in-new-patient-study 2019-04-17 02:32:45 daily 0.1 https://demo.pharmafocusasia.com/news/cambrex-to-acquire-pharmacore 2019-04-17 02:32:43 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-to-test-opdivo-with-nektar-drug-for-several-cancers 2019-04-17 02:32:42 daily 0.1 https://demo.pharmafocusasia.com/news/cerecor-announces-acquisition-of-tarp-ampa-receptor-antagonist-from-lilly 2016-09-27 04:27:55 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-jjs-autoimmune-drug-stelara-for-crohns-disease 2019-04-17 02:32:38 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-may-win-us-approval-of-eczema-drug-by-march 2019-04-17 02:32:36 daily 0.1 https://demo.pharmafocusasia.com/news/kite-immunotherapy-drug-helps-blood-cancer-patients-in-study 2019-04-17 02:32:34 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-and-sanofi-announce-dupilumab-biologics-license-application-accepted 2019-04-17 02:32:33 daily 0.1 https://demo.pharmafocusasia.com/news/marksans-pharma-gets-usfda-clearance-for-allergy-drug 2019-04-17 02:32:31 daily 0.1 https://demo.pharmafocusasia.com/news/ildong-pharma-to-launch-new-hepatitis-b-drug-next-year 2019-04-17 02:32:29 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-amgens-copy-of-abbvie-arthritis-drug-humira 2019-04-17 02:32:27 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-zykadia-gets-positive-results-faces-roche-pressure 2019-04-17 02:32:25 daily 0.1 https://demo.pharmafocusasia.com/news/lundbeck-says-alzheimers-drug-fails-in-late-stage-study 2019-04-17 02:32:23 daily 0.1 https://demo.pharmafocusasia.com/news/biostar-pharmaceuticals-signs-letter-of-intent 2019-04-17 02:32:21 daily 0.1 https://demo.pharmafocusasia.com/news/us-states-sue-opioid-maker-indivior-alleging-anticompetitive-practices 2019-04-17 02:32:19 daily 0.1 https://demo.pharmafocusasia.com/news/vanda-pharmaceuticals-prepares-to-explore-a-sale 2019-04-17 02:32:14 daily 0.1 https://demo.pharmafocusasia.com/news/evotec-and-bayer-partner-to-develop-new-treatments-to-fight-kidney-diseases 2019-04-17 02:32:12 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-cadila-recall-drugs-from-us-market 2019-04-17 02:32:10 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-pulls-cancer-drug-application-in-europe 2019-04-17 02:32:08 daily 0.1 https://demo.pharmafocusasia.com/news/united-nations-pledges-to-fight-drug-resistant-superbugs 2019-04-17 02:32:06 daily 0.1 https://demo.pharmafocusasia.com/news/akarna-therapeutics-ltd-acquired-by-allergan 2019-04-17 02:32:04 daily 0.1 https://demo.pharmafocusasia.com/news/mirna-therapeutics-halts-phase-clinical-study 2019-04-17 02:32:02 daily 0.1 https://demo.pharmafocusasia.com/news/zydus-cadila-partners-takeda-pharmaceutical-for-chikungunya-vaccine 2019-04-17 02:32:00 daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-names-insider-emma-walmsley-as-new-ceo 2019-04-17 02:31:58 daily 0.1 https://demo.pharmafocusasia.com/news/icon-completes-the-acquisition-of-clinical-research-management 2019-04-17 02:31:56 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-intensifies-entresto-push-with-new-analysis 2019-04-17 02:31:54 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-accelerated-approval-to-first-drug-for-duchenne-muscular-dystrophy 2019-04-17 02:31:53 daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-laboratories-announces-the-launch-of-paricalcitol-injection 2019-04-17 02:31:51 daily 0.1 https://demo.pharmafocusasia.com/news/ge-brings-off-the-shelf-biotech-drug-factories-to-ireland 2019-04-17 02:31:49 daily 0.1 https://demo.pharmafocusasia.com/news/twi-confirms-patent-challenge-relating-to-its-paragraph-iv-anda-filing 2019-04-17 02:31:47 daily 0.1 https://demo.pharmafocusasia.com/news/ema-panel-recommends-nod-for-pfizers-breast-cancer-drug 2019-04-17 02:31:45 daily 0.1 https://demo.pharmafocusasia.com/news/themis-medicare-inks-pact-with-nevakar-for-injectable-products 2019-04-17 02:31:43 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-vaccine-for-respiratory-disease-fails-in-late-stage-trial 2019-04-17 02:31:41 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-to-buy-vitae-pharmaceuticals 2019-04-17 02:31:40 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-says-diabetes-drug-semaglutide 2019-04-17 02:31:38 daily 0.1 https://demo.pharmafocusasia.com/news/acelrxs-opioid-painkiller-succeeds-in-key-study 2019-04-17 02:31:36 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-to-buy-raptor-pharma 2019-04-17 02:31:34 daily 0.1 https://demo.pharmafocusasia.com/news/fosun-pharma-looks-to-digest-indias-gland-eyes-other-markets 2019-04-17 02:31:32 daily 0.1 https://demo.pharmafocusasia.com/news/novabay-pharmaceuticals-neutrox-product-line-receives-ce-mark 2019-04-17 02:31:30 daily 0.1 https://demo.pharmafocusasia.com/news/fda-staff-flags-concerns-about-pfizers-quit-smoking-drug-study 2019-04-17 02:31:28 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-alphabet-set-up-jv-in-diabetes 2019-04-17 02:31:26 daily 0.1 https://demo.pharmafocusasia.com/news/us-justice-department-subpoenas-taro-over-generic-drug-pricing 2019-04-17 02:31:24 daily 0.1 https://demo.pharmafocusasia.com/news/dechra-pharmaceuticals-gets-fda-approval-for-first-us-generic-entrant-antibiotic 2019-04-17 02:31:23 daily 0.1 https://demo.pharmafocusasia.com/news/teva-says-aims-to-launch-epipen-like-device-in-us 2019-04-17 02:31:21 daily 0.1 https://demo.pharmafocusasia.com/news/generico-announces-collaboration-with-zhejiang-hisun 2019-04-17 02:31:19 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-ceo-says-clinton-plan-to-curb-drug-prices-would-hurt-consumers 2019-04-17 02:31:17 daily 0.1 https://demo.pharmafocusasia.com/news/tokai-pharmaceuticals-announces-review-of-strategic-alternatives 2019-04-17 02:31:15 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-initiates-global-phase-clinical-trial-of-dengue-vaccine-candidate 2019-04-17 02:31:13 daily 0.1 https://demo.pharmafocusasia.com/news/retrophin-kidney-drug-exceeds-expectations-in-trial 2019-04-17 02:31:12 daily 0.1 https://demo.pharmafocusasia.com/news/q-biomed-closes-licensing-agreement-for-fda-approved-drug 2019-04-17 02:31:10 daily 0.1 https://demo.pharmafocusasia.com/news/evoke-pharma-announces-non-clinical-pre-nda-meeting-with-fda 2019-04-17 02:31:08 daily 0.1 https://demo.pharmafocusasia.com/news/avara-acquires-astrazeneca-uk-manufacturing-facility daily 0.1 https://demo.pharmafocusasia.com/news/gsks-triple-drug-cuts-flare-ups-in-chronic-lung-disease 2019-04-17 02:31:04 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-vows-limited-price-hikes-says-outliers-deter-research 2019-04-17 02:31:03 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-to-stop-testing-drug-for-fibromyalgia 2019-04-17 02:31:01 daily 0.1 https://demo.pharmafocusasia.com/news/galapagos-gets-orphan-drug-designation-in-eu-for-glpg-in-idiopathic-pulmonary-fibrosis 2019-04-17 02:30:59 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-seeks-edge-over-rivals-in-severe-asthma-treatment 2019-04-17 02:30:57 daily 0.1 https://demo.pharmafocusasia.com/news/ogd-pharma-and-syndivia-launch-collaboration-to-develop-an-adc-targeting 2019-04-17 02:30:55 daily 0.1 https://demo.pharmafocusasia.com/news/alvogen-launches-first-generic-equivalent-of-copaxonetm-in-europe 2019-04-17 02:30:53 daily 0.1 https://demo.pharmafocusasia.com/news/merck-scraps-development-of-osteoporosis-drug-due-to-stroke-risk 2019-04-17 02:30:48 daily 0.1 https://demo.pharmafocusasia.com/news/us-lawmakers-question-mylans-medicaid-epipen-rebates 2019-04-17 02:30:46 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-joins-effort-to-develop-zika-vaccine-with-us-funding 2019-04-17 02:30:45 daily 0.1 https://demo.pharmafocusasia.com/news/roches-new-drug-strategy-buoyed-by-lung-cancer-study daily 0.1 https://demo.pharmafocusasia.com/news/third-us-patent-on-tevas-ms-drug-copaxone-invalidated 2019-04-17 02:30:41 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisks-veteran-ceo-lars-rebien-sorensen-to-step-down 2019-04-17 02:30:39 daily 0.1 https://demo.pharmafocusasia.com/news/sunovion-pharma-to-buy-canadas-cynapsus 2019-04-17 02:30:38 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-and-adamas-enter-settlement-with-amneal-pharmaceuticals 2019-04-17 02:30:36 daily 0.1 https://demo.pharmafocusasia.com/news/gensight-biologics-receives-orphan-drug-designation 2019-04-17 02:30:34 daily 0.1 https://demo.pharmafocusasia.com/news/plastic-cap-is-crux-of-mylan-argument-against-tevas-epipen 2019-04-17 02:30:32 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-novartis-biosimilar-to-amgens-enbrel 2019-04-17 02:30:30 daily 0.1 https://demo.pharmafocusasia.com/news/mdxhealth-and-teva-pharmaceuticals-sign-distribution-agreement-for-selectmdx 2019-04-17 02:30:28 daily 0.1 https://demo.pharmafocusasia.com/news/elite-announces-development-and-license-agreement-with-sungen-pharma 2019-04-17 02:30:27 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-pharmaceuticals-acquires-exclusive-licensing-rights 2019-04-17 02:30:25 daily 0.1 https://demo.pharmafocusasia.com/news/synlogic-proprietary-synthetic-biotic-receives-fda-orphan-drug-designation daily 0.1 https://demo.pharmafocusasia.com/news/fuan-pharmaceutical-group-plans-new-unit-in-chongqing 2019-04-17 02:30:21 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-intas-in-race-for-buyout-of-teva-uk 2019-04-17 02:30:20 daily 0.1 https://demo.pharmafocusasia.com/news/biotie-therapies-btt-receives-orphan-drug-designation 2019-04-17 02:30:18 daily 0.1 https://demo.pharmafocusasia.com/news/fda-warns-former-sun-pharma-us-drug-factory-over-quality-concerns 2019-04-17 02:30:16 daily 0.1 https://demo.pharmafocusasia.com/news/britains-ftse-edges-lower-as-pharmaceuticals-weigh-again 2019-04-17 02:30:14 daily 0.1 https://demo.pharmafocusasia.com/news/biolinerx-and-i-bridge-capital-establish-new-drug-development-joint-venture 2019-04-17 02:30:12 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-announces-positive-phase-results-for-ms-drug-siponimod 2019-04-17 02:30:10 daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-receives-fda-fast-track-designation-for-synacthen-depot-ind-application 2019-04-17 02:30:09 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-offers-discounts-on-epipen-amid-wave-of-criticism 2019-04-17 02:30:07 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-buys-part-of-astrazenecas-antibiotics-business 2019-04-17 02:30:05 daily 0.1 https://demo.pharmafocusasia.com/news/teva-plunges-after-two-us-copaxone-patents-invalidated 2019-04-17 02:30:03 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-faces-scrutiny-over-epipen-price-increases 2019-04-17 02:30:01 daily 0.1 https://demo.pharmafocusasia.com/news/nymox-pharmaceutical-new-crossover-study-results 2019-04-17 02:29:59 daily 0.1 https://demo.pharmafocusasia.com/news/anhui-fengyuan-pharmaceutical-receives-gmp-certificate 2019-04-17 02:29:57 daily 0.1 https://demo.pharmafocusasia.com/news/strides-shasun-gets-usfda-tentative-nod-for-ranitidine-tablets 2019-04-17 02:29:56 daily 0.1 https://demo.pharmafocusasia.com/news/cinven-to-acquire-pharmaceutical-research-firm-bioclinica daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-astrazeneca-get-fast-track-status-for-alzheimers-drug daily 0.1 https://demo.pharmafocusasia.com/news/senators-scrutinize-mylan-over-epipens-us-price-increases daily 0.1 https://demo.pharmafocusasia.com/news/valeant-names-zoetis-executive-as-cfo daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-nears-deal-to-acquire-medivation daily 0.1 https://demo.pharmafocusasia.com/news/philippines-duterte-threatens-to-quit-un-after-drugs-war-censure daily 0.1 https://demo.pharmafocusasia.com/news/portola-pharmaceuticals-announces-indexxa-review-update daily 0.1 https://demo.pharmafocusasia.com/news/phoenix-life-sciences-to-acquire-phoenix-bio-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-announces-new-timelines-for-us-fda-decision-on-iglarlixi daily 0.1 https://demo.pharmafocusasia.com/news/oncolys-biopharma-to-set-up-unit-oncolys-usa daily 0.1 https://demo.pharmafocusasia.com/news/amerigen-pharmaceutical-announces-final-approval-from-fda-for-generic-version-of-temodar daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-locates-growing-specialty-brands-businesses-in-bedminster daily 0.1 https://demo.pharmafocusasia.com/news/auriss-tinnitus-drug-misses-main-goals-in-study-shares-sink daily 0.1 https://demo.pharmafocusasia.com/news/valeant-again-able-to-loosen-debt-terms daily 0.1 https://demo.pharmafocusasia.com/news/sasmar-pharmaceuticals-announces-acquisition-of-aquatrove-biosciences daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-status-to-pulmatrixs-pur daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-announces-major-investment-in-us-manufacturing daily 0.1 https://demo.pharmafocusasia.com/news/sagent-pharma-says-initiates-a-nationwide-voluntary-recall-of-one-lot-of-oxacillin daily 0.1 https://demo.pharmafocusasia.com/news/piramal-pharma-solutions-announces-to-acquire-ash-stevens daily 0.1 https://demo.pharmafocusasia.com/news/asias-pharma-investment-shows-the-benefit-of-patent-protection daily 0.1 https://demo.pharmafocusasia.com/news/oncogenex-seeks-strategic-alternatives-after-drug-study-fails daily 0.1 https://demo.pharmafocusasia.com/news/strides-shasun-completes-acquisition-of-generic-partners daily 0.1 https://demo.pharmafocusasia.com/news/scintilla-pharmaceuticals-to-acquire-semnur-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/acelrx-pharmaceuticals-says-arx-phase-trial-met-primary-endpoint daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-closes-global-licencing-deal-with-leo-pharma-for-tralokinumab daily 0.1 https://demo.pharmafocusasia.com/news/hedge-funds-made-big-changes-at-drug-companies-in-second-quarter daily 0.1 https://demo.pharmafocusasia.com/news/alcami-announces-new-highly-potent-api-capabilities-and-capacity daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-wins-uk-cost-approval-for-longer-use-of-heart-drug daily 0.1 https://demo.pharmafocusasia.com/news/jacobs-awarded-contract-for-novartis-biotechnology-center-expansion daily 0.1 https://demo.pharmafocusasia.com/news/biotechs-resurgence-may-cost-big-pharma daily 0.1 https://demo.pharmafocusasia.com/news/fda-accepts-marathon-pharmaceuticals-new-drug-applications-for-deflazacort daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-bets-another-on-modernas-messenger-drugs daily 0.1 https://demo.pharmafocusasia.com/news/guilin-sanjin-pharmaceutical-gets-approval-to-start-clinical-trial-for-injection daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-announces-approvals-to-start-phase-study daily 0.1 https://demo.pharmafocusasia.com/news/jointown-pharmaceutical-group-unit-plans-to-set-up-jv daily 0.1 https://demo.pharmafocusasia.com/news/mylan-second-quarter-profit-edges-higher-eps-forecast-unchanged daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-drug-selumetinib-fails-in-lung-cancer-study daily 0.1 https://demo.pharmafocusasia.com/news/scintilla-to-acquire-scilex-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/alkermes-submits-supplemental-new-drug-application-to-fda daily 0.1 https://demo.pharmafocusasia.com/news/helsinn-group-mei-pharma-enter-deal-for-pracinostat-development daily 0.1 https://demo.pharmafocusasia.com/news/arbutus-announces-issuance-of-broad-new-us-patent-for-lnp-delivery-technology daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharma-gains-after-receiving-usfda-approval-for-kenalog-generic daily 0.1 https://demo.pharmafocusasia.com/news/shijiazhuang-yiling-pharmaceutical-announces-restructuring-among-units daily 0.1 https://demo.pharmafocusasia.com/news/north-china-pharmaceutical-gets-nod-for-clinic-trial daily 0.1 https://demo.pharmafocusasia.com/news/scinopharm-and-cvie-therapeutics-limited-to-jointly-develop-new-heart-failure-drug daily 0.1 https://demo.pharmafocusasia.com/news/cephalon-us-states-reach-settlement-over-generic-drugs daily 0.1 https://demo.pharmafocusasia.com/news/chinese-group-to-buy-australian-vitamin-firm-vitaco daily 0.1 https://demo.pharmafocusasia.com/news/avara-acquires-astellas-us-manufacturing-facility daily 0.1 https://demo.pharmafocusasia.com/news/mayne-pharma-closes-acquisition-of-generic-drug-portfolio-from-teva-and-allergan daily 0.1 https://demo.pharmafocusasia.com/news/teva-announces-acquisition-of-anda-inc daily 0.1 https://demo.pharmafocusasia.com/news/hikma-says-generic-drug-unit-to-be-hit-by-approval-delays daily 0.1 https://demo.pharmafocusasia.com/news/teva-completes-acquisition-of-actavis-generics daily 0.1 https://demo.pharmafocusasia.com/news/biogen-draws-takeover-interest-from-rival-drugmakers daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-in-settlement-of-celebrex-bextra-litigation daily 0.1 https://demo.pharmafocusasia.com/news/novartis-pill-gets-us-breakthrough-designation-in-breast-cancer daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-acquires-gene-therapy-firm-bamboo daily 0.1 https://demo.pharmafocusasia.com/news/indias-lupin-to-buy-branded-drugs-from-japans-shionogi daily 0.1 https://demo.pharmafocusasia.com/news/biogen-exercises-option-to-develop-muscle-drug-after-trial-success daily 0.1 https://demo.pharmafocusasia.com/news/advent-buys-stake-in-pharmaceutical-contractor-inventiv daily 0.1 https://demo.pharmafocusasia.com/news/ghana-pharmaceutical-companies-urged-to-merge-with-foreign-investors daily 0.1 https://demo.pharmafocusasia.com/news/ajanta-pharma-gets-usfda-nod-for-generic-acid-reflux-drug daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-revenue-jumps-on-higher-demand-for-drug-humira daily 0.1 https://demo.pharmafocusasia.com/news/ligand-announces-licensing-agreement-with-nucorion-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/seres-drug-for-treating-intestinal-infection-fails-in-study daily 0.1 https://demo.pharmafocusasia.com/news/us-and-uk-form-global-partnership-to-speed-new-antibiotics daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-and-western-oncolytics-announce-immuno-oncology-research-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-shares-hit-by-decline-of-yervoy-melanoma-drug daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-signs-licening-pact-with-spanish-firm-almirall-for-psoriasis-drug daily 0.1 https://demo.pharmafocusasia.com/news/gsk-chases-next-biotech-asthma-drug-with-jj-deal daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-amoydx-collaborate-to-bring-liquid-biopsy-ras-biomarker-testing daily 0.1 https://demo.pharmafocusasia.com/news/teva-wins-us-nod-for-actavis-after-divestiture-of-drugs daily 0.1 https://demo.pharmafocusasia.com/news/advent-cvc-bid-for-inventiv-ahead-of-ipo daily 0.1 https://demo.pharmafocusasia.com/news/chinas-fosun-to-buy-kkr-backed-gland-pharma daily 0.1 https://demo.pharmafocusasia.com/news/x-chem-and-abbvie-enter-into-multi-target-drug-discovery-partnership daily 0.1 https://demo.pharmafocusasia.com/news/recro-pharmas-intravenous-painkiller-succeeds-in-trial-shares-soar daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-pharmaceuticals-holding-unit-gets-gmp-certificate daily 0.1 https://demo.pharmafocusasia.com/news/apricus-biosciences-expands-partnership-with-ferring-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/germany-plans-to-extend-price-brake-for-drugs-under-statutory-insurance daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-licenses-enabling-technology-for-the-development daily 0.1 https://demo.pharmafocusasia.com/news/celgene-drug-fails-to-extend-survival-in-lymphoma-study daily 0.1 https://demo.pharmafocusasia.com/news/european-medicines-agency-suspends-scores-of-drugs-tested daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-hisun-pharmaceutical-unit-gets-gmp-certificate daily 0.1 https://demo.pharmafocusasia.com/news/china-launches-nationwide-inspection-of-vaccines daily 0.1 https://demo.pharmafocusasia.com/news/quva-pharma-acquires-biotech-pharmaceutical-facility-in-new-jersey daily 0.1 https://demo.pharmafocusasia.com/news/amgen-allergan-biosimilar-found-as-effective-as-roche-cancer-drug daily 0.1 https://demo.pharmafocusasia.com/news/galenica-to-buy-relypsa-to-strengthen-its-unit-vifor-pharma daily 0.1 https://demo.pharmafocusasia.com/news/roche-core-eps-ahead-of-market-view-on-drug-sales daily 0.1 https://demo.pharmafocusasia.com/news/lupin-seeks-to-invalidate-patent-on-bausch-lomb-eye-drug daily 0.1 https://demo.pharmafocusasia.com/news/indias-drug-approvals-near-record-despite-fda-inspection-blitz daily 0.1 https://demo.pharmafocusasia.com/news/celgene-to-collaborate-with-tiny-jounce-on-cancer-immunotherapy daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-backs-valeant-psoriasis-drug-with-risk-program daily 0.1 https://demo.pharmafocusasia.com/news/novartis-warns-profit-may-fall-on-higher-heart-drug-spending daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-raises-guidance-buoyed-by-pharma-growth daily 0.1 https://demo.pharmafocusasia.com/news/novartis-says-profit-may-drop-on-entresto-spending-gleevec daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-lung-cancer-drug-meets-main-goal-in-late-stage-trial daily 0.1 https://demo.pharmafocusasia.com/news/china-approves-use-of-gsk-vaccine-cervarix-for-cervical-cancer daily 0.1 https://demo.pharmafocusasia.com/news/ajanta-pharma-launches-acid-reflux-drug-in-us daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-seeks-europe-approval-for-its-humira-copy daily 0.1 https://demo.pharmafocusasia.com/news/torrent-intas-join-fray-for-teva-products-in-europe daily 0.1 https://demo.pharmafocusasia.com/news/mylan-to-get-eu-green-light-for-swedish-drugmaker-deal daily 0.1 https://demo.pharmafocusasia.com/news/sartorius-acquires-us-start-up-virocyt daily 0.1 https://demo.pharmafocusasia.com/news/valeant-psoriasis-drugs-suicide-risk-hard-to-assess daily 0.1 https://demo.pharmafocusasia.com/news/recordati-acquires-the-swiss-pharmaceutical-company-pro-farma daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharma-to-raise-in-bond-sale-next-week daily 0.1 https://demo.pharmafocusasia.com/news/granules-to-acquire-stake-in-uspharma daily 0.1 https://demo.pharmafocusasia.com/news/ex-drug-executive-shkreli-to-face-us-fraud-trial-in-june daily 0.1 https://demo.pharmafocusasia.com/news/teva-says-allergan-deal-to-close-any-time-expects-us-antitrust-clearance daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-resolves-faslodex-patent-litigation-in-us daily 0.1 https://demo.pharmafocusasia.com/news/antipsychotic-drug-also-relieves-nausea-from-cancer-chemotherapy daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-recalls-bottles-of-sirolimus-tablets-in-us daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-backs-amgen-copy-of-abbvie-arthritis-drug-humira daily 0.1 https://demo.pharmafocusasia.com/news/austrian-biotech-plans-zika-vaccine-clinical-trials daily 0.1 https://demo.pharmafocusasia.com/news/sages-drug-for-postpartum-depression-succeeds-in-mid-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/cipher-pharmaceuticals-announces-ozenoxacin-accepted-for-review-by-health-canada daily 0.1 https://demo.pharmafocusasia.com/news/martindale-pharma-announces-acquisition-of-viridian-pharma daily 0.1 https://demo.pharmafocusasia.com/news/celyad-enters-into-license-agreement-with-ono-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/novartis-copy-of-amgen-arthritis-drug-highly-similar daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-shires-keenly-watched-eye-drug daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-starts-rollout-of-gemcitabine-infusmart-in-six-european-nations daily 0.1 https://demo.pharmafocusasia.com/news/kiadis-pharma-and-the-leukemia-lymphoma-society-strengthen-partnership daily 0.1 https://demo.pharmafocusasia.com/news/ligand-enters-into-omniab-platform-license-agreement-with-gilead-sciences daily 0.1 https://demo.pharmafocusasia.com/news/funds-advised-by-apax-partners-to-acquire-neuraxpharm daily 0.1 https://demo.pharmafocusasia.com/news/amgen-drug-appears-highly-similar-to-humira-fda-staff daily 0.1 https://demo.pharmafocusasia.com/news/japans-eisai-weighs-legal-action-in-uk-cancer-drug-row daily 0.1 https://demo.pharmafocusasia.com/news/frances-valneva-says-has-generated-possible-zika-vaccine daily 0.1 https://demo.pharmafocusasia.com/news/fosun-independent-research-and-development-of-new-drugs daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-germanys-merck-begin-large-ovarian-cancer-trial daily 0.1 https://demo.pharmafocusasia.com/news/frances-sanofi-signs-zika-vaccine-research-deal-with-pentagon daily 0.1 https://demo.pharmafocusasia.com/news/alembic-pharma-gets-tentative-nod-from-usfda-for-febuxostat daily 0.1 https://demo.pharmafocusasia.com/news/cempra-announces-fda-acceptance-of-solithera-new-drug-applications daily 0.1 https://demo.pharmafocusasia.com/news/hamlet-pharma-signs-agreement-with-liansa-pharma-consulting daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-invests-to-expand-insulin-plant-in-kalundborg daily 0.1 https://demo.pharmafocusasia.com/news/ucb-receives-approval-for-epilepsy-drug-vimpat-in-japan daily 0.1 https://demo.pharmafocusasia.com/news/alliancepharma-to-buy-three-companies daily 0.1 https://demo.pharmafocusasia.com/news/spains-almirall-eyes-valeant-skin-drugs-to-boost-dermatology daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-boehringer-ingelheim-seek-cci-nod-for-global-asset-swap-deal daily 0.1 https://demo.pharmafocusasia.com/news/ina-research-announces-business-alliance-with-cmic-pharma-science daily 0.1 https://demo.pharmafocusasia.com/news/klaria-pharma-signs-agreement-with-laboratoires-plasto-sante-for-pharmaceutical-production daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-two-dermatology-drug-rights-to-leo-pharma daily 0.1 https://demo.pharmafocusasia.com/news/uk-drugs-regulator-to-halt-approvals-for-indian-clinical-trials-firm daily 0.1 https://demo.pharmafocusasia.com/news/torrent-pharma-acquires-manufacturing-unit-of-glochem-industries-limited 2016-07-01 01:02:06 daily 0.1 https://demo.pharmafocusasia.com/news/exosome-diagnostics-enters-partnership-with-takeda-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/ligand-receives-from-expansion-of-two-omniab-license-agreements daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-enters-into-definitive-agreement-to-acquire-three-us-otc-brands daily 0.1 https://demo.pharmafocusasia.com/news/center-point-clinical-services-signs-partnership-agreement-with-contravir-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/shire-says-adhd-drug-meets-main-goal-of-study daily 0.1 https://demo.pharmafocusasia.com/news/tesaros-ovarian-cancer-drug-study-succeeds-shares-soar daily 0.1 https://demo.pharmafocusasia.com/news/merck-and-moderna-announce-strategic-collaboration daily 0.1 https://demo.pharmafocusasia.com/news/kitovs-lead-drug-kit-achieves-manufacturing-milestone daily 0.1 https://demo.pharmafocusasia.com/news/gilead-wins-us-nod-for-drug-for-all-types-of-hepatitis-c daily 0.1 https://demo.pharmafocusasia.com/news/infinity-regains-worldwide-rights-to-duvelisib daily 0.1 https://demo.pharmafocusasia.com/news/us-panel-backs-claim-lilly-diabetes-drug-cuts-cardiac-death daily 0.1 https://demo.pharmafocusasia.com/news/mayne-pharma-announces-acquisition-of-us-generic-product-portfolio-from-teva-and-allergan 2016-06-28 01:51:00 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-invest-in-china-biotech-hub-first-in-asia daily 0.1 https://demo.pharmafocusasia.com/news/gw-pharma-says-cannabis-based-epilepsy-drug-meets-main-goal daily 0.1 https://demo.pharmafocusasia.com/news/roche-anticipates-quicker-us-approval-for-new-ms-drug daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-announces-expiration-of-hsr-waiting-period 2016-06-27 00:08:55 daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-hisun-pharmaceutical-unit-passes-fda-approval 2016-06-26 23:46:56 daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-hisoar-pharmaceutical-to-buy-stake-in-hunan-based-co daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-completes-acquisition-of-anacor-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-to-vote-whether-diabetes-drug-cuts-cardiac-death daily 0.1 https://demo.pharmafocusasia.com/news/takeda-revises-collaboration-agreement-with-amgen daily 0.1 https://demo.pharmafocusasia.com/news/antares-pharma-announces-settlement-of-patent-litigation-for-key-alliance-business-product daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-bets-on-new-products-to-boost-us-skincare-products-growth daily 0.1 https://demo.pharmafocusasia.com/news/mylan-says-indian-drug-industry-needs-more-transparency-from-fda daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-flu-vaccine-spray-fails-again-us-panel-recommends-shot daily 0.1 https://demo.pharmafocusasia.com/news/fujifilm-signs-deal-to-license-avigan-ingredient-with-china-drugmaker 2019-04-17 02:25:39 daily 0.1 https://demo.pharmafocusasia.com/news/mckesson-considers-it-unit-merger-with-change-healthcare 2019-04-17 02:25:37 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharmas-anti-bacterial-drug-being-recalled-in-us-market daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-allergan-sell-generic-drugs-to-impax-in-latest-divestiture daily 0.1 https://demo.pharmafocusasia.com/news/savara-pharmaceuticals-acquires-serendex-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/opko-health-says-fda-approves-new-drug-application-for-rayaldee daily 0.1 https://demo.pharmafocusasia.com/news/caladrius-subsidiary-to-manufacture-phase-cell-therapy-product-for-kiadis-pharma daily 0.1 https://demo.pharmafocusasia.com/news/inovio-pharma-gets-green-signal-to-test-zika-vaccine-in-human-trial 2019-04-17 02:25:27 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-aims-to-nearly-triple-biosimilar-drugs-on-market 2019-04-17 02:25:25 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-expands-development-of-t-cell-receptor-therapies daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-says-lung-drug-meets-late-stage-study-goals 2019-04-17 02:25:22 daily 0.1 https://demo.pharmafocusasia.com/news/eisai-launches-new-oral-suspension-formulation-for-antiepileptic-drug-fycompa daily 0.1 https://demo.pharmafocusasia.com/news/uk-cost-agency-speeds-approval-of-bristol-melanoma-drug-cocktail daily 0.1 https://demo.pharmafocusasia.com/news/mercks-keytruda-prolongs-life-in-big-lung-cancer-study daily 0.1 https://demo.pharmafocusasia.com/news/roche-skin-cancer-drugs-too-expensive-says-uk-cost-agency daily 0.1 https://demo.pharmafocusasia.com/news/aegerion-pharmaceuticals-and-qlt-agree-to-strategic-merger 2019-04-17 02:25:14 daily 0.1 https://demo.pharmafocusasia.com/news/mrc-technology-and-astrazeneca-call-for-epigenetic-targets-in-respiratory-disease 2019-04-17 02:25:12 daily 0.1 https://demo.pharmafocusasia.com/news/carbylan-therapeutics-and-kalvista-pharmaceuticals-enter-into-share-purchase-agreement 2019-04-17 02:25:10 daily 0.1 https://demo.pharmafocusasia.com/news/roundtable-healthcare-partners-completes-sale-of-the-topical-pharmaceutical-division daily 0.1 https://demo.pharmafocusasia.com/news/novartis-expands-partnership-with-medicines-for-malaria-venture daily 0.1 https://demo.pharmafocusasia.com/news/shire-buys-bowel-drug-rights-from-pfizer 2019-04-17 02:25:05 daily 0.1 https://demo.pharmafocusasia.com/news/senators-introduce-bill-aimed-at-getting-generic-drugs-to-market 2019-04-17 02:25:04 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-ceo-reiterates-plans-to-rebuild-embattled-company 2019-04-17 02:25:02 daily 0.1 https://demo.pharmafocusasia.com/news/novo-diabetes-drug-cuts-heart-risks-in-key-trial daily 0.1 https://demo.pharmafocusasia.com/news/mesoblast-regains-full-rights-to-stem-cell-heart-failure-treatment daily 0.1 https://demo.pharmafocusasia.com/news/nppa-issues-notices-to-drug-companies-over-violations-of-dpco daily 0.1 https://demo.pharmafocusasia.com/news/marinus-drug-for-focal-onset-seizures-fails-in-late-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-says-lixilan-diabetes-drug-trials-meet-targets daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-positive-results-from-pivotal-phase-clinical-trials-with-iglarlixi daily 0.1 https://demo.pharmafocusasia.com/news/indias-dr-reddys-in-deal-to-buy-eight-us-drugs-from-teva-allergan daily 0.1 https://demo.pharmafocusasia.com/news/eu-wants-more-transparency-on-abbvies-humira-worlds-top-drug daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-and-beta-bionics-to-collaborate daily 0.1 https://demo.pharmafocusasia.com/news/merck-to-acquire-biotech-company-afferent daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pays-to-settle-us-kickback-fraud-claims daily 0.1 https://demo.pharmafocusasia.com/news/colombia-to-set-new-price-for-novartis-cancer-drug daily 0.1 https://demo.pharmafocusasia.com/news/us-panel-backs-approval-for-merck-infectious-diarrhea-drug daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-rights-to-anaesthetics-to-south-africas-aspen daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-backs-approval-of-pfizers-opioid-painkiller daily 0.1 https://demo.pharmafocusasia.com/news/amgen-says-migraine-prevention-drug-meets-main-goal-of-study daily 0.1 https://demo.pharmafocusasia.com/news/jj-gsk-rheumatoid-arthritis-drug-meets-goals-of-large-trial daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-backs-tevas-abuse-resistant-opioid-painkiller 2016-06-08 00:23:01 daily 0.1 https://demo.pharmafocusasia.com/news/ruane-cunniff-cuts-valeant-pharmaceuticals-stake-almost-in-half daily 0.1 https://demo.pharmafocusasia.com/news/alkems-taloja-facility-gets-clean-chit-by-uk-health-regulator 2016-06-08 00:12:03 daily 0.1 https://demo.pharmafocusasia.com/news/genentech-osi-to-pay-over-drug-claims-us-justice-dept daily 0.1 https://demo.pharmafocusasia.com/news/tracon-pharmaceuticals-announces-positive-results-from-trc-and-trc-clinical-trials daily 0.1 https://demo.pharmafocusasia.com/news/alexion-shares-slump-as-drug-misses-goal-in-late-stage-trial daily 0.1 https://demo.pharmafocusasia.com/news/rpt-study-finds-targeted-cancer-drugs-may-work-in-range-of-tumor-types daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-regeneron-report-positive-skin-disease-trial daily 0.1 https://demo.pharmafocusasia.com/news/fosun-leads-the-race-to-buy-gland-pharma daily 0.1 https://demo.pharmafocusasia.com/news/orion-and-bayer-start-new-phase-study-of-prostate-cancer-drug daily 0.1 https://demo.pharmafocusasia.com/news/beijing-centergate-technologies-holding-unit-to-transfer-stake-in-pharmaceutical-co daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-and-cell-design-inc-collaborate-on-car-t-immunotherapy-research daily 0.1 https://demo.pharmafocusasia.com/news/facing-rival-drugs-novartis-gets-win-with-afinitor-in-europe daily 0.1 https://demo.pharmafocusasia.com/news/eu-court-advised-to-quash-german-prescription-drug-price-floor daily 0.1 https://demo.pharmafocusasia.com/news/global-cancer-drug-spending-to-exceed daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-eu-latam-gout-drug-rights-to-gruenenthal daily 0.1 https://demo.pharmafocusasia.com/news/partners-group-to-acquire-pci-pharma-services daily 0.1 https://demo.pharmafocusasia.com/news/medivation-sets-wednesday-as-cutoff-for-vote-on-sanofis-proposal-to-remove-board daily 0.1 https://demo.pharmafocusasia.com/news/gsk-seeks-lead-in-triple-lung-drug-market-with-filing-plan daily 0.1 https://demo.pharmafocusasia.com/news/roche-to-invest-expand-plant-in-puerto-rico daily 0.1 https://demo.pharmafocusasia.com/news/fda-asks-teva-pharmaceutical-for-further-study-on-huntingtons-drug daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-agrees-to-buy-celator daily 0.1 https://demo.pharmafocusasia.com/news/lipidor-and-cadila-pharmaceuticals-agree-on-phase-study-and-sale-of-psoriasis-product daily 0.1 https://demo.pharmafocusasia.com/news/roche-and-novartis-face-off-in-biosimilar-drug-battle daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-receives-final-european-approval-for-its-remicade-copy daily 0.1 https://demo.pharmafocusasia.com/news/kaken-pharmaceutical-signs-agreement-with-dong-a-st-for-clenafin-jublia-in-korea daily 0.1 https://demo.pharmafocusasia.com/news/indias-sun-pharma-arms-get-us-subpoena-over-drugs-pricing daily 0.1 https://demo.pharmafocusasia.com/news/north-china-pharmaceutical-gets-gmp-certificate daily 0.1 https://demo.pharmafocusasia.com/news/gsk-gets-eu-approval-for-first-gene-therapy-for-children daily 0.1 https://demo.pharmafocusasia.com/news/netherlands-gives-green-light-for-growing-human-embryos daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-new-arm-implant-to-treat-opioid-dependence daily 0.1 https://demo.pharmafocusasia.com/news/china-regulator-to-launch-drug-pricing-probe-in-june daily 0.1 https://demo.pharmafocusasia.com/news/roche-announces-positive-results-for-gazyva-in-phase-study daily 0.1 https://demo.pharmafocusasia.com/news/rpg-life-sciences-sells-biotech-business-to-intas-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/novartis-willing-to-sell-roche-stake-without-demanding-premium daily 0.1 https://demo.pharmafocusasia.com/news/us-panel-backs-approval-of-sanofi-combination-diabetes-drug daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-buys-otc-brands-from-us-based-ducere-pharma daily 0.1 https://demo.pharmafocusasia.com/news/fda-delays-decision-on-sareptas-muscle-wasting-disorder-drug daily 0.1 https://demo.pharmafocusasia.com/news/sartorius-to-expand-pharmaceutical-plant-in-puerto-rico daily 0.1 https://demo.pharmafocusasia.com/news/biotest-opens-new-plasma-collection-centre-in-brookings daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-recommends-approval-of-novo-nordisk-diabetes-drug daily 0.1 https://demo.pharmafocusasia.com/news/gsk-lung-drug-succeeds-in-big-uk-study daily 0.1 https://demo.pharmafocusasia.com/news/arbor-pharmaceuticals-to-acquire-xenoport daily 0.1 https://demo.pharmafocusasia.com/news/ucb-faces-us-patent-challenge-for-epilepsy-drug daily 0.1 https://demo.pharmafocusasia.com/news/france-faults-bial-and-biotrial-over-fatal-drug-trial daily 0.1 https://demo.pharmafocusasia.com/news/inquiry-points-to-maker-and-lab-in-fatal-french-drug-trial daily 0.1 https://demo.pharmafocusasia.com/news/drug-pricing-debate-looking-past-big-pharma-nightmare-scenario daily 0.1 https://demo.pharmafocusasia.com/news/guangdong-zhongsheng-pharmaceutical-amends-private-placement-plan daily 0.1 https://demo.pharmafocusasia.com/news/hikma-wins-dismissal-of-takeda-patent-lawsuit-over-gout-drug daily 0.1 https://demo.pharmafocusasia.com/news/china-slashes-gsk-astrazeneca-drug-prices-in-cost-cutting-drive daily 0.1 https://demo.pharmafocusasia.com/news/novartis-launches-new-entresto-trials-in-bid-to-boost-sales daily 0.1 https://demo.pharmafocusasia.com/news/roche-breast-cancer-drug-perjeta-rejected-by-uk-cost-agency daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-plc-to-acquire-worldwide-rights-to-interferon-gamma daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharma-ptsd-drug-shows-promise-in-mid-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/superbug-review-urges-big-pharma-to-pay-or-play-on-antibiotics daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-recalls-bottles-of-ondansetron-tablets-in-us daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-cancer-drug-shows-promise-in-combo-with-mercks-keytruda daily 0.1 https://demo.pharmafocusasia.com/news/deal-still-possible-in-colombia-novartis-cancer-drug-talks-minister daily 0.1 https://demo.pharmafocusasia.com/news/novartis-splits-drugs-business-into-two-pharma-chief-to-leave daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-lynparza-fails-in-gastric-cancer-combination-test daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-says-wins-patent-approvals-for-mob daily 0.1 https://demo.pharmafocusasia.com/news/mckesson-and-walmart-announce-sourcing-agreement-for-generic-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/anacor-shares-soar-on-pfizer-acquisition daily 0.1 https://demo.pharmafocusasia.com/news/valeant-to-increase-hospital-discounts-for-two-heart-drugs daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-fosun-says-it-has-made-non-binding-bid-for-indias-gland-pharma daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-blocks-its-drugs-from-use-in-lethal-injections daily 0.1 https://demo.pharmafocusasia.com/news/roche-moves-court-to-block-copies-of-cancer-drug-avastin-a-la-herceptin daily 0.1 https://demo.pharmafocusasia.com/news/stada-first-quarter-profit-beats-on-german-generic-boost daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-sees-more-challenges-in-us-business daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-ceo-says-drug-price-critique-by-independent-group-unscientific daily 0.1 https://demo.pharmafocusasia.com/news/mylan-launches-generic-frova-tablets-in-us daily 0.1 https://demo.pharmafocusasia.com/news/cigna-makes-deals-with-amgen-sanofi-for-pricey-cholesterol-drugs daily 0.1 https://demo.pharmafocusasia.com/news/baxter-emerges-as-frontrunner-to-buy-kkr-backed-gland-pharma daily 0.1 https://demo.pharmafocusasia.com/news/ex-fda-head-and-sanofi-call-for-harmonized-drug-regulation daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-cyclopharm-terminate-pact-for-technegas-in-us-market daily 0.1 https://demo.pharmafocusasia.com/news/allergan-profit-beats-estimates-share-buybacks-planned daily 0.1 https://demo.pharmafocusasia.com/news/jic-enters-into-exclusive-discussions-with-oaktree-to-acquire-sgd-pharma daily 0.1 https://demo.pharmafocusasia.com/news/uk-cost-body-finally-approves-limited-use-of-gsks-lupus-drug daily 0.1 https://demo.pharmafocusasia.com/news/kempharms-investigational-drug-receives-fast-track-designation daily 0.1 https://demo.pharmafocusasia.com/news/medicines-co-to-sell-cardiovascular-drugs-to-italys-chiesi daily 0.1 https://demo.pharmafocusasia.com/news/roche-commits-to-diabetes-testing-and-sees-return-to-growth daily 0.1 https://demo.pharmafocusasia.com/news/pharma-body-says-brexit-could-leave-uk-patients-facing-drug-delays daily 0.1 https://demo.pharmafocusasia.com/news/gates-foundation-backs-takeda-polio-vaccine-with-grant daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-jiuzhou-pharmaceutical-establishes-new-unit daily 0.1 https://demo.pharmafocusasia.com/news/china-regulator-to-launch-probe-into-foreign-local-drug-firms daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharm-finalizing-asset-sales-to-clear-allergan-deal daily 0.1 https://demo.pharmafocusasia.com/news/valeant-forms-committee-to-determine-drug-prices daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-secures-more-coverage-for-cholesterol-drug-praluent daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-says-it-will-try-to-oust-medivation-board-members-if-deal-talks-dont-start daily 0.1 https://demo.pharmafocusasia.com/news/tsumura-to-set-up-pharmaceutical-jv-in-china daily 0.1 https://demo.pharmafocusasia.com/news/bayer-says-its-drug-extends-lives-of-liver-cancer-patients daily 0.1 https://demo.pharmafocusasia.com/news/dubais-abraaj-exits-investment-in-tunisian-pharma-firm daily 0.1 https://demo.pharmafocusasia.com/news/epizymes-investigational-new-drug-application-gets-fda-nod daily 0.1 https://demo.pharmafocusasia.com/news/precision-for-medicine-acquires-applied-immunology 2019-04-17 02:22:10 daily 0.1 https://demo.pharmafocusasia.com/news/biogen-to-spin-off-hemophilia-drugs-and-focus-on-core-neuro-business 2019-04-17 02:22:08 daily 0.1 https://demo.pharmafocusasia.com/news/inovio-pharmaceuticals-completes-acquisition-of-needle-free-injection-technology 2019-04-17 02:22:06 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-ceo-still-interested-in-deals-after-losing-allergan 2019-04-17 02:22:05 daily 0.1 https://demo.pharmafocusasia.com/news/emd-serono-expands-biopharmaceutical-r-d-facility-in-billerica daily 0.1 https://demo.pharmafocusasia.com/news/france-gets-g-to-discuss-global-regulation-of-medicine-prices 2019-04-17 02:21:58 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-announces-fda-orphan-drug-designations-for-kte-c daily 0.1 https://demo.pharmafocusasia.com/news/applied-biomath-awarded-from-nih-for-systems-modeling-in-biotherapeutic-development daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-eyes-expansion-of-diabetes-medicines-segment-in-gulf daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-release-results-for-first-three-months-of-year daily 0.1 https://demo.pharmafocusasia.com/news/us-approves-first-drug-for-psychosis-linked-to-parkinsons daily 0.1 https://demo.pharmafocusasia.com/news/holography-trade-body-welcomes-new-un-anti-counterfeiting-report 2016-04-30 00:07:25 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-agrees-to-buy-stemcentrx daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-launches-fight-for-us-cancer-firm-medivation daily 0.1 https://demo.pharmafocusasia.com/news/acadia-drug-approval-could-clear-way-for-axovant-dementia-therapy daily 0.1 https://demo.pharmafocusasia.com/news/amgen-profit-rises-guidance-raised daily 0.1 https://demo.pharmafocusasia.com/news/bethlehem-sited-for-manufacturing-expansion-by-lubrizol-corporations-lifesciences 2016-04-28 00:20:29 daily 0.1 https://demo.pharmafocusasia.com/news/ubs-mpm-team-up-on-cancer-fund-to-speed-drug-development 2019-04-17 02:21:38 daily 0.1 https://demo.pharmafocusasia.com/news/merz-pharma-announces-new-investment-in-cytrellis-biosystems 2019-04-17 02:21:37 daily 0.1 https://demo.pharmafocusasia.com/news/montco-pharma-firm-partners-with-mayo-clinic-national-cancer-institute-on-study 2019-04-17 02:21:35 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-us-gout-drug-rights-to-ironwood 2019-04-17 02:21:33 daily 0.1 https://demo.pharmafocusasia.com/news/collegium-pharmas-opioid-painkiller-wins-us-approval daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-to-establish-national-headquarters-in-durham 2019-04-17 02:21:30 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-breaks-ground-on-waco-facility-expansion 2019-04-17 02:21:28 daily 0.1 https://demo.pharmafocusasia.com/news/us-panel-finds-sarepta-muscular-dystrophy-drug-not-proven-effective 2019-04-17 02:21:26 daily 0.1 https://demo.pharmafocusasia.com/news/recursion-pharmaceuticals-announces-research-agreement-with-sanofi-genzyme 2019-04-17 02:21:24 daily 0.1 https://demo.pharmafocusasia.com/news/fibrocell-receives-orphan-drug-designation 2019-04-17 02:21:22 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-to-prepare-the-sale-of-its-roche-stake 2019-04-17 02:21:21 daily 0.1 https://demo.pharmafocusasia.com/news/semler-gets-who-notice-of-concern-over-violation-of-ideal-laboratory-and-clinical-practices 2019-04-17 02:21:19 daily 0.1 https://demo.pharmafocusasia.com/news/lannett-to-co-develop-generic-insulin-product-for-us-market 2019-04-17 02:21:17 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-to-invest-in-chartres-production-site 2019-04-17 02:21:15 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-acquires-topical-dermatology-company-topokine-therapeutics 2019-04-17 02:21:13 daily 0.1 https://demo.pharmafocusasia.com/news/uk-agency-backs-cancer-drug-after-sanofi-cuts-price 2019-04-17 02:21:12 daily 0.1 https://demo.pharmafocusasia.com/news/sarepta-shares-sink-as-fda-staff-stay-sour-on-muscle-drug 2019-04-17 02:21:10 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-gets-option-on-early-argenx-cancer-drug 2019-04-17 02:21:08 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-earnings-fall-on-slide-in-cancer-drug-sales 2019-04-17 02:21:06 daily 0.1 https://demo.pharmafocusasia.com/news/yabao-pharmaceuticals-and-salus-pharma-announce-strategic-partnership-for-generic-drugs 2019-04-17 02:21:04 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-orphan-drug-exclusivity-to-spectrum-pharmaceuticals-evomela daily 0.1 https://demo.pharmafocusasia.com/news/nestle-extends-pharma-push-with-new-bet-on-gut-drugs 2019-04-17 02:21:01 daily 0.1 https://demo.pharmafocusasia.com/news/roche-sales-set-hard-challenge-for-drug-industry-rivals 2019-04-17 02:20:59 daily 0.1 https://demo.pharmafocusasia.com/news/un-reviews-war-on-drugs-amid-global-push-for-liberalization 2019-04-17 02:20:57 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-invest-to-expand-belgium-manufacturing-site 2019-04-17 02:20:55 daily 0.1 https://demo.pharmafocusasia.com/news/boehringers-operating-profit-up-percent-on-diabetes-drugs daily 0.1 https://demo.pharmafocusasia.com/news/nicox-submits-new-drug-application-for-ac-to-us-fda 2019-04-17 02:20:52 daily 0.1 https://demo.pharmafocusasia.com/news/roche-sues-intas-pharma-over-mircera-anaemia-drug-patent 2019-04-17 02:20:50 daily 0.1 https://demo.pharmafocusasia.com/news/sansheng-building-materials-signs-agreement-to-acquire-baikang-pharma 2019-04-17 02:20:48 daily 0.1 https://demo.pharmafocusasia.com/news/advent-baxter-set-to-submit-bids-for-indias-gland-pharma daily 0.1 https://demo.pharmafocusasia.com/news/ose-pharma-and-effimune-announce-the-signing-of-the-merger-treaty 2019-04-17 02:20:45 daily 0.1 https://demo.pharmafocusasia.com/news/fda-rejects-chiasmas-drug-to-treat-growth-disorder daily 0.1 https://demo.pharmafocusasia.com/news/hanmi-pharmaceutical-to-expand-bio-drug-production-plant 2019-04-17 02:20:41 daily 0.1 https://demo.pharmafocusasia.com/news/synta-pharmaceuticals-madrigal-announce-merger-agreement 2019-04-17 02:20:39 daily 0.1 https://demo.pharmafocusasia.com/news/repros-to-drop-testosterone-drug-in-us-if-key-study-fails 2019-04-17 02:20:38 daily 0.1 https://demo.pharmafocusasia.com/news/kiadis-pharma-fy-net-loss-widens-to-million-euros 2019-04-17 02:20:36 daily 0.1 https://demo.pharmafocusasia.com/news/redx-pharma-plc-set-for-new-headquarters-at-alderley-park 2019-04-17 02:20:34 daily 0.1 https://demo.pharmafocusasia.com/news/us-prescription-drug-spending-to-hit-year 2019-04-17 02:20:32 daily 0.1 https://demo.pharmafocusasia.com/news/vicore-pharma-gets-fimea-cleranes-for-phase-i-study 2019-04-17 02:20:30 daily 0.1 https://demo.pharmafocusasia.com/news/caisson-establishes-global-manufacturing-partnership-with-cordenpharma 2019-04-17 02:20:29 daily 0.1 https://demo.pharmafocusasia.com/news/us-congress-sends-obama-bill-on-zika-drug-development 2019-04-17 02:20:27 daily 0.1 https://demo.pharmafocusasia.com/news/pharmaceutical-research-firm-synteracthcr-explores-sale 2019-04-17 02:20:25 daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-votes-against-approving-cloviss-cancer-drug-on-current-data daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-must-face-revived-celebrex-bextra-safety-lawsuit 2019-04-17 02:20:21 daily 0.1 https://demo.pharmafocusasia.com/news/orchid-pharma-gets-eir-report-from-usfda-on-inspection-closure 2019-04-17 02:20:20 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-asks-ceo-to-cooperate-with-senate-committee 2019-04-17 02:20:18 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-grants-approval-to-sun-pharmas-ophthalmic-drug-bromfenac daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-new-drug-for-cll-in-patients-with-specific-chromosomal-abnormality 2019-04-17 02:20:14 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-roche-drug-gets-us-approval-for-rare-type-of-leukemia 2019-04-17 02:20:13 daily 0.1 https://demo.pharmafocusasia.com/news/india-ranks-last-in-how-its-national-policies-impact-global-biopharma-innovation 2016-04-11 03:15:26 daily 0.1 https://demo.pharmafocusasia.com/news/roche-says-fda-fast-tracks-atezolizumab-in-specific-type-of-lung-cancer 2019-04-17 02:20:06 daily 0.1 https://demo.pharmafocusasia.com/news/nz-pharmaceuticals-gets-cash-injection 2019-04-17 02:20:04 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-astrazeneca-announce-continuation-of-clinical-trial-for-amaranth 2019-04-17 02:20:02 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-completes-licensing-deal-after-pfizer-bid-collapses 2019-04-17 02:20:01 daily 0.1 https://demo.pharmafocusasia.com/news/adcock-ingram-to-sell-indian-pharmaceutical-unit 2019-04-17 02:19:59 daily 0.1 https://demo.pharmafocusasia.com/news/m-pharmaceutical-agrees-to-acquire-assets-from-chelatexx 2019-04-17 02:19:57 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-lenders-agree-to-amend-terms-of-debt 2019-04-17 02:19:55 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-to-develop-tesaros-drug-for-prostate-cancer 2016-04-07 03:03:45 daily 0.1 https://demo.pharmafocusasia.com/news/obama-inversion-curbs-kill-pfizers-allergan-deal daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-to-invest-in-kinsale-plant 2019-04-17 02:19:50 daily 0.1 https://demo.pharmafocusasia.com/news/cipher-pharmaceuticals-announces-canadian-launch-of-beteflam 2019-04-17 02:19:48 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-finishes-accounting-and-philidor-review-with-no-more-problems 2019-04-17 02:19:46 daily 0.1 https://demo.pharmafocusasia.com/news/citius-pharmaceuticals-completes-acquisition-of-leonard-meron-biosciences daily 0.1 https://demo.pharmafocusasia.com/news/serbia-invites-bids-for-percent-stake-in-galenika-drug-maker daily 0.1 https://demo.pharmafocusasia.com/news/rusan-pharma-launches-rd-centre-special-manufacturing-unit-in-gujarat-india daily 0.1 https://demo.pharmafocusasia.com/news/novartis-takes-entresto-case-to-us-cardiologist-meeting 2019-04-17 02:19:40 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-says-completes-divestment-of-three-brands 2019-04-17 02:19:38 daily 0.1 https://demo.pharmafocusasia.com/news/eu-recommends-conditional-approval-of-jjs-blood-cancer-drug 2016-04-04 01:41:04 daily 0.1 https://demo.pharmafocusasia.com/news/humanwell-healthcare-group-and-puracap-pharmaceutical-to-acquire-epic-pharma 2019-04-17 02:19:35 daily 0.1 https://demo.pharmafocusasia.com/news/array-biopharma-and-asahi-kasei-pharma-announce-collaboration 2019-04-17 02:19:33 daily 0.1 https://demo.pharmafocusasia.com/news/us-ftc-sues-endo-pharma-others-for-blocking-generic-versions-of-some-branded-drugs 2019-04-17 02:19:32 daily 0.1 https://demo.pharmafocusasia.com/news/teva-and-takeda-name-pharma-veteran-as-ceo-of-japan-joint-venture 2019-04-17 02:19:30 daily 0.1 https://demo.pharmafocusasia.com/news/jazz-pharmaceuticals-rare-liver-disorder-drug-wins-us-approval daily 0.1 https://demo.pharmafocusasia.com/news/natco-pharma-gains-on-sale-of-non-core-business-in-us 2019-04-17 02:19:27 daily 0.1 https://demo.pharmafocusasia.com/news/decline-in-financial-settlements-with-us-big-pharma 2019-04-17 02:19:25 daily 0.1 https://demo.pharmafocusasia.com/news/galmed-pharma-data-demonstrates-significant-reduction-of-inflammation 2019-04-17 02:19:23 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-to-buy-japanese-brands-from-novartis-in-deal 2019-04-17 02:19:21 daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-announces-research-collaboration-with-asahi-kasei-pharma 2019-04-17 02:19:19 daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-backs-acadia-drug-for-psychosis-linked-to-parkinsons daily 0.1 https://demo.pharmafocusasia.com/news/adamis-pharmaceuticals-to-acquire-us-compounding 2019-04-17 02:19:16 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-breaks-ground-on-production-facility-in-clayton-north-carolina 2019-04-17 02:19:14 daily 0.1 https://demo.pharmafocusasia.com/news/us-lawmakers-want-health-agencies-to-lower-prostate-cancer-drug-cost 2019-04-17 02:19:12 daily 0.1 https://demo.pharmafocusasia.com/news/us-scientists-develop-mouse-model-to-test-zika-vaccines-drugs 2019-04-17 02:19:10 daily 0.1 https://demo.pharmafocusasia.com/news/forge-therapeutics-and-active-motif-to-collaborate 2019-04-17 02:19:08 daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-laboratories-and-xenoport-enter-into-us-licensing-agreement daily 0.1 https://demo.pharmafocusasia.com/news/natco-pharma-slumps-after-receiving-usfda-observations-for-two-facilities 2019-04-17 02:19:05 daily 0.1 https://demo.pharmafocusasia.com/news/us-spends-a-year-on-unused-cancer-drugs 2019-04-17 02:19:03 daily 0.1 https://demo.pharmafocusasia.com/news/fda-staff-backs-acadias-drug-to-treat-psychosis-associated-with-parkinsons-disease daily 0.1 https://demo.pharmafocusasia.com/news/be-receives-an-order-govt-of-india-to-supply-liquid-pentavalent-vaccines 2016-03-24 03:38:40 daily 0.1 https://demo.pharmafocusasia.com/news/lakepharma-partners-with-ampersand-acquires-blue-sky-bioservices 2019-04-17 02:18:58 daily 0.1 https://demo.pharmafocusasia.com/news/merck-patents-on-hepatitis-c-treatment-found-valid-in-gilead-dispute 2019-04-17 02:18:56 daily 0.1 https://demo.pharmafocusasia.com/news/harbour-group-acquires-penntech-machinery-corp 2019-04-17 02:18:55 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-tevas-biotech-drug-for-severe-asthma daily 0.1 https://demo.pharmafocusasia.com/news/precision-for-medicine-to-acquire-act-oncology 2019-04-17 02:18:51 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-eli-lilly-drug-for-psoriasis 2019-04-17 02:18:49 daily 0.1 https://demo.pharmafocusasia.com/news/eiger-biopharmaceuticals-closes-merger-with-celladon 2019-04-17 02:18:47 daily 0.1 https://demo.pharmafocusasia.com/news/aegerion-pharmaceuticals-enters-into-agreement-with-sarissa-capital 2019-04-17 02:18:45 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-and-cadila-pharmaceuticals-enters-agreement-for-late-stage-development daily 0.1 https://demo.pharmafocusasia.com/news/xiangxue-pharma-to-acquire-stake-in-traditional-medicine-firm daily 0.1 https://demo.pharmafocusasia.com/news/fei-and-novalix-partner-to-provide-electron-microscopy-based-structural-biology-services daily 0.1 https://demo.pharmafocusasia.com/news/biomarin-drug-for-genetic-disorder-succeeds-in-late-stage-study 2019-04-17 02:18:39 daily 0.1 https://demo.pharmafocusasia.com/news/yifan-xinfu-pharma-plans-to-acquire-stakes-in-biopharma-firm 2019-04-17 02:18:37 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gains-after-usfda-nod-for-otc-medicine 2019-04-17 02:18:35 daily 0.1 https://demo.pharmafocusasia.com/news/profectus-and-vyriad-form-global-collaboration-to-develop-oncolytic-recombinant-vsv-vaccines daily 0.1 https://demo.pharmafocusasia.com/news/jj-psoriasis-drug-stelara-tames-crohns-disease-in-second-trial daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-rejects-eagle-pharmas-blood-thinner daily 0.1 https://demo.pharmafocusasia.com/news/biota-pharmaceuticals-announces-sale-of-antibiotic-assets-to-spero-therapeutics 2019-04-17 02:18:29 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-entered-into-clinical-trial-collaboration-with-genentech 2019-04-17 02:18:27 daily 0.1 https://demo.pharmafocusasia.com/news/us-commission-calls-for-urgent-action-to-protect-drug-affected-babies 2019-04-17 02:18:25 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-healthcare-launches-psoriasis-treatment-drug-in-india daily 0.1 https://demo.pharmafocusasia.com/news/braeburn-pharmaceuticals-invests-to-establish-manufacturing-research-center-in-durham-county daily 0.1 https://demo.pharmafocusasia.com/news/vitae-pharmas-psoriasis-drug-succeeds-in-mid-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/amgen-beats-sanofi-regeneron-at-cholesterol-drug-trial 2019-04-17 02:18:18 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharm-sees-close-of-allergan-generics-deal-by-june 2019-04-17 02:18:17 daily 0.1 https://demo.pharmafocusasia.com/news/drugmaker-vectura-group-to-buy-skyepharma 2019-04-17 02:18:12 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-dice-molecules-announce-drug-partnership daily 0.1 https://demo.pharmafocusasia.com/news/medica-nord-acquires-natumin-pharma daily 0.1 https://demo.pharmafocusasia.com/news/cipla-invests-in-us-chase-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/inovio-pharmaceuticals-acquires-needle-free-injection-technology daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-fosun-pharma-to-buy-stake-in-pharma-firm 2019-04-17 02:18:04 daily 0.1 https://demo.pharmafocusasia.com/news/gw-pharma-cannabis-drug-succeeds-in-epilepsy-trial 2019-04-17 02:18:02 daily 0.1 https://demo.pharmafocusasia.com/news/suven-life-gets-patent-for-neuro-degenerative-drug 2019-04-17 02:18:00 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-seeking-to-link-executive-pay-to-target 2019-04-17 02:17:58 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-abbott-india-shares-fall-as-regulator-bans-codeine-cough-syrups 2019-04-17 02:17:56 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-agrees-to-acquire-inderal-la-assets-from-cranford-pharmaceuticals 2019-04-17 02:17:54 daily 0.1 https://demo.pharmafocusasia.com/news/hovione-and-vertex-pharmaceuticals-partner-in-continuous-manufacturing 2019-04-17 02:17:53 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-drug-beats-abbvies-blockbuster-humira-in-human-trial daily 0.1 https://demo.pharmafocusasia.com/news/south-africas-adcock-in-talks-to-sell-part-of-its-india-business-to-oaknet-lifesciences daily 0.1 https://demo.pharmafocusasia.com/news/teva-set-to-win-eu-okay-for-allergan-deal daily 0.1 https://demo.pharmafocusasia.com/news/gilead-tries-to-block-mercks-patent-claims-on-new-hepatitis-c-drugs daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-shyndec-pharmaceutical-to-acquire-stakes-assets-in-pharma-firms daily 0.1 https://demo.pharmafocusasia.com/news/belgian-pharma-executives-may-face-trial-over-mexican-drug-cartel-trade 2019-04-17 02:17:42 daily 0.1 https://demo.pharmafocusasia.com/news/us-health-agency-estimates-prescription-drug-spend-rose 2019-04-17 02:17:41 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-completes-acquisition-of-gavis-pharma 2019-04-17 02:17:38 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-drug-price-cuts-are-hitting-big-pharma-where-it-hurts daily 0.1 https://demo.pharmafocusasia.com/news/amgen-withdraws-patent-suit-against-samsung-bioepis 2019-04-17 02:17:35 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-buys-rights-to-boehringer-psoriasis-drug 2019-04-17 02:17:33 daily 0.1 https://demo.pharmafocusasia.com/news/pci-pharma-services-explores-sale 2019-04-17 02:17:31 daily 0.1 https://demo.pharmafocusasia.com/news/ajanta-pharma-receives-us-fda-nod-for-migraine-drug-almotriptan-malate 2019-04-17 02:17:29 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-merck-spar-over-hepatitis-pill-royalties 2019-04-17 02:17:27 daily 0.1 https://demo.pharmafocusasia.com/news/pharma-crusader-takes-indias-drug-regulators-to-court daily 0.1 https://demo.pharmafocusasia.com/news/gsk-asthma-drug-nucalas-long-term-study-supports-safety-profile daily 0.1 https://demo.pharmafocusasia.com/news/ucla-sells-royalty-rights-connected-with-cancer-drug-to-royalty-pharma 2019-04-17 02:17:22 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-says-victoza-helps-lower-heart-risks 2019-04-17 02:17:20 daily 0.1 https://demo.pharmafocusasia.com/news/south-african-state-owned-drug-firm-seeks-anti-retroviral-supplies 2019-04-17 02:17:19 daily 0.1 https://demo.pharmafocusasia.com/news/generic-drug-etf-ailing-despite-political-focus-on-high-drug-prices 2019-04-17 02:17:17 daily 0.1 https://demo.pharmafocusasia.com/news/bcorp-enters-pharmaceutical-jv-with-australia-cw-network 2019-04-17 02:17:15 daily 0.1 https://demo.pharmafocusasia.com/news/ny-attorney-general-to-investigate-insurers-over-hepatitis-c-drugs 2019-04-17 02:17:13 daily 0.1 https://demo.pharmafocusasia.com/news/pricing-pressures-weigh-on-drug-industry-growth-moody-s daily 0.1 https://demo.pharmafocusasia.com/news/mckesson-expands-oncology-expertise-with-buy-of-vantage-oncology-and-biologics 2019-04-17 02:17:10 daily 0.1 https://demo.pharmafocusasia.com/news/norbrook-laboratories-newry-pharmaceutical-firm-grows-turnover-by-per-cent 2019-04-17 02:17:08 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-discloses-subpoena-over-patient-financial-assistance 2019-04-17 02:17:06 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gets-usfda-nod-for-antidote-to-analgesic-overdose 2019-04-17 02:17:04 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-two-heart-drugs-to-china-medical-for-usd-mln 2019-04-17 02:17:02 daily 0.1 https://demo.pharmafocusasia.com/news/aldeyra-s-eye-drug-found-effective-in-mid-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/west-pharmaceutical-services-invests-to-expand-production-center daily 0.1 https://demo.pharmafocusasia.com/news/gileads-hiv-drug-gets-closer-to-getting-europe-approval daily 0.1 https://demo.pharmafocusasia.com/news/sk-group-ratchets-up-move-for-pharmaceutical-biz 2019-04-17 02:16:56 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-seen-avoiding-tax-via-allergan-merger 2019-04-17 02:16:54 daily 0.1 https://demo.pharmafocusasia.com/news/kannalife-eyes-share-float-to-fund-cannabis-based-medicine 2019-04-17 02:16:52 daily 0.1 https://demo.pharmafocusasia.com/news/verily-vanderbilt-to-test-enrollment-in-us-precision-medicine-pilot 2019-04-17 02:16:50 daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-acerta-deal-endorsed-by-orphan-drug-status daily 0.1 https://demo.pharmafocusasia.com/news/ose-pharma-and-effimune-announce-proposed-merger daily 0.1 https://demo.pharmafocusasia.com/news/gilead-introduces-new-grants-programme-to-support-hiv-cure 2019-04-17 02:16:45 daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-to-create-jobs-at-expanded-irvine-plant 2019-04-17 02:16:43 daily 0.1 https://demo.pharmafocusasia.com/news/us-and-eu-regulators-urge-indian-drug-companies-to-step-up-standards 2019-04-17 02:16:42 daily 0.1 https://demo.pharmafocusasia.com/news/ithaca-ny-mayor-proposes-supervised-drug-injection-facility 2019-04-17 02:16:40 daily 0.1 https://demo.pharmafocusasia.com/news/unilife-and-amgen-enter-strategic-collaboration 2019-04-17 02:16:38 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-says-us-fda-accepts-diabetes-drug-application 2019-04-17 02:16:35 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-says-it-will-restate-earnings-after-board-review 2019-04-17 02:16:34 daily 0.1 https://demo.pharmafocusasia.com/news/shanghai-fosun-pharma-plans-medical-investment-management-firm-with-partners 2019-04-17 02:16:32 daily 0.1 https://demo.pharmafocusasia.com/news/negotiations-with-ethiopia-gabon-to-build-pharmaceutical-factories-funded-by-private-sector 2019-04-17 02:16:30 daily 0.1 https://demo.pharmafocusasia.com/news/china-suspends-ali-health-run-online-drug-monitoring-platform 2019-04-17 02:16:28 daily 0.1 https://demo.pharmafocusasia.com/news/teva-makes-concessions-in-eu-review-of-bid-for-allergan-unit 2019-04-17 02:16:26 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-wins-fda-breakthrough-therapy-for-aml-treatment 2019-04-17 02:16:24 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-completes-acquisition-of-us-generic-drug-companies 2019-04-17 02:16:23 daily 0.1 https://demo.pharmafocusasia.com/news/alnylams-new-norton-plant-seen-as-strengthening-state-s-pharma-hub daily 0.1 https://demo.pharmafocusasia.com/news/zafgens-obesity-drug-succeeds-in-mid-stage-trial daily 0.1 https://demo.pharmafocusasia.com/news/pharma-companies-increase-investments-in-biotech-segment 2019-04-17 02:16:14 daily 0.1 https://demo.pharmafocusasia.com/news/nls-pharma-acquires-a-portfolio-of-strategic-patents 2019-04-17 02:16:12 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-wins-fda-breakthrough-status-for-key-cancer-drug 2019-04-17 02:16:10 daily 0.1 https://demo.pharmafocusasia.com/news/uk-cost-agency-queries-value-of-alexion-drug 2019-04-17 02:16:08 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharma-surges-on-receiving-tentative-approval-from-usfda 2019-04-17 02:16:07 daily 0.1 https://demo.pharmafocusasia.com/news/carmot-therapeutics-extends-drug-discovery-collaboration-with-amgen 2019-04-17 02:16:05 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-loses-bid-to-nix-trial-over-generic-drug-blamed-for-reed-smith-partners-death 2016-02-17 00:37:55 daily 0.1 https://demo.pharmafocusasia.com/news/flexions-pain-drug-succeeds-in-study-shares-soar daily 0.1 https://demo.pharmafocusasia.com/news/nutra-pharma-announces-management-expansion-and-business-updates 2019-04-17 02:16:00 daily 0.1 https://demo.pharmafocusasia.com/news/gastric-reflux-drugs-may-be-tied-to-dementia-risk 2019-04-17 02:15:58 daily 0.1 https://demo.pharmafocusasia.com/news/cancer-researchers-claim-extraordinary-results-using-t-cell-therapy 2016-02-16 07:42:11 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-blood-cell-disorder-drug-meets-primary-goal-in-phase-trial 2019-04-17 02:15:55 daily 0.1 https://demo.pharmafocusasia.com/news/china-to-consolidate-drug-market-promote-traditional-medicines 2019-04-17 02:15:53 daily 0.1 https://demo.pharmafocusasia.com/news/protein-sciences-and-unigen-reach-agreement daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-to-seek-fda-re-inspection-of-halol-plant-by-end-june 2019-04-17 02:15:49 daily 0.1 https://demo.pharmafocusasia.com/news/teva-says-actavis-deal-to-close-by-april-as-profit-falls 2019-04-17 02:15:47 daily 0.1 https://demo.pharmafocusasia.com/news/south-africa-sets-up-state-owned-pharmaceutical-firm 2019-04-17 02:15:45 daily 0.1 https://demo.pharmafocusasia.com/news/air-liquides-arm-cryo-buys-pharma-logistics-firm-pdp-couriers daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharmaceuticals-agrees-to-acquire-all-of-beyond-human 2016-02-12 05:14:01 daily 0.1 https://demo.pharmafocusasia.com/news/qualicaps-acquires-genix-industria-farmaceutica daily 0.1 https://demo.pharmafocusasia.com/news/hikma-cuts-offer-for-boehringers-us-generic-drug-unit daily 0.1 https://demo.pharmafocusasia.com/news/imprimis-pharma-to-make-cheaper-alternative-to-retrophins-thiola 2016-02-11 05:58:02 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-nv-to-acquire-swedish-drug-maker-meda 2019-04-17 02:15:36 daily 0.1 https://demo.pharmafocusasia.com/news/-d-pharma-plc-acquires-tucana-health-limited 2019-04-17 02:15:34 daily 0.1 https://demo.pharmafocusasia.com/news/fda-puts-full-clinical-hold-on-cti-biopharmas-blood-cancer-drug daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-pharma-revenue-rises 2019-04-17 02:15:31 daily 0.1 https://demo.pharmafocusasia.com/news/denmarks-iss-says-expands-partnership-with-novartis daily 0.1 https://demo.pharmafocusasia.com/news/insurer-cigna-and-novartis-set-heart-drug-price-based-on-health-outcome 2019-04-17 02:15:27 daily 0.1 https://demo.pharmafocusasia.com/news/flamel-technologies-acquires-fsc-pediatrics 2019-04-17 02:15:26 daily 0.1 https://demo.pharmafocusasia.com/news/biocrysts-genetic-disorder-drug-fails-study-shares-slump daily 0.1 https://demo.pharmafocusasia.com/news/ferring-pharma-proposes-to-invest-in-pharma-city-telangana 2019-04-17 02:15:22 daily 0.1 https://demo.pharmafocusasia.com/news/innate-pharma-to-start-phase-clinical-trial-of-monalizumab 2019-04-17 02:15:20 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-gilead-sciences-shares-could-rise 2019-04-17 02:15:19 daily 0.1 https://demo.pharmafocusasia.com/news/drug-industry-launches-ad-campaign-aimed-at-lawmakers 2019-04-17 02:15:17 daily 0.1 https://demo.pharmafocusasia.com/news/pozen-and-tribute-combine-to-create-aralez-pharmaceuticals 2019-04-17 02:15:15 daily 0.1 https://demo.pharmafocusasia.com/news/china-resources-pharmaceutical-plans-hk-ipo 2019-04-17 02:15:13 daily 0.1 https://demo.pharmafocusasia.com/news/sigmoid-pharma-to-buy-irish-arm-of-japanese-group-freund-pharmatec 2019-04-17 02:15:11 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-jj-merck-evaluating-technologies-for-zika-vaccine 2019-04-17 02:15:10 daily 0.1 https://demo.pharmafocusasia.com/news/judge-rejects-request-for-bankruptcy-trustee-to-oversee-kalobios 2019-04-17 02:15:08 daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-initiates-dosing-of-patients-in-phase 2019-04-17 02:15:06 daily 0.1 https://demo.pharmafocusasia.com/news/bharat-biotech-gets-breakthrough-in-developing-zika-vaccine daily 0.1 https://demo.pharmafocusasia.com/news/merck-gives-cautious-outlook-as-sales-of-top-medicines-lag daily 0.1 https://demo.pharmafocusasia.com/news/gsk-dismisses-near-term-split-as-new-drugs-offset-falling-advair daily 0.1 https://demo.pharmafocusasia.com/news/florida-governor-declares-health-emergency-in-four-counties-over-zika daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-merck-said-to-consider-exiting-vaccine-joint-venture 2019-04-17 02:14:58 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-turing-boosted-drug-prices-to-fuel-preset-profits 2019-04-17 02:14:56 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-lupin-launch-generics-in-us 2019-04-17 02:14:54 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-patriarch-y-k-hamied-increases-stake-in-company 2019-04-17 02:14:52 daily 0.1 https://demo.pharmafocusasia.com/news/bap-pharma-opens-us-headquarters-in-landing-new-jersey 2019-04-17 02:14:50 daily 0.1 https://demo.pharmafocusasia.com/news/mckesson-to-sell-brazilian-pharmaceutical-distribution-business 2019-04-17 02:14:48 daily 0.1 https://demo.pharmafocusasia.com/news/china-fines-domestic-drug-firms-for-price-fixing 2019-04-17 02:14:46 daily 0.1 https://demo.pharmafocusasia.com/news/who-declares-zika-virus-a-global-health-emergency 2019-04-17 02:14:44 daily 0.1 https://demo.pharmafocusasia.com/news/president-dilma-rousseff-calls-on-brazil-society-to-unite-against-zika-virus 2019-04-17 02:14:42 daily 0.1 https://demo.pharmafocusasia.com/news/review-of-nhs-drugs-assessment-ordered 2019-04-17 02:14:40 daily 0.1 https://demo.pharmafocusasia.com/news/unichem-gets-usfda-approval-to-sell-prostate-drug 2019-04-17 02:14:38 daily 0.1 https://demo.pharmafocusasia.com/news/brazils-br-pharma-to-sell-of-new-shares daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-eisais-drug-halaven-for-type-of-soft-tissue-cancer daily 0.1 https://demo.pharmafocusasia.com/news/cphi-announces-new-collaboration-with-the-africa-pharmaceutical-summit 2019-04-17 02:14:32 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-gets-cci-nod-to-sell-in-consumer-healthcare-business 2019-04-17 02:14:30 daily 0.1 https://demo.pharmafocusasia.com/news/roche-expects-cancer-treatments-to-be-spared-us-pricing-curbs 2019-04-17 02:14:28 daily 0.1 https://demo.pharmafocusasia.com/news/who-says-zika-virus-spreads-explosively-four-million-cases-forecast 2019-04-17 02:14:26 daily 0.1 https://demo.pharmafocusasia.com/news/trillium-therapeutics-acquires-privately-held-fluorinov-pharma 2019-04-17 02:14:21 daily 0.1 https://demo.pharmafocusasia.com/news/massachusetts-official-challenges-gileads-hepatitis-c-drug-prices daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-neos-therapeutics-long-acting-adhd-drug daily 0.1 https://demo.pharmafocusasia.com/news/global-health-body-under-pressure-to-stop-zika-virus 2019-04-17 02:14:15 daily 0.1 https://demo.pharmafocusasia.com/news/big-pharmas-bet-on-big-data-creates-opportunities-and-risks daily 0.1 https://demo.pharmafocusasia.com/news/amatsigroup-acquires-q-biologicals 2019-04-17 02:14:12 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-launches-tresiba-in-the-united-states 2019-04-17 02:14:10 daily 0.1 https://demo.pharmafocusasia.com/news/biosimilar-drugs-get-boost-as-uk-cost-agency-backs-their-use 2019-04-17 02:14:07 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-astra-jj-link-with-universities-in-new-drug-research-fund 2019-04-17 02:14:05 daily 0.1 https://demo.pharmafocusasia.com/news/torrent-dr-reddys-aurobindo-cipla-lupin-in-race-to-buy-sagent-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/iran-to-triple-pharmaceutical-export-in-three-years 2019-04-17 02:14:02 daily 0.1 https://demo.pharmafocusasia.com/news/pharma-exports-to-developed-nations-become-easier-as-government-scraps daily 0.1 https://demo.pharmafocusasia.com/news/shire-completes-acquisition-of-dyax-corp 2019-04-17 02:13:58 daily 0.1 https://demo.pharmafocusasia.com/news/us-government-suspends-enrollment-in-cigna-medicare-advantage 2019-04-17 02:13:56 daily 0.1 https://demo.pharmafocusasia.com/news/india-issues-alert-to-deter-use-of-roches-avastin-drug-for-eyes daily 0.1 https://demo.pharmafocusasia.com/news/jj-stops-trials-of-drug-similar-to-one-linked-to-brain-death-in-france 2019-04-17 02:13:51 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-gets-cci-nod-for-investment-by-fil-capital 2019-04-17 02:13:50 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-pharma-to-open-new-clinical-supply-facility-in-japan 2019-04-17 02:13:48 daily 0.1 https://demo.pharmafocusasia.com/news/big-pharma-pushes-for-new-antibiotic-funds-to-fight-superbugs 2019-04-17 02:13:46 daily 0.1 https://demo.pharmafocusasia.com/news/mankind-pharma-plans-to-open-us-plant 2019-04-17 02:13:44 daily 0.1 https://demo.pharmafocusasia.com/news/capital-plans-ethiopian-pharma-aactory-after-investment 2019-04-17 02:13:41 daily 0.1 https://demo.pharmafocusasia.com/news/brazils-br-pharma-to-raise-fresh-capital-as-btg-pactual-mulls-exit daily 0.1 https://demo.pharmafocusasia.com/news/psychogenics-expands-its-drug-discovery-service-capabilities 2019-04-17 02:13:38 daily 0.1 https://demo.pharmafocusasia.com/news/two-indian-states-halt-sales-of-roches-avastin-drug daily 0.1 https://demo.pharmafocusasia.com/news/biden-pledges-faster-us-approval-for-cancer-drug-cocktails 2019-04-17 02:13:35 daily 0.1 https://demo.pharmafocusasia.com/news/colorcon-acquires-paulaur-corporations-pharmaceutical-sugar-spheres-business daily 0.1 https://demo.pharmafocusasia.com/news/tanzania-bans-lincoln-pharmas-bacteria-fighting-injection daily 0.1 https://demo.pharmafocusasia.com/news/pharma-major-lupin-targets-bn-revenue-from-inorganic-growth-by-fy- 2019-04-17 02:13:30 daily 0.1 https://demo.pharmafocusasia.com/news/cognition-life-science-selects-smart-science-laboratories-for-production 2019-04-17 02:13:27 daily 0.1 https://demo.pharmafocusasia.com/news/emcure-pharmaceuticals-acquires-canadian-company-and-its-marketing-arm-marcan 2019-04-17 02:13:24 daily 0.1 https://demo.pharmafocusasia.com/news/samsung-bioepis-enbrel-drug-copy-gets-eu-approval daily 0.1 https://demo.pharmafocusasia.com/news/pharma-investors-look-for-lessons-after-biomarin-fda-defeat 2019-04-17 02:13:19 daily 0.1 https://demo.pharmafocusasia.com/news/eleven-bios-eye-drug-fails-another-late-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-says-its-car-t-cancer-therapy-could-outshine-rivals 2019-04-17 02:13:14 daily 0.1 https://demo.pharmafocusasia.com/news/piramal-enterprises-in-talks-to-sell-stake-in-over-the-counter-drugs-business 2019-04-17 02:13:11 daily 0.1 https://demo.pharmafocusasia.com/news/court-upholds-patents-on-pfizer-cancer-drug-sutent 2019-04-17 02:13:08 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-and-leiden-university-medical-center-sign-research-and-license-agreement daily 0.1 https://demo.pharmafocusasia.com/news/roche-abbvie-get-us-priority-review-status-for-leukemia-drug 2019-04-17 02:13:03 daily 0.1 https://demo.pharmafocusasia.com/news/merck-biolinerx-to-study-drug-combo-to-fight-pancreatic-cancer 2019-04-17 02:13:01 daily 0.1 https://demo.pharmafocusasia.com/news/torrent-pharma-launches-adalimumab-biosimilar-in-india 2019-04-17 02:12:58 daily 0.1 https://demo.pharmafocusasia.com/news/drugmaker-shire-to-buy-baxalta-after-six-month-pursuit 2019-04-17 02:12:55 daily 0.1 https://demo.pharmafocusasia.com/news/nestle-signs-deal-with-seres-for-healthy-gut-drugs daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-says-ties-up-with-moderna-to-co-develop-immuno-oncology-mrna 2019-04-17 02:12:50 daily 0.1 https://demo.pharmafocusasia.com/news/mckesson-says-profit-to-be-hurt-by-weak-generic-drug-pricing 2019-04-17 02:12:47 daily 0.1 https://demo.pharmafocusasia.com/news/biomarin-ceo-waiting-on-fda-on-duchenne-drug-eyes-europe 2019-04-17 02:12:44 daily 0.1 https://demo.pharmafocusasia.com/news/cure-duchenne-ventures-llc-provides-funding-to-bamboo-therapeutics-to-help-advance-gene-therapy-treatment 2016-01-11 02:04:11 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-teams-with-innate-pharma-in-deal-to-develop-cancer-drugs 2019-04-17 02:12:39 daily 0.1 https://demo.pharmafocusasia.com/news/fresenius-kabi-usa-acquires-us-pharmaceutical-plant 2019-04-17 02:12:36 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-enters-into-translational-research-collaboration-with-adaptive-biotechnologies daily 0.1 https://demo.pharmafocusasia.com/news/allergan-inks-deal-for-anterios 2019-04-17 02:12:31 daily 0.1 https://demo.pharmafocusasia.com/news/dementia-discovery-fund-chooses-alector-for-first-investment 2019-04-17 02:12:28 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-files-for-eu-approval-of-haemophilia-b-treatment 2019-04-17 02:12:25 daily 0.1 https://demo.pharmafocusasia.com/news/jj-signs-deal-with-chinese-company-for-hepatitis-b-drug 2019-04-17 02:12:23 daily 0.1 https://demo.pharmafocusasia.com/news/bioq-pharma-and-cipla-enter-into-an-agreement daily 0.1 https://demo.pharmafocusasia.com/news/recro-pharmas-lead-painkiller-succeeds-in-mid-stage-trial daily 0.1 https://demo.pharmafocusasia.com/news/pennsylvania-based-vwr-acquires-therapak 2019-04-17 02:12:15 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-acquires-us-biologics-manufacturing-facility 2019-04-17 02:12:12 daily 0.1 https://demo.pharmafocusasia.com/news/the-carlyle-group-and-bourne-partners-form-phoenix-therapeutics-to-build-global-pharma-company 2019-04-17 02:12:09 daily 0.1 https://demo.pharmafocusasia.com/news/chinas-jiangsu-hansoh-pharmaceutical-plans-up-to-hong-kong-ipo daily 0.1 https://demo.pharmafocusasia.com/news/jj-seeking-to-divest-manufacturing-unit-noramco 2019-04-17 02:12:04 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-pharmaceuticals-receives-fda-approval-for-neostigmine-methylsulfate-injection 2019-04-17 02:12:01 daily 0.1 https://demo.pharmafocusasia.com/news/teva-active-biotech-halt-higher-doses-of-oral-ms-drug-in-trials 2019-04-17 02:11:58 daily 0.1 https://demo.pharmafocusasia.com/news/drugmaker-baxalta-in-deal-to-expand-immuno-oncology-business 2019-04-17 02:11:55 daily 0.1 https://demo.pharmafocusasia.com/news/drug-approvals-at-high-belie-industry-challenges 2019-04-17 02:11:49 daily 0.1 https://demo.pharmafocusasia.com/news/dublin-based-shire-in-advanced-talks-to-acquire-baxalta 2019-04-17 02:11:47 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-needs-to-set-itself-free 2019-04-17 02:11:44 daily 0.1 https://demo.pharmafocusasia.com/news/underwriters-buy-additional-in-teva-pharm-shares 2019-04-17 02:11:40 daily 0.1 https://demo.pharmafocusasia.com/news/hybio-pharmaceutical-receives-patent-license 2019-04-17 02:11:36 daily 0.1 https://demo.pharmafocusasia.com/news/oramed-announces-closing-of-licensing-and-investment-deal-with-htit daily 0.1 https://demo.pharmafocusasia.com/news/suven-life-gets-patent-for-neurodegenerative-drug 2019-04-17 02:11:30 daily 0.1 https://demo.pharmafocusasia.com/news/immune-pharmaceuticals-announces-exclusive-license-to-novel-bispecific-antibody-technology 2019-04-17 02:11:27 daily 0.1 https://demo.pharmafocusasia.com/news/stem-cells-help-evaluate-experimental-alzheimers-drugs daily 0.1 https://demo.pharmafocusasia.com/news/chimerix-antiviral-drug-fails-in-late-stage-study 2019-04-17 02:11:22 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-announces-details-of-new-business-venture-with-teva-in-japan 2019-04-17 02:11:19 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-expands-partnership-in-korea 2019-04-17 02:11:16 daily 0.1 https://demo.pharmafocusasia.com/news/ose-pharma-international-selects-centers-for-phase-tedopi-trial 2019-04-17 02:11:13 daily 0.1 https://demo.pharmafocusasia.com/news/natco-settles-patent-litigation-with-celgene-on-cancer-drug 2019-04-17 02:11:11 daily 0.1 https://demo.pharmafocusasia.com/news/dea-eases-requirements-for-natural-cannabis-derived-drug-research 2019-04-17 02:11:08 daily 0.1 https://demo.pharmafocusasia.com/news/vertice-pharma-completes-acquisition-of-vistapharm 2019-04-17 02:11:05 daily 0.1 https://demo.pharmafocusasia.com/news/orchid-pharma-unit-inks-pact-with-uk-entity-for-loan 2019-04-17 02:11:02 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-gets-us-approval-for-gout-drug-zurampic 2019-04-17 02:11:00 daily 0.1 https://demo.pharmafocusasia.com/news/german-generics-drugmaker-dermapharm-put-up-for-sale 2019-04-17 02:10:57 daily 0.1 https://demo.pharmafocusasia.com/news/furen-pharma-to-acquire-kaifeng-pharma daily 0.1 https://demo.pharmafocusasia.com/news/halozyme-enters-into-global-collaboration-and-licensing-agreement-with-lilly daily 0.1 https://demo.pharmafocusasia.com/news/bayer-forms-gene-editing-partnership-with-crispr-therapeutics 2019-04-17 02:10:49 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharmaceuticals-settles-patent-litigation-over-anti-depressant-drug daily 0.1 https://demo.pharmafocusasia.com/news/fuan-pharma-to-acquire-yantai-justware-pharma 2019-04-17 02:10:44 daily 0.1 https://demo.pharmafocusasia.com/news/indias-sun-pharma-shares-slump-after-fda-warning-letter daily 0.1 https://demo.pharmafocusasia.com/news/gsk-to-buy-hiv-drugs-from-bristol-myers-squibb 2019-04-17 02:10:38 daily 0.1 https://demo.pharmafocusasia.com/news/europe-recommends-lung-cancer-drugs-from-astrazeneca-lilly 2019-04-17 02:10:36 daily 0.1 https://demo.pharmafocusasia.com/news/ligand-pharma-to-acquire-genetic-engineering-company-omt-inc 2019-04-17 02:10:33 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-to-invest-in-galapagos-after-abbvie-snub 2019-04-17 02:10:30 daily 0.1 https://demo.pharmafocusasia.com/news/eye-drug-company-alimera-sciences-mulls-sale 2019-04-17 02:10:27 daily 0.1 https://demo.pharmafocusasia.com/news/martin-shkreli-pharma-executive-arrested-on-fraud-charges 2019-04-17 02:10:24 daily 0.1 https://demo.pharmafocusasia.com/news/malin-to-invest-in-poseida-therapeutics 2019-04-17 02:10:21 daily 0.1 https://demo.pharmafocusasia.com/news/endo-health-to-pay-over-fluoride-labeling-claims 2019-04-17 02:10:18 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-slashes-revenue-earnings-guidance 2019-04-17 02:10:15 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-eli-lillys-basaglar-diabetes-drug daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-plans-to-reshape-via-asset-swap-with-boehringer 2019-04-17 02:10:11 daily 0.1 https://demo.pharmafocusasia.com/news/kitov-pharmas-arthritis-drug-meets-main-goal-in-late-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/french-drug-developer-pharnext-to-take-rare-approach-to-pricing 2019-04-17 02:10:07 daily 0.1 https://demo.pharmafocusasia.com/news/mike-lynch-backed-data-medicine-firm-raises 2019-04-17 02:10:05 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-sells-bryan-manufacturing-unit-to-nostrum-laboratories 2019-04-17 02:10:03 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-reacquires-rights-to-three-drugs-from-glaxo 2019-04-17 02:10:02 daily 0.1 https://demo.pharmafocusasia.com/news/midatech-pharma-signs-supply-agreement-with-turkeys-centurion-pharma daily 0.1 https://demo.pharmafocusasia.com/news/atara-biotherapeutics-stops-development-of-kidney-drug 2019-04-17 02:09:58 daily 0.1 https://demo.pharmafocusasia.com/news/chinese-drugmaker-jiangsu-hansoh-pharma-plans-ipo 2019-04-17 02:09:56 daily 0.1 https://demo.pharmafocusasia.com/news/tianshan-wool-tex-to-acquire-jialin-pharma 2019-04-17 02:09:54 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-hires-attorney-crisis-management-firm-as-us-scrutiny-mounts 2019-04-17 02:09:52 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-in-talks-to-buy-cancer-drug-developer-acerta-pharma 2019-04-17 02:09:50 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-acquires-crealta-holdings 2019-04-17 02:09:48 daily 0.1 https://demo.pharmafocusasia.com/news/amri-and-multispan-ink-collaboration-agreement 2019-04-17 02:09:46 daily 0.1 https://demo.pharmafocusasia.com/news/raptor-pharmaceutical-plans-to-advance-development-of-brain-disorder-drug 2019-04-17 02:09:44 daily 0.1 https://demo.pharmafocusasia.com/news/alembic-pharma-arm-ties-up-with-novartis-for-drug-development 2019-04-17 02:09:41 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-canada-acquires-mercks-ophthalmology-portfolio daily 0.1 https://demo.pharmafocusasia.com/news/neobiocon-partners-novartis-to-launch-diabetes-drugs-in-uae 2019-04-17 02:09:37 daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-to-invest-extra-in-pharma-pipeline 2019-04-17 02:09:31 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-inks-pact-to-develop-nervous-system-drugs 2019-04-17 02:09:30 daily 0.1 https://demo.pharmafocusasia.com/news/cogyn-pharmaceuticals-updates-on-reverse-merger-transaction 2019-04-17 02:09:28 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-completes-acquisition-of-cardioxyl-pharmaceuticals 2019-04-17 02:09:26 daily 0.1 https://demo.pharmafocusasia.com/news/crossject-partners-with-xian-xintong-pharmaceutical-research daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-applies-for-fda-approval-of-faster-acting-diabetes-drug 2019-04-17 02:09:22 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-alexion-drug-for-ultra-rare-disease 2019-04-17 02:09:20 daily 0.1 https://demo.pharmafocusasia.com/news/tonix-pharma-us-defense-department-partner-on-ptsd-drug 2019-04-17 02:09:19 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-says-cart-study-findings-bolster-approval-case 2019-04-17 02:09:17 daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-threshold-drug-fails-in-late-stage-cancer-trials 2019-04-17 02:09:14 daily 0.1 https://demo.pharmafocusasia.com/news/spectrum-pharmaceuticals-and-onxeo-announce-phase-trial-results-of-belinostat-with-chop daily 0.1 https://demo.pharmafocusasia.com/news/nebraska-governor-suspends-efforts-to-buy-lethal-injection-drugs 2019-04-17 02:09:11 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-trial-shows-drug-improves-survival-for-aml-patients 2019-04-17 02:09:09 daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-announces-completion-of-novira-therapeutics-acquisition daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-files-for-eu-approval-of-faster-acting-diabetes-drug daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-got-offer-for-nc-drug-plant daily 0.1 https://demo.pharmafocusasia.com/news/innovus-pharma-signs-exclusive-license-and-distribution-agreement daily 0.1 https://demo.pharmafocusasia.com/news/shkrelis-kalobios-buys-chagas-disease-drug-rights daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-pharma-india-to-close-bengaluru-api-unit daily 0.1 https://demo.pharmafocusasia.com/news/charterhouse-weighs-sale-of-italian-drug-firm-doc-generici daily 0.1 https://demo.pharmafocusasia.com/news/biovista-announces-drug-repositioning-collaboration-with-astellas-pharma daily 0.1 https://demo.pharmafocusasia.com/news/goldman-sachs-invests-in-ascletis daily 0.1 https://demo.pharmafocusasia.com/news/alexions-bone-drug-too-expensive-for-britain daily 0.1 https://demo.pharmafocusasia.com/news/remedy-pharmaceuticals-completes-financing 2019-04-17 02:08:44 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gets-us-regulators-nod-for-osteoporosis-drug 2015-12-02 02:12:33 daily 0.1 https://demo.pharmafocusasia.com/news/meda-sells-euromed-in-spain 2019-04-17 02:08:39 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-to-close-its-research-subsidiary 2019-04-17 02:08:35 daily 0.1 https://demo.pharmafocusasia.com/news/sosei-subsidiary-heptares-therapeutics-signs-drug-discovery-deal-with-pfizer 2019-04-17 02:08:30 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-new-bristol-myers-treatment-for-multiple-myeloma 2019-04-17 02:08:24 daily 0.1 https://demo.pharmafocusasia.com/news/israels-oramed-pharmaceuticals-signed-china-licensing-investment-deal-with-hefei 2015-12-01 00:46:38 daily 0.1 https://demo.pharmafocusasia.com/news/mankind-pharma-to-invest-to-open-plants 2019-04-17 02:08:16 daily 0.1 https://demo.pharmafocusasia.com/news/roche-pulls-out-of-superbug-antibiotic-project daily 0.1 https://demo.pharmafocusasia.com/news/lannett-completes-acquisition-of-kremers-urban-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-said-to-weigh-allergy-therapy-unit-sale-to-trim-debt 2019-04-17 02:08:06 daily 0.1 https://demo.pharmafocusasia.com/news/french-pharmaceutical-firm-servier-plans-to-cut-jobs 2019-04-17 02:08:03 daily 0.1 https://demo.pharmafocusasia.com/news/indias-alkem-plans-to-double-us-revenue daily 0.1 https://demo.pharmafocusasia.com/news/alliance-pharma-says-buys-sinclair-is-pharmas-dermatology-unit daily 0.1 https://demo.pharmafocusasia.com/news/denmark-based-xellia-pharmaceuticals-to-open-manufacturing-center-in-bedford-ohio daily 0.1 https://demo.pharmafocusasia.com/news/amgen-files-for-us-approval-of-biosimilar-to-humira 2019-04-17 02:07:50 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-drops-appeal-of-order-blocking-alzheimers-drug-switch daily 0.1 https://demo.pharmafocusasia.com/news/wuxi-pharmatech-announces-shareholders-approval-of-merger-agreement daily 0.1 https://demo.pharmafocusasia.com/news/novartis-heart-failure-medicine-entresto-wins-eu-approval 2019-04-17 02:07:43 daily 0.1 https://demo.pharmafocusasia.com/news/taro-pharma-drops-plan-to-invest-in-suzlons-us-power-project 2019-04-17 02:07:41 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-us-drug-rights-to-perrigo 2019-04-17 02:07:39 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-cosentyx-receives-european-nod-to-treat-ankylosing-spondylitis-psoriatic-arthritis 2015-11-24 01:10:43 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-signs-deal-with-un-group-for-generic-hepatitis-c-drug 2019-04-17 02:07:35 daily 0.1 https://demo.pharmafocusasia.com/news/cvs-chooses-amgens-new-cholesterol-drug-over-competitor daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-set-to-buy-allergan 2019-04-17 02:07:31 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gains-after-receiving-usfda-approval-for-sildenafil-tablets 2019-04-17 02:07:29 daily 0.1 https://demo.pharmafocusasia.com/news/strides-shasun-gets-usfda-nod-to-market-dutasteride-capsules 2019-04-17 02:07:27 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-astrazeneca-swap-compounds-in-new-twist-on-open-drug-rd 2019-04-17 02:07:25 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-gets-fda-approval-for-skin-cancer-drug-combination 2019-04-17 02:07:23 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-withdraws-offer-for-depomed-after-court-ruling daily 0.1 https://demo.pharmafocusasia.com/news/swedish-pharma-firm-camurus-plans-ipo daily 0.1 https://demo.pharmafocusasia.com/news/former-sanofi-ceo-viehbacher-to-bankroll-new-drugs daily 0.1 https://demo.pharmafocusasia.com/news/slovenian-drugs-firm-krka-predicts-flat-profits-this-year daily 0.1 https://demo.pharmafocusasia.com/news/turing-pharmaceuticals-ceo-buys-kalobios-shares daily 0.1 https://demo.pharmafocusasia.com/news/fda-again-rejects-single-dose-use-of-amags-makena daily 0.1 https://demo.pharmafocusasia.com/news/cipla-glenmark-in-race-for-hived-off-teva-allergan-generics-in-us 2019-04-17 02:07:06 daily 0.1 https://demo.pharmafocusasia.com/news/european-biotech-gets-boost-as-genmab-market-value 2019-04-17 02:07:02 daily 0.1 https://demo.pharmafocusasia.com/news/warburg-pincus-to-invest-in-vertice-pharma 2019-04-17 02:06:59 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-biosimilar-takes-aim-at-amgen-drug-neulasta 2019-04-17 02:06:57 daily 0.1 https://demo.pharmafocusasia.com/news/global-drug-spending-to-hit 2019-04-17 02:06:55 daily 0.1 https://demo.pharmafocusasia.com/news/array-biopharma-pierre-fabre-announce-collaboration 2019-04-17 02:06:52 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-jj-drug-for-advanced-multiple-myeloma 2019-04-17 02:06:51 daily 0.1 https://demo.pharmafocusasia.com/news/roche-breast-cancer-drug-at-center-of-uk-pricing-row 2019-04-17 02:06:48 daily 0.1 https://demo.pharmafocusasia.com/news/clovis-shares-dive-as-fda-asks-for-more-data-on-lung-cancer-drug 2019-04-17 02:06:46 daily 0.1 https://demo.pharmafocusasia.com/news/japans-growing-generic-market-woos-more-indian-pharma-firms 2015-11-16 00:37:41 daily 0.1 https://demo.pharmafocusasia.com/news/us-drug-benefit-managers-clamp-down-on-specialty-pharmacies 2019-04-17 02:06:43 daily 0.1 https://demo.pharmafocusasia.com/news/astrazenecas-potential-cancer-pill-wins-early-approval daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-eyes-novartis-branded-portfolio-in-japan daily 0.1 https://demo.pharmafocusasia.com/news/panel-recommends-merck-co-continue-cholesterol-drug-study 2019-04-17 02:06:37 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-roche-find-outcome-based-drug-pricing-an-elusive-dream daily 0.1 https://demo.pharmafocusasia.com/news/germany-u-s-in-hot-pursuit-of-messenger-drug-molecules daily 0.1 https://demo.pharmafocusasia.com/news/u-s-fda-approves-gilead-s-hepatitis-c-drug-for-expanded-use daily 0.1 https://demo.pharmafocusasia.com/news/china-rejects-drug-applications-over-inadequate-trial-data 2019-04-17 02:06:30 daily 0.1 https://demo.pharmafocusasia.com/news/brasil-pharma-sells-money-losing-unit-for-million-seeks-fresh-capital 2019-04-17 02:06:28 daily 0.1 https://demo.pharmafocusasia.com/news/alnylam-medicines-co-cholesterol-drug-effective-for-six-months 2019-04-17 02:06:26 daily 0.1 https://demo.pharmafocusasia.com/news/x-rx-announces-autotaxin-inhibitor-collaboration-with-gilead-sciences 2019-04-17 02:06:22 daily 0.1 https://demo.pharmafocusasia.com/news/bioduro-llc-announces-merger-with-formex-llc 2019-04-17 02:06:20 daily 0.1 https://demo.pharmafocusasia.com/news/us-court-imposes-temporary-sales-ban-on-dr-reddys-generic-antacid daily 0.1 https://demo.pharmafocusasia.com/news/nicox-and-fera-pharmaceuticals-sign-exclusive-license-agreement 2015-11-10 02:02:37 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-diabetes-drug-cuts-heart-failure-death-hospitalization 2019-04-17 02:06:14 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-delayed-drug-to-avoid-in-payments-lawsuit-claims 2019-04-17 02:06:11 daily 0.1 https://demo.pharmafocusasia.com/news/cytokinetics-amgen-drug-shows-promise-in-heart-failure 2019-04-17 02:06:09 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-diabetes-drug-fails-to-help-heart-failure 2019-04-17 02:06:07 daily 0.1 https://demo.pharmafocusasia.com/news/hanmi-pharmaceutical-bags-license-deal-with-janssen 2019-04-17 02:06:04 daily 0.1 https://demo.pharmafocusasia.com/news/medicines-patent-pool-expands-mandate-to-hepatitis-c-and-tuberculosis-treatment 2019-04-17 02:06:02 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-to-buy-zs-pharma 2019-04-17 02:05:59 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-lexicon-sign-diabetes-license-and-collaboration-deal 2019-04-17 02:05:57 daily 0.1 https://demo.pharmafocusasia.com/news/nanorepro-announces-exclusive-five-year-contract-with-global-pharma-serbia daily 0.1 https://demo.pharmafocusasia.com/news/pharmerica-acquires-luker-pharmacy-management 2019-04-17 02:05:53 daily 0.1 https://demo.pharmafocusasia.com/news/eu-regulator-finds-no-safety-issues-with-gsk-merck-hpv-vaccines 2019-04-17 02:05:51 daily 0.1 https://demo.pharmafocusasia.com/news/crossject-secures-funding-for-the-development-of-three-new-drugs daily 0.1 https://demo.pharmafocusasia.com/news/roche-convinced-its-new-drugs-can-mitigate-biosimilars-risks 2019-04-17 02:05:48 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-teva-reach-deal-with-states-in-medicaid-pricing-case 2019-04-17 02:05:46 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-hanmi-sign-diabetes-treatment-license-agreement 2019-04-17 02:05:43 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-invests-in-new-insulin-filling-facility-in-denmark daily 0.1 https://demo.pharmafocusasia.com/news/johnson-johnson-announces-agreement-to-acquire-novira-therapeutics 2019-04-17 02:05:40 daily 0.1 https://demo.pharmafocusasia.com/news/pharma-giant-shire-to-acquire-dyax 2019-04-17 02:05:38 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-said-to-have-planned-philidor-expansion-before-shutdown 2019-04-17 02:05:36 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-and-colep-enters-agreement-for-late-stage-development 2019-04-17 02:05:34 daily 0.1 https://demo.pharmafocusasia.com/news/spac-completes-another-step-of-reverse-merger-with-cogyn-pharmaceuticals 2019-04-17 02:05:32 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-squibb-to-acquire-cardioxyl-pharma-in-deal 2019-04-17 02:05:30 daily 0.1 https://demo.pharmafocusasia.com/news/zoetis-to-buy-aquaculture-pharma-company 2019-04-17 02:05:28 daily 0.1 https://demo.pharmafocusasia.com/news/livzon-pharma-plans-to-raise-in-share-private-placement 2019-04-17 02:05:26 daily 0.1 https://demo.pharmafocusasia.com/news/miami-international-airport-launches-pharmaceutical-transport-certification-program 2019-04-17 02:05:23 daily 0.1 https://demo.pharmafocusasia.com/news/south-africa-asked-to-allow-generics-for-abbvie-hiv-drug 2019-04-17 02:05:21 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-completes-acquisition-of-insite-vision 2019-04-17 02:05:20 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-sells-stake-in-chinese-biotech-firm-biomab-holding 2019-04-17 02:05:17 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-pharmaceuticals-cuts-full-year-generics-revenue-forecast 2019-04-17 02:05:15 daily 0.1 https://demo.pharmafocusasia.com/news/pharma-pricing-authority-nppa-puts-cap-on-formulations-packs-prices daily 0.1 https://demo.pharmafocusasia.com/news/q-biomed-inc-and-mannin-research-inc-sign-definitive-license-agreement 2019-04-17 02:05:11 daily 0.1 https://demo.pharmafocusasia.com/news/beloteca-announces-opening-of-new-laboratory-in-san-diego 2019-04-17 02:05:09 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-and-wuxi-pharmatech-announce-collaboration 2019-04-17 02:05:07 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceutical-sets-out-actavis-funding-after-strong-earnings-update 2019-04-17 02:05:05 daily 0.1 https://demo.pharmafocusasia.com/news/medicago-engaged-by-the-canadian-government 2019-04-17 02:05:03 daily 0.1 https://demo.pharmafocusasia.com/news/vaxart-awarded-hhs-barda-contract-to-support-advanced-development-of-influenza-tablet-vaccine 2015-10-29 01:46:02 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-us-recalls-auvi-q-injections-for-severe-allergy 2019-04-17 02:04:59 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-in-merger-talks-with-botox-maker-allergan 2019-04-17 02:04:57 daily 0.1 https://demo.pharmafocusasia.com/news/indias-hilleman-laboratories-to-invest-to-develop-vaccines daily 0.1 https://demo.pharmafocusasia.com/news/merck-sees-acquisitions-as-beneficial-amid-biotech-slump 2019-04-17 02:04:53 daily 0.1 https://demo.pharmafocusasia.com/news/arena-pharmaceuticals-to-lay-off-percent-of-us-workers 2019-04-17 02:04:51 daily 0.1 https://demo.pharmafocusasia.com/news/shires-eye-drug-data-could-strengthen-bid-for-baxalta daily 0.1 https://demo.pharmafocusasia.com/news/alpine-immune-sciences-inks-deal-with-kite-pharma 2015-10-28 00:32:40 daily 0.1 https://demo.pharmafocusasia.com/news/sinovac-receives-clinical-trial-approval-for-varicella-vaccine-candidate 2019-04-17 02:04:45 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-extends-offer-to-acquire-depomed 2019-04-17 02:04:43 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-and-epivax-collaborate-to-produce-next-generation-botulinum-toxins 2019-04-17 02:04:41 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-to-set-up-panel-to-review-link-with-specialty-pharmacy 2019-04-17 02:04:39 daily 0.1 https://demo.pharmafocusasia.com/news/itera-to-provide-operational-services-to-vistin-pharma 2019-04-17 02:04:37 daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-votes-in-favor-of-approving-astrazenecas-gout-drug 2015-10-26 01:50:00 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-inks-pact-with-poland-based-celon-pharma 2019-04-17 02:04:33 daily 0.1 https://demo.pharmafocusasia.com/news/shanxi-zhendong-pharma-to-acquire-kangyuan-pharma 2019-04-17 02:04:28 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-lilly-expand-immuno-oncology-research-collaboration 2019-04-17 02:04:26 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-makes-moves-to-fend-off-mylan 2019-04-17 02:04:24 daily 0.1 https://demo.pharmafocusasia.com/news/merrimack-pharmas-cancer-drug-wins-fda-approval daily 0.1 https://demo.pharmafocusasia.com/news/germanys-boehringer-denied-patent-on-hiv-drug 2015-10-21 02:09:31 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-opens-new-drug-factory-in-russia 2019-04-17 02:04:18 daily 0.1 https://demo.pharmafocusasia.com/news/swedish-firm-recipharm-buys-majority-stake-in-nitin-lifesciences 2019-04-17 02:04:16 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-broadens-cancer-immune-therapy-pipeline-with-acquisition 2019-04-17 02:04:14 daily 0.1 https://demo.pharmafocusasia.com/news/actelion-raises-earnings-forecast-for-on-strong-drug-sales 2019-04-17 02:04:12 daily 0.1 https://demo.pharmafocusasia.com/news/regeneron-pharmaceuticals-to-invest-in-irish-biologics-plant 2019-04-17 02:04:10 daily 0.1 https://demo.pharmafocusasia.com/news/hovione-acquires-formulation-plant 2019-04-17 02:04:08 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-successfully-completes-aquesys-acquisition daily 0.1 https://demo.pharmafocusasia.com/news/jubilant-life-sciences-gets-usfda-nod-for-migraine-treatment-drug 2019-04-17 02:04:03 daily 0.1 https://demo.pharmafocusasia.com/news/venn-life-sciences-announced-completion-of-the-acquisition-of-kinesis-pharma-bv 2019-04-17 02:03:58 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-cancer-drug-shows-promise-as-treatment-for-parkinsons 2015-10-19 01:32:10 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-diabetes-drug-combination-faces-delay-after-fda-rebuff 2019-04-17 02:03:51 daily 0.1 https://demo.pharmafocusasia.com/news/beijing-science-sun-pharma-plans-medical-base 2019-04-17 02:03:45 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-five-prime-enter-licensing-deal 2019-04-17 02:03:41 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-under-investigation-by-federal-prosecutors 2015-10-15 02:03:17 daily 0.1 https://demo.pharmafocusasia.com/news/charterhouse-wins-out-on-french-pharmaceuticals-firm-cooper 2015-10-15 01:44:12 daily 0.1 https://demo.pharmafocusasia.com/news/fda-declines-to-expand-approval-of-pfizer-arthritis-drug 2015-10-15 02:24:11 daily 0.1 https://demo.pharmafocusasia.com/news/xbrane-acquires-italian-company-primm-pharma 2015-10-15 02:13:12 daily 0.1 https://demo.pharmafocusasia.com/news/futura-licenses-erectile-dysfunction-drug-to-quantum-pharma 2019-04-17 02:03:32 daily 0.1 https://demo.pharmafocusasia.com/news/pharm-olam-international-expands-to-larger-facility-in-poland 2019-04-17 02:03:30 daily 0.1 https://demo.pharmafocusasia.com/news/jjs-still-mulling-acquisitions-amid-share-buyback 2015-10-14 04:58:07 daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-halts-study-of-heart-drug 2019-04-17 02:03:27 daily 0.1 https://demo.pharmafocusasia.com/news/progenics-pharmaceuticals-makes-tender-offer-for-in-exini-diagnostics 2019-04-17 02:03:25 daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-bets-on-cancer-drugs-to-revitalise-german-firm 2019-04-17 02:03:23 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-buys-another-percent-in-israels-gamida-cell 2015-10-12 01:58:01 daily 0.1 https://demo.pharmafocusasia.com/news/hepalink-pharmas-us-unit-plans-to-invest-in-quest-pharmatech-oncoquest daily 0.1 https://demo.pharmafocusasia.com/news/fda-expands-lung-cancer-approval-for-bristol-myers-drug 2015-10-10 00:21:23 daily 0.1 https://demo.pharmafocusasia.com/news/jj-starts-clinical-trial-of-ebola-vaccine-in-sierra-leone 2015-10-09 02:17:32 daily 0.1 https://demo.pharmafocusasia.com/news/neurocrines-neurological-disorder-drug-effective-in-late-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/cipla-ties-up-with-serum-institute-to-sell-vaccines-in-south-africa 2015-10-09 01:54:13 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-grants-orphan-drug-status-to-astex-pharmas-guadecitabine-to-treat-aml 2015-10-08 00:35:13 daily 0.1 https://demo.pharmafocusasia.com/news/peru-has-grace-on-new-pharma-rules-under-tpp 2015-10-07 23:32:49 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-to-focus-on-speciality-products-in-us 2015-10-08 00:22:51 daily 0.1 https://demo.pharmafocusasia.com/news/express-scripts-sees-in-spending-on-new-cholesterol-drugs 2015-10-07 03:39:09 daily 0.1 https://demo.pharmafocusasia.com/news/amerisourcebergen-to-buy-pharmedium daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-approves-alkermes-schizophrenia-drug-aristada 2015-10-05 23:50:48 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-announces-expansion-and-relocation-of-us-corporate-headquarters 2019-04-17 02:03:01 daily 0.1 https://demo.pharmafocusasia.com/news/raptor-pharmaceutical-corp-completes-acquisition-of-quinsair 2019-04-17 02:02:58 daily 0.1 https://demo.pharmafocusasia.com/news/pacific-trade-talks-hinge-on-pharma-protections-as-deadline-nears 2019-04-17 02:02:56 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceutical-to-buy-rimsa 2019-04-17 02:02:54 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-pharma-completes-acquisition-of-novartis-vaccines-business 2019-04-17 02:02:50 daily 0.1 https://demo.pharmafocusasia.com/news/merck-plans-new-product-launch-across-latin-america 2019-04-17 02:02:43 daily 0.1 https://demo.pharmafocusasia.com/news/santhera-pharmaceuticals-launches-raxone-in-its-first-eu-market 2019-04-17 02:02:38 daily 0.1 https://demo.pharmafocusasia.com/news/china-fines-fosun-pharma-unit-for-violating-anti-monopoly-law 2019-04-17 02:02:31 daily 0.1 https://demo.pharmafocusasia.com/news/generic-drugmakers-win-order-invalidating-novartis-ms-drug-patent 2015-09-30 00:35:56 daily 0.1 https://demo.pharmafocusasia.com/news/mercks-once-weekly-diabetes-drug-approved-in-japan daily 0.1 https://demo.pharmafocusasia.com/news/valeant-plummets-after-democrats-seek-subpoena-on-drug-price-hikes 2019-04-17 02:02:17 daily 0.1 https://demo.pharmafocusasia.com/news/endo-completes-acquisition-of-par-pharmaceutical-holdings 2019-04-17 02:02:11 daily 0.1 https://demo.pharmafocusasia.com/news/novo-shares-jump-five-percent-after-fda-approves-new-diabetes-drug 2019-04-17 02:02:05 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-wins-eu-approval-for-praluent-anti-cholesterol-drug 2019-04-17 02:01:59 daily 0.1 https://demo.pharmafocusasia.com/news/bristols-opdivo-boosts-kidney-cancer-survival-beyond-two-years 2015-09-26 00:02:36 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-bayers-electronic-autoinjector-for-ms-therapy 2015-09-26 00:25:36 daily 0.1 https://demo.pharmafocusasia.com/news/merck-kgaa-pfizer-collaborate-with-dako-on-development-of-cdx-for-avelumab 2019-04-17 02:01:43 daily 0.1 https://demo.pharmafocusasia.com/news/livzon-pharma-plans-industry-fund-unit-in-alliance-with-epirus-switzerland 2019-04-17 02:01:37 daily 0.1 https://demo.pharmafocusasia.com/news/us-appeals-court-upholds-shires-patents-on-hyperactivity-drug daily 0.1 https://demo.pharmafocusasia.com/news/drug-firm-pfizer-to-sell-thane-plant-to-vidhi-research 2019-04-17 02:01:30 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-against-use-of-its-drug-for-lethal-injection-in-us 2019-04-17 02:01:27 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-allergan-say-avastin-copycat-succeeds-in-lung-cancer-study 2019-04-17 02:01:24 daily 0.1 https://demo.pharmafocusasia.com/news/idt-biologika-launches-us-manufacturing-operations-with-opening-of-rockville-facility 2015-09-22 23:22:50 daily 0.1 https://demo.pharmafocusasia.com/news/turing-pharmaceuticals-to-roll-back-price-hike 2019-04-17 02:01:18 daily 0.1 https://demo.pharmafocusasia.com/news/venn-life-sciences-to-acquire-kinesis-pharma 2019-04-17 02:01:15 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-to-build-manufacturing-plant-in-iran 2019-04-17 02:01:12 daily 0.1 https://demo.pharmafocusasia.com/news/bioclinica-acquires-synowledge 2019-04-17 02:01:08 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-to-acquire-two-ndas-from-merck 2019-04-17 02:01:04 daily 0.1 https://demo.pharmafocusasia.com/news/merck-antibody-reduces-risk-of-clostridium-difficile-recurrence 2019-04-17 02:01:01 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-sells-two-of-ranbaxys-cns-units-to-strides-arcolab daily 0.1 https://demo.pharmafocusasia.com/news/lilly-diabetes-drug-slashes-deaths-in-patients-with-heart-risk 2019-04-17 02:00:53 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-says-swissmedic-approves-heart-medicine-entresto 2019-04-17 02:00:46 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-to-buy-dezima-pharma 2019-04-17 02:00:38 daily 0.1 https://demo.pharmafocusasia.com/news/cannabis-drug-shows-promise-in-treating-schizophrenia 2019-04-17 02:00:33 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-expands-collaboration-with-netherlands-cancer-institute 2019-04-17 02:00:27 daily 0.1 https://demo.pharmafocusasia.com/news/acacia-pharma-hopes-to-raise-up-to-in-london-ipo 2019-04-17 02:00:25 daily 0.1 https://demo.pharmafocusasia.com/news/sanofis-combination-diabetes-drug-hits-goal-in-second-late-stage-trial daily 0.1 https://demo.pharmafocusasia.com/news/txcell-granted-us-orphan-drug-designation-for-col-treg 2019-04-17 02:00:21 daily 0.1 https://demo.pharmafocusasia.com/news/isis-pharmaceuticals-expands-partnership-with-astrazeneca 2019-04-17 02:00:20 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-seeks-fda-approval-for-monthly-dosing-option-for-repatha 2019-04-17 02:00:18 daily 0.1 https://demo.pharmafocusasia.com/news/actelion-in-talks-with-zs-pharma-amid-surge-in-biotech-deal-making 2019-04-17 02:00:16 daily 0.1 https://demo.pharmafocusasia.com/news/suven-life-gets-patents-for-neurodegenerative-drug 2019-04-17 02:00:14 daily 0.1 https://demo.pharmafocusasia.com/news/south-african-drug-group-aspen-aims-to-grow-in-us-market 2019-04-17 02:00:12 daily 0.1 https://demo.pharmafocusasia.com/news/greece-lifts-ban-on-re-export-of-medicines-imposed-in-july 2019-04-17 02:00:10 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-looking-to-divest-ireland-plant daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-inhaler-trial-fails-to-show-extension-of-life 2015-09-09 01:41:35 daily 0.1 https://demo.pharmafocusasia.com/news/purdue-pharma-announces-acquisition-of-trka-program-from-vm-pharma-llc 2015-09-09 02:25:31 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-begins-hostile-bid-for-depomed-after-rebuffs 2015-09-09 04:40:57 daily 0.1 https://demo.pharmafocusasia.com/news/companies-struggle-to-get-new-medicines-adopted-across-europe 2019-04-17 02:00:02 daily 0.1 https://demo.pharmafocusasia.com/news/newcastle-based-pharma-company-shield-therapeutics-set-for-listing 2019-04-17 02:00:01 daily 0.1 https://demo.pharmafocusasia.com/news/starpharma-signs-drug-delivery-license-with-astrazeneca 2019-04-17 01:59:59 daily 0.1 https://demo.pharmafocusasia.com/news/natco-pharma-gains-on-rbi-approval-to-hike-fiis-limit 2019-04-17 01:59:57 daily 0.1 https://demo.pharmafocusasia.com/news/pfizers-quit-smoking-drug-not-linked-to-depression-or-heart-risks daily 0.1 https://demo.pharmafocusasia.com/news/roche-hemophilia-drug-wins-fast-track-fda-designation 2019-04-17 01:59:54 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-invests-in-a-new-raw-material-warehouse-in-denmark 2019-04-17 01:59:52 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-to-acquire-us-based-invagen-exelan-pharma 2015-09-04 00:47:57 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-launches-neupogen-copycat-zarxio-in-us-market 2019-04-17 01:59:48 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-agrees-to-acquire-synergetics-usa 2015-09-03 02:13:29 daily 0.1 https://demo.pharmafocusasia.com/news/lannett-to-acquire-ucbs-kremers-urban-pharmaceuticals-unit daily 0.1 https://demo.pharmafocusasia.com/news/valeant-strikes-psoriasis-drug-pact-with-astrazeneca 2019-04-17 01:59:43 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-gets-eu-approval-for-drug-acquired-in-synageva-deal 2019-04-17 01:59:41 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-heart-failure-drug-cuts-deaths-in-mid-stage-trial 2019-04-17 01:59:40 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-completes-opiates-business-acquisition-in-australia 2019-04-17 01:59:38 daily 0.1 https://demo.pharmafocusasia.com/news/strides-arcolab-completes-acquisition-of-aspens-generic-business 2015-09-01 00:51:01 daily 0.1 https://demo.pharmafocusasia.com/news/google-sanofi-join-forces-on-diabetes-monitoring-and-treatment 2019-04-17 01:59:34 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-granted-right-to-buy-promedior 2019-04-17 01:59:33 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-wockhardt-recall-drugs-from-us-market 2019-04-17 01:59:31 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gains-on-usfda-approval-for-generic-osteoporosis-drug 2019-04-17 01:59:29 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-wins-federal-approval-for-its-biotech-drug-repatha-to-treat-artery-clogging-cholestrol daily 0.1 https://demo.pharmafocusasia.com/news/sucampo-pharma-makes-tender-offer-for-japans-r-tech-ueno daily 0.1 https://demo.pharmafocusasia.com/news/idt-biologika-acquires-gallant-custom-laboratories daily 0.1 https://demo.pharmafocusasia.com/news/alvogen-to-acquire-product-portfolio-from-pfizer 2019-04-17 01:59:23 daily 0.1 https://demo.pharmafocusasia.com/news/shire-to-attain-enhanced-cinryze-manufacturing-flexibility-and-capacity 2019-04-17 01:59:21 daily 0.1 https://demo.pharmafocusasia.com/news/ftc-recommends-tighter-controls-for-homeopathic-drugs 2019-04-17 01:59:19 daily 0.1 https://demo.pharmafocusasia.com/news/kiadis-pharma-net-loss-widens 2019-04-17 01:59:17 daily 0.1 https://demo.pharmafocusasia.com/news/medivation-to-acquire-worldwide-rights-to-talazoparib-from-biomarin 2019-04-17 01:59:15 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-peregrine-pharma-to-collaborate-on-immuno-oncology-combination 2019-04-17 01:59:13 daily 0.1 https://demo.pharmafocusasia.com/news/hepalink-usa-to-acquire-cytovance-biologics 2019-04-17 01:59:12 daily 0.1 https://demo.pharmafocusasia.com/news/regis-technologies-opens-pharmaceutical-manufacturing-center-in-morton-grove 2019-04-17 01:59:10 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-boehringer-diabetes-drug-cuts-heart-attack 2019-04-17 01:59:08 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-buys-remaining-rights-to-gsk-treatment 2019-04-17 01:59:06 daily 0.1 https://demo.pharmafocusasia.com/news/denmarks-drug-maker-lundbeck-to-cut-jobs-in-restructuring 2015-08-20 02:13:31 daily 0.1 https://demo.pharmafocusasia.com/news/depomed-rejects-horizon-pharmas-offer-for-the-third-time 2015-08-20 01:33:32 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-to-pay-million-to-states-for-promoting-off-label-drug-uses- daily 0.1 https://demo.pharmafocusasia.com/news/raptor-pharmaceutical-gets-fda-approval-of-expanded-label-for-procysbi 2019-04-17 01:59:00 daily 0.1 https://demo.pharmafocusasia.com/news/india-eu-working-to-end-trade-huff-over-generic-drugs 2019-04-17 01:58:58 daily 0.1 https://demo.pharmafocusasia.com/news/envarsus-xr-granted-orphan-drug-status-in-the-us 2019-04-17 01:58:56 daily 0.1 https://demo.pharmafocusasia.com/news/foreign-investment-promotion-board-clears-mylans-fdi-proposal daily 0.1 https://demo.pharmafocusasia.com/news/tonghua-dongbao-pharma-to-raise-in-private-placement 2019-04-17 01:58:52 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-hopes-big-clinical-trial-can-breath-new-life-into-lung-drug 2019-04-17 01:58:51 daily 0.1 https://demo.pharmafocusasia.com/news/roche-acquires-geneweave-to-strengthen-offerings-in-microbiology-diagnostics daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-to-seek-fda-approval-for-leukemia-drug-after-trial-success daily 0.1 https://demo.pharmafocusasia.com/news/oxford-pharmascience-to-start-pilot-clinical-study-for-oxpzero-ibuprofen 2019-04-17 01:58:46 daily 0.1 https://demo.pharmafocusasia.com/news/tonghua-golden-horse-pharma-to-acquire-pharma-firm-sanctity 2019-04-17 01:58:44 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-closes-north-carolina-plant-after-legionnaires-bacteria-found daily 0.1 https://demo.pharmafocusasia.com/news/mallinckrodt-buys-immunotherapy-maker-therakos 2019-04-17 01:58:37 daily 0.1 https://demo.pharmafocusasia.com/news/medpace-continues-to-grow-in-europe-with-expanded-facilities-in-stirling 2019-04-17 01:58:35 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-teams-up-with-evotec-apeiron-to-develop-immuno-oncology-pills 2019-04-17 01:58:33 daily 0.1 https://demo.pharmafocusasia.com/news/maryland-based-biotech-company-novavax-en-route-to-crack-a-vaccine-for-common-respiratory-virus 2019-04-17 01:58:31 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-bolsters-cancer-drug-pipeline-with-inovio-cancer-drug-deal 2019-04-17 01:58:30 daily 0.1 https://demo.pharmafocusasia.com/news/china-resources-sanjius-unit-to-acquire-zhongyi-pharma daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-widens-cancer-push-with-up-to-heptares-deal 2019-04-17 01:58:26 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-bristol-revive-cancer-drugs-that-rev-up-immune-system 2019-04-17 01:58:24 daily 0.1 https://demo.pharmafocusasia.com/news/imprimis-pharmaceuticals-expands-distribution-of-its-proprietary-ophthalmic-and-urologic-formulations 2015-08-06 03:17:26 daily 0.1 https://demo.pharmafocusasia.com/news/britain-raps-pfizer-over-inflated-epilepsy-drug-prices 2019-04-17 01:58:21 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-wins-eu-approval-for-hospira-buy 2019-04-17 01:58:19 daily 0.1 https://demo.pharmafocusasia.com/news/drugmaker-shire-bids-for-baxter-spin-off-baxalta 2019-04-17 01:58:17 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-isis-pharmaceuticals-announce-strategic-collaboration 2019-04-17 01:58:15 daily 0.1 https://demo.pharmafocusasia.com/news/ascendis-health-to-acquire-pct-in-farmalider-sa 2019-04-17 01:58:14 daily 0.1 https://demo.pharmafocusasia.com/news/shire-buys-us-based-foresight-biotherapeutics-inc 2019-04-17 01:58:12 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-pharmas-bengaluru-facility-to-be-operational daily 0.1 https://demo.pharmafocusasia.com/news/lexicon-pharmaceuticals-announces-positive-results 2015-08-03 00:55:13 daily 0.1 https://demo.pharmafocusasia.com/news/rise-in-pharmaceutical-ma-boosts-us-bridge-loan-issuance 2019-04-17 01:58:07 daily 0.1 https://demo.pharmafocusasia.com/news/tevas-ms-drug-copaxone-has-strong-second-quarter-sales 2015-07-31 01:08:41 daily 0.1 https://demo.pharmafocusasia.com/news/tigenix-announces-acquisition-of-coretherapix 2019-04-17 01:58:04 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-flags-up-pipeline-as-hiv-drugs-help-it-beat-profit-forecasts 2019-04-17 01:58:02 daily 0.1 https://demo.pharmafocusasia.com/news/british-biopharma-start-up-mereo-kicks-off-with-novartis-drugs 2019-04-17 01:58:00 daily 0.1 https://demo.pharmafocusasia.com/news/depomed-rejects-horizon-pharmas-latest-bid 2015-07-29 22:43:55 daily 0.1 https://demo.pharmafocusasia.com/news/hikma-pharmaceuticals-to-buy-boehringers-us-generics-unit daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-links-with-regeneron-in-cancer-drug-push 2019-04-17 01:57:55 daily 0.1 https://demo.pharmafocusasia.com/news/aequus-pharmaceuticals-announces-the-completion-of-the-acquisition-of-teora-health daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-sells-rare-cancer-drug-to-sanofi 2019-04-17 01:57:51 daily 0.1 https://demo.pharmafocusasia.com/news/teva-to-buy-allergan-generic-business 2019-04-17 01:57:50 daily 0.1 https://demo.pharmafocusasia.com/news/source-bioscience-to-buy-select-pharma-laboratories 2019-04-17 01:57:48 daily 0.1 https://demo.pharmafocusasia.com/news/jpmorgan-to-fund-lupins-gavis-deal 2015-07-27 00:12:47 daily 0.1 https://demo.pharmafocusasia.com/news/teva-in-talks-to-buy-allergans-generic-drug-unit 2015-07-26 23:33:48 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-said-to-be-exploring-split-into-two-businesses 2019-04-17 01:57:43 daily 0.1 https://demo.pharmafocusasia.com/news/worlds-first-malaria-vaccine-gets-go-ahead-from-eu-regulators 2015-07-24 01:56:05 daily 0.1 https://demo.pharmafocusasia.com/news/ra-pharmaceuticals-announces-series-b-financing 2019-04-17 01:57:39 daily 0.1 https://demo.pharmafocusasia.com/news/india-rejects-swiss-drug-maker-roche-patent-claims-on-valcyte-again 2019-04-17 01:57:38 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-buys-us-generics-firm-gavis 2019-04-17 01:57:36 daily 0.1 https://demo.pharmafocusasia.com/news/roche-readies-new-drugs-in-two-year-window-before-copycats-hit 2019-04-17 01:57:34 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-to-acquire-leading-german-dietary-supplement-brand-yokebe 2019-04-17 01:57:32 daily 0.1 https://demo.pharmafocusasia.com/news/novavax-s-ebola-vaccine-shows-promise-in-early-stage-trial daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-opdivo-found-effective-in-kidney-cancer 2015-07-21 03:10:51 daily 0.1 https://demo.pharmafocusasia.com/news/erytech-pharma-announces-positive-safety-review-for-ery-asp 2019-04-17 01:57:27 daily 0.1 https://demo.pharmafocusasia.com/news/indias-sun-pharma-heads-towards-biggest-ever-fall-on-sales-warning daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-agrees-to-acquire-egypts-amoun-pharmaceutical 2015-07-20 02:01:03 daily 0.1 https://demo.pharmafocusasia.com/news/torrent-pharma-completes-zyg-pharma-acquisition 2019-04-17 01:57:22 daily 0.1 https://demo.pharmafocusasia.com/news/canada-based-apotex-inc-recalls-hypertension-drug-in-us 2019-04-17 01:57:21 daily 0.1 https://demo.pharmafocusasia.com/news/albany-molecular-research-inc-acquires-gadea-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/india-expands-medicine-price-control-list-to-include-more-drugs 2019-04-17 01:57:17 daily 0.1 https://demo.pharmafocusasia.com/news/malin-announces-investment-in-uk-based-immunocore 2019-04-17 01:57:15 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-to-buy-receptos 2019-04-17 01:57:14 daily 0.1 https://demo.pharmafocusasia.com/news/greece-bans-export-of-drugs-after-pharmacists-supply-warnings 2015-07-15 00:26:59 daily 0.1 https://demo.pharmafocusasia.com/news/us-fda-bans-emcure-pharmas-india-plant-over-manufacturing-issues daily 0.1 https://demo.pharmafocusasia.com/news/amco-acquires-australian-company-boucher-and-muir 2019-04-17 01:57:09 daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-acquires-generic-drug-products-from-teva-pharmaceuticals 2019-04-17 01:57:07 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-says-us-fda-approves-lung-cancer-drug 2019-04-17 01:57:05 daily 0.1 https://demo.pharmafocusasia.com/news/gsk-first-drugmaker-to-tie-up-with-new-crick-institute 2019-04-17 01:57:03 daily 0.1 https://demo.pharmafocusasia.com/news/zhejiang-conba-pharma-sees-h-net-profit-up-over-pct 2019-04-17 01:57:01 daily 0.1 https://demo.pharmafocusasia.com/news/suven-life-gets-patent-for-chemical-molecules-to-be-used-in-neuro-degenerative-drugs 2019-04-17 01:56:59 daily 0.1 https://demo.pharmafocusasia.com/news/fda-strengthens-warning-label-for-certain-anti-inflammatory-drugs 2019-04-17 01:56:57 daily 0.1 https://demo.pharmafocusasia.com/news/us-house-passes-c-st-cures-bill-to-speed-new-drugs-to-market 2015-07-13 00:32:39 daily 0.1 https://demo.pharmafocusasia.com/news/cell-therapy-gets-a-boost-as-reneuron-raises 2019-04-17 01:56:54 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gets-usfda-nod-for-flecainide-acetate-tablets 2019-04-17 01:56:52 daily 0.1 https://demo.pharmafocusasia.com/news/meihuas-unit-to-sell-pct-stake-in-pharma-firm daily 0.1 https://demo.pharmafocusasia.com/news/biotech-clovis-oncology-raising-for-new-cancer-drugs 2019-04-17 01:56:48 daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-regeneron-say-japan-study-shows-praluent-drug-lowers-cholesterol 2019-04-17 01:56:43 daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-divests-gastrointestinal-drug 2019-04-17 01:56:41 daily 0.1 https://demo.pharmafocusasia.com/news/genmab-seeks-european-approval-for-leukemia-drug-arzerra 2019-04-17 01:56:39 daily 0.1 https://demo.pharmafocusasia.com/news/irish-pharma-group-nexvet-signs-rd-pet-drug-deal 2019-04-17 01:56:37 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-goes-hostile-with-offer-for-depomed 2015-07-08 00:25:23 daily 0.1 https://demo.pharmafocusasia.com/news/cardinal-health-completes-acquisition-of-the-harvard-drug-group 2019-04-17 01:56:34 daily 0.1 https://demo.pharmafocusasia.com/news/innate-pharma-says-co-development-deal-with-astrazeneca-gets-hsr-clearance 2019-04-17 01:56:32 daily 0.1 https://demo.pharmafocusasia.com/news/teva-plans-to-raise-mylan-bid 2019-04-17 01:56:30 daily 0.1 https://demo.pharmafocusasia.com/news/innate-pharma-and-ipc-collaborate-on-translational-research-for-novel-immune-checkpoint-inhibitors daily 0.1 https://demo.pharmafocusasia.com/news/jointown-pharmaceutical-signs-strategic-agreement-with-zhejiang-huahai 2019-04-17 01:56:27 daily 0.1 https://demo.pharmafocusasia.com/news/hospira-wins-french-biosimilar-drug-tender-at-pct-discount 2019-04-17 01:56:25 daily 0.1 https://demo.pharmafocusasia.com/news/south-korean-pharmaceutical-companies-expand-tech-exports-of-new-drug 2019-04-17 01:56:23 daily 0.1 https://demo.pharmafocusasia.com/news/jilin-aodong-pharmaceutical-plans-hong-kong-unit 2019-04-17 01:56:21 daily 0.1 https://demo.pharmafocusasia.com/news/vertex-pharmas-lung-disorder-therapy-wins-fda-nod 2015-07-03 02:06:00 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-acquires-biocom-in-russia 2019-04-17 01:56:18 daily 0.1 https://demo.pharmafocusasia.com/news/kiadis-pharma-raises-in-ipo 2019-04-17 01:56:16 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceutical-and-philips-to-jointly-invest-in-israeli-medical-device-firms 2019-04-17 01:56:14 daily 0.1 https://demo.pharmafocusasia.com/news/drugmakers-warn-greek-of-medicine-supply-shortages-if-europe-s-lethargy-continues daily 0.1 https://demo.pharmafocusasia.com/news/roche-looks-to-expand-with-its-multiple-sclerosis-drug-meeting-targets-in-final-stage-clinical-trials daily 0.1 https://demo.pharmafocusasia.com/news/celgene-partners-with-juno-therapeutics-on-cancer-therapies-announcing-billion-investment daily 0.1 https://demo.pharmafocusasia.com/news/novartis-to-test-new-pricing-model-with-heart-failure-drug daily 0.1 https://demo.pharmafocusasia.com/news/vitae-boehringer-diabetes-drug-fails-as-add-on-therapy-in-trial 2019-04-17 01:56:04 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-to-invest-in-juno-to-partner-in-cancer-therapies 2019-04-17 01:56:02 daily 0.1 https://demo.pharmafocusasia.com/news/indian-pharmas-struggle-to-tighten-standards-paves-way-for-ma-deals 2015-06-29 01:31:23 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-buys-pain-drug-firm-spinifex 2019-04-17 01:55:59 daily 0.1 https://demo.pharmafocusasia.com/news/celladon-to-suspend-development-of-gene-therapy-drug 2019-04-17 01:55:56 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-makes-takeover-approach-to-zoetis 2019-04-17 01:55:55 daily 0.1 https://demo.pharmafocusasia.com/news/santhera-drug-gets-chmp-recommendation 2019-04-17 01:55:53 daily 0.1 https://demo.pharmafocusasia.com/news/rheumatoid-arthritis-drug-tofacitinib-citrate-breakthrough-treatment-for-leucoderma 2019-04-17 01:55:51 daily 0.1 https://demo.pharmafocusasia.com/news/belgian-cancer-treatment-equipment-maker-iba-to-install-compact-proton-therapy-centers-in-uk daily 0.1 https://demo.pharmafocusasia.com/news/a-combination-of-drugs-can-treat-bipolar-depression-studies-neurorx-inc 2019-04-17 01:55:47 daily 0.1 https://demo.pharmafocusasia.com/news/hybio-pharmaceutical-tencent-plan-medical-online-service-platform 2019-04-17 01:55:46 daily 0.1 https://demo.pharmafocusasia.com/news/drugmaker-mylan-to-pursue-tel-aviv-listing-if-perrigo-deal-succeeds 2019-04-17 01:55:44 daily 0.1 https://demo.pharmafocusasia.com/news/drug-firm-jubilant-life-sciences-gets-usfda-nod-for-generic-levofloxacin-tablets 2019-04-17 01:55:42 daily 0.1 https://demo.pharmafocusasia.com/news/nantcell-acquires-italian-stem-cell-firm-vivabiocell 2015-06-24 07:12:50 daily 0.1 https://demo.pharmafocusasia.com/news/dbv-technologies-sa-confirms-initiation-of-viaskin-peanut-global-phase-iii-trial 2019-04-17 01:55:39 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-medicines-co-s-blood-clot-preventer-cangrelor-after-a-decade-involving-million-investment daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-bluebird-collaborate-on-cancer-t-cell-therapies 2019-04-17 01:55:35 daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-to-acquire-two-meningitis-vaccines-from-glaxosmithkline 2019-04-17 01:55:33 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-to-invest-billion-euros-in-r-d-this-year 2015-06-22 03:54:00 daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gets-usfda-nod-for-manufacturing-generic-drugs-entacapone-azithromycin-for-us-market 2015-06-22 04:23:12 daily 0.1 https://demo.pharmafocusasia.com/news/zealand-pharma-increases-share-capital-after-exercise-of-employee-warrants 2019-04-17 01:55:28 daily 0.1 https://demo.pharmafocusasia.com/news/biofrontera-pharma-completes-final-steps-for-fda-new-drug-application 2019-04-17 01:55:26 daily 0.1 https://demo.pharmafocusasia.com/news/european-private-equity-fund-cvc-singapore-s-temasek-to-buy-generics-firm-alvogen daily 0.1 https://demo.pharmafocusasia.com/news/teva-completes-the-purchase-of-interest-in-mylan 2019-04-17 01:55:23 daily 0.1 https://demo.pharmafocusasia.com/news/ophthalix-signs-definitive-agreement-to-acquire-improved-vision-systems daily 0.1 https://demo.pharmafocusasia.com/news/teva-to-collaborate-with-maker-of-microchip-based-implants 2019-04-17 01:55:20 daily 0.1 https://demo.pharmafocusasia.com/news/tianjin-ringpu-bio-tech-to-acquire-stakes-in-bio-pharma-firms 2019-04-17 01:55:18 daily 0.1 https://demo.pharmafocusasia.com/news/allergan-to-buy-kythera-biopharmaceuticals 2019-04-17 01:55:16 daily 0.1 https://demo.pharmafocusasia.com/news/merck-to-pay-for-misleading-marketing-of-pink-eye-drug 2019-04-17 01:55:14 daily 0.1 https://demo.pharmafocusasia.com/news/synergy-pharmas-constipation-drug-succeeds-in-late-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/tfs-to-acquire-us-based-viroxis-corporation-and-santalis-pharmaceuticals 2019-04-17 01:55:11 daily 0.1 https://demo.pharmafocusasia.com/news/west-pharmaceutical-services-celebrates-groundbreaking-of-waterford daily 0.1 https://demo.pharmafocusasia.com/news/gsk-invests-in-effort-to-demystify-cell-operating-system 2015-06-17 07:01:28 daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-and-avalon-bankroll-three-more-biotech-start-ups 2019-04-17 01:55:02 daily 0.1 https://demo.pharmafocusasia.com/news/cvs-health-to-buy-targets-pharmacy-business daily 0.1 https://demo.pharmafocusasia.com/news/ucb-finds-positive-results-in-late-stage-study-evaluating-arthritis-treatment 2019-04-17 01:54:59 daily 0.1 https://demo.pharmafocusasia.com/news/serodus-receives-approval-of-clinical-trial-application-for-ser-in-diabetic-nephropathy 2019-04-17 01:54:57 daily 0.1 https://demo.pharmafocusasia.com/news/lilly-shares-sizzle-as-investors-await-alzheimer-s-data daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-backs-approval-of-gsk-asthma-drug-mepolizumab-in-adults 2019-04-17 01:54:53 daily 0.1 https://demo.pharmafocusasia.com/news/consumer-watchdog-public-citizen-accuses-fda-of-wrongly-expanding-vanda-sleep-drug-hetlioz-use daily 0.1 https://demo.pharmafocusasia.com/news/medecins-sans-frontieres-urges-india-not-to-cave-to-pressure-on-affordable-drugs daily 0.1 https://demo.pharmafocusasia.com/news/horizon-discovery-group-plc-and-definigen-announce-collaboration 2015-06-11 03:42:40 daily 0.1 https://demo.pharmafocusasia.com/news/healthcare-investor-malin-acquires-stake-in-altan-pharma 2019-04-17 01:54:47 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-mid-stage-trial-of-vaccine-to-reverse-type-diabetes 2019-04-17 01:54:45 daily 0.1 https://demo.pharmafocusasia.com/news/drug-switch-study-bolsters-case-for-copies-of-biotech-medicine daily 0.1 https://demo.pharmafocusasia.com/news/roche-s-actemra-receives-fda-breakthrough-therapy-designation daily 0.1 https://demo.pharmafocusasia.com/news/canadians-hope-trial-can-revive-failed-roche-heart-drug daily 0.1 https://demo.pharmafocusasia.com/news/beijing-beilu-pharma-plans-investment-in-herbal-medicine-project 2019-04-17 01:54:38 daily 0.1 https://demo.pharmafocusasia.com/news/genmab-shares-rise-on-cancer-drugs-fda-licence-application daily 0.1 https://demo.pharmafocusasia.com/news/ar-treatment-from-aimmune-therapeutics-for-peanut-allergy-successfully-desensitized-patients-in-a-midstage-trial 2019-04-17 01:54:31 daily 0.1 https://demo.pharmafocusasia.com/news/drugs-giant-shire-keen-on-takeover-of-swiss-rival-actelion 2019-04-17 01:54:29 daily 0.1 https://demo.pharmafocusasia.com/news/beijing-bohui-s-unit-to-acquire-u-s-company-advion-for-million daily 0.1 https://demo.pharmafocusasia.com/news/dara-biosciences-to-merge-with-uks-midatech-pharma daily 0.1 https://demo.pharmafocusasia.com/news/amazon-google-race-to-get-your-dna-into-the-cloud 2019-04-17 01:54:24 daily 0.1 https://demo.pharmafocusasia.com/news/cardinal-to-buy-private-generic-drug-distributor-for-billion 2019-04-17 01:54:22 daily 0.1 https://demo.pharmafocusasia.com/news/dutch-biotech-group-kiadis-pharma-to-float-in-amsterdam-brussels-for-funding-research 2019-04-17 01:54:20 daily 0.1 https://demo.pharmafocusasia.com/news/shanxi-c-y-pharmaceutical-gets-regulatory-approval-for-private-placement 2019-04-17 01:54:17 daily 0.1 https://demo.pharmafocusasia.com/news/pillpack-raises-mln-to-take-on-us-pharmacies-like-cvs-rite-aid-walgreens 2019-04-17 01:54:15 daily 0.1 https://demo.pharmafocusasia.com/news/amerisourcebergen-invests-to-establish-distribution-hub-in-newburgh-new-york 2019-04-17 01:54:13 daily 0.1 https://demo.pharmafocusasia.com/news/novamedica-and-ferring-pharmaceuticals-bring-innovative-gastroenterological-products daily 0.1 https://demo.pharmafocusasia.com/news/lannett-completes-acquisition-of-silarx-pharmaceuticals 2019-04-17 01:54:10 daily 0.1 https://demo.pharmafocusasia.com/news/recipharm-signs-partnership-agreement-on-pharmaceutical-development-with-follicum 2019-04-17 01:54:08 daily 0.1 https://demo.pharmafocusasia.com/news/indias-lupin-cipla-bid-for-ucbs-us-generic-drugs-portfolio 2015-06-02 01:47:20 daily 0.1 https://demo.pharmafocusasia.com/news/kangmei-pharmaceutical-plans-health-database-centre-with-xinhua-news 2019-04-17 01:54:05 daily 0.1 https://demo.pharmafocusasia.com/news/bioinvent-international-enters-into-third-research-collaboration-with-university-of-southampton 2019-04-17 01:54:03 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-misses-profit-estimates-on-ranbaxy-costs daily 0.1 https://demo.pharmafocusasia.com/news/u-s-anti-legalization-group-urges-more-access-to-marijuana-research 2019-04-17 01:54:00 daily 0.1 https://demo.pharmafocusasia.com/news/heron-s-nausea-drug-meets-goal-in-late-stage-trial-shares-soar daily 0.1 https://demo.pharmafocusasia.com/news/fda-app-proves-pfizer-drug-to-treat-very-rare-lung-disease daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-and-lilly-to-test-new-cancer-drug-combination 2019-04-17 01:53:55 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-actavis-valeant-drugs-for-irritable-bowel-syndrome 2019-04-17 01:53:52 daily 0.1 https://demo.pharmafocusasia.com/news/australian-vitamin-manufacturer-blackmores-funds-million-dollar-research daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-hit-after-psoriasis-drug-brodalumab-linked-to-suicide-fears 2019-04-17 01:53:49 daily 0.1 https://demo.pharmafocusasia.com/news/virotherapy-uses-modified-herpes-virus-to-treat-skin-cancer daily 0.1 https://demo.pharmafocusasia.com/news/sutter-health-teams-up-with-boehringer-ingelheim-to-research-on-digital-health-programs 2019-04-17 01:53:45 daily 0.1 https://demo.pharmafocusasia.com/news/biotech-company-sbio-launches-ipo-in-hong-kong 2019-04-17 01:53:44 daily 0.1 https://demo.pharmafocusasia.com/news/tanner-pharmaceuticals-burnsadler-pharmaceuticals-merge-to-form-new-tanner-pharma-group 2019-04-17 01:53:42 daily 0.1 https://demo.pharmafocusasia.com/news/chongqing-sanxia-paints-sold-shares-of-beijing-beilu-pharma 2019-04-17 01:53:40 daily 0.1 https://demo.pharmafocusasia.com/news/nantong-jinghua-pharma-to-acquire-investment-company-for-mln-yuan 2019-04-17 01:53:38 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-pharma-to-invest-usd-million-to-set-up-cancer-drugs-facility-in-mihan-india daily 0.1 https://demo.pharmafocusasia.com/news/jiuzhitang-to-acquire-beijing-youbo-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/dr-reddys-partners-with-spains-ferrer-internacional-sa-to-launch-somazina-in-india 2015-05-22 06:54:01 daily 0.1 https://demo.pharmafocusasia.com/news/strides-arcolab-to-buy-generic-drugs-business-in-australia-from-aspen-pharmacare 2015-05-22 05:05:16 daily 0.1 https://demo.pharmafocusasia.com/news/argen-x-pairs-up-with-leo-pharma-in-m-dermatology-deal 2019-04-17 01:53:29 daily 0.1 https://demo.pharmafocusasia.com/news/wockhardt-gets-qidp-status-for-pneumonia-drug-from-usfda 2019-04-17 01:53:27 daily 0.1 https://demo.pharmafocusasia.com/news/novo-nordisk-baxter-clash-over-hemophilia-drug-patent 2019-04-17 01:53:25 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-patents-on-costly-hepatitis-c-drug-challenged-in-five-countries 2019-04-17 01:53:23 daily 0.1 https://demo.pharmafocusasia.com/news/novartis-says-lung-disease-drug-studies-show-positive-results 2019-04-17 01:53:21 daily 0.1 https://demo.pharmafocusasia.com/news/u-s-fda-approves-longer-acting-version-of-j-j-s-schizophrenia-drug-invega-trinza daily 0.1 https://demo.pharmafocusasia.com/news/amgen-cholesterol-drug-could-get-eu-green-light-this-week 2019-04-17 01:53:18 daily 0.1 https://demo.pharmafocusasia.com/news/biotech-group-ablynx-to-raise-mln-euros-from-convertible-bonds-for-research-pipeline 2019-04-17 01:53:16 daily 0.1 https://demo.pharmafocusasia.com/news/china-s-livzon-pharma-to-form-jv-with-us-biotech-firm-cynvenio-in-china daily 0.1 https://demo.pharmafocusasia.com/news/achillion-pharmaceuticals-partners-with-johnson-johnson-to-develop-hepatitis-c-drugs 2019-04-17 01:53:12 daily 0.1 https://demo.pharmafocusasia.com/news/vaccine-maker-medicago-invests-million-for-building-production-complex-in-quebec 2019-04-17 01:53:11 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-s-partner-menarini-asia-pacific-launches-kerasal-nail-in-china daily 0.1 https://demo.pharmafocusasia.com/news/astrazeneca-to-invest-million-in-swedish-biotech-drug-factory 2019-04-17 01:53:07 daily 0.1 https://demo.pharmafocusasia.com/news/lannett-company-to-acquire-privately-held-silarx-pharma 2019-04-17 01:53:05 daily 0.1 https://demo.pharmafocusasia.com/news/endo-international-to-buy-par-pharma 2015-05-19 03:43:51 daily 0.1 https://demo.pharmafocusasia.com/news/boehringer-ingelheim-buys-pharmaxis-phase-anti-inflammatory-drug-candidate 2015-05-18 00:54:31 daily 0.1 https://demo.pharmafocusasia.com/news/nantworks-to-acquire-cynviloq 2019-04-17 01:52:59 daily 0.1 https://demo.pharmafocusasia.com/news/africas-largest-generic-drug-maker-aspen-in-talks-to-acquire-baby-food-business 2015-05-15 05:38:07 daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-strides-arcolab-s-hiv-treatment-drug-lamivudine-and-zidovudine-for-us-market daily 0.1 https://demo.pharmafocusasia.com/news/boulder-based-pharmaceutical-company-nivalis-therapeutics-files-for-ipo 2019-04-17 01:52:54 daily 0.1 https://demo.pharmafocusasia.com/news/british-company-circassia-to-acquire-sweden-s-asthma-focused-firms-aerocrine-prosonix-for-million daily 0.1 https://demo.pharmafocusasia.com/news/paragon-bioteck-enters-promotional-agreement-to-expand-availability-of-ilast-portfolio-of-products 2015-05-14 05:36:00 daily 0.1 https://demo.pharmafocusasia.com/news/pharma-major-lupin-acquires-brazilian-drug-firm-medquimica 2019-04-17 01:52:49 daily 0.1 https://demo.pharmafocusasia.com/news/baxter-to-buy-leukemia-treatment-oncaspar 2019-04-17 01:52:47 daily 0.1 https://demo.pharmafocusasia.com/news/japan-based-takeda-readies-strategic-investment-in-israel daily 0.1 https://demo.pharmafocusasia.com/news/zydus-aims-to-develop-drug-for-fatty-liver-disease daily 0.1 https://demo.pharmafocusasia.com/news/sparc-to-raise-through-rights-issue 2019-04-17 01:52:41 daily 0.1 https://demo.pharmafocusasia.com/news/merck-receives-fda-fast-track-designation-for-evofosfamide 2019-04-17 01:52:39 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-to-acquire-patheons-mexican-business 2019-04-17 01:52:37 daily 0.1 https://demo.pharmafocusasia.com/news/cyclenium-pharma-announces-drug-discovery-collaboration-agreement-with-astellas-pharma daily 0.1 https://demo.pharmafocusasia.com/news/endo-international-plc-in-deal-with-south-african-pharmaceutical-company daily 0.1 https://demo.pharmafocusasia.com/news/university-of-north-carolina-partners-with-gsk-to-focus-on-hiv-cure 2019-04-17 01:52:32 daily 0.1 https://demo.pharmafocusasia.com/news/national-cancer-center-of-japan-and-takeda-partner-to-discover-anti-cancer-agents 2019-04-17 01:52:30 daily 0.1 https://demo.pharmafocusasia.com/news/cyclenium-pharma-and-haplogen-announce-drug-discovery-collaboration 2019-04-17 01:52:28 daily 0.1 https://demo.pharmafocusasia.com/news/morphosys-acquires-peptide-therapeutic-company-lanthio-pharma 2019-04-17 01:52:26 daily 0.1 https://demo.pharmafocusasia.com/news/gilead-sciences-to-buy-epitherapeutics daily 0.1 https://demo.pharmafocusasia.com/news/biopharma-company-kymab-raises-to-fund-antibody-generating-technology 2019-04-17 01:52:23 daily 0.1 https://demo.pharmafocusasia.com/news/uk-regulators-find-issues-with-indian-owned-api-distributor-relonchem 2019-04-17 01:52:21 daily 0.1 https://demo.pharmafocusasia.com/news/alexion-pharma-to-acquire-synageva-biopharma 2019-04-17 01:52:16 daily 0.1 https://demo.pharmafocusasia.com/news/ema-tightens-rules-on-“revolving-door”-for-committee-members-and-experts daily 0.1 https://demo.pharmafocusasia.com/news/ispe-developing-gap-analysis-tool-to-help-ensure-an-uninterrupted-supply-of-medicines 2019-04-17 01:52:13 daily 0.1 https://demo.pharmafocusasia.com/news/mouvex®-to-highlight-product-recovery-benefits-of-itseccentric-disc-pumps-at-achema- 2015-05-06 05:39:47 daily 0.1 https://demo.pharmafocusasia.com/news/envirotainer-achieves-qep-accredited-stations-milestone-with-kuehne-nagel’s-european-network-expansion 2015-05-06 06:01:28 daily 0.1 https://demo.pharmafocusasia.com/news/miami-based-opko-health-inc-acquires-eirgen-pharma-ireland daily 0.1 https://demo.pharmafocusasia.com/news/german-drugmaker-bayer-buys-rights-to-isis-pharmas-anti-clotting-drug daily 0.1 https://demo.pharmafocusasia.com/news/oncobiologics-opens-manufacturing-center-in-cranbury daily 0.1 https://demo.pharmafocusasia.com/news/global-cancer-drug-spending-hits-billion-in- daily 0.1 https://demo.pharmafocusasia.com/news/gileads-gaffe-leads-drugmakers-to-pledge-more-openness-on-price daily 0.1 https://demo.pharmafocusasia.com/news/peptidream-announces-peptide-discovery-collaboration-agreement-with-merck-co-inc daily 0.1 https://demo.pharmafocusasia.com/news/braeburn-expands-pipeline-to-include-two-schizophrenia-treatments daily 0.1 https://demo.pharmafocusasia.com/news/rusan-pharma-launches-nicotine-patch-baconil-in-india-for-tobacco-de-addiction 2019-04-17 01:51:56 daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-extends-exchange-offer-to-acquire-pharmacyclics 2019-04-17 01:51:54 daily 0.1 https://demo.pharmafocusasia.com/news/california-bio-tech-nanoblood-collaborates-with-south-dakota-to-commercialise-a-new-drug-used-as-blood-substitute daily 0.1 https://demo.pharmafocusasia.com/news/indian-scientists-find-triaminopyrimidine-a-drug-to-cure-malaria-in-a-single-dose 2019-04-17 01:51:50 daily 0.1 https://demo.pharmafocusasia.com/news/inertia-looms-as-barrier-to-india-swiss-trade-deal-due-to-pharmaceutical-patent-issues 2019-04-17 01:51:48 daily 0.1 https://demo.pharmafocusasia.com/news/uk-based-specialty-pharmaceutical-martindale-partners-with-aft-pharmaceuticals-to-expand-in-asia-pacific daily 0.1 https://demo.pharmafocusasia.com/news/guangxi-liuzhou-pharma-plans-to-raise-bln-yuan-in-private-placement 2019-04-17 01:51:45 daily 0.1 https://demo.pharmafocusasia.com/news/fda-panel-supports-approving-amgen-s-virus-based-melanoma-drug-t-vec- daily 0.1 https://demo.pharmafocusasia.com/news/us-states-propose-laws-to-force-pharma-companies-reveal-drug-development-cost 2019-04-17 01:51:41 daily 0.1 https://demo.pharmafocusasia.com/news/mylan-boosts-offer-for-perrigo 2019-04-17 01:51:39 daily 0.1 https://demo.pharmafocusasia.com/news/green-cross-to-build-factory-in-china daily 0.1 https://demo.pharmafocusasia.com/news/norwich-pharmaceuticals-breaks-ground-on-million-project daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-to-pay-to-settle-us-lawsuits 2019-04-17 01:51:34 daily 0.1 https://demo.pharmafocusasia.com/news/oncogenex-terminates-teva-collaboration-regaining-rights-to-custirsen 2019-04-17 01:51:32 daily 0.1 https://demo.pharmafocusasia.com/news/antares-terminates-leo-pharma-marketing-gaining-us-rights-to-otrexup-for-psoriasis 2019-04-17 01:51:30 daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-acquires-us-otc-brand-balmex-for-million 2019-04-17 01:51:28 daily 0.1 https://demo.pharmafocusasia.com/news/celgene-acquires-quanticel-pharmaceuticals-in-a-million-deal daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-close-to-seek-european-approval-for-gene-therapy-drug-to-fight-ada-scid 2019-04-17 01:51:25 daily 0.1 https://demo.pharmafocusasia.com/news/australia-health-minister-sussan-ley-confirms-pharmaceutical-benefits-scheme daily 0.1 https://demo.pharmafocusasia.com/news/swedish-orphan-said-to-be-open-to-sale-amid-boom-in-drug-deals 2019-04-17 01:51:21 daily 0.1 https://demo.pharmafocusasia.com/news/inc-research-collaborates-with-drugdev-to-create-innovative-cloud-based-solutions-in-global-clinical-trials daily 0.1 https://demo.pharmafocusasia.com/news/drug-companies-seek-to-speed-up-enrollment-in-clinical-trials-with-london-based-start-up-trialreach daily 0.1 https://demo.pharmafocusasia.com/news/-astrazeneca-to-collaborate-with-innate-pharma-on-commercialisation-for-iph-in-immuno-oncology 2015-04-24 07:21:04 daily 0.1 https://demo.pharmafocusasia.com/news/aerie-pharma-s-lead-experimental-eye-drug-fails-late-stage-study-shares-crumple daily 0.1 https://demo.pharmafocusasia.com/news/scientists-to-share-real-time-genetic-data-on-deadly-mers-ebola 2019-04-17 01:51:10 daily 0.1 https://demo.pharmafocusasia.com/news/breast-cancer-drugs-boost-q-sales-at-swiss-pharmaceutical-company-roche 2019-04-17 01:51:09 daily 0.1 https://demo.pharmafocusasia.com/news/concordia-healthcare-completes-acquiring-covis-pharma-assets-in-a-bn-deal 2019-04-17 01:51:07 daily 0.1 https://demo.pharmafocusasia.com/news/regen-biopharma-engages-charles-river-to-initiate-fda-requested-study-with-regard-to-hemaxellerate 2019-04-17 01:51:05 daily 0.1 https://demo.pharmafocusasia.com/news/erytech-pharma-strengthens-its-intellectual-property-position-in-the-us 2019-04-17 01:51:03 daily 0.1 https://demo.pharmafocusasia.com/news/ariad-pharmaceuticals-announces-the-issuance-of-u-s-patent-on-brigatinib-alk-inhibitor 2019-04-17 01:51:01 daily 0.1 https://demo.pharmafocusasia.com/news/perrigo-board-rejects-mylans-unsolicited-proposal 2015-04-22 03:58:26 daily 0.1 https://demo.pharmafocusasia.com/news/russian-ministry-of-health-approves-cancer-drug-paclical-from-sweden-based-oasmia-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/acacia-pharma-starts-phase-study-investigating-apd-in-combination-with-anti-emetics-for-ponv 2019-04-17 01:50:56 daily 0.1 https://demo.pharmafocusasia.com/news/teva-agrees-to-pay-million-to-resolve-charges-of-keeping-generic-manufacturers-off-the-market daily 0.1 https://demo.pharmafocusasia.com/news/taiwan-s-food-and-drug-administration-to-set-up-pharmaceutical-ingredient-recording-system daily 0.1 https://demo.pharmafocusasia.com/news/merck-submits-sbla-for-its-humanized-monoclonal-antibody-keytruda-to-treat-lung-cancer-nsclc daily 0.1 https://demo.pharmafocusasia.com/news/janssen-india-launches-invokana-as-differentiated-treatment-for-type-ii-diabetes 2019-04-17 01:50:50 daily 0.1 https://demo.pharmafocusasia.com/news/lupin-launches-zaxine-under-licensing-agreement-with-salix-in-canada 2019-04-17 01:50:48 daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceutical-considering-bid-for-mylan 2019-04-17 01:50:46 daily 0.1 https://demo.pharmafocusasia.com/news/kangmei-pharma-signs-framework-agreement-on-medicine-trading-ctr-with-yulin-govt 2019-04-17 01:50:44 daily 0.1 https://demo.pharmafocusasia.com/news/biotech-company-phosphagenics-initiates-oxycodone-patch-dosing-in-phase-clinical-trial 2019-04-17 01:50:42 daily 0.1 https://demo.pharmafocusasia.com/news/biotech-firm-targacept-ends-work-on-tc-drug-development-after-clinical-trial-failure- 2019-04-17 01:50:40 daily 0.1 https://demo.pharmafocusasia.com/news/discovery-gene-control-cocoa-butter-melting-point-improved-food-pharma-products 2015-04-17 00:56:59 daily 0.1 https://demo.pharmafocusasia.com/news/u-s-fda-approves-biopharmaceutical-company-amgen-s-cardiovascular-drug-corlanor daily 0.1 https://demo.pharmafocusasia.com/news/bayer-expands-clinical-development-program-for-its-oncology-candidate-copanlisib-bay- daily 0.1 https://demo.pharmafocusasia.com/news/-denmark-s-novo-nordisk-builds-million-insulin-plant-in-russia daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-collaborates-with-technion-for-research-on-oncology-drugs 2019-04-17 01:50:33 daily 0.1 https://demo.pharmafocusasia.com/news/bayer-healthcare-to-invest-million-to-build-drugs-testing-facility-in-berkeley- daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-gets-usfda-nod-to-sell-antibiotic-oral-suspension 2019-04-17 01:50:29 daily 0.1 https://demo.pharmafocusasia.com/news/medical-device-maker-angiodynamics-invests-in-cancer-drug-delivery-aspirant-embomedics 2015-04-15 05:29:50 daily 0.1 https://demo.pharmafocusasia.com/news/roche-aims-for-late-stage-trials-in-cancer-immunotherapy-drug-this-year 2019-04-17 01:50:26 daily 0.1 https://demo.pharmafocusasia.com/news/hi-tech-pharma-to-acquire-advanced-pharmaceuticals-and-nutritionals 2019-04-17 01:50:24 daily 0.1 https://demo.pharmafocusasia.com/news/patientslikeme-to-support-astrazeneca-with-patient-reported-data-for-pharmaceutical-research daily 0.1 https://demo.pharmafocusasia.com/news/australia-s-mesoblast-receives-million-cash-injection-from-us-biotech-celgene-corp 2015-04-14 02:00:20 daily 0.1 https://demo.pharmafocusasia.com/news/heilongjiang-zbd-pharma-announces-pricing-for-its-shanghai-ipo 2019-04-17 01:50:19 daily 0.1 https://demo.pharmafocusasia.com/news/medivir-ab-and-cancer-research-tech-collaborate-to-develop-cancer-drugs 2019-04-17 01:50:17 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharmas-friedreichs-ataxia-drug-gets-fast-track-designation daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-divests-australian-arm-to-eris-pharma 2019-04-17 01:50:14 daily 0.1 https://demo.pharmafocusasia.com/news/vietnamese-pharmaceutical-companies-challenged-by-indian-firms 2019-04-17 01:50:12 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharma-gets-usfda-nod-for-oral-contraceptives 2019-04-17 01:50:10 daily 0.1 https://demo.pharmafocusasia.com/news/mankind-pharma-wants-deals-sees-fy-domestic-sales-topping-million 2019-04-17 01:50:08 daily 0.1 https://demo.pharmafocusasia.com/news/tonghua-dongbao-pharma-to-invest-mln-yuan-in-insulin-project 2019-04-17 01:50:06 daily 0.1 https://demo.pharmafocusasia.com/news/portola-pharmaceuticals-to-file-for-fda-approval-of-the-blood-thinning-drug-andexanet-alfa-in- 2019-04-17 01:50:04 daily 0.1 https://demo.pharmafocusasia.com/news/-inovio-pharma-to-develop-ebola-treatment-backed-by-defense-advanced-research-projects-agency daily 0.1 https://demo.pharmafocusasia.com/news/uae-drug-distributor-building-plant-in-dubai 2019-04-17 01:50:00 daily 0.1 https://demo.pharmafocusasia.com/news/tonghua-dongbao-pharma-to-invest-in-insulin-project 2019-04-17 01:49:59 daily 0.1 https://demo.pharmafocusasia.com/news/cabinet-committee-on-economic-affairs-nod-to-over 2019-04-17 01:49:57 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharmaceuticals-gets-usfda-nod-for-post-menopause-osteoporosis-drug 2019-04-17 01:49:54 daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myers-invests-in-dutch-company-uniqure 2019-04-17 01:49:49 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-company-opens-new-uae-office-in-dubai 2019-04-17 01:49:48 daily 0.1 https://demo.pharmafocusasia.com/news/irelands-health-minister-leo-varadkar-gives-deadline-to-pharmaceutical-companies daily 0.1 https://demo.pharmafocusasia.com/news/australian-pharmaceutical-industry-calls-for-government-bailout-as-exports-slump-more-than-percent 2015-04-04 00:12:45 daily 0.1 https://demo.pharmafocusasia.com/news/biocryst-pharmaceuticals-awarded-m-contract-to-develop-ebola-treatment 2015-04-06 06:34:54 daily 0.1 https://demo.pharmafocusasia.com/news/merck-serono-mvv-to-develop-potential-antimalarial-therapy 2019-04-17 01:49:41 daily 0.1 https://demo.pharmafocusasia.com/news/covance-and-sihuan-pharma-partner-on-portfolio-development 2019-04-17 01:49:39 daily 0.1 https://demo.pharmafocusasia.com/news/indias-ranbaxy-hits-record-high-before-amalgamation-with-sun-pharma daily 0.1 https://demo.pharmafocusasia.com/news/masters-pharmaceutical-to-build-enormous-hq-move-jobs 2019-04-17 01:49:36 daily 0.1 https://demo.pharmafocusasia.com/news/ipo-bound-aduro-snags-big-pharma-cancer-immunotherapy-deal 2019-04-17 01:49:34 daily 0.1 https://demo.pharmafocusasia.com/news/horizon-pharma-to-buy-hyperion-therapeutics-for-million-in-cash 2019-04-17 01:49:32 daily 0.1 https://demo.pharmafocusasia.com/news/montreal-based-pharmacy-wholesale-services-to-construct-million-pharmaceutical-manufacturing-plant-in-sydney daily 0.1 https://demo.pharmafocusasia.com/news/high-takeovers-compared-with-negligible-new-projects-in-indian-pharma-make-centre-review-fdi-policy- daily 0.1 https://demo.pharmafocusasia.com/news/ohr-pharmas-eye-drug-fails-mid-stage-study daily 0.1 https://demo.pharmafocusasia.com/news/valneva-s-eb-based-prototype-influenza-vaccine-apporved-in-japan daily 0.1 https://demo.pharmafocusasia.com/news/biotech-giant-genentech-plans-to-invest-million-to-expand-hillsboro-production-facility 2019-04-17 01:49:23 daily 0.1 https://demo.pharmafocusasia.com/news/frank-kung-to-take-over-as-sagent-pharma-chairman-with-ceo-jeffrey-yordon-stepping-down 2019-04-17 01:49:22 daily 0.1 https://demo.pharmafocusasia.com/news/china-animal-husbandry-signs-mou-with-intervet-holding 2019-04-17 01:49:20 daily 0.1 https://demo.pharmafocusasia.com/news/conatus-pharmaceuticals-emricasan-proves-effective-in-mid-stage-liver-disease-study daily 0.1 https://demo.pharmafocusasia.com/news/jordan-s-hikma-pharma-investors-meet-for-potential-dollar-bond-leads daily 0.1 https://demo.pharmafocusasia.com/news/amoun-pharmaceutical-hires-goldman-sachs-after-the-potential-sale-valued-at-million-stalled 2019-04-17 01:49:15 daily 0.1 https://demo.pharmafocusasia.com/news/catalent-licenses-biohaven-to-use-zydis-odt-technology-in-drug-development 2019-04-17 01:49:13 daily 0.1 https://demo.pharmafocusasia.com/news/cytos-biotechnology-announces-cad-license-agreement-buy-out-by-novartis-for-million-swiss-francs 2015-03-25 05:52:34 daily 0.1 https://demo.pharmafocusasia.com/news/researchers-at-aurasense-discover-the-potential-of-spherical-nucleic-acids-to-modulate-immune-system daily 0.1 https://demo.pharmafocusasia.com/news/iict-develops-new-technology-to-make-hydrazine-hydrate-used-in-agrochemicals-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/german-pharmaceutical-company-stada-outsources-logistics-business-to-dhl 2019-04-17 01:49:06 daily 0.1 https://demo.pharmafocusasia.com/news/cincinnati-children-s-hospital-medical-center-and-specialty-pharmaceutical-firm-p-d-to-develop-pancreatitis-diagnosis daily 0.1 https://demo.pharmafocusasia.com/news/mei-pharma-shares-lose-market-value-as-cancer-drug-fails-mid-stage-study 2019-04-17 01:49:03 daily 0.1 https://demo.pharmafocusasia.com/news/sun-ranbaxy-deal-gets-final-cci-nod 2019-04-17 01:49:01 daily 0.1 https://demo.pharmafocusasia.com/news/apple-and-google-stake-a-claim-to-big-pharmas-turf 2015-03-23 07:33:04 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-touts-positive-results-with-new-heart-health-drug 2019-04-17 01:48:57 daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-pharma-falls-over-after-court-injunction-on-two-drugs 2019-04-17 01:48:55 daily 0.1 https://demo.pharmafocusasia.com/news/-new-bloackbuster-drugs-are-expected-to-drive-pharmaceutical-market-with-bristol-sanofi-and-novartis-in- daily 0.1 https://demo.pharmafocusasia.com/news/genetic-analysis-can-predict-bleeding-risk-in-warfarin-users 2019-04-17 01:48:52 daily 0.1 https://demo.pharmafocusasia.com/news/cyprus-pharmaceutical-firm-to-set-up-mn-manufacturing-plant-in-southern-vietnam daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-to-collaborate-with-hanmi-pharmaceutical-on-autoimmune-treatment 2019-04-17 01:48:48 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharma-acquires-salix 2019-04-17 01:48:47 daily 0.1 https://demo.pharmafocusasia.com/news/kite-pharma-acquires-netherlands-based-biotechnology-company-t-cell-factory 2019-04-17 01:48:45 daily 0.1 https://demo.pharmafocusasia.com/news/concert-pharmaceuticals-initiates-phase-clinical-study-to-evaluate-deuterated-ivacaftor-for-treating-cystic-fibrosis daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-announced-million-expansion-of-plant-in-puerto-rico 2019-04-17 01:48:41 daily 0.1 https://demo.pharmafocusasia.com/news/cloud-pharmaceuticals-teams-up-with-university-of-florida-to-pursue-in-silico-approach-in-developing-new-cancer-drugs daily 0.1 https://demo.pharmafocusasia.com/news/framingham-start-up-berg-uses-artificial-intelligence-to-find-cancer-drugs 2019-04-17 01:48:38 daily 0.1 https://demo.pharmafocusasia.com/news/daiichi-sankyo-facilitates-drug-discovery-project-for-through-collaborative-research- daily 0.1 https://demo.pharmafocusasia.com/news/gsk-pfizer-lilly-johnson-johnson-biogen-group-backs-mln-uk-led-dementia-research-fund daily 0.1 https://demo.pharmafocusasia.com/news/twi-pharmaceuticals-announces-the-first-shipment-of-its-generic-product-in-the-us-market 2019-04-17 01:48:33 daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceutical-trumps-endo 2019-04-17 01:48:31 daily 0.1 https://demo.pharmafocusasia.com/news/japan-s-pharma-market-to-reach-billion-in-value-by 2015-03-16 06:35:10 daily 0.1 https://demo.pharmafocusasia.com/news/healthcare-investment-firm-quadria-capital-invests-in-indonesian-pharma-co-soho 2019-04-17 01:48:28 daily 0.1 https://demo.pharmafocusasia.com/news/amgen-and-sanofi-sponsored-studies-identify-new-class-of-drugs-known-to-lower-cholesterol-and-reduce-risk-of-heart-attacks daily 0.1 https://demo.pharmafocusasia.com/news/tampa-pharmaceutical-manufacturer-xcelience-expands 2019-04-17 01:48:24 daily 0.1 https://demo.pharmafocusasia.com/news/in-big-shift-andme-will-invent-drugs-using-customer-data 2019-04-17 01:48:22 daily 0.1 https://demo.pharmafocusasia.com/news/uncertainty-weighs-on-endos-higher-bid-for-salix-pharmaceuticals 2015-03-13 02:27:57 daily 0.1 https://demo.pharmafocusasia.com/news/virtualscopics-ixico-to-collaborate-with-micron-targeting-pharma-and-biopharma-companies 2019-04-17 01:48:19 daily 0.1 https://demo.pharmafocusasia.com/news/epic-sciences-renders-circulating-tumor-cell-technology-for-collaboration-with-prostate-cancer-clinical-trials-consortium 2015-03-11 00:08:34 daily 0.1 https://demo.pharmafocusasia.com/news/proteins-critical-in-day-night-cycles-protect-cells-from-mutations-say-tsri-scientists 2019-04-17 01:48:15 daily 0.1 https://demo.pharmafocusasia.com/news/china-pharmaceutical-equipment-maker-shanghai-tofflon-science-and-technology-joins-world-s-billionaire-ranks daily 0.1 https://demo.pharmafocusasia.com/news/swiss-group-novartis-leads-productivity-bringing-down-pharma-costs- daily 0.1 https://demo.pharmafocusasia.com/news/-almac-announces-clinical-trial-for-ovarian-cancer-developing-alm-for-initial-indication daily 0.1 https://demo.pharmafocusasia.com/news/transtech-pharmas-new-licensing-deal daily 0.1 https://demo.pharmafocusasia.com/news/arrowhead-acquires-novartis-rnai-research-and-development-portfolio daily 0.1 https://demo.pharmafocusasia.com/news/ani-pharmaceuticals-acquires-generic-drug-product-from-teva-pharmaceuticals 2019-04-17 01:48:06 daily 0.1 https://demo.pharmafocusasia.com/news/baxters-bioscience-business-acquires-biopharmaceutical-company-suppremol daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-to-buy-pharmacyclics-to-boost-cancer-drugs-pipeline 2019-04-17 01:48:02 daily 0.1 https://demo.pharmafocusasia.com/news/sparc-gets-usfda-nod-for-its-anti-epileptic-drug 2019-04-17 01:48:00 daily 0.1 https://demo.pharmafocusasia.com/news/ranbaxy-loses-approvals-exclusivity-of-two-drugs-in-us 2019-04-17 01:47:56 daily 0.1 https://demo.pharmafocusasia.com/news/icon-completes-acquisition-of-medimedia-pharma-solutions 2019-04-17 01:47:54 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-to-buy-glaxos-opiates-business daily 0.1 https://demo.pharmafocusasia.com/news/yuyu-pharma-strengthens-global-market-invasion 2019-04-17 01:47:51 daily 0.1 https://demo.pharmafocusasia.com/news/zmapps-first-human-experiment daily 0.1 https://demo.pharmafocusasia.com/news/eli-lilly-to-introduce-lantus-insulin-copy-in-europe 2019-04-17 01:47:47 daily 0.1 https://demo.pharmafocusasia.com/news/lyric-pharmaceuticals-bags-million-for-its-gastro-drug 2019-04-17 01:47:45 daily 0.1 https://demo.pharmafocusasia.com/news/biota-pharmaceuticals-to-acquire-anaconda-pharma 2019-04-17 01:47:43 daily 0.1 https://demo.pharmafocusasia.com/news/bdi-pharma-awarded-contract-with-national-gpo-premier 2019-04-17 01:47:41 daily 0.1 https://demo.pharmafocusasia.com/news/takeda-pharmaceutical-regroups-singapore-operations-in-new-expanded-office 2019-04-17 01:47:39 daily 0.1 https://demo.pharmafocusasia.com/news/nugene-biopharma-formed-for-next-generation-stem-cell-pharmacology 2019-04-17 01:47:38 daily 0.1 https://demo.pharmafocusasia.com/news/shire-acquires-meritage-pharma 2019-04-17 01:47:36 daily 0.1 https://demo.pharmafocusasia.com/news/ferring-pharmaceuticals-acquires-novel-drug-delivery-technology-from-ctcbio-inc 2019-04-17 01:47:32 daily 0.1 https://demo.pharmafocusasia.com/news/ipsen-enters-into-option-agreement-to-acquire-canbex-therapeutics 2019-04-17 01:47:27 daily 0.1 https://demo.pharmafocusasia.com/news/intas-pharma-launches-its-first-biosimilar-product-accofil-in-europe daily 0.1 https://demo.pharmafocusasia.com/news/valeant-to-acquire-salix-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/neurobiopharm-receives-final-court-approval-and-completes-arrangement-with-neptune 2019-04-17 01:47:21 daily 0.1 https://demo.pharmafocusasia.com/news/queen-mary-university-and-takeda-pharmaceutical-announce-research-collaboration-to-develop-novel-therapies daily 0.1 https://demo.pharmafocusasia.com/news/cipla-plans-to-acquire-us-based-pharma-companies 2019-04-17 01:47:18 daily 0.1 https://demo.pharmafocusasia.com/news/actavis-ceo-expects-further-pharmaceutical-industry-consolidation 2019-04-17 01:47:16 daily 0.1 https://demo.pharmafocusasia.com/news/fda-grants-genentech-s-cobimetinib-priority-review-for-use-in-combination-with-zelboraf daily 0.1 https://demo.pharmafocusasia.com/news/particle-sciences-manufactures-clinical-supplies-for-kinexs-glioblastoma-therapeutic daily 0.1 https://demo.pharmafocusasia.com/news/tb-alliance-advances-next-generation-tb-drug-candidate-into-clinical-testing 2019-04-17 01:47:11 daily 0.1 https://demo.pharmafocusasia.com/news/shasun-pharma-to-sell-its-alivira-animal-health 2019-04-17 01:47:09 daily 0.1 https://demo.pharmafocusasia.com/news/teva-bolsters-injectable-portfolio-with-launch-of-generic-lovenox-and-generic-zyvox daily 0.1 https://demo.pharmafocusasia.com/news/invagen-pharmaceuticals-and-alphamed-realty-plans-manufacturing-distribution-centers daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-collaborates-with-lead-pharma-to-develop-treatments-for-autoimmune-diseases daily 0.1 https://demo.pharmafocusasia.com/news/lakeland-pharmacy-to-expand-to-service-va daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-limited-foresees-high-growth-in-injectables-biz 2019-04-17 01:47:01 daily 0.1 https://demo.pharmafocusasia.com/news/maverix-biomics-and-elsevier-sign-cooperation-agreement 2019-04-17 01:46:59 daily 0.1 https://demo.pharmafocusasia.com/news/capital-international-in-talks 2019-04-17 01:46:57 daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharma-declines-as-regulatory-issue-puts-pressure-on-profit 2019-04-17 01:46:56 daily 0.1 https://demo.pharmafocusasia.com/news/cipla-wins-usd-million-of-global-fund-arv-tender-to-treat-hiv-aids daily 0.1 https://demo.pharmafocusasia.com/news/novartis-heart-failure-medicine-lcz-granted-fda-priority-review daily 0.1 https://demo.pharmafocusasia.com/news/ghana-pharmaceutical-manufacturers-seek-government-to-withdraw-vat daily 0.1 https://demo.pharmafocusasia.com/news/envision-pharmaceutical-services-taken-over-by-pharmacy-retailer-rite-aid daily 0.1 https://demo.pharmafocusasia.com/news/texan-hedge-fund-manager-kyle-bass-war-against-the-us-pharmaceutical-industry daily 0.1 https://demo.pharmafocusasia.com/news/india-s-state-owned-homeo-pharmaceutical-manufacturing-unit-to-be-expanded daily 0.1 https://demo.pharmafocusasia.com/news/mri-data-helps-predict-drug-efficacy-observe-research-team-with-university-of-oxford daily 0.1 https://demo.pharmafocusasia.com/news/gsk-strengthens-early-stage-vaccine-pipeline-with-acquisition-of-glycovaxyn-ag 2015-02-26 03:47:08 daily 0.1 https://demo.pharmafocusasia.com/news/janssen-and-riyadh-pharma-sign-partnership-agreement 2019-04-17 01:46:41 daily 0.1 https://demo.pharmafocusasia.com/news/us-anesthesia-partners-with-greater-colorado-anesthesia 2015-02-11 04:36:59 daily 0.1 https://demo.pharmafocusasia.com/news/biotest-pharmaceuticals-opens-second-jacksonville-north-carolina-plasma-center daily 0.1 https://demo.pharmafocusasia.com/news/mylan-confirms-first-to-file-patent-challenge-relating-to-nexavar daily 0.1 https://demo.pharmafocusasia.com/news/moberg-pharma-extends-distribution-agreement-with-menarini-group-for-emtrix-to-russia daily 0.1 https://demo.pharmafocusasia.com/news/actavis-to-divest-doryx-to-mayne-pharma-for-approximately-million daily 0.1 https://demo.pharmafocusasia.com/news/cipla-jv-with-morocco-based-cooper-pharma-african-market daily 0.1 https://demo.pharmafocusasia.com/news/bmg-pharma-s-r-l-obtained-a-new-indication-on-molluscum-contagiosium-for-ce-marked-proprietary-product-ialuxid-gel daily 0.1 https://demo.pharmafocusasia.com/news/nanocarrier-drugs-for-pancreatic-cancer-now-being-produced-in-china daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-inc-plans-to-acquire-hospira-inc-for-billion 2015-02-26 03:22:58 daily 0.1 https://demo.pharmafocusasia.com/news/acura-pharmaceuticals-expands-meth-resistant-decongestant-line 2015-02-05 22:53:52 daily 0.1 https://demo.pharmafocusasia.com/news/can-fite-biopharma-ltd-completes-phase-ii-iii-trial-for-cf-in-treatment-of-psoriasis daily 0.1 https://demo.pharmafocusasia.com/news/isis-pharmas-diabetes-drug-takes-longer-than-expected-to-work daily 0.1 https://demo.pharmafocusasia.com/news/camargo-pharmaceutical-services-launches-new-brand-at-gpha-as-b-development-continues-upward-trend daily 0.1 https://demo.pharmafocusasia.com/news/qr-pharma-begins-collaboration-on-posiphen-and-huntingtons-disease daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceuticals-plans-to-acquire-salix-pharma 2019-04-17 01:46:17 daily 0.1 https://demo.pharmafocusasia.com/news/aurinia-pharmaceuticals-receives-grant-for-nanomicellar-formulation-patents-in-japan-and-china-for-topical-ophthalmic-administration-of-voclosporin 2015-02-04 08:21:20 daily 0.1 https://demo.pharmafocusasia.com/news/alliance-pharmaceuticals-limited-acquires-macuvision-europe-limited 2019-04-17 01:46:13 daily 0.1 https://demo.pharmafocusasia.com/news/icon-plc-to-acquire-medimedia-pharma-solutions-for-million 2019-04-17 01:46:11 daily 0.1 https://demo.pharmafocusasia.com/news/theravance-biopharma-inc-and-mylan-partner-to-develop-and-commercialize-a-novel-lama-compound-td- daily 0.1 https://demo.pharmafocusasia.com/news/boston-biotechnology-startup-flex-pharma-raises-million-in-ipo 2015-02-02 05:19:09 daily 0.1 https://demo.pharmafocusasia.com/news/divis-laboratories-invest-rs-crore-manufacturing-facility-in-andhra-pradesh-india daily 0.1 https://demo.pharmafocusasia.com/news/ireland-to-use-legislative-powers-to-impose-price-cuts-on-major-pharmaceutical-firms daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharmaranbaxy-deal-us-ftc daily 0.1 https://demo.pharmafocusasia.com/news/sun-pharmaceutical-wins-u-s-approval-to-buy-ranbaxy daily 0.1 https://demo.pharmafocusasia.com/news/serendex-pharmaceuticals-cmc-biologics-enter-exclusive-agreement-factor-viia daily 0.1 https://demo.pharmafocusasia.com/news/venaxis-receives-fda-not-substantially-equivalent-response-on-appy-k-submission daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-to-set-up-insulin-facility-in-telangana daily 0.1 https://demo.pharmafocusasia.com/news/adamis-pharmaceuticals-receives-notice-of-allowance-for-us-and-japanese-patents-for-its-dry-powder-inhaler daily 0.1 https://demo.pharmafocusasia.com/news/amerita-subsidiary-pharmerica-accelerates-growth-acquisition-infusionrx daily 0.1 https://demo.pharmafocusasia.com/news/intellicell-biosciences-licenses-indication-for-diabetes-to-invigorcell daily 0.1 https://demo.pharmafocusasia.com/news/ranbaxy-forfeits-days-exclusivity-for-generic-nexium daily 0.1 https://demo.pharmafocusasia.com/news/-kite-pharma-expands-r-d-in-chimeric-antigen-receptor-car-t-cell-therapy-with-sourasky-medical- daily 0.1 https://demo.pharmafocusasia.com/news/swiss-drug-company-novartis-expects-to-gain-momentum-in-business-depaite-weaker-profit daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-and-regeneron-take-the-lead-in-developing-new-cholesterol-drug daily 0.1 https://demo.pharmafocusasia.com/news/actavis-to-acquire-uk-generics-firm-auden-mckenzie daily 0.1 https://demo.pharmafocusasia.com/news/india-to-have-locally-made-low-cost-rotavirus-vaccine-this-year daily 0.1 https://demo.pharmafocusasia.com/news/fda-approves-a-second-vaccine-to-prevent-serogroup-b-meningococcal-disease daily 0.1 https://demo.pharmafocusasia.com/news/kite-expands-its-immuno-oncology-brain-trust-in-the-car-t-footrace daily 0.1 https://demo.pharmafocusasia.com/news/ema’s-chmp-nods-positive-for-novo-nordisk-s-saxenda-for-treating-obesity 2015-01-23 08:20:29 daily 0.1 https://demo.pharmafocusasia.com/news/dana-farber-expands-research-space-in-boston daily 0.1 https://demo.pharmafocusasia.com/news/supernus-sues-twi-for-infringement-of-oxtellar-xr-r-patents daily 0.1 https://demo.pharmafocusasia.com/news/ppd-expands-athlone-lab 2015-01-22 05:17:09 daily 0.1 https://demo.pharmafocusasia.com/news/the-dipped-to-rs-on-national-stock-exchange daily 0.1 https://demo.pharmafocusasia.com/news/neurovive-pharmaceutical-merger-between-oncore daily 0.1 https://demo.pharmafocusasia.com/news/indian-made-vaccine-approved-to-fight-meningitis-in-africa daily 0.1 https://demo.pharmafocusasia.com/news/vect-horus-announces-the-signing-of-a-scientific-collaboration-agreement-with-sanofi daily 0.1 https://demo.pharmafocusasia.com/news/solasia-pharma-meiji-seika-pharma-announce-license 2015-01-19 02:41:39 daily 0.1 https://demo.pharmafocusasia.com/news/oramed-granted-patent-in-israel-for-oral-administration-of-glp- daily 0.1 https://demo.pharmafocusasia.com/news/insurers-seek-lower-drug-prices-forcing-big-pharma-to-swallow-a-jagged-little-pill daily 0.1 https://demo.pharmafocusasia.com/news/uk-to-sell-interest-in-coldstream-laboratories-for-million daily 0.1 https://demo.pharmafocusasia.com/news/pharma-joins-european-alzheimers-research-initiative 2015-01-16 05:36:53 daily 0.1 https://demo.pharmafocusasia.com/news/roche-meiji-and-fedora-join-forces daily 0.1 https://demo.pharmafocusasia.com/news/piramals-pharma-solution-arm-to-invest-million-in-new-technology daily 0.1 https://demo.pharmafocusasia.com/news/arena-pharmaceuticals-initiates-phase- daily 0.1 https://demo.pharmafocusasia.com/news/debiopharm-group-regains-full-rights-to-alisporivir-program daily 0.1 https://demo.pharmafocusasia.com/news/tekmira-pharmaceuticals-and-oncore-biopharma-announce-merger-agreement- daily 0.1 https://demo.pharmafocusasia.com/news/shire-buy-specialty-drugmaker-nps-pharma daily 0.1 https://demo.pharmafocusasia.com/news/ansun-biopharma-resolves-government-investigation-continues-development-of-late-phase-investigational-anti-viral-therapies 2015-01-09 03:00:36 daily 0.1 https://demo.pharmafocusasia.com/news/viacyte-receives-clearance-from-health-canada-for-diabetes-clinical-trial daily 0.1 https://demo.pharmafocusasia.com/news/keryx-biopharmaceuticals-turns-veeva-commercial-cloud-support daily 0.1 https://demo.pharmafocusasia.com/news/imprimis-pharmaceuticals-looks-to-expand-its-ophthalmology-portfolio-with-lessdrops daily 0.1 https://demo.pharmafocusasia.com/news/inovio-pharmaceuticals-hiv-immunotherapy-shows-characteristics-considered-vital-to-treating-hiv daily 0.1 https://demo.pharmafocusasia.com/news/oculus-innovative-sciences-announces-new-dermatology-division-intraderm-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/news/pfizer-acquires-redvax-gmbh daily 0.1 https://demo.pharmafocusasia.com/news/amgen-ties-up-with-kite-pharma-for-cancer-drug-research daily 0.1 https://demo.pharmafocusasia.com/news/adapt-pharma-invests-in-maynooth-university-tech-spin-off daily 0.1 https://demo.pharmafocusasia.com/news/catamaran-completes-acquisition-of-salveo-specialty-pharmacy daily 0.1 https://demo.pharmafocusasia.com/news/pharma-and-biotech-on-a-roll-as-drug-approvals-hit-year-high 2015-01-04 07:50:36 daily 0.1 https://demo.pharmafocusasia.com/news/ariad-announces-commercialization-agreement-for-iclusig-in-seven-central-and-eastern-european-countries daily 0.1 https://demo.pharmafocusasia.com/news/biomarin-announces-approval-of-vimizim-in-japan-for-treatment-of-morquio-a-syndrome daily 0.1 https://demo.pharmafocusasia.com/news/knight-therapeutics-inc-and-neuraxon-inc-form-partnership-for-the-commercialization-of-neuraxons-innovative-products daily 0.1 https://demo.pharmafocusasia.com/news/swissmedic-approve-basilea-antibiotic-zevtera-treatment-pneumonia daily 0.1 https://demo.pharmafocusasia.com/news/miv-non-clinical-development-treatment-hepatitis-c-infection daily 0.1 https://demo.pharmafocusasia.com/news/roche-pay-next-generation-antibody-developer-dutalys daily 0.1 https://demo.pharmafocusasia.com/news/drreddy-laboratory-acquisition-habitrol-brand 2015-01-04 09:29:14 daily 0.1 https://demo.pharmafocusasia.com/news/lifeline-pharmaceutical-announce-mississippi daily 0.1 https://demo.pharmafocusasia.com/news/shire-consider-bid-nps-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/veridicus-health-acquire-global-pharmaceutical-solution daily 0.1 https://demo.pharmafocusasia.com/news/pozen-yosprala-complete-fda daily 0.1 https://demo.pharmafocusasia.com/news/poxel-announce-antidiabetic-agent daily 0.1 https://demo.pharmafocusasia.com/news/drreddy-launch-valganciclovir-tablet daily 0.1 https://demo.pharmafocusasia.com/news/opko-pfizer-global-agreement-long-acting-human-growth-hormone daily 0.1 https://demo.pharmafocusasia.com/news/biocon-setup-manufacturing-unit-andhra daily 0.1 https://demo.pharmafocusasia.com/news/zafgen-initiation-beloranib-severe-obesity daily 0.1 https://demo.pharmafocusasia.com/news/genmab-collaboration-janssen daily 0.1 https://demo.pharmafocusasia.com/news/abbott-acquisition-russian-veropharm daily 0.1 https://demo.pharmafocusasia.com/news/argen-x-therapeutic-antibody-alliance-shire-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/vical-enrollment-therapeutic daily 0.1 https://demo.pharmafocusasia.com/news/multicell-technologies-novel-antibody-drug-conjugate-patent-application daily 0.1 https://demo.pharmafocusasia.com/news/mylan-launch-generic-version-celebrex-capsule daily 0.1 https://demo.pharmafocusasia.com/news/avid-bioservice-expansion-cgmp-manufacturing daily 0.1 https://demo.pharmafocusasia.com/news/cci-clear-sun-pharma-ranbaxy daily 0.1 https://demo.pharmafocusasia.com/news/zydus-cadila-launch-biosimilar-abbvie-humira daily 0.1 https://demo.pharmafocusasia.com/news/pieris-achieve-glptox-milestone-collaboration-develop-anticalin-therapeutics daily 0.1 https://demo.pharmafocusasia.com/news/takeda-present-maintenance-single-agent-investigational-diagnosed-multiple-myeloma daily 0.1 https://demo.pharmafocusasia.com/news/merck-acquire-cubist-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/aurobindo-pharma-complete-natrol-acquisition daily 0.1 https://demo.pharmafocusasia.com/news/takeda-formalization-oncology-enhance-discovery-development-globalcommercialization-breakthrough-cancer-medicine daily 0.1 https://demo.pharmafocusasia.com/news/kkr-invest-arbor-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/cellectar-bioscience-orphan-designation-multiple-myeloma daily 0.1 https://demo.pharmafocusasia.com/news/aliz-pharma-acquire-right-peptide-tackle-bone-disease daily 0.1 https://demo.pharmafocusasia.com/news/india-telangana-plan-mega-pharma-city-spread-hyderabad daily 0.1 https://demo.pharmafocusasia.com/news/meda-pharmaceutical-cipla-sue-apotex-enforce-dymista-patent daily 0.1 https://demo.pharmafocusasia.com/news/actavis-launch-generic-version-intuniv daily 0.1 https://demo.pharmafocusasia.com/news/alimera-science-iluvien-receive-marketing-authorization-netherland-treatment-chronic-diabetic-macular-edema daily 0.1 https://demo.pharmafocusasia.com/news/pozen-sanofi-terminate-us-partnership daily 0.1 https://demo.pharmafocusasia.com/news/imbruvica-european-medicines-agency-waldenstrom-macroglobulinemia daily 0.1 https://demo.pharmafocusasia.com/news/ab-science-ultra-selective-kinase-inhibitor-preclinical-development daily 0.1 https://demo.pharmafocusasia.com/news/italy-suspend-batch-novartis-flu-vaccine daily 0.1 https://demo.pharmafocusasia.com/news/cipla-strides-arcolab-collaboration-malaria-venture daily 0.1 https://demo.pharmafocusasia.com/news/modern-bioscience-collaboration-johnson-johnson-innovation-janssen-novel-oral-therapy-rheumatoid-arthritis daily 0.1 https://demo.pharmafocusasia.com/news/avanir-pharmaceutical-receive-letter-fda daily 0.1 https://demo.pharmafocusasia.com/news/breckenridge-pharmaceutical-agreement-pharmaceutics-international daily 0.1 https://demo.pharmafocusasia.com/news/trimel-pharmaceutical-announce-additional-patent-covering-natesto daily 0.1 https://demo.pharmafocusasia.com/news/isis-pharmaceutical-initiate-isis-smnrx-children-spinal-muscular-atrophy daily 0.1 https://demo.pharmafocusasia.com/news/soliris-granted-orphan-drug-designation-japan-treatment-patient-neuromyelitis-optica daily 0.1 https://demo.pharmafocusasia.com/news/drreddy-launch-docetaxelinjection-usp daily 0.1 https://demo.pharmafocusasia.com/news/duaklir-genuair-european-union-chronic-obstructive-pulmonary-disease daily 0.1 https://demo.pharmafocusasia.com/news/supernus-pharmaceutical-sueszydus-infringement-trokendi-xr daily 0.1 https://demo.pharmafocusasia.com/news/yabao-pharmaceutical-mrctechnology-announce-exclusive-china-partnership daily 0.1 https://demo.pharmafocusasia.com/news/coqui-radio-pharmaceutical-ink-deal-invap daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceutical-announce-securities-repurchase-program daily 0.1 https://demo.pharmafocusasia.com/news/royaltypharma-buy-royalties-vertexpharma-drug daily 0.1 https://demo.pharmafocusasia.com/news/idri-announce-develop-thermostable-tb-vaccine daily 0.1 https://demo.pharmafocusasia.com/news/ranbaxy-sue-fda-revoking-nexium-valcyte-copies daily 0.1 https://demo.pharmafocusasia.com/news/bergenbio-receive-orphan-drug-designation-fda-treatment-acute-myeloid-leukaemia daily 0.1 https://demo.pharmafocusasia.com/news/organovo-announce-commercial-release-exvive-human-liver-tissue daily 0.1 https://demo.pharmafocusasia.com/news/teva-pharmaceutical-launch-treanda-injection daily 0.1 https://demo.pharmafocusasia.com/news/actavis-acquire-allergan-global-growth-pharmaceutical-company- daily 0.1 https://demo.pharmafocusasia.com/news/cardiomepharma-enter-commercialization-agreement-aspen-brinavess daily 0.1 https://demo.pharmafocusasia.com/news/catalent-acquire-micron-technologies daily 0.1 https://demo.pharmafocusasia.com/news/valeant-pharmaceutical-renovation-newjersey daily 0.1 https://demo.pharmafocusasia.com/news/amag-acquisition-lumarahealth-maternalhealth-business daily 0.1 https://demo.pharmafocusasia.com/news/fda-warn-cadila-pharma-drug-production daily 0.1 https://demo.pharmafocusasia.com/news/amgen-astrazeneca-brodalumab-patient-moderate-to-severe-plaque-psoriasis daily 0.1 https://demo.pharmafocusasia.com/news/scinopharm-nanjingking-chinesemarket daily 0.1 https://demo.pharmafocusasia.com/news/acelrxpharmaceutical-receive-iso-quality-management-system daily 0.1 https://demo.pharmafocusasia.com/news/advent-avista-kremers-urban-pharmaceutical-ucb daily 0.1 https://demo.pharmafocusasia.com/news/janssen-collaborate-multidrug-resistant-tuberculosistreatment-sirturo daily 0.1 https://demo.pharmafocusasia.com/news/meipharma-report-pracinostat-acute-myeloid-leukemia daily 0.1 https://demo.pharmafocusasia.com/news/proteostasis-astellas-deal daily 0.1 https://demo.pharmafocusasia.com/news/glenmark-generic-anda-omeprazoledr-capsule daily 0.1 https://demo.pharmafocusasia.com/news/imprimispharmaceutical-agreement-dropless-proprietary-formulation-ophthalmologist daily 0.1 https://demo.pharmafocusasia.com/news/ex-scientiapartner-sunovionpharmaceutical-research-psychiatricdisorder daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myer-squibb-sign-exclusive-agreement-acquire-denmark-galectobiotech daily 0.1 https://demo.pharmafocusasia.com/news/bayer-complete-acquisition-dihonpharmaceuticalgroup-china daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myer-squibb-expand-manufacturing-agreement-lonza 2015-01-02 05:06:40 daily 0.1 https://demo.pharmafocusasia.com/news/unitao-pharmaceutical-plan-establish-petersburg-virginia-pharmaceutical-manufacturing-hub daily 0.1 https://demo.pharmafocusasia.com/news/warburg-pincus-invest-lauruslab-acquire-stake daily 0.1 https://demo.pharmafocusasia.com/news/alembic-pharmaceutical-acquire-stake-adwiyamami daily 0.1 https://demo.pharmafocusasia.com/news/novartis-selling-holly-spring-vaccine-plant daily 0.1 https://demo.pharmafocusasia.com/news/cti-biopharma-buy-worldwide-right-selective-oral-anti-cancer-therapy-tosedostat daily 0.1 https://demo.pharmafocusasia.com/news/ranbaxy-might-bear-another-loss daily 0.1 https://demo.pharmafocusasia.com/news/million-incentive-nigerian-pharm-industry daily 0.1 https://demo.pharmafocusasia.com/news/glaxosmithkline-step-up-ebola-vaccine-development daily 0.1 https://demo.pharmafocusasia.com/news/boston-scientific-newcover-edge-surgical-lead-precision-spectra- daily 0.1 https://demo.pharmafocusasia.com/news/arborpharmaceutical-announce-fda-approval-sotylize daily 0.1 https://demo.pharmafocusasia.com/news/actavis-sign-option-acquire-rhythm-subsidiary daily 0.1 https://demo.pharmafocusasia.com/news/actavis-competing-pharma-giants daily 0.1 https://demo.pharmafocusasia.com/news/gujarat-get-bigger-chunk daily 0.1 https://demo.pharmafocusasia.com/news/taiho-oncology-receive-fda-fasttrack-designation- daily 0.1 https://demo.pharmafocusasia.com/news/natco-pharma-us-partner-get-fda daily 0.1 https://demo.pharmafocusasia.com/news/sanofi-regeneron-pharmaceutical-announce-phaseiii daily 0.1 https://demo.pharmafocusasia.com/news/actavis-confirm-generic-quillivant- daily 0.1 https://demo.pharmafocusasia.com/news/pharmaceutical-cannabidiol-production daily 0.1 https://demo.pharmafocusasia.com/news/aceirx-pharmaceutical-provide-update-patentportfolio daily 0.1 https://demo.pharmafocusasia.com/news/abotts-new-facility daily 0.1 https://demo.pharmafocusasia.com/news/abbvie-board-backout daily 0.1 https://demo.pharmafocusasia.com/news/bristol-myerssquibb-pharmacyclicspacts-janssen daily 0.1 https://demo.pharmafocusasia.com/news/akynzeo-prevention-chemotherapy daily 0.1 https://demo.pharmafocusasia.com/news/uk-based-synergyhealth-steriscorporation daily 0.1 https://demo.pharmafocusasia.com/news/trial-investigational-rotavirus daily 0.1 https://demo.pharmafocusasia.com/news/endo-acquire-auxilium daily 0.1 https://demo.pharmafocusasia.com/news/us-biotech-firm-biogen-idec daily 0.1 https://demo.pharmafocusasia.com/news/fda-call-down-sun-pharma daily 0.1 https://demo.pharmafocusasia.com/news/impax-acquire-tower-holdings daily 0.1 https://demo.pharmafocusasia.com/news/mexico-lab-grin daily 0.1 https://demo.pharmafocusasia.com/news/india-pharma-majors-sun daily 0.1 https://demo.pharmafocusasia.com/news/specialty-pharmaceutical daily 0.1 https://demo.pharmafocusasia.com/news/lupin-focus 2014-12-23 04:45:29 daily 0.1